id	sid	tid	token	lemma	pos
50458	1	1	THE	the	DT
50458	1	2	TOXINS	toxin	NNS
50458	1	3	AND	and	CC
50458	1	4	VENOMS	venoms	NN
50458	1	5	AND	and	CC
50458	1	6	THEIR	their	NN
50458	1	7	ANTIBODIES	antibody	NNS
50458	1	8	BY	by	IN
50458	1	9	EM	em	NN
50458	1	10	.	.	.
50458	2	1	POZZI	POZZI	NNP
50458	2	2	-	-	HYPH
50458	2	3	ESCOT	ESCOT	NNP
50458	2	4	AUTHORIZED	AUTHORIZED	NNP
50458	2	5	TRANSLATION	translation	NN
50458	2	6	BY	by	IN
50458	2	7	ALFRED	ALFRED	NNP
50458	2	8	I.	I.	NNP
50458	2	9	COHN	COHN	NNP
50458	2	10	,	,	,
50458	2	11	PHAR	PHAR	NNP
50458	2	12	.	.	.
50458	3	1	D.	D.	NNP
50458	3	2	_	_	NNP
50458	3	3	FIRST	FIRST	NNP
50458	3	4	EDITION	EDITION	NNP
50458	3	5	_	_	NNP
50458	3	6	FIRST	FIRST	NNP
50458	3	7	THOUSAND	thousand	CD
50458	3	8	NEW	NEW	NNP
50458	3	9	YORK	YORK	NNP
50458	3	10	JOHN	JOHN	NNP
50458	3	11	WILEY	WILEY	NNP
50458	3	12	&	&	CC
50458	3	13	SONS	SONS	NNP
50458	3	14	LONDON	LONDON	NNP
50458	3	15	:	:	:
50458	3	16	CHAPMAN	CHAPMAN	NNP
50458	3	17	&	&	CC
50458	3	18	HALL	HALL	NNP
50458	3	19	,	,	,
50458	3	20	LIMITED	LIMITED	NNP
50458	3	21	1906	1906	CD
50458	3	22	Copyright	copyright	NN
50458	3	23	,	,	,
50458	3	24	1906	1906	CD
50458	3	25	BY	by	IN
50458	3	26	ALFRED	ALFRED	NNP
50458	3	27	I.	I.	NNP
50458	3	28	COHN	COHN	NNP
50458	3	29	ROBERT	ROBERT	NNP
50458	3	30	DRUMMOND	DRUMMOND	NNS
50458	3	31	,	,	,
50458	3	32	PRINTER	PRINTER	NNP
50458	3	33	,	,	,
50458	3	34	NEW	NEW	NNP
50458	3	35	YORK	YORK	NNP
50458	3	36	INTRODUCTION	introduction	NN
50458	3	37	.	.	.
50458	4	1	Our	-PRON-	PRP$
50458	4	2	knowledge	knowledge	NN
50458	4	3	of	of	IN
50458	4	4	the	the	DT
50458	4	5	toxins	toxin	NNS
50458	4	6	is	be	VBZ
50458	4	7	of	of	IN
50458	4	8	quite	quite	RB
50458	4	9	recent	recent	JJ
50458	4	10	date	date	NN
50458	4	11	.	.	.
50458	5	1	It	-PRON-	PRP
50458	5	2	is	be	VBZ
50458	5	3	hardly	hardly	RB
50458	5	4	twenty	twenty	CD
50458	5	5	years	year	NNS
50458	5	6	since	since	IN
50458	5	7	we	-PRON-	PRP
50458	5	8	began	begin	VBD
50458	5	9	to	to	TO
50458	5	10	acquire	acquire	VB
50458	5	11	a	a	DT
50458	5	12	knowledge	knowledge	NN
50458	5	13	of	of	IN
50458	5	14	the	the	DT
50458	5	15	facts	fact	NNS
50458	5	16	that	that	WDT
50458	5	17	are	be	VBP
50458	5	18	detailed	detail	VBN
50458	5	19	in	in	IN
50458	5	20	this	this	DT
50458	5	21	volume	volume	NN
50458	5	22	,	,	,
50458	5	23	and	and	CC
50458	5	24	to	to	TO
50458	5	25	which	which	WDT
50458	5	26	modern	modern	JJ
50458	5	27	medicine	medicine	NN
50458	5	28	owes	owe	VBZ
50458	5	29	its	-PRON-	PRP$
50458	5	30	most	most	RBS
50458	5	31	recent	recent	JJ
50458	5	32	and	and	CC
50458	5	33	marvelous	marvelous	JJ
50458	5	34	progress	progress	NN
50458	5	35	,	,	,
50458	5	36	particularly	particularly	RB
50458	5	37	in	in	IN
50458	5	38	serotherapy	serotherapy	NN
50458	5	39	.	.	.
50458	6	1	In	in	IN
50458	6	2	this	this	DT
50458	6	3	volume	volume	NN
50458	6	4	we	-PRON-	PRP
50458	6	5	have	have	VBP
50458	6	6	studied	study	VBN
50458	6	7	,	,	,
50458	6	8	besides	besides	IN
50458	6	9	the	the	DT
50458	6	10	true	true	JJ
50458	6	11	toxins	toxin	NNS
50458	6	12	--	--	:
50458	6	13	substances	substance	NNS
50458	6	14	of	of	IN
50458	6	15	cellular	cellular	JJ
50458	6	16	origin	origin	NN
50458	6	17	and	and	CC
50458	6	18	of	of	IN
50458	6	19	albuminoid	albuminoid	NN
50458	6	20	nature	nature	NN
50458	6	21	and	and	CC
50458	6	22	unknown	unknown	JJ
50458	6	23	composition	composition	NN
50458	6	24	--	--	:
50458	6	25	other	other	JJ
50458	6	26	toxic	toxic	JJ
50458	6	27	substances	substance	NNS
50458	6	28	,	,	,
50458	6	29	the	the	DT
50458	6	30	nitrogenized	nitrogenized	JJ
50458	6	31	alkaloidal	alkaloidal	NN
50458	6	32	bases	basis	NNS
50458	6	33	introduced	introduce	VBN
50458	6	34	into	into	IN
50458	6	35	science	science	NN
50458	6	36	through	through	IN
50458	6	37	the	the	DT
50458	6	38	researches	research	NNS
50458	6	39	of	of	IN
50458	6	40	Selmi	Selmi	NNP
50458	6	41	,	,	,
50458	6	42	Armand	Armand	NNP
50458	6	43	Gautier	Gautier	NNP
50458	6	44	,	,	,
50458	6	45	and	and	CC
50458	6	46	von	von	NNP
50458	6	47	Behring	Behring	NNP
50458	6	48	,	,	,
50458	6	49	and	and	CC
50458	6	50	which	which	WDT
50458	6	51	are	be	VBP
50458	6	52	highly	highly	RB
50458	6	53	hydrogenized	hydrogenize	VBN
50458	6	54	nitrogenous	nitrogenous	JJ
50458	6	55	crystallizable	crystallizable	JJ
50458	6	56	principles	principle	NNS
50458	6	57	of	of	IN
50458	6	58	definite	definite	JJ
50458	6	59	chemical	chemical	JJ
50458	6	60	composition	composition	NN
50458	6	61	--	--	:
50458	6	62	the	the	DT
50458	6	63	products	product	NNS
50458	6	64	of	of	IN
50458	6	65	the	the	DT
50458	6	66	more	more	RBR
50458	6	67	or	or	CC
50458	6	68	less	less	RBR
50458	6	69	advanced	advanced	JJ
50458	6	70	breaking	break	VBG
50458	6	71	down	down	RP
50458	6	72	of	of	IN
50458	6	73	albuminoids	albuminoid	NNS
50458	6	74	.	.	.
50458	7	1	Although	although	IN
50458	7	2	these	these	DT
50458	7	3	principles	principle	NNS
50458	7	4	differ	differ	VBP
50458	7	5	widely	widely	RB
50458	7	6	,	,	,
50458	7	7	by	by	IN
50458	7	8	reason	reason	NN
50458	7	9	of	of	IN
50458	7	10	their	-PRON-	PRP$
50458	7	11	physiological	physiological	JJ
50458	7	12	properties	property	NNS
50458	7	13	as	as	IN
50458	7	14	a	a	DT
50458	7	15	whole	whole	NN
50458	7	16	,	,	,
50458	7	17	from	from	IN
50458	7	18	the	the	DT
50458	7	19	toxic	toxic	JJ
50458	7	20	albuminoids	albuminoid	NNS
50458	7	21	,	,	,
50458	7	22	or	or	CC
50458	7	23	true	true	JJ
50458	7	24	toxins	toxin	NNS
50458	7	25	,	,	,
50458	7	26	it	-PRON-	PRP
50458	7	27	appears	appear	VBZ
50458	7	28	proper	proper	JJ
50458	7	29	to	to	TO
50458	7	30	consider	consider	VB
50458	7	31	them	-PRON-	PRP
50458	7	32	as	as	IN
50458	7	33	products	product	NNS
50458	7	34	of	of	IN
50458	7	35	the	the	DT
50458	7	36	advanced	advanced	JJ
50458	7	37	decomposition	decomposition	NN
50458	7	38	of	of	IN
50458	7	39	these	these	DT
50458	7	40	toxins	toxin	NNS
50458	7	41	--	--	:
50458	7	42	and	and	CC
50458	7	43	in	in	IN
50458	7	44	this	this	DT
50458	7	45	respect	respect	NN
50458	7	46	their	-PRON-	PRP$
50458	7	47	study	study	NN
50458	7	48	becomes	become	VBZ
50458	7	49	imperative	imperative	JJ
50458	7	50	,	,	,
50458	7	51	the	the	DT
50458	7	52	more	more	RBR
50458	7	53	so	so	RB
50458	7	54	as	as	IN
50458	7	55	they	-PRON-	PRP
50458	7	56	are	be	VBP
50458	7	57	very	very	RB
50458	7	58	frequently	frequently	RB
50458	7	59	encountered	encounter	VBN
50458	7	60	together	together	RB
50458	7	61	with	with	IN
50458	7	62	the	the	DT
50458	7	63	toxins	toxin	NNS
50458	7	64	,	,	,
50458	7	65	particularly	particularly	RB
50458	7	66	in	in	IN
50458	7	67	serpent	serpent	NN
50458	7	68	-	-	HYPH
50458	7	69	venoms	venom	NNS
50458	7	70	,	,	,
50458	7	71	where	where	WRB
50458	7	72	their	-PRON-	PRP$
50458	7	73	action	action	NN
50458	7	74	is	be	VBZ
50458	7	75	exerted	exert	VBN
50458	7	76	in	in	IN
50458	7	77	addition	addition	NN
50458	7	78	to	to	IN
50458	7	79	that	that	DT
50458	7	80	of	of	IN
50458	7	81	the	the	DT
50458	7	82	true	true	JJ
50458	7	83	toxins	toxin	NNS
50458	7	84	.	.	.
50458	8	1	In	in	IN
50458	8	2	the	the	DT
50458	8	3	first	first	JJ
50458	8	4	volume	volume	NN
50458	8	5	of	of	IN
50458	8	6	this	this	DT
50458	8	7	collection	collection	NN
50458	8	8	we	-PRON-	PRP
50458	8	9	dwelt	dwell	VBD
50458	8	10	on	on	IN
50458	8	11	the	the	DT
50458	8	12	essentially	essentially	RB
50458	8	13	reducing	reduce	VBG
50458	8	14	nature	nature	NN
50458	8	15	of	of	IN
50458	8	16	the	the	DT
50458	8	17	cellular	cellular	JJ
50458	8	18	functionation	functionation	NN
50458	8	19	.	.	.
50458	9	1	To	to	IN
50458	9	2	this	this	DT
50458	9	3	functionation	functionation	NN
50458	9	4	--	--	:
50458	9	5	causing	cause	VBG
50458	9	6	the	the	DT
50458	9	7	splitting	splitting	NN
50458	9	8	up	up	RP
50458	9	9	or	or	CC
50458	9	10	decomposition	decomposition	NN
50458	9	11	by	by	IN
50458	9	12	hydrolysis	hydrolysis	NN
50458	9	13	of	of	IN
50458	9	14	nitrogenized	nitrogenized	JJ
50458	9	15	albuminoid	albuminoid	NN
50458	9	16	foods	food	NNS
50458	9	17	--	--	:
50458	9	18	is	be	VBZ
50458	9	19	due	due	JJ
50458	9	20	the	the	DT
50458	9	21	formation	formation	NN
50458	9	22	of	of	IN
50458	9	23	these	these	DT
50458	9	24	toxic	toxic	JJ
50458	9	25	basic	basic	JJ
50458	9	26	products	product	NNS
50458	9	27	within	within	IN
50458	9	28	the	the	DT
50458	9	29	organism	organism	NN
50458	9	30	,	,	,
50458	9	31	whether	whether	IN
50458	9	32	normally	normally	RB
50458	9	33	,	,	,
50458	9	34	or	or	CC
50458	9	35	because	because	IN
50458	9	36	of	of	IN
50458	9	37	certain	certain	JJ
50458	9	38	pathological	pathological	JJ
50458	9	39	conditions	condition	NNS
50458	9	40	.	.	.
50458	10	1	This	this	DT
50458	10	2	alone	alone	RB
50458	10	3	suffices	suffice	VBZ
50458	10	4	to	to	TO
50458	10	5	show	show	VB
50458	10	6	that	that	IN
50458	10	7	,	,	,
50458	10	8	during	during	IN
50458	10	9	physiological	physiological	JJ
50458	10	10	life	life	NN
50458	10	11	,	,	,
50458	10	12	oxygen	oxygen	NN
50458	10	13	plays	play	VBZ
50458	10	14	an	an	DT
50458	10	15	essentially	essentially	RB
50458	10	16	antitoxic	antitoxic	VBN
50458	10	17	rôle	rôle	VBZ
50458	10	18	within	within	IN
50458	10	19	the	the	DT
50458	10	20	organism	organism	NN
50458	10	21	.	.	.
50458	11	1	It	-PRON-	PRP
50458	11	2	is	be	VBZ
50458	11	3	hoped	hope	VBN
50458	11	4	that	that	IN
50458	11	5	this	this	DT
50458	11	6	succinct	succinct	JJ
50458	11	7	résumé	résumé	NN
50458	11	8	,	,	,
50458	11	9	which	which	WDT
50458	11	10	it	-PRON-	PRP
50458	11	11	has	have	VBZ
50458	11	12	been	be	VBN
50458	11	13	sought	seek	VBN
50458	11	14	to	to	TO
50458	11	15	make	make	VB
50458	11	16	as	as	RB
50458	11	17	clear	clear	JJ
50458	11	18	as	as	IN
50458	11	19	possible	possible	JJ
50458	11	20	,	,	,
50458	11	21	will	will	MD
50458	11	22	be	be	VB
50458	11	23	of	of	IN
50458	11	24	service	service	NN
50458	11	25	to	to	IN
50458	11	26	those	those	DT
50458	11	27	who	who	WP
50458	11	28	,	,	,
50458	11	29	while	while	IN
50458	11	30	not	not	RB
50458	11	31	scientists	scientist	NNS
50458	11	32	actively	actively	RB
50458	11	33	engaged	engage	VBN
50458	11	34	in	in	IN
50458	11	35	scientific	scientific	JJ
50458	11	36	progress	progress	NN
50458	11	37	,	,	,
50458	11	38	desire	desire	NN
50458	11	39	to	to	TO
50458	11	40	be	be	VB
50458	11	41	abreast	abreast	JJ
50458	11	42	of	of	IN
50458	11	43	the	the	DT
50458	11	44	knowledge	knowledge	NN
50458	11	45	of	of	IN
50458	11	46	modern	modern	JJ
50458	11	47	evolution	evolution	NN
50458	11	48	,	,	,
50458	11	49	but	but	CC
50458	11	50	yet	yet	RB
50458	11	51	are	be	VBP
50458	11	52	not	not	RB
50458	11	53	in	in	IN
50458	11	54	a	a	DT
50458	11	55	position	position	NN
50458	11	56	to	to	TO
50458	11	57	consult	consult	VB
50458	11	58	original	original	JJ
50458	11	59	papers	paper	NNS
50458	11	60	or	or	CC
50458	11	61	large	large	JJ
50458	11	62	treatises	treatise	NNS
50458	11	63	.	.	.
50458	12	1	CONTENTS	content	NNS
50458	12	2	.	.	.
50458	13	1	PAGE	page	NN
50458	13	2	INTRODUCTION	introduction	NN
50458	13	3	iii	iii	CD
50458	13	4	PART	PART	VBN
50458	13	5	I.	i.	NN
50458	14	1	_	_	NNP
50458	14	2	GENERALITIES	GENERALITIES	NNP
50458	14	3	REGARDING	regard	VBG
50458	14	4	TOXINS	toxin	NNS
50458	14	5	AND	and	CC
50458	14	6	ANTITOXINS	antitoxin	NNS
50458	14	7	.	.	.
50458	14	8	_	_	NNP
50458	14	9	CHAPTER	CHAPTER	NNP
50458	14	10	I.	I.	NNP
50458	14	11	ALKALOIDAL	ALKALOIDAL	NNP
50458	14	12	TOXINS	toxin	NNS
50458	14	13	,	,	,
50458	14	14	PTOMAINES	PTOMAINES	NNP
50458	14	15	,	,	,
50458	14	16	AND	and	CC
50458	14	17	LEUCOMAINES	LEUCOMAINES	NNP
50458	14	18	.	.	.
50458	15	1	Alkaloidal	alkaloidal	JJ
50458	15	2	products	product	NNS
50458	15	3	of	of	IN
50458	15	4	cellular	cellular	JJ
50458	15	5	life	life	NN
50458	15	6	1	1	CD
50458	15	7	Ptomaines	ptomaine	NNS
50458	15	8	4	4	CD
50458	15	9	Physiological	physiological	JJ
50458	15	10	action	action	NN
50458	15	11	5	5	CD
50458	15	12	Extraction	extraction	NN
50458	15	13	5	5	CD
50458	15	14	Classification	Classification	NNP
50458	15	15	,	,	,
50458	15	16	etc	etc	FW
50458	15	17	.	.	.
50458	16	1	7	7	CD
50458	16	2	Leucomaines	leucomaine	NNS
50458	16	3	10	10	CD
50458	16	4	Xanthic	xanthic	NN
50458	16	5	leucomaines	leucomaine	NNS
50458	16	6	12	12	CD
50458	16	7	Creatinic	creatinic	JJ
50458	16	8	leucomaines	leucomaine	NNS
50458	16	9	13	13	CD
50458	16	10	Neurinic	Neurinic	NNP
50458	16	11	leucomaines	leucomaine	NNS
50458	16	12	13	13	CD
50458	16	13	Indeterminate	indeterminate	JJ
50458	16	14	leucomaines	leucomaine	NNS
50458	16	15	14	14	CD
50458	16	16	CHAPTER	chapter	NN
50458	16	17	II	II	NNP
50458	16	18	.	.	.
50458	17	1	TOXINS	toxin	NNS
50458	17	2	AND	and	CC
50458	17	3	ANTITOXINS	antitoxin	NNS
50458	17	4	.	.	.
50458	18	1	Toxins	toxin	NNS
50458	18	2	15	15	CD
50458	18	3	Action	action	NN
50458	18	4	of	of	IN
50458	18	5	pathogenic	pathogenic	JJ
50458	18	6	bacteria	bacteria	NNS
50458	18	7	16	16	CD
50458	18	8	Action	action	NN
50458	18	9	of	of	IN
50458	18	10	toxins	toxin	NNS
50458	18	11	17	17	CD
50458	18	12	Nature	nature	NN
50458	18	13	of	of	IN
50458	18	14	toxins	toxin	NNS
50458	18	15	18	18	CD
50458	18	16	Origin	origin	NN
50458	18	17	of	of	IN
50458	18	18	toxins	toxin	NNS
50458	18	19	20	20	CD
50458	18	20	Autointoxications	Autointoxications	NNPS
50458	18	21	21	21	CD
50458	18	22	General	general	JJ
50458	18	23	mode	mode	NN
50458	18	24	of	of	IN
50458	18	25	action	action	NN
50458	18	26	23	23	CD
50458	18	27	Constitution	Constitution	NNP
50458	18	28	of	of	IN
50458	18	29	toxins	toxin	NNS
50458	18	30	;	;	:
50458	18	31	Ehrlich	Ehrlich	NNP
50458	18	32	's	's	POS
50458	18	33	theory	theory	NN
50458	18	34	24	24	CD
50458	18	35	Means	mean	NNS
50458	18	36	of	of	IN
50458	18	37	defense	defense	NN
50458	18	38	possessed	possess	VBN
50458	18	39	by	by	IN
50458	18	40	the	the	DT
50458	18	41	organism	organism	NN
50458	18	42	against	against	IN
50458	18	43	the	the	DT
50458	18	44	action	action	NN
50458	18	45	of	of	IN
50458	18	46	toxins	toxin	NNS
50458	18	47	28	28	CD
50458	18	48	Pasteur	Pasteur	NNP
50458	18	49	's	's	POS
50458	18	50	vaccination	vaccination	NN
50458	18	51	method	method	NN
50458	18	52	30	30	CD
50458	18	53	Virus	Virus	NNP
50458	18	54	action	action	NN
50458	18	55	30	30	CD
50458	18	56	Phagocytosis	Phagocytosis	NNP
50458	18	57	32	32	CD
50458	18	58	Antitoxins	Antitoxins	NNP
50458	18	59	33	33	CD
50458	18	60	Mode	mode	NN
50458	18	61	of	of	IN
50458	18	62	action	action	NN
50458	18	63	35	35	CD
50458	18	64	Formation	formation	NN
50458	18	65	;	;	:
50458	18	66	Ehrlich	Ehrlich	NNP
50458	18	67	's	's	POS
50458	18	68	theory	theory	NN
50458	18	69	38	38	CD
50458	18	70	Serotherapy	serotherapy	NN
50458	18	71	41	41	CD
50458	18	72	PART	PART	VBN
50458	18	73	II	ii	CD
50458	18	74	.	.	.
50458	19	1	_	_	NNP
50458	19	2	THE	the	DT
50458	19	3	TOXINS	TOXINS	NNP
50458	19	4	PROPER	proper	NN
50458	19	5	.	.	.
50458	19	6	_	_	NNP
50458	19	7	CHAPTER	CHAPTER	NNP
50458	19	8	III	III	NNP
50458	19	9	.	.	.
50458	20	1	I.	I.	NNP
50458	21	1	VEGETABLE	VEGETABLE	NNP
50458	21	2	AND	and	CC
50458	21	3	ANIMAL	ANIMAL	NNP
50458	21	4	TOXINS	toxin	NNS
50458	21	5	.	.	.
50458	22	1	42	42	CD
50458	22	2	Abrin	Abrin	NNP
50458	22	3	42	42	CD
50458	22	4	Ricin	Ricin	NNPS
50458	22	5	44	44	CD
50458	22	6	Robin	Robin	NNP
50458	22	7	45	45	CD
50458	22	8	Toxicity	Toxicity	NNP
50458	22	9	of	of	IN
50458	22	10	the	the	DT
50458	22	11	vegetable	vegetable	NN
50458	22	12	diastases	diastasis	NNS
50458	22	13	45	45	CD
50458	22	14	II	ii	CD
50458	22	15	.	.	.
50458	23	1	TOXINS	toxin	NNS
50458	23	2	FROM	from	IN
50458	23	3	MUSHROOMS	MUSHROOMS	NNP
50458	23	4	46	46	CD
50458	23	5	Phalline	Phalline	NNP
50458	23	6	48	48	CD
50458	23	7	Symptomatology	Symptomatology	NNP
50458	23	8	49	49	CD
50458	23	9	Antidiastases	Antidiastases	NNPS
50458	23	10	51	51	CD
50458	23	11	III	iii	CD
50458	23	12	.	.	.
50458	24	1	ANIMAL	ANIMAL	NNP
50458	24	2	TOXINS	toxin	NNS
50458	24	3	53	53	CD
50458	24	4	Peptotoxin	Peptotoxin	NNP
50458	24	5	53	53	CD
50458	24	6	Alimentary	Alimentary	NNP
50458	24	7	Intoxications	Intoxications	NNP
50458	24	8	55	55	CD
50458	24	9	Urinary	Urinary	NNP
50458	24	10	toxins	toxin	VBZ
50458	24	11	57	57	CD
50458	24	12	Variation	variation	NN
50458	24	13	of	of	IN
50458	24	14	urinary	urinary	JJ
50458	24	15	toxicity	toxicity	NN
50458	24	16	59	59	CD
50458	24	17	Autointoxications	autointoxication	NNS
50458	24	18	(	(	-LRB-
50458	24	19	animal	animal	NN
50458	24	20	)	)	-RRB-
50458	24	21	60	60	CD
50458	24	22	Glandular	glandular	JJ
50458	24	23	secretions	secretion	NNS
50458	24	24	62	62	CD
50458	24	25	Suprarenal	suprarenal	JJ
50458	24	26	capsules	capsule	NNS
50458	24	27	63	63	CD
50458	24	28	CHAPTER	CHAPTER	NNP
50458	24	29	IV	IV	NNP
50458	24	30	.	.	.
50458	25	1	THE	the	DT
50458	25	2	MICROBIAL	MICROBIAL	NNP
50458	25	3	TOXINS	toxin	NNS
50458	25	4	.	.	.
50458	26	1	Pyogenic	pyogenic	JJ
50458	26	2	and	and	CC
50458	26	3	pyretogenic	pyretogenic	NN
50458	26	4	properties	property	NNS
50458	26	5	66	66	CD
50458	26	6	Anthrax	anthrax	NN
50458	26	7	toxin	toxin	NN
50458	26	8	67	67	CD
50458	26	9	Tubercular	Tubercular	NNP
50458	26	10	toxin	toxin	NN
50458	26	11	69	69	CD
50458	26	12	Diphtheria	Diphtheria	NNP
50458	26	13	toxin	toxin	NN
50458	26	14	71	71	CD
50458	26	15	Tetanus	Tetanus	NNP
50458	26	16	toxin	toxin	NN
50458	26	17	76	76	CD
50458	26	18	Mallein	Mallein	NNP
50458	26	19	79	79	CD
50458	26	20	Typhoid	Typhoid	NNP
50458	26	21	toxin	toxin	NN
50458	26	22	80	80	CD
50458	26	23	Cholera	Cholera	NNP
50458	26	24	toxin	toxin	NN
50458	26	25	82	82	CD
50458	26	26	CHAPTER	chapter	NN
50458	26	27	V.	V.	NNP
50458	26	28	THE	the	DT
50458	26	29	VENOMS	VENOMS	NNP
50458	26	30	.	.	.
50458	27	1	General	general	JJ
50458	27	2	nature	nature	NN
50458	27	3	of	of	IN
50458	27	4	venoms	venom	NNS
50458	27	5	85	85	CD
50458	27	6	Venomous	venomous	JJ
50458	27	7	serpents	serpent	NNS
50458	27	8	87	87	CD
50458	27	9	Nature	nature	NN
50458	27	10	of	of	IN
50458	27	11	serpent	serpent	NN
50458	27	12	-	-	HYPH
50458	27	13	venoms	venom	NNS
50458	27	14	88	88	CD
50458	27	15	Natural	natural	JJ
50458	27	16	immunity	immunity	NN
50458	27	17	towards	towards	IN
50458	27	18	serpent	serpent	NN
50458	27	19	-	-	HYPH
50458	27	20	venoms	venom	NNS
50458	27	21	90	90	CD
50458	27	22	Artificial	artificial	JJ
50458	27	23	immunity	immunity	NN
50458	27	24	towards	towards	IN
50458	27	25	serpent	serpent	JJ
50458	27	26	venoms	venom	NNS
50458	27	27	91	91	CD
50458	27	28	Venoms	venom	NNS
50458	27	29	of	of	IN
50458	27	30	batrachians	batrachian	NNS
50458	27	31	and	and	CC
50458	27	32	saurians	saurians	NNPS
50458	27	33	92	92	CD
50458	27	34	Fish	fish	NN
50458	27	35	-	-	HYPH
50458	27	36	poisons	poison	NNS
50458	27	37	95	95	CD
50458	27	38	Poisons	poison	NNS
50458	27	39	of	of	IN
50458	27	40	the	the	DT
50458	27	41	hymenoptera	hymenoptera	NN
50458	27	42	96	96	CD
50458	27	43	Poisons	poison	NNS
50458	27	44	of	of	IN
50458	27	45	scorpions	scorpion	NNS
50458	27	46	97	97	CD
50458	27	47	Poisonous	poisonous	JJ
50458	27	48	blood	blood	NN
50458	27	49	and	and	CC
50458	27	50	serums	serum	NNS
50458	27	51	98	98	CD
50458	27	52	Poisonous	poisonous	JJ
50458	27	53	meats	meat	NNS
50458	27	54	100	100	CD
50458	27	55	TOXINS	toxin	NNS
50458	27	56	AND	and	CC
50458	27	57	VENOMS	venoms	NN
50458	27	58	.	.	.
50458	28	1	PART	PART	NNP
50458	28	2	I.	I.	NNP
50458	29	1	_	_	NNP
50458	29	2	GENERALITIES	GENERALITIES	NNP
50458	29	3	REGARDING	regard	VBG
50458	29	4	TOXINS	toxin	NNS
50458	29	5	AND	and	CC
50458	29	6	ANTITOXINS	antitoxin	NNS
50458	29	7	.	.	.
50458	29	8	_	_	NNP
50458	29	9	CHAPTER	CHAPTER	NNP
50458	29	10	I.	I.	NNP
50458	29	11	ALKALOIDAL	ALKALOIDAL	NNP
50458	29	12	TOXINS	toxin	NNS
50458	29	13	,	,	,
50458	29	14	PTOMAINES	PTOMAINES	NNP
50458	29	15	AND	and	CC
50458	29	16	LEUCOMAINES	LEUCOMAINES	NNP
50458	29	17	.	.	.
50458	30	1	=	=	NFP
50458	30	2	Alkaloidal	Alkaloidal	NNP
50458	30	3	Products	Products	NNPS
50458	30	4	of	of	IN
50458	30	5	Cellular	Cellular	NNP
50458	30	6	Life.=	Life.=	NNP
50458	30	7	Before	before	IN
50458	30	8	entering	enter	VBG
50458	30	9	upon	upon	IN
50458	30	10	the	the	DT
50458	30	11	study	study	NN
50458	30	12	of	of	IN
50458	30	13	the	the	DT
50458	30	14	true	true	JJ
50458	30	15	toxins	toxin	NNS
50458	30	16	,	,	,
50458	30	17	which	which	WDT
50458	30	18	are	be	VBP
50458	30	19	products	product	NNS
50458	30	20	of	of	IN
50458	30	21	an	an	DT
50458	30	22	alkaloidal	alkaloidal	JJ
50458	30	23	nature	nature	NN
50458	30	24	and	and	CC
50458	30	25	of	of	IN
50458	30	26	unknown	unknown	JJ
50458	30	27	composition	composition	NN
50458	30	28	,	,	,
50458	30	29	it	-PRON-	PRP
50458	30	30	is	be	VBZ
50458	30	31	necessary	necessary	JJ
50458	30	32	to	to	TO
50458	30	33	say	say	VB
50458	30	34	a	a	DT
50458	30	35	few	few	JJ
50458	30	36	words	word	NNS
50458	30	37	regarding	regard	VBG
50458	30	38	the	the	DT
50458	30	39	most	most	RBS
50458	30	40	definite	definite	NN
50458	30	41	of	of	IN
50458	30	42	the	the	DT
50458	30	43	toxic	toxic	JJ
50458	30	44	alkaloidal	alkaloidal	NN
50458	30	45	principles	principle	NNS
50458	30	46	that	that	WDT
50458	30	47	are	be	VBP
50458	30	48	frequently	frequently	RB
50458	30	49	encountered	encounter	VBN
50458	30	50	under	under	IN
50458	30	51	various	various	JJ
50458	30	52	conditions	condition	NNS
50458	30	53	,	,	,
50458	30	54	conjointly	conjointly	RB
50458	30	55	with	with	IN
50458	30	56	the	the	DT
50458	30	57	true	true	JJ
50458	30	58	toxins	toxin	NNS
50458	30	59	,	,	,
50458	30	60	particularly	particularly	RB
50458	30	61	in	in	IN
50458	30	62	venoms	venom	NNS
50458	30	63	,	,	,
50458	30	64	and	and	CC
50458	30	65	which	which	WDT
50458	30	66	,	,	,
50458	30	67	furthermore	furthermore	RB
50458	30	68	,	,	,
50458	30	69	are	be	VBP
50458	30	70	closely	closely	RB
50458	30	71	allied	allied	JJ
50458	30	72	to	to	IN
50458	30	73	these	these	DT
50458	30	74	albuminoid	albuminoid	NN
50458	30	75	toxins	toxin	NNS
50458	30	76	.	.	.
50458	31	1	These	these	DT
50458	31	2	principles	principle	NNS
50458	31	3	are	be	VBP
50458	31	4	formed	form	VBN
50458	31	5	in	in	IN
50458	31	6	essentially	essentially	RB
50458	31	7	reducing	reduce	VBG
50458	31	8	media	medium	NNS
50458	31	9	,	,	,
50458	31	10	whether	whether	IN
50458	31	11	it	-PRON-	PRP
50458	31	12	be	be	VB
50458	31	13	within	within	IN
50458	31	14	the	the	DT
50458	31	15	body	body	NN
50458	31	16	of	of	IN
50458	31	17	the	the	DT
50458	31	18	organism	organism	NN
50458	31	19	,	,	,
50458	31	20	and	and	CC
50458	31	21	by	by	IN
50458	31	22	the	the	DT
50458	31	23	simple	simple	JJ
50458	31	24	exercise	exercise	NN
50458	31	25	of	of	IN
50458	31	26	its	-PRON-	PRP$
50458	31	27	normal	normal	JJ
50458	31	28	function	function	NN
50458	31	29	,	,	,
50458	31	30	in	in	IN
50458	31	31	which	which	WDT
50458	31	32	case	case	NN
50458	31	33	the	the	DT
50458	31	34	principles	principle	NNS
50458	31	35	bear	bear	VBP
50458	31	36	the	the	DT
50458	31	37	generic	generic	JJ
50458	31	38	name	name	NN
50458	31	39	_	_	NNP
50458	31	40	leucomaines_[1	leucomaines_[1	NNP
50458	31	41	]	]	-RRB-
50458	31	42	;	;	,
50458	31	43	or	or	CC
50458	31	44	whether	whether	IN
50458	31	45	due	due	IN
50458	31	46	to	to	IN
50458	31	47	the	the	DT
50458	31	48	action	action	NN
50458	31	49	of	of	IN
50458	31	50	anaerobic	anaerobic	JJ
50458	31	51	microbes	microbe	NNS
50458	31	52	,	,	,
50458	31	53	when	when	WRB
50458	31	54	they	-PRON-	PRP
50458	31	55	are	be	VBP
50458	31	56	designated	designate	VBN
50458	31	57	as	as	IN
50458	31	58	ptomaines	ptomaine	NNS
50458	31	59	.	.	.
50458	32	1	[	[	-LRB-
50458	32	2	2	2	LS
50458	32	3	]	]	-RRB-
50458	32	4	These	these	DT
50458	32	5	basic	basic	JJ
50458	32	6	principles	principle	NNS
50458	32	7	,	,	,
50458	32	8	which	which	WDT
50458	32	9	are	be	VBP
50458	32	10	essentially	essentially	RB
50458	32	11	the	the	DT
50458	32	12	products	product	NNS
50458	32	13	of	of	IN
50458	32	14	cellular	cellular	JJ
50458	32	15	secretion	secretion	NN
50458	32	16	,	,	,
50458	32	17	are	be	VBP
50458	32	18	usually	usually	RB
50458	32	19	toxic	toxic	JJ
50458	32	20	,	,	,
50458	32	21	and	and	CC
50458	32	22	sometimes	sometimes	RB
50458	32	23	even	even	RB
50458	32	24	extremely	extremely	RB
50458	32	25	so	so	RB
50458	32	26	.	.	.
50458	33	1	[	[	-LRB-
50458	33	2	1	1	CD
50458	33	3	]	]	-RRB-
50458	33	4	ARMAND	ARMAND	NNP
50458	33	5	GAUTIER	GAUTIER	NNP
50458	33	6	:	:	:
50458	33	7	Sur	Sur	NNP
50458	33	8	les	les	FW
50458	33	9	leucomaines	leucomaine	NNS
50458	33	10	,	,	,
50458	33	11	nouveaux	nouveaux	JJ
50458	33	12	alcaloides	alcaloide	NNS
50458	33	13	,	,	,
50458	33	14	dérivés	dérivés	NNP
50458	33	15	de	de	NNP
50458	33	16	la	la	NNP
50458	33	17	transformation	transformation	NNP
50458	33	18	des	des	FW
50458	33	19	substances	substance	NNS
50458	33	20	protéiques	protéiques	NNP
50458	33	21	des	des	NNP
50458	33	22	tissus	tissus	NNP
50458	33	23	vivants	vivants	NNP
50458	33	24	.	.	.
50458	34	1	_	_	NNP
50458	34	2	Bull	Bull	NNP
50458	34	3	.	.	.
50458	35	1	Soc	Soc	NNP
50458	35	2	.	.	.
50458	36	1	Chim	Chim	NNP
50458	36	2	.	.	.
50458	36	3	_	_	NNP
50458	36	4	,	,	,
50458	36	5	2e	2e	CD
50458	36	6	série	série	NN
50458	36	7	,	,	,
50458	36	8	XLIII	XLIII	NNP
50458	36	9	,	,	,
50458	36	10	p.	p.	NN
50458	36	11	158	158	CD
50458	36	12	.	.	.
50458	37	1	[	[	-LRB-
50458	37	2	2	2	CD
50458	37	3	]	]	-RRB-
50458	37	4	ARMAND	ARMAND	NNP
50458	37	5	GAUTIER	GAUTIER	NNP
50458	37	6	:	:	:
50458	37	7	"	"	``
50458	37	8	Communication	communication	NN
50458	37	9	sur	sur	FW
50458	37	10	les	les	FW
50458	37	11	bases	basis	NNS
50458	37	12	d'origine	d'origine	NNP
50458	37	13	putréfactive	putréfactive	NN
50458	37	14	.	.	.
50458	37	15	"	"	''
50458	38	1	_	_	NNP
50458	38	2	Bull	Bull	NNP
50458	38	3	.	.	.
50458	39	1	Soc	Soc	NNP
50458	39	2	.	.	.
50458	40	1	Chim	Chim	NNP
50458	40	2	.	.	.
50458	40	3	_	_	NNP
50458	40	4	(	(	-LRB-
50458	40	5	2	2	CD
50458	40	6	)	)	-RRB-
50458	40	7	,	,	,
50458	40	8	XXXVII	XXXVII	NNP
50458	40	9	,	,	,
50458	40	10	p.	p.	NN
50458	40	11	305	305	CD
50458	40	12	.	.	.
50458	41	1	As	as	IN
50458	41	2	we	-PRON-	PRP
50458	41	3	shall	shall	MD
50458	41	4	presently	presently	RB
50458	41	5	see	see	VB
50458	41	6	,	,	,
50458	41	7	ptomaines	ptomaine	NNS
50458	41	8	are	be	VBP
50458	41	9	essentially	essentially	RB
50458	41	10	products	product	NNS
50458	41	11	formed	form	VBN
50458	41	12	during	during	IN
50458	41	13	putrefactive	putrefactive	JJ
50458	41	14	fermentation	fermentation	NN
50458	41	15	.	.	.
50458	42	1	The	the	DT
50458	42	2	toxic	toxic	JJ
50458	42	3	properties	property	NNS
50458	42	4	of	of	IN
50458	42	5	extracts	extract	NNS
50458	42	6	from	from	IN
50458	42	7	the	the	DT
50458	42	8	cadaveric	cadaveric	JJ
50458	42	9	fluids	fluid	NNS
50458	42	10	have	have	VBP
50458	42	11	long	long	RB
50458	42	12	been	be	VBN
50458	42	13	known	know	VBN
50458	42	14	.	.	.
50458	43	1	Already	already	RB
50458	43	2	in	in	IN
50458	43	3	1838	1838	CD
50458	43	4	Panum[3	Panum[3	NNP
50458	43	5	]	]	-RRB-
50458	43	6	had	have	VBD
50458	43	7	met	meet	VBN
50458	43	8	with	with	IN
50458	43	9	these	these	DT
50458	43	10	products	product	NNS
50458	43	11	in	in	IN
50458	43	12	snake	snake	NN
50458	43	13	venoms	venom	NNS
50458	43	14	.	.	.
50458	44	1	Bergmann	Bergmann	NNP
50458	44	2	and	and	CC
50458	44	3	Schmiedberg[4	Schmiedberg[4	NNP
50458	44	4	]	]	-RRB-
50458	44	5	in	in	IN
50458	44	6	1868	1868	CD
50458	44	7	isolated	isolate	VBD
50458	44	8	from	from	IN
50458	44	9	septic	septic	NN
50458	44	10	pus	pus	NNP
50458	44	11	a	a	DT
50458	44	12	toxic	toxic	JJ
50458	44	13	substance	substance	NN
50458	44	14	which	which	WDT
50458	44	15	they	-PRON-	PRP
50458	44	16	named	name	VBD
50458	44	17	_	_	NNP
50458	44	18	sepsin	sepsin	NN
50458	44	19	_	_	NNP
50458	44	20	;	;	:
50458	44	21	and	and	CC
50458	44	22	almost	almost	RB
50458	44	23	at	at	IN
50458	44	24	the	the	DT
50458	44	25	same	same	JJ
50458	44	26	time	time	NN
50458	44	27	Zuelzer	Zuelzer	NNP
50458	44	28	and	and	CC
50458	44	29	Sonnenschein[5	Sonnenschein[5	NNP
50458	44	30	]	]	-RRB-
50458	44	31	reported	report	VBD
50458	44	32	having	have	VBG
50458	44	33	isolated	isolate	VBN
50458	44	34	from	from	IN
50458	44	35	anatomical	anatomical	JJ
50458	44	36	preparations	preparation	NNS
50458	44	37	an	an	DT
50458	44	38	alkaloid	alkaloid	RB
50458	44	39	possessing	possess	VBG
50458	44	40	mydriatic	mydriatic	JJ
50458	44	41	properties	property	NNS
50458	44	42	.	.	.
50458	45	1	It	-PRON-	PRP
50458	45	2	is	be	VBZ
50458	45	3	,	,	,
50458	45	4	however	however	RB
50458	45	5	,	,	,
50458	45	6	due	due	JJ
50458	45	7	particularly	particularly	RB
50458	45	8	to	to	IN
50458	45	9	the	the	DT
50458	45	10	researches	research	NNS
50458	45	11	of	of	IN
50458	45	12	Selmi	Selmi	NNP
50458	45	13	and	and	CC
50458	45	14	Armand	Armand	NNP
50458	45	15	Gautier	Gautier	NNP
50458	45	16	that	that	IN
50458	45	17	we	-PRON-	PRP
50458	45	18	are	be	VBP
50458	45	19	now	now	RB
50458	45	20	so	so	RB
50458	45	21	well	well	RB
50458	45	22	informed	informed	JJ
50458	45	23	regarding	regard	VBG
50458	45	24	these	these	DT
50458	45	25	toxic	toxic	JJ
50458	45	26	principles	principle	NNS
50458	45	27	.	.	.
50458	46	1	[	[	-LRB-
50458	46	2	3	3	CD
50458	46	3	]	]	-RRB-
50458	46	4	_	_	NNP
50458	46	5	Virchow	Virchow	NNP
50458	46	6	Archiv	Archiv	NNP
50458	46	7	.	.	.
50458	46	8	_	_	NNP
50458	46	9	,	,	,
50458	46	10	X	X	NNP
50458	46	11	,	,	,
50458	46	12	p.	p.	NN
50458	46	13	301	301	CD
50458	46	14	.	.	.
50458	47	1	[	[	-LRB-
50458	47	2	4	4	CD
50458	47	3	]	]	-RRB-
50458	47	4	_	_	NNP
50458	47	5	Medic	Medic	NNP
50458	47	6	.	.	.
50458	48	1	Centralblatt	Centralblatt	NNP
50458	48	2	_	_	NNP
50458	48	3	,	,	,
50458	48	4	1868	1868	CD
50458	48	5	,	,	,
50458	48	6	p.	p.	NN
50458	48	7	497	497	CD
50458	48	8	.	.	.
50458	49	1	[	[	-LRB-
50458	49	2	5	5	CD
50458	49	3	]	]	-RRB-
50458	49	4	_	_	NNP
50458	49	5	Berlin	Berlin	NNP
50458	49	6	.	.	.
50458	50	1	Klin	Klin	NNP
50458	50	2	.	.	.
50458	51	1	Woch	Woch	NNP
50458	51	2	.	.	.
50458	51	3	_	_	NNP
50458	51	4	,	,	,
50458	51	5	1869	1869	CD
50458	51	6	,	,	,
50458	51	7	No	no	UH
50458	51	8	.	.	.
50458	52	1	2	2	LS
50458	52	2	.	.	.
50458	53	1	The	the	DT
50458	53	2	labors	labor	NNS
50458	53	3	of	of	IN
50458	53	4	Armand	Armand	NNP
50458	53	5	Gautier	Gautier	NNP
50458	53	6	were	be	VBD
50458	53	7	first	first	RB
50458	53	8	published	publish	VBN
50458	53	9	in	in	IN
50458	53	10	his	-PRON-	PRP$
50458	53	11	_	_	NNP
50458	53	12	Traité	Traité	NNP
50458	53	13	de	de	FW
50458	53	14	Chimie	Chimie	NNP
50458	53	15	Appliquée	Appliquée	NNP
50458	53	16	à	à	NNP
50458	53	17	la	la	NNP
50458	53	18	Physiologie	Physiologie	NNP
50458	53	19	_	_	NNP
50458	53	20	;	;	:
50458	53	21	those	those	DT
50458	53	22	of	of	IN
50458	53	23	Selmi	Selmi	NNPS
50458	53	24	in	in	IN
50458	53	25	the	the	DT
50458	53	26	_	_	NNP
50458	53	27	Actes	Actes	NNP
50458	53	28	de	de	NNP
50458	53	29	l'Académie	l'Académie	NNP
50458	53	30	de	de	NNP
50458	53	31	Bologne	Bologne	NNP
50458	53	32	_	_	NNP
50458	53	33	.	.	.
50458	54	1	At	at	IN
50458	54	2	first	first	JJ
50458	54	3	sight	sight	NN
50458	54	4	,	,	,
50458	54	5	there	there	EX
50458	54	6	appears	appear	VBZ
50458	54	7	to	to	TO
50458	54	8	be	be	VB
50458	54	9	a	a	DT
50458	54	10	great	great	JJ
50458	54	11	difference	difference	NN
50458	54	12	between	between	IN
50458	54	13	these	these	DT
50458	54	14	alkaloidal	alkaloidal	NN
50458	54	15	bases	basis	NNS
50458	54	16	,	,	,
50458	54	17	the	the	DT
50458	54	18	ptomaines	ptomaine	NNS
50458	54	19	and	and	CC
50458	54	20	leucomaines	leucomaine	NNS
50458	54	21	,	,	,
50458	54	22	and	and	CC
50458	54	23	the	the	DT
50458	54	24	albuminoid	albuminoid	NN
50458	54	25	toxins	toxin	NNS
50458	54	26	proper	proper	JJ
50458	54	27	.	.	.
50458	55	1	The	the	DT
50458	55	2	toxic	toxic	JJ
50458	55	3	bases	basis	NNS
50458	55	4	of	of	IN
50458	55	5	the	the	DT
50458	55	6	first	first	JJ
50458	55	7	two	two	CD
50458	55	8	groups	group	NNS
50458	55	9	are	be	VBP
50458	55	10	quite	quite	RB
50458	55	11	definite	definite	JJ
50458	55	12	chemical	chemical	JJ
50458	55	13	products	product	NNS
50458	55	14	which	which	WDT
50458	55	15	can	can	MD
50458	55	16	be	be	VB
50458	55	17	generally	generally	RB
50458	55	18	obtained	obtain	VBN
50458	55	19	quite	quite	RB
50458	55	20	pure	pure	JJ
50458	55	21	,	,	,
50458	55	22	and	and	CC
50458	55	23	frequently	frequently	RB
50458	55	24	in	in	IN
50458	55	25	crystalline	crystalline	NN
50458	55	26	form	form	NN
50458	55	27	.	.	.
50458	56	1	The	the	DT
50458	56	2	toxins	toxin	NNS
50458	56	3	proper	proper	JJ
50458	56	4	,	,	,
50458	56	5	on	on	IN
50458	56	6	the	the	DT
50458	56	7	other	other	JJ
50458	56	8	hand	hand	NN
50458	56	9	,	,	,
50458	56	10	are	be	VBP
50458	56	11	highly	highly	RB
50458	56	12	complex	complex	JJ
50458	56	13	albuminoid	albuminoid	NN
50458	56	14	substances	substance	NNS
50458	56	15	which	which	WDT
50458	56	16	greatly	greatly	RB
50458	56	17	resemble	resemble	VBP
50458	56	18	the	the	DT
50458	56	19	true	true	JJ
50458	56	20	diastases	diastasis	NNS
50458	56	21	in	in	IN
50458	56	22	all	all	PDT
50458	56	23	their	-PRON-	PRP$
50458	56	24	properties	property	NNS
50458	56	25	.	.	.
50458	57	1	Nevertheless	nevertheless	RB
50458	57	2	,	,	,
50458	57	3	between	between	IN
50458	57	4	the	the	DT
50458	57	5	toxic	toxic	JJ
50458	57	6	alkaloids	alkaloid	NNS
50458	57	7	,	,	,
50458	57	8	ptomaines	ptomaine	NNS
50458	57	9	and	and	CC
50458	57	10	leucomaines	leucomaine	NNS
50458	57	11	,	,	,
50458	57	12	and	and	CC
50458	57	13	the	the	DT
50458	57	14	toxic	toxic	JJ
50458	57	15	albuminoids	albuminoid	NNS
50458	57	16	,	,	,
50458	57	17	or	or	CC
50458	57	18	more	more	RBR
50458	57	19	properly	properly	RB
50458	57	20	toxins	toxin	NNS
50458	57	21	,	,	,
50458	57	22	there	there	EX
50458	57	23	exists	exist	VBZ
50458	57	24	no	no	DT
50458	57	25	absolutely	absolutely	RB
50458	57	26	sharp	sharp	JJ
50458	57	27	line	line	NN
50458	57	28	of	of	IN
50458	57	29	demarcation	demarcation	NN
50458	57	30	,	,	,
50458	57	31	but	but	CC
50458	57	32	there	there	EX
50458	57	33	is	be	VBZ
50458	57	34	a	a	DT
50458	57	35	gradual	gradual	JJ
50458	57	36	passage	passage	NN
50458	57	37	from	from	IN
50458	57	38	the	the	DT
50458	57	39	one	one	NN
50458	57	40	to	to	IN
50458	57	41	the	the	DT
50458	57	42	other	other	JJ
50458	57	43	by	by	IN
50458	57	44	every	every	DT
50458	57	45	intermediary	intermediary	JJ
50458	57	46	grade	grade	NN
50458	57	47	,	,	,
50458	57	48	as	as	IN
50458	57	49	a	a	DT
50458	57	50	result	result	NN
50458	57	51	of	of	IN
50458	57	52	the	the	DT
50458	57	53	breaking	break	VBG
50458	57	54	down	down	RP
50458	57	55	of	of	IN
50458	57	56	the	the	DT
50458	57	57	albuminoid	albuminoid	NN
50458	57	58	molecule	molecule	NN
50458	57	59	.	.	.
50458	58	1	We	-PRON-	PRP
50458	58	2	shall	shall	MD
50458	58	3	see	see	VB
50458	58	4	,	,	,
50458	58	5	moreover	moreover	RB
50458	58	6	,	,	,
50458	58	7	as	as	IN
50458	58	8	we	-PRON-	PRP
50458	58	9	proceed	proceed	VBP
50458	58	10	,	,	,
50458	58	11	that	that	IN
50458	58	12	these	these	DT
50458	58	13	substances	substance	NNS
50458	58	14	are	be	VBP
50458	58	15	formed	form	VBN
50458	58	16	under	under	IN
50458	58	17	coexistent	coexistent	NN
50458	58	18	circumstances	circumstance	NNS
50458	58	19	,	,	,
50458	58	20	and	and	CC
50458	58	21	that	that	IN
50458	58	22	they	-PRON-	PRP
50458	58	23	are	be	VBP
50458	58	24	,	,	,
50458	58	25	hence	hence	RB
50458	58	26	,	,	,
50458	58	27	found	find	VBD
50458	58	28	together	together	RB
50458	58	29	,	,	,
50458	58	30	whether	whether	IN
50458	58	31	it	-PRON-	PRP
50458	58	32	be	be	VBP
50458	58	33	in	in	IN
50458	58	34	virus	virus	NN
50458	58	35	or	or	CC
50458	58	36	in	in	IN
50458	58	37	snake	snake	NN
50458	58	38	venom	venom	NN
50458	58	39	.	.	.
50458	59	1	We	-PRON-	PRP
50458	59	2	will	will	MD
50458	59	3	first	first	RB
50458	59	4	consider	consider	VB
50458	59	5	the	the	DT
50458	59	6	ptomaines	ptomaine	NNS
50458	59	7	,	,	,
50458	59	8	and	and	CC
50458	59	9	then	then	RB
50458	59	10	the	the	DT
50458	59	11	leucomaines	leucomaine	NNS
50458	59	12	.	.	.
50458	60	1	=	=	NFP
50458	60	2	Ptomaines.=	Ptomaines.=	NNP
50458	60	3	This	this	DT
50458	60	4	name	name	NN
50458	60	5	is	be	VBZ
50458	60	6	more	more	RBR
50458	60	7	specially	specially	RB
50458	60	8	reserved	reserved	JJ
50458	60	9	to	to	TO
50458	60	10	designate	designate	VB
50458	60	11	those	those	DT
50458	60	12	alkaloidal	alkaloidal	NN
50458	60	13	substances	substance	NNS
50458	60	14	,	,	,
50458	60	15	generally	generally	RB
50458	60	16	highly	highly	RB
50458	60	17	hydrogenized	hydrogenize	VBN
50458	60	18	,	,	,
50458	60	19	that	that	WDT
50458	60	20	are	be	VBP
50458	60	21	formed	form	VBN
50458	60	22	outside	outside	IN
50458	60	23	the	the	DT
50458	60	24	organism	organism	NN
50458	60	25	,	,	,
50458	60	26	from	from	IN
50458	60	27	the	the	DT
50458	60	28	fermentative	fermentative	JJ
50458	60	29	action	action	NN
50458	60	30	of	of	IN
50458	60	31	anaerobic	anaerobic	JJ
50458	60	32	microbes	microbe	NNS
50458	60	33	on	on	IN
50458	60	34	albuminoid	albuminoid	NN
50458	60	35	substances	substance	NNS
50458	60	36	.	.	.
50458	61	1	These	these	DT
50458	61	2	bases	basis	NNS
50458	61	3	are	be	VBP
50458	61	4	generally	generally	RB
50458	61	5	volatile	volatile	JJ
50458	61	6	,	,	,
50458	61	7	with	with	IN
50458	61	8	an	an	DT
50458	61	9	intense	intense	JJ
50458	61	10	and	and	CC
50458	61	11	tenacious	tenacious	JJ
50458	61	12	purulent	purulent	NN
50458	61	13	odor	odor	RB
50458	61	14	;	;	:
50458	61	15	often	often	RB
50458	61	16	,	,	,
50458	61	17	however	however	RB
50458	61	18	,	,	,
50458	61	19	they	-PRON-	PRP
50458	61	20	possess	possess	VBP
50458	61	21	a	a	DT
50458	61	22	floral	floral	JJ
50458	61	23	odor	odor	NN
50458	61	24	(	(	-LRB-
50458	61	25	aubépine	aubépine	NNP
50458	61	26	,	,	,
50458	61	27	syringa	syringa	NNP
50458	61	28	)	)	-RRB-
50458	61	29	,	,	,
50458	61	30	and	and	CC
50458	61	31	even	even	RB
50458	61	32	like	like	IN
50458	61	33	that	that	DT
50458	61	34	of	of	IN
50458	61	35	musk	musk	NN
50458	61	36	.	.	.
50458	62	1	They	-PRON-	PRP
50458	62	2	combine	combine	VBP
50458	62	3	readily	readily	RB
50458	62	4	with	with	IN
50458	62	5	acids	acid	NNS
50458	62	6	and	and	CC
50458	62	7	with	with	IN
50458	62	8	the	the	DT
50458	62	9	chlorides	chloride	NNS
50458	62	10	of	of	IN
50458	62	11	the	the	DT
50458	62	12	heavy	heavy	JJ
50458	62	13	metals	metal	NNS
50458	62	14	,	,	,
50458	62	15	yielding	yield	VBG
50458	62	16	crystallizable	crystallizable	JJ
50458	62	17	salts	salt	NNS
50458	62	18	.	.	.
50458	63	1	The	the	DT
50458	63	2	ptomaines	ptomaine	NNS
50458	63	3	afford	afford	VBP
50458	63	4	no	no	DT
50458	63	5	specific	specific	JJ
50458	63	6	reaction	reaction	NN
50458	63	7	whereby	whereby	WRB
50458	63	8	they	-PRON-	PRP
50458	63	9	may	may	MD
50458	63	10	be	be	VB
50458	63	11	readily	readily	RB
50458	63	12	identified	identify	VBN
50458	63	13	;	;	:
50458	63	14	and	and	CC
50458	63	15	their	-PRON-	PRP$
50458	63	16	identification	identification	NN
50458	63	17	is	be	VBZ
50458	63	18	effected	effect	VBN
50458	63	19	only	only	RB
50458	63	20	after	after	IN
50458	63	21	a	a	DT
50458	63	22	painstaking	painstaking	JJ
50458	63	23	analysis	analysis	NN
50458	63	24	.	.	.
50458	64	1	We	-PRON-	PRP
50458	64	2	must	must	MD
50458	64	3	here	here	RB
50458	64	4	call	call	VB
50458	64	5	attention	attention	NN
50458	64	6	,	,	,
50458	64	7	however	however	RB
50458	64	8	,	,	,
50458	64	9	to	to	IN
50458	64	10	several	several	JJ
50458	64	11	of	of	IN
50458	64	12	their	-PRON-	PRP$
50458	64	13	more	more	RBR
50458	64	14	common	common	JJ
50458	64	15	properties	property	NNS
50458	64	16	,	,	,
50458	64	17	beginning	begin	VBG
50458	64	18	with	with	IN
50458	64	19	their	-PRON-	PRP$
50458	64	20	basic	basic	JJ
50458	64	21	character	character	NN
50458	64	22	,	,	,
50458	64	23	their	-PRON-	PRP$
50458	64	24	oxidizability	oxidizability	NN
50458	64	25	by	by	IN
50458	64	26	the	the	DT
50458	64	27	air	air	NN
50458	64	28	and	and	CC
50458	64	29	consequently	consequently	RB
50458	64	30	their	-PRON-	PRP$
50458	64	31	well	well	RB
50458	64	32	-	-	HYPH
50458	64	33	defined	define	VBN
50458	64	34	reducing	reduce	VBG
50458	64	35	power	power	NN
50458	64	36	--	--	:
50458	64	37	a	a	DT
50458	64	38	property	property	NN
50458	64	39	that	that	WDT
50458	64	40	led	lead	VBD
50458	64	41	Selmi	Selmi	VBN
50458	64	42	to	to	TO
50458	64	43	propose	propose	VB
50458	64	44	a	a	DT
50458	64	45	mixture	mixture	NN
50458	64	46	of	of	IN
50458	64	47	ferric	ferric	JJ
50458	64	48	chloride	chloride	NN
50458	64	49	and	and	CC
50458	64	50	potassium	potassium	NN
50458	64	51	ferricyanide	ferricyanide	NN
50458	64	52	as	as	IN
50458	64	53	a	a	DT
50458	64	54	reagent	reagent	NN
50458	64	55	for	for	IN
50458	64	56	their	-PRON-	PRP$
50458	64	57	detection	detection	NN
50458	64	58	.	.	.
50458	65	1	[	[	-LRB-
50458	65	2	6	6	CD
50458	65	3	]	]	-RRB-
50458	65	4	They	-PRON-	PRP
50458	65	5	are	be	VBP
50458	65	6	precipitated	precipitate	VBN
50458	65	7	by	by	IN
50458	65	8	all	all	PDT
50458	65	9	the	the	DT
50458	65	10	general	general	JJ
50458	65	11	reagents	reagent	NNS
50458	65	12	for	for	IN
50458	65	13	the	the	DT
50458	65	14	vegetable	vegetable	NN
50458	65	15	alkaloids	alkaloid	NNS
50458	65	16	.	.	.
50458	66	1	Selmi	Selmi	NNP
50458	66	2	has	have	VBZ
50458	66	3	given	give	VBN
50458	66	4	several	several	JJ
50458	66	5	reactions	reaction	NNS
50458	66	6	,	,	,
50458	66	7	such	such	JJ
50458	66	8	as	as	IN
50458	66	9	those	those	DT
50458	66	10	afforded	afford	VBN
50458	66	11	by	by	IN
50458	66	12	sulphuric	sulphuric	JJ
50458	66	13	,	,	,
50458	66	14	hydrochloric	hydrochloric	JJ
50458	66	15	,	,	,
50458	66	16	and	and	CC
50458	66	17	nitric	nitric	JJ
50458	66	18	acids	acid	NNS
50458	66	19	,	,	,
50458	66	20	which	which	WDT
50458	66	21	appear	appear	VBP
50458	66	22	,	,	,
50458	66	23	however	however	RB
50458	66	24	,	,	,
50458	66	25	to	to	TO
50458	66	26	apply	apply	VB
50458	66	27	much	much	RB
50458	66	28	more	more	JJR
50458	66	29	to	to	IN
50458	66	30	the	the	DT
50458	66	31	impurities	impurity	NNS
50458	66	32	present	present	JJ
50458	66	33	than	than	IN
50458	66	34	to	to	IN
50458	66	35	the	the	DT
50458	66	36	bases	basis	NNS
50458	66	37	themselves	-PRON-	PRP
50458	66	38	.	.	.
50458	67	1	[	[	-LRB-
50458	67	2	6	6	CD
50458	67	3	]	]	-RRB-
50458	67	4	Sulle	Sulle	NNP
50458	67	5	ptomaïne	ptomaïne	NN
50458	67	6	od	od	NNP
50458	67	7	alcaloïdi	alcaloïdi	NNP
50458	67	8	cadaverici	cadaverici	NNP
50458	67	9	.	.	.
50458	68	1	Bologne	bologne	VB
50458	68	2	,	,	,
50458	68	3	CLXXXVII	clxxxvii	NN
50458	68	4	,	,	,
50458	68	5	p.	p.	NN
50458	68	6	11	11	CD
50458	68	7	.	.	.
50458	69	1	The	the	DT
50458	69	2	physiological	physiological	JJ
50458	69	3	action	action	NN
50458	69	4	of	of	IN
50458	69	5	these	these	DT
50458	69	6	bases	basis	NNS
50458	69	7	varies	vary	VBZ
50458	69	8	greatly	greatly	RB
50458	69	9	;	;	:
50458	69	10	in	in	IN
50458	69	11	some	some	DT
50458	69	12	the	the	DT
50458	69	13	action	action	NN
50458	69	14	is	be	VBZ
50458	69	15	an	an	DT
50458	69	16	extremely	extremely	RB
50458	69	17	toxic	toxic	JJ
50458	69	18	one	one	NN
50458	69	19	,	,	,
50458	69	20	as	as	IN
50458	69	21	in	in	IN
50458	69	22	the	the	DT
50458	69	23	case	case	NN
50458	69	24	of	of	IN
50458	69	25	neurine	neurine	NNP
50458	69	26	and	and	CC
50458	69	27	muscarine	muscarine	NNP
50458	69	28	,	,	,
50458	69	29	which	which	WDT
50458	69	30	are	be	VBP
50458	69	31	true	true	JJ
50458	69	32	ptomaines	ptomaine	NNS
50458	69	33	;	;	:
50458	69	34	there	there	EX
50458	69	35	are	be	VBP
50458	69	36	others	other	NNS
50458	69	37	,	,	,
50458	69	38	such	such	JJ
50458	69	39	as	as	IN
50458	69	40	cadaverine	cadaverine	NN
50458	69	41	and	and	CC
50458	69	42	putrescine	putrescine	NN
50458	69	43	,	,	,
50458	69	44	which	which	WDT
50458	69	45	are	be	VBP
50458	69	46	quite	quite	RB
50458	69	47	innocuous	innocuous	JJ
50458	69	48	.	.	.
50458	70	1	The	the	DT
50458	70	2	physiological	physiological	JJ
50458	70	3	action	action	NN
50458	70	4	of	of	IN
50458	70	5	these	these	DT
50458	70	6	bases	basis	NNS
50458	70	7	,	,	,
50458	70	8	like	like	IN
50458	70	9	that	that	DT
50458	70	10	of	of	IN
50458	70	11	the	the	DT
50458	70	12	true	true	JJ
50458	70	13	toxins	toxin	NNS
50458	70	14	,	,	,
50458	70	15	is	be	VBZ
50458	70	16	studied	study	VBN
50458	70	17	by	by	IN
50458	70	18	making	make	VBG
50458	70	19	hypodermic	hypodermic	JJ
50458	70	20	injections	injection	NNS
50458	70	21	of	of	IN
50458	70	22	solutions	solution	NNS
50458	70	23	of	of	IN
50458	70	24	the	the	DT
50458	70	25	bases	basis	NNS
50458	70	26	in	in	IN
50458	70	27	healthy	healthy	JJ
50458	70	28	animals	animal	NNS
50458	70	29	,	,	,
50458	70	30	such	such	JJ
50458	70	31	as	as	IN
50458	70	32	guinea	guinea	NN
50458	70	33	-	-	HYPH
50458	70	34	pigs	pig	NNS
50458	70	35	,	,	,
50458	70	36	rabbits	rabbit	NNS
50458	70	37	,	,	,
50458	70	38	and	and	CC
50458	70	39	dogs	dog	NNS
50458	70	40	.	.	.
50458	71	1	In	in	IN
50458	71	2	animals	animal	NNS
50458	71	3	,	,	,
50458	71	4	the	the	DT
50458	71	5	principal	principal	JJ
50458	71	6	phenomena	phenomenon	NNS
50458	71	7	observed	observe	VBN
50458	71	8	by	by	IN
50458	71	9	Selmi	Selmi	NNS
50458	71	10	to	to	TO
50458	71	11	follow	follow	VB
50458	71	12	the	the	DT
50458	71	13	injection	injection	NN
50458	71	14	of	of	IN
50458	71	15	the	the	DT
50458	71	16	substances	substance	NNS
50458	71	17	are	be	VBP
50458	71	18	the	the	DT
50458	71	19	following	follow	VBG
50458	71	20	:	:	:
50458	71	21	At	at	IN
50458	71	22	first	first	JJ
50458	71	23	dilatation	dilatation	NN
50458	71	24	of	of	IN
50458	71	25	the	the	DT
50458	71	26	pupil	pupil	NN
50458	71	27	,	,	,
50458	71	28	then	then	RB
50458	71	29	constriction	constriction	NN
50458	71	30	;	;	,
50458	71	31	tetanic	tetanic	JJ
50458	71	32	convulsions	convulsion	NNS
50458	71	33	,	,	,
50458	71	34	soon	soon	RB
50458	71	35	followed	follow	VBN
50458	71	36	by	by	IN
50458	71	37	muscular	muscular	JJ
50458	71	38	relaxation	relaxation	NN
50458	71	39	,	,	,
50458	71	40	and	and	CC
50458	71	41	retardation	retardation	NN
50458	71	42	,	,	,
50458	71	43	rarely	rarely	RB
50458	71	44	acceleration	acceleration	NN
50458	71	45	,	,	,
50458	71	46	of	of	IN
50458	71	47	heart	heart	NN
50458	71	48	-	-	HYPH
50458	71	49	beat	beat	VBN
50458	71	50	;	;	,
50458	71	51	absolute	absolute	JJ
50458	71	52	loss	loss	NN
50458	71	53	of	of	IN
50458	71	54	cutaneous	cutaneous	JJ
50458	71	55	sensibility	sensibility	NN
50458	71	56	;	;	:
50458	71	57	loss	loss	NN
50458	71	58	of	of	IN
50458	71	59	muscular	muscular	JJ
50458	71	60	contractility	contractility	NN
50458	71	61	;	;	:
50458	71	62	paralysis	paralysis	NN
50458	71	63	of	of	IN
50458	71	64	the	the	DT
50458	71	65	vasomotors	vasomotor	NNS
50458	71	66	;	;	:
50458	71	67	greatly	greatly	RB
50458	71	68	retarded	retarded	JJ
50458	71	69	respiration	respiration	NN
50458	71	70	;	;	:
50458	71	71	stupor	stupor	NN
50458	71	72	,	,	,
50458	71	73	followed	follow	VBN
50458	71	74	by	by	IN
50458	71	75	death	death	NN
50458	71	76	with	with	IN
50458	71	77	the	the	DT
50458	71	78	heart	heart	NN
50458	71	79	in	in	IN
50458	71	80	systole	systole	NNP
50458	71	81	.	.	.
50458	72	1	It	-PRON-	PRP
50458	72	2	must	must	MD
50458	72	3	be	be	VB
50458	72	4	observed	observe	VBN
50458	72	5	that	that	IN
50458	72	6	in	in	IN
50458	72	7	a	a	DT
50458	72	8	number	number	NN
50458	72	9	of	of	IN
50458	72	10	cases	case	NNS
50458	72	11	where	where	WRB
50458	72	12	toxic	toxic	JJ
50458	72	13	researches	research	NNS
50458	72	14	had	have	VBD
50458	72	15	been	be	VBN
50458	72	16	made	make	VBN
50458	72	17	in	in	IN
50458	72	18	the	the	DT
50458	72	19	past	past	NN
50458	72	20	,	,	,
50458	72	21	these	these	DT
50458	72	22	bases	basis	NNS
50458	72	23	had	have	VBD
50458	72	24	been	be	VBN
50458	72	25	mistaken	mistake	VBN
50458	72	26	for	for	IN
50458	72	27	poisons	poison	NNS
50458	72	28	which	which	WDT
50458	72	29	were	be	VBD
50458	72	30	believed	believe	VBN
50458	72	31	to	to	TO
50458	72	32	have	have	VB
50458	72	33	been	be	VBN
50458	72	34	introduced	introduce	VBN
50458	72	35	into	into	IN
50458	72	36	the	the	DT
50458	72	37	organism	organism	NN
50458	72	38	with	with	IN
50458	72	39	criminal	criminal	JJ
50458	72	40	intent	intent	NN
50458	72	41	.	.	.
50458	73	1	No	no	DT
50458	73	2	one	one	NN
50458	73	3	will	will	MD
50458	73	4	ever	ever	RB
50458	73	5	know	know	VB
50458	73	6	how	how	WRB
50458	73	7	many	many	JJ
50458	73	8	have	have	VBP
50458	73	9	fallen	fall	VBN
50458	73	10	victims	victim	NNS
50458	73	11	in	in	IN
50458	73	12	the	the	DT
50458	73	13	past	past	NN
50458	73	14	to	to	IN
50458	73	15	ignorance	ignorance	NN
50458	73	16	regarding	regard	VBG
50458	73	17	the	the	DT
50458	73	18	cellular	cellular	JJ
50458	73	19	mechanism	mechanism	NN
50458	73	20	!	!	.
50458	74	1	The	the	DT
50458	74	2	extraction	extraction	NN
50458	74	3	of	of	IN
50458	74	4	these	these	DT
50458	74	5	bases	basis	NNS
50458	74	6	is	be	VBZ
50458	74	7	a	a	DT
50458	74	8	tedious	tedious	JJ
50458	74	9	and	and	CC
50458	74	10	difficult	difficult	JJ
50458	74	11	operation	operation	NN
50458	74	12	.	.	.
50458	75	1	The	the	DT
50458	75	2	materials	material	NNS
50458	75	3	must	must	MD
50458	75	4	first	first	RB
50458	75	5	be	be	VB
50458	75	6	exhausted	exhaust	VBN
50458	75	7	with	with	IN
50458	75	8	water	water	NN
50458	75	9	slightly	slightly	RB
50458	75	10	acidulated	acidulate	VBN
50458	75	11	;	;	:
50458	75	12	then	then	RB
50458	75	13	,	,	,
50458	75	14	after	after	IN
50458	75	15	precipitating	precipitate	VBG
50458	75	16	the	the	DT
50458	75	17	albuminoids	albuminoid	NNS
50458	75	18	by	by	IN
50458	75	19	boiling	boil	VBG
50458	75	20	and	and	CC
50458	75	21	defecating	defecate	VBG
50458	75	22	by	by	IN
50458	75	23	adding	add	VBG
50458	75	24	lead	lead	NN
50458	75	25	acetate	acetate	NNP
50458	75	26	,	,	,
50458	75	27	the	the	DT
50458	75	28	liquid	liquid	NN
50458	75	29	is	be	VBZ
50458	75	30	evaporated	evaporate	VBN
50458	75	31	to	to	IN
50458	75	32	one	one	CD
50458	75	33	-	-	HYPH
50458	75	34	half	half	NN
50458	75	35	its	-PRON-	PRP$
50458	75	36	volume	volume	NN
50458	75	37	and	and	CC
50458	75	38	dialyzed	dialyze	VBN
50458	75	39	in	in	IN
50458	75	40	a	a	DT
50458	75	41	vacuum	vacuum	NN
50458	75	42	.	.	.
50458	76	1	[	[	-LRB-
50458	76	2	7	7	CD
50458	76	3	]	]	-RRB-
50458	76	4	[	[	-LRB-
50458	76	5	7	7	CD
50458	76	6	]	]	-RRB-
50458	76	7	ARMAND	ARMAND	NNP
50458	76	8	GAUTIER	GAUTIER	NNP
50458	76	9	:	:	:
50458	76	10	_	_	NNP
50458	76	11	C.	C.	NNP
50458	77	1	rend	rend	VB
50458	77	2	.	.	.
50458	78	1	de	de	NNP
50458	78	2	l'Académie	l'Académie	NNP
50458	78	3	des	des	NNP
50458	78	4	Sciences	Sciences	NNP
50458	78	5	_	_	NNP
50458	78	6	,	,	,
50458	78	7	CXIV	CXIV	NNP
50458	78	8	,	,	,
50458	78	9	p.	p.	NN
50458	78	10	1256	1256	CD
50458	78	11	.	.	.
50458	79	1	_	_	NNP
50458	79	2	Ibid	Ibid	NNP
50458	79	3	.	.	.
50458	79	4	_	_	NNP
50458	79	5	,	,	,
50458	79	6	XCVII	XCVII	NNP
50458	79	7	,	,	,
50458	79	8	p.	p.	NN
50458	79	9	264	264	CD
50458	79	10	,	,	,
50458	79	11	and	and	CC
50458	79	12	XCIV	xciv	NN
50458	79	13	,	,	,
50458	79	14	p.	p.	NN
50458	79	15	1600	1600	CD
50458	79	16	.	.	.
50458	80	1	Phosphomolybdate	phosphomolybdate	NN
50458	80	2	is	be	VBZ
50458	80	3	then	then	RB
50458	80	4	added	add	VBN
50458	80	5	to	to	IN
50458	80	6	the	the	DT
50458	80	7	dialyzed	dialyzed	JJ
50458	80	8	liquid	liquid	NN
50458	80	9	,	,	,
50458	80	10	and	and	CC
50458	80	11	the	the	DT
50458	80	12	precipitate	precipitate	NN
50458	80	13	formed	form	VBN
50458	80	14	,	,	,
50458	80	15	which	which	WDT
50458	80	16	now	now	RB
50458	80	17	contains	contain	VBZ
50458	80	18	all	all	PDT
50458	80	19	the	the	DT
50458	80	20	bases	basis	NNS
50458	80	21	,	,	,
50458	80	22	decomposed	decompose	VBN
50458	80	23	by	by	IN
50458	80	24	boiling	boil	VBG
50458	80	25	with	with	IN
50458	80	26	lead	lead	JJ
50458	80	27	acetate	acetate	RB
50458	80	28	.	.	.
50458	81	1	After	after	IN
50458	81	2	removing	remove	VBG
50458	81	3	the	the	DT
50458	81	4	excess	excess	NN
50458	81	5	of	of	IN
50458	81	6	lead	lead	NN
50458	81	7	,	,	,
50458	81	8	there	there	EX
50458	81	9	is	be	VBZ
50458	81	10	thus	thus	RB
50458	81	11	obtained	obtain	VBN
50458	81	12	a	a	DT
50458	81	13	limpid	limpid	JJ
50458	81	14	solution	solution	NN
50458	81	15	of	of	IN
50458	81	16	all	all	PDT
50458	81	17	the	the	DT
50458	81	18	alkaloidal	alkaloidal	NN
50458	81	19	bases	basis	NNS
50458	81	20	in	in	IN
50458	81	21	the	the	DT
50458	81	22	form	form	NN
50458	81	23	of	of	IN
50458	81	24	acetates	acetate	NNS
50458	81	25	.	.	.
50458	82	1	These	these	DT
50458	82	2	are	be	VBP
50458	82	3	separated	separate	VBN
50458	82	4	by	by	IN
50458	82	5	alcohol	alcohol	NN
50458	82	6	and	and	CC
50458	82	7	by	by	IN
50458	82	8	means	mean	NNS
50458	82	9	of	of	IN
50458	82	10	fractional	fractional	JJ
50458	82	11	precipitations	precipitation	NNS
50458	82	12	with	with	IN
50458	82	13	various	various	JJ
50458	82	14	metallic	metallic	JJ
50458	82	15	salts	salt	NNS
50458	82	16	,	,	,
50458	82	17	depending	depend	VBG
50458	82	18	upon	upon	IN
50458	82	19	the	the	DT
50458	82	20	known	know	VBN
50458	82	21	properties	property	NNS
50458	82	22	of	of	IN
50458	82	23	the	the	DT
50458	82	24	bases	basis	NNS
50458	82	25	.	.	.
50458	83	1	In	in	IN
50458	83	2	order	order	NN
50458	83	3	to	to	TO
50458	83	4	facilitate	facilitate	VB
50458	83	5	their	-PRON-	PRP$
50458	83	6	study	study	NN
50458	83	7	,	,	,
50458	83	8	the	the	DT
50458	83	9	ptomaines	ptomaine	NNS
50458	83	10	have	have	VBP
50458	83	11	been	be	VBN
50458	83	12	grouped	group	VBN
50458	83	13	under	under	IN
50458	83	14	two	two	CD
50458	83	15	distinct	distinct	JJ
50458	83	16	classes	class	NNS
50458	83	17	,	,	,
50458	83	18	the	the	DT
50458	83	19	one	one	NN
50458	83	20	embracing	embrace	VBG
50458	83	21	the	the	DT
50458	83	22	cadaveric	cadaveric	JJ
50458	83	23	or	or	CC
50458	83	24	putrefactive	putrefactive	JJ
50458	83	25	ptomaines	ptomaine	NNS
50458	83	26	,	,	,
50458	83	27	of	of	IN
50458	83	28	undetermined	undetermined	JJ
50458	83	29	microbial	microbial	JJ
50458	83	30	origin	origin	NN
50458	83	31	,	,	,
50458	83	32	the	the	DT
50458	83	33	other	other	JJ
50458	83	34	containing	contain	VBG
50458	83	35	the	the	DT
50458	83	36	ptomaines	ptomaine	NNS
50458	83	37	formed	form	VBN
50458	83	38	by	by	IN
50458	83	39	microbes	microbe	NNS
50458	83	40	of	of	IN
50458	83	41	known	know	VBN
50458	83	42	character	character	NN
50458	83	43	.	.	.
50458	84	1	Each	each	DT
50458	84	2	of	of	IN
50458	84	3	these	these	DT
50458	84	4	two	two	CD
50458	84	5	groups	group	NNS
50458	84	6	is	be	VBZ
50458	84	7	itself	-PRON-	PRP
50458	84	8	divided	divide	VBN
50458	84	9	into	into	IN
50458	84	10	subgroups	subgroup	NNS
50458	84	11	,	,	,
50458	84	12	as	as	IN
50458	84	13	shown	show	VBN
50458	84	14	in	in	IN
50458	84	15	the	the	DT
50458	84	16	following	following	JJ
50458	84	17	table	table	NN
50458	84	18	:	:	:
50458	84	19	GROUP	GROUP	NNP
50458	84	20	I.	I.	NNP
50458	85	1	=	=	NFP
50458	85	2	CADAVERIC	CADAVERIC	NNP
50458	85	3	PTOMAINES	PTOMAINES	NNP
50458	85	4	OF	of	IN
50458	85	5	UNDETERMINED	UNDETERMINED	NNP
50458	85	6	MICROBIAL	MICROBIAL	NNP
50458	85	7	ORIGIN.=	ORIGIN.=	NNP
50458	85	8	_	_	NNP
50458	85	9	a.	a.	NN
50458	85	10	_	_	NNP
50458	85	11	Amines	Amines	NNP
50458	85	12	.	.	.
50458	86	1	_	_	NNP
50458	86	2	b.	b.	NNP
50458	86	3	_	_	NNP
50458	86	4	Guanidines	Guanidines	NNP
50458	86	5	.	.	.
50458	87	1	_	_	NNP
50458	87	2	c.	c.	NNP
50458	87	3	_	_	NNP
50458	87	4	Oxamines	Oxamines	NNP
50458	87	5	(	(	-LRB-
50458	87	6	fatty	fatty	NNP
50458	87	7	or	or	CC
50458	87	8	aromatic	aromatic	JJ
50458	87	9	)	)	-RRB-
50458	87	10	.	.	.
50458	88	1	_	_	NNP
50458	88	2	d.	d.	NNP
50458	88	3	_	_	NNP
50458	88	4	Amido	Amido	NNP
50458	88	5	Acids	Acids	NNP
50458	88	6	.	.	.
50458	89	1	_	_	NNP
50458	89	2	e.	e.	NNP
50458	89	3	_	_	NNP
50458	89	4	Carbopyridic	Carbopyridic	NNP
50458	89	5	Acids	Acids	NNP
50458	89	6	and	and	CC
50458	89	7	analogues	analogue	NNS
50458	89	8	.	.	.
50458	90	1	_	_	NNP
50458	90	2	f.	f.	NNP
50458	90	3	_	_	NNP
50458	90	4	Undetermined	Undetermined	NNP
50458	90	5	Ptomaines	Ptomaines	NNP
50458	90	6	.	.	.
50458	91	1	GROUP	GROUP	NNP
50458	91	2	II	II	NNP
50458	91	3	.	.	.
50458	92	1	=	=	NFP
50458	92	2	PTOMAINES	PTOMAINES	NNP
50458	92	3	OF	of	IN
50458	92	4	KNOWN	KNOWN	NNP
50458	92	5	MICROBIAL	MICROBIAL	NNP
50458	92	6	ORIGIN.=	ORIGIN.=	NNPS
50458	92	7	_	_	NNP
50458	92	8	a.	a.	NN
50458	92	9	_	_	NNP
50458	92	10	Ptomaines	Ptomaines	NNP
50458	92	11	extracted	extract	VBD
50458	92	12	from	from	IN
50458	92	13	microbial	microbial	JJ
50458	92	14	cells	cell	NNS
50458	92	15	.	.	.
50458	93	1	_	_	NNP
50458	93	2	b.	b.	NN
50458	93	3	_	_	NNP
50458	93	4	Ptomaines	Ptomaines	NNP
50458	93	5	from	from	IN
50458	93	6	pathological	pathological	JJ
50458	93	7	urines	urine	NNS
50458	93	8	.	.	.
50458	94	1	We	-PRON-	PRP
50458	94	2	will	will	MD
50458	94	3	not	not	RB
50458	94	4	here	here	RB
50458	94	5	enter	enter	VB
50458	94	6	upon	upon	IN
50458	94	7	a	a	DT
50458	94	8	detailed	detailed	JJ
50458	94	9	study	study	NN
50458	94	10	of	of	IN
50458	94	11	the	the	DT
50458	94	12	bases	basis	NNS
50458	94	13	belonging	belong	VBG
50458	94	14	to	to	IN
50458	94	15	each	each	DT
50458	94	16	of	of	IN
50458	94	17	these	these	DT
50458	94	18	groups	group	NNS
50458	94	19	.	.	.
50458	95	1	This	this	DT
50458	95	2	subject	subject	NN
50458	95	3	is	be	VBZ
50458	95	4	a	a	DT
50458	95	5	vast	vast	JJ
50458	95	6	one	one	NN
50458	95	7	,	,	,
50458	95	8	requiring	require	VBG
50458	95	9	for	for	IN
50458	95	10	its	-PRON-	PRP$
50458	95	11	treatment	treatment	NN
50458	95	12	a	a	DT
50458	95	13	volume	volume	NN
50458	95	14	devoted	devote	VBN
50458	95	15	to	to	IN
50458	95	16	it	-PRON-	PRP
50458	95	17	alone	alone	JJ
50458	95	18	.	.	.
50458	96	1	We	-PRON-	PRP
50458	96	2	will	will	MD
50458	96	3	here	here	RB
50458	96	4	simply	simply	RB
50458	96	5	touch	touch	VB
50458	96	6	upon	upon	IN
50458	96	7	the	the	DT
50458	96	8	principal	principal	JJ
50458	96	9	properties	property	NNS
50458	96	10	of	of	IN
50458	96	11	several	several	JJ
50458	96	12	of	of	IN
50458	96	13	the	the	DT
50458	96	14	bases	basis	NNS
50458	96	15	of	of	IN
50458	96	16	each	each	DT
50458	96	17	of	of	IN
50458	96	18	the	the	DT
50458	96	19	subgroups	subgroup	NNS
50458	96	20	named	name	VBN
50458	96	21	.	.	.
50458	97	1	BASES	basis	NNS
50458	97	2	OF	of	IN
50458	97	3	GROUP	GROUP	NNP
50458	97	4	I.	I.	NNP
50458	98	1	_	_	NNP
50458	98	2	a.	a.	NN
50458	98	3	_	_	NNP
50458	98	4	=	=	SYM
50458	98	5	Amines.=--Among	Amines.=--Among	``
50458	98	6	these	these	DT
50458	98	7	we	-PRON-	PRP
50458	98	8	find	find	VBP
50458	98	9	nearly	nearly	RB
50458	98	10	all	all	PDT
50458	98	11	the	the	DT
50458	98	12	fatty	fatty	NN
50458	98	13	amines	amine	NNS
50458	98	14	,	,	,
50458	98	15	such	such	JJ
50458	98	16	as	as	IN
50458	98	17	the	the	DT
50458	98	18	methylamines	methylamine	NNS
50458	98	19	and	and	CC
50458	98	20	the	the	DT
50458	98	21	cyclic	cyclic	NN
50458	98	22	alkaloids	alkaloid	NNS
50458	98	23	such	such	JJ
50458	98	24	as	as	IN
50458	98	25	pyridine	pyridine	NNP
50458	98	26	.	.	.
50458	99	1	They	-PRON-	PRP
50458	99	2	are	be	VBP
50458	99	3	formed	form	VBN
50458	99	4	particularly	particularly	RB
50458	99	5	by	by	IN
50458	99	6	the	the	DT
50458	99	7	putrefaction	putrefaction	NN
50458	99	8	of	of	IN
50458	99	9	fish	fish	NN
50458	99	10	.	.	.
50458	100	1	Certain	certain	JJ
50458	100	2	of	of	IN
50458	100	3	these	these	DT
50458	100	4	bases	basis	NNS
50458	100	5	are	be	VBP
50458	100	6	very	very	RB
50458	100	7	toxic	toxic	JJ
50458	100	8	,	,	,
50458	100	9	for	for	IN
50458	100	10	instance	instance	NN
50458	100	11	trimethylene	trimethylene	NNP
50458	100	12	diamine	diamine	NNP
50458	100	13	,	,	,
50458	100	14	the	the	DT
50458	100	15	collidines	collidine	NNS
50458	100	16	,	,	,
50458	100	17	and	and	CC
50458	100	18	the	the	DT
50458	100	19	parvolines	parvoline	NNS
50458	100	20	.	.	.
50458	101	1	_	_	NNP
50458	101	2	b.	b.	NNP
50458	101	3	_	_	NNP
50458	101	4	=	=	SYM
50458	101	5	Guanidines.=--Among	guanidines.=--among	ADD
50458	101	6	the	the	DT
50458	101	7	products	product	NNS
50458	101	8	of	of	IN
50458	101	9	ordinary	ordinary	JJ
50458	101	10	putrefaction	putrefaction	NN
50458	101	11	there	there	EX
50458	101	12	has	have	VBZ
50458	101	13	been	be	VBN
50458	101	14	found	find	VBN
50458	101	15	so	so	RB
50458	101	16	far	far	RB
50458	101	17	only	only	JJ
50458	101	18	methylguanidine	methylguanidine	NN
50458	101	19	,	,	,
50458	101	20	C{2}H{7}N{3	C{2}H{7}N{3	NNP
50458	101	21	}	}	-RRB-
50458	101	22	.	.	.
50458	102	1	This	this	DT
50458	102	2	is	be	VBZ
50458	102	3	a	a	DT
50458	102	4	highly	highly	RB
50458	102	5	toxic	toxic	JJ
50458	102	6	base	base	NN
50458	102	7	of	of	IN
50458	102	8	which	which	WDT
50458	102	9	0.2	0.2	CD
50458	102	10	Gm	Gm	NNP
50458	102	11	.	.	.
50458	103	1	is	be	VBZ
50458	103	2	fatal	fatal	JJ
50458	103	3	to	to	IN
50458	103	4	a	a	DT
50458	103	5	guinea	guinea	NN
50458	103	6	-	-	HYPH
50458	103	7	pig	pig	NN
50458	103	8	.	.	.
50458	104	1	_	_	NNP
50458	104	2	c.	c.	NNP
50458	104	3	_	_	NNP
50458	104	4	=	=	SYM
50458	104	5	Oxamines.=--Under	Oxamines.=--Under	NNP
50458	104	6	this	this	DT
50458	104	7	designation	designation	NN
50458	104	8	the	the	DT
50458	104	9	following	follow	VBG
50458	104	10	bases	basis	NNS
50458	104	11	are	be	VBP
50458	104	12	comprised	comprise	VBN
50458	104	13	:	:	:
50458	104	14	1	1	CD
50458	104	15	.	.	.
50458	105	1	Neurine	Neurine	NNP
50458	105	2	bases	basis	NNS
50458	105	3	;	;	:
50458	105	4	2	2	LS
50458	105	5	.	.	.
50458	105	6	oxygenized	oxygenized	JJ
50458	105	7	aromatic	aromatic	JJ
50458	105	8	bases	basis	NNS
50458	105	9	;	;	:
50458	105	10	3	3	LS
50458	105	11	.	.	.
50458	105	12	bases	basis	NNS
50458	105	13	of	of	IN
50458	105	14	unknown	unknown	JJ
50458	105	15	constitution	constitution	NN
50458	105	16	.	.	.
50458	106	1	Amongst	amongst	IN
50458	106	2	them	-PRON-	PRP
50458	106	3	we	-PRON-	PRP
50458	106	4	find	find	VBP
50458	106	5	neurine	neurine	NN
50458	106	6	and	and	CC
50458	106	7	choline	choline	NN
50458	106	8	,	,	,
50458	106	9	which	which	WDT
50458	106	10	are	be	VBP
50458	106	11	toxic	toxic	JJ
50458	106	12	,	,	,
50458	106	13	and	and	CC
50458	106	14	betaine	betaine	JJ
50458	106	15	,	,	,
50458	106	16	which	which	WDT
50458	106	17	is	be	VBZ
50458	106	18	innocuous	innocuous	JJ
50458	106	19	.	.	.
50458	107	1	They	-PRON-	PRP
50458	107	2	are	be	VBP
50458	107	3	found	find	VBN
50458	107	4	particularly	particularly	RB
50458	107	5	in	in	IN
50458	107	6	putrid	putrid	JJ
50458	107	7	fish	fish	NN
50458	107	8	.	.	.
50458	108	1	_	_	NNP
50458	108	2	d.	d.	NNP
50458	108	3	_	_	NNP
50458	108	4	=	=	SYM
50458	108	5	Amido	Amido	NNP
50458	108	6	Acids.=--These	Acids.=--These	''
50458	108	7	ptomaines	ptomaine	NNS
50458	108	8	,	,	,
50458	108	9	which	which	WDT
50458	108	10	are	be	VBP
50458	108	11	usually	usually	RB
50458	108	12	innocuous	innocuous	JJ
50458	108	13	in	in	IN
50458	108	14	small	small	JJ
50458	108	15	quantities	quantity	NNS
50458	108	16	,	,	,
50458	108	17	are	be	VBP
50458	108	18	particularly	particularly	RB
50458	108	19	the	the	DT
50458	108	20	products	product	NNS
50458	108	21	of	of	IN
50458	108	22	the	the	DT
50458	108	23	decomposition	decomposition	NN
50458	108	24	of	of	IN
50458	108	25	albuminoid	albuminoid	NN
50458	108	26	substances	substance	NNS
50458	108	27	.	.	.
50458	109	1	Among	among	IN
50458	109	2	them	-PRON-	PRP
50458	109	3	we	-PRON-	PRP
50458	109	4	find	find	VBP
50458	109	5	glycocoll	glycocoll	NN
50458	109	6	,	,	,
50458	109	7	leucine	leucine	NNP
50458	109	8	,	,	,
50458	109	9	and	and	CC
50458	109	10	tyrosine	tyrosine	NN
50458	109	11	,	,	,
50458	109	12	as	as	IN
50458	109	13	members	member	NNS
50458	109	14	of	of	IN
50458	109	15	this	this	DT
50458	109	16	group	group	NN
50458	109	17	.	.	.
50458	110	1	_	_	NNP
50458	110	2	e.	e.	NNP
50458	110	3	_	_	NNP
50458	110	4	=	=	SYM
50458	110	5	Carbopyridic	Carbopyridic	NNP
50458	110	6	and	and	CC
50458	110	7	Carboquinoleic	Carboquinoleic	NNP
50458	110	8	Acids.=--So	Acids.=--So	NNP
50458	110	9	far	far	RB
50458	110	10	only	only	RB
50458	110	11	one	one	CD
50458	110	12	base	base	NN
50458	110	13	is	be	VBZ
50458	110	14	known	know	VBN
50458	110	15	belonging	belong	VBG
50458	110	16	to	to	IN
50458	110	17	this	this	DT
50458	110	18	group	group	NN
50458	110	19	,	,	,
50458	110	20	and	and	CC
50458	110	21	that	that	DT
50458	110	22	is	be	VBZ
50458	110	23	morrhuic	morrhuic	NNS
50458	110	24	acid	acid	NNP
50458	110	25	,	,	,
50458	110	26	which	which	WDT
50458	110	27	is	be	VBZ
50458	110	28	found	find	VBN
50458	110	29	in	in	IN
50458	110	30	the	the	DT
50458	110	31	decomposed	decompose	VBN
50458	110	32	livers	liver	NNS
50458	110	33	of	of	IN
50458	110	34	codfish	codfish	NN
50458	110	35	,	,	,
50458	110	36	and	and	CC
50458	110	37	which	which	WDT
50458	110	38	is	be	VBZ
50458	110	39	a	a	DT
50458	110	40	powerful	powerful	JJ
50458	110	41	appetizer	appetizer	NN
50458	110	42	and	and	CC
50458	110	43	stimulant	stimulant	NN
50458	110	44	in	in	IN
50458	110	45	disassimilation	disassimilation	NN
50458	110	46	.	.	.
50458	111	1	_	_	NNP
50458	111	2	f.	f.	NNP
50458	111	3	_	_	NNP
50458	111	4	=	=	SYM
50458	111	5	Undetermined	Undetermined	NNP
50458	111	6	Ptomaines.=--Under	Ptomaines.=--Under	NNP
50458	111	7	this	this	DT
50458	111	8	heading	heading	NN
50458	111	9	are	be	VBP
50458	111	10	classed	class	VBN
50458	111	11	certain	certain	JJ
50458	111	12	undetermined	undetermined	JJ
50458	111	13	bases	basis	NNS
50458	111	14	,	,	,
50458	111	15	such	such	JJ
50458	111	16	as	as	IN
50458	111	17	those	those	DT
50458	111	18	found	find	VBN
50458	111	19	in	in	IN
50458	111	20	normal	normal	JJ
50458	111	21	urines	urine	NNS
50458	111	22	,	,	,
50458	111	23	and	and	CC
50458	111	24	in	in	IN
50458	111	25	spoiled	spoiled	JJ
50458	111	26	meats	meat	NNS
50458	111	27	and	and	CC
50458	111	28	bread	bread	NN
50458	111	29	.	.	.
50458	112	1	BASES	basis	NNS
50458	112	2	OF	of	IN
50458	112	3	GROUP	GROUP	NNP
50458	112	4	II	II	NNP
50458	112	5	.	.	.
50458	113	1	_	_	NNP
50458	113	2	a.	a.	NN
50458	113	3	_	_	NNP
50458	113	4	=	=	SYM
50458	113	5	Ptomaines	Ptomaines	NNP
50458	113	6	Isolated	isolate	VBN
50458	113	7	from	from	IN
50458	113	8	Cultures	culture	NNS
50458	113	9	of	of	IN
50458	113	10	Pathogenic	pathogenic	JJ
50458	113	11	Bacteria.=--Bacterial	bacteria.=--bacterial	JJ
50458	113	12	cultures	culture	NNS
50458	113	13	contain	contain	VBP
50458	113	14	,	,	,
50458	113	15	besides	besides	IN
50458	113	16	the	the	DT
50458	113	17	true	true	JJ
50458	113	18	toxins	toxin	NNS
50458	113	19	,	,	,
50458	113	20	a	a	DT
50458	113	21	certain	certain	JJ
50458	113	22	number	number	NN
50458	113	23	of	of	IN
50458	113	24	alkaloidal	alkaloidal	NN
50458	113	25	bases	basis	NNS
50458	113	26	which	which	WDT
50458	113	27	sometimes	sometimes	RB
50458	113	28	possess	possess	VBP
50458	113	29	considerable	considerable	JJ
50458	113	30	toxicity	toxicity	NN
50458	113	31	.	.	.
50458	114	1	In	in	IN
50458	114	2	the	the	DT
50458	114	3	cultures	culture	NNS
50458	114	4	of	of	IN
50458	114	5	streptococcus	streptococcus	NN
50458	114	6	pyogenes	pyogene	NNS
50458	114	7	there	there	EX
50458	114	8	are	be	VBP
50458	114	9	found	find	VBN
50458	114	10	trimethylamine	trimethylamine	NN
50458	114	11	and	and	CC
50458	114	12	xanthic	xanthic	JJ
50458	114	13	bases	basis	NNS
50458	114	14	;	;	:
50458	114	15	in	in	IN
50458	114	16	those	those	DT
50458	114	17	of	of	IN
50458	114	18	staphylococcus	staphylococcus	NN
50458	114	19	pyogenes	pyogene	NNS
50458	114	20	aureus	aureus	NNP
50458	114	21	are	be	VBP
50458	114	22	found	find	VBN
50458	114	23	xanthic	xanthic	JJ
50458	114	24	bases	basis	NNS
50458	114	25	and	and	CC
50458	114	26	creatinine	creatinine	NN
50458	114	27	;	;	:
50458	114	28	while	while	IN
50458	114	29	pyocyanine	pyocyanine	NN
50458	114	30	and	and	CC
50458	114	31	pyoxanthine	pyoxanthine	NN
50458	114	32	are	be	VBP
50458	114	33	found	find	VBN
50458	114	34	in	in	IN
50458	114	35	the	the	DT
50458	114	36	cultures	culture	NNS
50458	114	37	of	of	IN
50458	114	38	bacillus	bacillus	NN
50458	114	39	pyocyaneus	pyocyaneu	NNS
50458	114	40	,	,	,
50458	114	41	etc	etc	FW
50458	114	42	.	.	.
50458	115	1	_	_	NNP
50458	115	2	b.	b.	NNP
50458	115	3	_	_	NNP
50458	115	4	=	=	SYM
50458	115	5	Ptomaines	Ptomaines	NNP
50458	115	6	Isolated	isolate	VBN
50458	115	7	from	from	IN
50458	115	8	Pathological	pathological	JJ
50458	115	9	Urines.=--Toxic	urines.=--toxic	JJ
50458	115	10	ptomaine	ptomaine	NN
50458	115	11	bases	basis	NNS
50458	115	12	have	have	VBP
50458	115	13	been	be	VBN
50458	115	14	found	find	VBN
50458	115	15	in	in	IN
50458	115	16	the	the	DT
50458	115	17	urines	urine	NNS
50458	115	18	of	of	IN
50458	115	19	a	a	DT
50458	115	20	large	large	JJ
50458	115	21	number	number	NN
50458	115	22	of	of	IN
50458	115	23	diseases	disease	NNS
50458	115	24	.	.	.
50458	116	1	[	[	-LRB-
50458	116	2	8	8	CD
50458	116	3	]	]	-RRB-
50458	116	4	It	-PRON-	PRP
50458	116	5	is	be	VBZ
50458	116	6	quite	quite	RB
50458	116	7	probable	probable	JJ
50458	116	8	that	that	IN
50458	116	9	these	these	DT
50458	116	10	bases	basis	NNS
50458	116	11	are	be	VBP
50458	116	12	the	the	DT
50458	116	13	results	result	NNS
50458	116	14	of	of	IN
50458	116	15	a	a	DT
50458	116	16	general	general	JJ
50458	116	17	pathological	pathological	JJ
50458	116	18	condition	condition	NN
50458	116	19	due	due	JJ
50458	116	20	to	to	IN
50458	116	21	some	some	DT
50458	116	22	bacterial	bacterial	JJ
50458	116	23	disease	disease	NN
50458	116	24	,	,	,
50458	116	25	the	the	DT
50458	116	26	toxic	toxic	JJ
50458	116	27	products	product	NNS
50458	116	28	of	of	IN
50458	116	29	which	which	WDT
50458	116	30	are	be	VBP
50458	116	31	eliminated	eliminate	VBN
50458	116	32	by	by	IN
50458	116	33	the	the	DT
50458	116	34	kidneys	kidney	NNS
50458	116	35	.	.	.
50458	117	1	[	[	-LRB-
50458	117	2	8	8	CD
50458	117	3	]	]	-RRB-
50458	117	4	GRIFFITHS	GRIFFITHS	NNP
50458	117	5	:	:	:
50458	117	6	_	_	NNP
50458	117	7	C.	C.	NNP
50458	118	1	rend	rend	VB
50458	118	2	.	.	.
50458	119	1	de	de	NNP
50458	119	2	l'Académie	l'Académie	NNP
50458	119	3	des	des	NNP
50458	119	4	Sciences	Sciences	NNP
50458	119	5	_	_	NNP
50458	119	6	,	,	,
50458	119	7	CXV	CXV	NNP
50458	119	8	,	,	,
50458	119	9	pp	pp	NNP
50458	119	10	.	.	.
50458	120	1	285	285	CD
50458	120	2	and	and	CC
50458	120	3	667	667	CD
50458	120	4	.	.	.
50458	121	1	From	from	IN
50458	121	2	the	the	DT
50458	121	3	urines	urine	NNS
50458	121	4	of	of	IN
50458	121	5	epileptics	epileptic	NNS
50458	121	6	Griffiths[9	griffiths[9	NN
50458	121	7	]	]	-RRB-
50458	121	8	isolated	isolate	VBD
50458	121	9	a	a	DT
50458	121	10	colorless	colorless	JJ
50458	121	11	base	base	NN
50458	121	12	crystallizing	crystallize	VBG
50458	121	13	in	in	IN
50458	121	14	prisms	prism	NNS
50458	121	15	having	have	VBG
50458	121	16	the	the	DT
50458	121	17	formula	formula	NN
50458	121	18	C{12}H{15}N{5}O{7	C{12}H{15}N{5}O{7	:
50458	121	19	}	}	-RRB-
50458	121	20	,	,	,
50458	121	21	and	and	CC
50458	121	22	which	which	WDT
50458	121	23	was	be	VBD
50458	121	24	found	find	VBN
50458	121	25	to	to	TO
50458	121	26	be	be	VB
50458	121	27	exceedingly	exceedingly	RB
50458	121	28	toxic	toxic	JJ
50458	121	29	;	;	:
50458	121	30	the	the	DT
50458	121	31	same	same	JJ
50458	121	32	investigator	investigator	NN
50458	121	33	isolated	isolate	VBD
50458	121	34	from	from	IN
50458	121	35	the	the	DT
50458	121	36	urines	urine	NNS
50458	121	37	of	of	IN
50458	121	38	eczematous	eczematous	JJ
50458	121	39	subjects	subject	NNS
50458	121	40	a	a	DT
50458	121	41	ptomaine	ptomaine	NN
50458	121	42	which	which	WDT
50458	121	43	he	-PRON-	PRP
50458	121	44	named	name	VBD
50458	121	45	_	_	NNP
50458	121	46	eczemine_,[10	eczemine_,[10	NNP
50458	121	47	]	]	-RRB-
50458	121	48	and	and	CC
50458	121	49	which	which	WDT
50458	121	50	is	be	VBZ
50458	121	51	also	also	RB
50458	121	52	highly	highly	RB
50458	121	53	toxic	toxic	JJ
50458	121	54	.	.	.
50458	122	1	[	[	-LRB-
50458	122	2	9	9	CD
50458	122	3	]	]	-RRB-
50458	122	4	E.	E.	NNP
50458	122	5	POUCHET	POUCHET	NNP
50458	122	6	:	:	:
50458	122	7	Contribution	Contribution	NNP
50458	122	8	à	à	NNP
50458	122	9	l'étude	l'étude	NNP
50458	122	10	des	des	NNP
50458	122	11	matières	matière	NNS
50458	122	12	extractives	extractive	NNS
50458	122	13	de	de	NNP
50458	122	14	l'urine	l'urine	NNP
50458	122	15	,	,	,
50458	122	16	_	_	NNP
50458	122	17	Thèse	Thèse	NNP
50458	122	18	_	_	NNP
50458	122	19	,	,	,
50458	122	20	Paris	Paris	NNP
50458	122	21	,	,	,
50458	122	22	1880	1880	CD
50458	122	23	;	;	:
50458	122	24	_	_	NNP
50458	122	25	Ibid	Ibid	NNP
50458	122	26	.	.	.
50458	122	27	_	_	NNP
50458	122	28	,	,	,
50458	122	29	_	_	NNP
50458	122	30	C.	C.	NNP
50458	123	1	rend	rend	VB
50458	123	2	.	.	.
50458	124	1	de	de	NNP
50458	124	2	l'Académie	l'Académie	NNP
50458	124	3	des	des	NNP
50458	124	4	Sc	Sc	NNP
50458	124	5	.	.	.
50458	124	6	_	_	NNP
50458	124	7	,	,	,
50458	124	8	XCVII	XCVII	NNP
50458	124	9	,	,	,
50458	124	10	p.	p.	NN
50458	124	11	1560	1560	CD
50458	124	12	;	;	:
50458	124	13	BOUCHARD	BOUCHARD	NNP
50458	124	14	:	:	:
50458	124	15	_	_	NNP
50458	124	16	C.	C.	NNP
50458	125	1	rend	rend	VB
50458	125	2	.	.	.
50458	126	1	Soc	Soc	NNP
50458	126	2	.	.	.
50458	127	1	de	de	NNP
50458	127	2	Biolog	Biolog	NNP
50458	127	3	.	.	.
50458	127	4	_	_	NNP
50458	127	5	,	,	,
50458	127	6	Aug.	August	NNP
50458	127	7	12	12	CD
50458	127	8	,	,	,
50458	127	9	1882	1882	CD
50458	127	10	.	.	.
50458	128	1	[	[	-LRB-
50458	128	2	10	10	CD
50458	128	3	]	]	-RRB-
50458	128	4	GRIFFITHS	GRIFFITHS	NNP
50458	128	5	:	:	:
50458	128	6	_	_	NNP
50458	128	7	C.	C.	NNP
50458	129	1	rend	rend	VB
50458	129	2	.	.	.
50458	130	1	de	de	NNP
50458	130	2	l'Académie	l'Académie	NNP
50458	130	3	des	des	NNP
50458	130	4	Sciences	Sciences	NNP
50458	130	5	_	_	NNP
50458	130	6	,	,	,
50458	130	7	CXVI	CXVI	NNP
50458	130	8	,	,	,
50458	130	9	p.	p.	NN
50458	130	10	1206	1206	CD
50458	130	11	.	.	.
50458	131	1	In	in	IN
50458	131	2	certain	certain	JJ
50458	131	3	cases	case	NNS
50458	131	4	of	of	IN
50458	131	5	cystinuria	cystinuria	NNS
50458	131	6	there	there	EX
50458	131	7	are	be	VBP
50458	131	8	found	find	VBN
50458	131	9	in	in	IN
50458	131	10	the	the	DT
50458	131	11	urine	urine	NN
50458	131	12	sulphurized	sulphurize	VBD
50458	131	13	ptomaines	ptomaine	NNS
50458	131	14	,	,	,
50458	131	15	and	and	CC
50458	131	16	in	in	IN
50458	131	17	measles	measle	NNS
50458	131	18	the	the	DT
50458	131	19	urine	urine	NN
50458	131	20	contains	contain	VBZ
50458	131	21	an	an	DT
50458	131	22	undetermined	undetermined	JJ
50458	131	23	ptomaine	ptomaine	NN
50458	131	24	,	,	,
50458	131	25	_	_	NNP
50458	131	26	rubedine	rubedine	NNP
50458	131	27	_	_	NNP
50458	131	28	,	,	,
50458	131	29	which	which	WDT
50458	131	30	is	be	VBZ
50458	131	31	very	very	RB
50458	131	32	poisonous	poisonous	JJ
50458	131	33	.	.	.
50458	132	1	_	_	NNP
50458	132	2	Typhotoxine	Typhotoxine	NNP
50458	132	3	_	_	NNP
50458	132	4	,	,	,
50458	132	5	a	a	DT
50458	132	6	very	very	RB
50458	132	7	toxic	toxic	JJ
50458	132	8	ptomaine	ptomaine	NN
50458	132	9	,	,	,
50458	132	10	has	have	VBZ
50458	132	11	been	be	VBN
50458	132	12	isolated	isolate	VBN
50458	132	13	from	from	IN
50458	132	14	the	the	DT
50458	132	15	urine	urine	NN
50458	132	16	of	of	IN
50458	132	17	typhoid	typhoid	NN
50458	132	18	patients	patient	NNS
50458	132	19	;	;	:
50458	132	20	_	_	NNP
50458	132	21	erysipeline	erysipeline	NN
50458	132	22	_	_	NNP
50458	132	23	,	,	,
50458	132	24	a	a	DT
50458	132	25	hardly	hardly	RB
50458	132	26	less	less	RBR
50458	132	27	toxic	toxic	JJ
50458	132	28	base	base	NN
50458	132	29	,	,	,
50458	132	30	exists	exist	VBZ
50458	132	31	in	in	IN
50458	132	32	the	the	DT
50458	132	33	urine	urine	NN
50458	132	34	of	of	IN
50458	132	35	erysipelatic	erysipelatic	JJ
50458	132	36	subjects	subject	NNS
50458	132	37	;	;	:
50458	132	38	while	while	IN
50458	132	39	_	_	NNP
50458	132	40	spasmotoxine	spasmotoxine	NN
50458	132	41	_	_	NNP
50458	132	42	,	,	,
50458	132	43	_	_	NNP
50458	132	44	tetanotoxine	tetanotoxine	NN
50458	132	45	_	_	NNP
50458	132	46	,	,	,
50458	132	47	and	and	CC
50458	132	48	_	_	NNP
50458	132	49	tetanine	tetanine	NN
50458	132	50	_	_	NNP
50458	132	51	,	,	,
50458	132	52	exceedingly	exceedingly	RB
50458	132	53	active	active	JJ
50458	132	54	alkaloids	alkaloid	NNS
50458	132	55	,	,	,
50458	132	56	are	be	VBP
50458	132	57	found	find	VBN
50458	132	58	in	in	IN
50458	132	59	the	the	DT
50458	132	60	urines	urine	NNS
50458	132	61	of	of	IN
50458	132	62	tetanus	tetanus	NN
50458	132	63	patients	patient	NNS
50458	132	64	.	.	.
50458	133	1	[	[	-LRB-
50458	133	2	11	11	CD
50458	133	3	]	]	-RRB-
50458	133	4	[	[	-LRB-
50458	133	5	11	11	CD
50458	133	6	]	]	-RRB-
50458	133	7	BRIEGER	BRIEGER	NNP
50458	133	8	:	:	:
50458	133	9	Untersuchungen	Untersuchungen	NNP
50458	133	10	über	über	NN
50458	133	11	die	die	VBP
50458	133	12	Ptomaine	Ptomaine	NNP
50458	133	13	,	,	,
50458	133	14	dritten	dritten	JJ
50458	133	15	Teil	Teil	NNP
50458	133	16	,	,	,
50458	133	17	p.	p.	NN
50458	133	18	93	93	CD
50458	133	19	;	;	:
50458	133	20	_	_	NNP
50458	133	21	Berichte	Berichte	NNP
50458	133	22	d.	d.	NNP
50458	133	23	D.	D.	NNP
50458	133	24	Chem	Chem	NNP
50458	133	25	.	.	.
50458	134	1	Gesellschaft	Gesellschaft	NNP
50458	134	2	_	_	NNP
50458	134	3	,	,	,
50458	134	4	1886	1886	CD
50458	134	5	,	,	,
50458	134	6	p.	p.	NN
50458	134	7	3159	3159	CD
50458	134	8	;	;	:
50458	134	9	1887	1887	CD
50458	134	10	,	,	,
50458	134	11	p.	p.	NN
50458	134	12	69	69	CD
50458	134	13	.	.	.
50458	135	1	As	as	IN
50458	135	2	a	a	DT
50458	135	3	general	general	JJ
50458	135	4	rule	rule	NN
50458	135	5	,	,	,
50458	135	6	all	all	DT
50458	135	7	abnormal	abnormal	JJ
50458	135	8	urines	urine	NNS
50458	135	9	contain	contain	VBP
50458	135	10	toxic	toxic	JJ
50458	135	11	bases	basis	NNS
50458	135	12	;	;	:
50458	135	13	the	the	DT
50458	135	14	kidneys	kidney	NNS
50458	135	15	appear	appear	VBP
50458	135	16	,	,	,
50458	135	17	in	in	IN
50458	135	18	fact	fact	NN
50458	135	19	,	,	,
50458	135	20	to	to	TO
50458	135	21	serve	serve	VB
50458	135	22	as	as	IN
50458	135	23	a	a	DT
50458	135	24	means	means	NN
50458	135	25	of	of	IN
50458	135	26	eliminating	eliminate	VBG
50458	135	27	the	the	DT
50458	135	28	toxic	toxic	JJ
50458	135	29	products	product	NNS
50458	135	30	that	that	WDT
50458	135	31	form	form	VBP
50458	135	32	in	in	IN
50458	135	33	large	large	JJ
50458	135	34	quantity	quantity	NN
50458	135	35	whenever	whenever	WRB
50458	135	36	,	,	,
50458	135	37	and	and	CC
50458	135	38	for	for	IN
50458	135	39	whatever	whatever	WDT
50458	135	40	cause	cause	NN
50458	135	41	,	,	,
50458	135	42	the	the	DT
50458	135	43	organism	organism	NN
50458	135	44	ceases	cease	VBZ
50458	135	45	to	to	TO
50458	135	46	functionate	functionate	VB
50458	135	47	normally	normally	RB
50458	135	48	,	,	,
50458	135	49	whether	whether	IN
50458	135	50	it	-PRON-	PRP
50458	135	51	be	be	VB
50458	135	52	as	as	IN
50458	135	53	a	a	DT
50458	135	54	whole	whole	NN
50458	135	55	,	,	,
50458	135	56	or	or	CC
50458	135	57	in	in	IN
50458	135	58	any	any	DT
50458	135	59	one	one	CD
50458	135	60	of	of	IN
50458	135	61	its	-PRON-	PRP$
50458	135	62	parts	part	NNS
50458	135	63	.	.	.
50458	136	1	[	[	-LRB-
50458	136	2	12	12	CD
50458	136	3	]	]	-RRB-
50458	136	4	[	[	-LRB-
50458	136	5	12	12	CD
50458	136	6	]	]	-RRB-
50458	136	7	CHARRIN	CHARRIN	NNP
50458	136	8	:	:	:
50458	136	9	_	_	NNP
50458	136	10	Les	Les	NNP
50458	136	11	poisons	poison	NNS
50458	136	12	de	de	IN
50458	136	13	l'urine	l'urine	NNP
50458	136	14	_	_	NNP
50458	136	15	:	:	:
50458	136	16	Encyclopédie	Encyclopédie	NNP
50458	136	17	Léauté	Léauté	NNP
50458	136	18	.	.	.
50458	137	1	=	=	NFP
50458	137	2	Leucomaines.=[13	Leucomaines.=[13	NNS
50458	137	3	]	]	-RRB-
50458	137	4	[	[	-LRB-
50458	137	5	13	13	CD
50458	137	6	]	]	-RRB-
50458	137	7	ARMAND	ARMAND	NNP
50458	137	8	GAUTIER	GAUTIER	NNP
50458	137	9	:	:	:
50458	137	10	_	_	NNP
50458	137	11	Bull	Bull	NNP
50458	137	12	.	.	.
50458	138	1	Acad	Acad	NNS
50458	138	2	.	.	.
50458	139	1	de	de	NNP
50458	139	2	Médecin	Médecin	NNP
50458	139	3	_	_	NNP
50458	139	4	(	(	-LRB-
50458	139	5	2	2	CD
50458	139	6	)	)	-RRB-
50458	139	7	,	,	,
50458	139	8	XV	XV	NNP
50458	139	9	,	,	,
50458	139	10	p.	p.	NN
50458	139	11	115	115	CD
50458	139	12	.	.	.
50458	140	1	The	the	DT
50458	140	2	leucomaines	leucomaine	NNS
50458	140	3	are	be	VBP
50458	140	4	basic	basic	JJ
50458	140	5	substances	substance	NNS
50458	140	6	,	,	,
50458	140	7	nearly	nearly	RB
50458	140	8	allied	ally	VBN
50458	140	9	to	to	IN
50458	140	10	the	the	DT
50458	140	11	ptomaines	ptomaine	NNS
50458	140	12	,	,	,
50458	140	13	but	but	CC
50458	140	14	still	still	RB
50458	140	15	more	more	RBR
50458	140	16	closely	closely	RB
50458	140	17	related	related	JJ
50458	140	18	to	to	IN
50458	140	19	the	the	DT
50458	140	20	ureides	ureide	NNS
50458	140	21	.	.	.
50458	141	1	They	-PRON-	PRP
50458	141	2	are	be	VBP
50458	141	3	formed	form	VBN
50458	141	4	directly	directly	RB
50458	141	5	or	or	CC
50458	141	6	indirectly	indirectly	RB
50458	141	7	by	by	IN
50458	141	8	the	the	DT
50458	141	9	breaking	break	VBG
50458	141	10	down	down	RP
50458	141	11	of	of	IN
50458	141	12	protoplasmal	protoplasmal	JJ
50458	141	13	albuminoids	albuminoid	NNS
50458	141	14	.	.	.
50458	142	1	The	the	DT
50458	142	2	agents	agent	NNS
50458	142	3	that	that	WDT
50458	142	4	effect	effect	VBP
50458	142	5	the	the	DT
50458	142	6	breaking	break	VBG
50458	142	7	down	down	RP
50458	142	8	are	be	VBP
50458	142	9	the	the	DT
50458	142	10	hydrolyzing	hydrolyze	VBG
50458	142	11	ferments	ferment	NNS
50458	142	12	of	of	IN
50458	142	13	the	the	DT
50458	142	14	economy	economy	NN
50458	142	15	.	.	.
50458	143	1	It	-PRON-	PRP
50458	143	2	is	be	VBZ
50458	143	3	well	well	JJ
50458	143	4	to	to	TO
50458	143	5	recall	recall	VB
50458	143	6	here	here	RB
50458	143	7	that	that	IN
50458	143	8	these	these	DT
50458	143	9	phenomena	phenomenon	NNS
50458	143	10	of	of	IN
50458	143	11	hydrolyzation	hydrolyzation	NN
50458	143	12	occur	occur	VBP
50458	143	13	within	within	IN
50458	143	14	the	the	DT
50458	143	15	cell	cell	NN
50458	143	16	itself	-PRON-	PRP
50458	143	17	and	and	CC
50458	143	18	in	in	IN
50458	143	19	a	a	DT
50458	143	20	practically	practically	RB
50458	143	21	reducing	reduce	VBG
50458	143	22	medium	medium	NN
50458	143	23	,	,	,
50458	143	24	as	as	IN
50458	143	25	we	-PRON-	PRP
50458	143	26	have	have	VBP
50458	143	27	already	already	RB
50458	143	28	stated	state	VBN
50458	143	29	.	.	.
50458	144	1	The	the	DT
50458	144	2	inmost	inmost	JJ
50458	144	3	mechanism	mechanism	NN
50458	144	4	of	of	IN
50458	144	5	these	these	DT
50458	144	6	phenomena	phenomenon	NNS
50458	144	7	can	can	MD
50458	144	8	not	not	RB
50458	144	9	here	here	RB
50458	144	10	be	be	VB
50458	144	11	detailed	detailed	JJ
50458	144	12	;	;	:
50458	144	13	it	-PRON-	PRP
50458	144	14	will	will	MD
50458	144	15	be	be	VB
50458	144	16	found	find	VBN
50458	144	17	described	describe	VBN
50458	144	18	by	by	IN
50458	144	19	Armand	Armand	NNP
50458	144	20	Gautier	Gautier	NNP
50458	144	21	in	in	IN
50458	144	22	the	the	DT
50458	144	23	_	_	NNP
50458	144	24	Chimie	Chimie	NNP
50458	144	25	Biologique	Biologique	NNP
50458	144	26	_	_	NNP
50458	144	27	,	,	,
50458	144	28	and	and	CC
50458	144	29	in	in	IN
50458	144	30	his	-PRON-	PRP$
50458	144	31	work	work	NN
50458	144	32	_	_	NNP
50458	144	33	Chimie	Chimie	NNP
50458	144	34	de	de	NNP
50458	144	35	la	la	NNP
50458	144	36	Cellule	Cellule	NNP
50458	144	37	Vivante	Vivante	NNP
50458	144	38	_	_	NNP
50458	144	39	.	.	.
50458	145	1	[	[	-LRB-
50458	145	2	14	14	CD
50458	145	3	]	]	-RRB-
50458	145	4	[	[	-LRB-
50458	145	5	14	14	CD
50458	145	6	]	]	-RRB-
50458	145	7	ARMAND	ARMAND	NNP
50458	145	8	GAUTIER	GAUTIER	NNP
50458	145	9	:	:	:
50458	145	10	Leçons	Leçons	NNP
50458	145	11	de	de	NNP
50458	145	12	chimie	chimie	NNP
50458	145	13	biologique	biologique	NNP
50458	145	14	.	.	.
50458	146	1	Published	publish	VBN
50458	146	2	by	by	IN
50458	146	3	Masson	Masson	NNP
50458	146	4	;	;	:
50458	146	5	_	_	NNP
50458	146	6	Ibid	Ibid	NNP
50458	146	7	.	.	.
50458	146	8	_	_	NNP
50458	146	9	,	,	,
50458	146	10	Chimie	Chimie	NNP
50458	146	11	de	de	NNP
50458	146	12	la	la	NNP
50458	146	13	cellule	cellule	NNP
50458	146	14	vivante	vivante	NNP
50458	146	15	.	.	.
50458	147	1	Also	also	RB
50458	147	2	published	publish	VBN
50458	147	3	by	by	IN
50458	147	4	Masson	Masson	NNP
50458	147	5	.	.	.
50458	148	1	The	the	DT
50458	148	2	extraction	extraction	NN
50458	148	3	of	of	IN
50458	148	4	these	these	DT
50458	148	5	bases	basis	NNS
50458	148	6	is	be	VBZ
50458	148	7	an	an	DT
50458	148	8	extremely	extremely	RB
50458	148	9	delicate	delicate	JJ
50458	148	10	operation	operation	NN
50458	148	11	.	.	.
50458	149	1	It	-PRON-	PRP
50458	149	2	is	be	VBZ
50458	149	3	necessary	necessary	JJ
50458	149	4	to	to	TO
50458	149	5	operate	operate	VB
50458	149	6	with	with	IN
50458	149	7	a	a	DT
50458	149	8	large	large	JJ
50458	149	9	quantity	quantity	NN
50458	149	10	of	of	IN
50458	149	11	substance	substance	NN
50458	149	12	,	,	,
50458	149	13	say	say	VBP
50458	149	14	50	50	CD
50458	149	15	kilos	kilo	NNS
50458	149	16	.	.	.
50458	150	1	The	the	DT
50458	150	2	substance	substance	NN
50458	150	3	is	be	VBZ
50458	150	4	finely	finely	RB
50458	150	5	chopped	chop	VBN
50458	150	6	,	,	,
50458	150	7	then	then	RB
50458	150	8	exhausted	exhaust	VBN
50458	150	9	with	with	IN
50458	150	10	twice	twice	PDT
50458	150	11	its	-PRON-	PRP$
50458	150	12	weight	weight	NN
50458	150	13	of	of	IN
50458	150	14	water	water	NN
50458	150	15	acidulated	acidulate	VBN
50458	150	16	with	with	IN
50458	150	17	acetic	acetic	JJ
50458	150	18	acid	acid	NN
50458	150	19	(	(	-LRB-
50458	150	20	0.2	0.2	CD
50458	150	21	Cc	Cc	NNP
50458	150	22	.	.	.
50458	151	1	per	per	IN
50458	151	2	liter	liter	RB
50458	151	3	)	)	-RRB-
50458	151	4	and	and	CC
50458	151	5	containing	contain	VBG
50458	151	6	a	a	DT
50458	151	7	trace	trace	NN
50458	151	8	of	of	IN
50458	151	9	oil	oil	NN
50458	151	10	of	of	IN
50458	151	11	mustard	mustard	NN
50458	151	12	,	,	,
50458	151	13	which	which	WDT
50458	151	14	is	be	VBZ
50458	151	15	intended	intend	VBN
50458	151	16	to	to	TO
50458	151	17	act	act	VB
50458	151	18	as	as	IN
50458	151	19	an	an	DT
50458	151	20	antiseptic	antiseptic	NN
50458	151	21	.	.	.
50458	152	1	The	the	DT
50458	152	2	albuminoids	albuminoid	NNS
50458	152	3	are	be	VBP
50458	152	4	precipitated	precipitate	VBN
50458	152	5	by	by	IN
50458	152	6	boiling	boil	VBG
50458	152	7	,	,	,
50458	152	8	the	the	DT
50458	152	9	solution	solution	NN
50458	152	10	then	then	RB
50458	152	11	filtered	filter	VBD
50458	152	12	,	,	,
50458	152	13	evaporated	evaporate	VBD
50458	152	14	in	in	IN
50458	152	15	a	a	DT
50458	152	16	vacuum	vacuum	NN
50458	152	17	at	at	IN
50458	152	18	60	60	CD
50458	152	19	°	°	NNS
50458	152	20	C.	C.	NNP
50458	152	21	,	,	,
50458	152	22	and	and	CC
50458	152	23	the	the	DT
50458	152	24	bases	basis	NNS
50458	152	25	extracted	extract	VBN
50458	152	26	with	with	IN
50458	152	27	95-per	95-per	CD
50458	152	28	cent	cent	NN
50458	152	29	.	.	.
50458	153	1	alcohol	alcohol	NN
50458	153	2	.	.	.
50458	154	1	The	the	DT
50458	154	2	alkaloidal	alkaloidal	NN
50458	154	3	bases	basis	NNS
50458	154	4	obtained	obtain	VBN
50458	154	5	in	in	IN
50458	154	6	this	this	DT
50458	154	7	manner	manner	NN
50458	154	8	are	be	VBP
50458	154	9	separated	separate	VBN
50458	154	10	by	by	IN
50458	154	11	crystallization	crystallization	NN
50458	154	12	from	from	IN
50458	154	13	alcohol	alcohol	NN
50458	154	14	or	or	CC
50458	154	15	by	by	IN
50458	154	16	various	various	JJ
50458	154	17	other	other	JJ
50458	154	18	chemical	chemical	NN
50458	154	19	methods	method	NNS
50458	154	20	,	,	,
50458	154	21	the	the	DT
50458	154	22	description	description	NN
50458	154	23	of	of	IN
50458	154	24	which	which	WDT
50458	154	25	we	-PRON-	PRP
50458	154	26	will	will	MD
50458	154	27	not	not	RB
50458	154	28	enter	enter	VB
50458	154	29	upon	upon	IN
50458	154	30	here	here	RB
50458	154	31	.	.	.
50458	155	1	In	in	IN
50458	155	2	order	order	NN
50458	155	3	to	to	TO
50458	155	4	facilitate	facilitate	VB
50458	155	5	the	the	DT
50458	155	6	study	study	NN
50458	155	7	of	of	IN
50458	155	8	the	the	DT
50458	155	9	leucomaines	leucomaine	NNS
50458	155	10	they	-PRON-	PRP
50458	155	11	are	be	VBP
50458	155	12	classed	class	VBN
50458	155	13	under	under	IN
50458	155	14	three	three	CD
50458	155	15	groups	group	NNS
50458	155	16	,	,	,
50458	155	17	according	accord	VBG
50458	155	18	to	to	IN
50458	155	19	their	-PRON-	PRP$
50458	155	20	chemical	chemical	JJ
50458	155	21	affinities	affinity	NNS
50458	155	22	.	.	.
50458	156	1	These	these	DT
50458	156	2	groups	group	NNS
50458	156	3	are	be	VBP
50458	156	4	as	as	IN
50458	156	5	follows	follow	VBZ
50458	156	6	:	:	:
50458	156	7	1	1	CD
50458	156	8	.	.	.
50458	157	1	=	=	NFP
50458	157	2	Xanthic	xanthic	VB
50458	157	3	Leucomaines.=--The	leucomaines.=--the	NN
50458	157	4	bases	basis	NNS
50458	157	5	of	of	IN
50458	157	6	this	this	DT
50458	157	7	group	group	NN
50458	157	8	appear	appear	VBP
50458	157	9	to	to	TO
50458	157	10	have	have	VB
50458	157	11	a	a	DT
50458	157	12	composition	composition	NN
50458	157	13	resembling	resemble	VBG
50458	157	14	that	that	DT
50458	157	15	of	of	IN
50458	157	16	uric	uric	JJ
50458	157	17	acid	acid	NN
50458	157	18	.	.	.
50458	158	1	When	when	WRB
50458	158	2	hydrolyzed	hydrolyze	VBN
50458	158	3	,	,	,
50458	158	4	they	-PRON-	PRP
50458	158	5	yield	yield	VBP
50458	158	6	urea	urea	NNP
50458	158	7	and	and	CC
50458	158	8	guanidine	guanidine	NNP
50458	158	9	.	.	.
50458	159	1	They	-PRON-	PRP
50458	159	2	are	be	VBP
50458	159	3	weak	weak	JJ
50458	159	4	bases	basis	NNS
50458	159	5	,	,	,
50458	159	6	and	and	CC
50458	159	7	exhibit	exhibit	VB
50458	159	8	both	both	CC
50458	159	9	basic	basic	JJ
50458	159	10	and	and	CC
50458	159	11	weakly	weakly	JJ
50458	159	12	acid	acid	JJ
50458	159	13	properties	property	NNS
50458	159	14	.	.	.
50458	160	1	They	-PRON-	PRP
50458	160	2	all	all	DT
50458	160	3	possess	possess	VBP
50458	160	4	the	the	DT
50458	160	5	common	common	JJ
50458	160	6	characteristic	characteristic	NN
50458	160	7	of	of	IN
50458	160	8	being	be	VBG
50458	160	9	precipitated	precipitate	VBN
50458	160	10	by	by	IN
50458	160	11	copper	copper	NN
50458	160	12	acetate	acetate	NN
50458	160	13	in	in	IN
50458	160	14	acid	acid	JJ
50458	160	15	solution	solution	NN
50458	160	16	with	with	IN
50458	160	17	heat	heat	NN
50458	160	18	,	,	,
50458	160	19	and	and	CC
50458	160	20	by	by	IN
50458	160	21	ammoniacal	ammoniacal	JJ
50458	160	22	silver	silver	NN
50458	160	23	nitrate	nitrate	JJ
50458	160	24	in	in	IN
50458	160	25	the	the	DT
50458	160	26	cold	cold	NN
50458	160	27	.	.	.
50458	161	1	According	accord	VBG
50458	161	2	to	to	IN
50458	161	3	Kossel	Kossel	NNP
50458	161	4	,	,	,
50458	161	5	these	these	DT
50458	161	6	bases	basis	NNS
50458	161	7	are	be	VBP
50458	161	8	derived	derive	VBN
50458	161	9	from	from	IN
50458	161	10	the	the	DT
50458	161	11	nucleo	nucleo	NNP
50458	161	12	-	-	HYPH
50458	161	13	albumins	albumin	NNS
50458	161	14	which	which	WDT
50458	161	15	are	be	VBP
50458	161	16	found	find	VBN
50458	161	17	in	in	IN
50458	161	18	the	the	DT
50458	161	19	cell	cell	NN
50458	161	20	nuclei	nucleus	NNS
50458	161	21	,	,	,
50458	161	22	and	and	CC
50458	161	23	which	which	WDT
50458	161	24	are	be	VBP
50458	161	25	,	,	,
50458	161	26	as	as	IN
50458	161	27	we	-PRON-	PRP
50458	161	28	know	know	VBP
50458	161	29	,	,	,
50458	161	30	substances	substance	VBZ
50458	161	31	rich	rich	JJ
50458	161	32	in	in	IN
50458	161	33	nitrogen	nitrogen	NN
50458	161	34	and	and	CC
50458	161	35	phosphorus	phosphorus	NN
50458	161	36	.	.	.
50458	162	1	Among	among	IN
50458	162	2	the	the	DT
50458	162	3	bases	basis	NNS
50458	162	4	of	of	IN
50458	162	5	this	this	DT
50458	162	6	group	group	NN
50458	162	7	may	may	MD
50458	162	8	be	be	VB
50458	162	9	mentioned	mention	VBN
50458	162	10	_	_	NNP
50458	162	11	adenine	adenine	NN
50458	162	12	_	_	NNP
50458	162	13	,	,	,
50458	162	14	C{5}H{5}N{5	C{5}H{5}N{5	NNP
50458	162	15	}	}	-RRB-
50458	162	16	,	,	,
50458	162	17	which	which	WDT
50458	162	18	is	be	VBZ
50458	162	19	obtained	obtain	VBN
50458	162	20	from	from	IN
50458	162	21	infusions	infusion	NNS
50458	162	22	of	of	IN
50458	162	23	tea	tea	NN
50458	162	24	.	.	.
50458	163	1	[	[	-LRB-
50458	163	2	15	15	CD
50458	163	3	]	]	-RRB-
50458	163	4	This	this	DT
50458	163	5	base	base	NN
50458	163	6	is	be	VBZ
50458	163	7	non	non	JJ
50458	163	8	-	-	JJ
50458	163	9	toxic	toxic	JJ
50458	163	10	;	;	:
50458	163	11	it	-PRON-	PRP
50458	163	12	was	be	VBD
50458	163	13	discovered	discover	VBN
50458	163	14	by	by	IN
50458	163	15	Kossel,[16	Kossel,[16	NNP
50458	163	16	]	]	-RRB-
50458	163	17	and	and	CC
50458	163	18	it	-PRON-	PRP
50458	163	19	crystallizes	crystallize	VBZ
50458	163	20	easily	easily	RB
50458	163	21	.	.	.
50458	164	1	[	[	-LRB-
50458	164	2	15	15	CD
50458	164	3	]	]	-RRB-
50458	164	4	KRUGER	KRUGER	NNP
50458	164	5	:	:	:
50458	164	6	_	_	NNP
50458	164	7	Bull	Bull	NNP
50458	164	8	.	.	.
50458	165	1	Soc	Soc	NNP
50458	165	2	.	.	.
50458	166	1	Chim	Chim	NNP
50458	166	2	.	.	.
50458	166	3	_	_	NNP
50458	166	4	(	(	-LRB-
50458	166	5	3	3	CD
50458	166	6	)	)	-RRB-
50458	166	7	,	,	,
50458	166	8	VIII	VIII	NNP
50458	166	9	,	,	,
50458	166	10	p.	p.	NN
50458	166	11	687	687	CD
50458	166	12	.	.	.
50458	167	1	[	[	-LRB-
50458	167	2	16	16	CD
50458	167	3	]	]	-RRB-
50458	167	4	KOSSEL	KOSSEL	NNP
50458	167	5	:	:	:
50458	167	6	_	_	NNP
50458	167	7	Zeitschrift	Zeitschrift	NNP
50458	167	8	für	für	NN
50458	167	9	physiol	physiol	NN
50458	167	10	.	.	.
50458	168	1	Chim	Chim	NNP
50458	168	2	.	.	.
50458	168	3	_	_	NNP
50458	168	4	,	,	,
50458	168	5	X	X	NNP
50458	168	6	,	,	,
50458	168	7	p.	p.	NN
50458	168	8	248	248	CD
50458	168	9	;	;	:
50458	168	10	and	and	CC
50458	168	11	_	_	NNP
50458	168	12	Bull	Bull	NNP
50458	168	13	.	.	.
50458	169	1	Soc	Soc	NNP
50458	169	2	.	.	.
50458	170	1	Chim	Chim	NNP
50458	170	2	.	.	.
50458	170	3	_	_	NNP
50458	170	4	(	(	-LRB-
50458	170	5	3	3	CD
50458	170	6	)	)	-RRB-
50458	170	7	,	,	,
50458	170	8	III	III	NNP
50458	170	9	,	,	,
50458	170	10	p.	p.	NN
50458	170	11	239	239	CD
50458	170	12	.	.	.
50458	171	1	Some	some	DT
50458	171	2	others	other	NNS
50458	171	3	of	of	IN
50458	171	4	this	this	DT
50458	171	5	group	group	NN
50458	171	6	are	be	VBP
50458	171	7	:	:	:
50458	171	8	_	_	NNP
50458	171	9	Guanine	Guanine	NNP
50458	171	10	_	_	NNP
50458	171	11	,	,	,
50458	171	12	C{5}H{5}N{5}O	C{5}H{5}N{5}O	NNP
50458	171	13	,	,	,
50458	171	14	non	non	JJ
50458	171	15	-	-	JJ
50458	171	16	toxic	toxic	JJ
50458	171	17	,	,	,
50458	171	18	discovered	discover	VBN
50458	171	19	by	by	IN
50458	171	20	Unger	Unger	NNP
50458	171	21	;	;	:
50458	171	22	_	_	NNP
50458	171	23	pseudo	pseudo	NNP
50458	171	24	-	-	NNP
50458	171	25	xanthine	xanthine	NNP
50458	171	26	_	_	NNP
50458	171	27	,	,	,
50458	171	28	obtained	obtain	VBN
50458	171	29	from	from	IN
50458	171	30	muscular	muscular	JJ
50458	171	31	tissues	tissue	NNS
50458	171	32	;	;	:
50458	171	33	_	_	NNP
50458	171	34	sarcine	sarcine	NNP
50458	171	35	_	_	NNP
50458	171	36	,	,	,
50458	171	37	C{5}H{4}N{4}O	C{5}H{4}N{4}O	NNP
50458	171	38	,	,	,
50458	171	39	also	also	RB
50458	171	40	but	but	CC
50458	171	41	slightly	slightly	RB
50458	171	42	toxic	toxic	JJ
50458	171	43	,	,	,
50458	171	44	discovered	discover	VBN
50458	171	45	by	by	IN
50458	171	46	Scherer	Scherer	NNP
50458	171	47	;	;	:
50458	171	48	_	_	NNP
50458	171	49	xanthine	xanthine	NNP
50458	171	50	_	_	NNP
50458	171	51	,	,	,
50458	171	52	C{5}H{4}N{4}O{2	C{5}H{4}N{4}O{2	NNP
50458	171	53	}	}	-RRB-
50458	171	54	,	,	,
50458	171	55	which	which	WDT
50458	171	56	is	be	VBZ
50458	171	57	found	find	VBN
50458	171	58	in	in	IN
50458	171	59	many	many	JJ
50458	171	60	urines	urine	NNS
50458	171	61	,	,	,
50458	171	62	and	and	CC
50458	171	63	which	which	WDT
50458	171	64	acts	act	VBZ
50458	171	65	as	as	IN
50458	171	66	a	a	DT
50458	171	67	stimulant	stimulant	NN
50458	171	68	on	on	IN
50458	171	69	the	the	DT
50458	171	70	cardiac	cardiac	JJ
50458	171	71	muscles	muscle	NNS
50458	171	72	;	;	:
50458	171	73	_	_	NNP
50458	171	74	paraxanthine	paraxanthine	NN
50458	171	75	_	_	NNP
50458	171	76	,	,	,
50458	171	77	C{7}H{8}N{4}O{2	C{7}H{8}N{4}O{2	NNP
50458	171	78	}	}	-RRB-
50458	171	79	,	,	,
50458	171	80	a	a	DT
50458	171	81	toxic	toxic	JJ
50458	171	82	base	base	NN
50458	171	83	found	find	VBN
50458	171	84	in	in	IN
50458	171	85	certain	certain	JJ
50458	171	86	pathological	pathological	JJ
50458	171	87	urines	urine	NNS
50458	171	88	;	;	:
50458	171	89	_	_	NNP
50458	171	90	caffeine	caffeine	NN
50458	171	91	_	_	NNP
50458	171	92	and	and	CC
50458	171	93	_	_	NNP
50458	171	94	theobromine	theobromine	NN
50458	171	95	_	_	NNP
50458	171	96	,	,	,
50458	171	97	powerful	powerful	JJ
50458	171	98	diuretic	diuretic	JJ
50458	171	99	bases	basis	NNS
50458	171	100	;	;	:
50458	171	101	and	and	CC
50458	171	102	_	_	NNP
50458	171	103	carnine	carnine	NN
50458	171	104	_	_	NNP
50458	171	105	,	,	,
50458	171	106	C{7}H{8}N{4}O{3	C{7}H{8}N{4}O{3	NNP
50458	171	107	}	}	-RRB-
50458	171	108	,	,	,
50458	171	109	from	from	IN
50458	171	110	meat	meat	NN
50458	171	111	,	,	,
50458	171	112	a	a	DT
50458	171	113	muscular	muscular	JJ
50458	171	114	stimulant	stimulant	NN
50458	171	115	like	like	IN
50458	171	116	caffeine	caffeine	NN
50458	171	117	.	.	.
50458	172	1	2	2	LS
50458	172	2	.	.	.
50458	173	1	=	=	NFP
50458	173	2	Creatinic	Creatinic	NNP
50458	173	3	Leucomaines.=--These	Leucomaines.=--These	''
50458	173	4	have	have	VBP
50458	173	5	for	for	IN
50458	173	6	their	-PRON-	PRP$
50458	173	7	type	type	NN
50458	173	8	guanidine	guanidine	NN
50458	173	9	;	;	:
50458	173	10	they	-PRON-	PRP
50458	173	11	differ	differ	VBP
50458	173	12	from	from	IN
50458	173	13	the	the	DT
50458	173	14	xanthic	xanthic	JJ
50458	173	15	bases	basis	NNS
50458	173	16	in	in	IN
50458	173	17	that	that	IN
50458	173	18	they	-PRON-	PRP
50458	173	19	are	be	VBP
50458	173	20	not	not	RB
50458	173	21	precipitated	precipitate	VBN
50458	173	22	by	by	IN
50458	173	23	copper	copper	NN
50458	173	24	acetate	acetate	NN
50458	173	25	,	,	,
50458	173	26	but	but	CC
50458	173	27	frequently	frequently	RB
50458	173	28	are	be	VBP
50458	173	29	by	by	IN
50458	173	30	ammoniacal	ammoniacal	JJ
50458	173	31	silver	silver	NN
50458	173	32	nitrate	nitrate	JJ
50458	173	33	.	.	.
50458	174	1	They	-PRON-	PRP
50458	174	2	yield	yield	VBP
50458	174	3	double	double	JJ
50458	174	4	salts	salt	NNS
50458	174	5	with	with	IN
50458	174	6	the	the	DT
50458	174	7	chlorides	chloride	NNS
50458	174	8	of	of	IN
50458	174	9	zinc	zinc	NN
50458	174	10	and	and	CC
50458	174	11	cadmium	cadmium	NN
50458	174	12	.	.	.
50458	175	1	To	to	IN
50458	175	2	this	this	DT
50458	175	3	group	group	NN
50458	175	4	belong	belong	VBP
50458	175	5	_	_	NNP
50458	175	6	glycocyanine	glycocyanine	NN
50458	175	7	_	_	NNP
50458	175	8	,	,	,
50458	175	9	C{3}H{7}N{3}O{2	C{3}H{7}N{3}O{2	NNP
50458	175	10	}	}	-RRB-
50458	175	11	,	,	,
50458	175	12	and	and	CC
50458	175	13	_	_	NNP
50458	175	14	glycocyanidine	glycocyanidine	NN
50458	175	15	_	_	NNP
50458	175	16	,	,	,
50458	175	17	C{3}H{7}N{3}O	C{3}H{7}N{3}O	NNP
50458	175	18	,	,	,
50458	175	19	both	both	DT
50458	175	20	very	very	RB
50458	175	21	toxic	toxic	JJ
50458	175	22	;	;	:
50458	175	23	_	_	NNP
50458	175	24	creatine	creatine	NN
50458	175	25	_	_	NNP
50458	175	26	,	,	,
50458	175	27	C{4}H{9}N{3}O{2	C{4}H{9}N{3}O{2	NNP
50458	175	28	}	}	-RRB-
50458	175	29	,	,	,
50458	175	30	only	only	RB
50458	175	31	slightly	slightly	RB
50458	175	32	toxic	toxic	JJ
50458	175	33	;	;	:
50458	175	34	_	_	NNP
50458	175	35	creatinine	creatinine	NN
50458	175	36	_	_	NNP
50458	175	37	,	,	,
50458	175	38	C{4}H{7}N{3}O	C{4}H{7}N{3}O	NNP
50458	175	39	;	;	:
50458	175	40	_	_	NNP
50458	175	41	lysatine	lysatine	NN
50458	175	42	_	_	NNP
50458	175	43	,	,	,
50458	175	44	which	which	WDT
50458	175	45	very	very	RB
50458	175	46	easily	easily	RB
50458	175	47	decomposes	decompose	VBZ
50458	175	48	to	to	TO
50458	175	49	form	form	VB
50458	175	50	urea	urea	NNP
50458	175	51	;	;	:
50458	175	52	_	_	NNP
50458	175	53	lysatinine	lysatinine	NN
50458	175	54	_	_	NNP
50458	175	55	,	,	,
50458	175	56	_	_	NNP
50458	175	57	xanthocreatine	xanthocreatine	NNP
50458	175	58	_	_	NNP
50458	175	59	;	;	:
50458	175	60	_	_	NNP
50458	175	61	arginine	arginine	NNP
50458	175	62	_	_	NNP
50458	175	63	,	,	,
50458	175	64	a	a	DT
50458	175	65	vegetable	vegetable	NN
50458	175	66	base	base	NN
50458	175	67	,	,	,
50458	175	68	etc	etc	FW
50458	175	69	.	.	.
50458	176	1	3	3	LS
50458	176	2	.	.	.
50458	177	1	=	=	NFP
50458	177	2	Neurinic	neurinic	JJ
50458	177	3	Leucomaines.=--These	Leucomaines.=--These	``
50458	177	4	have	have	VBP
50458	177	5	none	none	NN
50458	177	6	of	of	IN
50458	177	7	the	the	DT
50458	177	8	characteristics	characteristic	NNS
50458	177	9	of	of	IN
50458	177	10	the	the	DT
50458	177	11	preceding	precede	VBG
50458	177	12	bases	basis	NNS
50458	177	13	;	;	:
50458	177	14	their	-PRON-	PRP$
50458	177	15	type	type	NN
50458	177	16	is	be	VBZ
50458	177	17	neurine	neurine	NN
50458	177	18	,	,	,
50458	177	19	a	a	DT
50458	177	20	highly	highly	RB
50458	177	21	toxic	toxic	JJ
50458	177	22	base	base	NN
50458	177	23	found	find	VBN
50458	177	24	in	in	IN
50458	177	25	the	the	DT
50458	177	26	brain	brain	NN
50458	177	27	,	,	,
50458	177	28	nerves	nerve	NNS
50458	177	29	,	,	,
50458	177	30	and	and	CC
50458	177	31	certain	certain	JJ
50458	177	32	fish	fish	NN
50458	177	33	ova	ova	NNP
50458	177	34	.	.	.
50458	178	1	These	these	DT
50458	178	2	bases	basis	NNS
50458	178	3	are	be	VBP
50458	178	4	sometimes	sometimes	RB
50458	178	5	normally	normally	RB
50458	178	6	produced	produce	VBN
50458	178	7	by	by	IN
50458	178	8	the	the	DT
50458	178	9	animal	animal	NN
50458	178	10	economy	economy	NN
50458	178	11	,	,	,
50458	178	12	and	and	CC
50458	178	13	are	be	VBP
50458	178	14	also	also	RB
50458	178	15	frequently	frequently	RB
50458	178	16	the	the	DT
50458	178	17	result	result	NN
50458	178	18	of	of	IN
50458	178	19	microbic	microbic	JJ
50458	178	20	action	action	NN
50458	178	21	.	.	.
50458	179	1	They	-PRON-	PRP
50458	179	2	are	be	VBP
50458	179	3	the	the	DT
50458	179	4	result	result	NN
50458	179	5	of	of	IN
50458	179	6	the	the	DT
50458	179	7	simple	simple	JJ
50458	179	8	phenomena	phenomenon	NNS
50458	179	9	of	of	IN
50458	179	10	fermentative	fermentative	JJ
50458	179	11	hydrolyzation	hydrolyzation	NN
50458	179	12	of	of	IN
50458	179	13	protagons	protagon	NNS
50458	179	14	and	and	CC
50458	179	15	lecithins	lecithin	NNS
50458	179	16	.	.	.
50458	180	1	Among	among	IN
50458	180	2	these	these	DT
50458	180	3	bases	basis	NNS
50458	180	4	are	be	VBP
50458	180	5	_	_	NNP
50458	180	6	choline	choline	NN
50458	180	7	_	_	NNP
50458	180	8	,	,	,
50458	180	9	a	a	DT
50458	180	10	weak	weak	JJ
50458	180	11	alkaloid	alkaloid	NN
50458	180	12	,	,	,
50458	180	13	and	and	CC
50458	180	14	_	_	NNP
50458	180	15	betaine	betaine	NN
50458	180	16	_	_	NNP
50458	180	17	,	,	,
50458	180	18	which	which	WDT
50458	180	19	appears	appear	VBZ
50458	180	20	to	to	TO
50458	180	21	be	be	VB
50458	180	22	non	non	JJ
50458	180	23	-	-	JJ
50458	180	24	toxic	toxic	JJ
50458	180	25	.	.	.
50458	181	1	The	the	DT
50458	181	2	former	former	JJ
50458	181	3	has	have	VBZ
50458	181	4	the	the	DT
50458	181	5	formula	formula	NN
50458	181	6	C{5}H{15}NO{2	C{5}H{15}NO{2	NNS
50458	181	7	}	}	-RRB-
50458	181	8	;	;	:
50458	181	9	it	-PRON-	PRP
50458	181	10	was	be	VBD
50458	181	11	discovered	discover	VBN
50458	181	12	by	by	IN
50458	181	13	Stocker	Stocker	NNP
50458	181	14	.	.	.
50458	182	1	Wurtz	Wurtz	NNP
50458	182	2	synthesized	synthesize	VBD
50458	182	3	it	-PRON-	PRP
50458	182	4	by	by	IN
50458	182	5	combining	combine	VBG
50458	182	6	trimethylamine	trimethylamine	NN
50458	182	7	and	and	CC
50458	182	8	glycol	glycol	NN
50458	182	9	-	-	HYPH
50458	182	10	monochlorhydrine	monochlorhydrine	NN
50458	182	11	,	,	,
50458	182	12	and	and	CC
50458	182	13	treating	treat	VBG
50458	182	14	the	the	DT
50458	182	15	resulting	result	VBG
50458	182	16	hydrochloride	hydrochloride	NN
50458	182	17	with	with	IN
50458	182	18	silver	silver	NN
50458	182	19	oxide	oxide	NN
50458	182	20	.	.	.
50458	183	1	Betaine	betaine	JJ
50458	183	2	,	,	,
50458	183	3	C{5}H{11}NO{2	C{5}H{11}NO{2	NNS
50458	183	4	}	}	-RRB-
50458	183	5	,	,	,
50458	183	6	is	be	VBZ
50458	183	7	found	find	VBN
50458	183	8	in	in	IN
50458	183	9	beets	beet	NNS
50458	183	10	;	;	:
50458	183	11	it	-PRON-	PRP
50458	183	12	was	be	VBD
50458	183	13	discovered	discover	VBN
50458	183	14	by	by	IN
50458	183	15	Scheibler	Scheibler	NNP
50458	183	16	.	.	.
50458	184	1	Neurine	Neurine	NNP
50458	184	2	is	be	VBZ
50458	184	3	,	,	,
50458	184	4	chemically	chemically	RB
50458	184	5	,	,	,
50458	184	6	trimethylvinylammonium	trimethylvinylammonium	NN
50458	184	7	hydrate	hydrate	NN
50458	184	8	.	.	.
50458	185	1	4	4	LS
50458	185	2	.	.	.
50458	186	1	=	=	NFP
50458	186	2	Undetermined	Undetermined	NNP
50458	186	3	Leucomaines.=--Among	Leucomaines.=--Among	NNP
50458	186	4	these	these	DT
50458	186	5	bases	basis	NNS
50458	186	6	several	several	JJ
50458	186	7	are	be	VBP
50458	186	8	important	important	JJ
50458	186	9	in	in	IN
50458	186	10	more	more	JJR
50458	186	11	than	than	IN
50458	186	12	one	one	CD
50458	186	13	respect	respect	NN
50458	186	14	.	.	.
50458	187	1	For	for	IN
50458	187	2	instance	instance	NN
50458	187	3	_	_	NNP
50458	187	4	spermine	spermine	NN
50458	187	5	_	_	NNP
50458	187	6	,	,	,
50458	187	7	which	which	WDT
50458	187	8	is	be	VBZ
50458	187	9	found	find	VBN
50458	187	10	in	in	IN
50458	187	11	the	the	DT
50458	187	12	sperm	sperm	NN
50458	187	13	,	,	,
50458	187	14	is	be	VBZ
50458	187	15	a	a	DT
50458	187	16	strong	strong	JJ
50458	187	17	base	base	NN
50458	187	18	possessing	possess	VBG
50458	187	19	a	a	DT
50458	187	20	powerfully	powerfully	RB
50458	187	21	dynamic	dynamic	JJ
50458	187	22	and	and	CC
50458	187	23	tonic	tonic	NN
50458	187	24	action	action	NN
50458	187	25	on	on	IN
50458	187	26	the	the	DT
50458	187	27	nerves	nerve	NNS
50458	187	28	.	.	.
50458	188	1	It	-PRON-	PRP
50458	188	2	acts	act	VBZ
50458	188	3	as	as	IN
50458	188	4	an	an	DT
50458	188	5	oxidizer	oxidizer	NN
50458	188	6	.	.	.
50458	189	1	Spermine	Spermine	NNP
50458	189	2	was	be	VBD
50458	189	3	first	first	RB
50458	189	4	obtained	obtain	VBN
50458	189	5	by	by	IN
50458	189	6	Schreiner[17	Schreiner[17	NNP
50458	189	7	]	]	-RRB-
50458	189	8	from	from	IN
50458	189	9	the	the	DT
50458	189	10	sperm	sperm	NN
50458	189	11	of	of	IN
50458	189	12	mammifers	mammifer	NNS
50458	189	13	in	in	IN
50458	189	14	which	which	WDT
50458	189	15	it	-PRON-	PRP
50458	189	16	occurs	occur	VBZ
50458	189	17	as	as	IN
50458	189	18	a	a	DT
50458	189	19	phosphate	phosphate	NN
50458	189	20	.	.	.
50458	190	1	It	-PRON-	PRP
50458	190	2	has	have	VBZ
50458	190	3	the	the	DT
50458	190	4	formula	formula	NN
50458	190	5	C{5}H{14}N{2	C{5}H{14}N{2	NNP
50458	190	6	}	}	-RRB-
50458	190	7	.	.	.
50458	191	1	It	-PRON-	PRP
50458	191	2	was	be	VBD
50458	191	3	physiologically	physiologically	RB
50458	191	4	studied	study	VBN
50458	191	5	by	by	IN
50458	191	6	Poehl	Poehl	NNP
50458	191	7	,	,	,
50458	191	8	Tarchanoff	Tarchanoff	NNP
50458	191	9	,	,	,
50458	191	10	Weljaminoff	Weljaminoff	NNP
50458	191	11	,	,	,
50458	191	12	and	and	CC
50458	191	13	Joffroy	Joffroy	NNP
50458	191	14	.	.	.
50458	192	1	[	[	-LRB-
50458	192	2	18	18	CD
50458	192	3	]	]	-RRB-
50458	192	4	_	_	NNP
50458	192	5	Plasmaine	Plasmaine	NNP
50458	192	6	_	_	NNP
50458	192	7	,	,	,
50458	192	8	a	a	DT
50458	192	9	toxic	toxic	JJ
50458	192	10	base	base	NN
50458	192	11	found	find	VBN
50458	192	12	in	in	IN
50458	192	13	the	the	DT
50458	192	14	blood	blood	NN
50458	192	15	and	and	CC
50458	192	16	discovered	discover	VBN
50458	192	17	by	by	IN
50458	192	18	R.	R.	NNP
50458	192	19	Wurtz,[19	Wurtz,[19	NNP
50458	192	20	]	]	-RRB-
50458	192	21	has	have	VBZ
50458	192	22	the	the	DT
50458	192	23	formula	formula	NN
50458	192	24	C{5}H{15}N{5	C{5}H{15}N{5	NNP
50458	192	25	}	}	-RRB-
50458	192	26	;	;	:
50458	192	27	_	_	NNP
50458	192	28	protamine	protamine	NN
50458	192	29	_	_	NNP
50458	192	30	,	,	,
50458	192	31	from	from	IN
50458	192	32	fish	fish	NN
50458	192	33	milt	milt	NN
50458	192	34	,	,	,
50458	192	35	was	be	VBD
50458	192	36	discovered	discover	VBN
50458	192	37	by	by	IN
50458	192	38	Micocher	Micocher	NNP
50458	192	39	.	.	.
50458	193	1	[	[	-LRB-
50458	193	2	20	20	CD
50458	193	3	]	]	-RRB-
50458	193	4	[	[	-LRB-
50458	193	5	17	17	CD
50458	193	6	]	]	-RRB-
50458	193	7	_	_	NNP
50458	193	8	Liebig	Liebig	NNP
50458	193	9	's	's	POS
50458	193	10	Ann	Ann	NNP
50458	193	11	.	.	.
50458	194	1	der	der	IN
50458	194	2	Chemie	Chemie	NNP
50458	194	3	_	_	NNP
50458	194	4	,	,	,
50458	194	5	CXCIV	CXCIV	NNP
50458	194	6	,	,	,
50458	194	7	p.	p.	NN
50458	194	8	68	68	CD
50458	194	9	.	.	.
50458	195	1	[	[	-LRB-
50458	195	2	18	18	CD
50458	195	3	]	]	-RRB-
50458	195	4	_	_	NNP
50458	195	5	Journ	Journ	NNP
50458	195	6	.	.	.
50458	196	1	Soc	Soc	NNP
50458	196	2	.	.	.
50458	197	1	Phys	phys	NN
50458	197	2	.	.	.
50458	198	1	Chim	chim	UH
50458	198	2	.	.	.
50458	199	1	Russe	Russe	NNP
50458	199	2	_	_	NNP
50458	199	3	,	,	,
50458	199	4	1893	1893	CD
50458	199	5	,	,	,
50458	199	6	No	no	UH
50458	199	7	.	.	.
50458	200	1	2	2	LS
50458	200	2	;	;	:
50458	200	3	and	and	CC
50458	200	4	_	_	NNP
50458	200	5	Bull	Bull	NNP
50458	200	6	.	.	.
50458	201	1	Soc	Soc	NNP
50458	201	2	.	.	.
50458	202	1	Chim	Chim	NNP
50458	202	2	.	.	.
50458	202	3	_	_	NNP
50458	202	4	(	(	-LRB-
50458	202	5	3	3	CD
50458	202	6	)	)	-RRB-
50458	202	7	,	,	,
50458	202	8	XII	XII	NNP
50458	202	9	,	,	,
50458	202	10	p.	p.	NN
50458	202	11	243	243	CD
50458	202	12	.	.	.
50458	203	1	[	[	-LRB-
50458	203	2	19	19	CD
50458	203	3	]	]	-RRB-
50458	203	4	_	_	NNP
50458	203	5	Leucomaines	Leucomaines	NNP
50458	203	6	du	du	VBZ
50458	203	7	Sang	Sang	NNP
50458	203	8	Normal	Normal	NNP
50458	203	9	_	_	NNP
50458	203	10	,	,	,
50458	203	11	Thèse	Thèse	NNP
50458	203	12	,	,	,
50458	203	13	Paris	Paris	NNP
50458	203	14	,	,	,
50458	203	15	1889	1889	CD
50458	203	16	.	.	.
50458	204	1	[	[	-LRB-
50458	204	2	20	20	CD
50458	204	3	]	]	-RRB-
50458	204	4	_	_	NNP
50458	204	5	Joh	Joh	NNP
50458	204	6	reab	reab	NN
50458	204	7	.	.	.
50458	205	1	de	de	NNP
50458	205	2	Thiérchen	Thiérchen	NNP
50458	205	3	_	_	NNP
50458	205	4	,	,	,
50458	205	5	1874	1874	CD
50458	205	6	,	,	,
50458	205	7	p.	p.	NN
50458	205	8	341	341	CD
50458	205	9	;	;	:
50458	205	10	Picard	Picard	NNP
50458	205	11	,	,	,
50458	205	12	_	_	NNP
50458	205	13	Ibid	Ibid	NNP
50458	205	14	.	.	.
50458	205	15	_	_	NNP
50458	205	16	,	,	,
50458	205	17	p.	p.	NN
50458	205	18	355	355	CD
50458	205	19	.	.	.
50458	206	1	CHAPTER	CHAPTER	NNP
50458	206	2	II	II	NNP
50458	206	3	.	.	.
50458	207	1	TOXINS	toxin	NNS
50458	207	2	AND	and	CC
50458	207	3	ANTITOXINS	antitoxin	NNS
50458	207	4	.	.	.
50458	208	1	We	-PRON-	PRP
50458	208	2	have	have	VBP
50458	208	3	already	already	RB
50458	208	4	seen	see	VBN
50458	208	5	,	,	,
50458	208	6	in	in	IN
50458	208	7	the	the	DT
50458	208	8	preceding	precede	VBG
50458	208	9	chapter	chapter	NN
50458	208	10	,	,	,
50458	208	11	that	that	IN
50458	208	12	the	the	DT
50458	208	13	microbes	microbe	NNS
50458	208	14	and	and	CC
50458	208	15	the	the	DT
50458	208	16	cells	cell	NNS
50458	208	17	of	of	IN
50458	208	18	various	various	JJ
50458	208	19	organisms	organism	NNS
50458	208	20	are	be	VBP
50458	208	21	capable	capable	JJ
50458	208	22	of	of	IN
50458	208	23	secreting	secrete	VBG
50458	208	24	definite	definite	JJ
50458	208	25	products	product	NNS
50458	208	26	of	of	IN
50458	208	27	a	a	DT
50458	208	28	toxic	toxic	JJ
50458	208	29	nature	nature	NN
50458	208	30	to	to	TO
50458	208	31	which	which	WDT
50458	208	32	the	the	DT
50458	208	33	names	name	NNS
50458	208	34	"	"	``
50458	208	35	ptomaines	ptomaine	NNS
50458	208	36	"	"	''
50458	208	37	and	and	CC
50458	208	38	"	"	``
50458	208	39	leucomaines	leucomaine	NNS
50458	208	40	"	"	''
50458	208	41	have	have	VBP
50458	208	42	been	be	VBN
50458	208	43	given	give	VBN
50458	208	44	.	.	.
50458	209	1	Researches	Researches	NNP
50458	209	2	,	,	,
50458	209	3	which	which	WDT
50458	209	4	were	be	VBD
50458	209	5	begun	begin	VBN
50458	209	6	scarcely	scarcely	RB
50458	209	7	twenty	twenty	CD
50458	209	8	years	year	NNS
50458	209	9	ago	ago	RB
50458	209	10	,	,	,
50458	209	11	have	have	VBP
50458	209	12	shown	show	VBN
50458	209	13	that	that	IN
50458	209	14	,	,	,
50458	209	15	besides	besides	IN
50458	209	16	these	these	DT
50458	209	17	crystallizable	crystallizable	JJ
50458	209	18	and	and	CC
50458	209	19	definite	definite	JJ
50458	209	20	products	product	NNS
50458	209	21	,	,	,
50458	209	22	we	-PRON-	PRP
50458	209	23	meet	meet	VBP
50458	209	24	with	with	IN
50458	209	25	basic	basic	JJ
50458	209	26	non	non	JJ
50458	209	27	-	-	JJ
50458	209	28	crystallizable	crystallizable	JJ
50458	209	29	substances	substance	NNS
50458	209	30	of	of	IN
50458	209	31	unknown	unknown	JJ
50458	209	32	composition	composition	NN
50458	209	33	,	,	,
50458	209	34	possessing	possess	VBG
50458	209	35	special	special	JJ
50458	209	36	toxic	toxic	JJ
50458	209	37	properties	property	NNS
50458	209	38	,	,	,
50458	209	39	sometimes	sometimes	RB
50458	209	40	even	even	RB
50458	209	41	of	of	IN
50458	209	42	extreme	extreme	JJ
50458	209	43	violence	violence	NN
50458	209	44	.	.	.
50458	210	1	These	these	DT
50458	210	2	substances	substance	NNS
50458	210	3	have	have	VBP
50458	210	4	been	be	VBN
50458	210	5	named	name	VBN
50458	210	6	"	"	``
50458	210	7	toxins	toxin	NNS
50458	210	8	.	.	.
50458	210	9	"	"	''
50458	211	1	At	at	IN
50458	211	2	first	first	RB
50458	211	3	this	this	DT
50458	211	4	generic	generic	JJ
50458	211	5	name	name	NN
50458	211	6	was	be	VBD
50458	211	7	extended	extend	VBN
50458	211	8	toward	toward	IN
50458	211	9	indefinite	indefinite	JJ
50458	211	10	basic	basic	JJ
50458	211	11	organic	organic	JJ
50458	211	12	products	product	NNS
50458	211	13	that	that	WDT
50458	211	14	could	could	MD
50458	211	15	be	be	VB
50458	211	16	isolated	isolate	VBN
50458	211	17	from	from	IN
50458	211	18	tissues	tissue	NNS
50458	211	19	and	and	CC
50458	211	20	tumors	tumor	NNS
50458	211	21	both	both	CC
50458	211	22	normal	normal	JJ
50458	211	23	and	and	CC
50458	211	24	abnormal	abnormal	JJ
50458	211	25	;	;	:
50458	211	26	later	later	RB
50458	211	27	on	on	RB
50458	211	28	,	,	,
50458	211	29	however	however	RB
50458	211	30	,	,	,
50458	211	31	the	the	DT
50458	211	32	name	name	NN
50458	211	33	was	be	VBD
50458	211	34	applied	apply	VBN
50458	211	35	to	to	IN
50458	211	36	toxic	toxic	JJ
50458	211	37	substances	substance	NNS
50458	211	38	,	,	,
50458	211	39	equally	equally	RB
50458	211	40	indefinite	indefinite	JJ
50458	211	41	,	,	,
50458	211	42	isolated	isolate	VBN
50458	211	43	from	from	IN
50458	211	44	the	the	DT
50458	211	45	culture	culture	NN
50458	211	46	media	medium	NNS
50458	211	47	of	of	IN
50458	211	48	microbes	microbe	NNS
50458	211	49	and	and	CC
50458	211	50	the	the	DT
50458	211	51	active	active	JJ
50458	211	52	constituent	constituent	NN
50458	211	53	of	of	IN
50458	211	54	various	various	JJ
50458	211	55	venoms	venom	NNS
50458	211	56	.	.	.
50458	212	1	It	-PRON-	PRP
50458	212	2	is	be	VBZ
50458	212	3	only	only	RB
50458	212	4	since	since	IN
50458	212	5	1885	1885	CD
50458	212	6	,	,	,
50458	212	7	when	when	WRB
50458	212	8	Charrin	Charrin	NNP
50458	212	9	called	call	VBD
50458	212	10	attention	attention	NN
50458	212	11	to	to	IN
50458	212	12	them	-PRON-	PRP
50458	212	13	,	,	,
50458	212	14	that	that	IN
50458	212	15	investigations	investigation	NNS
50458	212	16	began	begin	VBD
50458	212	17	to	to	TO
50458	212	18	be	be	VB
50458	212	19	made	make	VBN
50458	212	20	regarding	regard	VBG
50458	212	21	them	-PRON-	PRP
50458	212	22	.	.	.
50458	213	1	In	in	IN
50458	213	2	1888	1888	CD
50458	213	3	Roux	Roux	NNP
50458	213	4	and	and	CC
50458	213	5	Yersin,[21	Yersin,[21	NNP
50458	213	6	]	]	-RRB-
50458	213	7	in	in	IN
50458	213	8	their	-PRON-	PRP$
50458	213	9	beautiful	beautiful	JJ
50458	213	10	researches	research	NNS
50458	213	11	on	on	IN
50458	213	12	diphtheria	diphtheria	NN
50458	213	13	,	,	,
50458	213	14	pointed	point	VBD
50458	213	15	out	out	RP
50458	213	16	the	the	DT
50458	213	17	diastatic	diastatic	JJ
50458	213	18	nature	nature	NN
50458	213	19	of	of	IN
50458	213	20	the	the	DT
50458	213	21	properties	property	NNS
50458	213	22	of	of	IN
50458	213	23	the	the	DT
50458	213	24	active	active	JJ
50458	213	25	albuminoid	albuminoid	NN
50458	213	26	matter	matter	NN
50458	213	27	existing	exist	VBG
50458	213	28	in	in	IN
50458	213	29	the	the	DT
50458	213	30	cultures	culture	NNS
50458	213	31	of	of	IN
50458	213	32	the	the	DT
50458	213	33	specific	specific	JJ
50458	213	34	bacilli	bacilli	NN
50458	213	35	of	of	IN
50458	213	36	this	this	DT
50458	213	37	disease	disease	NN
50458	213	38	.	.	.
50458	214	1	From	from	IN
50458	214	2	that	that	DT
50458	214	3	period	period	NN
50458	214	4	,	,	,
50458	214	5	these	these	DT
50458	214	6	products	product	NNS
50458	214	7	began	begin	VBD
50458	214	8	to	to	TO
50458	214	9	take	take	VB
50458	214	10	a	a	DT
50458	214	11	more	more	JJR
50458	214	12	and	and	CC
50458	214	13	more	more	RBR
50458	214	14	prominent	prominent	JJ
50458	214	15	place	place	NN
50458	214	16	,	,	,
50458	214	17	from	from	IN
50458	214	18	year	year	NN
50458	214	19	to	to	IN
50458	214	20	year	year	NN
50458	214	21	,	,	,
50458	214	22	in	in	IN
50458	214	23	the	the	DT
50458	214	24	study	study	NN
50458	214	25	of	of	IN
50458	214	26	pathological	pathological	JJ
50458	214	27	affections	affection	NNS
50458	214	28	,	,	,
50458	214	29	and	and	CC
50458	214	30	,	,	,
50458	214	31	by	by	IN
50458	214	32	developing	develop	VBG
50458	214	33	the	the	DT
50458	214	34	knowledge	knowledge	NN
50458	214	35	of	of	IN
50458	214	36	immunity	immunity	NN
50458	214	37	,	,	,
50458	214	38	they	-PRON-	PRP
50458	214	39	have	have	VBP
50458	214	40	opened	open	VBN
50458	214	41	a	a	DT
50458	214	42	new	new	JJ
50458	214	43	path	path	NN
50458	214	44	to	to	IN
50458	214	45	the	the	DT
50458	214	46	investigations	investigation	NNS
50458	214	47	of	of	IN
50458	214	48	therapeutic	therapeutic	JJ
50458	214	49	technic	technic	NN
50458	214	50	.	.	.
50458	215	1	[	[	-LRB-
50458	215	2	21	21	CD
50458	215	3	]	]	-RRB-
50458	215	4	ROUX	ROUX	NNP
50458	215	5	and	and	CC
50458	215	6	YERSIN	YERSIN	NNP
50458	215	7	;	;	:
50458	215	8	Mémoire	Mémoire	NNP
50458	215	9	sur	sur	FW
50458	215	10	Diphtérie	Diphtérie	NNP
50458	215	11	.	.	.
50458	216	1	_	_	NNP
50458	216	2	Ann	Ann	NNP
50458	216	3	.	.	.
50458	217	1	Inst	inst	RB
50458	217	2	.	.	.
50458	218	1	Pasteur	Pasteur	NNP
50458	218	2	_	_	NNP
50458	218	3	,	,	,
50458	218	4	1888	1888	CD
50458	218	5	-	-	SYM
50458	218	6	1889	1889	CD
50458	218	7	.	.	.
50458	219	1	It	-PRON-	PRP
50458	219	2	is	be	VBZ
50458	219	3	due	due	JJ
50458	219	4	to	to	IN
50458	219	5	the	the	DT
50458	219	6	knowledge	knowledge	NN
50458	219	7	of	of	IN
50458	219	8	these	these	DT
50458	219	9	principles	principle	NNS
50458	219	10	that	that	WDT
50458	219	11	we	-PRON-	PRP
50458	219	12	have	have	VBP
50458	219	13	learned	learn	VBN
50458	219	14	that	that	IN
50458	219	15	the	the	DT
50458	219	16	infectious	infectious	JJ
50458	219	17	microbes	microbe	NNS
50458	219	18	,	,	,
50458	219	19	far	far	RB
50458	219	20	from	from	IN
50458	219	21	acting	act	VBG
50458	219	22	as	as	IN
50458	219	23	they	-PRON-	PRP
50458	219	24	were	be	VBD
50458	219	25	believed	believe	VBN
50458	219	26	to	to	TO
50458	219	27	do	do	VB
50458	219	28	only	only	RB
50458	219	29	a	a	DT
50458	219	30	few	few	JJ
50458	219	31	years	year	NNS
50458	219	32	ago	ago	RB
50458	219	33	,	,	,
50458	219	34	and	and	CC
50458	219	35	which	which	WDT
50458	219	36	Pasteur	Pasteur	NNP
50458	219	37	strongly	strongly	RB
50458	219	38	maintained	maintain	VBD
50458	219	39	to	to	TO
50458	219	40	be	be	VB
50458	219	41	by	by	IN
50458	219	42	vital	vital	JJ
50458	219	43	parasitism	parasitism	NN
50458	219	44	--	--	:
50458	219	45	such	such	JJ
50458	219	46	as	as	IN
50458	219	47	would	would	MD
50458	219	48	be	be	VB
50458	219	49	the	the	DT
50458	219	50	case	case	NN
50458	219	51	with	with	IN
50458	219	52	the	the	DT
50458	219	53	carbonizing	carbonize	VBG
50458	219	54	bacteria	bacteria	NNS
50458	219	55	which	which	WDT
50458	219	56	,	,	,
50458	219	57	according	accord	VBG
50458	219	58	to	to	IN
50458	219	59	Pasteur	Pasteur	NNP
50458	219	60	,	,	,
50458	219	61	act	act	VB
50458	219	62	by	by	IN
50458	219	63	diverting	divert	VBG
50458	219	64	the	the	DT
50458	219	65	oxygen	oxygen	NN
50458	219	66	,	,	,
50458	219	67	or	or	CC
50458	219	68	causing	cause	VBG
50458	219	69	capillary	capillary	JJ
50458	219	70	embolisms	embolism	NNS
50458	219	71	--	--	:
50458	219	72	owe	owe	VBP
50458	219	73	their	-PRON-	PRP$
50458	219	74	pathogenic	pathogenic	JJ
50458	219	75	action	action	NN
50458	219	76	to	to	IN
50458	219	77	the	the	DT
50458	219	78	toxic	toxic	JJ
50458	219	79	substances	substance	NNS
50458	219	80	which	which	WDT
50458	219	81	are	be	VBP
50458	219	82	the	the	DT
50458	219	83	products	product	NNS
50458	219	84	of	of	IN
50458	219	85	their	-PRON-	PRP$
50458	219	86	secretion	secretion	NN
50458	219	87	,	,	,
50458	219	88	and	and	CC
50458	219	89	which	which	WDT
50458	219	90	spread	spread	VBD
50458	219	91	throughout	throughout	IN
50458	219	92	the	the	DT
50458	219	93	organism	organism	NN
50458	219	94	,	,	,
50458	219	95	even	even	RB
50458	219	96	though	though	IN
50458	219	97	the	the	DT
50458	219	98	microbe	microbe	NN
50458	219	99	frequently	frequently	RB
50458	219	100	is	be	VBZ
50458	219	101	localized	localize	VBN
50458	219	102	in	in	IN
50458	219	103	a	a	DT
50458	219	104	very	very	RB
50458	219	105	circumscribed	circumscribe	VBN
50458	219	106	spot	spot	NN
50458	219	107	,	,	,
50458	219	108	as	as	IN
50458	219	109	in	in	IN
50458	219	110	tetanus	tetanus	NN
50458	219	111	and	and	CC
50458	219	112	in	in	IN
50458	219	113	diphtheria	diphtheria	NN
50458	219	114	.	.	.
50458	220	1	The	the	DT
50458	220	2	idea	idea	NN
50458	220	3	of	of	IN
50458	220	4	intoxication	intoxication	NN
50458	220	5	by	by	IN
50458	220	6	these	these	DT
50458	220	7	products	product	NNS
50458	220	8	has	have	VBZ
50458	220	9	now	now	RB
50458	220	10	replaced	replace	VBN
50458	220	11	the	the	DT
50458	220	12	idea	idea	NN
50458	220	13	of	of	IN
50458	220	14	the	the	DT
50458	220	15	direct	direct	JJ
50458	220	16	action	action	NN
50458	220	17	of	of	IN
50458	220	18	the	the	DT
50458	220	19	microbe	microbe	NN
50458	220	20	on	on	IN
50458	220	21	the	the	DT
50458	220	22	elements	element	NNS
50458	220	23	or	or	CC
50458	220	24	the	the	DT
50458	220	25	liquids	liquid	NNS
50458	220	26	of	of	IN
50458	220	27	the	the	DT
50458	220	28	organism	organism	NN
50458	220	29	.	.	.
50458	221	1	The	the	DT
50458	221	2	occurrence	occurrence	NN
50458	221	3	that	that	WDT
50458	221	4	takes	take	VBZ
50458	221	5	place	place	NN
50458	221	6	in	in	IN
50458	221	7	diphtheria	diphtheria	NN
50458	221	8	and	and	CC
50458	221	9	tetanus	tetanus	NN
50458	221	10	is	be	VBZ
50458	221	11	one	one	CD
50458	221	12	of	of	IN
50458	221	13	the	the	DT
50458	221	14	best	good	JJS
50458	221	15	examples	example	NNS
50458	221	16	to	to	TO
50458	221	17	cite	cite	VB
50458	221	18	in	in	IN
50458	221	19	support	support	NN
50458	221	20	of	of	IN
50458	221	21	this	this	DT
50458	221	22	view	view	NN
50458	221	23	.	.	.
50458	222	1	Here	here	RB
50458	222	2	,	,	,
50458	222	3	in	in	IN
50458	222	4	fact	fact	NN
50458	222	5	,	,	,
50458	222	6	the	the	DT
50458	222	7	pathogenic	pathogenic	JJ
50458	222	8	microbe	microbe	NN
50458	222	9	is	be	VBZ
50458	222	10	found	find	VBN
50458	222	11	only	only	RB
50458	222	12	in	in	IN
50458	222	13	a	a	DT
50458	222	14	very	very	RB
50458	222	15	limited	limited	JJ
50458	222	16	area	area	NN
50458	222	17	in	in	IN
50458	222	18	the	the	DT
50458	222	19	organism	organism	NN
50458	222	20	attacked	attack	VBD
50458	222	21	--	--	:
50458	222	22	the	the	DT
50458	222	23	false	false	JJ
50458	222	24	membrane	membrane	NN
50458	222	25	,	,	,
50458	222	26	in	in	IN
50458	222	27	the	the	DT
50458	222	28	case	case	NN
50458	222	29	of	of	IN
50458	222	30	diphtheria	diphtheria	NN
50458	222	31	,	,	,
50458	222	32	or	or	CC
50458	222	33	frequently	frequently	RB
50458	222	34	only	only	RB
50458	222	35	a	a	DT
50458	222	36	slight	slight	JJ
50458	222	37	wound	wound	NN
50458	222	38	in	in	IN
50458	222	39	the	the	DT
50458	222	40	case	case	NN
50458	222	41	of	of	IN
50458	222	42	tetanus	tetanus	NN
50458	222	43	,	,	,
50458	222	44	and	and	CC
50458	222	45	the	the	DT
50458	222	46	microbe	microbe	NN
50458	222	47	becomes	become	VBZ
50458	222	48	localized	localize	VBN
50458	222	49	there	there	RB
50458	222	50	only	only	RB
50458	222	51	.	.	.
50458	223	1	Now	now	RB
50458	223	2	,	,	,
50458	223	3	in	in	IN
50458	223	4	both	both	DT
50458	223	5	cases	case	NNS
50458	223	6	,	,	,
50458	223	7	there	there	EX
50458	223	8	are	be	VBP
50458	223	9	general	general	JJ
50458	223	10	phenomena	phenomenon	NNS
50458	223	11	of	of	IN
50458	223	12	toxic	toxic	JJ
50458	223	13	effects	effect	NNS
50458	223	14	.	.	.
50458	224	1	There	there	EX
50458	224	2	must	must	MD
50458	224	3	hence	hence	RB
50458	224	4	be	be	VB
50458	224	5	a	a	DT
50458	224	6	diffusion	diffusion	NN
50458	224	7	of	of	IN
50458	224	8	toxic	toxic	JJ
50458	224	9	substances	substance	NNS
50458	224	10	which	which	WDT
50458	224	11	,	,	,
50458	224	12	distributed	distribute	VBN
50458	224	13	by	by	IN
50458	224	14	the	the	DT
50458	224	15	blood	blood	NN
50458	224	16	,	,	,
50458	224	17	affect	affect	VB
50458	224	18	the	the	DT
50458	224	19	different	different	JJ
50458	224	20	systems	system	NNS
50458	224	21	and	and	CC
50458	224	22	exert	exert	VB
50458	224	23	a	a	DT
50458	224	24	toxic	toxic	JJ
50458	224	25	action	action	NN
50458	224	26	on	on	IN
50458	224	27	the	the	DT
50458	224	28	entire	entire	JJ
50458	224	29	organism	organism	NN
50458	224	30	.	.	.
50458	225	1	It	-PRON-	PRP
50458	225	2	must	must	MD
50458	225	3	be	be	VB
50458	225	4	observed	observe	VBN
50458	225	5	that	that	IN
50458	225	6	the	the	DT
50458	225	7	toxins	toxin	NNS
50458	225	8	act	act	VBP
50458	225	9	as	as	IN
50458	225	10	toxic	toxic	JJ
50458	225	11	agents	agent	NNS
50458	225	12	only	only	RB
50458	225	13	when	when	WRB
50458	225	14	in	in	IN
50458	225	15	a	a	DT
50458	225	16	condition	condition	NN
50458	225	17	to	to	TO
50458	225	18	be	be	VB
50458	225	19	introduced	introduce	VBN
50458	225	20	into	into	IN
50458	225	21	the	the	DT
50458	225	22	circulation	circulation	NN
50458	225	23	subcutaneously	subcutaneously	RB
50458	225	24	.	.	.
50458	226	1	The	the	DT
50458	226	2	cause	cause	NN
50458	226	3	of	of	IN
50458	226	4	this	this	DT
50458	226	5	innocuousness	innocuousness	NN
50458	226	6	of	of	IN
50458	226	7	the	the	DT
50458	226	8	toxins	toxin	NNS
50458	226	9	when	when	WRB
50458	226	10	given	give	VBN
50458	226	11	per	per	IN
50458	226	12	os	os	NNP
50458	226	13	has	have	VBZ
50458	226	14	frequently	frequently	RB
50458	226	15	been	be	VBN
50458	226	16	studied	study	VBN
50458	226	17	.	.	.
50458	227	1	It	-PRON-	PRP
50458	227	2	appears	appear	VBZ
50458	227	3	to	to	TO
50458	227	4	be	be	VB
50458	227	5	quite	quite	RB
50458	227	6	probable	probable	JJ
50458	227	7	that	that	IN
50458	227	8	the	the	DT
50458	227	9	cause	cause	NN
50458	227	10	of	of	IN
50458	227	11	the	the	DT
50458	227	12	attenuation	attenuation	NN
50458	227	13	of	of	IN
50458	227	14	the	the	DT
50458	227	15	morbid	morbid	NN
50458	227	16	properties	property	NNS
50458	227	17	is	be	VBZ
50458	227	18	due	due	JJ
50458	227	19	to	to	IN
50458	227	20	the	the	DT
50458	227	21	intervention	intervention	NN
50458	227	22	of	of	IN
50458	227	23	the	the	DT
50458	227	24	digestive	digestive	JJ
50458	227	25	microbes	microbe	NNS
50458	227	26	.	.	.
50458	228	1	Such	such	JJ
50458	228	2	is	be	VBZ
50458	228	3	the	the	DT
50458	228	4	opinion	opinion	NN
50458	228	5	of	of	IN
50458	228	6	Levaditi	Levaditi	NNP
50458	228	7	and	and	CC
50458	228	8	Charrin[22	charrin[22	ADD
50458	228	9	]	]	-RRB-
50458	228	10	;	;	:
50458	228	11	it	-PRON-	PRP
50458	228	12	is	be	VBZ
50458	228	13	also	also	RB
50458	228	14	the	the	DT
50458	228	15	conclusion	conclusion	NN
50458	228	16	that	that	WDT
50458	228	17	is	be	VBZ
50458	228	18	to	to	TO
50458	228	19	be	be	VB
50458	228	20	drawn	draw	VBN
50458	228	21	from	from	IN
50458	228	22	the	the	DT
50458	228	23	experiments	experiment	NNS
50458	228	24	of	of	IN
50458	228	25	Mme	Mme	NNP
50458	228	26	.	.	.
50458	229	1	Metchnikoff	metchnikoff	RB
50458	229	2	and	and	CC
50458	229	3	of	of	IN
50458	229	4	Calmette[23	Calmette[23	NNS
50458	229	5	]	]	-RRB-
50458	229	6	on	on	IN
50458	229	7	the	the	DT
50458	229	8	modifications	modification	NNS
50458	229	9	undergone	undergo	VBN
50458	229	10	by	by	IN
50458	229	11	a	a	DT
50458	229	12	vegetable	vegetable	JJ
50458	229	13	toxalbumin	toxalbumin	NN
50458	229	14	,	,	,
50458	229	15	abrin	abrin	NNP
50458	229	16	,	,	,
50458	229	17	and	and	CC
50458	229	18	by	by	IN
50458	229	19	serpent	serpent	JJ
50458	229	20	venoms	venom	NNS
50458	229	21	,	,	,
50458	229	22	when	when	WRB
50458	229	23	these	these	DT
50458	229	24	toxalbumins	toxalbumin	NNS
50458	229	25	are	be	VBP
50458	229	26	inoculated	inoculate	VBN
50458	229	27	with	with	IN
50458	229	28	the	the	DT
50458	229	29	bacillus	bacillus	NN
50458	229	30	subtilis	subtili	VBZ
50458	229	31	chromogenus	chromogenus	NN
50458	229	32	.	.	.
50458	230	1	Moreover	moreover	RB
50458	230	2	,	,	,
50458	230	3	Charrin	Charrin	NNP
50458	230	4	and	and	CC
50458	230	5	Lefèvre,[24	Lefèvre,[24	NNP
50458	230	6	]	]	-RRB-
50458	230	7	on	on	IN
50458	230	8	the	the	DT
50458	230	9	one	one	CD
50458	230	10	hand	hand	NN
50458	230	11	,	,	,
50458	230	12	and	and	CC
50458	230	13	Nencki	Nencki	NNP
50458	230	14	,	,	,
50458	230	15	Sieber	Sieber	NNP
50458	230	16	and	and	CC
50458	230	17	Somanowsky,[25	Somanowsky,[25	NNP
50458	230	18	]	]	-RRB-
50458	230	19	and	and	CC
50458	230	20	Carrière,[26	carrière,[26	NN
50458	230	21	]	]	-RRB-
50458	230	22	on	on	IN
50458	230	23	the	the	DT
50458	230	24	other	other	JJ
50458	230	25	hand	hand	NN
50458	230	26	,	,	,
50458	230	27	have	have	VBP
50458	230	28	discovered	discover	VBN
50458	230	29	that	that	IN
50458	230	30	the	the	DT
50458	230	31	digestive	digestive	JJ
50458	230	32	ferments	ferment	NNS
50458	230	33	,	,	,
50458	230	34	particularly	particularly	RB
50458	230	35	trypsin	trypsin	NNP
50458	230	36	,	,	,
50458	230	37	destroy	destroy	VB
50458	230	38	,	,	,
50458	230	39	even	even	RB
50458	230	40	though	though	IN
50458	230	41	but	but	CC
50458	230	42	little	little	JJ
50458	230	43	,	,	,
50458	230	44	the	the	DT
50458	230	45	toxins	toxin	NNS
50458	230	46	secreted	secrete	VBN
50458	230	47	by	by	IN
50458	230	48	the	the	DT
50458	230	49	Loeffler	Loeffler	NNP
50458	230	50	and	and	CC
50458	230	51	Nicolaier	Nicolaier	NNP
50458	230	52	bacilli	bacilli	NNP
50458	230	53	.	.	.
50458	231	1	This	this	DT
50458	231	2	is	be	VBZ
50458	231	3	practically	practically	RB
50458	231	4	contrary	contrary	JJ
50458	231	5	to	to	IN
50458	231	6	the	the	DT
50458	231	7	opinion	opinion	NN
50458	231	8	of	of	IN
50458	231	9	Behring	Behring	NNP
50458	231	10	and	and	CC
50458	231	11	of	of	IN
50458	231	12	Rauson,[27	Rauson,[27	NNS
50458	231	13	]	]	-RRB-
50458	231	14	according	accord	VBG
50458	231	15	to	to	IN
50458	231	16	which	which	WDT
50458	231	17	the	the	DT
50458	231	18	innocuousness	innocuousness	NN
50458	231	19	of	of	IN
50458	231	20	the	the	DT
50458	231	21	microbial	microbial	JJ
50458	231	22	poisons	poison	NNS
50458	231	23	when	when	WRB
50458	231	24	administered	administer	VBN
50458	231	25	per	per	IN
50458	231	26	os	os	NNP
50458	231	27	is	be	VBZ
50458	231	28	due	due	JJ
50458	231	29	exclusively	exclusively	RB
50458	231	30	to	to	IN
50458	231	31	the	the	DT
50458	231	32	lack	lack	NN
50458	231	33	of	of	IN
50458	231	34	absorption	absorption	NN
50458	231	35	.	.	.
50458	232	1	[	[	-LRB-
50458	232	2	22	22	CD
50458	232	3	]	]	-RRB-
50458	232	4	CHARRIN	charrin	NN
50458	232	5	and	and	CC
50458	232	6	LEVADITI	levaditi	NN
50458	232	7	:	:	:
50458	232	8	Le	Le	NNP
50458	232	9	sort	sort	RB
50458	232	10	de	de	NNP
50458	232	11	toxines	toxines	NNP
50458	232	12	introduites	introduite	VBZ
50458	232	13	dans	dan	NNS
50458	232	14	le	le	NNP
50458	232	15	tube	tube	NN
50458	232	16	digestif	digestif	NN
50458	232	17	.	.	.
50458	233	1	_	_	NNP
50458	233	2	Journal	Journal	NNP
50458	233	3	de	de	NNP
50458	233	4	Physiologie	Physiologie	NNP
50458	233	5	et	et	NNP
50458	233	6	de	de	NNP
50458	233	7	Pathologie	Pathologie	NNP
50458	233	8	Générales	Générales	NNP
50458	233	9	_	_	NNP
50458	233	10	,	,	,
50458	233	11	1898	1898	CD
50458	233	12	,	,	,
50458	233	13	p.	p.	NN
50458	233	14	226	226	CD
50458	233	15	.	.	.
50458	234	1	[	[	-LRB-
50458	234	2	23	23	CD
50458	234	3	]	]	-RRB-
50458	234	4	Citing	cite	VBG
50458	234	5	Metchnikoff	Metchnikoff	NNP
50458	234	6	.	.	.
50458	235	1	[	[	-LRB-
50458	235	2	24	24	CD
50458	235	3	]	]	-RRB-
50458	235	4	_	_	NNP
50458	235	5	C.	C.	NNP
50458	236	1	rend	rend	VB
50458	236	2	.	.	.
50458	237	1	de	de	NNP
50458	237	2	la	la	NNP
50458	237	3	Soc	Soc	NNP
50458	237	4	.	.	.
50458	238	1	de	de	NNP
50458	238	2	Biologie	Biologie	NNP
50458	238	3	_	_	NNP
50458	238	4	,	,	,
50458	238	5	1898	1898	CD
50458	238	6	.	.	.
50458	239	1	[	[	-LRB-
50458	239	2	25	25	CD
50458	239	3	]	]	-RRB-
50458	239	4	_	_	NNP
50458	239	5	Centralblatt	Centralblatt	NNP
50458	239	6	für	für	NN
50458	239	7	Bakt	Bakt	NNP
50458	239	8	.	.	.
50458	239	9	_	_	NNP
50458	239	10	,	,	,
50458	239	11	1898	1898	CD
50458	239	12	.	.	.
50458	240	1	[	[	-LRB-
50458	240	2	26	26	CD
50458	240	3	]	]	-RRB-
50458	240	4	_	_	NNP
50458	240	5	C.	C.	NNP
50458	241	1	rend	rend	VB
50458	241	2	.	.	.
50458	242	1	de	de	NNP
50458	242	2	la	la	NNP
50458	242	3	Soc	Soc	NNP
50458	242	4	.	.	.
50458	243	1	de	de	NNP
50458	243	2	Biologie	Biologie	NNP
50458	243	3	_	_	NNP
50458	243	4	,	,	,
50458	243	5	1899	1899	CD
50458	243	6	.	.	.
50458	244	1	[	[	-LRB-
50458	244	2	27	27	CD
50458	244	3	]	]	-RRB-
50458	244	4	_	_	NNP
50458	244	5	Deutsche	Deutsche	NNP
50458	244	6	Med	Med	NNP
50458	244	7	.	.	.
50458	245	1	Wochenschr	Wochenschr	NNP
50458	245	2	.	.	.
50458	245	3	_	_	NNP
50458	245	4	,	,	,
50458	245	5	1898	1898	CD
50458	245	6	,	,	,
50458	245	7	No	no	UH
50458	245	8	.	.	.
50458	246	1	8	8	LS
50458	246	2	.	.	.
50458	247	1	=	=	NFP
50458	247	2	Nature	nature	NN
50458	247	3	of	of	IN
50458	247	4	the	the	DT
50458	247	5	Toxins.=--The	toxins.=--the	JJ
50458	247	6	molecules	molecule	NNS
50458	247	7	of	of	IN
50458	247	8	the	the	DT
50458	247	9	toxins	toxin	NNS
50458	247	10	are	be	VBP
50458	247	11	very	very	RB
50458	247	12	nearly	nearly	RB
50458	247	13	like	like	IN
50458	247	14	those	those	DT
50458	247	15	of	of	IN
50458	247	16	the	the	DT
50458	247	17	diastases	diastasis	NNS
50458	247	18	.	.	.
50458	248	1	Like	like	IN
50458	248	2	these	these	DT
50458	248	3	,	,	,
50458	248	4	the	the	DT
50458	248	5	toxins	toxin	NNS
50458	248	6	appear	appear	VBP
50458	248	7	to	to	TO
50458	248	8	have	have	VB
50458	248	9	a	a	DT
50458	248	10	very	very	RB
50458	248	11	complex	complex	JJ
50458	248	12	,	,	,
50458	248	13	and	and	CC
50458	248	14	very	very	RB
50458	248	15	unstable	unstable	JJ
50458	248	16	,	,	,
50458	248	17	internal	internal	JJ
50458	248	18	structure	structure	NN
50458	248	19	.	.	.
50458	249	1	Their	-PRON-	PRP$
50458	249	2	mode	mode	NN
50458	249	3	of	of	IN
50458	249	4	action	action	NN
50458	249	5	frequently	frequently	RB
50458	249	6	depends	depend	VBZ
50458	249	7	,	,	,
50458	249	8	as	as	IN
50458	249	9	in	in	IN
50458	249	10	the	the	DT
50458	249	11	case	case	NN
50458	249	12	of	of	IN
50458	249	13	the	the	DT
50458	249	14	diastases	diastasis	NNS
50458	249	15	,	,	,
50458	249	16	upon	upon	IN
50458	249	17	the	the	DT
50458	249	18	medium	medium	NN
50458	249	19	in	in	IN
50458	249	20	which	which	WDT
50458	249	21	they	-PRON-	PRP
50458	249	22	occur	occur	VBP
50458	249	23	.	.	.
50458	250	1	Again	again	RB
50458	250	2	,	,	,
50458	250	3	like	like	IN
50458	250	4	the	the	DT
50458	250	5	diastases	diastasis	NNS
50458	250	6	,	,	,
50458	250	7	they	-PRON-	PRP
50458	250	8	are	be	VBP
50458	250	9	generally	generally	RB
50458	250	10	destroyed	destroy	VBN
50458	250	11	by	by	IN
50458	250	12	the	the	DT
50458	250	13	action	action	NN
50458	250	14	of	of	IN
50458	250	15	sufficiently	sufficiently	RB
50458	250	16	prolonged	prolong	VBN
50458	250	17	heat	heat	NN
50458	250	18	,	,	,
50458	250	19	but	but	CC
50458	250	20	less	less	RBR
50458	250	21	easily	easily	RB
50458	250	22	,	,	,
50458	250	23	for	for	IN
50458	250	24	there	there	EX
50458	250	25	are	be	VBP
50458	250	26	certain	certain	JJ
50458	250	27	toxins	toxin	NNS
50458	250	28	that	that	WDT
50458	250	29	resist	resist	VBP
50458	250	30	a	a	DT
50458	250	31	temperature	temperature	NN
50458	250	32	of	of	IN
50458	250	33	100	100	CD
50458	250	34	°	°	,
50458	250	35	C.	C.	NNP
50458	250	36	for	for	IN
50458	250	37	an	an	DT
50458	250	38	indefinite	indefinite	JJ
50458	250	39	period	period	NN
50458	250	40	.	.	.
50458	251	1	They	-PRON-	PRP
50458	251	2	are	be	VBP
50458	251	3	,	,	,
50458	251	4	like	like	IN
50458	251	5	the	the	DT
50458	251	6	diastatic	diastatic	JJ
50458	251	7	albuminoids	albuminoid	NNS
50458	251	8	,	,	,
50458	251	9	insoluble	insoluble	JJ
50458	251	10	in	in	IN
50458	251	11	strong	strong	JJ
50458	251	12	alcohol	alcohol	NN
50458	251	13	,	,	,
50458	251	14	and	and	CC
50458	251	15	are	be	VBP
50458	251	16	precipitated	precipitate	VBN
50458	251	17	from	from	IN
50458	251	18	their	-PRON-	PRP$
50458	251	19	solutions	solution	NNS
50458	251	20	on	on	IN
50458	251	21	the	the	DT
50458	251	22	addition	addition	NN
50458	251	23	of	of	IN
50458	251	24	this	this	DT
50458	251	25	reagent	reagent	NN
50458	251	26	.	.	.
50458	252	1	They	-PRON-	PRP
50458	252	2	easily	easily	RB
50458	252	3	adhere	adhere	VBP
50458	252	4	to	to	IN
50458	252	5	precipitates	precipitate	NNS
50458	252	6	that	that	DT
50458	252	7	form	form	NN
50458	252	8	in	in	IN
50458	252	9	liquids	liquid	NNS
50458	252	10	in	in	IN
50458	252	11	which	which	WDT
50458	252	12	they	-PRON-	PRP
50458	252	13	occur	occur	VBP
50458	252	14	in	in	IN
50458	252	15	solution	solution	NN
50458	252	16	,	,	,
50458	252	17	and	and	CC
50458	252	18	possess	possess	VB
50458	252	19	the	the	DT
50458	252	20	remarkable	remarkable	JJ
50458	252	21	property	property	NN
50458	252	22	of	of	IN
50458	252	23	diastases	diastasis	NNS
50458	252	24	in	in	IN
50458	252	25	that	that	DT
50458	252	26	imponderable	imponderable	JJ
50458	252	27	masses	masse	NNS
50458	252	28	produce	produce	VBP
50458	252	29	considerable	considerable	JJ
50458	252	30	results	result	NNS
50458	252	31	.	.	.
50458	253	1	[	[	-LRB-
50458	253	2	28	28	CD
50458	253	3	]	]	-RRB-
50458	253	4	[	[	-LRB-
50458	253	5	28	28	CD
50458	253	6	]	]	-RRB-
50458	253	7	See	see	VB
50458	253	8	POZZI	POZZI	NNP
50458	253	9	-	-	HYPH
50458	253	10	ESCOT	ESCOT	NNP
50458	253	11	:	:	:
50458	253	12	Les	Les	NNP
50458	253	13	diastases	diastase	VBZ
50458	253	14	et	et	NN
50458	253	15	leurs	leurs	NN
50458	253	16	applications	application	NNS
50458	253	17	,	,	,
50458	253	18	published	publish	VBN
50458	253	19	by	by	IN
50458	253	20	Masson	Masson	NNP
50458	253	21	,	,	,
50458	253	22	1900	1900	CD
50458	253	23	;	;	:
50458	253	24	and	and	CC
50458	253	25	_	_	NNP
50458	253	26	Traité	Traité	NNP
50458	253	27	de	de	NNP
50458	253	28	Physico	Physico	NNP
50458	253	29	-	-	HYPH
50458	253	30	chimie	chimie	NNP
50458	253	31	_	_	NNP
50458	253	32	.	.	.
50458	254	1	Although	although	IN
50458	254	2	closely	closely	RB
50458	254	3	allied	ally	VBN
50458	254	4	to	to	IN
50458	254	5	certain	certain	JJ
50458	254	6	alkaloidal	alkaloidal	NN
50458	254	7	bases	basis	NNS
50458	254	8	,	,	,
50458	254	9	the	the	DT
50458	254	10	toxins	toxin	NNS
50458	254	11	are	be	VBP
50458	254	12	sharply	sharply	RB
50458	254	13	distinguished	distinguish	VBN
50458	254	14	by	by	IN
50458	254	15	the	the	DT
50458	254	16	remarkable	remarkable	JJ
50458	254	17	fact	fact	NN
50458	254	18	that	that	IN
50458	254	19	their	-PRON-	PRP$
50458	254	20	action	action	NN
50458	254	21	is	be	VBZ
50458	254	22	never	never	RB
50458	254	23	immediate	immediate	JJ
50458	254	24	,	,	,
50458	254	25	but	but	CC
50458	254	26	is	be	VBZ
50458	254	27	always	always	RB
50458	254	28	preceded	precede	VBN
50458	254	29	by	by	IN
50458	254	30	a	a	DT
50458	254	31	period	period	NN
50458	254	32	of	of	IN
50458	254	33	incubation	incubation	NN
50458	254	34	,	,	,
50458	254	35	which	which	WDT
50458	254	36	may	may	MD
50458	254	37	be	be	VB
50458	254	38	quite	quite	RB
50458	254	39	long	long	JJ
50458	254	40	.	.	.
50458	255	1	Like	like	IN
50458	255	2	the	the	DT
50458	255	3	alkaloidal	alkaloidal	NN
50458	255	4	bases	basis	NNS
50458	255	5	,	,	,
50458	255	6	they	-PRON-	PRP
50458	255	7	appear	appear	VBP
50458	255	8	to	to	TO
50458	255	9	result	result	VB
50458	255	10	from	from	IN
50458	255	11	the	the	DT
50458	255	12	hydrolyzing	hydrolyzing	NN
50458	255	13	breaking	break	VBG
50458	255	14	down	down	RP
50458	255	15	of	of	IN
50458	255	16	albuminoids	albuminoid	NNS
50458	255	17	and	and	CC
50458	255	18	nucleo	nucleo	NNP
50458	255	19	-	-	HYPH
50458	255	20	albumins	albumin	NNS
50458	255	21	,	,	,
50458	255	22	and	and	CC
50458	255	23	they	-PRON-	PRP
50458	255	24	appear	appear	VBP
50458	255	25	to	to	TO
50458	255	26	be	be	VB
50458	255	27	intermediary	intermediary	JJ
50458	255	28	,	,	,
50458	255	29	from	from	IN
50458	255	30	a	a	DT
50458	255	31	chemical	chemical	NN
50458	255	32	point	point	NN
50458	255	33	of	of	IN
50458	255	34	view	view	NN
50458	255	35	,	,	,
50458	255	36	between	between	IN
50458	255	37	these	these	DT
50458	255	38	bodies	body	NNS
50458	255	39	,	,	,
50458	255	40	the	the	DT
50458	255	41	general	general	JJ
50458	255	42	characters	character	NNS
50458	255	43	of	of	IN
50458	255	44	which	which	WDT
50458	255	45	they	-PRON-	PRP
50458	255	46	retain	retain	VBP
50458	255	47	,	,	,
50458	255	48	and	and	CC
50458	255	49	the	the	DT
50458	255	50	alkaloids	alkaloid	NNS
50458	255	51	proper	proper	JJ
50458	255	52	,	,	,
50458	255	53	or	or	CC
50458	255	54	ptomaines	ptomaine	NNS
50458	255	55	,	,	,
50458	255	56	to	to	TO
50458	255	57	which	which	WDT
50458	255	58	we	-PRON-	PRP
50458	255	59	have	have	VBP
50458	255	60	called	call	VBN
50458	255	61	attention	attention	NN
50458	255	62	,	,	,
50458	255	63	and	and	CC
50458	255	64	the	the	DT
50458	255	65	principal	principal	JJ
50458	255	66	chemical	chemical	NN
50458	255	67	and	and	CC
50458	255	68	physiological	physiological	JJ
50458	255	69	properties	property	NNS
50458	255	70	of	of	IN
50458	255	71	which	which	WDT
50458	255	72	they	-PRON-	PRP
50458	255	73	possess	possess	VBP
50458	255	74	.	.	.
50458	256	1	No	no	DT
50458	256	2	absolutely	absolutely	RB
50458	256	3	precise	precise	JJ
50458	256	4	knowledge	knowledge	NN
50458	256	5	is	be	VBZ
50458	256	6	had	have	VBN
50458	256	7	regarding	regard	VBG
50458	256	8	the	the	DT
50458	256	9	chemical	chemical	NN
50458	256	10	nature	nature	NN
50458	256	11	and	and	CC
50458	256	12	constitution	constitution	NN
50458	256	13	of	of	IN
50458	256	14	these	these	DT
50458	256	15	remarkable	remarkable	JJ
50458	256	16	substances	substance	NNS
50458	256	17	.	.	.
50458	257	1	A	a	DT
50458	257	2	number	number	NN
50458	257	3	of	of	IN
50458	257	4	analyses	analysis	NNS
50458	257	5	of	of	IN
50458	257	6	these	these	DT
50458	257	7	substances	substance	NNS
50458	257	8	have	have	VBP
50458	257	9	been	be	VBN
50458	257	10	published	publish	VBN
50458	257	11	which	which	WDT
50458	257	12	,	,	,
50458	257	13	in	in	IN
50458	257	14	general	general	JJ
50458	257	15	,	,	,
50458	257	16	permit	permit	VB
50458	257	17	no	no	DT
50458	257	18	definite	definite	JJ
50458	257	19	conclusion	conclusion	NN
50458	257	20	to	to	TO
50458	257	21	be	be	VB
50458	257	22	drawn	draw	VBN
50458	257	23	.	.	.
50458	258	1	[	[	-LRB-
50458	258	2	29	29	CD
50458	258	3	]	]	-RRB-
50458	258	4	I	-PRON-	PRP
50458	258	5	have	have	VBP
50458	258	6	,	,	,
50458	258	7	however	however	RB
50458	258	8	,	,	,
50458	258	9	elaborated	elaborate	VBD
50458	258	10	several	several	JJ
50458	258	11	speculative	speculative	JJ
50458	258	12	ideas	idea	NNS
50458	258	13	regarding	regard	VBG
50458	258	14	this	this	DT
50458	258	15	subject	subject	NN
50458	258	16	.	.	.
50458	259	1	[	[	-LRB-
50458	259	2	30	30	CD
50458	259	3	]	]	-RRB-
50458	259	4	[	[	-LRB-
50458	259	5	29	29	CD
50458	259	6	]	]	-RRB-
50458	259	7	Regarding	regard	VBG
50458	259	8	this	this	DT
50458	259	9	see	see	VB
50458	259	10	the	the	DT
50458	259	11	works	work	NNS
50458	259	12	by	by	IN
50458	259	13	KOCH	KOCH	NNP
50458	259	14	and	and	CC
50458	259	15	BRIEGER	BRIEGER	NNP
50458	259	16	,	,	,
50458	259	17	_	_	NNP
50458	259	18	Deutsche	Deutsche	NNP
50458	259	19	Medicin	Medicin	NNP
50458	259	20	.	.	.
50458	260	1	Wochenschr	Wochenschr	NNP
50458	260	2	.	.	.
50458	260	3	_	_	NNP
50458	260	4	,	,	,
50458	260	5	Oct.	October	NNP
50458	260	6	22	22	CD
50458	260	7	,	,	,
50458	260	8	1891	1891	CD
50458	260	9	.	.	.
50458	261	1	[	[	-LRB-
50458	261	2	30	30	CD
50458	261	3	]	]	-RRB-
50458	261	4	POZZI	POZZI	NNP
50458	261	5	-	-	HYPH
50458	261	6	ESCOT	ESCOT	NNP
50458	261	7	:	:	:
50458	261	8	Nature	nature	NN
50458	261	9	des	des	NNP
50458	261	10	Diastases	diastasis	NNS
50458	261	11	.	.	.
50458	262	1	Published	publish	VBN
50458	262	2	by	by	IN
50458	262	3	J.	J.	NNP
50458	262	4	Rousset	Rousset	NNP
50458	262	5	,	,	,
50458	262	6	Paris	Paris	NNP
50458	262	7	,	,	,
50458	262	8	1903	1903	CD
50458	262	9	.	.	.
50458	263	1	See	see	VB
50458	263	2	also	also	RB
50458	263	3	Recherches	Recherches	NNP
50458	263	4	de	de	IN
50458	263	5	la	la	NNP
50458	263	6	Nature	Nature	NNP
50458	263	7	Chimique	Chimique	NNP
50458	263	8	des	des	NNP
50458	263	9	Diastases	Diastases	NNP
50458	263	10	Oxydantes	Oxydantes	NNPS
50458	263	11	.	.	.
50458	264	1	_	_	NNP
50458	264	2	Revue	Revue	NNP
50458	264	3	génér	génér	NN
50458	264	4	.	.	.
50458	265	1	de	de	NNP
50458	265	2	chimie	chimie	NNP
50458	265	3	_	_	NNP
50458	265	4	,	,	,
50458	265	5	VII	VII	NNP
50458	265	6	,	,	,
50458	265	7	pp	pp	NNP
50458	265	8	.	.	.
50458	266	1	129	129	CD
50458	266	2	-	-	SYM
50458	266	3	136	136	CD
50458	266	4	;	;	:
50458	266	5	and	and	CC
50458	266	6	Aperçus	Aperçus	NNP
50458	266	7	sur	sur	FW
50458	266	8	la	la	FW
50458	266	9	nature	nature	NN
50458	266	10	chimique	chimique	NN
50458	266	11	des	des	NNP
50458	266	12	Diastases	Diastases	NNP
50458	266	13	,	,	,
50458	266	14	_	_	NNP
50458	266	15	Bulletin	Bulletin	NNP
50458	266	16	de	de	IN
50458	266	17	l'Association	l'Association	NNP
50458	266	18	de	de	NNP
50458	266	19	Chimistes	Chimistes	NNP
50458	266	20	_	_	NNP
50458	266	21	,	,	,
50458	266	22	1904	1904	CD
50458	266	23	,	,	,
50458	266	24	p.	p.	NN
50458	267	1	769.--Propriétés	769.--propriétés	ADD
50458	267	2	Catalytiques	Catalytiques	NNP
50458	267	3	de	de	IN
50458	267	4	Quelques	Quelques	NNP
50458	267	5	Diastases	Diastases	NNP
50458	267	6	;	;	:
50458	267	7	_	_	NNP
50458	267	8	Ibid	Ibid	NNP
50458	267	9	.	.	.
50458	267	10	_	_	NNP
50458	267	11	,	,	,
50458	267	12	1904	1904	CD
50458	267	13	,	,	,
50458	267	14	p.	p.	NN
50458	267	15	1247	1247	CD
50458	267	16	.	.	.
50458	268	1	We	-PRON-	PRP
50458	268	2	must	must	MD
50458	268	3	here	here	RB
50458	268	4	call	call	VB
50458	268	5	particular	particular	JJ
50458	268	6	attention	attention	NN
50458	268	7	to	to	IN
50458	268	8	the	the	DT
50458	268	9	ideas	idea	NNS
50458	268	10	of	of	IN
50458	268	11	Ehrlich	Ehrlich	NNP
50458	268	12	regarding	regard	VBG
50458	268	13	the	the	DT
50458	268	14	constitution	constitution	NN
50458	268	15	of	of	IN
50458	268	16	the	the	DT
50458	268	17	toxins	toxin	NNS
50458	268	18	.	.	.
50458	269	1	According	accord	VBG
50458	269	2	to	to	IN
50458	269	3	this	this	DT
50458	269	4	scientist	scientist	NN
50458	269	5	,	,	,
50458	269	6	their	-PRON-	PRP$
50458	269	7	molecules	molecule	NNS
50458	269	8	contain	contain	VBP
50458	269	9	two	two	CD
50458	269	10	functional	functional	JJ
50458	269	11	groups	group	NNS
50458	269	12	;	;	:
50458	269	13	the	the	DT
50458	269	14	one	one	NN
50458	269	15	,	,	,
50458	269	16	to	to	TO
50458	269	17	which	which	WDT
50458	269	18	he	-PRON-	PRP
50458	269	19	has	have	VBZ
50458	269	20	given	give	VBN
50458	269	21	the	the	DT
50458	269	22	name	name	NN
50458	269	23	"	"	``
50458	269	24	haptophore	haptophore	NNP
50458	269	25	,	,	,
50458	269	26	"	"	''
50458	269	27	is	be	VBZ
50458	269	28	that	that	DT
50458	269	29	which	which	WDT
50458	269	30	enables	enable	VBZ
50458	269	31	the	the	DT
50458	269	32	toxin	toxin	NN
50458	269	33	to	to	TO
50458	269	34	attach	attach	VB
50458	269	35	itself	-PRON-	PRP
50458	269	36	to	to	IN
50458	269	37	any	any	DT
50458	269	38	cellular	cellular	JJ
50458	269	39	element	element	NN
50458	269	40	whatever	whatever	WDT
50458	269	41	,	,	,
50458	269	42	and	and	CC
50458	269	43	which	which	WDT
50458	269	44	it	-PRON-	PRP
50458	269	45	then	then	RB
50458	269	46	renders	render	VBZ
50458	269	47	non	non	JJ
50458	269	48	-	-	JJ
50458	269	49	toxic	toxic	JJ
50458	269	50	by	by	IN
50458	269	51	means	mean	NNS
50458	269	52	of	of	IN
50458	269	53	the	the	DT
50458	269	54	other	other	JJ
50458	269	55	,	,	,
50458	269	56	or	or	CC
50458	269	57	"	"	``
50458	269	58	toxophore	toxophore	NN
50458	269	59	,	,	,
50458	269	60	"	"	''
50458	269	61	group	group	NN
50458	269	62	.	.	.
50458	270	1	We	-PRON-	PRP
50458	270	2	will	will	MD
50458	270	3	particularize	particularize	VB
50458	270	4	farther	farther	RB
50458	270	5	on	on	IN
50458	270	6	regarding	regard	VBG
50458	270	7	this	this	DT
50458	270	8	very	very	RB
50458	270	9	important	important	JJ
50458	270	10	conception	conception	NN
50458	270	11	.	.	.
50458	271	1	=	=	NFP
50458	271	2	Origin	origin	NN
50458	271	3	of	of	IN
50458	271	4	the	the	DT
50458	271	5	Toxins.=--These	toxins.=--these	JJ
50458	271	6	toxic	toxic	JJ
50458	271	7	bodies	body	NNS
50458	271	8	result	result	VBP
50458	271	9	either	either	CC
50458	271	10	as	as	IN
50458	271	11	the	the	DT
50458	271	12	products	product	NNS
50458	271	13	of	of	IN
50458	271	14	the	the	DT
50458	271	15	secretion	secretion	NN
50458	271	16	of	of	IN
50458	271	17	microbial	microbial	JJ
50458	271	18	life	life	NN
50458	271	19	,	,	,
50458	271	20	or	or	CC
50458	271	21	as	as	IN
50458	271	22	the	the	DT
50458	271	23	result	result	NN
50458	271	24	of	of	IN
50458	271	25	the	the	DT
50458	271	26	normal	normal	JJ
50458	271	27	functionation	functionation	NN
50458	271	28	of	of	IN
50458	271	29	cellular	cellular	JJ
50458	271	30	life	life	NN
50458	271	31	in	in	IN
50458	271	32	the	the	DT
50458	271	33	higher	high	JJR
50458	271	34	vegetable	vegetable	NN
50458	271	35	or	or	CC
50458	271	36	animal	animal	NN
50458	271	37	organisms	organism	NNS
50458	271	38	.	.	.
50458	272	1	They	-PRON-	PRP
50458	272	2	are	be	VBP
50458	272	3	the	the	DT
50458	272	4	direct	direct	JJ
50458	272	5	products	product	NNS
50458	272	6	of	of	IN
50458	272	7	life	life	NN
50458	272	8	,	,	,
50458	272	9	and	and	CC
50458	272	10	do	do	VBP
50458	272	11	not	not	RB
50458	272	12	result	result	VB
50458	272	13	,	,	,
50458	272	14	as	as	IN
50458	272	15	was	be	VBD
50458	272	16	formerly	formerly	RB
50458	272	17	believed	believe	VBN
50458	272	18	,	,	,
50458	272	19	from	from	IN
50458	272	20	a	a	DT
50458	272	21	more	more	RBR
50458	272	22	or	or	CC
50458	272	23	less	less	RBR
50458	272	24	profound	profound	JJ
50458	272	25	modification	modification	NN
50458	272	26	of	of	IN
50458	272	27	the	the	DT
50458	272	28	more	more	RBR
50458	272	29	or	or	CC
50458	272	30	less	less	RBR
50458	272	31	complex	complex	JJ
50458	272	32	albuminoids	albuminoid	NNS
50458	272	33	that	that	WDT
50458	272	34	serve	serve	VBP
50458	272	35	as	as	IN
50458	272	36	a	a	DT
50458	272	37	food	food	NN
50458	272	38	for	for	IN
50458	272	39	the	the	DT
50458	272	40	various	various	JJ
50458	272	41	species	specie	NNS
50458	272	42	of	of	IN
50458	272	43	microbes	microbe	NNS
50458	272	44	,	,	,
50458	272	45	or	or	CC
50458	272	46	for	for	IN
50458	272	47	the	the	DT
50458	272	48	cellular	cellular	JJ
50458	272	49	elements	element	NNS
50458	272	50	.	.	.
50458	273	1	The	the	DT
50458	273	2	vegetable	vegetable	NN
50458	273	3	toxins	toxin	NNS
50458	273	4	are	be	VBP
50458	273	5	less	less	RBR
50458	273	6	numerous	numerous	JJ
50458	273	7	than	than	IN
50458	273	8	the	the	DT
50458	273	9	animal	animal	NN
50458	273	10	toxins	toxin	NNS
50458	273	11	.	.	.
50458	274	1	They	-PRON-	PRP
50458	274	2	are	be	VBP
50458	274	3	met	meet	VBN
50458	274	4	with	with	IN
50458	274	5	,	,	,
50458	274	6	nevertheless	nevertheless	RB
50458	274	7	,	,	,
50458	274	8	in	in	IN
50458	274	9	almost	almost	RB
50458	274	10	all	all	DT
50458	274	11	mushrooms	mushroom	NNS
50458	274	12	which	which	WDT
50458	274	13	are	be	VBP
50458	274	14	reputed	repute	VBN
50458	274	15	or	or	CC
50458	274	16	known	know	VBN
50458	274	17	to	to	TO
50458	274	18	be	be	VB
50458	274	19	toxic	toxic	JJ
50458	274	20	;	;	:
50458	274	21	the	the	DT
50458	274	22	seed	seed	NN
50458	274	23	of	of	IN
50458	274	24	the	the	DT
50458	274	25	castor	castor	NN
50458	274	26	plant	plant	NN
50458	274	27	contains	contain	VBZ
50458	274	28	a	a	DT
50458	274	29	very	very	RB
50458	274	30	toxic	toxic	JJ
50458	274	31	vegetable	vegetable	NN
50458	274	32	albuminoid	albuminoid	NN
50458	274	33	,	,	,
50458	274	34	as	as	IN
50458	274	35	is	be	VBZ
50458	274	36	likewise	likewise	RB
50458	274	37	the	the	DT
50458	274	38	case	case	NN
50458	274	39	with	with	IN
50458	274	40	Abrus	Abrus	NNP
50458	274	41	precatorius	precatorius	NN
50458	274	42	(	(	-LRB-
50458	274	43	jequirity	jequirity	NN
50458	274	44	-	-	HYPH
50458	274	45	bean	bean	NN
50458	274	46	)	)	-RRB-
50458	274	47	,	,	,
50458	274	48	and	and	CC
50458	274	49	certain	certain	JJ
50458	274	50	others	other	NNS
50458	274	51	.	.	.
50458	275	1	The	the	DT
50458	275	2	true	true	JJ
50458	275	3	physiological	physiological	JJ
50458	275	4	toxins	toxin	NNS
50458	275	5	occupy	occupy	VBP
50458	275	6	a	a	DT
50458	275	7	very	very	RB
50458	275	8	important	important	JJ
50458	275	9	place	place	NN
50458	275	10	in	in	IN
50458	275	11	the	the	DT
50458	275	12	realization	realization	NN
50458	275	13	of	of	IN
50458	275	14	the	the	DT
50458	275	15	conditions	condition	NNS
50458	275	16	that	that	WDT
50458	275	17	govern	govern	VBP
50458	275	18	health	health	NN
50458	275	19	,	,	,
50458	275	20	sickness	sickness	NN
50458	275	21	,	,	,
50458	275	22	and	and	CC
50458	275	23	death	death	NN
50458	275	24	.	.	.
50458	276	1	We	-PRON-	PRP
50458	276	2	will	will	MD
50458	276	3	see	see	VB
50458	276	4	later	later	RB
50458	276	5	on	on	RB
50458	276	6	that	that	IN
50458	276	7	they	-PRON-	PRP
50458	276	8	are	be	VBP
50458	276	9	met	meet	VBN
50458	276	10	with	with	IN
50458	276	11	in	in	IN
50458	276	12	quite	quite	RB
50458	276	13	large	large	JJ
50458	276	14	number	number	NN
50458	276	15	in	in	IN
50458	276	16	the	the	DT
50458	276	17	bladder	bladder	NN
50458	276	18	,	,	,
50458	276	19	whence	whence	NN
50458	276	20	they	-PRON-	PRP
50458	276	21	are	be	VBP
50458	276	22	voided	void	VBN
50458	276	23	in	in	IN
50458	276	24	the	the	DT
50458	276	25	urine	urine	NN
50458	276	26	.	.	.
50458	277	1	Their	-PRON-	PRP$
50458	277	2	number	number	NN
50458	277	3	varies	vary	VBZ
50458	277	4	considerably	considerably	RB
50458	277	5	,	,	,
50458	277	6	according	accord	VBG
50458	277	7	to	to	IN
50458	277	8	diverse	diverse	JJ
50458	277	9	influences	influence	NNS
50458	277	10	(	(	-LRB-
50458	277	11	waking	waking	NN
50458	277	12	,	,	,
50458	277	13	slumber	slumber	NNP
50458	277	14	,	,	,
50458	277	15	eating	eat	VBG
50458	277	16	,	,	,
50458	277	17	fasting	fasting	NN
50458	277	18	,	,	,
50458	277	19	fatigue	fatigue	NN
50458	277	20	,	,	,
50458	277	21	oxygen	oxygen	NN
50458	277	22	,	,	,
50458	277	23	brainwork	brainwork	NN
50458	277	24	,	,	,
50458	277	25	health	health	NN
50458	277	26	,	,	,
50458	277	27	disease	disease	NN
50458	277	28	,	,	,
50458	277	29	etc	etc	FW
50458	277	30	.	.	.
50458	277	31	)	)	-RRB-
50458	277	32	.	.	.
50458	278	1	It	-PRON-	PRP
50458	278	2	is	be	VBZ
50458	278	3	necessary	necessary	JJ
50458	278	4	here	here	RB
50458	278	5	to	to	TO
50458	278	6	observe	observe	VB
50458	278	7	that	that	IN
50458	278	8	the	the	DT
50458	278	9	renal	renal	JJ
50458	278	10	system	system	NN
50458	278	11	serves	serve	VBZ
50458	278	12	for	for	IN
50458	278	13	the	the	DT
50458	278	14	purification	purification	NN
50458	278	15	of	of	IN
50458	278	16	the	the	DT
50458	278	17	entire	entire	JJ
50458	278	18	organism	organism	NN
50458	278	19	,	,	,
50458	278	20	and	and	CC
50458	278	21	that	that	IN
50458	278	22	in	in	IN
50458	278	23	the	the	DT
50458	278	24	case	case	NN
50458	278	25	of	of	IN
50458	278	26	normal	normal	JJ
50458	278	27	life	life	NN
50458	278	28	we	-PRON-	PRP
50458	278	29	will	will	MD
50458	278	30	find	find	VB
50458	278	31	in	in	IN
50458	278	32	the	the	DT
50458	278	33	renal	renal	JJ
50458	278	34	system	system	NN
50458	278	35	a	a	DT
50458	278	36	large	large	JJ
50458	278	37	portion	portion	NN
50458	278	38	of	of	IN
50458	278	39	the	the	DT
50458	278	40	products	product	NNS
50458	278	41	of	of	IN
50458	278	42	the	the	DT
50458	278	43	cellular	cellular	JJ
50458	278	44	secretion	secretion	NN
50458	278	45	of	of	IN
50458	278	46	the	the	DT
50458	278	47	organism	organism	NN
50458	278	48	,	,	,
50458	278	49	and	and	CC
50458	278	50	among	among	IN
50458	278	51	the	the	DT
50458	278	52	number	number	NN
50458	278	53	there	there	EX
50458	278	54	are	be	VBP
50458	278	55	found	find	VBN
50458	278	56	,	,	,
50458	278	57	as	as	IN
50458	278	58	we	-PRON-	PRP
50458	278	59	know	know	VBP
50458	278	60	,	,	,
50458	278	61	a	a	DT
50458	278	62	certain	certain	JJ
50458	278	63	number	number	NN
50458	278	64	of	of	IN
50458	278	65	alkaloidal	alkaloidal	NN
50458	278	66	bases	basis	NNS
50458	278	67	.	.	.
50458	279	1	We	-PRON-	PRP
50458	279	2	will	will	MD
50458	279	3	take	take	VB
50458	279	4	up	up	RP
50458	279	5	later	later	RB
50458	279	6	the	the	DT
50458	279	7	subject	subject	NN
50458	279	8	of	of	IN
50458	279	9	urinary	urinary	JJ
50458	279	10	toxicity	toxicity	NN
50458	279	11	.	.	.
50458	280	1	=	=	NFP
50458	280	2	Autointoxications.=--The	autointoxications.=--the	DT
50458	280	3	toxins	toxin	NNS
50458	280	4	are	be	VBP
50458	280	5	also	also	RB
50458	280	6	encountered	encounter	VBN
50458	280	7	,	,	,
50458	280	8	and	and	CC
50458	280	9	often	often	RB
50458	280	10	in	in	IN
50458	280	11	some	some	DT
50458	280	12	number	number	NN
50458	280	13	,	,	,
50458	280	14	in	in	IN
50458	280	15	the	the	DT
50458	280	16	muscular	muscular	JJ
50458	280	17	tissues	tissue	NNS
50458	280	18	and	and	CC
50458	280	19	in	in	IN
50458	280	20	the	the	DT
50458	280	21	blood	blood	NN
50458	280	22	,	,	,
50458	280	23	particularly	particularly	RB
50458	280	24	in	in	IN
50458	280	25	those	those	DT
50458	280	26	of	of	IN
50458	280	27	batrachians	batrachian	NNS
50458	280	28	,	,	,
50458	280	29	mureids	mureid	NNS
50458	280	30	,	,	,
50458	280	31	and	and	CC
50458	280	32	saurians	saurians	NNPS
50458	280	33	.	.	.
50458	281	1	In	in	IN
50458	281	2	the	the	DT
50458	281	3	organism	organism	NN
50458	281	4	these	these	DT
50458	281	5	toxins	toxin	NNS
50458	281	6	,	,	,
50458	281	7	developed	develop	VBN
50458	281	8	by	by	IN
50458	281	9	the	the	DT
50458	281	10	activity	activity	NN
50458	281	11	of	of	IN
50458	281	12	the	the	DT
50458	281	13	various	various	JJ
50458	281	14	cells	cell	NNS
50458	281	15	,	,	,
50458	281	16	may	may	MD
50458	281	17	cause	cause	VB
50458	281	18	autointoxication	autointoxication	NN
50458	281	19	whenever	whenever	WRB
50458	281	20	,	,	,
50458	281	21	for	for	IN
50458	281	22	one	one	CD
50458	281	23	cause	cause	NN
50458	281	24	or	or	CC
50458	281	25	another	another	DT
50458	281	26	,	,	,
50458	281	27	their	-PRON-	PRP$
50458	281	28	normal	normal	JJ
50458	281	29	elimination	elimination	NN
50458	281	30	ceases	cease	NNS
50458	281	31	.	.	.
50458	282	1	"	"	``
50458	282	2	Although	although	IN
50458	282	3	there	there	EX
50458	282	4	are	be	VBP
50458	282	5	an	an	DT
50458	282	6	infinity	infinity	NN
50458	282	7	of	of	IN
50458	282	8	diseases	disease	NNS
50458	282	9	,	,	,
50458	282	10	"	"	''
50458	282	11	remarked	remark	VBD
50458	282	12	Prof.	Prof.	NNP
50458	282	13	Bouchard	Bouchard	NNP
50458	282	14	,	,	,
50458	282	15	"	"	``
50458	282	16	there	there	EX
50458	282	17	are	be	VBP
50458	282	18	but	but	IN
50458	282	19	a	a	DT
50458	282	20	few	few	JJ
50458	282	21	ways	way	NNS
50458	282	22	of	of	IN
50458	282	23	becoming	become	VBG
50458	282	24	ill	ill	JJ
50458	282	25	.	.	.
50458	282	26	"	"	''
50458	282	27	Of	of	IN
50458	282	28	these	these	DT
50458	282	29	ways	way	NNS
50458	282	30	that	that	DT
50458	282	31	of	of	IN
50458	282	32	autointoxication	autointoxication	NN
50458	282	33	is	be	VBZ
50458	282	34	the	the	DT
50458	282	35	most	most	RBS
50458	282	36	frequent	frequent	JJ
50458	282	37	.	.	.
50458	283	1	"	"	``
50458	283	2	What	what	WP
50458	283	3	else	else	RB
50458	283	4	is	be	VBZ
50458	283	5	it	-PRON-	PRP
50458	283	6	,	,	,
50458	283	7	then	then	RB
50458	283	8	,	,	,
50458	283	9	"	"	''
50458	283	10	says	say	VBZ
50458	283	11	Prof.	Prof.	NNP
50458	283	12	Charrin	Charrin	NNP
50458	283	13	,	,	,
50458	283	14	"	"	``
50458	283	15	in	in	IN
50458	283	16	the	the	DT
50458	283	17	last	last	JJ
50458	283	18	analysis	analysis	NN
50458	283	19	,	,	,
50458	283	20	but	but	CC
50458	283	21	to	to	TO
50458	283	22	die	die	VB
50458	283	23	from	from	IN
50458	283	24	affections	affection	NNS
50458	283	25	of	of	IN
50458	283	26	the	the	DT
50458	283	27	kidney	kidney	NN
50458	283	28	,	,	,
50458	283	29	the	the	DT
50458	283	30	liver	liver	NN
50458	283	31	,	,	,
50458	283	32	the	the	DT
50458	283	33	heart	heart	NN
50458	283	34	,	,	,
50458	283	35	the	the	DT
50458	283	36	lung	lung	NN
50458	283	37	,	,	,
50458	283	38	etc	etc	FW
50458	283	39	.	.	FW
50458	283	40	,	,	,
50458	283	41	if	if	IN
50458	283	42	it	-PRON-	PRP
50458	283	43	be	be	VBP
50458	283	44	not	not	RB
50458	283	45	to	to	TO
50458	283	46	succumb	succumb	VB
50458	283	47	because	because	IN
50458	283	48	of	of	IN
50458	283	49	the	the	DT
50458	283	50	lack	lack	NN
50458	283	51	of	of	IN
50458	283	52	oxygen	oxygen	NN
50458	283	53	,	,	,
50458	283	54	the	the	DT
50458	283	55	accumulation	accumulation	NN
50458	283	56	of	of	IN
50458	283	57	carbonic	carbonic	JJ
50458	283	58	acid	acid	NN
50458	283	59	,	,	,
50458	283	60	the	the	DT
50458	283	61	influence	influence	NN
50458	283	62	of	of	IN
50458	283	63	the	the	DT
50458	283	64	numerous	numerous	JJ
50458	283	65	urinary	urinary	JJ
50458	283	66	poisons	poison	NNS
50458	283	67	,	,	,
50458	283	68	the	the	DT
50458	283	69	action	action	NN
50458	283	70	of	of	IN
50458	283	71	acids	acid	NNS
50458	283	72	,	,	,
50458	283	73	of	of	IN
50458	283	74	salts	salt	NNS
50458	283	75	,	,	,
50458	283	76	of	of	IN
50458	283	77	biliary	biliary	JJ
50458	283	78	pigments	pigment	NNS
50458	283	79	,	,	,
50458	283	80	or	or	CC
50458	283	81	the	the	DT
50458	283	82	effect	effect	NN
50458	283	83	of	of	IN
50458	283	84	noxious	noxious	JJ
50458	283	85	principles	principle	NNS
50458	283	86	,	,	,
50458	283	87	which	which	WDT
50458	283	88	the	the	DT
50458	283	89	hepatic	hepatic	JJ
50458	283	90	cell	cell	NN
50458	283	91	must	must	MD
50458	283	92	normally	normally	RB
50458	283	93	destroy	destroy	VB
50458	283	94	or	or	CC
50458	283	95	at	at	IN
50458	283	96	least	least	JJS
50458	283	97	attenuate	attenuate	NN
50458	283	98	.	.	.
50458	283	99	"	"	''
50458	284	1	These	these	DT
50458	284	2	autointoxications	autointoxication	NNS
50458	284	3	,	,	,
50458	284	4	always	always	RB
50458	284	5	due	due	JJ
50458	284	6	to	to	IN
50458	284	7	poor	poor	JJ
50458	284	8	elimination	elimination	NN
50458	284	9	of	of	IN
50458	284	10	toxic	toxic	JJ
50458	284	11	principles	principle	NNS
50458	284	12	,	,	,
50458	284	13	toxins	toxin	NNS
50458	284	14	formed	form	VBN
50458	284	15	in	in	IN
50458	284	16	very	very	RB
50458	284	17	great	great	JJ
50458	284	18	number	number	NN
50458	284	19	in	in	IN
50458	284	20	the	the	DT
50458	284	21	organism	organism	NN
50458	284	22	,	,	,
50458	284	23	and	and	CC
50458	284	24	which	which	WDT
50458	284	25	the	the	DT
50458	284	26	normal	normal	JJ
50458	284	27	modes	mode	NNS
50458	284	28	of	of	IN
50458	284	29	evacuation	evacuation	NN
50458	284	30	or	or	CC
50458	284	31	destruction	destruction	NN
50458	284	32	do	do	VBP
50458	284	33	not	not	RB
50458	284	34	eliminate	eliminate	VB
50458	284	35	,	,	,
50458	284	36	are	be	VBP
50458	284	37	always	always	RB
50458	284	38	found	find	VBN
50458	284	39	to	to	TO
50458	284	40	be	be	VB
50458	284	41	the	the	DT
50458	284	42	cause	cause	NN
50458	284	43	of	of	IN
50458	284	44	all	all	DT
50458	284	45	diseases	disease	NNS
50458	284	46	,	,	,
50458	284	47	even	even	RB
50458	284	48	those	those	DT
50458	284	49	that	that	WDT
50458	284	50	are	be	VBP
50458	284	51	manifested	manifest	VBN
50458	284	52	by	by	IN
50458	284	53	attacks	attack	NNS
50458	284	54	of	of	IN
50458	284	55	the	the	DT
50458	284	56	cerebro	cerebro	JJ
50458	284	57	-	-	HYPH
50458	284	58	spinal	spinal	JJ
50458	284	59	axis	axis	NN
50458	284	60	,	,	,
50458	284	61	and	and	CC
50458	284	62	that	that	DT
50458	284	63	exhibit	exhibit	NN
50458	284	64	variously	variously	RB
50458	284	65	mania	mania	NN
50458	284	66	,	,	,
50458	284	67	insanity	insanity	NN
50458	284	68	,	,	,
50458	284	69	symptoms	symptom	NNS
50458	284	70	of	of	IN
50458	284	71	hyperexcitability	hyperexcitability	NN
50458	284	72	,	,	,
50458	284	73	etc	etc	FW
50458	284	74	.	.	.
50458	285	1	These	these	DT
50458	285	2	autointoxications	autointoxication	NNS
50458	285	3	are	be	VBP
50458	285	4	controlled	control	VBN
50458	285	5	by	by	IN
50458	285	6	the	the	DT
50458	285	7	nervous	nervous	JJ
50458	285	8	system	system	NN
50458	285	9	,	,	,
50458	285	10	and	and	CC
50458	285	11	the	the	DT
50458	285	12	latter	latter	JJ
50458	285	13	alone	alone	RB
50458	285	14	is	be	VBZ
50458	285	15	the	the	DT
50458	285	16	cause	cause	NN
50458	285	17	of	of	IN
50458	285	18	a	a	DT
50458	285	19	larger	large	JJR
50458	285	20	number	number	NN
50458	285	21	of	of	IN
50458	285	22	maladies	malady	NNS
50458	285	23	than	than	IN
50458	285	24	is	be	VBZ
50458	285	25	generally	generally	RB
50458	285	26	believed	believe	VBN
50458	285	27	;	;	:
50458	285	28	in	in	IN
50458	285	29	fact	fact	NN
50458	285	30	,	,	,
50458	285	31	if	if	IN
50458	285	32	the	the	DT
50458	285	33	mechanism	mechanism	NN
50458	285	34	of	of	IN
50458	285	35	nutrition	nutrition	NN
50458	285	36	be	be	VB
50458	285	37	reduced	reduce	VBN
50458	285	38	to	to	IN
50458	285	39	its	-PRON-	PRP$
50458	285	40	most	most	RBS
50458	285	41	simple	simple	JJ
50458	285	42	elements	element	NNS
50458	285	43	,	,	,
50458	285	44	it	-PRON-	PRP
50458	285	45	will	will	MD
50458	285	46	be	be	VB
50458	285	47	seen	see	VBN
50458	285	48	to	to	TO
50458	285	49	consist	consist	VB
50458	285	50	of	of	IN
50458	285	51	the	the	DT
50458	285	52	penetration	penetration	NN
50458	285	53	of	of	IN
50458	285	54	the	the	DT
50458	285	55	foods	food	NNS
50458	285	56	,	,	,
50458	285	57	of	of	IN
50458	285	58	the	the	DT
50458	285	59	plasmatic	plasmatic	JJ
50458	285	60	principles	principle	NNS
50458	285	61	,	,	,
50458	285	62	to	to	IN
50458	285	63	the	the	DT
50458	285	64	cells	cell	NNS
50458	285	65	;	;	:
50458	285	66	of	of	IN
50458	285	67	their	-PRON-	PRP$
50458	285	68	transformation	transformation	NN
50458	285	69	within	within	IN
50458	285	70	the	the	DT
50458	285	71	interior	interior	NN
50458	285	72	of	of	IN
50458	285	73	the	the	DT
50458	285	74	cells	cell	NNS
50458	285	75	,	,	,
50458	285	76	and	and	CC
50458	285	77	finally	finally	RB
50458	285	78	the	the	DT
50458	285	79	rejection	rejection	NN
50458	285	80	of	of	IN
50458	285	81	all	all	PDT
50458	285	82	the	the	DT
50458	285	83	matter	matter	NN
50458	285	84	that	that	WDT
50458	285	85	could	could	MD
50458	285	86	not	not	RB
50458	285	87	be	be	VB
50458	285	88	utilized	utilize	VBN
50458	285	89	.	.	.
50458	286	1	It	-PRON-	PRP
50458	286	2	is	be	VBZ
50458	286	3	the	the	DT
50458	286	4	nervous	nervous	JJ
50458	286	5	system	system	NN
50458	286	6	that	that	WDT
50458	286	7	commands	command	VBZ
50458	286	8	or	or	CC
50458	286	9	dominates	dominate	VBZ
50458	286	10	this	this	DT
50458	286	11	mechanism	mechanism	NN
50458	286	12	,	,	,
50458	286	13	that	that	WDT
50458	286	14	controls	control	VBZ
50458	286	15	the	the	DT
50458	286	16	taking	taking	NN
50458	286	17	-	-	HYPH
50458	286	18	up	up	NN
50458	286	19	of	of	IN
50458	286	20	assimilable	assimilable	JJ
50458	286	21	elements	element	NNS
50458	286	22	and	and	CC
50458	286	23	the	the	DT
50458	286	24	elimination	elimination	NN
50458	286	25	of	of	IN
50458	286	26	toxic	toxic	JJ
50458	286	27	principles	principle	NNS
50458	286	28	,	,	,
50458	286	29	the	the	DT
50458	286	30	fruit	fruit	NN
50458	286	31	of	of	IN
50458	286	32	assimilation	assimilation	NN
50458	286	33	or	or	CC
50458	286	34	disassimilation	disassimilation	NN
50458	286	35	,	,	,
50458	286	36	and	and	CC
50458	286	37	in	in	IN
50458	286	38	such	such	PDT
50458	286	39	a	a	DT
50458	286	40	manner	manner	NN
50458	286	41	,	,	,
50458	286	42	in	in	IN
50458	286	43	fact	fact	NN
50458	286	44	,	,	,
50458	286	45	that	that	IN
50458	286	46	this	this	DT
50458	286	47	same	same	JJ
50458	286	48	nervous	nervous	JJ
50458	286	49	system	system	NN
50458	286	50	can	can	MD
50458	286	51	,	,	,
50458	286	52	at	at	IN
50458	286	53	its	-PRON-	PRP$
50458	286	54	will	will	NN
50458	286	55	,	,	,
50458	286	56	cause	cause	VB
50458	286	57	starvation	starvation	NN
50458	286	58	,	,	,
50458	286	59	or	or	CC
50458	286	60	intoxicate	intoxicate	VBP
50458	286	61	.	.	.
50458	287	1	The	the	DT
50458	287	2	marvelous	marvelous	JJ
50458	287	3	cures	cure	NNS
50458	287	4	obtained	obtain	VBN
50458	287	5	by	by	IN
50458	287	6	magnetic	magnetic	JJ
50458	287	7	methods	method	NNS
50458	287	8	are	be	VBP
50458	287	9	due	due	JJ
50458	287	10	to	to	IN
50458	287	11	no	no	DT
50458	287	12	other	other	JJ
50458	287	13	causes	cause	NNS
50458	287	14	than	than	IN
50458	287	15	favorable	favorable	JJ
50458	287	16	changes	change	NNS
50458	287	17	in	in	IN
50458	287	18	the	the	DT
50458	287	19	nervous	nervous	JJ
50458	287	20	system	system	NN
50458	287	21	.	.	.
50458	288	1	=	=	NFP
50458	288	2	General	General	NNP
50458	288	3	Mode	Mode	NNP
50458	288	4	of	of	IN
50458	288	5	Action.=--The	Action.=--The	NNP
50458	288	6	toxins	toxin	NNS
50458	288	7	,	,	,
50458	288	8	of	of	IN
50458	288	9	whatever	whatever	WDT
50458	288	10	kind	kind	NN
50458	288	11	,	,	,
50458	288	12	always	always	RB
50458	288	13	behave	behave	VB
50458	288	14	like	like	IN
50458	288	15	diastases	diastasis	NNS
50458	288	16	,	,	,
50458	288	17	in	in	IN
50458	288	18	the	the	DT
50458	288	19	sense	sense	NN
50458	288	20	that	that	IN
50458	288	21	their	-PRON-	PRP$
50458	288	22	definite	definite	JJ
50458	288	23	action	action	NN
50458	288	24	appears	appear	VBZ
50458	288	25	to	to	TO
50458	288	26	be	be	VB
50458	288	27	absolutely	absolutely	RB
50458	288	28	independent	independent	JJ
50458	288	29	of	of	IN
50458	288	30	their	-PRON-	PRP$
50458	288	31	mass	mass	NN
50458	288	32	,	,	,
50458	288	33	and	and	CC
50458	288	34	that	that	IN
50458	288	35	imponderable	imponderable	JJ
50458	288	36	quantities	quantity	NNS
50458	288	37	suffice	suffice	VBP
50458	288	38	to	to	TO
50458	288	39	cause	cause	VB
50458	288	40	serious	serious	JJ
50458	288	41	morbid	morbid	NN
50458	288	42	affections	affection	NNS
50458	288	43	and	and	CC
50458	288	44	profound	profound	JJ
50458	288	45	modifications	modification	NNS
50458	288	46	in	in	IN
50458	288	47	nutrition	nutrition	NN
50458	288	48	.	.	.
50458	289	1	Koch	Koch	NNP
50458	289	2	has	have	VBZ
50458	289	3	shown	show	VBN
50458	289	4	that	that	IN
50458	289	5	tuberculin	tuberculin	NN
50458	289	6	is	be	VBZ
50458	289	7	capable	capable	JJ
50458	289	8	of	of	IN
50458	289	9	affecting	affect	VBG
50458	289	10	60	60	CD
50458	289	11	trillion	trillion	CD
50458	289	12	times	time	NNS
50458	289	13	its	-PRON-	PRP$
50458	289	14	weight	weight	NN
50458	289	15	of	of	IN
50458	289	16	the	the	DT
50458	289	17	living	live	VBG
50458	289	18	human	human	JJ
50458	289	19	being	being	NN
50458	289	20	.	.	.
50458	290	1	According	accord	VBG
50458	290	2	to	to	IN
50458	290	3	Vaillard	Vaillard	NNP
50458	290	4	one	one	CD
50458	290	5	milligramme	milligramme	NN
50458	290	6	of	of	IN
50458	290	7	tetanus	tetanus	NN
50458	290	8	toxin	toxin	NN
50458	290	9	will	will	MD
50458	290	10	kill	kill	VB
50458	290	11	a	a	DT
50458	290	12	horse	horse	NN
50458	290	13	weighing	weigh	VBG
50458	290	14	600	600	CD
50458	290	15	kilos	kilo	NNS
50458	290	16	.	.	.
50458	291	1	These	these	DT
50458	291	2	two	two	CD
50458	291	3	examples	example	NNS
50458	291	4	show	show	VBP
50458	291	5	what	what	WP
50458	291	6	an	an	DT
50458	291	7	enormous	enormous	JJ
50458	291	8	power	power	NN
50458	291	9	the	the	DT
50458	291	10	toxins	toxin	NNS
50458	291	11	possess	possess	VBP
50458	291	12	.	.	.
50458	292	1	My	-PRON-	PRP$
50458	292	2	views	view	NNS
50458	292	3	regarding	regard	VBG
50458	292	4	the	the	DT
50458	292	5	manner	manner	NN
50458	292	6	in	in	IN
50458	292	7	which	which	WDT
50458	292	8	diastases	diastasis	NNS
50458	292	9	act	act	VBP
50458	292	10	I	-PRON-	PRP
50458	292	11	have	have	VBP
50458	292	12	developed	develop	VBN
50458	292	13	at	at	IN
50458	292	14	length	length	NN
50458	292	15	in	in	IN
50458	292	16	my	-PRON-	PRP$
50458	292	17	work	work	NN
50458	292	18	_	_	NNP
50458	292	19	Nature	Nature	NNP
50458	292	20	des	des	NNP
50458	292	21	Diastases	Diastases	NNP
50458	292	22	_	_	NNP
50458	292	23	.	.	.
50458	293	1	The	the	DT
50458	293	2	close	close	JJ
50458	293	3	analogy	analogy	NN
50458	293	4	between	between	IN
50458	293	5	these	these	DT
50458	293	6	substances	substance	NNS
50458	293	7	and	and	CC
50458	293	8	the	the	DT
50458	293	9	toxins	toxin	NNS
50458	293	10	,	,	,
50458	293	11	an	an	DT
50458	293	12	analogy	analogy	NN
50458	293	13	upon	upon	IN
50458	293	14	which	which	WDT
50458	293	15	,	,	,
50458	293	16	moreover	moreover	RB
50458	293	17	,	,	,
50458	293	18	I	-PRON-	PRP
50458	293	19	have	have	VBP
50458	293	20	dwelt	dwell	VBN
50458	293	21	at	at	IN
50458	293	22	some	some	DT
50458	293	23	length	length	NN
50458	293	24	,	,	,
50458	293	25	permits	permit	VBZ
50458	293	26	me	-PRON-	PRP
50458	293	27	to	to	TO
50458	293	28	refer	refer	VB
50458	293	29	the	the	DT
50458	293	30	reader	reader	NN
50458	293	31	who	who	WP
50458	293	32	is	be	VBZ
50458	293	33	desirous	desirous	JJ
50458	293	34	of	of	IN
50458	293	35	fuller	full	JJR
50458	293	36	details	detail	NNS
50458	293	37	to	to	IN
50458	293	38	the	the	DT
50458	293	39	small	small	JJ
50458	293	40	work	work	NN
50458	293	41	just	just	RB
50458	293	42	mentioned	mention	VBD
50458	293	43	.	.	.
50458	294	1	The	the	DT
50458	294	2	mode	mode	NN
50458	294	3	of	of	IN
50458	294	4	action	action	NN
50458	294	5	of	of	IN
50458	294	6	diastases	diastasis	NNS
50458	294	7	resembles	resemble	VBZ
50458	294	8	singularly	singularly	RB
50458	294	9	closely	closely	RB
50458	294	10	that	that	DT
50458	294	11	of	of	IN
50458	294	12	the	the	DT
50458	294	13	catalytic	catalytic	JJ
50458	294	14	substances	substance	NNS
50458	294	15	,	,	,
50458	294	16	and	and	CC
50458	294	17	we	-PRON-	PRP
50458	294	18	will	will	MD
50458	294	19	admit	admit	VB
50458	294	20	,	,	,
50458	294	21	for	for	IN
50458	294	22	the	the	DT
50458	294	23	moment	moment	NN
50458	294	24	,	,	,
50458	294	25	that	that	IN
50458	294	26	they	-PRON-	PRP
50458	294	27	act	act	VBP
50458	294	28	by	by	IN
50458	294	29	intermediary	intermediary	JJ
50458	294	30	combination	combination	NN
50458	294	31	,	,	,
50458	294	32	resulting	result	VBG
50458	294	33	in	in	IN
50458	294	34	their	-PRON-	PRP$
50458	294	35	rapid	rapid	JJ
50458	294	36	decomposition	decomposition	NN
50458	294	37	.	.	.
50458	295	1	We	-PRON-	PRP
50458	295	2	owe	owe	VBP
50458	295	3	to	to	IN
50458	295	4	Ehrlich[31	ehrlich[31	ADD
50458	295	5	]	]	-RRB-
50458	295	6	a	a	DT
50458	295	7	new	new	JJ
50458	295	8	conception	conception	NN
50458	295	9	relative	relative	JJ
50458	295	10	to	to	IN
50458	295	11	the	the	DT
50458	295	12	nature	nature	NN
50458	295	13	and	and	CC
50458	295	14	mode	mode	NN
50458	295	15	of	of	IN
50458	295	16	action	action	NN
50458	295	17	of	of	IN
50458	295	18	the	the	DT
50458	295	19	diastases	diastasis	NNS
50458	295	20	,	,	,
50458	295	21	and	and	CC
50458	295	22	which	which	WDT
50458	295	23	to	to	IN
50458	295	24	-	-	HYPH
50458	295	25	day	day	NN
50458	295	26	plays	play	VBZ
50458	295	27	an	an	DT
50458	295	28	important	important	JJ
50458	295	29	rôle	rôle	NN
50458	295	30	in	in	IN
50458	295	31	all	all	DT
50458	295	32	our	-PRON-	PRP$
50458	295	33	conceptions	conception	NNS
50458	295	34	regarding	regard	VBG
50458	295	35	immunity	immunity	NN
50458	295	36	.	.	.
50458	296	1	[	[	-LRB-
50458	296	2	32	32	CD
50458	296	3	]	]	-RRB-
50458	296	4	[	[	-LRB-
50458	296	5	31	31	CD
50458	296	6	]	]	-RRB-
50458	296	7	EHRLICH	ehrlich	NN
50458	296	8	:	:	:
50458	296	9	_	_	NNP
50458	296	10	Klinisches	Klinisches	NNPS
50458	296	11	Jahrbuch	Jahrbuch	NNP
50458	296	12	_	_	NNP
50458	296	13	,	,	,
50458	296	14	1897	1897	CD
50458	296	15	,	,	,
50458	296	16	VI	VI	NNP
50458	296	17	.	.	.
50458	297	1	_	_	NNP
50458	297	2	Proceedings	Proceedings	NNP
50458	297	3	of	of	IN
50458	297	4	the	the	DT
50458	297	5	Royal	Royal	NNP
50458	297	6	Society	Society	NNP
50458	297	7	_	_	NNP
50458	297	8	,	,	,
50458	297	9	1900	1900	CD
50458	297	10	,	,	,
50458	297	11	No	no	UH
50458	297	12	.	.	.
50458	298	1	482	482	CD
50458	298	2	,	,	,
50458	298	3	p.	p.	NN
50458	298	4	424	424	CD
50458	298	5	.	.	.
50458	299	1	_	_	NNP
50458	299	2	Nothnagles	Nothnagles	NNP
50458	299	3	'	'	POS
50458	299	4	specielle	specielle	NN
50458	299	5	Pathologie	Pathologie	NNP
50458	299	6	und	und	JJ
50458	299	7	Therapie	Therapie	NNP
50458	299	8	_	_	NNP
50458	299	9	,	,	,
50458	299	10	1901	1901	CD
50458	299	11	,	,	,
50458	299	12	VIII	VIII	NNP
50458	299	13	,	,	,
50458	299	14	Schlussbetrachtungen	Schlussbetrachtungen	NNP
50458	299	15	,	,	,
50458	299	16	p.	p.	NN
50458	299	17	163	163	CD
50458	299	18	.	.	.
50458	300	1	[	[	-LRB-
50458	300	2	32	32	CD
50458	300	3	]	]	-RRB-
50458	300	4	To	to	TO
50458	300	5	have	have	VB
50458	300	6	a	a	DT
50458	300	7	complete	complete	JJ
50458	300	8	exposé	exposé	NN
50458	300	9	regarding	regard	VBG
50458	300	10	this	this	DT
50458	300	11	question	question	NN
50458	300	12	,	,	,
50458	300	13	it	-PRON-	PRP
50458	300	14	will	will	MD
50458	300	15	be	be	VB
50458	300	16	profitable	profitable	JJ
50458	300	17	to	to	TO
50458	300	18	consult	consult	VB
50458	300	19	No	no	UH
50458	300	20	.	.	.
50458	301	1	4	4	CD
50458	301	2	of	of	IN
50458	301	3	this	this	DT
50458	301	4	collection	collection	NN
50458	301	5	on	on	IN
50458	301	6	_	_	NNP
50458	301	7	Sérums	Sérums	NNP
50458	301	8	Immunisants	Immunisants	NNP
50458	301	9	_	_	NNP
50458	301	10	.	.	.
50458	302	1	According	accord	VBG
50458	302	2	to	to	IN
50458	302	3	this	this	DT
50458	302	4	scientist	scientist	NN
50458	302	5	,	,	,
50458	302	6	the	the	DT
50458	302	7	complex	complex	JJ
50458	302	8	molecule	molecule	NN
50458	302	9	of	of	IN
50458	302	10	albuminoid	albuminoid	NN
50458	302	11	substances	substance	NNS
50458	302	12	is	be	VBZ
50458	302	13	constituted	constitute	VBN
50458	302	14	by	by	IN
50458	302	15	a	a	DT
50458	302	16	fixed	fix	VBN
50458	302	17	central	central	JJ
50458	302	18	nucleus	nucleus	NN
50458	302	19	,	,	,
50458	302	20	and	and	CC
50458	302	21	by	by	IN
50458	302	22	a	a	DT
50458	302	23	number	number	NN
50458	302	24	of	of	IN
50458	302	25	lateral	lateral	JJ
50458	302	26	chains	chain	NNS
50458	302	27	or	or	CC
50458	302	28	receptors	receptor	NNS
50458	302	29	,	,	,
50458	302	30	fixed	fix	VBN
50458	302	31	to	to	IN
50458	302	32	this	this	DT
50458	302	33	nucleus	nucleus	NN
50458	302	34	,	,	,
50458	302	35	which	which	WDT
50458	302	36	possess	possess	VBP
50458	302	37	diverse	diverse	JJ
50458	302	38	accessory	accessory	JJ
50458	302	39	functions	function	NNS
50458	302	40	,	,	,
50458	302	41	and	and	CC
50458	302	42	which	which	WDT
50458	302	43	serve	serve	VBP
50458	302	44	,	,	,
50458	302	45	particularly	particularly	RB
50458	302	46	,	,	,
50458	302	47	for	for	IN
50458	302	48	the	the	DT
50458	302	49	nutrition	nutrition	NN
50458	302	50	of	of	IN
50458	302	51	the	the	DT
50458	302	52	cells	cell	NNS
50458	302	53	.	.	.
50458	303	1	These	these	DT
50458	303	2	receptors	receptor	NNS
50458	303	3	have	have	VBP
50458	303	4	a	a	DT
50458	303	5	great	great	JJ
50458	303	6	affinity	affinity	NN
50458	303	7	for	for	IN
50458	303	8	the	the	DT
50458	303	9	various	various	JJ
50458	303	10	substances	substance	NNS
50458	303	11	necessary	necessary	JJ
50458	303	12	for	for	IN
50458	303	13	the	the	DT
50458	303	14	support	support	NN
50458	303	15	of	of	IN
50458	303	16	the	the	DT
50458	303	17	living	live	VBG
50458	303	18	elements	element	NNS
50458	303	19	,	,	,
50458	303	20	and	and	CC
50458	303	21	they	-PRON-	PRP
50458	303	22	seize	seize	VBP
50458	303	23	upon	upon	IN
50458	303	24	the	the	DT
50458	303	25	alimentary	alimentary	JJ
50458	303	26	substances	substance	NNS
50458	303	27	,	,	,
50458	303	28	in	in	IN
50458	303	29	normal	normal	JJ
50458	303	30	life	life	NN
50458	303	31	,	,	,
50458	303	32	just	just	RB
50458	303	33	as	as	IN
50458	303	34	a	a	DT
50458	303	35	leaf	leaf	NN
50458	303	36	of	of	IN
50458	303	37	the	the	DT
50458	303	38	_	_	NNP
50458	303	39	Dionæa	Dionæa	NNP
50458	303	40	_	_	NNP
50458	303	41	seizes	seize	VBZ
50458	303	42	a	a	DT
50458	303	43	fly	fly	NN
50458	303	44	which	which	WDT
50458	303	45	serves	serve	VBZ
50458	303	46	as	as	IN
50458	303	47	its	-PRON-	PRP$
50458	303	48	food	food	NN
50458	303	49	.	.	.
50458	304	1	In	in	IN
50458	304	2	these	these	DT
50458	304	3	special	special	JJ
50458	304	4	conditions	condition	NNS
50458	304	5	the	the	DT
50458	304	6	receptors	receptor	NNS
50458	304	7	may	may	MD
50458	304	8	attach	attach	VB
50458	304	9	themselves	-PRON-	PRP
50458	304	10	to	to	IN
50458	304	11	the	the	DT
50458	304	12	complex	complex	JJ
50458	304	13	molecules	molecule	NNS
50458	304	14	of	of	IN
50458	304	15	albuminoid	albuminoid	NN
50458	304	16	substances	substance	NNS
50458	304	17	,	,	,
50458	304	18	such	such	JJ
50458	304	19	as	as	IN
50458	304	20	the	the	DT
50458	304	21	different	different	JJ
50458	304	22	toxins	toxin	NNS
50458	304	23	.	.	.
50458	305	1	Ehrlich	ehrlich	NN
50458	305	2	supposes	suppose	NNS
50458	305	3	,	,	,
50458	305	4	as	as	IN
50458	305	5	we	-PRON-	PRP
50458	305	6	have	have	VBP
50458	305	7	already	already	RB
50458	305	8	seen	see	VBN
50458	305	9	,	,	,
50458	305	10	that	that	IN
50458	305	11	a	a	DT
50458	305	12	toxin	toxin	NN
50458	305	13	contains	contain	VBZ
50458	305	14	two	two	CD
50458	305	15	special	special	JJ
50458	305	16	groups	group	NNS
50458	305	17	--	--	:
50458	305	18	a	a	DT
50458	305	19	_	_	NNP
50458	305	20	toxophore	toxophore	NN
50458	305	21	_	_	NNP
50458	305	22	group	group	NN
50458	305	23	,	,	,
50458	305	24	which	which	WDT
50458	305	25	poisons	poison	NNS
50458	305	26	,	,	,
50458	305	27	and	and	CC
50458	305	28	a	a	DT
50458	305	29	_	_	NNP
50458	305	30	haptophore	haptophore	NN
50458	305	31	_	_	NNP
50458	305	32	group	group	NN
50458	305	33	,	,	,
50458	305	34	which	which	WDT
50458	305	35	combines	combine	VBZ
50458	305	36	with	with	IN
50458	305	37	the	the	DT
50458	305	38	receptor	receptor	NN
50458	305	39	.	.	.
50458	306	1	According	accord	VBG
50458	306	2	to	to	IN
50458	306	3	this	this	DT
50458	306	4	theory	theory	NN
50458	306	5	,	,	,
50458	306	6	the	the	DT
50458	306	7	toxophore	toxophore	NN
50458	306	8	group	group	NN
50458	306	9	of	of	IN
50458	306	10	a	a	DT
50458	306	11	toxin	toxin	NN
50458	306	12	can	can	MD
50458	306	13	act	act	VB
50458	306	14	on	on	IN
50458	306	15	an	an	DT
50458	306	16	organism	organism	NN
50458	306	17	_	_	NNP
50458	306	18	only	only	RB
50458	306	19	_	_	NNP
50458	306	20	when	when	WRB
50458	306	21	the	the	DT
50458	306	22	haptophore	haptophore	NN
50458	306	23	group	group	NN
50458	306	24	of	of	IN
50458	306	25	the	the	DT
50458	306	26	toxin	toxin	NN
50458	306	27	encounters	encounter	VBZ
50458	306	28	a	a	DT
50458	306	29	suitable	suitable	JJ
50458	306	30	attachment	attachment	NN
50458	306	31	or	or	CC
50458	306	32	receptor	receptor	NN
50458	306	33	.	.	.
50458	307	1	The	the	DT
50458	307	2	receptors	receptor	NNS
50458	307	3	attached	attach	VBD
50458	307	4	to	to	IN
50458	307	5	the	the	DT
50458	307	6	living	live	VBG
50458	307	7	protoplasmic	protoplasmic	NN
50458	307	8	molecule	molecule	NN
50458	307	9	attract	attract	VBP
50458	307	10	the	the	DT
50458	307	11	toxin	toxin	NN
50458	307	12	,	,	,
50458	307	13	just	just	RB
50458	307	14	as	as	IN
50458	307	15	a	a	DT
50458	307	16	lightning	lightning	NN
50458	307	17	-	-	HYPH
50458	307	18	rod	rod	NN
50458	307	19	attracts	attract	VBZ
50458	307	20	the	the	DT
50458	307	21	lightning	lightning	NN
50458	307	22	.	.	.
50458	308	1	It	-PRON-	PRP
50458	308	2	is	be	VBZ
50458	308	3	hence	hence	RB
50458	308	4	clearly	clearly	RB
50458	308	5	proved	prove	VBN
50458	308	6	that	that	IN
50458	308	7	the	the	DT
50458	308	8	toxigenic	toxigenic	JJ
50458	308	9	poisons	poison	NNS
50458	308	10	exert	exert	VBP
50458	308	11	their	-PRON-	PRP$
50458	308	12	noxious	noxious	JJ
50458	308	13	action	action	NN
50458	308	14	on	on	IN
50458	308	15	the	the	DT
50458	308	16	cellular	cellular	JJ
50458	308	17	elements	element	NNS
50458	308	18	of	of	IN
50458	308	19	sensitive	sensitive	JJ
50458	308	20	organisms	organism	NNS
50458	308	21	,	,	,
50458	308	22	by	by	IN
50458	308	23	entering	enter	VBG
50458	308	24	into	into	IN
50458	308	25	combination	combination	NN
50458	308	26	with	with	IN
50458	308	27	these	these	DT
50458	308	28	.	.	.
50458	309	1	Experience	experience	NN
50458	309	2	has	have	VBZ
50458	309	3	shown	show	VBN
50458	309	4	that	that	IN
50458	309	5	they	-PRON-	PRP
50458	309	6	attach	attach	VBP
50458	309	7	themselves	-PRON-	PRP
50458	309	8	,	,	,
50458	309	9	in	in	IN
50458	309	10	a	a	DT
50458	309	11	most	most	RBS
50458	309	12	rigorously	rigorously	RB
50458	309	13	elective	elective	JJ
50458	309	14	manner	manner	NN
50458	309	15	,	,	,
50458	309	16	to	to	IN
50458	309	17	the	the	DT
50458	309	18	tissues	tissue	NNS
50458	309	19	,	,	,
50458	309	20	and	and	CC
50458	309	21	rapidly	rapidly	RB
50458	309	22	disappear	disappear	VBP
50458	309	23	from	from	IN
50458	309	24	the	the	DT
50458	309	25	general	general	JJ
50458	309	26	circulation	circulation	NN
50458	309	27	.	.	.
50458	310	1	Numerous	numerous	JJ
50458	310	2	facts	fact	NNS
50458	310	3	,	,	,
50458	310	4	clearly	clearly	RB
50458	310	5	established	establish	VBN
50458	310	6	,	,	,
50458	310	7	attest	attest	VB
50458	310	8	the	the	DT
50458	310	9	reality	reality	NN
50458	310	10	of	of	IN
50458	310	11	this	this	DT
50458	310	12	fixation	fixation	NN
50458	310	13	or	or	CC
50458	310	14	attachment	attachment	NN
50458	310	15	.	.	.
50458	311	1	It	-PRON-	PRP
50458	311	2	is	be	VBZ
50458	311	3	thus	thus	RB
50458	311	4	that	that	IN
50458	311	5	von	von	NNP
50458	311	6	Behring	Behring	NNP
50458	311	7	and	and	CC
50458	311	8	Wernicke[33	wernicke[33	CD
50458	311	9	]	]	-RRB-
50458	311	10	sought	seek	VBD
50458	311	11	to	to	TO
50458	311	12	ascertain	ascertain	VB
50458	311	13	the	the	DT
50458	311	14	quantity	quantity	NN
50458	311	15	of	of	IN
50458	311	16	antitoxin	antitoxin	NN
50458	311	17	(	(	-LRB-
50458	311	18	we	-PRON-	PRP
50458	311	19	will	will	MD
50458	311	20	see	see	VB
50458	311	21	farther	farther	RB
50458	311	22	on	on	IN
50458	311	23	that	that	IN
50458	311	24	this	this	DT
50458	311	25	name	name	NN
50458	311	26	is	be	VBZ
50458	311	27	given	give	VBN
50458	311	28	to	to	IN
50458	311	29	those	those	DT
50458	311	30	substances	substance	NNS
50458	311	31	which	which	WDT
50458	311	32	neutralize	neutralize	VBP
50458	311	33	the	the	DT
50458	311	34	activity	activity	NN
50458	311	35	of	of	IN
50458	311	36	toxins	toxin	NNS
50458	311	37	under	under	IN
50458	311	38	certain	certain	JJ
50458	311	39	conditions	condition	NNS
50458	311	40	)	)	-RRB-
50458	311	41	which	which	WDT
50458	311	42	,	,	,
50458	311	43	introduced	introduce	VBD
50458	311	44	a	a	DT
50458	311	45	certain	certain	JJ
50458	311	46	time	time	NN
50458	311	47	after	after	IN
50458	311	48	the	the	DT
50458	311	49	introduction	introduction	NN
50458	311	50	of	of	IN
50458	311	51	the	the	DT
50458	311	52	poison	poison	NN
50458	311	53	,	,	,
50458	311	54	will	will	MD
50458	311	55	save	save	VB
50458	311	56	the	the	DT
50458	311	57	life	life	NN
50458	311	58	of	of	IN
50458	311	59	the	the	DT
50458	311	60	animal	animal	NN
50458	311	61	.	.	.
50458	312	1	They	-PRON-	PRP
50458	312	2	have	have	VBP
50458	312	3	experimented	experiment	VBN
50458	312	4	with	with	IN
50458	312	5	diphtheria	diphtheria	NN
50458	312	6	toxin	toxin	NN
50458	312	7	,	,	,
50458	312	8	which	which	WDT
50458	312	9	we	-PRON-	PRP
50458	312	10	will	will	MD
50458	312	11	study	study	VB
50458	312	12	later	later	RBR
50458	312	13	,	,	,
50458	312	14	and	and	CC
50458	312	15	they	-PRON-	PRP
50458	312	16	have	have	VBP
50458	312	17	demonstrated	demonstrate	VBN
50458	312	18	that	that	IN
50458	312	19	,	,	,
50458	312	20	if	if	IN
50458	312	21	the	the	DT
50458	312	22	antitoxic	antitoxic	NN
50458	312	23	serum	serum	NN
50458	312	24	be	be	VB
50458	312	25	introduced	introduce	VBN
50458	312	26	immediately	immediately	RB
50458	312	27	after	after	IN
50458	312	28	the	the	DT
50458	312	29	toxin	toxin	NN
50458	312	30	,	,	,
50458	312	31	a	a	DT
50458	312	32	dose	dose	NN
50458	312	33	of	of	IN
50458	312	34	antitoxin	antitoxin	NN
50458	312	35	twice	twice	RB
50458	312	36	as	as	RB
50458	312	37	large	large	JJ
50458	312	38	as	as	IN
50458	312	39	that	that	DT
50458	312	40	of	of	IN
50458	312	41	the	the	DT
50458	312	42	toxin	toxin	NN
50458	312	43	suffices	suffice	VBZ
50458	312	44	to	to	TO
50458	312	45	effect	effect	VB
50458	312	46	a	a	DT
50458	312	47	cure	cure	NN
50458	312	48	.	.	.
50458	313	1	[	[	-LRB-
50458	313	2	33	33	CD
50458	313	3	]	]	-RRB-
50458	313	4	VON	VON	NNP
50458	313	5	BEHRING	behring	NN
50458	313	6	and	and	CC
50458	313	7	WERNICKE	WERNICKE	NNP
50458	313	8	:	:	:
50458	313	9	Zeitschrift	Zeitschrift	NNP
50458	313	10	für	für	NN
50458	313	11	Hygiene	Hygiene	NNP
50458	313	12	,	,	,
50458	313	13	XII	XII	NNP
50458	313	14	.	.	.
50458	314	1	Eight	eight	CD
50458	314	2	hours	hour	NNS
50458	314	3	after	after	IN
50458	314	4	the	the	DT
50458	314	5	administration	administration	NN
50458	314	6	of	of	IN
50458	314	7	the	the	DT
50458	314	8	toxin	toxin	NN
50458	314	9	the	the	DT
50458	314	10	dose	dose	NN
50458	314	11	must	must	MD
50458	314	12	be	be	VB
50458	314	13	trebled	treble	VBN
50458	314	14	,	,	,
50458	314	15	while	while	IN
50458	314	16	after	after	IN
50458	314	17	thirty	thirty	CD
50458	314	18	-	-	HYPH
50458	314	19	six	six	CD
50458	314	20	hours	hour	NNS
50458	314	21	it	-PRON-	PRP
50458	314	22	is	be	VBZ
50458	314	23	necessary	necessary	JJ
50458	314	24	to	to	TO
50458	314	25	have	have	VB
50458	314	26	recourse	recourse	VBN
50458	314	27	to	to	IN
50458	314	28	a	a	DT
50458	314	29	quantity	quantity	NN
50458	314	30	of	of	IN
50458	314	31	antitoxin	antitoxin	NN
50458	314	32	eight	eight	CD
50458	314	33	times	time	NNS
50458	314	34	as	as	RB
50458	314	35	great	great	JJ
50458	314	36	.	.	.
50458	315	1	These	these	DT
50458	315	2	experiments	experiment	NNS
50458	315	3	show	show	VBP
50458	315	4	that	that	IN
50458	315	5	the	the	DT
50458	315	6	curative	curative	JJ
50458	315	7	action	action	NN
50458	315	8	of	of	IN
50458	315	9	the	the	DT
50458	315	10	antitoxin	antitoxin	NN
50458	315	11	is	be	VBZ
50458	315	12	so	so	RB
50458	315	13	much	much	RB
50458	315	14	the	the	DT
50458	315	15	less	less	RBR
50458	315	16	the	the	DT
50458	315	17	longer	long	JJR
50458	315	18	the	the	DT
50458	315	19	period	period	NN
50458	315	20	of	of	IN
50458	315	21	time	time	NN
50458	315	22	that	that	WDT
50458	315	23	has	have	VBZ
50458	315	24	elapsed	elapse	VBN
50458	315	25	between	between	IN
50458	315	26	the	the	DT
50458	315	27	introduction	introduction	NN
50458	315	28	of	of	IN
50458	315	29	the	the	DT
50458	315	30	toxin	toxin	NN
50458	315	31	and	and	CC
50458	315	32	the	the	DT
50458	315	33	antitoxin	antitoxin	NN
50458	315	34	.	.	.
50458	316	1	This	this	DT
50458	316	2	is	be	VBZ
50458	316	3	because	because	IN
50458	316	4	the	the	DT
50458	316	5	toxin	toxin	NN
50458	316	6	has	have	VBZ
50458	316	7	become	become	VBN
50458	316	8	so	so	RB
50458	316	9	intimately	intimately	RB
50458	316	10	attached	attach	VBN
50458	316	11	to	to	IN
50458	316	12	the	the	DT
50458	316	13	tissues	tissue	NNS
50458	316	14	that	that	WDT
50458	316	15	the	the	DT
50458	316	16	antitoxin	antitoxin	NN
50458	316	17	introduced	introduce	VBN
50458	316	18	has	have	VBZ
50458	316	19	not	not	RB
50458	316	20	the	the	DT
50458	316	21	power	power	NN
50458	316	22	to	to	TO
50458	316	23	destroy	destroy	VB
50458	316	24	the	the	DT
50458	316	25	combination	combination	NN
50458	316	26	.	.	.
50458	317	1	These	these	DT
50458	317	2	facts	fact	NNS
50458	317	3	have	have	VBP
50458	317	4	been	be	VBN
50458	317	5	confirmed	confirm	VBN
50458	317	6	by	by	IN
50458	317	7	Donitz[34	donitz[34	ADD
50458	317	8	]	]	-RRB-
50458	317	9	and	and	CC
50458	317	10	by	by	IN
50458	317	11	the	the	DT
50458	317	12	classic	classic	JJ
50458	317	13	experiments	experiment	NNS
50458	317	14	of	of	IN
50458	317	15	Decroly	Decroly	NNP
50458	317	16	and	and	CC
50458	317	17	Rousse	Rousse	NNP
50458	317	18	.	.	.
50458	318	1	[	[	-LRB-
50458	318	2	35	35	CD
50458	318	3	]	]	-RRB-
50458	318	4	[	[	-LRB-
50458	318	5	34	34	CD
50458	318	6	]	]	-RRB-
50458	318	7	DONITZ	DONITZ	NNP
50458	318	8	:	:	:
50458	318	9	Ueber	Ueber	NNP
50458	318	10	die	die	VB
50458	318	11	Grenzen	Grenzen	NNP
50458	318	12	der	der	IN
50458	318	13	Wirksamkeit	Wirksamkeit	NNP
50458	318	14	des	des	NNP
50458	318	15	Diphtheria	Diphtheria	NNP
50458	318	16	Heilserums	Heilserums	NNP
50458	318	17	.	.	.
50458	319	1	_	_	NNP
50458	319	2	Deutsche	Deutsche	NNP
50458	319	3	Med	Med	NNP
50458	319	4	.	.	.
50458	320	1	Woch	Woch	NNP
50458	320	2	.	.	.
50458	320	3	_	_	NNP
50458	320	4	,	,	,
50458	320	5	No	no	UH
50458	320	6	.	.	.
50458	321	1	27	27	CD
50458	321	2	,	,	,
50458	321	3	1897	1897	CD
50458	321	4	.	.	.
50458	322	1	[	[	-LRB-
50458	322	2	35	35	CD
50458	322	3	]	]	-RRB-
50458	322	4	DECROLY	DECROLY	NNP
50458	322	5	et	et	NN
50458	322	6	ROUSSE	ROUSSE	NNS
50458	322	7	:	:	:
50458	322	8	_	_	NNP
50458	322	9	Arch	Arch	NNP
50458	322	10	.	.	.
50458	323	1	Int	Int	NNP
50458	323	2	.	.	.
50458	324	1	de	de	NNP
50458	324	2	Pharmacodyn	Pharmacodyn	NNP
50458	324	3	.	.	.
50458	324	4	_	_	NNP
50458	324	5	,	,	,
50458	324	6	III	III	NNP
50458	324	7	and	and	CC
50458	324	8	VI	VI	NNP
50458	324	9	;	;	:
50458	324	10	Masoin	Masoin	NNP
50458	324	11	:	:	:
50458	324	12	_	_	NNP
50458	324	13	Arch	Arch	NNP
50458	324	14	.	.	.
50458	325	1	Intern	intern	NN
50458	325	2	.	.	.
50458	326	1	de	de	NNP
50458	326	2	Pharmacodyn	Pharmacodyn	NNP
50458	326	3	.	.	.
50458	326	4	_	_	NNP
50458	326	5	,	,	,
50458	326	6	II	II	NNP
50458	326	7	,	,	,
50458	326	8	1903	1903	CD
50458	326	9	.	.	.
50458	327	1	This	this	DT
50458	327	2	is	be	VBZ
50458	327	3	not	not	RB
50458	327	4	,	,	,
50458	327	5	however	however	RB
50458	327	6	,	,	,
50458	327	7	the	the	DT
50458	327	8	case	case	NN
50458	327	9	with	with	IN
50458	327	10	cold	cold	JJ
50458	327	11	-	-	HYPH
50458	327	12	blooded	blooded	JJ
50458	327	13	animals	animal	NNS
50458	327	14	,	,	,
50458	327	15	which	which	WDT
50458	327	16	,	,	,
50458	327	17	generally	generally	RB
50458	327	18	,	,	,
50458	327	19	are	be	VBP
50458	327	20	not	not	RB
50458	327	21	affected	affect	VBN
50458	327	22	by	by	IN
50458	327	23	injections	injection	NNS
50458	327	24	of	of	IN
50458	327	25	poisonous	poisonous	JJ
50458	327	26	toxins	toxin	NNS
50458	327	27	.	.	.
50458	328	1	Thus	thus	RB
50458	328	2	Metchnikoff[36	metchnikoff[36	ADD
50458	328	3	]	]	-RRB-
50458	328	4	and	and	CC
50458	328	5	his	-PRON-	PRP$
50458	328	6	pupils	pupil	NNS
50458	328	7	have	have	VBP
50458	328	8	been	be	VBN
50458	328	9	able	able	JJ
50458	328	10	to	to	TO
50458	328	11	show	show	VB
50458	328	12	that	that	IN
50458	328	13	the	the	DT
50458	328	14	toxins	toxin	NNS
50458	328	15	introduced	introduce	VBN
50458	328	16	into	into	IN
50458	328	17	certain	certain	JJ
50458	328	18	cold	cold	JJ
50458	328	19	-	-	HYPH
50458	328	20	blooded	blooded	JJ
50458	328	21	animals	animal	NNS
50458	328	22	(	(	-LRB-
50458	328	23	Oryetes	Oryetes	NNP
50458	328	24	nasicorius	nasicorius	NN
50458	328	25	)	)	-RRB-
50458	328	26	may	may	MD
50458	328	27	remain	remain	VB
50458	328	28	for	for	IN
50458	328	29	several	several	JJ
50458	328	30	months	month	NNS
50458	328	31	without	without	IN
50458	328	32	alteration	alteration	NN
50458	328	33	in	in	IN
50458	328	34	their	-PRON-	PRP$
50458	328	35	circulation	circulation	NN
50458	328	36	.	.	.
50458	329	1	[	[	-LRB-
50458	329	2	36	36	CD
50458	329	3	]	]	-RRB-
50458	329	4	METCHNIKOFF	METCHNIKOFF	NNP
50458	329	5	:	:	:
50458	329	6	_	_	NNP
50458	329	7	L'Immunité	L'Immunité	NNP
50458	329	8	_	_	NNP
50458	329	9	,	,	,
50458	329	10	Paris	Paris	NNP
50458	329	11	,	,	,
50458	329	12	1902	1902	CD
50458	329	13	;	;	:
50458	329	14	MORGENROTH	morgenroth	NN
50458	329	15	:	:	:
50458	329	16	Zur	Zur	NNP
50458	329	17	Kenntniss	Kenntniss	NNP
50458	329	18	des	des	NNP
50458	329	19	Tetanus	Tetanus	NNP
50458	329	20	des	des	FW
50458	329	21	Frosches	Frosches	NNP
50458	329	22	.	.	.
50458	330	1	_	_	NNP
50458	330	2	Deutsche	Deutsche	NNP
50458	330	3	Med	Med	NNP
50458	330	4	.	.	.
50458	331	1	Woch	Woch	NNP
50458	331	2	.	.	.
50458	331	3	_	_	NNP
50458	331	4	,	,	,
50458	331	5	No	no	UH
50458	331	6	.	.	.
50458	332	1	35	35	CD
50458	332	2	,	,	,
50458	332	3	1898	1898	CD
50458	332	4	.	.	.
50458	333	1	If	if	IN
50458	333	2	we	-PRON-	PRP
50458	333	3	consider	consider	VBP
50458	333	4	the	the	DT
50458	333	5	facts	fact	NNS
50458	333	6	of	of	IN
50458	333	7	the	the	DT
50458	333	8	theory	theory	NN
50458	333	9	of	of	IN
50458	333	10	Ehrlich	Ehrlich	NNP
50458	333	11	's	's	POS
50458	333	12	lateral	lateral	JJ
50458	333	13	chains	chain	NNS
50458	333	14	,	,	,
50458	333	15	which	which	WDT
50458	333	16	we	-PRON-	PRP
50458	333	17	have	have	VBP
50458	333	18	mentioned	mention	VBN
50458	333	19	,	,	,
50458	333	20	we	-PRON-	PRP
50458	333	21	are	be	VBP
50458	333	22	led	lead	VBN
50458	333	23	to	to	IN
50458	333	24	well	well	RB
50458	333	25	-	-	HYPH
50458	333	26	defined	define	VBN
50458	333	27	conclusions	conclusion	NNS
50458	333	28	regarding	regard	VBG
50458	333	29	the	the	DT
50458	333	30	mode	mode	NN
50458	333	31	of	of	IN
50458	333	32	action	action	NN
50458	333	33	of	of	IN
50458	333	34	the	the	DT
50458	333	35	toxins	toxin	NNS
50458	333	36	.	.	.
50458	334	1	In	in	IN
50458	334	2	fact	fact	NN
50458	334	3	,	,	,
50458	334	4	since	since	IN
50458	334	5	these	these	DT
50458	334	6	toxins	toxin	NNS
50458	334	7	exhibit	exhibit	VBP
50458	334	8	a	a	DT
50458	334	9	pronounced	pronounced	JJ
50458	334	10	chemical	chemical	NN
50458	334	11	affinity	affinity	NN
50458	334	12	for	for	IN
50458	334	13	the	the	DT
50458	334	14	tissues	tissue	NNS
50458	334	15	,	,	,
50458	334	16	and	and	CC
50458	334	17	while	while	IN
50458	334	18	,	,	,
50458	334	19	on	on	IN
50458	334	20	the	the	DT
50458	334	21	other	other	JJ
50458	334	22	hand	hand	NN
50458	334	23	,	,	,
50458	334	24	they	-PRON-	PRP
50458	334	25	can	can	MD
50458	334	26	attach	attach	VB
50458	334	27	themselves	-PRON-	PRP
50458	334	28	only	only	RB
50458	334	29	because	because	IN
50458	334	30	of	of	IN
50458	334	31	the	the	DT
50458	334	32	presence	presence	NN
50458	334	33	of	of	IN
50458	334	34	certain	certain	JJ
50458	334	35	functional	functional	JJ
50458	334	36	groups	group	NNS
50458	334	37	of	of	IN
50458	334	38	the	the	DT
50458	334	39	protoplasmic	protoplasmic	NNP
50458	334	40	molecules	molecule	NNS
50458	334	41	,	,	,
50458	334	42	this	this	DT
50458	334	43	union	union	NN
50458	334	44	can	can	MD
50458	334	45	take	take	VB
50458	334	46	place	place	NN
50458	334	47	only	only	RB
50458	334	48	in	in	IN
50458	334	49	certain	certain	JJ
50458	334	50	specific	specific	JJ
50458	334	51	centers	center	NNS
50458	334	52	.	.	.
50458	335	1	This	this	DT
50458	335	2	has	have	VBZ
50458	335	3	been	be	VBN
50458	335	4	fully	fully	RB
50458	335	5	confirmed	confirm	VBN
50458	335	6	by	by	IN
50458	335	7	experiments	experiment	NNS
50458	335	8	_	_	NNP
50458	335	9	in	in	IN
50458	335	10	vitro	vitro	FW
50458	335	11	_	_	NNP
50458	335	12	.	.	.
50458	336	1	It	-PRON-	PRP
50458	336	2	is	be	VBZ
50458	336	3	known	know	VBN
50458	336	4	,	,	,
50458	336	5	since	since	IN
50458	336	6	the	the	DT
50458	336	7	researches	research	NNS
50458	336	8	of	of	IN
50458	336	9	Ehrlich,[37	Ehrlich,[37	NNP
50458	336	10	]	]	-RRB-
50458	336	11	Wassermann	Wassermann	NNP
50458	336	12	and	and	CC
50458	336	13	Takaki,[38	Takaki,[38	NNP
50458	336	14	]	]	-RRB-
50458	336	15	Marie,[39	Marie,[39	NNP
50458	336	16	]	]	-RRB-
50458	336	17	Metchnikoff,[40	Metchnikoff,[40	NNP
50458	336	18	]	]	-RRB-
50458	336	19	and	and	CC
50458	336	20	a	a	DT
50458	336	21	host	host	NN
50458	336	22	of	of	IN
50458	336	23	other	other	JJ
50458	336	24	scientists	scientist	NNS
50458	336	25	,	,	,
50458	336	26	that	that	IN
50458	336	27	this	this	DT
50458	336	28	fixation	fixation	NN
50458	336	29	is	be	VBZ
50458	336	30	due	due	JJ
50458	336	31	to	to	IN
50458	336	32	a	a	DT
50458	336	33	clearly	clearly	RB
50458	336	34	elective	elective	JJ
50458	336	35	property	property	NN
50458	336	36	.	.	.
50458	337	1	It	-PRON-	PRP
50458	337	2	is	be	VBZ
50458	337	3	for	for	IN
50458	337	4	this	this	DT
50458	337	5	reason	reason	NN
50458	337	6	that	that	IN
50458	337	7	the	the	DT
50458	337	8	tetanus	tetanus	NNP
50458	337	9	toxin	toxin	NN
50458	337	10	fixes	fix	VBZ
50458	337	11	itself	-PRON-	PRP
50458	337	12	only	only	RB
50458	337	13	upon	upon	IN
50458	337	14	the	the	DT
50458	337	15	nervous	nervous	JJ
50458	337	16	tissue	tissue	NN
50458	337	17	,	,	,
50458	337	18	and	and	CC
50458	337	19	that	that	IN
50458	337	20	in	in	IN
50458	337	21	this	this	DT
50458	337	22	action	action	NN
50458	337	23	all	all	DT
50458	337	24	passes	pass	VBZ
50458	337	25	as	as	IN
50458	337	26	if	if	IN
50458	337	27	the	the	DT
50458	337	28	nervous	nervous	JJ
50458	337	29	tissue	tissue	NN
50458	337	30	had	have	VBD
50458	337	31	been	be	VBN
50458	337	32	provided	provide	VBN
50458	337	33	with	with	IN
50458	337	34	functional	functional	JJ
50458	337	35	groups	group	NNS
50458	337	36	possessing	possess	VBG
50458	337	37	an	an	DT
50458	337	38	elective	elective	JJ
50458	337	39	affinity	affinity	NN
50458	337	40	for	for	IN
50458	337	41	the	the	DT
50458	337	42	tetanic	tetanic	JJ
50458	337	43	poison	poison	NN
50458	337	44	.	.	.
50458	338	1	[	[	-LRB-
50458	338	2	37	37	CD
50458	338	3	]	]	-RRB-
50458	338	4	EHRLICH	ehrlich	NN
50458	338	5	:	:	:
50458	338	6	_	_	NNP
50458	338	7	Berl	Berl	NNP
50458	338	8	.	.	.
50458	339	1	Klin	Klin	NNP
50458	339	2	.	.	.
50458	340	1	Woch	Woch	NNP
50458	340	2	.	.	.
50458	340	3	_	_	NNP
50458	340	4	,	,	,
50458	340	5	No	no	UH
50458	340	6	.	.	.
50458	341	1	12	12	CD
50458	341	2	,	,	,
50458	341	3	1898	1898	CD
50458	341	4	.	.	.
50458	342	1	[	[	-LRB-
50458	342	2	38	38	CD
50458	342	3	]	]	-RRB-
50458	342	4	WASSERMANN	wassermann	NN
50458	342	5	and	and	CC
50458	342	6	TAKAKI	takaki	NN
50458	342	7	:	:	:
50458	342	8	_	_	NNP
50458	342	9	Berl	Berl	NNP
50458	342	10	.	.	.
50458	343	1	Klin	Klin	NNP
50458	343	2	.	.	.
50458	344	1	Woch	Woch	NNP
50458	344	2	.	.	.
50458	344	3	_	_	NNP
50458	344	4	,	,	,
50458	344	5	_	_	NNP
50458	344	6	Med	Med	NNP
50458	344	7	.	.	.
50458	344	8	_	_	NNP
50458	344	9	,	,	,
50458	344	10	p.	p.	NN
50458	344	11	5	5	CD
50458	344	12	,	,	,
50458	344	13	1898	1898	CD
50458	344	14	.	.	.
50458	345	1	[	[	-LRB-
50458	345	2	39	39	CD
50458	345	3	]	]	-RRB-
50458	345	4	MARIE	MARIE	NNP
50458	345	5	:	:	:
50458	345	6	Sur	sur	NN
50458	345	7	les	les	FW
50458	345	8	Propriétés	Propriétés	NNP
50458	345	9	Antitoxiques	Antitoxiques	NNPS
50458	345	10	aux	aux	NN
50458	345	11	Centres	centre	VBZ
50458	345	12	Nerveux	Nerveux	NNP
50458	345	13	de	de	NNP
50458	345	14	l'Animal	l'Animal	NNP
50458	345	15	Sain	Sain	NNP
50458	345	16	.	.	.
50458	346	1	_	_	NNP
50458	346	2	Ann	Ann	NNP
50458	346	3	.	.	.
50458	347	1	Inst	inst	RB
50458	347	2	.	.	.
50458	348	1	Past	past	NN
50458	348	2	.	.	.
50458	348	3	_	_	NNP
50458	348	4	,	,	,
50458	348	5	1898	1898	CD
50458	348	6	,	,	,
50458	348	7	p.	p.	NN
50458	348	8	1	1	CD
50458	348	9	.	.	.
50458	349	1	[	[	-LRB-
50458	349	2	40	40	CD
50458	349	3	]	]	-RRB-
50458	349	4	METCHNIKOFF	metchnikoff	JJ
50458	349	5	:	:	:
50458	349	6	Recherches	recherche	NNS
50458	349	7	sur	sur	NNP
50458	349	8	l'Influence	l'Influence	NNP
50458	349	9	de	de	NNP
50458	349	10	l'Organism	l'Organism	NNP
50458	349	11	sur	sur	FW
50458	349	12	les	les	NNP
50458	349	13	Toxines	Toxines	NNP
50458	349	14	.	.	.
50458	350	1	_	_	NNP
50458	350	2	Ann	Ann	NNP
50458	350	3	.	.	.
50458	351	1	Inst	inst	RB
50458	351	2	.	.	.
50458	352	1	Past	past	NN
50458	352	2	.	.	.
50458	352	3	_	_	NNP
50458	352	4	,	,	,
50458	352	5	1899	1899	CD
50458	352	6	,	,	,
50458	352	7	p.	p.	NN
50458	352	8	82	82	CD
50458	352	9	.	.	.
50458	353	1	=	=	NFP
50458	353	2	Means	Means	NNPS
50458	353	3	of	of	IN
50458	353	4	Defense	Defense	NNP
50458	353	5	Possessed	possess	VBN
50458	353	6	by	by	IN
50458	353	7	the	the	DT
50458	353	8	Organism	Organism	NNP
50458	353	9	against	against	IN
50458	353	10	the	the	DT
50458	353	11	Action	Action	NNP
50458	353	12	of	of	IN
50458	353	13	Toxins.=--We	Toxins.=--We	NNP
50458	353	14	have	have	VBP
50458	353	15	already	already	RB
50458	353	16	seen	see	VBN
50458	353	17	that	that	IN
50458	353	18	the	the	DT
50458	353	19	renal	renal	JJ
50458	353	20	organs	organ	NNS
50458	353	21	serve	serve	VBP
50458	353	22	for	for	IN
50458	353	23	the	the	DT
50458	353	24	elimination	elimination	NN
50458	353	25	of	of	IN
50458	353	26	the	the	DT
50458	353	27	toxins	toxin	NNS
50458	353	28	normally	normally	RB
50458	353	29	produced	produce	VBN
50458	353	30	in	in	IN
50458	353	31	the	the	DT
50458	353	32	organism	organism	NN
50458	353	33	by	by	IN
50458	353	34	the	the	DT
50458	353	35	simple	simple	JJ
50458	353	36	play	play	NN
50458	353	37	of	of	IN
50458	353	38	its	-PRON-	PRP$
50458	353	39	cellular	cellular	JJ
50458	353	40	mechanism	mechanism	NN
50458	353	41	.	.	.
50458	354	1	Experience	experience	NN
50458	354	2	has	have	VBZ
50458	354	3	shown	show	VBN
50458	354	4	that	that	IN
50458	354	5	the	the	DT
50458	354	6	toxins	toxin	NNS
50458	354	7	introduced	introduce	VBN
50458	354	8	from	from	IN
50458	354	9	without	without	IN
50458	354	10	into	into	IN
50458	354	11	the	the	DT
50458	354	12	circulation	circulation	NN
50458	354	13	are	be	VBP
50458	354	14	generally	generally	RB
50458	354	15	finally	finally	RB
50458	354	16	eliminated	eliminate	VBN
50458	354	17	,	,	,
50458	354	18	even	even	RB
50458	354	19	though	though	IN
50458	354	20	in	in	IN
50458	354	21	the	the	DT
50458	354	22	meantime	meantime	NN
50458	354	23	the	the	DT
50458	354	24	modifications	modification	NNS
50458	354	25	they	-PRON-	PRP
50458	354	26	have	have	VBP
50458	354	27	imprinted	imprint	VBN
50458	354	28	on	on	IN
50458	354	29	the	the	DT
50458	354	30	economy	economy	NN
50458	354	31	may	may	MD
50458	354	32	be	be	VB
50458	354	33	transmitted	transmit	VBN
50458	354	34	hereditarily	hereditarily	RB
50458	354	35	;	;	:
50458	354	36	and	and	CC
50458	354	37	that	that	IN
50458	354	38	their	-PRON-	PRP$
50458	354	39	influence	influence	NN
50458	354	40	on	on	IN
50458	354	41	the	the	DT
50458	354	42	general	general	JJ
50458	354	43	nutrition	nutrition	NN
50458	354	44	and	and	CC
50458	354	45	the	the	DT
50458	354	46	normal	normal	JJ
50458	354	47	functionation	functionation	NN
50458	354	48	of	of	IN
50458	354	49	the	the	DT
50458	354	50	entire	entire	JJ
50458	354	51	organism	organism	NN
50458	354	52	persists	persist	VBZ
50458	354	53	even	even	RB
50458	354	54	after	after	IN
50458	354	55	their	-PRON-	PRP$
50458	354	56	elimination	elimination	NN
50458	354	57	.	.	.
50458	355	1	Much	much	JJ
50458	355	2	has	have	VBZ
50458	355	3	been	be	VBN
50458	355	4	said	say	VBN
50458	355	5	regarding	regard	VBG
50458	355	6	the	the	DT
50458	355	7	elimination	elimination	NN
50458	355	8	of	of	IN
50458	355	9	these	these	DT
50458	355	10	toxins	toxin	NNS
50458	355	11	by	by	IN
50458	355	12	the	the	DT
50458	355	13	urine	urine	NN
50458	355	14	,	,	,
50458	355	15	but	but	CC
50458	355	16	the	the	DT
50458	355	17	experiments	experiment	NNS
50458	355	18	made	make	VBN
50458	355	19	by	by	IN
50458	355	20	Métin	Métin	NNP
50458	355	21	,	,	,
50458	355	22	at	at	IN
50458	355	23	the	the	DT
50458	355	24	Institut	Institut	NNP
50458	355	25	Pasteur	Pasteur	NNP
50458	355	26	,	,	,
50458	355	27	have	have	VBP
50458	355	28	shown	show	VBN
50458	355	29	the	the	DT
50458	355	30	inaccuracy	inaccuracy	NN
50458	355	31	of	of	IN
50458	355	32	this	this	DT
50458	355	33	assumption	assumption	NN
50458	355	34	,	,	,
50458	355	35	and	and	CC
50458	355	36	it	-PRON-	PRP
50458	355	37	has	have	VBZ
50458	355	38	been	be	VBN
50458	355	39	necessary	necessary	JJ
50458	355	40	to	to	TO
50458	355	41	seek	seek	VB
50458	355	42	another	another	DT
50458	355	43	.	.	.
50458	356	1	It	-PRON-	PRP
50458	356	2	has	have	VBZ
50458	356	3	been	be	VBN
50458	356	4	remarked	remark	VBN
50458	356	5	that	that	IN
50458	356	6	oxidation	oxidation	NN
50458	356	7	destroys	destroy	VBZ
50458	356	8	the	the	DT
50458	356	9	toxins	toxin	NNS
50458	356	10	_	_	NNP
50458	356	11	in	in	IN
50458	356	12	vitro	vitro	FW
50458	356	13	_	_	NNP
50458	356	14	,	,	,
50458	356	15	and	and	CC
50458	356	16	it	-PRON-	PRP
50458	356	17	has	have	VBZ
50458	356	18	been	be	VBN
50458	356	19	thought	think	VBN
50458	356	20	that	that	IN
50458	356	21	a	a	DT
50458	356	22	process	process	NN
50458	356	23	resembling	resemble	VBG
50458	356	24	disinfection	disinfection	NN
50458	356	25	may	may	MD
50458	356	26	well	well	RB
50458	356	27	take	take	VB
50458	356	28	place	place	NN
50458	356	29	within	within	IN
50458	356	30	the	the	DT
50458	356	31	tissues	tissue	NNS
50458	356	32	of	of	IN
50458	356	33	the	the	DT
50458	356	34	animal	animal	NN
50458	356	35	economy	economy	NN
50458	356	36	,	,	,
50458	356	37	but	but	CC
50458	356	38	no	no	DT
50458	356	39	decision	decision	NN
50458	356	40	has	have	VBZ
50458	356	41	been	be	VBN
50458	356	42	arrived	arrive	VBN
50458	356	43	at	at	IN
50458	356	44	regarding	regard	VBG
50458	356	45	the	the	DT
50458	356	46	possible	possible	JJ
50458	356	47	mechanism	mechanism	NN
50458	356	48	of	of	IN
50458	356	49	this	this	DT
50458	356	50	action	action	NN
50458	356	51	,	,	,
50458	356	52	which	which	WDT
50458	356	53	some	some	DT
50458	356	54	attribute	attribute	NN
50458	356	55	to	to	IN
50458	356	56	the	the	DT
50458	356	57	action	action	NN
50458	356	58	of	of	IN
50458	356	59	the	the	DT
50458	356	60	oxidizing	oxidizing	JJ
50458	356	61	ferments	ferment	NNS
50458	356	62	of	of	IN
50458	356	63	the	the	DT
50458	356	64	organism	organism	NN
50458	356	65	,	,	,
50458	356	66	or	or	CC
50458	356	67	to	to	IN
50458	356	68	the	the	DT
50458	356	69	action	action	NN
50458	356	70	of	of	IN
50458	356	71	certain	certain	JJ
50458	356	72	special	special	JJ
50458	356	73	cells	cell	NNS
50458	356	74	.	.	.
50458	357	1	According	accord	VBG
50458	357	2	to	to	IN
50458	357	3	Poehl	Poehl	NNP
50458	357	4	,	,	,
50458	357	5	there	there	EX
50458	357	6	is	be	VBZ
50458	357	7	developed	develop	VBN
50458	357	8	as	as	IN
50458	357	9	destroyer	destroyer	NN
50458	357	10	a	a	DT
50458	357	11	substance	substance	NN
50458	357	12	possessing	possess	VBG
50458	357	13	energetic	energetic	JJ
50458	357	14	oxidizing	oxidizing	JJ
50458	357	15	properties	property	NNS
50458	357	16	,	,	,
50458	357	17	which	which	WDT
50458	357	18	he	-PRON-	PRP
50458	357	19	has	have	VBZ
50458	357	20	isolated	isolate	VBN
50458	357	21	and	and	CC
50458	357	22	named	name	VBN
50458	357	23	_	_	NNP
50458	357	24	spermine	spermine	NN
50458	357	25	_	_	NNP
50458	357	26	,	,	,
50458	357	27	and	and	CC
50458	357	28	which	which	WDT
50458	357	29	is	be	VBZ
50458	357	30	found	find	VBN
50458	357	31	in	in	IN
50458	357	32	most	most	JJS
50458	357	33	of	of	IN
50458	357	34	the	the	DT
50458	357	35	organic	organic	JJ
50458	357	36	fluids	fluid	NNS
50458	357	37	and	and	CC
50458	357	38	particularly	particularly	RB
50458	357	39	in	in	IN
50458	357	40	the	the	DT
50458	357	41	leucocytes	leucocyte	NNS
50458	357	42	,	,	,
50458	357	43	the	the	DT
50458	357	44	special	special	JJ
50458	357	45	rôle	rôle	NN
50458	357	46	of	of	IN
50458	357	47	which	which	WDT
50458	357	48	we	-PRON-	PRP
50458	357	49	will	will	MD
50458	357	50	presently	presently	RB
50458	357	51	study	study	VB
50458	357	52	.	.	.
50458	358	1	There	there	EX
50458	358	2	develops	develop	VBZ
50458	358	3	still	still	RB
50458	358	4	another	another	DT
50458	358	5	cause	cause	NN
50458	358	6	of	of	IN
50458	358	7	elimination	elimination	NN
50458	358	8	,	,	,
50458	358	9	or	or	CC
50458	358	10	,	,	,
50458	358	11	to	to	TO
50458	358	12	be	be	VB
50458	358	13	more	more	RBR
50458	358	14	exact	exact	JJ
50458	358	15	,	,	,
50458	358	16	of	of	IN
50458	358	17	the	the	DT
50458	358	18	neutralization	neutralization	NN
50458	358	19	of	of	IN
50458	358	20	the	the	DT
50458	358	21	toxic	toxic	JJ
50458	358	22	principles	principle	NNS
50458	358	23	in	in	IN
50458	358	24	defense	defense	NN
50458	358	25	of	of	IN
50458	358	26	the	the	DT
50458	358	27	organism	organism	NN
50458	358	28	against	against	IN
50458	358	29	the	the	DT
50458	358	30	toxins	toxin	NNS
50458	358	31	,	,	,
50458	358	32	and	and	CC
50458	358	33	that	that	DT
50458	358	34	is	be	VBZ
50458	358	35	the	the	DT
50458	358	36	formation	formation	NN
50458	358	37	of	of	IN
50458	358	38	_	_	NNP
50458	358	39	antitoxins	antitoxins	NNP
50458	358	40	_	_	NNP
50458	358	41	.	.	.
50458	359	1	It	-PRON-	PRP
50458	359	2	is	be	VBZ
50458	359	3	well	well	RB
50458	359	4	known	know	VBN
50458	359	5	that	that	IN
50458	359	6	the	the	DT
50458	359	7	term	term	NN
50458	359	8	_	_	NNP
50458	359	9	virus	virus	NN
50458	359	10	_	_	NNP
50458	359	11	has	have	VBZ
50458	359	12	been	be	VBN
50458	359	13	reserved	reserve	VBN
50458	359	14	to	to	TO
50458	359	15	designate	designate	VB
50458	359	16	physiological	physiological	JJ
50458	359	17	liquids	liquid	NNS
50458	359	18	which	which	WDT
50458	359	19	were	be	VBD
50458	359	20	characterized	characterize	VBN
50458	359	21	,	,	,
50458	359	22	when	when	WRB
50458	359	23	first	first	RB
50458	359	24	they	-PRON-	PRP
50458	359	25	were	be	VBD
50458	359	26	known	know	VBN
50458	359	27	,	,	,
50458	359	28	by	by	IN
50458	359	29	their	-PRON-	PRP$
50458	359	30	property	property	NN
50458	359	31	of	of	IN
50458	359	32	transmitting	transmit	VBG
50458	359	33	to	to	IN
50458	359	34	an	an	DT
50458	359	35	organism	organism	NN
50458	359	36	certain	certain	JJ
50458	359	37	functional	functional	JJ
50458	359	38	affections	affection	NNS
50458	359	39	,	,	,
50458	359	40	but	but	CC
50458	359	41	the	the	DT
50458	359	42	true	true	JJ
50458	359	43	character	character	NN
50458	359	44	of	of	IN
50458	359	45	which	which	WDT
50458	359	46	is	be	VBZ
50458	359	47	to	to	TO
50458	359	48	expend	expend	VB
50458	359	49	their	-PRON-	PRP$
50458	359	50	toxicity	toxicity	NN
50458	359	51	upon	upon	IN
50458	359	52	the	the	DT
50458	359	53	microbes	microbe	NNS
50458	359	54	which	which	WDT
50458	359	55	occur	occur	VBP
50458	359	56	and	and	CC
50458	359	57	are	be	VBP
50458	359	58	reproduced	reproduce	VBN
50458	359	59	in	in	IN
50458	359	60	the	the	DT
50458	359	61	organism	organism	NN
50458	359	62	,	,	,
50458	359	63	or	or	CC
50458	359	64	upon	upon	IN
50458	359	65	the	the	DT
50458	359	66	organized	organize	VBN
50458	359	67	plastidulary	plastidulary	JJ
50458	359	68	granulations	granulation	NNS
50458	359	69	,	,	,
50458	359	70	as	as	IN
50458	359	71	in	in	IN
50458	359	72	the	the	DT
50458	359	73	case	case	NN
50458	359	74	of	of	IN
50458	359	75	the	the	DT
50458	359	76	rabic	rabic	JJ
50458	359	77	virus	virus	NN
50458	359	78	,	,	,
50458	359	79	the	the	DT
50458	359	80	special	special	JJ
50458	359	81	microbe	microbe	NN
50458	359	82	of	of	IN
50458	359	83	which	which	WDT
50458	359	84	has	have	VBZ
50458	359	85	not	not	RB
50458	359	86	as	as	RB
50458	359	87	yet	yet	RB
50458	359	88	been	be	VBN
50458	359	89	isolated	isolate	VBN
50458	359	90	.	.	.
50458	360	1	Pasteur	Pasteur	NNP
50458	360	2	,	,	,
50458	360	3	when	when	WRB
50458	360	4	studying	study	VBG
50458	360	5	rabies	rabie	NNS
50458	360	6	,	,	,
50458	360	7	found	find	VBD
50458	360	8	that	that	IN
50458	360	9	the	the	DT
50458	360	10	brain	brain	NN
50458	360	11	and	and	CC
50458	360	12	spinal	spinal	JJ
50458	360	13	marrow	marrow	NN
50458	360	14	of	of	IN
50458	360	15	rabid	rabid	JJ
50458	360	16	animals	animal	NNS
50458	360	17	contained	contain	VBD
50458	360	18	the	the	DT
50458	360	19	pure	pure	JJ
50458	360	20	rabic	rabic	NN
50458	360	21	virus	virus	NN
50458	360	22	in	in	IN
50458	360	23	considerable	considerable	JJ
50458	360	24	quantity	quantity	NN
50458	360	25	,	,	,
50458	360	26	and	and	CC
50458	360	27	that	that	IN
50458	360	28	every	every	DT
50458	360	29	particle	particle	NN
50458	360	30	of	of	IN
50458	360	31	the	the	DT
50458	360	32	marrow	marrow	NN
50458	360	33	was	be	VBD
50458	360	34	capable	capable	JJ
50458	360	35	of	of	IN
50458	360	36	imparting	impart	VBG
50458	360	37	rabies	rabie	NNS
50458	360	38	to	to	IN
50458	360	39	a	a	DT
50458	360	40	perfectly	perfectly	RB
50458	360	41	healthy	healthy	JJ
50458	360	42	dog	dog	NN
50458	360	43	.	.	.
50458	361	1	After	after	IN
50458	361	2	having	have	VBG
50458	361	3	ascertained	ascertain	VBN
50458	361	4	this	this	DT
50458	361	5	fact	fact	NN
50458	361	6	,	,	,
50458	361	7	he	-PRON-	PRP
50458	361	8	found	find	VBD
50458	361	9	that	that	IN
50458	361	10	he	-PRON-	PRP
50458	361	11	could	could	MD
50458	361	12	_	_	NNP
50458	361	13	attenuate	attenuate	VB
50458	361	14	the	the	DT
50458	361	15	action	action	NN
50458	361	16	of	of	IN
50458	361	17	the	the	DT
50458	361	18	virus	virus	NN
50458	361	19	_	_	NNP
50458	361	20	,	,	,
50458	361	21	either	either	CC
50458	361	22	by	by	IN
50458	361	23	passing	pass	VBG
50458	361	24	the	the	DT
50458	361	25	virus	virus	NN
50458	361	26	through	through	IN
50458	361	27	certain	certain	JJ
50458	361	28	animal	animal	NN
50458	361	29	organisms	organism	NNS
50458	361	30	,	,	,
50458	361	31	such	such	JJ
50458	361	32	as	as	IN
50458	361	33	the	the	DT
50458	361	34	monkey	monkey	NN
50458	361	35	or	or	CC
50458	361	36	rabbit	rabbit	NN
50458	361	37	,	,	,
50458	361	38	by	by	IN
50458	361	39	gently	gently	RB
50458	361	40	heating	heating	NN
50458	361	41	,	,	,
50458	361	42	or	or	CC
50458	361	43	even	even	RB
50458	361	44	by	by	IN
50458	361	45	allowing	allow	VBG
50458	361	46	it	-PRON-	PRP
50458	361	47	to	to	TO
50458	361	48	oxidize	oxidize	VB
50458	361	49	and	and	CC
50458	361	50	partially	partially	RB
50458	361	51	dry	dry	JJ
50458	361	52	in	in	IN
50458	361	53	the	the	DT
50458	361	54	air	air	NN
50458	361	55	,	,	,
50458	361	56	or	or	CC
50458	361	57	else	else	RB
50458	361	58	by	by	IN
50458	361	59	submitting	submit	VBG
50458	361	60	it	-PRON-	PRP
50458	361	61	to	to	IN
50458	361	62	the	the	DT
50458	361	63	action	action	NN
50458	361	64	of	of	IN
50458	361	65	antiseptics	antiseptic	NNS
50458	361	66	or	or	CC
50458	361	67	alternating	alternate	VBG
50458	361	68	electric	electric	JJ
50458	361	69	currents	current	NNS
50458	361	70	of	of	IN
50458	361	71	very	very	RB
50458	361	72	high	high	JJ
50458	361	73	tension	tension	NN
50458	361	74	.	.	.
50458	362	1	Experiments	experiment	NNS
50458	362	2	have	have	VBP
50458	362	3	shown	show	VBN
50458	362	4	that	that	IN
50458	362	5	a	a	DT
50458	362	6	deadly	deadly	JJ
50458	362	7	virus	virus	NN
50458	362	8	,	,	,
50458	362	9	attenuated	attenuate	VBN
50458	362	10	by	by	IN
50458	362	11	one	one	CD
50458	362	12	of	of	IN
50458	362	13	the	the	DT
50458	362	14	means	mean	NNS
50458	362	15	mentioned	mention	VBN
50458	362	16	,	,	,
50458	362	17	may	may	MD
50458	362	18	be	be	VB
50458	362	19	injected	inject	VBN
50458	362	20	,	,	,
50458	362	21	without	without	IN
50458	362	22	danger	danger	NN
50458	362	23	of	of	IN
50458	362	24	death	death	NN
50458	362	25	,	,	,
50458	362	26	into	into	IN
50458	362	27	the	the	DT
50458	362	28	living	living	NN
50458	362	29	animal	animal	NN
50458	362	30	;	;	:
50458	362	31	and	and	CC
50458	362	32	what	what	WP
50458	362	33	is	be	VBZ
50458	362	34	still	still	RB
50458	362	35	better	well	JJR
50458	362	36	,	,	,
50458	362	37	the	the	DT
50458	362	38	animal	animal	NN
50458	362	39	thus	thus	RB
50458	362	40	treated	treat	VBD
50458	362	41	acquires	acquire	VBZ
50458	362	42	the	the	DT
50458	362	43	power	power	NN
50458	362	44	of	of	IN
50458	362	45	resisting	resist	VBG
50458	362	46	large	large	JJ
50458	362	47	doses	dose	NNS
50458	362	48	of	of	IN
50458	362	49	the	the	DT
50458	362	50	virus	virus	NN
50458	362	51	,	,	,
50458	362	52	less	less	JJR
50458	362	53	and	and	CC
50458	362	54	less	less	RBR
50458	362	55	attenuated	attenuated	JJ
50458	362	56	,	,	,
50458	362	57	and	and	CC
50458	362	58	that	that	IN
50458	362	59	it	-PRON-	PRP
50458	362	60	is	be	VBZ
50458	362	61	possible	possible	JJ
50458	362	62	to	to	TO
50458	362	63	reach	reach	VB
50458	362	64	a	a	DT
50458	362	65	point	point	NN
50458	362	66	where	where	WRB
50458	362	67	the	the	DT
50458	362	68	animal	animal	NN
50458	362	69	economy	economy	NN
50458	362	70	may	may	MD
50458	362	71	become	become	VB
50458	362	72	habituated	habituated	JJ
50458	362	73	to	to	IN
50458	362	74	very	very	RB
50458	362	75	large	large	JJ
50458	362	76	doses	dose	NNS
50458	362	77	of	of	IN
50458	362	78	a	a	DT
50458	362	79	highly	highly	RB
50458	362	80	virulent	virulent	JJ
50458	362	81	virus	virus	NN
50458	362	82	without	without	IN
50458	362	83	the	the	DT
50458	362	84	organism	organism	NN
50458	362	85	experiencing	experience	VBG
50458	362	86	any	any	DT
50458	362	87	visible	visible	JJ
50458	362	88	illness	illness	NN
50458	362	89	--	--	:
50458	362	90	that	that	RB
50458	362	91	is	is	RB
50458	362	92	,	,	,
50458	362	93	the	the	DT
50458	362	94	organism	organism	NN
50458	362	95	has	have	VBZ
50458	362	96	been	be	VBN
50458	362	97	_	_	NNP
50458	362	98	vaccinated	vaccinate	VBN
50458	362	99	_	_	NNP
50458	362	100	with	with	IN
50458	362	101	regard	regard	NN
50458	362	102	to	to	IN
50458	362	103	the	the	DT
50458	362	104	particular	particular	JJ
50458	362	105	virus	virus	NN
50458	362	106	.	.	.
50458	363	1	Experiments	experiment	NNS
50458	363	2	have	have	VBP
50458	363	3	shown	show	VBN
50458	363	4	that	that	IN
50458	363	5	this	this	DT
50458	363	6	property	property	NN
50458	363	7	is	be	VBZ
50458	363	8	not	not	RB
50458	363	9	peculiar	peculiar	JJ
50458	363	10	to	to	IN
50458	363	11	microbial	microbial	JJ
50458	363	12	virus	virus	NN
50458	363	13	alone	alone	RB
50458	363	14	,	,	,
50458	363	15	but	but	CC
50458	363	16	that	that	IN
50458	363	17	it	-PRON-	PRP
50458	363	18	is	be	VBZ
50458	363	19	common	common	JJ
50458	363	20	to	to	IN
50458	363	21	the	the	DT
50458	363	22	venoms	venom	NNS
50458	363	23	the	the	DT
50458	363	24	toxicity	toxicity	NN
50458	363	25	of	of	IN
50458	363	26	which	which	WDT
50458	363	27	is	be	VBZ
50458	363	28	essentially	essentially	RB
50458	363	29	due	due	JJ
50458	363	30	to	to	IN
50458	363	31	some	some	DT
50458	363	32	toxins	toxin	NNS
50458	363	33	,	,	,
50458	363	34	with	with	IN
50458	363	35	the	the	DT
50458	363	36	exception	exception	NN
50458	363	37	of	of	IN
50458	363	38	those	those	DT
50458	363	39	agents	agent	NNS
50458	363	40	noted	note	VBD
50458	363	41	.	.	.
50458	364	1	The	the	DT
50458	364	2	attenuated	attenuate	VBN
50458	364	3	viruses	virus	NNS
50458	364	4	act	act	NNP
50458	364	5	,	,	,
50458	364	6	as	as	IN
50458	364	7	vaccins	vaccin	NNS
50458	364	8	,	,	,
50458	364	9	through	through	IN
50458	364	10	their	-PRON-	PRP$
50458	364	11	soluble	soluble	JJ
50458	364	12	constituents	constituent	NNS
50458	364	13	,	,	,
50458	364	14	which	which	WDT
50458	364	15	,	,	,
50458	364	16	either	either	CC
50458	364	17	directly	directly	RB
50458	364	18	,	,	,
50458	364	19	by	by	IN
50458	364	20	modifying	modify	VBG
50458	364	21	the	the	DT
50458	364	22	nutrition	nutrition	NN
50458	364	23	of	of	IN
50458	364	24	certain	certain	JJ
50458	364	25	cells	cell	NNS
50458	364	26	,	,	,
50458	364	27	or	or	CC
50458	364	28	indirectly	indirectly	RB
50458	364	29	,	,	,
50458	364	30	by	by	IN
50458	364	31	inducing	induce	VBG
50458	364	32	reactions	reaction	NNS
50458	364	33	of	of	IN
50458	364	34	the	the	DT
50458	364	35	nervous	nervous	JJ
50458	364	36	centers	center	NNS
50458	364	37	which	which	WDT
50458	364	38	preside	preside	VBP
50458	364	39	over	over	IN
50458	364	40	this	this	DT
50458	364	41	nutrition	nutrition	NN
50458	364	42	,	,	,
50458	364	43	profoundly	profoundly	RB
50458	364	44	change	change	VBP
50458	364	45	the	the	DT
50458	364	46	conditions	condition	NNS
50458	364	47	of	of	IN
50458	364	48	life	life	NN
50458	364	49	and	and	CC
50458	364	50	give	give	VB
50458	364	51	rise	rise	NN
50458	364	52	to	to	IN
50458	364	53	the	the	DT
50458	364	54	pathological	pathological	JJ
50458	364	55	condition	condition	NN
50458	364	56	--	--	:
50458	364	57	the	the	DT
50458	364	58	vaccined	vaccined	JJ
50458	364	59	state	state	NN
50458	364	60	.	.	.
50458	365	1	Experiments	experiment	NNS
50458	365	2	by	by	IN
50458	365	3	Behring	behre	VBG
50458	365	4	and	and	CC
50458	365	5	Kitasato[41	Kitasato[41	NNP
50458	365	6	]	]	-RRB-
50458	365	7	have	have	VBP
50458	365	8	shown	show	VBN
50458	365	9	that	that	IN
50458	365	10	the	the	DT
50458	365	11	tumors	tumor	NNS
50458	365	12	of	of	IN
50458	365	13	a	a	DT
50458	365	14	vaccinated	vaccinated	JJ
50458	365	15	animal	animal	NN
50458	365	16	,	,	,
50458	365	17	freed	free	VBN
50458	365	18	from	from	IN
50458	365	19	all	all	DT
50458	365	20	organized	organized	JJ
50458	365	21	matter	matter	NN
50458	365	22	visible	visible	JJ
50458	365	23	under	under	IN
50458	365	24	the	the	DT
50458	365	25	microscope	microscope	NN
50458	365	26	by	by	IN
50458	365	27	filtration	filtration	NN
50458	365	28	through	through	IN
50458	365	29	porcelain	porcelain	NN
50458	365	30	,	,	,
50458	365	31	contains	contain	VBZ
50458	365	32	principles	principle	NNS
50458	365	33	capable	capable	JJ
50458	365	34	of	of	IN
50458	365	35	directly	directly	RB
50458	365	36	or	or	CC
50458	365	37	indirectly	indirectly	RB
50458	365	38	protecting	protect	VBG
50458	365	39	other	other	JJ
50458	365	40	animals	animal	NNS
50458	365	41	from	from	IN
50458	365	42	the	the	DT
50458	365	43	disease	disease	NN
50458	365	44	caused	cause	VBN
50458	365	45	by	by	IN
50458	365	46	the	the	DT
50458	365	47	corresponding	correspond	VBG
50458	365	48	virus	virus	NN
50458	365	49	.	.	.
50458	366	1	Meanwhile	meanwhile	RB
50458	366	2	,	,	,
50458	366	3	experiments	experiment	NNS
50458	366	4	have	have	VBP
50458	366	5	shown	show	VBN
50458	366	6	that	that	IN
50458	366	7	the	the	DT
50458	366	8	vaccinating	vaccinating	NN
50458	366	9	matters	matter	NNS
50458	366	10	are	be	VBP
50458	366	11	totally	totally	RB
50458	366	12	eliminated	eliminate	VBN
50458	366	13	;	;	:
50458	366	14	nevertheless	nevertheless	RB
50458	366	15	,	,	,
50458	366	16	after	after	IN
50458	366	17	their	-PRON-	PRP$
50458	366	18	elimination	elimination	NN
50458	366	19	,	,	,
50458	366	20	the	the	DT
50458	366	21	immunity	immunity	NN
50458	366	22	acquired	acquire	VBD
50458	366	23	remains	remain	VBZ
50458	366	24	with	with	IN
50458	366	25	the	the	DT
50458	366	26	animal	animal	NN
50458	366	27	,	,	,
50458	366	28	which	which	WDT
50458	366	29	then	then	RB
50458	366	30	continues	continue	VBZ
50458	366	31	to	to	TO
50458	366	32	be	be	VB
50458	366	33	protected	protect	VBN
50458	366	34	against	against	IN
50458	366	35	the	the	DT
50458	366	36	corresponding	correspond	VBG
50458	366	37	virus	virus	NN
50458	366	38	.	.	.
50458	367	1	[	[	-LRB-
50458	367	2	41	41	CD
50458	367	3	]	]	-RRB-
50458	367	4	_	_	NNP
50458	367	5	Deutsche	Deutsche	NNP
50458	367	6	Med	Med	NNP
50458	367	7	.	.	.
50458	368	1	Wochenschr	Wochenschr	NNP
50458	368	2	.	.	.
50458	368	3	_	_	NNP
50458	368	4	,	,	,
50458	368	5	1890	1890	CD
50458	368	6	,	,	,
50458	368	7	p.	p.	NN
50458	368	8	1113	1113	CD
50458	368	9	.	.	.
50458	369	1	Interest	interest	NN
50458	369	2	in	in	IN
50458	369	3	this	this	DT
50458	369	4	subject	subject	NN
50458	369	5	has	have	VBZ
50458	369	6	incited	incite	VBN
50458	369	7	numerous	numerous	JJ
50458	369	8	researches	research	NNS
50458	369	9	with	with	IN
50458	369	10	a	a	DT
50458	369	11	regard	regard	NN
50458	369	12	to	to	IN
50458	369	13	bringing	bring	VBG
50458	369	14	to	to	TO
50458	369	15	light	light	VB
50458	369	16	the	the	DT
50458	369	17	mechanism	mechanism	NN
50458	369	18	of	of	IN
50458	369	19	this	this	DT
50458	369	20	immunization	immunization	NN
50458	369	21	;	;	:
50458	369	22	and	and	CC
50458	369	23	this	this	DT
50458	369	24	will	will	MD
50458	369	25	form	form	VB
50458	369	26	the	the	DT
50458	369	27	subject	subject	NN
50458	369	28	of	of	IN
50458	369	29	another	another	DT
50458	369	30	volume	volume	NN
50458	369	31	of	of	IN
50458	369	32	this	this	DT
50458	369	33	collection	collection	NN
50458	369	34	.	.	.
50458	370	1	We	-PRON-	PRP
50458	370	2	may	may	MD
50458	370	3	state	state	VB
50458	370	4	here	here	RB
50458	370	5	,	,	,
50458	370	6	however	however	RB
50458	370	7	,	,	,
50458	370	8	that	that	IN
50458	370	9	there	there	EX
50458	370	10	have	have	VBP
50458	370	11	been	be	VBN
50458	370	12	recognized	recognize	VBN
50458	370	13	two	two	CD
50458	370	14	concurrent	concurrent	JJ
50458	370	15	causes	cause	NNS
50458	370	16	of	of	IN
50458	370	17	this	this	DT
50458	370	18	preservative	preservative	JJ
50458	370	19	action	action	NN
50458	370	20	;	;	:
50458	370	21	the	the	DT
50458	370	22	one	one	NN
50458	370	23	,	,	,
50458	370	24	called	call	VBD
50458	370	25	_	_	NNP
50458	370	26	phagocytosis	phagocytosis	NN
50458	370	27	_	_	NNP
50458	370	28	,	,	,
50458	370	29	results	result	NNS
50458	370	30	from	from	IN
50458	370	31	the	the	DT
50458	370	32	fact	fact	NN
50458	370	33	that	that	IN
50458	370	34	the	the	DT
50458	370	35	microbe	microbe	NN
50458	370	36	introduced	introduce	VBN
50458	370	37	into	into	IN
50458	370	38	the	the	DT
50458	370	39	vaccined	vaccined	JJ
50458	370	40	organism	organism	NN
50458	370	41	becomes	become	VBZ
50458	370	42	incapable	incapable	JJ
50458	370	43	of	of	IN
50458	370	44	producing	produce	VBG
50458	370	45	its	-PRON-	PRP$
50458	370	46	usual	usual	JJ
50458	370	47	toxins	toxin	NNS
50458	370	48	,	,	,
50458	370	49	while	while	IN
50458	370	50	on	on	IN
50458	370	51	the	the	DT
50458	370	52	other	other	JJ
50458	370	53	hand	hand	NN
50458	370	54	the	the	DT
50458	370	55	immunization	immunization	NN
50458	370	56	renders	render	VBZ
50458	370	57	the	the	DT
50458	370	58	organism	organism	NN
50458	370	59	capable	capable	JJ
50458	370	60	of	of	IN
50458	370	61	secreting	secrete	VBG
50458	370	62	substances	substance	NNS
50458	370	63	possessing	possess	VBG
50458	370	64	an	an	DT
50458	370	65	activity	activity	NN
50458	370	66	contrary	contrary	JJ
50458	370	67	to	to	IN
50458	370	68	that	that	DT
50458	370	69	of	of	IN
50458	370	70	the	the	DT
50458	370	71	virus	virus	NN
50458	370	72	,	,	,
50458	370	73	in	in	IN
50458	370	74	fact	fact	NN
50458	370	75	true	true	JJ
50458	370	76	counter	counter	NN
50458	370	77	-	-	NNS
50458	370	78	poisons	poison	NNS
50458	370	79	,	,	,
50458	370	80	comprised	comprise	VBN
50458	370	81	under	under	IN
50458	370	82	the	the	DT
50458	370	83	general	general	JJ
50458	370	84	name	name	NN
50458	370	85	_	_	NNP
50458	370	86	antitoxins	antitoxins	NNP
50458	370	87	_	_	NNP
50458	370	88	.	.	.
50458	371	1	=	=	NFP
50458	371	2	Phagocytosis.=--We	Phagocytosis.=--We	NNP
50458	371	3	have	have	VBP
50458	371	4	seen	see	VBN
50458	371	5	that	that	IN
50458	371	6	an	an	DT
50458	371	7	organism	organism	NN
50458	371	8	subjected	subject	VBN
50458	371	9	to	to	IN
50458	371	10	a	a	DT
50458	371	11	toxic	toxic	JJ
50458	371	12	invasion	invasion	NN
50458	371	13	tends	tend	VBZ
50458	371	14	to	to	TO
50458	371	15	protect	protect	VB
50458	371	16	itself	-PRON-	PRP
50458	371	17	by	by	IN
50458	371	18	proper	proper	JJ
50458	371	19	means	mean	NNS
50458	371	20	of	of	IN
50458	371	21	defense	defense	NN
50458	371	22	;	;	:
50458	371	23	and	and	CC
50458	371	24	one	one	CD
50458	371	25	of	of	IN
50458	371	26	those	those	DT
50458	371	27	is	be	VBZ
50458	371	28	the	the	DT
50458	371	29	direct	direct	JJ
50458	371	30	putting	putting	NN
50458	371	31	into	into	IN
50458	371	32	activity	activity	NN
50458	371	33	of	of	IN
50458	371	34	the	the	DT
50458	371	35	living	live	VBG
50458	371	36	cellular	cellular	JJ
50458	371	37	elements	element	NNS
50458	371	38	themselves	-PRON-	PRP
50458	371	39	,	,	,
50458	371	40	and	and	CC
50458	371	41	in	in	IN
50458	371	42	particular	particular	JJ
50458	371	43	,	,	,
50458	371	44	the	the	DT
50458	371	45	leucocytes	leucocyte	NNS
50458	371	46	,	,	,
50458	371	47	or	or	CC
50458	371	48	white	white	JJ
50458	371	49	corpuscles	corpuscle	NNS
50458	371	50	,	,	,
50458	371	51	found	find	VBN
50458	371	52	in	in	IN
50458	371	53	more	more	JJR
50458	371	54	or	or	CC
50458	371	55	less	less	JJR
50458	371	56	number	number	NN
50458	371	57	,	,	,
50458	371	58	according	accord	VBG
50458	371	59	to	to	IN
50458	371	60	pathological	pathological	JJ
50458	371	61	conditions	condition	NNS
50458	371	62	,	,	,
50458	371	63	in	in	IN
50458	371	64	the	the	DT
50458	371	65	blood	blood	NN
50458	371	66	and	and	CC
50458	371	67	lymphatic	lymphatic	JJ
50458	371	68	fluids	fluid	NNS
50458	371	69	.	.	.
50458	372	1	[	[	-LRB-
50458	372	2	42	42	CD
50458	372	3	]	]	-RRB-
50458	372	4	[	[	-LRB-
50458	372	5	42	42	CD
50458	372	6	]	]	-RRB-
50458	372	7	It	-PRON-	PRP
50458	372	8	is	be	VBZ
50458	372	9	necessary	necessary	JJ
50458	372	10	here	here	RB
50458	372	11	to	to	TO
50458	372	12	consult	consult	VB
50458	372	13	the	the	DT
50458	372	14	work	work	NN
50458	372	15	by	by	IN
50458	372	16	LEVADITI	levaditi	NN
50458	372	17	:	:	:
50458	372	18	Le	Le	NNP
50458	372	19	Leucocyte	Leucocyte	NNP
50458	372	20	et	et	NNP
50458	372	21	ses	se	VBZ
50458	372	22	Granulations	Granulations	NNPS
50458	372	23	.	.	.
50458	373	1	_	_	NNP
50458	373	2	Scientia	Scientia	NNP
50458	373	3	_	_	NNP
50458	373	4	,	,	,
50458	373	5	Naud	Naud	NNP
50458	373	6	,	,	,
50458	373	7	publisher	publisher	NN
50458	373	8	,	,	,
50458	373	9	Paris	Paris	NNP
50458	373	10	,	,	,
50458	373	11	1903	1903	CD
50458	373	12	;	;	:
50458	373	13	also	also	RB
50458	373	14	METCHNIKOFF	metchnikoff	JJ
50458	373	15	:	:	:
50458	373	16	L'Immunité	L'Immunité	NNP
50458	373	17	,	,	,
50458	373	18	Paris	Paris	NNP
50458	373	19	,	,	,
50458	373	20	1902	1902	CD
50458	373	21	,	,	,
50458	373	22	Masson	Masson	NNP
50458	373	23	,	,	,
50458	373	24	publisher	publisher	NN
50458	373	25	.	.	.
50458	374	1	Metchnikoff	Metchnikoff	NNP
50458	374	2	has	have	VBZ
50458	374	3	shown	show	VBN
50458	374	4	that	that	IN
50458	374	5	the	the	DT
50458	374	6	moment	moment	NN
50458	374	7	a	a	DT
50458	374	8	foreign	foreign	JJ
50458	374	9	element	element	NN
50458	374	10	,	,	,
50458	374	11	particularly	particularly	RB
50458	374	12	a	a	DT
50458	374	13	microbe	microbe	NN
50458	374	14	,	,	,
50458	374	15	enters	enter	VBZ
50458	374	16	the	the	DT
50458	374	17	organism	organism	NN
50458	374	18	,	,	,
50458	374	19	these	these	DT
50458	374	20	leucocytes	leucocyte	NNS
50458	374	21	come	come	VBP
50458	374	22	flocking	flock	VBG
50458	374	23	from	from	IN
50458	374	24	all	all	DT
50458	374	25	parts	part	NNS
50458	374	26	of	of	IN
50458	374	27	the	the	DT
50458	374	28	body	body	NN
50458	374	29	,	,	,
50458	374	30	collect	collect	VB
50458	374	31	around	around	IN
50458	374	32	the	the	DT
50458	374	33	bacterial	bacterial	JJ
50458	374	34	element	element	NN
50458	374	35	,	,	,
50458	374	36	penetrate	penetrate	VB
50458	374	37	it	-PRON-	PRP
50458	374	38	,	,	,
50458	374	39	and	and	CC
50458	374	40	begin	begin	VB
50458	374	41	to	to	TO
50458	374	42	digest	digest	VB
50458	374	43	it	-PRON-	PRP
50458	374	44	.	.	.
50458	375	1	These	these	DT
50458	375	2	elements	element	NNS
50458	375	3	have	have	VBP
50458	375	4	received	receive	VBN
50458	375	5	the	the	DT
50458	375	6	name	name	NN
50458	375	7	_	_	NNP
50458	375	8	phagocytes	phagocyte	NNS
50458	375	9	_	_	NNP
50458	375	10	.	.	.
50458	376	1	The	the	DT
50458	376	2	name	name	NN
50458	376	3	_	_	NNP
50458	376	4	chemotaxis	chemotaxis	NNP
50458	376	5	_	_	NNP
50458	376	6	has	have	VBZ
50458	376	7	been	be	VBN
50458	376	8	given	give	VBN
50458	376	9	to	to	IN
50458	376	10	the	the	DT
50458	376	11	property	property	NN
50458	376	12	by	by	IN
50458	376	13	virtue	virtue	NN
50458	376	14	of	of	IN
50458	376	15	which	which	WDT
50458	376	16	they	-PRON-	PRP
50458	376	17	approach	approach	VBP
50458	376	18	(	(	-LRB-
50458	376	19	positive	positive	JJ
50458	376	20	chemotaxis	chemotaxi	NNS
50458	376	21	)	)	-RRB-
50458	376	22	or	or	CC
50458	376	23	move	move	VB
50458	376	24	away	away	RB
50458	376	25	from	from	IN
50458	376	26	(	(	-LRB-
50458	376	27	negative	negative	JJ
50458	376	28	chemotaxis	chemotaxis	NN
50458	376	29	)	)	-RRB-
50458	376	30	certain	certain	JJ
50458	376	31	substances	substance	NNS
50458	376	32	which	which	WDT
50458	376	33	affect	affect	VBP
50458	376	34	them	-PRON-	PRP
50458	376	35	powerfully	powerfully	RB
50458	376	36	.	.	.
50458	377	1	Experiments	experiment	NNS
50458	377	2	have	have	VBP
50458	377	3	shown	show	VBN
50458	377	4	that	that	IN
50458	377	5	the	the	DT
50458	377	6	leucocytes	leucocyte	NNS
50458	377	7	are	be	VBP
50458	377	8	attracted	attract	VBN
50458	377	9	by	by	IN
50458	377	10	the	the	DT
50458	377	11	products	product	NNS
50458	377	12	secreted	secrete	VBN
50458	377	13	by	by	IN
50458	377	14	pathogenic	pathogenic	JJ
50458	377	15	microbes	microbe	NNS
50458	377	16	,	,	,
50458	377	17	or	or	CC
50458	377	18	saprophytes	saprophyte	NNS
50458	377	19	.	.	.
50458	378	1	Attracted	attract	VBN
50458	378	2	by	by	IN
50458	378	3	the	the	DT
50458	378	4	latter	latter	JJ
50458	378	5	,	,	,
50458	378	6	the	the	DT
50458	378	7	white	white	JJ
50458	378	8	corpuscles	corpuscle	NNS
50458	378	9	surround	surround	VBP
50458	378	10	,	,	,
50458	378	11	envelop	envelop	NN
50458	378	12	,	,	,
50458	378	13	and	and	CC
50458	378	14	finally	finally	RB
50458	378	15	digest	digest	VB
50458	378	16	them	-PRON-	PRP
50458	378	17	;	;	:
50458	378	18	and	and	CC
50458	378	19	when	when	WRB
50458	378	20	it	-PRON-	PRP
50458	378	21	happens	happen	VBZ
50458	378	22	that	that	IN
50458	378	23	all	all	PDT
50458	378	24	the	the	DT
50458	378	25	pathogenic	pathogenic	JJ
50458	378	26	microbes	microbe	NNS
50458	378	27	within	within	IN
50458	378	28	an	an	DT
50458	378	29	organism	organism	NN
50458	378	30	are	be	VBP
50458	378	31	absorbed	absorb	VBN
50458	378	32	,	,	,
50458	378	33	the	the	DT
50458	378	34	organism	organism	NN
50458	378	35	survives	survive	VBZ
50458	378	36	,	,	,
50458	378	37	while	while	IN
50458	378	38	in	in	IN
50458	378	39	the	the	DT
50458	378	40	contrary	contrary	JJ
50458	378	41	case	case	NN
50458	378	42	it	-PRON-	PRP
50458	378	43	succumbs	succumb	VBZ
50458	378	44	.	.	.
50458	379	1	Attention	attention	NN
50458	379	2	must	must	MD
50458	379	3	be	be	VB
50458	379	4	called	call	VBN
50458	379	5	to	to	IN
50458	379	6	this	this	DT
50458	379	7	attack	attack	NN
50458	379	8	by	by	IN
50458	379	9	the	the	DT
50458	379	10	white	white	JJ
50458	379	11	corpuscles	corpuscle	NNS
50458	379	12	within	within	IN
50458	379	13	the	the	DT
50458	379	14	limits	limit	NNS
50458	379	15	where	where	WRB
50458	379	16	they	-PRON-	PRP
50458	379	17	are	be	VBP
50458	379	18	normally	normally	RB
50458	379	19	confined	confine	VBN
50458	379	20	.	.	.
50458	380	1	It	-PRON-	PRP
50458	380	2	is	be	VBZ
50458	380	3	a	a	DT
50458	380	4	pathologic	pathologic	JJ
50458	380	5	diapedesis	diapedesis	NN
50458	380	6	--	--	:
50458	380	7	a	a	DT
50458	380	8	leucocytosis	leucocytosis	NN
50458	380	9	provoked	provoke	VBN
50458	380	10	by	by	IN
50458	380	11	the	the	DT
50458	380	12	irritation	irritation	NN
50458	380	13	of	of	IN
50458	380	14	the	the	DT
50458	380	15	tissues	tissue	NNS
50458	380	16	--	--	:
50458	380	17	and	and	CC
50458	380	18	caused	cause	VBN
50458	380	19	either	either	CC
50458	380	20	by	by	IN
50458	380	21	the	the	DT
50458	380	22	presence	presence	NN
50458	380	23	alone	alone	RB
50458	380	24	of	of	IN
50458	380	25	foreign	foreign	JJ
50458	380	26	elements	element	NNS
50458	380	27	,	,	,
50458	380	28	or	or	CC
50458	380	29	by	by	IN
50458	380	30	the	the	DT
50458	380	31	soluble	soluble	JJ
50458	380	32	products	product	NNS
50458	380	33	secreted	secrete	VBN
50458	380	34	by	by	IN
50458	380	35	them	-PRON-	PRP
50458	380	36	.	.	.
50458	381	1	When	when	WRB
50458	381	2	,	,	,
50458	381	3	for	for	IN
50458	381	4	any	any	DT
50458	381	5	reason	reason	NN
50458	381	6	whatever	whatever	WDT
50458	381	7	,	,	,
50458	381	8	this	this	DT
50458	381	9	phagocytic	phagocytic	JJ
50458	381	10	action	action	NN
50458	381	11	is	be	VBZ
50458	381	12	impeded	impede	VBN
50458	381	13	,	,	,
50458	381	14	the	the	DT
50458	381	15	resistance	resistance	NN
50458	381	16	of	of	IN
50458	381	17	the	the	DT
50458	381	18	organism	organism	NN
50458	381	19	to	to	IN
50458	381	20	pathogenic	pathogenic	JJ
50458	381	21	infection	infection	NN
50458	381	22	ceases	cease	VBZ
50458	381	23	to	to	TO
50458	381	24	be	be	VB
50458	381	25	effective	effective	JJ
50458	381	26	,	,	,
50458	381	27	and	and	CC
50458	381	28	the	the	DT
50458	381	29	organism	organism	NN
50458	381	30	may	may	MD
50458	381	31	therefore	therefore	RB
50458	381	32	be	be	VB
50458	381	33	invaded	invade	VBN
50458	381	34	by	by	IN
50458	381	35	the	the	DT
50458	381	36	microbe	microbe	NN
50458	381	37	.	.	.
50458	382	1	Numerous	numerous	JJ
50458	382	2	causes	cause	NNS
50458	382	3	may	may	MD
50458	382	4	contribute	contribute	VB
50458	382	5	to	to	TO
50458	382	6	impede	impede	VB
50458	382	7	this	this	DT
50458	382	8	action	action	NN
50458	382	9	.	.	.
50458	383	1	=	=	NFP
50458	383	2	The	the	DT
50458	383	3	Antitoxins.=	antitoxins.=	NN
50458	383	4	We	-PRON-	PRP
50458	383	5	have	have	VBP
50458	383	6	seen	see	VBN
50458	383	7	that	that	IN
50458	383	8	the	the	DT
50458	383	9	second	second	JJ
50458	383	10	means	mean	NNS
50458	383	11	of	of	IN
50458	383	12	defense	defense	NN
50458	383	13	possessed	possess	VBN
50458	383	14	by	by	IN
50458	383	15	the	the	DT
50458	383	16	organism	organism	NN
50458	383	17	resides	reside	VBZ
50458	383	18	in	in	IN
50458	383	19	the	the	DT
50458	383	20	action	action	NN
50458	383	21	of	of	IN
50458	383	22	special	special	JJ
50458	383	23	products	product	NNS
50458	383	24	,	,	,
50458	383	25	true	true	JJ
50458	383	26	defensive	defensive	JJ
50458	383	27	secretions	secretion	NNS
50458	383	28	,	,	,
50458	383	29	possessing	possess	VBG
50458	383	30	an	an	DT
50458	383	31	activity	activity	NN
50458	383	32	contrary	contrary	JJ
50458	383	33	to	to	IN
50458	383	34	that	that	DT
50458	383	35	of	of	IN
50458	383	36	the	the	DT
50458	383	37	toxins	toxin	NNS
50458	383	38	,	,	,
50458	383	39	and	and	CC
50458	383	40	which	which	WDT
50458	383	41	are	be	VBP
50458	383	42	secreted	secrete	VBN
50458	383	43	by	by	IN
50458	383	44	the	the	DT
50458	383	45	cells	cell	NNS
50458	383	46	of	of	IN
50458	383	47	the	the	DT
50458	383	48	organism	organism	NN
50458	383	49	under	under	IN
50458	383	50	the	the	DT
50458	383	51	influence	influence	NN
50458	383	52	of	of	IN
50458	383	53	the	the	DT
50458	383	54	vaccins	vaccin	NNS
50458	383	55	.	.	.
50458	384	1	This	this	DT
50458	384	2	is	be	VBZ
50458	384	3	a	a	DT
50458	384	4	property	property	NN
50458	384	5	common	common	JJ
50458	384	6	to	to	IN
50458	384	7	every	every	DT
50458	384	8	organism	organism	NN
50458	384	9	,	,	,
50458	384	10	and	and	CC
50458	384	11	which	which	WDT
50458	384	12	is	be	VBZ
50458	384	13	observed	observe	VBN
50458	384	14	even	even	RB
50458	384	15	in	in	IN
50458	384	16	non	non	JJ
50458	384	17	-	-	JJ
50458	384	18	vaccinated	vaccinated	JJ
50458	384	19	subjects	subject	NNS
50458	384	20	,	,	,
50458	384	21	although	although	IN
50458	384	22	in	in	IN
50458	384	23	this	this	DT
50458	384	24	case	case	NN
50458	384	25	the	the	DT
50458	384	26	secretion	secretion	NN
50458	384	27	forms	form	VBZ
50458	384	28	with	with	IN
50458	384	29	great	great	JJ
50458	384	30	difficulty	difficulty	NN
50458	384	31	and	and	CC
50458	384	32	in	in	IN
50458	384	33	small	small	JJ
50458	384	34	quantity	quantity	NN
50458	384	35	.	.	.
50458	385	1	When	when	WRB
50458	385	2	an	an	DT
50458	385	3	organism	organism	NN
50458	385	4	subjected	subject	VBD
50458	385	5	to	to	IN
50458	385	6	the	the	DT
50458	385	7	toxic	toxic	JJ
50458	385	8	action	action	NN
50458	385	9	of	of	IN
50458	385	10	a	a	DT
50458	385	11	bacterial	bacterial	JJ
50458	385	12	infection	infection	NN
50458	385	13	does	do	VBZ
50458	385	14	not	not	RB
50458	385	15	succumb	succumb	VB
50458	385	16	to	to	IN
50458	385	17	the	the	DT
50458	385	18	intoxication	intoxication	NN
50458	385	19	,	,	,
50458	385	20	it	-PRON-	PRP
50458	385	21	emerges	emerge	VBZ
50458	385	22	from	from	IN
50458	385	23	the	the	DT
50458	385	24	test	test	NN
50458	385	25	gifted	gift	VBN
50458	385	26	with	with	IN
50458	385	27	a	a	DT
50458	385	28	new	new	JJ
50458	385	29	property	property	NN
50458	385	30	,	,	,
50458	385	31	which	which	WDT
50458	385	32	may	may	MD
50458	385	33	be	be	VB
50458	385	34	augmented	augment	VBN
50458	385	35	by	by	IN
50458	385	36	habituation	habituation	NN
50458	385	37	,	,	,
50458	385	38	and	and	CC
50458	385	39	which	which	WDT
50458	385	40	borders	border	VBZ
50458	385	41	on	on	IN
50458	385	42	immunity	immunity	NN
50458	385	43	.	.	.
50458	386	1	At	at	IN
50458	386	2	first	first	RB
50458	386	3	we	-PRON-	PRP
50458	386	4	were	be	VBD
50458	386	5	content	content	JJ
50458	386	6	to	to	TO
50458	386	7	vaccinate	vaccinate	VB
50458	386	8	small	small	JJ
50458	386	9	animals	animal	NNS
50458	386	10	in	in	IN
50458	386	11	the	the	DT
50458	386	12	laboratory	laboratory	NN
50458	386	13	,	,	,
50458	386	14	but	but	CC
50458	386	15	in	in	IN
50458	386	16	proportion	proportion	NN
50458	386	17	as	as	IN
50458	386	18	the	the	DT
50458	386	19	discoveries	discovery	NNS
50458	386	20	in	in	IN
50458	386	21	this	this	DT
50458	386	22	domain	domain	NN
50458	386	23	extended	extend	VBD
50458	386	24	,	,	,
50458	386	25	and	and	CC
50458	386	26	there	there	RB
50458	386	27	developed	develop	VBD
50458	386	28	a	a	DT
50458	386	29	need	need	NN
50458	386	30	for	for	IN
50458	386	31	large	large	JJ
50458	386	32	quantities	quantity	NNS
50458	386	33	of	of	IN
50458	386	34	antitoxins	antitoxin	NNS
50458	386	35	,	,	,
50458	386	36	recourse	recourse	NNP
50458	386	37	was	be	VBD
50458	386	38	had	have	VBN
50458	386	39	to	to	IN
50458	386	40	the	the	DT
50458	386	41	larger	large	JJR
50458	386	42	animals	animal	NNS
50458	386	43	,	,	,
50458	386	44	particularly	particularly	RB
50458	386	45	horses	horse	NNS
50458	386	46	and	and	CC
50458	386	47	cattle	cattle	NNS
50458	386	48	.	.	.
50458	387	1	From	from	IN
50458	387	2	the	the	DT
50458	387	3	moment	moment	NN
50458	387	4	that	that	IN
50458	387	5	large	large	JJ
50458	387	6	quantities	quantity	NNS
50458	387	7	of	of	IN
50458	387	8	blood	blood	NN
50458	387	9	and	and	CC
50458	387	10	antitoxic	antitoxic	NN
50458	387	11	serum	serum	NNP
50458	387	12	were	be	VBD
50458	387	13	at	at	IN
50458	387	14	command	command	NN
50458	387	15	,	,	,
50458	387	16	search	search	NN
50458	387	17	was	be	VBD
50458	387	18	made	make	VBN
50458	387	19	for	for	IN
50458	387	20	a	a	DT
50458	387	21	means	means	NN
50458	387	22	of	of	IN
50458	387	23	isolating	isolate	VBG
50458	387	24	the	the	DT
50458	387	25	antitoxin	antitoxin	NN
50458	387	26	and	and	CC
50458	387	27	determining	determine	VBG
50458	387	28	its	-PRON-	PRP$
50458	387	29	properties	property	NNS
50458	387	30	.	.	.
50458	388	1	Experiments	experiment	NNS
50458	388	2	so	so	RB
50458	388	3	far	far	RB
50458	388	4	made	make	VBN
50458	388	5	have	have	VBP
50458	388	6	shown	show	VBN
50458	388	7	that	that	IN
50458	388	8	the	the	DT
50458	388	9	antitoxins	antitoxin	NNS
50458	388	10	are	be	VBP
50458	388	11	substances	substance	NNS
50458	388	12	of	of	IN
50458	388	13	an	an	DT
50458	388	14	albuminoid	albuminoid	NN
50458	388	15	nature	nature	NN
50458	388	16	,	,	,
50458	388	17	of	of	IN
50458	388	18	unknown	unknown	JJ
50458	388	19	composition	composition	NN
50458	388	20	,	,	,
50458	388	21	and	and	CC
50458	388	22	which	which	WDT
50458	388	23	are	be	VBP
50458	388	24	very	very	RB
50458	388	25	closely	closely	RB
50458	388	26	united	united	JJ
50458	388	27	to	to	IN
50458	388	28	the	the	DT
50458	388	29	albuminoid	albuminoid	JJ
50458	388	30	substances	substance	NNS
50458	388	31	of	of	IN
50458	388	32	the	the	DT
50458	388	33	serum	serum	NN
50458	388	34	.	.	.
50458	389	1	It	-PRON-	PRP
50458	389	2	must	must	MD
50458	389	3	be	be	VB
50458	389	4	observed	observe	VBN
50458	389	5	,	,	,
50458	389	6	however	however	RB
50458	389	7	,	,	,
50458	389	8	that	that	IN
50458	389	9	Behring	Behring	NNP
50458	389	10	and	and	CC
50458	389	11	Knorr	Knorr	NNP
50458	389	12	oppose	oppose	VBP
50458	389	13	the	the	DT
50458	389	14	assertion	assertion	NN
50458	389	15	regarding	regard	VBG
50458	389	16	the	the	DT
50458	389	17	albuminoid	albuminoid	NN
50458	389	18	nature	nature	NN
50458	389	19	of	of	IN
50458	389	20	tetanic	tetanic	JJ
50458	389	21	antitoxin	antitoxin	NN
50458	389	22	,	,	,
50458	389	23	but	but	CC
50458	389	24	their	-PRON-	PRP$
50458	389	25	reasons	reason	NNS
50458	389	26	for	for	IN
50458	389	27	this	this	DT
50458	389	28	do	do	VBP
50458	389	29	not	not	RB
50458	389	30	appear	appear	VB
50458	389	31	to	to	TO
50458	389	32	be	be	VB
50458	389	33	well	well	RB
50458	389	34	founded	found	VBN
50458	389	35	.	.	.
50458	390	1	In	in	IN
50458	390	2	general	general	JJ
50458	390	3	,	,	,
50458	390	4	these	these	DT
50458	390	5	antitoxins	antitoxin	NNS
50458	390	6	are	be	VBP
50458	390	7	precipitable	precipitable	JJ
50458	390	8	with	with	IN
50458	390	9	the	the	DT
50458	390	10	globulins	globulin	NNS
50458	390	11	,	,	,
50458	390	12	and	and	CC
50458	390	13	possess	possess	VBP
50458	390	14	quite	quite	RB
50458	390	15	considerable	considerable	JJ
50458	390	16	powers	power	NNS
50458	390	17	of	of	IN
50458	390	18	resistance	resistance	NN
50458	390	19	towards	towards	IN
50458	390	20	physical	physical	JJ
50458	390	21	and	and	CC
50458	390	22	chemical	chemical	JJ
50458	390	23	agents	agent	NNS
50458	390	24	.	.	.
50458	391	1	Thus	thus	RB
50458	391	2	they	-PRON-	PRP
50458	391	3	are	be	VBP
50458	391	4	destroyed	destroy	VBN
50458	391	5	only	only	RB
50458	391	6	at	at	IN
50458	391	7	a	a	DT
50458	391	8	temperature	temperature	NN
50458	391	9	above	above	IN
50458	391	10	60	60	CD
50458	391	11	-	-	SYM
50458	391	12	65	65	CD
50458	391	13	°	°	,
50458	391	14	C.	C.	NNP
50458	391	15	Kept	Kept	NNP
50458	391	16	in	in	IN
50458	391	17	the	the	DT
50458	391	18	dry	dry	JJ
50458	391	19	state	state	NN
50458	391	20	,	,	,
50458	391	21	in	in	IN
50458	391	22	the	the	DT
50458	391	23	residue	residue	NN
50458	391	24	of	of	IN
50458	391	25	evaporated	evaporated	JJ
50458	391	26	serum	serum	NN
50458	391	27	,	,	,
50458	391	28	and	and	CC
50458	391	29	away	away	RB
50458	391	30	from	from	IN
50458	391	31	the	the	DT
50458	391	32	light	light	NN
50458	391	33	and	and	CC
50458	391	34	all	all	DT
50458	391	35	oxidizing	oxidizing	JJ
50458	391	36	action	action	NN
50458	391	37	,	,	,
50458	391	38	it	-PRON-	PRP
50458	391	39	is	be	VBZ
50458	391	40	possible	possible	JJ
50458	391	41	to	to	TO
50458	391	42	preserve	preserve	VB
50458	391	43	their	-PRON-	PRP$
50458	391	44	activity	activity	NN
50458	391	45	for	for	IN
50458	391	46	a	a	DT
50458	391	47	very	very	RB
50458	391	48	long	long	JJ
50458	391	49	time	time	NN
50458	391	50	.	.	.
50458	392	1	They	-PRON-	PRP
50458	392	2	are	be	VBP
50458	392	3	essentially	essentially	RB
50458	392	4	humoral	humoral	JJ
50458	392	5	substances	substance	NNS
50458	392	6	;	;	:
50458	392	7	they	-PRON-	PRP
50458	392	8	are	be	VBP
50458	392	9	found	find	VBN
50458	392	10	in	in	IN
50458	392	11	the	the	DT
50458	392	12	blood	blood	NN
50458	392	13	of	of	IN
50458	392	14	vaccinated	vaccinated	JJ
50458	392	15	animals	animal	NNS
50458	392	16	,	,	,
50458	392	17	from	from	IN
50458	392	18	which	which	WDT
50458	392	19	may	may	MD
50458	392	20	be	be	VB
50458	392	21	obtained	obtain	VBN
50458	392	22	antitoxic	antitoxic	NN
50458	392	23	serums	serum	NNS
50458	392	24	with	with	IN
50458	392	25	a	a	DT
50458	392	26	specific	specific	JJ
50458	392	27	but	but	CC
50458	392	28	transient	transient	JJ
50458	392	29	immunity	immunity	NN
50458	392	30	;	;	:
50458	392	31	and	and	CC
50458	392	32	they	-PRON-	PRP
50458	392	33	are	be	VBP
50458	392	34	also	also	RB
50458	392	35	found	find	VBN
50458	392	36	in	in	IN
50458	392	37	the	the	DT
50458	392	38	plasmas	plasma	NNS
50458	392	39	of	of	IN
50458	392	40	the	the	DT
50458	392	41	lymph	lymph	NN
50458	392	42	and	and	CC
50458	392	43	exudates	exudate	NNS
50458	392	44	,	,	,
50458	392	45	in	in	IN
50458	392	46	aqueous	aqueous	JJ
50458	392	47	tumors	tumor	NNS
50458	392	48	,	,	,
50458	392	49	and	and	CC
50458	392	50	in	in	IN
50458	392	51	the	the	DT
50458	392	52	milk	milk	NN
50458	392	53	.	.	.
50458	393	1	They	-PRON-	PRP
50458	393	2	are	be	VBP
50458	393	3	seldom	seldom	RB
50458	393	4	found	find	VBN
50458	393	5	in	in	IN
50458	393	6	the	the	DT
50458	393	7	cells	cell	NNS
50458	393	8	.	.	.
50458	394	1	=	=	NFP
50458	394	2	Mode	mode	NN
50458	394	3	of	of	IN
50458	394	4	Action.=--Frequent	action.=--frequent	JJ
50458	394	5	attention	attention	NN
50458	394	6	has	have	VBZ
50458	394	7	been	be	VBN
50458	394	8	paid	pay	VBN
50458	394	9	to	to	IN
50458	394	10	the	the	DT
50458	394	11	mode	mode	NN
50458	394	12	of	of	IN
50458	394	13	action	action	NN
50458	394	14	of	of	IN
50458	394	15	the	the	DT
50458	394	16	antitoxins	antitoxin	NNS
50458	394	17	upon	upon	IN
50458	394	18	the	the	DT
50458	394	19	toxins	toxin	NNS
50458	394	20	,	,	,
50458	394	21	a	a	DT
50458	394	22	phenomenon	phenomenon	NN
50458	394	23	of	of	IN
50458	394	24	great	great	JJ
50458	394	25	importance	importance	NN
50458	394	26	in	in	IN
50458	394	27	relation	relation	NN
50458	394	28	to	to	IN
50458	394	29	the	the	DT
50458	394	30	phenomenon	phenomenon	NN
50458	394	31	of	of	IN
50458	394	32	immunity	immunity	NN
50458	394	33	acquired	acquire	VBN
50458	394	34	against	against	IN
50458	394	35	the	the	DT
50458	394	36	toxins	toxin	NNS
50458	394	37	.	.	.
50458	395	1	At	at	IN
50458	395	2	the	the	DT
50458	395	3	beginning	beginning	NN
50458	395	4	of	of	IN
50458	395	5	our	-PRON-	PRP$
50458	395	6	knowledge	knowledge	NN
50458	395	7	on	on	IN
50458	395	8	this	this	DT
50458	395	9	subject	subject	NN
50458	395	10	,	,	,
50458	395	11	the	the	DT
50458	395	12	idea	idea	NN
50458	395	13	of	of	IN
50458	395	14	a	a	DT
50458	395	15	destruction	destruction	NN
50458	395	16	of	of	IN
50458	395	17	the	the	DT
50458	395	18	toxin	toxin	NN
50458	395	19	immediately	immediately	RB
50458	395	20	suggested	suggest	VBD
50458	395	21	itself	-PRON-	PRP
50458	395	22	,	,	,
50458	395	23	and	and	CC
50458	395	24	was	be	VBD
50458	395	25	advanced	advance	VBN
50458	395	26	by	by	IN
50458	395	27	von	von	NNP
50458	395	28	Behring	Behring	NNP
50458	395	29	.	.	.
50458	396	1	[	[	-LRB-
50458	396	2	43	43	CD
50458	396	3	]	]	-RRB-
50458	396	4	According	accord	VBG
50458	396	5	to	to	IN
50458	396	6	this	this	DT
50458	396	7	scientist	scientist	NN
50458	396	8	the	the	DT
50458	396	9	antibody	antibody	NN
50458	396	10	inhibits	inhibit	VBZ
50458	396	11	the	the	DT
50458	396	12	morbigenic	morbigenic	JJ
50458	396	13	action	action	NN
50458	396	14	of	of	IN
50458	396	15	the	the	DT
50458	396	16	toxin	toxin	NN
50458	396	17	by	by	IN
50458	396	18	neutralizing	neutralize	VBG
50458	396	19	the	the	DT
50458	396	20	toxin	toxin	NN
50458	396	21	,	,	,
50458	396	22	combining	combine	VBG
50458	396	23	with	with	IN
50458	396	24	the	the	DT
50458	396	25	latter	latter	JJ
50458	396	26	to	to	TO
50458	396	27	form	form	VB
50458	396	28	a	a	DT
50458	396	29	compound	compound	NN
50458	396	30	of	of	IN
50458	396	31	a	a	DT
50458	396	32	chemical	chemical	NN
50458	396	33	nature	nature	NN
50458	396	34	which	which	WDT
50458	396	35	is	be	VBZ
50458	396	36	devoid	devoid	JJ
50458	396	37	of	of	IN
50458	396	38	toxicity	toxicity	NN
50458	396	39	and	and	CC
50458	396	40	without	without	IN
50458	396	41	action	action	NN
50458	396	42	on	on	IN
50458	396	43	the	the	DT
50458	396	44	organism	organism	NN
50458	396	45	.	.	.
50458	397	1	According	accord	VBG
50458	397	2	to	to	IN
50458	397	3	this	this	DT
50458	397	4	theory	theory	NN
50458	397	5	,	,	,
50458	397	6	the	the	DT
50458	397	7	influence	influence	NN
50458	397	8	of	of	IN
50458	397	9	the	the	DT
50458	397	10	antitoxin	antitoxin	NN
50458	397	11	on	on	IN
50458	397	12	the	the	DT
50458	397	13	toxin	toxin	NN
50458	397	14	is	be	VBZ
50458	397	15	direct	direct	JJ
50458	397	16	,	,	,
50458	397	17	and	and	CC
50458	397	18	does	do	VBZ
50458	397	19	not	not	RB
50458	397	20	require	require	VB
50458	397	21	the	the	DT
50458	397	22	intervention	intervention	NN
50458	397	23	of	of	IN
50458	397	24	the	the	DT
50458	397	25	living	live	VBG
50458	397	26	cellular	cellular	JJ
50458	397	27	protoplasm	protoplasm	NN
50458	397	28	.	.	.
50458	398	1	Such	such	JJ
50458	398	2	was	be	VBD
50458	398	3	also	also	RB
50458	398	4	the	the	DT
50458	398	5	belief	belief	NN
50458	398	6	of	of	IN
50458	398	7	Prof.	Prof.	NNP
50458	399	1	Ehrlich	ehrlich	NN
50458	399	2	.	.	.
50458	400	1	[	[	-LRB-
50458	400	2	44	44	CD
50458	400	3	]	]	-RRB-
50458	400	4	[	[	-LRB-
50458	400	5	43	43	CD
50458	400	6	]	]	-RRB-
50458	400	7	VON	VON	NNP
50458	400	8	BEHRING	BEHRING	NNP
50458	400	9	and	and	CC
50458	400	10	KITASATO	KITASATO	NNP
50458	400	11	:	:	:
50458	400	12	_	_	NNP
50458	400	13	Deutsch	Deutsch	NNP
50458	400	14	.	.	.
50458	401	1	med	med	JJ
50458	401	2	.	.	.
50458	402	1	Wochenschr	Wochenschr	NNP
50458	402	2	.	.	.
50458	402	3	_	_	NNP
50458	402	4	,	,	,
50458	402	5	1890	1890	CD
50458	402	6	,	,	,
50458	402	7	p.	p.	NN
50458	402	8	1113	1113	CD
50458	402	9	.	.	.
50458	403	1	[	[	-LRB-
50458	403	2	44	44	CD
50458	403	3	]	]	-RRB-
50458	403	4	EHRLICH	ehrlich	NN
50458	403	5	:	:	:
50458	403	6	_	_	NNP
50458	403	7	Klin	Klin	NNP
50458	403	8	.	.	.
50458	404	1	Jahrb	Jahrb	NNP
50458	404	2	.	.	.
50458	404	3	_	_	NNP
50458	404	4	1897	1897	CD
50458	404	5	,	,	,
50458	404	6	VI	VI	NNP
50458	404	7	,	,	,
50458	404	8	p.	p.	NN
50458	404	9	292	292	CD
50458	404	10	.	.	.
50458	405	1	Buchner	buchner	NN
50458	405	2	,	,	,
50458	405	3	a	a	DT
50458	405	4	little	little	JJ
50458	405	5	later	later	RB
50458	405	6	,	,	,
50458	405	7	believed	believe	VBD
50458	405	8	that	that	IN
50458	405	9	the	the	DT
50458	405	10	antitoxin	antitoxin	NN
50458	405	11	,	,	,
50458	405	12	instead	instead	RB
50458	405	13	of	of	IN
50458	405	14	acting	act	VBG
50458	405	15	directly	directly	RB
50458	405	16	on	on	IN
50458	405	17	the	the	DT
50458	405	18	toxin	toxin	NN
50458	405	19	,	,	,
50458	405	20	exercised	exercise	VBD
50458	405	21	a	a	DT
50458	405	22	direct	direct	JJ
50458	405	23	influence	influence	NN
50458	405	24	on	on	IN
50458	405	25	the	the	DT
50458	405	26	living	live	VBG
50458	405	27	elements	element	NNS
50458	405	28	of	of	IN
50458	405	29	the	the	DT
50458	405	30	organism	organism	NN
50458	405	31	,	,	,
50458	405	32	preserving	preserve	VBG
50458	405	33	them	-PRON-	PRP
50458	405	34	from	from	IN
50458	405	35	intoxication	intoxication	NN
50458	405	36	.	.	.
50458	406	1	[	[	-LRB-
50458	406	2	45	45	CD
50458	406	3	]	]	-RRB-
50458	406	4	[	[	-LRB-
50458	406	5	45	45	CD
50458	406	6	]	]	-RRB-
50458	406	7	BUCHNER	buchner	NN
50458	406	8	:	:	:
50458	406	9	_	_	NNP
50458	406	10	Münchener	Münchener	NNP
50458	406	11	med	med	NNP
50458	406	12	.	.	.
50458	407	1	Wochenschr	Wochenschr	NNP
50458	407	2	.	.	.
50458	407	3	_	_	NNP
50458	407	4	,	,	,
50458	407	5	1893	1893	CD
50458	407	6	,	,	,
50458	407	7	p.	p.	NN
50458	407	8	480	480	CD
50458	407	9	.	.	.
50458	408	1	Such	such	JJ
50458	408	2	was	be	VBD
50458	408	3	also	also	RB
50458	408	4	the	the	DT
50458	408	5	opinion	opinion	NN
50458	408	6	of	of	IN
50458	408	7	Roux[46	Roux[46	NNP
50458	408	8	]	]	-RRB-
50458	408	9	;	;	:
50458	408	10	and	and	CC
50458	408	11	Calmette	Calmette	NNP
50458	408	12	demonstrated	demonstrate	VBD
50458	408	13	that	that	IN
50458	408	14	a	a	DT
50458	408	15	mixture	mixture	NN
50458	408	16	of	of	IN
50458	408	17	venom	venom	NN
50458	408	18	and	and	CC
50458	408	19	of	of	IN
50458	408	20	a	a	DT
50458	408	21	non	non	JJ
50458	408	22	-	-	JJ
50458	408	23	toxic	toxic	JJ
50458	408	24	antivenom	antivenom	NN
50458	408	25	recovered	recover	VBD
50458	408	26	its	-PRON-	PRP$
50458	408	27	toxicity	toxicity	NN
50458	408	28	on	on	IN
50458	408	29	being	be	VBG
50458	408	30	heated	heat	VBN
50458	408	31	to	to	IN
50458	408	32	68	68	CD
50458	408	33	°	°	,
50458	408	34	C	C	NNP
50458	408	35	,	,	,
50458	408	36	whereby	whereby	WRB
50458	408	37	the	the	DT
50458	408	38	antivenom	antivenom	NN
50458	408	39	was	be	VBD
50458	408	40	destroyed	destroy	VBN
50458	408	41	(	(	-LRB-
50458	408	42	Calmette	calmette	NN
50458	408	43	:	:	:
50458	408	44	_	_	NNP
50458	408	45	Le	Le	NNP
50458	408	46	Venin	Venin	NNP
50458	408	47	des	des	NNP
50458	408	48	Serpents	Serpents	NNP
50458	408	49	_	_	NNP
50458	408	50	,	,	,
50458	408	51	Paris	Paris	NNP
50458	408	52	,	,	,
50458	408	53	1897	1897	CD
50458	408	54	,	,	,
50458	408	55	p.	p.	NN
50458	408	56	58	58	CD
50458	408	57	)	)	-RRB-
50458	408	58	;	;	:
50458	408	59	and	and	CC
50458	408	60	Wassermann	Wassermann	NNP
50458	408	61	arrived	arrive	VBD
50458	408	62	at	at	IN
50458	408	63	the	the	DT
50458	408	64	same	same	JJ
50458	408	65	result	result	NN
50458	408	66	.	.	.
50458	409	1	[	[	-LRB-
50458	409	2	47	47	CD
50458	409	3	]	]	-RRB-
50458	409	4	[	[	-LRB-
50458	409	5	46	46	CD
50458	409	6	]	]	-RRB-
50458	409	7	ROUX	roux	NN
50458	409	8	:	:	:
50458	409	9	_	_	NNP
50458	409	10	Annales	Annales	NNP
50458	409	11	de	de	NNP
50458	409	12	l'Institut	l'Institut	NNP
50458	409	13	Pasteur	Pasteur	NNP
50458	409	14	_	_	NNP
50458	409	15	,	,	,
50458	409	16	1894	1894	CD
50458	409	17	,	,	,
50458	409	18	VIII	VIII	NNP
50458	409	19	,	,	,
50458	409	20	p.	p.	NN
50458	409	21	724	724	CD
50458	409	22	.	.	.
50458	410	1	[	[	-LRB-
50458	410	2	47	47	CD
50458	410	3	]	]	-RRB-
50458	410	4	WASSERMANN	wassermann	NN
50458	410	5	:	:	:
50458	410	6	_	_	NNP
50458	410	7	Zeitschr	Zeitschr	NNP
50458	410	8	.	.	.
50458	411	1	für	für	NNP
50458	411	2	Hygiene	Hygiene	NNP
50458	411	3	_	_	NNP
50458	411	4	.	.	.
50458	412	1	The	the	DT
50458	412	2	array	array	NN
50458	412	3	of	of	IN
50458	412	4	proofs	proof	NNS
50458	412	5	offered	offer	VBN
50458	412	6	by	by	IN
50458	412	7	these	these	DT
50458	412	8	scientists	scientist	NNS
50458	412	9	,	,	,
50458	412	10	which	which	WDT
50458	412	11	we	-PRON-	PRP
50458	412	12	can	can	MD
50458	412	13	not	not	RB
50458	412	14	here	here	RB
50458	412	15	enlarge	enlarge	VB
50458	412	16	upon	upon	IN
50458	412	17	without	without	IN
50458	412	18	uselessly	uselessly	RB
50458	412	19	extending	extend	VBG
50458	412	20	our	-PRON-	PRP$
50458	412	21	subject	subject	NN
50458	412	22	,	,	,
50458	412	23	would	would	MD
50458	412	24	tend	tend	VB
50458	412	25	to	to	TO
50458	412	26	make	make	VB
50458	412	27	one	one	CD
50458	412	28	believe	believe	VB
50458	412	29	,	,	,
50458	412	30	at	at	IN
50458	412	31	first	first	JJ
50458	412	32	glance	glance	NN
50458	412	33	,	,	,
50458	412	34	that	that	IN
50458	412	35	the	the	DT
50458	412	36	antitoxin	antitoxin	NN
50458	412	37	does	do	VBZ
50458	412	38	not	not	RB
50458	412	39	act	act	VB
50458	412	40	directly	directly	RB
50458	412	41	on	on	IN
50458	412	42	the	the	DT
50458	412	43	toxin	toxin	NN
50458	412	44	,	,	,
50458	412	45	but	but	CC
50458	412	46	at	at	IN
50458	412	47	the	the	DT
50458	412	48	present	present	JJ
50458	412	49	time	time	NN
50458	412	50	Buchner	Buchner	NNP
50458	412	51	's	's	POS
50458	412	52	theory	theory	NN
50458	412	53	appears	appear	VBZ
50458	412	54	untenable	untenable	JJ
50458	412	55	.	.	.
50458	413	1	Numerous	numerous	JJ
50458	413	2	researches	research	NNS
50458	413	3	have	have	VBP
50458	413	4	proved	prove	VBN
50458	413	5	conclusively	conclusively	RB
50458	413	6	that	that	IN
50458	413	7	the	the	DT
50458	413	8	toxin	toxin	NN
50458	413	9	and	and	CC
50458	413	10	the	the	DT
50458	413	11	antitoxin	antitoxin	NN
50458	413	12	have	have	VBP
50458	413	13	a	a	DT
50458	413	14	specific	specific	JJ
50458	413	15	affinity	affinity	NN
50458	413	16	for	for	IN
50458	413	17	each	each	DT
50458	413	18	other	other	JJ
50458	413	19	,	,	,
50458	413	20	by	by	IN
50458	413	21	virtue	virtue	NN
50458	413	22	of	of	IN
50458	413	23	which	which	WDT
50458	413	24	these	these	DT
50458	413	25	principles	principle	NNS
50458	413	26	combine	combine	VBP
50458	413	27	to	to	TO
50458	413	28	form	form	VB
50458	413	29	a	a	DT
50458	413	30	substance	substance	NN
50458	413	31	free	free	JJ
50458	413	32	from	from	IN
50458	413	33	all	all	DT
50458	413	34	toxicity	toxicity	NN
50458	413	35	,	,	,
50458	413	36	but	but	CC
50458	413	37	unstable	unstable	JJ
50458	413	38	,	,	,
50458	413	39	and	and	CC
50458	413	40	which	which	WDT
50458	413	41	may	may	MD
50458	413	42	be	be	VB
50458	413	43	decomposed	decompose	VBN
50458	413	44	by	by	IN
50458	413	45	heat	heat	NN
50458	413	46	or	or	CC
50458	413	47	certain	certain	JJ
50458	413	48	other	other	JJ
50458	413	49	factors	factor	NNS
50458	413	50	.	.	.
50458	414	1	[	[	-LRB-
50458	414	2	48	48	CD
50458	414	3	]	]	-RRB-
50458	414	4	[	[	-LRB-
50458	414	5	48	48	CD
50458	414	6	]	]	-RRB-
50458	414	7	J.	J.	NNP
50458	414	8	DANZSY	DANZSY	NNP
50458	414	9	:	:	:
50458	414	10	_	_	NNP
50458	414	11	Annales	Annales	NNP
50458	414	12	de	de	NNP
50458	414	13	l'Institut	l'Institut	NNP
50458	414	14	Pasteur	Pasteur	NNP
50458	414	15	_	_	NNP
50458	414	16	,	,	,
50458	414	17	XVI	XVI	NNP
50458	414	18	,	,	,
50458	414	19	p.	p.	NN
50458	414	20	331	331	CD
50458	414	21	.	.	.
50458	415	1	Some	some	DT
50458	415	2	recent	recent	JJ
50458	415	3	experiments	experiment	NNS
50458	415	4	by	by	IN
50458	415	5	J.	J.	NNP
50458	415	6	Martin	Martin	NNP
50458	415	7	and	and	CC
50458	415	8	Cherry	Cherry	NNP
50458	415	9	(	(	-LRB-
50458	415	10	_	_	NNP
50458	415	11	Proceedings	Proceedings	NNP
50458	415	12	of	of	IN
50458	415	13	the	the	DT
50458	415	14	Royal	Royal	NNP
50458	415	15	Society	Society	NNP
50458	415	16	_	_	NNP
50458	415	17	,	,	,
50458	415	18	1898	1898	CD
50458	415	19	,	,	,
50458	415	20	LXIII	LXIII	NNP
50458	415	21	,	,	,
50458	415	22	p.	p.	NN
50458	415	23	423	423	CD
50458	415	24	)	)	-RRB-
50458	415	25	have	have	VBP
50458	415	26	clearly	clearly	RB
50458	415	27	brought	bring	VBN
50458	415	28	out	out	RP
50458	415	29	this	this	DT
50458	415	30	fact	fact	NN
50458	415	31	.	.	.
50458	416	1	These	these	DT
50458	416	2	authors	author	NNS
50458	416	3	made	make	VBD
50458	416	4	mixtures	mixture	NNS
50458	416	5	of	of	IN
50458	416	6	serpent	serpent	JJ
50458	416	7	venom	venom	NN
50458	416	8	with	with	IN
50458	416	9	its	-PRON-	PRP$
50458	416	10	antivenom	antivenom	NN
50458	416	11	,	,	,
50458	416	12	which	which	WDT
50458	416	13	they	-PRON-	PRP
50458	416	14	filtered	filter	VBD
50458	416	15	through	through	IN
50458	416	16	a	a	DT
50458	416	17	layer	layer	NN
50458	416	18	of	of	IN
50458	416	19	gelatin	gelatin	NN
50458	416	20	,	,	,
50458	416	21	under	under	IN
50458	416	22	the	the	DT
50458	416	23	supposition	supposition	NN
50458	416	24	that	that	IN
50458	416	25	,	,	,
50458	416	26	if	if	IN
50458	416	27	the	the	DT
50458	416	28	venom	venom	NN
50458	416	29	and	and	CC
50458	416	30	its	-PRON-	PRP$
50458	416	31	antivenom	antivenom	NNS
50458	416	32	were	be	VBD
50458	416	33	not	not	RB
50458	416	34	chemically	chemically	RB
50458	416	35	combined	combine	VBN
50458	416	36	,	,	,
50458	416	37	the	the	DT
50458	416	38	former	former	JJ
50458	416	39	alone	alone	RB
50458	416	40	would	would	MD
50458	416	41	be	be	VB
50458	416	42	able	able	JJ
50458	416	43	to	to	TO
50458	416	44	pass	pass	VB
50458	416	45	through	through	RP
50458	416	46	into	into	IN
50458	416	47	the	the	DT
50458	416	48	filtrate	filtrate	JJ
50458	416	49	,	,	,
50458	416	50	because	because	IN
50458	416	51	its	-PRON-	PRP$
50458	416	52	molecules	molecule	NNS
50458	416	53	are	be	VBP
50458	416	54	so	so	RB
50458	416	55	much	much	RB
50458	416	56	smaller	small	JJR
50458	416	57	.	.	.
50458	417	1	Martin	Martin	NNP
50458	417	2	and	and	CC
50458	417	3	Cherry	Cherry	NNP
50458	417	4	allowed	allow	VBD
50458	417	5	the	the	DT
50458	417	6	venom	venom	NN
50458	417	7	and	and	CC
50458	417	8	its	-PRON-	PRP$
50458	417	9	antivenom	antivenom	NN
50458	417	10	to	to	TO
50458	417	11	remain	remain	VB
50458	417	12	in	in	IN
50458	417	13	contact	contact	NN
50458	417	14	for	for	IN
50458	417	15	varying	vary	VBG
50458	417	16	periods	period	NNS
50458	417	17	before	before	IN
50458	417	18	filtering	filter	VBG
50458	417	19	.	.	.
50458	418	1	As	as	IN
50458	418	2	the	the	DT
50458	418	3	result	result	NN
50458	418	4	of	of	IN
50458	418	5	a	a	DT
50458	418	6	series	series	NN
50458	418	7	of	of	IN
50458	418	8	experiments	experiment	NNS
50458	418	9	carried	carry	VBN
50458	418	10	out	out	RP
50458	418	11	with	with	IN
50458	418	12	this	this	DT
50458	418	13	idea	idea	NN
50458	418	14	,	,	,
50458	418	15	they	-PRON-	PRP
50458	418	16	have	have	VBP
50458	418	17	demonstrated	demonstrate	VBN
50458	418	18	that	that	IN
50458	418	19	the	the	DT
50458	418	20	filtrate	filtrate	NN
50458	418	21	obtained	obtain	VBN
50458	418	22	after	after	IN
50458	418	23	allowing	allow	VBG
50458	418	24	a	a	DT
50458	418	25	few	few	JJ
50458	418	26	minutes	minute	NNS
50458	418	27	'	'	POS
50458	418	28	contact	contact	NN
50458	418	29	between	between	IN
50458	418	30	the	the	DT
50458	418	31	two	two	CD
50458	418	32	substances	substance	NNS
50458	418	33	,	,	,
50458	418	34	was	be	VBD
50458	418	35	decidedly	decidedly	RB
50458	418	36	toxic	toxic	JJ
50458	418	37	,	,	,
50458	418	38	while	while	IN
50458	418	39	that	that	DT
50458	418	40	obtained	obtain	VBD
50458	418	41	after	after	IN
50458	418	42	a	a	DT
50458	418	43	contact	contact	NN
50458	418	44	of	of	IN
50458	418	45	half	half	PDT
50458	418	46	an	an	DT
50458	418	47	hour	hour	NN
50458	418	48	was	be	VBD
50458	418	49	absolutely	absolutely	RB
50458	418	50	non	non	JJ
50458	418	51	-	-	JJ
50458	418	52	toxic	toxic	JJ
50458	418	53	.	.	.
50458	419	1	From	from	IN
50458	419	2	this	this	DT
50458	419	3	the	the	DT
50458	419	4	authors	author	NNS
50458	419	5	conclude	conclude	VBP
50458	419	6	that	that	IN
50458	419	7	the	the	DT
50458	419	8	antitoxin	antitoxin	NN
50458	419	9	enters	enter	VBZ
50458	419	10	into	into	IN
50458	419	11	chemical	chemical	NN
50458	419	12	union	union	NN
50458	419	13	with	with	IN
50458	419	14	the	the	DT
50458	419	15	venom	venom	NN
50458	419	16	,	,	,
50458	419	17	but	but	CC
50458	419	18	that	that	IN
50458	419	19	the	the	DT
50458	419	20	combination	combination	NN
50458	419	21	does	do	VBZ
50458	419	22	not	not	RB
50458	419	23	take	take	VB
50458	419	24	place	place	NN
50458	419	25	immediately	immediately	RB
50458	419	26	,	,	,
50458	419	27	and	and	CC
50458	419	28	requires	require	VBZ
50458	419	29	a	a	DT
50458	419	30	certain	certain	JJ
50458	419	31	length	length	NN
50458	419	32	of	of	IN
50458	419	33	time	time	NN
50458	419	34	for	for	IN
50458	419	35	its	-PRON-	PRP$
50458	419	36	accomplishment	accomplishment	NN
50458	419	37	.	.	.
50458	420	1	Ehrlich	Ehrlich	NNP
50458	420	2	and	and	CC
50458	420	3	Knorr	Knorr	NNP
50458	420	4	have	have	VBP
50458	420	5	demonstrated	demonstrate	VBN
50458	420	6	that	that	IN
50458	420	7	the	the	DT
50458	420	8	neutralization	neutralization	NN
50458	420	9	is	be	VBZ
50458	420	10	less	less	RBR
50458	420	11	rapid	rapid	JJ
50458	420	12	in	in	IN
50458	420	13	dilute	dilute	JJ
50458	420	14	solutions	solution	NNS
50458	420	15	than	than	IN
50458	420	16	in	in	IN
50458	420	17	concentrated	concentrated	JJ
50458	420	18	ones	one	NNS
50458	420	19	.	.	.
50458	421	1	Prof.	Prof.	NNP
50458	421	2	Svante	Svante	NNP
50458	421	3	Arrhenius	Arrhenius	NNP
50458	421	4	has	have	VBZ
50458	421	5	completed	complete	VBN
50458	421	6	our	-PRON-	PRP$
50458	421	7	knowledge	knowledge	NN
50458	421	8	regarding	regard	VBG
50458	421	9	the	the	DT
50458	421	10	mode	mode	NN
50458	421	11	of	of	IN
50458	421	12	combination	combination	NN
50458	421	13	between	between	IN
50458	421	14	the	the	DT
50458	421	15	toxins	toxin	NNS
50458	421	16	and	and	CC
50458	421	17	the	the	DT
50458	421	18	antitoxins	antitoxin	NNS
50458	421	19	,	,	,
50458	421	20	by	by	IN
50458	421	21	demonstrating	demonstrate	VBG
50458	421	22	the	the	DT
50458	421	23	occurrence	occurrence	NN
50458	421	24	of	of	IN
50458	421	25	limited	limited	JJ
50458	421	26	reactions	reaction	NNS
50458	421	27	analogous	analogous	JJ
50458	421	28	to	to	IN
50458	421	29	the	the	DT
50458	421	30	etherification	etherification	NN
50458	421	31	of	of	IN
50458	421	32	an	an	DT
50458	421	33	alcohol	alcohol	NN
50458	421	34	by	by	IN
50458	421	35	an	an	DT
50458	421	36	acid	acid	NN
50458	421	37	,	,	,
50458	421	38	and	and	CC
50458	421	39	in	in	IN
50458	421	40	such	such	PDT
50458	421	41	a	a	DT
50458	421	42	manner	manner	NN
50458	421	43	that	that	IN
50458	421	44	there	there	EX
50458	421	45	always	always	RB
50458	421	46	exists	exist	VBZ
50458	421	47	,	,	,
50458	421	48	in	in	IN
50458	421	49	a	a	DT
50458	421	50	mixture	mixture	NN
50458	421	51	of	of	IN
50458	421	52	these	these	DT
50458	421	53	two	two	CD
50458	421	54	substances	substance	NNS
50458	421	55	,	,	,
50458	421	56	a	a	DT
50458	421	57	certain	certain	JJ
50458	421	58	quantity	quantity	NN
50458	421	59	of	of	IN
50458	421	60	free	free	JJ
50458	421	61	toxin	toxin	NN
50458	421	62	and	and	CC
50458	421	63	antitoxin	antitoxin	NN
50458	421	64	.	.	.
50458	422	1	This	this	DT
50458	422	2	is	be	VBZ
50458	422	3	an	an	DT
50458	422	4	important	important	JJ
50458	422	5	modification	modification	NN
50458	422	6	of	of	IN
50458	422	7	the	the	DT
50458	422	8	general	general	JJ
50458	422	9	ideas	idea	NNS
50458	422	10	held	hold	VBN
50458	422	11	in	in	IN
50458	422	12	this	this	DT
50458	422	13	respect	respect	NN
50458	422	14	.	.	.
50458	423	1	[	[	-LRB-
50458	423	2	49	49	CD
50458	423	3	]	]	-RRB-
50458	423	4	[	[	-LRB-
50458	423	5	49	49	CD
50458	423	6	]	]	-RRB-
50458	423	7	SVANTE	SVANTE	NNP
50458	423	8	ARRHENIUS	arrheniu	NNS
50458	423	9	:	:	:
50458	423	10	La	La	NNP
50458	423	11	Physico	Physico	NNP
50458	423	12	-	-	HYPH
50458	423	13	chimie	chimie	NNP
50458	423	14	des	des	NNP
50458	423	15	Toxines	Toxines	NNP
50458	423	16	et	et	NNP
50458	423	17	des	des	FW
50458	423	18	Antitoxines	Antitoxines	NNP
50458	423	19	.	.	.
50458	424	1	_	_	NNP
50458	424	2	Conférences	Conférences	NNPS
50458	424	3	de	de	NNP
50458	424	4	la	la	NNP
50458	424	5	Société	Société	NNP
50458	424	6	chimique	chimique	NN
50458	424	7	de	de	IN
50458	424	8	Paris	Paris	NNP
50458	424	9	_	_	NNP
50458	424	10	,	,	,
50458	424	11	May	May	NNP
50458	424	12	20	20	CD
50458	424	13	,	,	,
50458	424	14	1904	1904	CD
50458	424	15	.	.	.
50458	425	1	See	see	VB
50458	425	2	also	also	RB
50458	425	3	MADSEN	madsen	NN
50458	425	4	AND	and	CC
50458	425	5	ARRHENIUS	arrhenius	NN
50458	425	6	:	:	:
50458	425	7	Testkrift	testkrift	VB
50458	425	8	red	red	JJ
50458	425	9	indivulsen	indivulsen	NN
50458	425	10	of	of	IN
50458	425	11	Stotens	Stotens	NNP
50458	425	12	Serum	Serum	NNP
50458	425	13	Institut	Institut	NNP
50458	425	14	.	.	.
50458	426	1	Copenhagen	Copenhagen	NNP
50458	426	2	,	,	,
50458	426	3	1902	1902	CD
50458	426	4	.	.	.
50458	427	1	It	-PRON-	PRP
50458	427	2	appears	appear	VBZ
50458	427	3	necessary	necessary	JJ
50458	427	4	to	to	TO
50458	427	5	bring	bring	VB
50458	427	6	here	here	RB
50458	427	7	more	more	RBR
50458	427	8	clearly	clearly	RB
50458	427	9	in	in	IN
50458	427	10	evidence	evidence	NN
50458	427	11	the	the	DT
50458	427	12	fact	fact	NN
50458	427	13	that	that	IN
50458	427	14	_	_	NNP
50458	427	15	the	the	DT
50458	427	16	antitoxin	antitoxin	NN
50458	427	17	inhibits	inhibit	VBZ
50458	427	18	the	the	DT
50458	427	19	noxious	noxious	JJ
50458	427	20	action	action	NN
50458	427	21	of	of	IN
50458	427	22	the	the	DT
50458	427	23	toxin	toxin	NN
50458	427	24	,	,	,
50458	427	25	even	even	RB
50458	427	26	outside	outside	IN
50458	427	27	the	the	DT
50458	427	28	living	live	VBG
50458	427	29	organism	organism	NN
50458	427	30	,	,	,
50458	427	31	by	by	IN
50458	427	32	uniting	unite	VBG
50458	427	33	with	with	IN
50458	427	34	it	-PRON-	PRP
50458	427	35	to	to	TO
50458	427	36	form	form	VB
50458	427	37	a	a	DT
50458	427	38	compound	compound	NN
50458	427	39	in	in	IN
50458	427	40	identically	identically	RB
50458	427	41	the	the	DT
50458	427	42	same	same	JJ
50458	427	43	manner	manner	NN
50458	427	44	as	as	IN
50458	427	45	when	when	WRB
50458	427	46	a	a	DT
50458	427	47	strong	strong	JJ
50458	427	48	base	base	NN
50458	427	49	and	and	CC
50458	427	50	a	a	DT
50458	427	51	strong	strong	JJ
50458	427	52	acid	acid	NN
50458	427	53	are	be	VBP
50458	427	54	brought	bring	VBN
50458	427	55	together	together	RB
50458	427	56	_	_	NNP
50458	427	57	.	.	.
50458	428	1	As	as	IN
50458	428	2	we	-PRON-	PRP
50458	428	3	have	have	VBP
50458	428	4	seen	see	VBN
50458	428	5	,	,	,
50458	428	6	all	all	PDT
50458	428	7	the	the	DT
50458	428	8	conditions	condition	NNS
50458	428	9	of	of	IN
50458	428	10	environment	environment	NN
50458	428	11	that	that	WDT
50458	428	12	favor	favor	VBP
50458	428	13	or	or	CC
50458	428	14	retard	retard	VB
50458	428	15	the	the	DT
50458	428	16	formation	formation	NN
50458	428	17	of	of	IN
50458	428	18	salts	salt	NNS
50458	428	19	,	,	,
50458	428	20	in	in	IN
50458	428	21	a	a	DT
50458	428	22	like	like	JJ
50458	428	23	sense	sense	NN
50458	428	24	influence	influence	VBP
50458	428	25	the	the	DT
50458	428	26	neutralization	neutralization	NN
50458	428	27	of	of	IN
50458	428	28	the	the	DT
50458	428	29	toxin	toxin	NN
50458	428	30	by	by	IN
50458	428	31	its	-PRON-	PRP$
50458	428	32	antitoxin	antitoxin	NN
50458	428	33	.	.	.
50458	429	1	=	=	NFP
50458	429	2	Formation	Formation	NNP
50458	429	3	of	of	IN
50458	429	4	Antitoxins.=--Ehrlich	Antitoxins.=--Ehrlich	NNP
50458	429	5	's	's	POS
50458	429	6	theory	theory	NN
50458	429	7	of	of	IN
50458	429	8	side	side	NN
50458	429	9	chains	chain	NNS
50458	429	10	,	,	,
50458	429	11	to	to	TO
50458	429	12	which	which	WDT
50458	429	13	reference	reference	NN
50458	429	14	has	have	VBZ
50458	429	15	already	already	RB
50458	429	16	been	be	VBN
50458	429	17	made	make	VBN
50458	429	18	,	,	,
50458	429	19	furnishes	furnish	VBZ
50458	429	20	us	-PRON-	PRP
50458	429	21	with	with	IN
50458	429	22	an	an	DT
50458	429	23	explanation	explanation	NN
50458	429	24	of	of	IN
50458	429	25	the	the	DT
50458	429	26	formation	formation	NN
50458	429	27	of	of	IN
50458	429	28	the	the	DT
50458	429	29	antitoxins	antitoxin	NNS
50458	429	30	in	in	IN
50458	429	31	tumors	tumor	NNS
50458	429	32	.	.	.
50458	430	1	Let	let	VB
50458	430	2	us	-PRON-	PRP
50458	430	3	suppose	suppose	VB
50458	430	4	that	that	IN
50458	430	5	,	,	,
50458	430	6	in	in	IN
50458	430	7	the	the	DT
50458	430	8	organism	organism	NN
50458	430	9	,	,	,
50458	430	10	a	a	DT
50458	430	11	cell	cell	NN
50458	430	12	had	have	VBD
50458	430	13	come	come	VBN
50458	430	14	into	into	IN
50458	430	15	contact	contact	NN
50458	430	16	only	only	RB
50458	430	17	with	with	IN
50458	430	18	certain	certain	JJ
50458	430	19	toxic	toxic	JJ
50458	430	20	molecules	molecule	NNS
50458	430	21	incapable	incapable	JJ
50458	430	22	of	of	IN
50458	430	23	compromising	compromise	VBG
50458	430	24	its	-PRON-	PRP$
50458	430	25	life	life	NN
50458	430	26	,	,	,
50458	430	27	and	and	CC
50458	430	28	that	that	IN
50458	430	29	the	the	DT
50458	430	30	only	only	JJ
50458	430	31	result	result	NN
50458	430	32	was	be	VBD
50458	430	33	the	the	DT
50458	430	34	immobilization	immobilization	NN
50458	430	35	of	of	IN
50458	430	36	the	the	DT
50458	430	37	receptors	receptor	NNS
50458	430	38	which	which	WDT
50458	430	39	are	be	VBP
50458	430	40	united	united	JJ
50458	430	41	with	with	IN
50458	430	42	the	the	DT
50458	430	43	haptophore	haptophore	JJ
50458	430	44	groups	group	NNS
50458	430	45	of	of	IN
50458	430	46	the	the	DT
50458	430	47	opposing	oppose	VBG
50458	430	48	toxins	toxin	NNS
50458	430	49	.	.	.
50458	431	1	It	-PRON-	PRP
50458	431	2	is	be	VBZ
50458	431	3	known	know	VBN
50458	431	4	that	that	IN
50458	431	5	,	,	,
50458	431	6	by	by	IN
50458	431	7	virtue	virtue	NN
50458	431	8	of	of	IN
50458	431	9	a	a	DT
50458	431	10	property	property	NN
50458	431	11	inherent	inherent	JJ
50458	431	12	in	in	IN
50458	431	13	all	all	DT
50458	431	14	living	live	VBG
50458	431	15	organisms	organism	NNS
50458	431	16	,	,	,
50458	431	17	during	during	IN
50458	431	18	the	the	DT
50458	431	19	phenomena	phenomenon	NNS
50458	431	20	of	of	IN
50458	431	21	reparation	reparation	NN
50458	431	22	,	,	,
50458	431	23	there	there	EX
50458	431	24	is	be	VBZ
50458	431	25	generally	generally	RB
50458	431	26	an	an	DT
50458	431	27	overproduction	overproduction	NN
50458	431	28	of	of	IN
50458	431	29	the	the	DT
50458	431	30	neoformed	neoformed	JJ
50458	431	31	parts	part	NNS
50458	431	32	.	.	.
50458	432	1	In	in	IN
50458	432	2	the	the	DT
50458	432	3	case	case	NN
50458	432	4	we	-PRON-	PRP
50458	432	5	here	here	RB
50458	432	6	speak	speak	VBP
50458	432	7	of	of	IN
50458	432	8	,	,	,
50458	432	9	as	as	IN
50458	432	10	the	the	DT
50458	432	11	receptors	receptor	NNS
50458	432	12	fill	fill	VBP
50458	432	13	an	an	DT
50458	432	14	important	important	JJ
50458	432	15	function	function	NN
50458	432	16	in	in	IN
50458	432	17	the	the	DT
50458	432	18	nutrition	nutrition	NN
50458	432	19	of	of	IN
50458	432	20	the	the	DT
50458	432	21	opposing	opposing	JJ
50458	432	22	cellular	cellular	JJ
50458	432	23	elements	element	NNS
50458	432	24	,	,	,
50458	432	25	once	once	IN
50458	432	26	they	-PRON-	PRP
50458	432	27	become	become	VBP
50458	432	28	united	united	JJ
50458	432	29	with	with	IN
50458	432	30	the	the	DT
50458	432	31	toxic	toxic	JJ
50458	432	32	haptophores	haptophore	NNS
50458	432	33	,	,	,
50458	432	34	they	-PRON-	PRP
50458	432	35	become	become	VBP
50458	432	36	incapable	incapable	JJ
50458	432	37	of	of	IN
50458	432	38	filling	fill	VBG
50458	432	39	their	-PRON-	PRP$
50458	432	40	normal	normal	JJ
50458	432	41	function	function	NN
50458	432	42	of	of	IN
50458	432	43	nutrition	nutrition	NN
50458	432	44	.	.	.
50458	433	1	Under	under	IN
50458	433	2	these	these	DT
50458	433	3	conditions	condition	NNS
50458	433	4	the	the	DT
50458	433	5	cells	cell	NNS
50458	433	6	develop	develop	VBP
50458	433	7	so	so	RB
50458	433	8	large	large	JJ
50458	433	9	a	a	DT
50458	433	10	quantity	quantity	NN
50458	433	11	of	of	IN
50458	433	12	receptors	receptor	NNS
50458	433	13	that	that	WDT
50458	433	14	,	,	,
50458	433	15	filling	fill	VBG
50458	433	16	the	the	DT
50458	433	17	cells	cell	NNS
50458	433	18	,	,	,
50458	433	19	and	and	CC
50458	433	20	not	not	RB
50458	433	21	finding	find	VBG
50458	433	22	any	any	DT
50458	433	23	more	more	JJR
50458	433	24	room	room	NN
50458	433	25	,	,	,
50458	433	26	they	-PRON-	PRP
50458	433	27	spread	spread	VBD
50458	433	28	into	into	IN
50458	433	29	the	the	DT
50458	433	30	blood	blood	NN
50458	433	31	and	and	CC
50458	433	32	other	other	JJ
50458	433	33	liquids	liquid	NNS
50458	433	34	of	of	IN
50458	433	35	the	the	DT
50458	433	36	organism	organism	NN
50458	433	37	.	.	.
50458	434	1	Under	under	IN
50458	434	2	these	these	DT
50458	434	3	conditions	condition	NNS
50458	434	4	,	,	,
50458	434	5	every	every	DT
50458	434	6	new	new	JJ
50458	434	7	injection	injection	NN
50458	434	8	of	of	IN
50458	434	9	toxin	toxin	NN
50458	434	10	into	into	IN
50458	434	11	the	the	DT
50458	434	12	organism	organism	NN
50458	434	13	is	be	VBZ
50458	434	14	absorbed	absorb	VBN
50458	434	15	into	into	IN
50458	434	16	the	the	DT
50458	434	17	blood	blood	NN
50458	434	18	where	where	WRB
50458	434	19	it	-PRON-	PRP
50458	434	20	meets	meet	VBZ
50458	434	21	with	with	IN
50458	434	22	the	the	DT
50458	434	23	free	free	JJ
50458	434	24	receptors	receptor	NNS
50458	434	25	which	which	WDT
50458	434	26	possess	possess	VBP
50458	434	27	great	great	JJ
50458	434	28	avidity	avidity	NN
50458	434	29	for	for	IN
50458	434	30	the	the	DT
50458	434	31	haptophore	haptophore	JJ
50458	434	32	group	group	NN
50458	434	33	of	of	IN
50458	434	34	its	-PRON-	PRP$
50458	434	35	molecule	molecule	NN
50458	434	36	,	,	,
50458	434	37	and	and	CC
50458	434	38	the	the	DT
50458	434	39	two	two	CD
50458	434	40	groups	group	NNS
50458	434	41	immediately	immediately	RB
50458	434	42	unite	unite	VBP
50458	434	43	,	,	,
50458	434	44	before	before	IN
50458	434	45	the	the	DT
50458	434	46	haptophore	haptophore	JJ
50458	434	47	group	group	NN
50458	434	48	of	of	IN
50458	434	49	the	the	DT
50458	434	50	toxin	toxin	NN
50458	434	51	has	have	VBZ
50458	434	52	been	be	VBN
50458	434	53	able	able	JJ
50458	434	54	to	to	TO
50458	434	55	attack	attack	VB
50458	434	56	and	and	CC
50458	434	57	intoxicate	intoxicate	VB
50458	434	58	a	a	DT
50458	434	59	cellular	cellular	JJ
50458	434	60	element	element	NN
50458	434	61	.	.	.
50458	435	1	We	-PRON-	PRP
50458	435	2	thus	thus	RB
50458	435	3	see	see	VBP
50458	435	4	that	that	IN
50458	435	5	the	the	DT
50458	435	6	receptors	receptor	NNS
50458	435	7	which	which	WDT
50458	435	8	,	,	,
50458	435	9	when	when	WRB
50458	435	10	in	in	IN
50458	435	11	a	a	DT
50458	435	12	free	free	JJ
50458	435	13	state	state	NN
50458	435	14	in	in	IN
50458	435	15	tumors	tumor	NNS
50458	435	16	,	,	,
50458	435	17	play	play	VB
50458	435	18	the	the	DT
50458	435	19	rôle	rôle	NN
50458	435	20	of	of	IN
50458	435	21	antitoxics	antitoxic	NNS
50458	435	22	or	or	CC
50458	435	23	antitoxins	antitoxin	NNS
50458	435	24	,	,	,
50458	435	25	become	become	VB
50458	435	26	,	,	,
50458	435	27	within	within	IN
50458	435	28	the	the	DT
50458	435	29	cellular	cellular	JJ
50458	435	30	elements	element	NNS
50458	435	31	themselves	-PRON-	PRP
50458	435	32	,	,	,
50458	435	33	the	the	DT
50458	435	34	vehicle	vehicle	NN
50458	435	35	of	of	IN
50458	435	36	intoxications	intoxication	NNS
50458	435	37	.	.	.
50458	436	1	Figuratively	figuratively	RB
50458	436	2	speaking	speak	VBG
50458	436	3	,	,	,
50458	436	4	so	so	RB
50458	436	5	long	long	RB
50458	436	6	as	as	IN
50458	436	7	these	these	DT
50458	436	8	fixators	fixator	NNS
50458	436	9	are	be	VBP
50458	436	10	attached	attach	VBN
50458	436	11	to	to	IN
50458	436	12	the	the	DT
50458	436	13	molecule	molecule	NN
50458	436	14	of	of	IN
50458	436	15	the	the	DT
50458	436	16	living	living	NN
50458	436	17	protoplasm	protoplasm	NN
50458	436	18	they	-PRON-	PRP
50458	436	19	attract	attract	VBP
50458	436	20	the	the	DT
50458	436	21	toxin	toxin	NN
50458	436	22	.	.	.
50458	437	1	According	accord	VBG
50458	437	2	to	to	IN
50458	437	3	this	this	DT
50458	437	4	ingenious	ingenious	JJ
50458	437	5	conception	conception	NN
50458	437	6	,	,	,
50458	437	7	the	the	DT
50458	437	8	formation	formation	NN
50458	437	9	of	of	IN
50458	437	10	antitoxins	antitoxin	NNS
50458	437	11	is	be	VBZ
50458	437	12	hence	hence	RB
50458	437	13	absolutely	absolutely	RB
50458	437	14	independent	independent	JJ
50458	437	15	of	of	IN
50458	437	16	the	the	DT
50458	437	17	action	action	NN
50458	437	18	of	of	IN
50458	437	19	the	the	DT
50458	437	20	toxophore	toxophore	NN
50458	437	21	elements	element	NNS
50458	437	22	on	on	IN
50458	437	23	the	the	DT
50458	437	24	cellular	cellular	JJ
50458	437	25	elements	element	NNS
50458	437	26	,	,	,
50458	437	27	and	and	CC
50458	437	28	it	-PRON-	PRP
50458	437	29	suffices	suffice	VBZ
50458	437	30	that	that	IN
50458	437	31	these	these	DT
50458	437	32	possess	possess	VBP
50458	437	33	receptors	receptor	NNS
50458	437	34	or	or	CC
50458	437	35	side	side	NN
50458	437	36	chains	chain	NNS
50458	437	37	capable	capable	JJ
50458	437	38	of	of	IN
50458	437	39	uniting	unite	VBG
50458	437	40	with	with	IN
50458	437	41	the	the	DT
50458	437	42	haptophore	haptophore	JJ
50458	437	43	groups	group	NNS
50458	437	44	of	of	IN
50458	437	45	the	the	DT
50458	437	46	toxin	toxin	NN
50458	437	47	.	.	.
50458	438	1	This	this	DT
50458	438	2	explains	explain	VBZ
50458	438	3	why	why	WRB
50458	438	4	it	-PRON-	PRP
50458	438	5	has	have	VBZ
50458	438	6	been	be	VBN
50458	438	7	possible	possible	JJ
50458	438	8	to	to	TO
50458	438	9	produce	produce	VB
50458	438	10	antitoxins	antitoxin	NNS
50458	438	11	from	from	IN
50458	438	12	toxins	toxin	NNS
50458	438	13	which	which	WDT
50458	438	14	have	have	VBP
50458	438	15	lost	lose	VBN
50458	438	16	some	some	DT
50458	438	17	of	of	IN
50458	438	18	their	-PRON-	PRP$
50458	438	19	toxic	toxic	JJ
50458	438	20	properties	property	NNS
50458	438	21	,	,	,
50458	438	22	but	but	CC
50458	438	23	which	which	WDT
50458	438	24	have	have	VBP
50458	438	25	preserved	preserve	VBN
50458	438	26	their	-PRON-	PRP$
50458	438	27	property	property	NN
50458	438	28	of	of	IN
50458	438	29	uniting	unite	VBG
50458	438	30	with	with	IN
50458	438	31	antitoxic	antitoxic	JJ
50458	438	32	substances	substance	NNS
50458	438	33	.	.	.
50458	439	1	Ehrlich	Ehrlich	NNP
50458	439	2	gives	give	VBZ
50458	439	3	the	the	DT
50458	439	4	name	name	NN
50458	439	5	_	_	NNP
50458	439	6	toxoids	toxoids	NNPS
50458	439	7	_	_	NNP
50458	439	8	to	to	IN
50458	439	9	those	those	DT
50458	439	10	modified	modify	VBN
50458	439	11	toxins	toxin	NNS
50458	439	12	that	that	WDT
50458	439	13	have	have	VBP
50458	439	14	lost	lose	VBN
50458	439	15	their	-PRON-	PRP$
50458	439	16	toxophore	toxophore	NN
50458	439	17	groups	group	NNS
50458	439	18	,	,	,
50458	439	19	while	while	IN
50458	439	20	the	the	DT
50458	439	21	haptophore	haptophore	NN
50458	439	22	group	group	NN
50458	439	23	,	,	,
50458	439	24	the	the	DT
50458	439	25	producer	producer	NN
50458	439	26	of	of	IN
50458	439	27	the	the	DT
50458	439	28	immunizing	immunize	VBG
50458	439	29	substance	substance	NN
50458	439	30	,	,	,
50458	439	31	is	be	VBZ
50458	439	32	still	still	RB
50458	439	33	preserved	preserve	VBN
50458	439	34	intact	intact	JJ
50458	439	35	.	.	.
50458	440	1	According	accord	VBG
50458	440	2	to	to	IN
50458	440	3	Metchnikoff	Metchnikoff	NNP
50458	440	4	's	's	POS
50458	440	5	theory	theory	NN
50458	440	6	,	,	,
50458	440	7	which	which	WDT
50458	440	8	is	be	VBZ
50458	440	9	very	very	RB
50458	440	10	similar	similar	JJ
50458	440	11	,	,	,
50458	440	12	it	-PRON-	PRP
50458	440	13	seems	seem	VBZ
50458	440	14	quite	quite	RB
50458	440	15	possible	possible	JJ
50458	440	16	that	that	IN
50458	440	17	the	the	DT
50458	440	18	phagocytes	phagocyte	NNS
50458	440	19	,	,	,
50458	440	20	thanks	thank	NNS
50458	440	21	to	to	IN
50458	440	22	the	the	DT
50458	440	23	facility	facility	NN
50458	440	24	with	with	IN
50458	440	25	which	which	WDT
50458	440	26	they	-PRON-	PRP
50458	440	27	absorb	absorb	VBP
50458	440	28	poisons	poison	NNS
50458	440	29	,	,	,
50458	440	30	occupy	occupy	VBP
50458	440	31	an	an	DT
50458	440	32	important	important	JJ
50458	440	33	place	place	NN
50458	440	34	as	as	IN
50458	440	35	producers	producer	NNS
50458	440	36	of	of	IN
50458	440	37	antitoxins	antitoxin	NNS
50458	440	38	.	.	.
50458	441	1	It	-PRON-	PRP
50458	441	2	has	have	VBZ
50458	441	3	not	not	RB
50458	441	4	been	be	VBN
50458	441	5	possible	possible	JJ
50458	441	6	so	so	RB
50458	441	7	far	far	RB
50458	441	8	to	to	TO
50458	441	9	verify	verify	VB
50458	441	10	this	this	DT
50458	441	11	theory	theory	NN
50458	441	12	in	in	IN
50458	441	13	our	-PRON-	PRP$
50458	441	14	at	at	IN
50458	441	15	present	present	JJ
50458	441	16	imperfect	imperfect	JJ
50458	441	17	knowledge	knowledge	NN
50458	441	18	regarding	regard	VBG
50458	441	19	this	this	DT
50458	441	20	subject	subject	NN
50458	441	21	.	.	.
50458	442	1	The	the	DT
50458	442	2	domain	domain	NN
50458	442	3	of	of	IN
50458	442	4	immunity	immunity	NN
50458	442	5	has	have	VBZ
50458	442	6	,	,	,
50458	442	7	however	however	RB
50458	442	8	,	,	,
50458	442	9	made	make	VBD
50458	442	10	brilliant	brilliant	JJ
50458	442	11	conquests	conquest	NNS
50458	442	12	during	during	IN
50458	442	13	these	these	DT
50458	442	14	last	last	JJ
50458	442	15	few	few	JJ
50458	442	16	years	year	NNS
50458	442	17	,	,	,
50458	442	18	so	so	IN
50458	442	19	that	that	IN
50458	442	20	we	-PRON-	PRP
50458	442	21	should	should	MD
50458	442	22	not	not	RB
50458	442	23	despair	despair	VB
50458	442	24	of	of	IN
50458	442	25	arriving	arrive	VBG
50458	442	26	at	at	IN
50458	442	27	a	a	DT
50458	442	28	definite	definite	JJ
50458	442	29	solution	solution	NN
50458	442	30	before	before	IN
50458	442	31	long	long	RB
50458	442	32	.	.	.
50458	443	1	In	in	IN
50458	443	2	the	the	DT
50458	443	3	vaccinated	vaccinated	JJ
50458	443	4	animal	animal	NN
50458	443	5	the	the	DT
50458	443	6	antitoxin	antitoxin	NN
50458	443	7	is	be	VBZ
50458	443	8	reproduced	reproduce	VBN
50458	443	9	,	,	,
50458	443	10	and	and	CC
50458	443	11	it	-PRON-	PRP
50458	443	12	is	be	VBZ
50458	443	13	possible	possible	JJ
50458	443	14	to	to	TO
50458	443	15	obtain	obtain	VB
50458	443	16	several	several	JJ
50458	443	17	times	time	NNS
50458	443	18	,	,	,
50458	443	19	from	from	IN
50458	443	20	the	the	DT
50458	443	21	vaccinated	vaccinated	JJ
50458	443	22	animals	animal	NNS
50458	443	23	,	,	,
50458	443	24	successive	successive	JJ
50458	443	25	portions	portion	NNS
50458	443	26	of	of	IN
50458	443	27	antitoxic	antitoxic	NN
50458	443	28	serum	serum	NN
50458	443	29	.	.	.
50458	444	1	[	[	-LRB-
50458	444	2	50	50	CD
50458	444	3	]	]	-RRB-
50458	444	4	The	the	DT
50458	444	5	protective	protective	JJ
50458	444	6	power	power	NN
50458	444	7	of	of	IN
50458	444	8	these	these	DT
50458	444	9	antitoxins	antitoxin	NNS
50458	444	10	is	be	VBZ
50458	444	11	absolutely	absolutely	RB
50458	444	12	marvelous	marvelous	JJ
50458	444	13	.	.	.
50458	445	1	An	an	DT
50458	445	2	animal	animal	NN
50458	445	3	accustomed	accustom	VBN
50458	445	4	gradually	gradually	RB
50458	445	5	to	to	IN
50458	445	6	the	the	DT
50458	445	7	tetanic	tetanic	JJ
50458	445	8	virus	virus	NN
50458	445	9	yields	yield	VBZ
50458	445	10	a	a	DT
50458	445	11	serum	serum	NN
50458	445	12	containing	contain	VBG
50458	445	13	an	an	DT
50458	445	14	antitoxin	antitoxin	NN
50458	445	15	a	a	DT
50458	445	16	thousand	thousand	CD
50458	445	17	times	time	NNS
50458	445	18	more	more	RBR
50458	445	19	active	active	JJ
50458	445	20	than	than	IN
50458	445	21	the	the	DT
50458	445	22	virus	virus	NN
50458	445	23	.	.	.
50458	446	1	[	[	-LRB-
50458	446	2	50	50	CD
50458	446	3	]	]	-RRB-
50458	446	4	CH	CH	NNP
50458	446	5	.	.	.
50458	447	1	SALMONSEN	SALMONSEN	NNP
50458	447	2	et	et	NNP
50458	447	3	TH	TH	NNP
50458	447	4	.	.	.
50458	448	1	MADSEN	MADSEN	NNP
50458	448	2	:	:	:
50458	448	3	Réproduction	Réproduction	NNP
50458	448	4	de	de	IN
50458	448	5	la	la	NNP
50458	448	6	substance	substance	NN
50458	448	7	antitoxique	antitoxique	NNP
50458	448	8	.	.	.
50458	449	1	_	_	NNP
50458	449	2	Ann	Ann	NNP
50458	449	3	.	.	.
50458	450	1	Inst	inst	RB
50458	450	2	.	.	.
50458	451	1	Pasteur	Pasteur	NNP
50458	451	2	_	_	NNP
50458	451	3	,	,	,
50458	451	4	XII	XII	NNP
50458	451	5	,	,	,
50458	451	6	p.	p.	NN
50458	451	7	762	762	CD
50458	451	8	.	.	.
50458	452	1	ROUX	ROUX	NNP
50458	452	2	et	et	NNP
50458	452	3	VAILLARD	VAILLARD	NNP
50458	452	4	:	:	:
50458	452	5	_	_	NNP
50458	452	6	Ibid	Ibid	NNP
50458	452	7	.	.	.
50458	452	8	_	_	NNP
50458	452	9	,	,	,
50458	452	10	1893	1893	CD
50458	452	11	,	,	,
50458	452	12	p.	p.	NN
50458	452	13	83	83	CD
50458	452	14	.	.	.
50458	453	1	According	accord	VBG
50458	453	2	to	to	IN
50458	453	3	Vaillard	Vaillard	NNP
50458	453	4	,	,	,
50458	453	5	a	a	DT
50458	453	6	quintillionth	quintillionth	NN
50458	453	7	of	of	IN
50458	453	8	a	a	DT
50458	453	9	cubic	cubic	JJ
50458	453	10	centimeter	centimeter	NN
50458	453	11	of	of	IN
50458	453	12	this	this	DT
50458	453	13	antitetanic	antitetanic	JJ
50458	453	14	serum	serum	NN
50458	453	15	suffices	suffice	VBZ
50458	453	16	to	to	TO
50458	453	17	preserve	preserve	VB
50458	453	18	one	one	CD
50458	453	19	gramme	gramme	NN
50458	453	20	of	of	IN
50458	453	21	living	living	NN
50458	453	22	mouse	mouse	NN
50458	453	23	from	from	IN
50458	453	24	the	the	DT
50458	453	25	effects	effect	NNS
50458	453	26	of	of	IN
50458	453	27	a	a	DT
50458	453	28	dose	dose	NN
50458	453	29	of	of	IN
50458	453	30	tetanic	tetanic	JJ
50458	453	31	serum	serum	NN
50458	453	32	that	that	WDT
50458	453	33	would	would	MD
50458	453	34	otherwise	otherwise	RB
50458	453	35	be	be	VB
50458	453	36	surely	surely	RB
50458	453	37	fatal	fatal	JJ
50458	453	38	.	.	.
50458	454	1	In	in	IN
50458	454	2	the	the	DT
50458	454	3	animal	animal	NN
50458	454	4	,	,	,
50458	454	5	the	the	DT
50458	454	6	antitoxins	antitoxin	NNS
50458	454	7	are	be	VBP
50458	454	8	eliminated	eliminate	VBN
50458	454	9	mostly	mostly	RB
50458	454	10	by	by	IN
50458	454	11	the	the	DT
50458	454	12	fluids	fluid	NNS
50458	454	13	of	of	IN
50458	454	14	the	the	DT
50458	454	15	body	body	NN
50458	454	16	,	,	,
50458	454	17	and	and	CC
50458	454	18	particularly	particularly	RB
50458	454	19	by	by	IN
50458	454	20	the	the	DT
50458	454	21	urine	urine	NN
50458	454	22	.	.	.
50458	455	1	Ehrlich	Ehrlich	NNP
50458	455	2	has	have	VBZ
50458	455	3	demonstrated	demonstrate	VBN
50458	455	4	that	that	IN
50458	455	5	they	-PRON-	PRP
50458	455	6	also	also	RB
50458	455	7	pass	pass	VBP
50458	455	8	into	into	IN
50458	455	9	the	the	DT
50458	455	10	milk	milk	NN
50458	455	11	,	,	,
50458	455	12	and	and	CC
50458	455	13	this	this	DT
50458	455	14	fact	fact	NN
50458	455	15	is	be	VBZ
50458	455	16	confirmed	confirm	VBN
50458	455	17	by	by	IN
50458	455	18	a	a	DT
50458	455	19	large	large	JJ
50458	455	20	number	number	NN
50458	455	21	of	of	IN
50458	455	22	observers	observer	NNS
50458	455	23	.	.	.
50458	456	1	It	-PRON-	PRP
50458	456	2	explains	explain	VBZ
50458	456	3	the	the	DT
50458	456	4	immunity	immunity	NN
50458	456	5	acquired	acquire	VBN
50458	456	6	by	by	IN
50458	456	7	nurslings	nursling	NNS
50458	456	8	,	,	,
50458	456	9	and	and	CC
50458	456	10	which	which	WDT
50458	456	11	is	be	VBZ
50458	456	12	transmitted	transmit	VBN
50458	456	13	by	by	IN
50458	456	14	the	the	DT
50458	456	15	milk	milk	NN
50458	456	16	.	.	.
50458	457	1	=	=	NFP
50458	457	2	Serotherapy.=--The	serotherapy.=--the	CD
50458	457	3	search	search	NN
50458	457	4	for	for	IN
50458	457	5	antitoxins	antitoxin	NNS
50458	457	6	and	and	CC
50458	457	7	their	-PRON-	PRP$
50458	457	8	rôle	rôle	NNS
50458	457	9	in	in	IN
50458	457	10	the	the	DT
50458	457	11	etiology	etiology	NN
50458	457	12	of	of	IN
50458	457	13	infectious	infectious	JJ
50458	457	14	diseases	disease	NNS
50458	457	15	are	be	VBP
50458	457	16	fundamental	fundamental	JJ
50458	457	17	points	point	NNS
50458	457	18	in	in	IN
50458	457	19	actual	actual	JJ
50458	457	20	therapy	therapy	NN
50458	457	21	.	.	.
50458	458	1	It	-PRON-	PRP
50458	458	2	has	have	VBZ
50458	458	3	been	be	VBN
50458	458	4	demonstrated	demonstrate	VBN
50458	458	5	that	that	IN
50458	458	6	the	the	DT
50458	458	7	serums	serum	NNS
50458	458	8	of	of	IN
50458	458	9	certain	certain	JJ
50458	458	10	vaccinated	vaccinated	JJ
50458	458	11	animals	animal	NNS
50458	458	12	enjoy	enjoy	VBP
50458	458	13	very	very	RB
50458	458	14	extended	extended	JJ
50458	458	15	antitoxic	antitoxic	NN
50458	458	16	therapeutic	therapeutic	JJ
50458	458	17	properties	property	NNS
50458	458	18	;	;	:
50458	458	19	for	for	IN
50458	458	20	instance	instance	NN
50458	458	21	,	,	,
50458	458	22	the	the	DT
50458	458	23	serum	serum	NN
50458	458	24	of	of	IN
50458	458	25	vaccinated	vaccinated	JJ
50458	458	26	rabbits	rabbit	NNS
50458	458	27	is	be	VBZ
50458	458	28	an	an	DT
50458	458	29	antivenom	antivenom	NN
50458	458	30	towards	towards	IN
50458	458	31	erysipelas	erysipela	NNS
50458	458	32	;	;	:
50458	458	33	and	and	CC
50458	458	34	the	the	DT
50458	458	35	sterilized	sterilize	VBN
50458	458	36	cultures	culture	NNS
50458	458	37	of	of	IN
50458	458	38	the	the	DT
50458	458	39	pneumococcus	pneumococcus	NN
50458	458	40	or	or	CC
50458	458	41	of	of	IN
50458	458	42	the	the	DT
50458	458	43	Bacillus	Bacillus	NNP
50458	458	44	pyocyaneus	pyocyaneus	NN
50458	458	45	prevents	prevent	VBZ
50458	458	46	infection	infection	NN
50458	458	47	of	of	IN
50458	458	48	carbuncle	carbuncle	NN
50458	458	49	(	(	-LRB-
50458	458	50	anthrax	anthrax	NN
50458	458	51	)	)	-RRB-
50458	458	52	.	.	.
50458	459	1	The	the	DT
50458	459	2	antivenomous	antivenomous	JJ
50458	459	3	serum	serum	NN
50458	459	4	of	of	IN
50458	459	5	the	the	DT
50458	459	6	ass	ass	NN
50458	459	7	immunized	immunize	VBN
50458	459	8	by	by	IN
50458	459	9	injections	injection	NNS
50458	459	10	of	of	IN
50458	459	11	increasing	increase	VBG
50458	459	12	doses	dose	NNS
50458	459	13	of	of	IN
50458	459	14	the	the	DT
50458	459	15	venom	venom	NN
50458	459	16	of	of	IN
50458	459	17	the	the	DT
50458	459	18	terrible	terrible	JJ
50458	459	19	naja	naja	NNP
50458	459	20	is	be	VBZ
50458	459	21	a	a	DT
50458	459	22	perfect	perfect	JJ
50458	459	23	prophylactic	prophylactic	JJ
50458	459	24	and	and	CC
50458	459	25	curative	curative	JJ
50458	459	26	,	,	,
50458	459	27	not	not	RB
50458	459	28	only	only	RB
50458	459	29	as	as	IN
50458	459	30	regards	regard	VBZ
50458	459	31	the	the	DT
50458	459	32	venom	venom	NN
50458	459	33	of	of	IN
50458	459	34	this	this	DT
50458	459	35	serpent	serpent	NN
50458	459	36	,	,	,
50458	459	37	but	but	CC
50458	459	38	also	also	RB
50458	459	39	against	against	IN
50458	459	40	that	that	DT
50458	459	41	of	of	IN
50458	459	42	the	the	DT
50458	459	43	crotalus	crotalus	NN
50458	459	44	,	,	,
50458	459	45	trigonocephalus	trigonocephalus	NN
50458	459	46	,	,	,
50458	459	47	and	and	CC
50458	459	48	viper	viper	NN
50458	459	49	.	.	.
50458	460	1	We	-PRON-	PRP
50458	460	2	shall	shall	MD
50458	460	3	take	take	VB
50458	460	4	up	up	RP
50458	460	5	the	the	DT
50458	460	6	study	study	NN
50458	460	7	of	of	IN
50458	460	8	serotherapeutics	serotherapeutic	NNS
50458	460	9	in	in	IN
50458	460	10	another	another	DT
50458	460	11	volume	volume	NN
50458	460	12	of	of	IN
50458	460	13	this	this	DT
50458	460	14	collection	collection	NN
50458	460	15	.	.	.
50458	461	1	PART	PART	NNP
50458	461	2	II	ii	CD
50458	461	3	.	.	.
50458	462	1	_	_	NNP
50458	462	2	THE	the	DT
50458	462	3	TOXINS	TOXINS	NNP
50458	462	4	PROPER	proper	NN
50458	462	5	.	.	.
50458	462	6	_	_	NNP
50458	462	7	CHAPTER	CHAPTER	NNP
50458	462	8	III	III	NNP
50458	462	9	.	.	.
50458	463	1	I.	I.	NNP
50458	464	1	VEGETABLE	VEGETABLE	NNP
50458	464	2	AND	and	CC
50458	464	3	ANIMAL	ANIMAL	NNP
50458	464	4	TOXINS	toxin	NNS
50458	464	5	.	.	.
50458	465	1	The	the	DT
50458	465	2	vegetable	vegetable	NN
50458	465	3	toxins	toxin	NNS
50458	465	4	possess	possess	VBP
50458	465	5	the	the	DT
50458	465	6	characteristic	characteristic	JJ
50458	465	7	property	property	NN
50458	465	8	of	of	IN
50458	465	9	being	be	VBG
50458	465	10	innocuous	innocuous	JJ
50458	465	11	,	,	,
50458	465	12	and	and	CC
50458	465	13	of	of	IN
50458	465	14	being	be	VBG
50458	465	15	almost	almost	RB
50458	465	16	completely	completely	RB
50458	465	17	devoid	devoid	JJ
50458	465	18	of	of	IN
50458	465	19	poisonousness	poisonousness	NN
50458	465	20	,	,	,
50458	465	21	when	when	WRB
50458	465	22	they	-PRON-	PRP
50458	465	23	are	be	VBP
50458	465	24	absorbed	absorb	VBN
50458	465	25	by	by	IN
50458	465	26	the	the	DT
50458	465	27	intestines	intestine	NNS
50458	465	28	;	;	:
50458	465	29	we	-PRON-	PRP
50458	465	30	can	can	MD
50458	465	31	see	see	VB
50458	465	32	,	,	,
50458	465	33	from	from	IN
50458	465	34	this	this	DT
50458	465	35	,	,	,
50458	465	36	how	how	WRB
50458	465	37	greatly	greatly	RB
50458	465	38	they	-PRON-	PRP
50458	465	39	differ	differ	VBP
50458	465	40	from	from	IN
50458	465	41	the	the	DT
50458	465	42	poisons	poison	NNS
50458	465	43	proper	proper	JJ
50458	465	44	.	.	.
50458	466	1	[	[	-LRB-
50458	466	2	51	51	CD
50458	466	3	]	]	-RRB-
50458	466	4	[	[	-LRB-
50458	466	5	51	51	CD
50458	466	6	]	]	-RRB-
50458	466	7	It	-PRON-	PRP
50458	466	8	is	be	VBZ
50458	466	9	understood	understand	VBN
50458	466	10	that	that	IN
50458	466	11	the	the	DT
50458	466	12	active	active	JJ
50458	466	13	principles	principle	NNS
50458	466	14	of	of	IN
50458	466	15	mushrooms	mushroom	NNS
50458	466	16	are	be	VBP
50458	466	17	not	not	RB
50458	466	18	comprised	comprise	VBN
50458	466	19	under	under	IN
50458	466	20	this	this	DT
50458	466	21	definition	definition	NN
50458	466	22	,	,	,
50458	466	23	but	but	CC
50458	466	24	they	-PRON-	PRP
50458	466	25	will	will	MD
50458	466	26	be	be	VB
50458	466	27	studied	study	VBN
50458	466	28	under	under	IN
50458	466	29	the	the	DT
50458	466	30	next	next	JJ
50458	466	31	heading	heading	NN
50458	466	32	.	.	.
50458	467	1	The	the	DT
50458	467	2	vegetable	vegetable	NN
50458	467	3	toxins	toxin	NNS
50458	467	4	known	know	VBN
50458	467	5	are	be	VBP
50458	467	6	quite	quite	RB
50458	467	7	numerous	numerous	JJ
50458	467	8	;	;	:
50458	467	9	nevertheless	nevertheless	RB
50458	467	10	our	-PRON-	PRP$
50458	467	11	knowledge	knowledge	NN
50458	467	12	regarding	regard	VBG
50458	467	13	them	-PRON-	PRP
50458	467	14	is	be	VBZ
50458	467	15	very	very	RB
50458	467	16	incomplete	incomplete	JJ
50458	467	17	.	.	.
50458	468	1	Our	-PRON-	PRP$
50458	468	2	review	review	NN
50458	468	3	of	of	IN
50458	468	4	them	-PRON-	PRP
50458	468	5	will	will	MD
50458	468	6	be	be	VB
50458	468	7	chiefly	chiefly	RB
50458	468	8	descriptive	descriptive	JJ
50458	468	9	.	.	.
50458	469	1	Many	many	JJ
50458	469	2	of	of	IN
50458	469	3	the	the	DT
50458	469	4	leguminous	leguminous	JJ
50458	469	5	plants	plant	NNS
50458	469	6	are	be	VBP
50458	469	7	poisonous	poisonous	JJ
50458	469	8	,	,	,
50458	469	9	either	either	CC
50458	469	10	because	because	IN
50458	469	11	of	of	IN
50458	469	12	emanations	emanation	NNS
50458	469	13	exhaled	exhale	VBN
50458	469	14	by	by	IN
50458	469	15	them	-PRON-	PRP
50458	469	16	,	,	,
50458	469	17	or	or	CC
50458	469	18	by	by	IN
50458	469	19	reason	reason	NN
50458	469	20	of	of	IN
50458	469	21	their	-PRON-	PRP$
50458	469	22	alkaloids	alkaloid	NNS
50458	469	23	,	,	,
50458	469	24	or	or	CC
50458	469	25	because	because	IN
50458	469	26	of	of	IN
50458	469	27	some	some	DT
50458	469	28	toxins	toxin	NNS
50458	469	29	contained	contain	VBN
50458	469	30	in	in	IN
50458	469	31	them	-PRON-	PRP
50458	469	32	.	.	.
50458	470	1	We	-PRON-	PRP
50458	470	2	shall	shall	MD
50458	470	3	commence	commence	VB
50458	470	4	with	with	IN
50458	470	5	these	these	DT
50458	470	6	.	.	.
50458	471	1	=	=	NFP
50458	471	2	Abrin.=--This	Abrin.=--This	NNP
50458	471	3	toxin	toxin	NN
50458	471	4	,	,	,
50458	471	5	which	which	WDT
50458	471	6	was	be	VBD
50458	471	7	studied	study	VBN
50458	471	8	in	in	IN
50458	471	9	particular	particular	JJ
50458	471	10	by	by	IN
50458	471	11	Warden	Warden	NNP
50458	471	12	and	and	CC
50458	471	13	Waddell,[52	Waddell,[52	.
50458	471	14	]	]	-RRB-
50458	471	15	then	then	RB
50458	471	16	by	by	IN
50458	471	17	Kobert[53	kobert[53	CD
50458	471	18	]	]	-RRB-
50458	471	19	and	and	CC
50458	471	20	de	de	NNP
50458	471	21	Hellin,[54	Hellin,[54	NNP
50458	471	22	]	]	-RRB-
50458	471	23	is	be	VBZ
50458	471	24	found	find	VBN
50458	471	25	in	in	IN
50458	471	26	the	the	DT
50458	471	27	fruit	fruit	NN
50458	471	28	of	of	IN
50458	471	29	the	the	DT
50458	471	30	Leguminosæ	Leguminosæ	NNP
50458	471	31	,	,	,
50458	471	32	Abrus	Abrus	NNP
50458	471	33	precatorius	precatorius	NN
50458	471	34	(	(	-LRB-
50458	471	35	wild	wild	JJ
50458	471	36	licorice	licorice	NN
50458	471	37	,	,	,
50458	471	38	or	or	CC
50458	471	39	jequirity	jequirity	NN
50458	471	40	)	)	-RRB-
50458	471	41	.	.	.
50458	472	1	Its	-PRON-	PRP$
50458	472	2	name	name	NN
50458	472	3	was	be	VBD
50458	472	4	given	give	VBN
50458	472	5	it	-PRON-	PRP
50458	472	6	by	by	IN
50458	472	7	Warden	Warden	NNP
50458	472	8	and	and	CC
50458	472	9	Waddell	Waddell	NNP
50458	472	10	,	,	,
50458	472	11	who	who	WP
50458	472	12	discovered	discover	VBD
50458	472	13	both	both	CC
50458	472	14	its	-PRON-	PRP$
50458	472	15	toxic	toxic	JJ
50458	472	16	nature	nature	NN
50458	472	17	and	and	CC
50458	472	18	the	the	DT
50458	472	19	vegetable	vegetable	NN
50458	472	20	toxin	toxin	NN
50458	472	21	;	;	:
50458	472	22	the	the	DT
50458	472	23	toxin	toxin	NN
50458	472	24	is	be	VBZ
50458	472	25	found	find	VBN
50458	472	26	only	only	RB
50458	472	27	in	in	IN
50458	472	28	the	the	DT
50458	472	29	seeds	seed	NNS
50458	472	30	.	.	.
50458	473	1	To	to	TO
50458	473	2	extract	extract	VB
50458	473	3	it	-PRON-	PRP
50458	473	4	,	,	,
50458	473	5	the	the	DT
50458	473	6	seeds	seed	NNS
50458	473	7	are	be	VBP
50458	473	8	macerated	macerate	VBN
50458	473	9	in	in	IN
50458	473	10	water	water	NN
50458	473	11	,	,	,
50458	473	12	and	and	CC
50458	473	13	the	the	DT
50458	473	14	solution	solution	NN
50458	473	15	filtered	filter	VBN
50458	473	16	and	and	CC
50458	473	17	precipitated	precipitate	VBN
50458	473	18	with	with	IN
50458	473	19	alcohol	alcohol	NN
50458	473	20	;	;	:
50458	473	21	the	the	DT
50458	473	22	precipitate	precipitate	NN
50458	473	23	which	which	WDT
50458	473	24	forms	form	NNS
50458	473	25	is	be	VBZ
50458	473	26	collected	collect	VBN
50458	473	27	and	and	CC
50458	473	28	dissolved	dissolve	VBN
50458	473	29	in	in	IN
50458	473	30	distilled	distilled	JJ
50458	473	31	water	water	NN
50458	473	32	,	,	,
50458	473	33	from	from	IN
50458	473	34	which	which	WDT
50458	473	35	it	-PRON-	PRP
50458	473	36	is	be	VBZ
50458	473	37	again	again	RB
50458	473	38	precipitated	precipitate	VBN
50458	473	39	by	by	IN
50458	473	40	adding	add	VBG
50458	473	41	powdered	powder	VBN
50458	473	42	ammonium	ammonium	NN
50458	473	43	sulphate	sulphate	NN
50458	473	44	.	.	.
50458	474	1	The	the	DT
50458	474	2	precipitate	precipitate	NN
50458	474	3	is	be	VBZ
50458	474	4	then	then	RB
50458	474	5	collected	collect	VBN
50458	474	6	and	and	CC
50458	474	7	submitted	submit	VBN
50458	474	8	to	to	IN
50458	474	9	dialysis	dialysis	VB
50458	474	10	in	in	IN
50458	474	11	order	order	NN
50458	474	12	to	to	TO
50458	474	13	eliminate	eliminate	VB
50458	474	14	the	the	DT
50458	474	15	ammonium	ammonium	NN
50458	474	16	sulphate	sulphate	NN
50458	474	17	.	.	.
50458	475	1	The	the	DT
50458	475	2	abrin	abrin	NN
50458	475	3	so	so	RB
50458	475	4	obtained	obtain	VBD
50458	475	5	forms	form	NNS
50458	475	6	an	an	DT
50458	475	7	albuminoid	albuminoid	NN
50458	475	8	substance[55	substance[55	NN
50458	475	9	]	]	-RRB-
50458	475	10	stable	stable	JJ
50458	475	11	at	at	IN
50458	475	12	100	100	CD
50458	475	13	°	°	NNS
50458	475	14	C.	C.	NNP
50458	475	15	,	,	,
50458	475	16	and	and	CC
50458	475	17	possessing	possess	VBG
50458	475	18	rotatory	rotatory	JJ
50458	475	19	power	power	NN
50458	475	20	;	;	:
50458	475	21	it	-PRON-	PRP
50458	475	22	liquefies	liquefy	VBZ
50458	475	23	starch	starch	NN
50458	475	24	paste	paste	NN
50458	475	25	,	,	,
50458	475	26	and	and	CC
50458	475	27	is	be	VBZ
50458	475	28	extremely	extremely	RB
50458	475	29	toxic	toxic	JJ
50458	475	30	.	.	.
50458	476	1	One	one	CD
50458	476	2	milligramme	milligramme	NN
50458	476	3	suffices	suffice	VBZ
50458	476	4	to	to	TO
50458	476	5	kill	kill	VB
50458	476	6	a	a	DT
50458	476	7	rabbit	rabbit	NN
50458	476	8	within	within	IN
50458	476	9	several	several	JJ
50458	476	10	hours	hour	NNS
50458	476	11	.	.	.
50458	477	1	It	-PRON-	PRP
50458	477	2	must	must	MD
50458	477	3	be	be	VB
50458	477	4	observed	observe	VBN
50458	477	5	,	,	,
50458	477	6	however	however	RB
50458	477	7	,	,	,
50458	477	8	that	that	IN
50458	477	9	,	,	,
50458	477	10	as	as	IN
50458	477	11	is	be	VBZ
50458	477	12	the	the	DT
50458	477	13	case	case	NN
50458	477	14	with	with	IN
50458	477	15	all	all	PDT
50458	477	16	the	the	DT
50458	477	17	toxins	toxin	NNS
50458	477	18	,	,	,
50458	477	19	abrin	abrin	NNP
50458	477	20	acts	act	VBZ
50458	477	21	or	or	CC
50458	477	22	kills	kill	VBZ
50458	477	23	only	only	RB
50458	477	24	after	after	IN
50458	477	25	a	a	DT
50458	477	26	period	period	NN
50458	477	27	of	of	IN
50458	477	28	incubation	incubation	NN
50458	477	29	which	which	WDT
50458	477	30	generally	generally	RB
50458	477	31	exceeds	exceed	VBZ
50458	477	32	twenty	twenty	CD
50458	477	33	-	-	HYPH
50458	477	34	four	four	CD
50458	477	35	hours	hour	NNS
50458	477	36	.	.	.
50458	478	1	[	[	-LRB-
50458	478	2	52	52	CD
50458	478	3	]	]	-RRB-
50458	478	4	WARDEN	WARDEN	NNS
50458	478	5	and	and	CC
50458	478	6	WADDELL	waddell	NN
50458	478	7	:	:	:
50458	478	8	_	_	NNP
50458	478	9	Non	non	JJ
50458	478	10	-	-	JJ
50458	478	11	bacillar	bacillar	JJ
50458	478	12	Nature	nature	NN
50458	478	13	of	of	IN
50458	478	14	Abrus	Abrus	NNP
50458	478	15	Poison	Poison	NNP
50458	478	16	_	_	NNP
50458	478	17	.	.	.
50458	479	1	Calcutta	Calcutta	NNP
50458	479	2	,	,	,
50458	479	3	1884	1884	CD
50458	479	4	.	.	.
50458	480	1	[	[	-LRB-
50458	480	2	53	53	CD
50458	480	3	]	]	-RRB-
50458	480	4	KOBERT	KOBERT	NNP
50458	480	5	:	:	:
50458	480	6	_	_	NNP
50458	480	7	Arbeit	Arbeit	NNP
50458	480	8	.	.	.
50458	481	1	aus	aus	NNP
50458	481	2	dem	dem	NNP
50458	481	3	Pharmak	Pharmak	NNP
50458	481	4	.	.	.
50458	482	1	Institut	Institut	NNP
50458	482	2	.	.	.
50458	482	3	_	_	NNP
50458	482	4	Dorpat	Dorpat	NNP
50458	482	5	,	,	,
50458	482	6	1893	1893	CD
50458	482	7	.	.	.
50458	483	1	[	[	-LRB-
50458	483	2	54	54	CD
50458	483	3	]	]	-RRB-
50458	483	4	HELLIN	HELLIN	NNP
50458	483	5	:	:	:
50458	483	6	_	_	NNP
50458	483	7	Inaug	Inaug	NNP
50458	483	8	.	.	.
50458	484	1	Dissert	Dissert	NNP
50458	484	2	.	.	.
50458	484	3	_	_	NNP
50458	484	4	Dorpat	Dorpat	NNP
50458	484	5	,	,	,
50458	484	6	1891	1891	CD
50458	484	7	.	.	.
50458	485	1	[	[	-LRB-
50458	485	2	55	55	CD
50458	485	3	]	]	-RRB-
50458	485	4	EHRLICH	ehrlich	NN
50458	485	5	:	:	:
50458	485	6	Experiment	experiment	NN
50458	485	7	.	.	.
50458	486	1	Untersuchungen	Untersuchungen	NNP
50458	486	2	über	über	NN
50458	486	3	Immunität	Immunität	NNP
50458	486	4	.	.	.
50458	487	1	_	_	NNP
50458	487	2	Deutsch	Deutsch	NNP
50458	487	3	.	.	.
50458	488	1	Med	Med	NNP
50458	488	2	.	.	.
50458	489	1	Woch	Woch	NNP
50458	489	2	.	.	.
50458	489	3	_	_	NNP
50458	489	4	,	,	,
50458	489	5	1891	1891	CD
50458	489	6	.	.	.
50458	490	1	It	-PRON-	PRP
50458	490	2	is	be	VBZ
50458	490	3	possible	possible	JJ
50458	490	4	to	to	TO
50458	490	5	vaccinate	vaccinate	VB
50458	490	6	an	an	DT
50458	490	7	organism	organism	NN
50458	490	8	so	so	IN
50458	490	9	as	as	IN
50458	490	10	to	to	TO
50458	490	11	withstand	withstand	VB
50458	490	12	a	a	DT
50458	490	13	lethal	lethal	JJ
50458	490	14	dose	dose	NN
50458	490	15	of	of	IN
50458	490	16	abrin	abrin	NN
50458	490	17	,	,	,
50458	490	18	but	but	CC
50458	490	19	it	-PRON-	PRP
50458	490	20	requires	require	VBZ
50458	490	21	quite	quite	PDT
50458	490	22	a	a	DT
50458	490	23	long	long	JJ
50458	490	24	time	time	NN
50458	490	25	;	;	:
50458	490	26	it	-PRON-	PRP
50458	490	27	is	be	VBZ
50458	490	28	effected	effect	VBN
50458	490	29	by	by	IN
50458	490	30	injecting	inject	VBG
50458	490	31	into	into	IN
50458	490	32	a	a	DT
50458	490	33	suitable	suitable	JJ
50458	490	34	animal	animal	NN
50458	490	35	very	very	RB
50458	490	36	small	small	JJ
50458	490	37	doses	dose	NNS
50458	490	38	of	of	IN
50458	490	39	the	the	DT
50458	490	40	substance	substance	NN
50458	490	41	,	,	,
50458	490	42	and	and	CC
50458	490	43	increasing	increase	VBG
50458	490	44	the	the	DT
50458	490	45	quantity	quantity	NN
50458	490	46	gradually	gradually	RB
50458	490	47	.	.	.
50458	491	1	Rabbits	rabbit	NNS
50458	491	2	which	which	WDT
50458	491	3	have	have	VBP
50458	491	4	been	be	VBN
50458	491	5	rendered	render	VBN
50458	491	6	highly	highly	RB
50458	491	7	immune	immune	JJ
50458	491	8	towards	towards	IN
50458	491	9	venoms	venom	NNS
50458	491	10	are	be	VBP
50458	491	11	capable	capable	JJ
50458	491	12	of	of	IN
50458	491	13	resisting	resist	VBG
50458	491	14	without	without	IN
50458	491	15	inconvenience	inconvenience	NN
50458	491	16	doses	dose	NNS
50458	491	17	of	of	IN
50458	491	18	abrin	abrin	NN
50458	491	19	which	which	WDT
50458	491	20	are	be	VBP
50458	491	21	ordinarily	ordinarily	RB
50458	491	22	fatal	fatal	JJ
50458	491	23	;	;	:
50458	491	24	and	and	CC
50458	491	25	the	the	DT
50458	491	26	blood	blood	NN
50458	491	27	serum	serum	NN
50458	491	28	afforded	afford	VBN
50458	491	29	by	by	IN
50458	491	30	them	-PRON-	PRP
50458	491	31	contains	contain	VBZ
50458	491	32	a	a	DT
50458	491	33	specific	specific	JJ
50458	491	34	antibody	antibody	NN
50458	491	35	for	for	IN
50458	491	36	the	the	DT
50458	491	37	substance	substance	NN
50458	491	38	.	.	.
50458	492	1	=	=	NFP
50458	492	2	Ricin.=--This	Ricin.=--This	NNP
50458	492	3	vegetable	vegetable	NN
50458	492	4	toxalbumin	toxalbumin	NN
50458	492	5	has	have	VBZ
50458	492	6	been	be	VBN
50458	492	7	studied	study	VBN
50458	492	8	particularly	particularly	RB
50458	492	9	by	by	IN
50458	492	10	Stillmark,[56	stillmark,[56	NN
50458	492	11	]	]	-RRB-
50458	492	12	by	by	IN
50458	492	13	Dixon,[57	Dixon,[57	NNP
50458	492	14	]	]	-RRB-
50458	492	15	and	and	CC
50458	492	16	Thuson	Thuson	NNP
50458	492	17	.	.	.
50458	493	1	[	[	-LRB-
50458	493	2	58	58	CD
50458	493	3	]	]	-RRB-
50458	493	4	It	-PRON-	PRP
50458	493	5	is	be	VBZ
50458	493	6	found	find	VBN
50458	493	7	in	in	IN
50458	493	8	the	the	DT
50458	493	9	seeds	seed	NNS
50458	493	10	of	of	IN
50458	493	11	the	the	DT
50458	493	12	castor	castor	NN
50458	493	13	plant	plant	NN
50458	493	14	;	;	:
50458	493	15	three	three	CD
50458	493	16	or	or	CC
50458	493	17	four	four	CD
50458	493	18	of	of	IN
50458	493	19	the	the	DT
50458	493	20	seeds	seed	NNS
50458	493	21	suffice	suffice	VBP
50458	493	22	to	to	TO
50458	493	23	cause	cause	VB
50458	493	24	a	a	DT
50458	493	25	gastroenteritis	gastroenteritis	NN
50458	493	26	accompanied	accompany	VBN
50458	493	27	by	by	IN
50458	493	28	serious	serious	JJ
50458	493	29	symptoms	symptom	NNS
50458	493	30	and	and	CC
50458	493	31	even	even	RB
50458	493	32	by	by	IN
50458	493	33	death	death	NN
50458	493	34	.	.	.
50458	494	1	[	[	-LRB-
50458	494	2	56	56	CD
50458	494	3	]	]	-RRB-
50458	494	4	STILLMARK	STILLMARK	NNP
50458	494	5	:	:	:
50458	494	6	_	_	NNP
50458	494	7	Arbeit	Arbeit	NNP
50458	494	8	.	.	.
50458	495	1	aus	aus	NNP
50458	495	2	dem	dem	NNP
50458	495	3	pharmacol	pharmacol	NNP
50458	495	4	.	.	.
50458	496	1	Inst	inst	RB
50458	496	2	.	.	.
50458	497	1	Dorpat	Dorpat	NNP
50458	497	2	_	_	NNP
50458	497	3	,	,	,
50458	497	4	1889	1889	CD
50458	497	5	.	.	.
50458	498	1	[	[	-LRB-
50458	498	2	57	57	CD
50458	498	3	]	]	-RRB-
50458	498	4	DIXON	DIXON	NNP
50458	498	5	:	:	:
50458	498	6	_	_	NNP
50458	498	7	Austr	Austr	NNP
50458	498	8	.	.	.
50458	499	1	Med	Med	NNP
50458	499	2	.	.	.
50458	500	1	Gazette	Gazette	NNP
50458	500	2	_	_	NNP
50458	500	3	,	,	,
50458	500	4	1887	1887	CD
50458	500	5	.	.	.
50458	501	1	[	[	-LRB-
50458	501	2	58	58	CD
50458	501	3	]	]	-RRB-
50458	501	4	THUSON	THUSON	NNP
50458	501	5	:	:	:
50458	501	6	_	_	NNP
50458	501	7	Journ	Journ	NNP
50458	501	8	.	.	.
50458	502	1	f.	f.	NNP
50458	502	2	prakt	prakt	NNP
50458	502	3	.	.	.
50458	503	1	Chem	Chem	NNP
50458	503	2	.	.	.
50458	503	3	_	_	NNP
50458	503	4	,	,	,
50458	503	5	XCIV	XCIV	NNP
50458	503	6	,	,	,
50458	503	7	p.	p.	NN
50458	503	8	444	444	CD
50458	503	9	.	.	.
50458	504	1	It	-PRON-	PRP
50458	504	2	was	be	VBD
50458	504	3	first	first	RB
50458	504	4	isolated	isolate	VBN
50458	504	5	by	by	IN
50458	504	6	P.	P.	NNP
50458	504	7	Ehrlich	Ehrlich	NNP
50458	504	8	,	,	,
50458	504	9	by	by	IN
50458	504	10	treating	treat	VBG
50458	504	11	the	the	DT
50458	504	12	seeds	seed	NNS
50458	504	13	with	with	IN
50458	504	14	lukewarm	lukewarm	JJ
50458	504	15	water	water	NN
50458	504	16	,	,	,
50458	504	17	and	and	CC
50458	504	18	precipitating	precipitate	VBG
50458	504	19	the	the	DT
50458	504	20	aqueous	aqueous	JJ
50458	504	21	solution	solution	NN
50458	504	22	with	with	IN
50458	504	23	alcohol	alcohol	NN
50458	504	24	.	.	.
50458	505	1	The	the	DT
50458	505	2	toxalbumin	toxalbumin	NN
50458	505	3	is	be	VBZ
50458	505	4	soluble	soluble	JJ
50458	505	5	in	in	IN
50458	505	6	water	water	NN
50458	505	7	,	,	,
50458	505	8	but	but	CC
50458	505	9	on	on	IN
50458	505	10	boiling	boil	VBG
50458	505	11	the	the	DT
50458	505	12	solution	solution	NN
50458	505	13	,	,	,
50458	505	14	the	the	DT
50458	505	15	substance	substance	NN
50458	505	16	loses	lose	VBZ
50458	505	17	in	in	IN
50458	505	18	great	great	JJ
50458	505	19	measure	measure	NN
50458	505	20	its	-PRON-	PRP$
50458	505	21	activity	activity	NN
50458	505	22	.	.	.
50458	506	1	Ricin	Ricin	NNS
50458	506	2	possesses	possess	VBZ
50458	506	3	considerable	considerable	JJ
50458	506	4	activity	activity	NN
50458	506	5	.	.	.
50458	507	1	0.00003	0.00003	CD
50458	507	2	Gm	Gm	NNP
50458	507	3	.	.	.
50458	508	1	suffice	suffice	VB
50458	508	2	to	to	TO
50458	508	3	kill	kill	VB
50458	508	4	a	a	DT
50458	508	5	rabbit	rabbit	NN
50458	508	6	when	when	WRB
50458	508	7	injected	inject	VBN
50458	508	8	hypodermically	hypodermically	RB
50458	508	9	;	;	:
50458	508	10	0.2	0.2	CD
50458	508	11	Gm	Gm	NNP
50458	508	12	.	.	.
50458	509	1	are	be	VBP
50458	509	2	fatal	fatal	JJ
50458	509	3	to	to	TO
50458	509	4	man	man	VB
50458	509	5	.	.	.
50458	510	1	The	the	DT
50458	510	2	action	action	NN
50458	510	3	is	be	VBZ
50458	510	4	not	not	RB
50458	510	5	immediate	immediate	JJ
50458	510	6	,	,	,
50458	510	7	but	but	CC
50458	510	8	follows	follow	VBZ
50458	510	9	a	a	DT
50458	510	10	period	period	NN
50458	510	11	of	of	IN
50458	510	12	incubation	incubation	NN
50458	510	13	.	.	.
50458	511	1	Ehrlich	Ehrlich	NNP
50458	511	2	has	have	VBZ
50458	511	3	shown	show	VBN
50458	511	4	that	that	IN
50458	511	5	,	,	,
50458	511	6	exercising	exercise	VBG
50458	511	7	precaution	precaution	NN
50458	511	8	,	,	,
50458	511	9	it	-PRON-	PRP
50458	511	10	is	be	VBZ
50458	511	11	possible	possible	JJ
50458	511	12	to	to	TO
50458	511	13	create	create	VB
50458	511	14	,	,	,
50458	511	15	as	as	IN
50458	511	16	with	with	IN
50458	511	17	abrin	abrin	NNP
50458	511	18	,	,	,
50458	511	19	a	a	DT
50458	511	20	condition	condition	NN
50458	511	21	of	of	IN
50458	511	22	tolerance	tolerance	NN
50458	511	23	or	or	CC
50458	511	24	habituation	habituation	NN
50458	511	25	,	,	,
50458	511	26	and	and	CC
50458	511	27	in	in	IN
50458	511	28	consequence	consequence	NN
50458	511	29	to	to	TO
50458	511	30	cause	cause	VB
50458	511	31	the	the	DT
50458	511	32	formation	formation	NN
50458	511	33	of	of	IN
50458	511	34	a	a	DT
50458	511	35	specific	specific	JJ
50458	511	36	antibody	antibody	NN
50458	511	37	.	.	.
50458	512	1	=	=	NFP
50458	512	2	Robin.=--This	Robin.=--This	NNP
50458	512	3	toxic	toxic	JJ
50458	512	4	albuminoid	albuminoid	NN
50458	512	5	was	be	VBD
50458	512	6	obtained	obtain	VBN
50458	512	7	from	from	IN
50458	512	8	the	the	DT
50458	512	9	bark	bark	NN
50458	512	10	of	of	IN
50458	512	11	an	an	DT
50458	512	12	Acacia	Acacia	NNP
50458	512	13	(	(	-LRB-
50458	512	14	Robinia	Robinia	NNP
50458	512	15	Pseudacacia	Pseudacacia	NNP
50458	512	16	)	)	-RRB-
50458	512	17	by	by	IN
50458	512	18	Power	Power	NNP
50458	512	19	and	and	CC
50458	512	20	Cambier,[59	Cambier,[59	NNP
50458	512	21	]	]	-RRB-
50458	512	22	by	by	IN
50458	512	23	exhausting	exhaust	VBG
50458	512	24	with	with	IN
50458	512	25	water	water	NN
50458	512	26	at	at	IN
50458	512	27	a	a	DT
50458	512	28	temperature	temperature	NN
50458	512	29	of	of	IN
50458	512	30	about	about	RB
50458	512	31	30	30	CD
50458	512	32	°	°	,
50458	512	33	C.	C.	NNP
50458	512	34	,	,	,
50458	512	35	and	and	CC
50458	512	36	precipitating	precipitate	VBG
50458	512	37	the	the	DT
50458	512	38	infusion	infusion	NN
50458	512	39	with	with	IN
50458	512	40	alcohol	alcohol	NN
50458	512	41	.	.	.
50458	513	1	The	the	DT
50458	513	2	substance	substance	NN
50458	513	3	is	be	VBZ
50458	513	4	analogous	analogous	JJ
50458	513	5	to	to	IN
50458	513	6	ricin	ricin	NNS
50458	513	7	,	,	,
50458	513	8	and	and	CC
50458	513	9	like	like	IN
50458	513	10	this	this	DT
50458	513	11	,	,	,
50458	513	12	possesses	possess	VBZ
50458	513	13	powerful	powerful	JJ
50458	513	14	toxic	toxic	JJ
50458	513	15	properties	property	NNS
50458	513	16	.	.	.
50458	514	1	[	[	-LRB-
50458	514	2	59	59	CD
50458	514	3	]	]	-RRB-
50458	514	4	POWER	POWER	NNS
50458	514	5	and	and	CC
50458	514	6	CAMBIER	CAMBIER	NNP
50458	514	7	:	:	:
50458	514	8	_	_	NNP
50458	514	9	Pharm	Pharm	NNP
50458	514	10	.	.	.
50458	515	1	Journ	Journ	NNP
50458	515	2	.	.	.
50458	516	1	and	and	CC
50458	516	2	Transact	Transact	NNP
50458	516	3	.	.	.
50458	516	4	_	_	NNP
50458	516	5	,	,	,
50458	516	6	1890	1890	CD
50458	516	7	.	.	.
50458	517	1	=	=	NFP
50458	517	2	Toxicity	toxicity	NN
50458	517	3	of	of	IN
50458	517	4	the	the	DT
50458	517	5	Vegetable	Vegetable	NNP
50458	517	6	Diastases.=--The	Diastases.=--The	NNP
50458	517	7	diastases	diastasis	NNS
50458	517	8	,	,	,
50458	517	9	which	which	WDT
50458	517	10	have	have	VBP
50458	517	11	been	be	VBN
50458	517	12	treated	treat	VBN
50458	517	13	of	of	IN
50458	517	14	in	in	IN
50458	517	15	a	a	DT
50458	517	16	volume	volume	NN
50458	517	17	of	of	IN
50458	517	18	the	the	DT
50458	517	19	Encyclopédie	Encyclopédie	NNP
50458	517	20	Léauté,[60	Léauté,[60	NNP
50458	517	21	]	]	-RRB-
50458	517	22	and	and	CC
50458	517	23	to	to	TO
50458	517	24	which	which	WDT
50458	517	25	we	-PRON-	PRP
50458	517	26	would	would	MD
50458	517	27	refer	refer	VB
50458	517	28	the	the	DT
50458	517	29	reader	reader	NN
50458	517	30	who	who	WP
50458	517	31	is	be	VBZ
50458	517	32	desirous	desirous	JJ
50458	517	33	of	of	IN
50458	517	34	more	more	RBR
50458	517	35	complete	complete	JJ
50458	517	36	details	detail	NNS
50458	517	37	,	,	,
50458	517	38	develop	develop	VB
50458	517	39	powerfully	powerfully	RB
50458	517	40	energetic	energetic	JJ
50458	517	41	toxic	toxic	JJ
50458	517	42	properties	property	NNS
50458	517	43	when	when	WRB
50458	517	44	injected	inject	VBN
50458	517	45	into	into	IN
50458	517	46	the	the	DT
50458	517	47	organism	organism	NN
50458	517	48	.	.	.
50458	518	1	Thus	thus	RB
50458	518	2	_	_	NNP
50458	518	3	amylase	amylase	JJ
50458	518	4	_	_	NNP
50458	518	5	causes	cause	VBZ
50458	518	6	,	,	,
50458	518	7	when	when	WRB
50458	518	8	injected	inject	VBN
50458	518	9	subcutaneously	subcutaneously	RB
50458	518	10	,	,	,
50458	518	11	a	a	DT
50458	518	12	considerable	considerable	JJ
50458	518	13	rise	rise	NN
50458	518	14	of	of	IN
50458	518	15	temperature	temperature	NN
50458	518	16	,	,	,
50458	518	17	but	but	CC
50458	518	18	without	without	IN
50458	518	19	any	any	DT
50458	518	20	other	other	JJ
50458	518	21	toxic	toxic	JJ
50458	518	22	symptoms	symptom	NNS
50458	518	23	.	.	.
50458	519	1	_	_	NNP
50458	519	2	Invertin	Invertin	NNP
50458	519	3	_	_	NNP
50458	519	4	or	or	CC
50458	519	5	_	_	NNP
50458	519	6	sucrase	sucrase	NN
50458	519	7	_	_	NNP
50458	519	8	was	be	VBD
50458	519	9	studied	study	VBN
50458	519	10	by	by	IN
50458	519	11	Roussy	Roussy	NNP
50458	519	12	under	under	IN
50458	519	13	the	the	DT
50458	519	14	name	name	NN
50458	519	15	_	_	NNP
50458	519	16	pyretogenin	pyretogenin	NNP
50458	519	17	_	_	NNP
50458	519	18	,	,	,
50458	519	19	but	but	CC
50458	519	20	it	-PRON-	PRP
50458	519	21	appears	appear	VBZ
50458	519	22	probable	probable	JJ
50458	519	23	that	that	IN
50458	519	24	this	this	DT
50458	519	25	diastase	diastase	NN
50458	519	26	was	be	VBD
50458	519	27	not	not	RB
50458	519	28	the	the	DT
50458	519	29	only	only	JJ
50458	519	30	substance	substance	NN
50458	519	31	present	present	JJ
50458	519	32	in	in	IN
50458	519	33	the	the	DT
50458	519	34	product	product	NN
50458	519	35	,	,	,
50458	519	36	but	but	CC
50458	519	37	that	that	IN
50458	519	38	there	there	EX
50458	519	39	were	be	VBD
50458	519	40	present	present	JJ
50458	519	41	reducing	reduce	VBG
50458	519	42	diastases	diastasis	NNS
50458	519	43	,	,	,
50458	519	44	as	as	IN
50458	519	45	we	-PRON-	PRP
50458	519	46	have	have	VBP
50458	519	47	already	already	RB
50458	519	48	shown	show	VBN
50458	519	49	in	in	IN
50458	519	50	the	the	DT
50458	519	51	first	first	JJ
50458	519	52	volume	volume	NN
50458	519	53	of	of	IN
50458	519	54	this	this	DT
50458	519	55	collection	collection	NN
50458	519	56	,	,	,
50458	519	57	devoted	devote	VBN
50458	519	58	to	to	IN
50458	519	59	the	the	DT
50458	519	60	phenomena	phenomenon	NNS
50458	519	61	of	of	IN
50458	519	62	reduction	reduction	NN
50458	519	63	within	within	IN
50458	519	64	the	the	DT
50458	519	65	living	live	VBG
50458	519	66	organism	organism	NN
50458	519	67	.	.	.
50458	520	1	[	[	-LRB-
50458	520	2	60	60	CD
50458	520	3	]	]	-RRB-
50458	520	4	POZZI	POZZI	NNP
50458	520	5	-	-	HYPH
50458	520	6	ESCOT	ESCOT	NNP
50458	520	7	:	:	:
50458	520	8	_	_	NNP
50458	520	9	Les	Les	NNP
50458	520	10	Diastases	Diastases	NNP
50458	520	11	et	et	NNP
50458	520	12	leurs	leur	VBZ
50458	520	13	Applications	Applications	NNPS
50458	520	14	_	_	NNP
50458	520	15	,	,	,
50458	520	16	Masson	Masson	NNP
50458	520	17	,	,	,
50458	520	18	1900	1900	CD
50458	520	19	.	.	.
50458	521	1	The	the	DT
50458	521	2	pyretogenin	pyretogenin	NN
50458	521	3	of	of	IN
50458	521	4	Roussy	Roussy	NNP
50458	521	5	gives	give	VBZ
50458	521	6	rise	rise	NN
50458	521	7	to	to	IN
50458	521	8	an	an	DT
50458	521	9	attack	attack	NN
50458	521	10	of	of	IN
50458	521	11	violent	violent	JJ
50458	521	12	fever	fever	NN
50458	521	13	,	,	,
50458	521	14	but	but	CC
50458	521	15	it	-PRON-	PRP
50458	521	16	loses	lose	VBZ
50458	521	17	all	all	DT
50458	521	18	activity	activity	NN
50458	521	19	when	when	WRB
50458	521	20	heated	heat	VBN
50458	521	21	to	to	IN
50458	521	22	80	80	CD
50458	521	23	-	-	SYM
50458	521	24	100	100	CD
50458	521	25	°	°	,
50458	521	26	C.	C.	NNP
50458	521	27	Through	through	IN
50458	521	28	his	-PRON-	PRP$
50458	521	29	researches	research	NNS
50458	521	30	,	,	,
50458	521	31	Roussy	Roussy	NNP
50458	521	32	clearly	clearly	RB
50458	521	33	demonstrated,[61	demonstrated,[61	NN
50458	521	34	]	]	-RRB-
50458	521	35	for	for	IN
50458	521	36	the	the	DT
50458	521	37	first	first	JJ
50458	521	38	time	time	NN
50458	521	39	,	,	,
50458	521	40	that	that	IN
50458	521	41	the	the	DT
50458	521	42	fever	fever	NN
50458	521	43	may	may	MD
50458	521	44	cause	cause	VB
50458	521	45	the	the	DT
50458	521	46	formation	formation	NN
50458	521	47	within	within	IN
50458	521	48	the	the	DT
50458	521	49	blood	blood	NN
50458	521	50	of	of	IN
50458	521	51	a	a	DT
50458	521	52	substance	substance	NN
50458	521	53	clearly	clearly	RB
50458	521	54	belonging	belong	VBG
50458	521	55	to	to	IN
50458	521	56	the	the	DT
50458	521	57	class	class	NN
50458	521	58	of	of	IN
50458	521	59	soluble	soluble	JJ
50458	521	60	ferments	ferment	NNS
50458	521	61	or	or	CC
50458	521	62	zymases	zymase	NNS
50458	521	63	.	.	.
50458	522	1	Now	now	RB
50458	522	2	,	,	,
50458	522	3	it	-PRON-	PRP
50458	522	4	is	be	VBZ
50458	522	5	well	well	RB
50458	522	6	known	know	VBN
50458	522	7	that	that	IN
50458	522	8	within	within	IN
50458	522	9	the	the	DT
50458	522	10	animal	animal	NN
50458	522	11	economy	economy	NN
50458	522	12	there	there	RB
50458	522	13	exist	exist	VBP
50458	522	14	many	many	JJ
50458	522	15	ferments	ferment	NNS
50458	522	16	of	of	IN
50458	522	17	this	this	DT
50458	522	18	character	character	NN
50458	522	19	;	;	,
50458	522	20	and	and	CC
50458	522	21	experiment	experiment	NN
50458	522	22	has	have	VBZ
50458	522	23	shown	show	VBN
50458	522	24	that	that	IN
50458	522	25	they	-PRON-	PRP
50458	522	26	can	can	MD
50458	522	27	,	,	,
50458	522	28	at	at	IN
50458	522	29	a	a	DT
50458	522	30	given	give	VBN
50458	522	31	period	period	NN
50458	522	32	and	and	CC
50458	522	33	under	under	IN
50458	522	34	various	various	JJ
50458	522	35	influences	influence	NNS
50458	522	36	,	,	,
50458	522	37	leave	leave	VB
50458	522	38	the	the	DT
50458	522	39	cells	cell	NNS
50458	522	40	in	in	IN
50458	522	41	which	which	WDT
50458	522	42	they	-PRON-	PRP
50458	522	43	are	be	VBP
50458	522	44	normally	normally	RB
50458	522	45	localized	localize	VBN
50458	522	46	,	,	,
50458	522	47	pass	pass	VB
50458	522	48	into	into	IN
50458	522	49	the	the	DT
50458	522	50	blood	blood	NN
50458	522	51	plasma	plasma	NN
50458	522	52	,	,	,
50458	522	53	and	and	CC
50458	522	54	reach	reach	VB
50458	522	55	the	the	DT
50458	522	56	nervous	nervous	JJ
50458	522	57	centers	center	NNS
50458	522	58	,	,	,
50458	522	59	where	where	WRB
50458	522	60	they	-PRON-	PRP
50458	522	61	cause	cause	VBP
50458	522	62	serious	serious	JJ
50458	522	63	effects	effect	NNS
50458	522	64	.	.	.
50458	523	1	We	-PRON-	PRP
50458	523	2	have	have	VBP
50458	523	3	already	already	RB
50458	523	4	dwelt	dwell	VBN
50458	523	5	upon	upon	IN
50458	523	6	the	the	DT
50458	523	7	mechanism	mechanism	NN
50458	523	8	of	of	IN
50458	523	9	autointoxication	autointoxication	NN
50458	523	10	of	of	IN
50458	523	11	the	the	DT
50458	523	12	organism	organism	NN
50458	523	13	.	.	.
50458	524	1	The	the	DT
50458	524	2	toxic	toxic	JJ
50458	524	3	action	action	NN
50458	524	4	of	of	IN
50458	524	5	certain	certain	JJ
50458	524	6	digestive	digestive	JJ
50458	524	7	diastases	diastasis	NNS
50458	524	8	has	have	VBZ
50458	524	9	been	be	VBN
50458	524	10	shown	show	VBN
50458	524	11	by	by	IN
50458	524	12	Hildebrandt	Hildebrandt	NNP
50458	524	13	,	,	,
50458	524	14	who	who	WP
50458	524	15	has	have	VBZ
50458	524	16	demonstrated	demonstrate	VBN
50458	524	17	that	that	IN
50458	524	18	0.1	0.1	CD
50458	524	19	Gm	Gm	NNP
50458	524	20	.	.	.
50458	525	1	of	of	IN
50458	525	2	pepsin	pepsin	NNP
50458	525	3	is	be	VBZ
50458	525	4	capable	capable	JJ
50458	525	5	of	of	IN
50458	525	6	killing	kill	VBG
50458	525	7	a	a	DT
50458	525	8	rabbit	rabbit	NN
50458	525	9	in	in	IN
50458	525	10	two	two	CD
50458	525	11	or	or	CC
50458	525	12	three	three	CD
50458	525	13	days	day	NNS
50458	525	14	.	.	.
50458	526	1	[	[	-LRB-
50458	526	2	61	61	CD
50458	526	3	]	]	-RRB-
50458	526	4	ROUSSY	ROUSSY	NNP
50458	526	5	:	:	:
50458	526	6	_	_	NNP
50458	526	7	Aperçu	Aperçu	NNP
50458	526	8	historique	historique	NNP
50458	526	9	sur	sur	NNP
50458	526	10	les	les	NNP
50458	526	11	ferments	ferment	NNS
50458	526	12	et	et	NNP
50458	526	13	fermentations	fermentation	NNS
50458	526	14	_	_	NNP
50458	526	15	.	.	.
50458	527	1	Paris	Paris	NNP
50458	527	2	,	,	,
50458	527	3	1901	1901	CD
50458	527	4	.	.	.
50458	528	1	J.	J.	NNP
50458	528	2	Rousset	Rousset	NNP
50458	528	3	,	,	,
50458	528	4	publ	publ	NNS
50458	528	5	.	.	.
50458	529	1	II	ii	CD
50458	529	2	.	.	.
50458	530	1	TOXINS	toxin	NNS
50458	530	2	FROM	from	IN
50458	530	3	MUSHROOMS	MUSHROOMS	NNP
50458	530	4	.	.	.
50458	531	1	Mushrooms	mushroom	NNS
50458	531	2	are	be	VBP
50458	531	3	alimentary	alimentary	JJ
50458	531	4	substances	substance	NNS
50458	531	5	of	of	IN
50458	531	6	the	the	DT
50458	531	7	highest	high	JJS
50458	531	8	order	order	NN
50458	531	9	,	,	,
50458	531	10	causing	cause	VBG
50458	531	11	a	a	DT
50458	531	12	general	general	JJ
50458	531	13	stimulation	stimulation	NN
50458	531	14	of	of	IN
50458	531	15	the	the	DT
50458	531	16	entire	entire	JJ
50458	531	17	organism	organism	NN
50458	531	18	.	.	.
50458	532	1	The	the	DT
50458	532	2	substances	substance	NNS
50458	532	3	met	meet	VBD
50458	532	4	with	with	IN
50458	532	5	belong	belong	NN
50458	532	6	,	,	,
50458	532	7	according	accord	VBG
50458	532	8	to	to	IN
50458	532	9	their	-PRON-	PRP$
50458	532	10	composition	composition	NN
50458	532	11	,	,	,
50458	532	12	to	to	IN
50458	532	13	different	different	JJ
50458	532	14	classes	class	NNS
50458	532	15	--	--	:
50458	532	16	celluloses	cellulose	NNS
50458	532	17	,	,	,
50458	532	18	sugars	sugar	NNS
50458	532	19	,	,	,
50458	532	20	and	and	CC
50458	532	21	amylaceous	amylaceous	JJ
50458	532	22	substances	substance	NNS
50458	532	23	,	,	,
50458	532	24	alcohols	alcohol	NNS
50458	532	25	,	,	,
50458	532	26	acids	acid	NNS
50458	532	27	,	,	,
50458	532	28	fats	fat	NNS
50458	532	29	,	,	,
50458	532	30	astringents	astringent	NNS
50458	532	31	,	,	,
50458	532	32	essential	essential	JJ
50458	532	33	oils	oil	NNS
50458	532	34	,	,	,
50458	532	35	resins	resin	NNS
50458	532	36	,	,	,
50458	532	37	alkaloids	alkaloid	NNS
50458	532	38	,	,	,
50458	532	39	and	and	CC
50458	532	40	albuminoids	albuminoid	NNS
50458	532	41	.	.	.
50458	533	1	The	the	DT
50458	533	2	study	study	NN
50458	533	3	of	of	IN
50458	533	4	the	the	DT
50458	533	5	last	last	JJ
50458	533	6	only	only	RB
50458	533	7	,	,	,
50458	533	8	the	the	DT
50458	533	9	albuminoids	albuminoid	NNS
50458	533	10	and	and	CC
50458	533	11	diastases	diastasis	NNS
50458	533	12	,	,	,
50458	533	13	interests	interest	NNS
50458	533	14	us	-PRON-	PRP
50458	533	15	here	here	RB
50458	533	16	.	.	.
50458	534	1	The	the	DT
50458	534	2	most	most	RBS
50458	534	3	important	important	JJ
50458	534	4	of	of	IN
50458	534	5	these	these	DT
50458	534	6	albuminoid	albuminoid	NN
50458	534	7	substances	substance	NNS
50458	534	8	,	,	,
50458	534	9	_	_	NNP
50458	534	10	phallin	phallin	NNP
50458	534	11	_	_	NNP
50458	534	12	,	,	,
50458	534	13	was	be	VBD
50458	534	14	discovered	discover	VBN
50458	534	15	in	in	IN
50458	534	16	1890	1890	CD
50458	534	17	by	by	IN
50458	534	18	Kobert	Kobert	NNP
50458	534	19	.	.	.
50458	535	1	Pouchet	Pouchet	NNP
50458	535	2	also	also	RB
50458	535	3	has	have	VBZ
50458	535	4	isolated	isolate	VBN
50458	535	5	a	a	DT
50458	535	6	whole	whole	JJ
50458	535	7	series	series	NN
50458	535	8	of	of	IN
50458	535	9	other	other	JJ
50458	535	10	toxic	toxic	JJ
50458	535	11	albuminoids	albuminoid	NNS
50458	535	12	,	,	,
50458	535	13	particularly	particularly	RB
50458	535	14	from	from	IN
50458	535	15	Amanita	Amanita	NNP
50458	535	16	muscaria	muscaria	NN
50458	535	17	(	(	-LRB-
50458	535	18	Fly	Fly	NNP
50458	535	19	Agaric	Agaric	NNP
50458	535	20	)	)	-RRB-
50458	535	21	.	.	.
50458	536	1	There	there	EX
50458	536	2	are	be	VBP
50458	536	3	alimentary	alimentary	JJ
50458	536	4	as	as	RB
50458	536	5	well	well	RB
50458	536	6	as	as	IN
50458	536	7	toxic	toxic	JJ
50458	536	8	species	specie	NNS
50458	536	9	in	in	IN
50458	536	10	every	every	DT
50458	536	11	possible	possible	JJ
50458	536	12	variety	variety	NN
50458	536	13	among	among	IN
50458	536	14	mushrooms	mushroom	NNS
50458	536	15	,	,	,
50458	536	16	some	some	DT
50458	536	17	species	specie	NNS
50458	536	18	consisting	consist	VBG
50458	536	19	chiefly	chiefly	RB
50458	536	20	of	of	IN
50458	536	21	the	the	DT
50458	536	22	edible	edible	JJ
50458	536	23	kind	kind	NN
50458	536	24	,	,	,
50458	536	25	others	other	NNS
50458	536	26	consisting	consist	VBG
50458	536	27	of	of	IN
50458	536	28	the	the	DT
50458	536	29	poisonous	poisonous	JJ
50458	536	30	variety	variety	NN
50458	536	31	.	.	.
50458	537	1	In	in	IN
50458	537	2	consequence	consequence	NN
50458	537	3	of	of	IN
50458	537	4	the	the	DT
50458	537	5	toxicity	toxicity	NN
50458	537	6	of	of	IN
50458	537	7	mushrooms	mushroom	NNS
50458	537	8	,	,	,
50458	537	9	great	great	JJ
50458	537	10	attention	attention	NN
50458	537	11	must	must	MD
50458	537	12	be	be	VB
50458	537	13	given	give	VBN
50458	537	14	to	to	IN
50458	537	15	the	the	DT
50458	537	16	treatment	treatment	NN
50458	537	17	to	to	TO
50458	537	18	which	which	WDT
50458	537	19	they	-PRON-	PRP
50458	537	20	are	be	VBP
50458	537	21	subjected	subject	VBN
50458	537	22	when	when	WRB
50458	537	23	it	-PRON-	PRP
50458	537	24	is	be	VBZ
50458	537	25	desired	desire	VBN
50458	537	26	to	to	TO
50458	537	27	utilize	utilize	VB
50458	537	28	them	-PRON-	PRP
50458	537	29	for	for	IN
50458	537	30	alimentary	alimentary	JJ
50458	537	31	purposes	purpose	NNS
50458	537	32	.	.	.
50458	538	1	Thus	thus	RB
50458	538	2	the	the	DT
50458	538	3	toxic	toxic	JJ
50458	538	4	principles	principle	NNS
50458	538	5	of	of	IN
50458	538	6	several	several	JJ
50458	538	7	varieties	variety	NNS
50458	538	8	can	can	MD
50458	538	9	be	be	VB
50458	538	10	removed	remove	VBN
50458	538	11	,	,	,
50458	538	12	and	and	CC
50458	538	13	the	the	DT
50458	538	14	mushrooms	mushroom	NNS
50458	538	15	rendered	render	VBN
50458	538	16	edible	edible	JJ
50458	538	17	by	by	IN
50458	538	18	very	very	RB
50458	538	19	simple	simple	JJ
50458	538	20	means	mean	NNS
50458	538	21	.	.	.
50458	539	1	Pouchet	Pouchet	NNP
50458	539	2	has	have	VBZ
50458	539	3	made	make	VBN
50458	539	4	a	a	DT
50458	539	5	very	very	RB
50458	539	6	ingenious	ingenious	JJ
50458	539	7	comparison	comparison	NN
50458	539	8	between	between	IN
50458	539	9	the	the	DT
50458	539	10	ethereal	ethereal	NN
50458	539	11	,	,	,
50458	539	12	alcoholic	alcoholic	JJ
50458	539	13	,	,	,
50458	539	14	saline	saline	JJ
50458	539	15	,	,	,
50458	539	16	and	and	CC
50458	539	17	aqueous	aqueous	JJ
50458	539	18	extracts	extract	NNS
50458	539	19	of	of	IN
50458	539	20	mushrooms	mushroom	NNS
50458	539	21	,	,	,
50458	539	22	and	and	CC
50458	539	23	bacterial	bacterial	JJ
50458	539	24	cultures	culture	NNS
50458	539	25	.	.	.
50458	540	1	The	the	DT
50458	540	2	analogy	analogy	NN
50458	540	3	is	be	VBZ
50458	540	4	striking	strike	VBG
50458	540	5	as	as	IN
50458	540	6	to	to	IN
50458	540	7	the	the	DT
50458	540	8	presence	presence	NN
50458	540	9	of	of	IN
50458	540	10	toxin	toxin	NN
50458	540	11	,	,	,
50458	540	12	toxalbumose	toxalbumose	RB
50458	540	13	,	,	,
50458	540	14	and	and	CC
50458	540	15	albumoses	albumose	VBZ
50458	540	16	more	more	RBR
50458	540	17	or	or	CC
50458	540	18	less	less	RBR
50458	540	19	toxic	toxic	JJ
50458	540	20	;	;	:
50458	540	21	it	-PRON-	PRP
50458	540	22	is	be	VBZ
50458	540	23	moreover	moreover	RB
50458	540	24	not	not	RB
50458	540	25	exaggerated	exaggerate	VBN
50458	540	26	,	,	,
50458	540	27	since	since	IN
50458	540	28	,	,	,
50458	540	29	according	accord	VBG
50458	540	30	to	to	IN
50458	540	31	the	the	DT
50458	540	32	classification	classification	NN
50458	540	33	generally	generally	RB
50458	540	34	admitted	admit	VBN
50458	540	35	,	,	,
50458	540	36	mushrooms	mushroom	NNS
50458	540	37	are	be	VBP
50458	540	38	nothing	nothing	NN
50458	540	39	more	more	JJR
50458	540	40	than	than	IN
50458	540	41	the	the	DT
50458	540	42	very	very	RB
50458	540	43	advanced	advanced	JJ
50458	540	44	representatives	representative	NNS
50458	540	45	of	of	IN
50458	540	46	a	a	DT
50458	540	47	group	group	NN
50458	540	48	the	the	DT
50458	540	49	more	more	RBR
50458	540	50	simple	simple	JJ
50458	540	51	members	member	NNS
50458	540	52	of	of	IN
50458	540	53	which	which	WDT
50458	540	54	constitute	constitute	VBP
50458	540	55	the	the	DT
50458	540	56	bacteria	bacteria	NNS
50458	540	57	.	.	.
50458	541	1	The	the	DT
50458	541	2	same	same	JJ
50458	541	3	author	author	NN
50458	541	4	has	have	VBZ
50458	541	5	shown	show	VBN
50458	541	6	that	that	DT
50458	541	7	phallin	phallin	NN
50458	541	8	obtained	obtain	VBD
50458	541	9	from	from	IN
50458	541	10	the	the	DT
50458	541	11	juice	juice	NN
50458	541	12	of	of	IN
50458	541	13	the	the	DT
50458	541	14	Fly	Fly	NNP
50458	541	15	Agaric	Agaric	NNP
50458	541	16	will	will	MD
50458	541	17	kill	kill	VB
50458	541	18	a	a	DT
50458	541	19	guinea	guinea	NN
50458	541	20	-	-	HYPH
50458	541	21	pig	pig	NN
50458	541	22	weighing	weigh	VBG
50458	541	23	600	600	CD
50458	541	24	grammes	gramme	NNS
50458	541	25	in	in	IN
50458	541	26	one	one	CD
50458	541	27	hour	hour	NN
50458	541	28	.	.	.
50458	542	1	As	as	IN
50458	542	2	we	-PRON-	PRP
50458	542	3	have	have	VBP
50458	542	4	already	already	RB
50458	542	5	stated	state	VBN
50458	542	6	,	,	,
50458	542	7	it	-PRON-	PRP
50458	542	8	is	be	VBZ
50458	542	9	the	the	DT
50458	542	10	phalline	phalline	NN
50458	542	11	to	to	TO
50458	542	12	which	which	WDT
50458	542	13	the	the	DT
50458	542	14	ordinary	ordinary	JJ
50458	542	15	disorders	disorder	NNS
50458	542	16	which	which	WDT
50458	542	17	mushrooms	mushroom	NNS
50458	542	18	cause	cause	NN
50458	542	19	are	be	VBP
50458	542	20	due	due	JJ
50458	542	21	.	.	.
50458	543	1	According	accord	VBG
50458	543	2	to	to	IN
50458	543	3	Kobert	Kobert	NNP
50458	543	4	,	,	,
50458	543	5	a	a	DT
50458	543	6	1:250	1:250	CD
50458	543	7	000	000	CD
50458	543	8	solution	solution	NN
50458	543	9	of	of	IN
50458	543	10	this	this	DT
50458	543	11	substance	substance	NN
50458	543	12	causes	cause	VBZ
50458	543	13	an	an	DT
50458	543	14	intense	intense	JJ
50458	543	15	hemolysis	hemolysis	NN
50458	543	16	,	,	,
50458	543	17	with	with	IN
50458	543	18	all	all	DT
50458	543	19	its	-PRON-	PRP$
50458	543	20	disastrous	disastrous	JJ
50458	543	21	consequences	consequence	NNS
50458	543	22	.	.	.
50458	544	1	According	accord	VBG
50458	544	2	to	to	IN
50458	544	3	Pouchet	Pouchet	NNP
50458	544	4	,	,	,
50458	544	5	the	the	DT
50458	544	6	flesh	flesh	NN
50458	544	7	of	of	IN
50458	544	8	mushrooms	mushroom	NNS
50458	544	9	must	must	MD
50458	544	10	be	be	VB
50458	544	11	compared	compare	VBN
50458	544	12	with	with	IN
50458	544	13	meat	meat	NN
50458	544	14	that	that	WDT
50458	544	15	has	have	VBZ
50458	544	16	been	be	VBN
50458	544	17	kept	keep	VBN
50458	544	18	for	for	IN
50458	544	19	some	some	DT
50458	544	20	time	time	NN
50458	544	21	to	to	TO
50458	544	22	become	become	VB
50458	544	23	tender	tender	JJ
50458	544	24	,	,	,
50458	544	25	and	and	CC
50458	544	26	it	-PRON-	PRP
50458	544	27	is	be	VBZ
50458	544	28	well	well	RB
50458	544	29	known	know	VBN
50458	544	30	that	that	IN
50458	544	31	though	though	IN
50458	544	32	this	this	DT
50458	544	33	"	"	``
50458	544	34	tendering	tendering	JJ
50458	544	35	"	"	''
50458	544	36	process	process	NN
50458	544	37	renders	render	VBZ
50458	544	38	the	the	DT
50458	544	39	meat	meat	NN
50458	544	40	more	more	RBR
50458	544	41	digestible	digestible	JJ
50458	544	42	,	,	,
50458	544	43	it	-PRON-	PRP
50458	544	44	may	may	MD
50458	544	45	also	also	RB
50458	544	46	allow	allow	VB
50458	544	47	the	the	DT
50458	544	48	meat	meat	NN
50458	544	49	to	to	TO
50458	544	50	acquire	acquire	VB
50458	544	51	noxious	noxious	JJ
50458	544	52	properties	property	NNS
50458	544	53	,	,	,
50458	544	54	due	due	IN
50458	544	55	to	to	IN
50458	544	56	the	the	DT
50458	544	57	presence	presence	NN
50458	544	58	of	of	IN
50458	544	59	toxins	toxin	NNS
50458	544	60	.	.	.
50458	545	1	Phallin	Phallin	NNP
50458	545	2	is	be	VBZ
50458	545	3	the	the	DT
50458	545	4	type	type	NN
50458	545	5	of	of	IN
50458	545	6	those	those	DT
50458	545	7	toxic	toxic	JJ
50458	545	8	albuminoids	albuminoid	NNS
50458	545	9	of	of	IN
50458	545	10	unknown	unknown	JJ
50458	545	11	composition	composition	NN
50458	545	12	which	which	WDT
50458	545	13	exist	exist	VBP
50458	545	14	in	in	IN
50458	545	15	mushrooms	mushroom	NNS
50458	545	16	,	,	,
50458	545	17	and	and	CC
50458	545	18	which	which	WDT
50458	545	19	are	be	VBP
50458	545	20	comprised	comprise	VBN
50458	545	21	under	under	IN
50458	545	22	the	the	DT
50458	545	23	name	name	NN
50458	545	24	_	_	NNP
50458	545	25	sapotoxins	sapotoxins	NNP
50458	545	26	_	_	NNP
50458	545	27	.	.	.
50458	546	1	The	the	DT
50458	546	2	intravenous	intravenous	JJ
50458	546	3	injection	injection	NN
50458	546	4	of	of	IN
50458	546	5	phallin	phallin	NNP
50458	546	6	into	into	IN
50458	546	7	an	an	DT
50458	546	8	animal	animal	NN
50458	546	9	,	,	,
50458	546	10	in	in	IN
50458	546	11	the	the	DT
50458	546	12	proportion	proportion	NN
50458	546	13	of	of	IN
50458	546	14	1	1	CD
50458	546	15	part	part	NN
50458	546	16	to	to	IN
50458	546	17	1	1	CD
50458	546	18	000	000	CD
50458	546	19	000	000	CD
50458	546	20	parts	part	NNS
50458	546	21	of	of	IN
50458	546	22	body	body	NN
50458	546	23	weight	weight	NN
50458	546	24	,	,	,
50458	546	25	causes	cause	VBZ
50458	546	26	sudden	sudden	JJ
50458	546	27	death	death	NN
50458	546	28	within	within	IN
50458	546	29	one	one	CD
50458	546	30	minute	minute	NN
50458	546	31	;	;	:
50458	546	32	in	in	IN
50458	546	33	the	the	DT
50458	546	34	proportion	proportion	NN
50458	546	35	of	of	IN
50458	546	36	1:5	1:5	CD
50458	546	37	000	000	CD
50458	546	38	000	000	CD
50458	546	39	,	,	,
50458	546	40	death	death	NN
50458	546	41	occurs	occur	VBZ
50458	546	42	in	in	RB
50458	546	43	about	about	RB
50458	546	44	three	three	CD
50458	546	45	minutes	minute	NNS
50458	546	46	;	;	:
50458	546	47	in	in	IN
50458	546	48	the	the	DT
50458	546	49	proportion	proportion	NN
50458	546	50	of	of	IN
50458	546	51	1:50	1:50	CD
50458	546	52	000	000	CD
50458	546	53	000	000	CD
50458	546	54	,	,	,
50458	546	55	death	death	NN
50458	546	56	also	also	RB
50458	546	57	occurs	occur	VBZ
50458	546	58	,	,	,
50458	546	59	but	but	CC
50458	546	60	is	be	VBZ
50458	546	61	greatly	greatly	RB
50458	546	62	retarded	retarded	JJ
50458	546	63	.	.	.
50458	547	1	An	an	DT
50458	547	2	injection	injection	NN
50458	547	3	of	of	IN
50458	547	4	0.0005	0.0005	NNP
50458	547	5	Gm	Gm	NNP
50458	547	6	.	.	.
50458	548	1	per	per	IN
50458	548	2	kilo	kilo	NNP
50458	548	3	of	of	IN
50458	548	4	body	body	NN
50458	548	5	weight	weight	NN
50458	548	6	of	of	IN
50458	548	7	animal	animal	NN
50458	548	8	causes	cause	VBZ
50458	548	9	solution	solution	NN
50458	548	10	of	of	IN
50458	548	11	the	the	DT
50458	548	12	blood	blood	NN
50458	548	13	corpuscles	corpuscle	NNS
50458	548	14	to	to	IN
50458	548	15	such	such	PDT
50458	548	16	an	an	DT
50458	548	17	extent	extent	NN
50458	548	18	that	that	IN
50458	548	19	thirty	thirty	CD
50458	548	20	minutes	minute	NNS
50458	548	21	later	later	RB
50458	548	22	the	the	DT
50458	548	23	blood	blood	NN
50458	548	24	serum	serum	NN
50458	548	25	is	be	VBZ
50458	548	26	strongly	strongly	RB
50458	548	27	colored	color	VBN
50458	548	28	red	red	JJ
50458	548	29	,	,	,
50458	548	30	as	as	RB
50458	548	31	well	well	RB
50458	548	32	as	as	IN
50458	548	33	the	the	DT
50458	548	34	veins	vein	NNS
50458	548	35	.	.	.
50458	549	1	Instead	instead	RB
50458	549	2	of	of	IN
50458	549	3	being	be	VBG
50458	549	4	easily	easily	RB
50458	549	5	altered	alter	VBN
50458	549	6	under	under	IN
50458	549	7	the	the	DT
50458	549	8	influence	influence	NN
50458	549	9	of	of	IN
50458	549	10	an	an	DT
50458	549	11	elevated	elevated	JJ
50458	549	12	temperature	temperature	NN
50458	549	13	,	,	,
50458	549	14	as	as	IN
50458	549	15	are	be	VBP
50458	549	16	many	many	JJ
50458	549	17	of	of	IN
50458	549	18	the	the	DT
50458	549	19	albuminoid	albuminoid	NN
50458	549	20	substances	substance	NNS
50458	549	21	,	,	,
50458	549	22	whereby	whereby	WRB
50458	549	23	their	-PRON-	PRP$
50458	549	24	toxic	toxic	JJ
50458	549	25	power	power	NN
50458	549	26	is	be	VBZ
50458	549	27	lost	lose	VBN
50458	549	28	,	,	,
50458	549	29	phallin	phallin	NNP
50458	549	30	may	may	MD
50458	549	31	be	be	VB
50458	549	32	boiled	boil	VBN
50458	549	33	for	for	IN
50458	549	34	half	half	PDT
50458	549	35	an	an	DT
50458	549	36	hour	hour	NN
50458	549	37	with	with	IN
50458	549	38	water	water	NN
50458	549	39	without	without	IN
50458	549	40	undergoing	undergo	VBG
50458	549	41	any	any	DT
50458	549	42	noticeable	noticeable	JJ
50458	549	43	alteration	alteration	NN
50458	549	44	.	.	.
50458	550	1	Pellegrini	Pellegrini	NNP
50458	550	2	has	have	VBZ
50458	550	3	observed	observe	VBN
50458	550	4	that	that	IN
50458	550	5	the	the	DT
50458	550	6	dried	dry	VBN
50458	550	7	juice	juice	NN
50458	550	8	of	of	IN
50458	550	9	Amanita	Amanita	NNP
50458	550	10	Phalloides	Phalloides	NNP
50458	550	11	(	(	-LRB-
50458	550	12	Death	death	NN
50458	550	13	-	-	HYPH
50458	550	14	cup	cup	NNP
50458	550	15	)	)	-RRB-
50458	550	16	preserves	preserve	VBZ
50458	550	17	its	-PRON-	PRP$
50458	550	18	properties	property	NNS
50458	550	19	for	for	IN
50458	550	20	more	more	JJR
50458	550	21	than	than	IN
50458	550	22	a	a	DT
50458	550	23	year	year	NN
50458	550	24	.	.	.
50458	551	1	According	accord	VBG
50458	551	2	to	to	IN
50458	551	3	a	a	DT
50458	551	4	recent	recent	JJ
50458	551	5	paper	paper	NN
50458	551	6	by	by	IN
50458	551	7	Gillot	Gillot	NNP
50458	551	8	,	,	,
50458	551	9	the	the	DT
50458	551	10	symptoms	symptom	NNS
50458	551	11	of	of	IN
50458	551	12	poisoning	poisoning	NN
50458	551	13	by	by	IN
50458	551	14	mushrooms	mushroom	NNS
50458	551	15	must	must	MD
50458	551	16	be	be	VB
50458	551	17	ascribed	ascribe	VBN
50458	551	18	to	to	IN
50458	551	19	albuminoids	albuminoid	NNS
50458	551	20	(	(	-LRB-
50458	551	21	phallin	phallin	NNP
50458	551	22	and	and	CC
50458	551	23	albumose	albumose	NNP
50458	551	24	)	)	-RRB-
50458	551	25	,	,	,
50458	551	26	alkaloids	alkaloids	NNP
50458	551	27	(	(	-LRB-
50458	551	28	muscarine	muscarine	NNP
50458	551	29	,	,	,
50458	551	30	choline	choline	NNP
50458	551	31	,	,	,
50458	551	32	or	or	CC
50458	551	33	betaine	betaine	JJ
50458	551	34	)	)	-RRB-
50458	551	35	,	,	,
50458	551	36	or	or	CC
50458	551	37	to	to	IN
50458	551	38	resinoids	resinoid	NNS
50458	551	39	(	(	-LRB-
50458	551	40	cambogic	cambogic	NNP
50458	551	41	and	and	CC
50458	551	42	agaricic	agaricic	NNP
50458	551	43	acids	acids	NNP
50458	551	44	)	)	-RRB-
50458	551	45	.	.	.
50458	552	1	The	the	DT
50458	552	2	_	_	NNP
50458	552	3	alkaloids	alkaloid	VBZ
50458	552	4	_	_	NNP
50458	552	5	found	find	VBD
50458	552	6	in	in	IN
50458	552	7	mushrooms	mushroom	NNS
50458	552	8	are	be	VBP
50458	552	9	:	:	:
50458	552	10	_	_	NNP
50458	552	11	Muscaridine	Muscaridine	NNP
50458	552	12	_	_	NNP
50458	552	13	(	(	-LRB-
50458	552	14	an	an	DT
50458	552	15	oxyneurine	oxyneurine	NN
50458	552	16	)	)	-RRB-
50458	552	17	,	,	,
50458	552	18	which	which	WDT
50458	552	19	possesses	possess	VBZ
50458	552	20	considerable	considerable	JJ
50458	552	21	toxicity	toxicity	NN
50458	552	22	,	,	,
50458	552	23	and	and	CC
50458	552	24	of	of	IN
50458	552	25	which	which	WDT
50458	552	26	0.00005	0.00005	NNP
50458	552	27	Gm	Gm	NNP
50458	552	28	.	.	.
50458	553	1	suffices	suffice	VBZ
50458	553	2	to	to	TO
50458	553	3	kill	kill	VB
50458	553	4	a	a	DT
50458	553	5	frog	frog	NN
50458	553	6	;	;	:
50458	553	7	_	_	NNP
50458	553	8	neurine	neurine	NN
50458	553	9	_	_	NNP
50458	553	10	(	(	-LRB-
50458	553	11	trimethylethylammonium	trimethylethylammonium	NNP
50458	553	12	hydroxide	hydroxide	NNP
50458	553	13	)	)	-RRB-
50458	553	14	;	;	:
50458	553	15	_	_	NNP
50458	553	16	choline	choline	NN
50458	553	17	_	_	NNP
50458	553	18	(	(	-LRB-
50458	553	19	trimethyloxyethylammonium	trimethyloxyethylammonium	NN
50458	553	20	hydroxide	hydroxide	NN
50458	553	21	)	)	-RRB-
50458	553	22	;	;	:
50458	553	23	_	_	NNP
50458	553	24	mycetomuscarine	mycetomuscarine	NNP
50458	553	25	_	_	NNP
50458	553	26	;	;	:
50458	553	27	_	_	NNP
50458	553	28	anhydromuscarine	anhydromuscarine	NN
50458	553	29	_	_	NNP
50458	553	30	(	(	-LRB-
50458	553	31	an	an	DT
50458	553	32	oxyneurine	oxyneurine	NN
50458	553	33	)	)	-RRB-
50458	553	34	;	;	:
50458	553	35	and	and	CC
50458	553	36	a	a	DT
50458	553	37	whole	whole	JJ
50458	553	38	series	series	NN
50458	553	39	of	of	IN
50458	553	40	various	various	JJ
50458	553	41	betaines	betaine	NNS
50458	553	42	.	.	.
50458	554	1	=	=	NFP
50458	554	2	Symptomology.=--It	Symptomology.=--It	NNP
50458	554	3	is	be	VBZ
50458	554	4	quite	quite	RB
50458	554	5	natural	natural	JJ
50458	554	6	to	to	TO
50458	554	7	divide	divide	VB
50458	554	8	this	this	DT
50458	554	9	symptomology	symptomology	NN
50458	554	10	into	into	IN
50458	554	11	three	three	CD
50458	554	12	different	different	JJ
50458	554	13	periods	period	NNS
50458	554	14	;	;	:
50458	554	15	that	that	DT
50458	554	16	of	of	IN
50458	554	17	incubation	incubation	NN
50458	554	18	,	,	,
50458	554	19	that	that	DT
50458	554	20	of	of	IN
50458	554	21	manifestation	manifestation	NN
50458	554	22	of	of	IN
50458	554	23	symptoms	symptom	NNS
50458	554	24	,	,	,
50458	554	25	and	and	CC
50458	554	26	that	that	DT
50458	554	27	of	of	IN
50458	554	28	termination	termination	NN
50458	554	29	.	.	.
50458	555	1	The	the	DT
50458	555	2	duration	duration	NN
50458	555	3	of	of	IN
50458	555	4	the	the	DT
50458	555	5	first	first	JJ
50458	555	6	period	period	NN
50458	555	7	,	,	,
50458	555	8	that	that	DT
50458	555	9	of	of	IN
50458	555	10	incubation	incubation	NN
50458	555	11	,	,	,
50458	555	12	is	be	VBZ
50458	555	13	exceedingly	exceedingly	RB
50458	555	14	variable	variable	JJ
50458	555	15	;	;	:
50458	555	16	it	-PRON-	PRP
50458	555	17	very	very	RB
50458	555	18	rarely	rarely	RB
50458	555	19	lasts	last	VBZ
50458	555	20	more	more	JJR
50458	555	21	than	than	IN
50458	555	22	forty	forty	CD
50458	555	23	-	-	HYPH
50458	555	24	eight	eight	CD
50458	555	25	hours	hour	NNS
50458	555	26	,	,	,
50458	555	27	and	and	CC
50458	555	28	becomes	become	VBZ
50458	555	29	general	general	JJ
50458	555	30	only	only	RB
50458	555	31	a	a	DT
50458	555	32	few	few	JJ
50458	555	33	hours	hour	NNS
50458	555	34	after	after	IN
50458	555	35	absorption	absorption	NN
50458	555	36	.	.	.
50458	556	1	Certain	certain	JJ
50458	556	2	conditions	condition	NNS
50458	556	3	influence	influence	VBP
50458	556	4	the	the	DT
50458	556	5	duration	duration	NN
50458	556	6	;	;	:
50458	556	7	firstly	firstly	RB
50458	556	8	the	the	DT
50458	556	9	quantity	quantity	NN
50458	556	10	of	of	IN
50458	556	11	mushrooms	mushroom	NNS
50458	556	12	ingested	ingest	VBN
50458	556	13	,	,	,
50458	556	14	then	then	RB
50458	556	15	the	the	DT
50458	556	16	manner	manner	NN
50458	556	17	in	in	IN
50458	556	18	which	which	WDT
50458	556	19	they	-PRON-	PRP
50458	556	20	were	be	VBD
50458	556	21	prepared	prepare	VBN
50458	556	22	;	;	:
50458	556	23	and	and	CC
50458	556	24	,	,	,
50458	556	25	to	to	IN
50458	556	26	some	some	DT
50458	556	27	extent	extent	NN
50458	556	28	,	,	,
50458	556	29	the	the	DT
50458	556	30	nature	nature	NN
50458	556	31	of	of	IN
50458	556	32	the	the	DT
50458	556	33	organism	organism	NN
50458	556	34	,	,	,
50458	556	35	whether	whether	IN
50458	556	36	child	child	NN
50458	556	37	or	or	CC
50458	556	38	adult	adult	NN
50458	556	39	,	,	,
50458	556	40	healthy	healthy	JJ
50458	556	41	or	or	CC
50458	556	42	in	in	IN
50458	556	43	poor	poor	JJ
50458	556	44	health	health	NN
50458	556	45	.	.	.
50458	557	1	When	when	WRB
50458	557	2	it	-PRON-	PRP
50458	557	3	is	be	VBZ
50458	557	4	a	a	DT
50458	557	5	question	question	NN
50458	557	6	of	of	IN
50458	557	7	the	the	DT
50458	557	8	more	more	RBR
50458	557	9	particularly	particularly	RB
50458	557	10	alkaloid	alkaloid	RB
50458	557	11	-	-	HYPH
50458	557	12	containing	contain	VBG
50458	557	13	mushrooms	mushroom	NNS
50458	557	14	,	,	,
50458	557	15	especially	especially	RB
50458	557	16	when	when	WRB
50458	557	17	the	the	DT
50458	557	18	poisoning	poisoning	NN
50458	557	19	is	be	VBZ
50458	557	20	due	due	JJ
50458	557	21	to	to	IN
50458	557	22	muscarine	muscarine	NN
50458	557	23	,	,	,
50458	557	24	the	the	DT
50458	557	25	toxic	toxic	JJ
50458	557	26	symptoms	symptom	NNS
50458	557	27	generally	generally	RB
50458	557	28	develop	develop	VBP
50458	557	29	rapidly	rapidly	RB
50458	557	30	,	,	,
50458	557	31	the	the	DT
50458	557	32	first	first	JJ
50458	557	33	symptoms	symptom	NNS
50458	557	34	appearing	appear	VBG
50458	557	35	about	about	RB
50458	557	36	one	one	CD
50458	557	37	hour	hour	NN
50458	557	38	after	after	IN
50458	557	39	the	the	DT
50458	557	40	ingestion	ingestion	NN
50458	557	41	of	of	IN
50458	557	42	the	the	DT
50458	557	43	mushrooms	mushroom	NNS
50458	557	44	.	.	.
50458	558	1	On	on	IN
50458	558	2	the	the	DT
50458	558	3	other	other	JJ
50458	558	4	hand	hand	NN
50458	558	5	,	,	,
50458	558	6	if	if	IN
50458	558	7	the	the	DT
50458	558	8	poisoning	poisoning	NN
50458	558	9	is	be	VBZ
50458	558	10	due	due	JJ
50458	558	11	to	to	IN
50458	558	12	one	one	CD
50458	558	13	of	of	IN
50458	558	14	the	the	DT
50458	558	15	albuminoid	albuminoid	NN
50458	558	16	group	group	NNP
50458	558	17	,	,	,
50458	558	18	and	and	CC
50458	558	19	particularly	particularly	RB
50458	558	20	in	in	IN
50458	558	21	the	the	DT
50458	558	22	case	case	NN
50458	558	23	of	of	IN
50458	558	24	phallin	phallin	NNP
50458	558	25	,	,	,
50458	558	26	the	the	DT
50458	558	27	period	period	NN
50458	558	28	of	of	IN
50458	558	29	incubation	incubation	NN
50458	558	30	is	be	VBZ
50458	558	31	longer	long	JJR
50458	558	32	,	,	,
50458	558	33	and	and	CC
50458	558	34	may	may	MD
50458	558	35	last	last	VB
50458	558	36	ten	ten	CD
50458	558	37	,	,	,
50458	558	38	twenty	twenty	CD
50458	558	39	,	,	,
50458	558	40	thirty	thirty	CD
50458	558	41	,	,	,
50458	558	42	or	or	CC
50458	558	43	even	even	RB
50458	558	44	forty	forty	CD
50458	558	45	-	-	HYPH
50458	558	46	eight	eight	CD
50458	558	47	hours	hour	NNS
50458	558	48	and	and	CC
50458	558	49	more	more	JJR
50458	558	50	.	.	.
50458	559	1	The	the	DT
50458	559	2	symptoms	symptom	NNS
50458	559	3	begin	begin	VBP
50458	559	4	with	with	IN
50458	559	5	dizziness	dizziness	NN
50458	559	6	and	and	CC
50458	559	7	an	an	DT
50458	559	8	indefinable	indefinable	JJ
50458	559	9	sensation	sensation	NN
50458	559	10	of	of	IN
50458	559	11	being	be	VBG
50458	559	12	ill	ill	JJ
50458	559	13	.	.	.
50458	560	1	The	the	DT
50458	560	2	second	second	JJ
50458	560	3	period	period	NN
50458	560	4	is	be	VBZ
50458	560	5	characterized	characterize	VBN
50458	560	6	chiefly	chiefly	RB
50458	560	7	by	by	IN
50458	560	8	digestive	digestive	JJ
50458	560	9	and	and	CC
50458	560	10	by	by	IN
50458	560	11	nervous	nervous	JJ
50458	560	12	derangements	derangement	NNS
50458	560	13	.	.	.
50458	561	1	The	the	DT
50458	561	2	digestive	digestive	JJ
50458	561	3	derangements	derangement	NNS
50458	561	4	are	be	VBP
50458	561	5	evidenced	evidence	VBN
50458	561	6	by	by	IN
50458	561	7	very	very	RB
50458	561	8	violent	violent	JJ
50458	561	9	and	and	CC
50458	561	10	painful	painful	JJ
50458	561	11	vomiting	vomiting	NN
50458	561	12	,	,	,
50458	561	13	and	and	CC
50458	561	14	diarrheas	diarrhea	NNS
50458	561	15	of	of	IN
50458	561	16	choleraic	choleraic	NN
50458	561	17	or	or	CC
50458	561	18	dysenteric	dysenteric	JJ
50458	561	19	character	character	NN
50458	561	20	.	.	.
50458	562	1	The	the	DT
50458	562	2	nervous	nervous	JJ
50458	562	3	derangements	derangement	NNS
50458	562	4	vary	vary	VBP
50458	562	5	according	accord	VBG
50458	562	6	to	to	IN
50458	562	7	whether	whether	IN
50458	562	8	they	-PRON-	PRP
50458	562	9	are	be	VBP
50458	562	10	developed	develop	VBN
50458	562	11	by	by	IN
50458	562	12	an	an	DT
50458	562	13	alkaloid	alkaloid	NN
50458	562	14	,	,	,
50458	562	15	which	which	WDT
50458	562	16	causes	cause	VBZ
50458	562	17	delirium	delirium	NN
50458	562	18	with	with	IN
50458	562	19	hallucination	hallucination	NN
50458	562	20	,	,	,
50458	562	21	or	or	CC
50458	562	22	by	by	IN
50458	562	23	albuminoids	albuminoid	NNS
50458	562	24	,	,	,
50458	562	25	which	which	WDT
50458	562	26	cause	cause	VBP
50458	562	27	depression	depression	NN
50458	562	28	,	,	,
50458	562	29	ataxo	ataxo	JJ
50458	562	30	-	-	HYPH
50458	562	31	adynamia	adynamia	NN
50458	562	32	,	,	,
50458	562	33	and	and	CC
50458	562	34	stupor	stupor	NN
50458	562	35	,	,	,
50458	562	36	these	these	DT
50458	562	37	being	be	VBG
50458	562	38	particularly	particularly	RB
50458	562	39	characteristic	characteristic	JJ
50458	562	40	of	of	IN
50458	562	41	the	the	DT
50458	562	42	action	action	NN
50458	562	43	of	of	IN
50458	562	44	the	the	DT
50458	562	45	toxic	toxic	JJ
50458	562	46	albuminoids	albuminoid	NNS
50458	562	47	.	.	.
50458	563	1	As	as	IN
50458	563	2	for	for	IN
50458	563	3	the	the	DT
50458	563	4	period	period	NN
50458	563	5	of	of	IN
50458	563	6	termination	termination	NN
50458	563	7	,	,	,
50458	563	8	it	-PRON-	PRP
50458	563	9	results	result	VBZ
50458	563	10	either	either	CC
50458	563	11	in	in	IN
50458	563	12	death	death	NN
50458	563	13	or	or	CC
50458	563	14	a	a	DT
50458	563	15	cure	cure	NN
50458	563	16	.	.	.
50458	564	1	If	if	IN
50458	564	2	the	the	DT
50458	564	3	poisoning	poisoning	NN
50458	564	4	is	be	VBZ
50458	564	5	due	due	JJ
50458	564	6	to	to	IN
50458	564	7	phallin	phallin	NN
50458	564	8	,	,	,
50458	564	9	death	death	NN
50458	564	10	appears	appear	VBZ
50458	564	11	to	to	TO
50458	564	12	be	be	VB
50458	564	13	an	an	DT
50458	564	14	almost	almost	RB
50458	564	15	inevitable	inevitable	JJ
50458	564	16	consequence	consequence	NN
50458	564	17	,	,	,
50458	564	18	as	as	IN
50458	564	19	it	-PRON-	PRP
50458	564	20	occurs	occur	VBZ
50458	564	21	in	in	IN
50458	564	22	80	80	CD
50458	564	23	per	per	NN
50458	564	24	cent	cent	NN
50458	564	25	.	.	.
50458	565	1	or	or	CC
50458	565	2	more	more	JJR
50458	565	3	of	of	IN
50458	565	4	the	the	DT
50458	565	5	cases	case	NNS
50458	565	6	.	.	.
50458	566	1	The	the	DT
50458	566	2	poisoning	poisoning	NN
50458	566	3	by	by	IN
50458	566	4	the	the	DT
50458	566	5	alkaloids	alkaloid	NNS
50458	566	6	is	be	VBZ
50458	566	7	less	less	RBR
50458	566	8	dangerous	dangerous	JJ
50458	566	9	,	,	,
50458	566	10	and	and	CC
50458	566	11	the	the	DT
50458	566	12	cure	cure	NN
50458	566	13	,	,	,
50458	566	14	when	when	WRB
50458	566	15	it	-PRON-	PRP
50458	566	16	does	do	VBZ
50458	566	17	occur	occur	VB
50458	566	18	,	,	,
50458	566	19	is	be	VBZ
50458	566	20	very	very	RB
50458	566	21	rapid	rapid	JJ
50458	566	22	,	,	,
50458	566	23	almost	almost	RB
50458	566	24	immediate	immediate	JJ
50458	566	25	,	,	,
50458	566	26	in	in	IN
50458	566	27	fact	fact	NN
50458	566	28	,	,	,
50458	566	29	while	while	IN
50458	566	30	in	in	IN
50458	566	31	the	the	DT
50458	566	32	case	case	NN
50458	566	33	of	of	IN
50458	566	34	the	the	DT
50458	566	35	toxic	toxic	JJ
50458	566	36	albuminoids	albuminoid	NNS
50458	566	37	the	the	DT
50458	566	38	cure	cure	NN
50458	566	39	is	be	VBZ
50458	566	40	very	very	RB
50458	566	41	slow	slow	JJ
50458	566	42	,	,	,
50458	566	43	and	and	CC
50458	566	44	attended	attend	VBN
50458	566	45	by	by	IN
50458	566	46	relapses	relapse	NNS
50458	566	47	.	.	.
50458	567	1	One	one	CD
50458	567	2	characteristic	characteristic	NN
50458	567	3	of	of	IN
50458	567	4	these	these	DT
50458	567	5	toxalbumins	toxalbumin	NNS
50458	567	6	is	be	VBZ
50458	567	7	that	that	IN
50458	567	8	they	-PRON-	PRP
50458	567	9	are	be	VBP
50458	567	10	apt	apt	JJ
50458	567	11	to	to	TO
50458	567	12	develop	develop	VB
50458	567	13	specific	specific	JJ
50458	567	14	antitoxalbumins	antitoxalbumin	NNS
50458	567	15	.	.	.
50458	568	1	This	this	DT
50458	568	2	fact	fact	NN
50458	568	3	has	have	VBZ
50458	568	4	been	be	VBN
50458	568	5	verified	verify	VBN
50458	568	6	not	not	RB
50458	568	7	only	only	RB
50458	568	8	in	in	IN
50458	568	9	the	the	DT
50458	568	10	case	case	NN
50458	568	11	of	of	IN
50458	568	12	abrin	abrin	NNP
50458	568	13	,	,	,
50458	568	14	ricin	ricin	NNP
50458	568	15	,	,	,
50458	568	16	robin	robin	NNP
50458	568	17	,	,	,
50458	568	18	and	and	CC
50458	568	19	their	-PRON-	PRP$
50458	568	20	analogues	analogue	NNS
50458	568	21	,	,	,
50458	568	22	but	but	CC
50458	568	23	also	also	RB
50458	568	24	in	in	IN
50458	568	25	that	that	DT
50458	568	26	of	of	IN
50458	568	27	the	the	DT
50458	568	28	vegetable	vegetable	NN
50458	568	29	and	and	CC
50458	568	30	animal	animal	NN
50458	568	31	diastases	diastasis	NNS
50458	568	32	possessing	possess	VBG
50458	568	33	toxic	toxic	JJ
50458	568	34	properties	property	NNS
50458	568	35	even	even	RB
50458	568	36	in	in	IN
50458	568	37	the	the	DT
50458	568	38	slightest	slight	JJS
50458	568	39	degree	degree	NN
50458	568	40	only	only	RB
50458	568	41	.	.	.
50458	569	1	These	these	DT
50458	569	2	antibodies	antibody	NNS
50458	569	3	generally	generally	RB
50458	569	4	exhibit	exhibit	VBP
50458	569	5	their	-PRON-	PRP$
50458	569	6	action	action	NN
50458	569	7	_	_	NNP
50458	569	8	in	in	IN
50458	569	9	vitro	vitro	FW
50458	569	10	_	_	NNP
50458	569	11	.	.	.
50458	570	1	Thus	thus	RB
50458	570	2	antiricin	antiricin	VBZ
50458	570	3	exerts	exert	NNS
50458	570	4	its	-PRON-	PRP$
50458	570	5	antiagglutinative	antiagglutinative	JJ
50458	570	6	action	action	NN
50458	570	7	on	on	IN
50458	570	8	the	the	DT
50458	570	9	erythrocytes	erythrocyte	NNS
50458	570	10	_	_	NNP
50458	570	11	in	in	IN
50458	570	12	vitro	vitro	FW
50458	570	13	_	_	NNP
50458	570	14	in	in	IN
50458	570	15	a	a	DT
50458	570	16	saline	saline	JJ
50458	570	17	medium	medium	NN
50458	570	18	in	in	IN
50458	570	19	which	which	WDT
50458	570	20	the	the	DT
50458	570	21	erythrocytes	erythrocyte	NNS
50458	570	22	can	can	MD
50458	570	23	not	not	RB
50458	570	24	live	live	VB
50458	570	25	.	.	.
50458	571	1	Here	here	RB
50458	571	2	,	,	,
50458	571	3	again	again	RB
50458	571	4	,	,	,
50458	571	5	as	as	IN
50458	571	6	in	in	IN
50458	571	7	the	the	DT
50458	571	8	case	case	NN
50458	571	9	of	of	IN
50458	571	10	the	the	DT
50458	571	11	antitoxins	antitoxin	NNS
50458	571	12	,	,	,
50458	571	13	it	-PRON-	PRP
50458	571	14	must	must	MD
50458	571	15	be	be	VB
50458	571	16	admitted	admit	VBN
50458	571	17	that	that	IN
50458	571	18	the	the	DT
50458	571	19	antitoxalbumin	antitoxalbumin	NN
50458	571	20	possesses	possess	VBZ
50458	571	21	a	a	DT
50458	571	22	specific	specific	JJ
50458	571	23	affinity	affinity	NN
50458	571	24	by	by	IN
50458	571	25	virtue	virtue	NN
50458	571	26	of	of	IN
50458	571	27	which	which	WDT
50458	571	28	it	-PRON-	PRP
50458	571	29	unites	unite	VBZ
50458	571	30	chemically	chemically	RB
50458	571	31	with	with	IN
50458	571	32	the	the	DT
50458	571	33	toxalbumin	toxalbumin	NN
50458	571	34	to	to	TO
50458	571	35	give	give	VB
50458	571	36	rise	rise	NN
50458	571	37	to	to	IN
50458	571	38	a	a	DT
50458	571	39	new	new	JJ
50458	571	40	substance	substance	NN
50458	571	41	which	which	WDT
50458	571	42	is	be	VBZ
50458	571	43	devoid	devoid	JJ
50458	571	44	of	of	IN
50458	571	45	toxicity	toxicity	NN
50458	571	46	.	.	.
50458	572	1	The	the	DT
50458	572	2	first	first	JJ
50458	572	3	antidiastase	antidiastase	NN
50458	572	4	obtained	obtain	VBN
50458	572	5	by	by	IN
50458	572	6	immunization	immunization	NN
50458	572	7	methods	method	NNS
50458	572	8	,	,	,
50458	572	9	and	and	CC
50458	572	10	according	accord	VBG
50458	572	11	to	to	IN
50458	572	12	the	the	DT
50458	572	13	mechanism	mechanism	NN
50458	572	14	we	-PRON-	PRP
50458	572	15	have	have	VBP
50458	572	16	already	already	RB
50458	572	17	seen	see	VBN
50458	572	18	,	,	,
50458	572	19	was	be	VBD
50458	572	20	_	_	NNP
50458	572	21	antiemulsin	antiemulsin	NN
50458	572	22	_	_	NNP
50458	572	23	,	,	,
50458	572	24	obtained	obtain	VBN
50458	572	25	by	by	IN
50458	572	26	Hildebrandt	Hildebrandt	NNP
50458	572	27	.	.	.
50458	573	1	[	[	-LRB-
50458	573	2	62	62	CD
50458	573	3	]	]	-RRB-
50458	573	4	This	this	DT
50458	573	5	antiemulsin	antiemulsin	NN
50458	573	6	counteracts	counteract	NNS
50458	573	7	,	,	,
50458	573	8	both	both	CC
50458	573	9	_	_	NNP
50458	573	10	in	in	IN
50458	573	11	vivo	vivo	NNP
50458	573	12	_	_	NNP
50458	573	13	and	and	CC
50458	573	14	_	_	NNP
50458	573	15	in	in	IN
50458	573	16	vitro	vitro	FW
50458	573	17	_	_	NNP
50458	573	18	,	,	,
50458	573	19	the	the	DT
50458	573	20	specific	specific	JJ
50458	573	21	action	action	NN
50458	573	22	of	of	IN
50458	573	23	emulsin	emulsin	NNP
50458	573	24	.	.	.
50458	574	1	These	these	DT
50458	574	2	studies	study	NNS
50458	574	3	have	have	VBP
50458	574	4	been	be	VBN
50458	574	5	followed	follow	VBN
50458	574	6	by	by	IN
50458	574	7	a	a	DT
50458	574	8	large	large	JJ
50458	574	9	number	number	NN
50458	574	10	of	of	IN
50458	574	11	scientists	scientist	NNS
50458	574	12	,	,	,
50458	574	13	particularly	particularly	RB
50458	574	14	by	by	IN
50458	574	15	Camus	Camus	NNP
50458	574	16	and	and	CC
50458	574	17	Gley,[63	Gley,[63	NNP
50458	574	18	]	]	-RRB-
50458	574	19	Carnot	Carnot	NNP
50458	574	20	,	,	,
50458	574	21	Mesnil,[64	Mesnil,[64	NNP
50458	574	22	]	]	-RRB-
50458	574	23	and	and	CC
50458	574	24	Charron	Charron	NNP
50458	574	25	and	and	CC
50458	574	26	Levaditi,[65	Levaditi,[65	NNP
50458	574	27	]	]	-RRB-
50458	574	28	in	in	IN
50458	574	29	the	the	DT
50458	574	30	case	case	NN
50458	574	31	of	of	IN
50458	574	32	trypsin	trypsin	NNP
50458	574	33	;	;	:
50458	574	34	and	and	CC
50458	574	35	Sachs[66	sachs[66	ADD
50458	574	36	]	]	-RRB-
50458	574	37	in	in	IN
50458	574	38	the	the	DT
50458	574	39	case	case	NN
50458	574	40	of	of	IN
50458	574	41	animal	animal	NN
50458	574	42	pepsin	pepsin	NN
50458	574	43	.	.	.
50458	575	1	Gessard[67	gessard[67	ADD
50458	575	2	]	]	-RRB-
50458	575	3	obtained	obtain	VBN
50458	575	4	a	a	DT
50458	575	5	very	very	RB
50458	575	6	active	active	JJ
50458	575	7	_	_	NNP
50458	575	8	antityrosinase	antityrosinase	NN
50458	575	9	_	_	NNP
50458	575	10	,	,	,
50458	575	11	and	and	CC
50458	575	12	Mohl	Mohl	NNP
50458	575	13	an	an	DT
50458	575	14	_	_	NNP
50458	575	15	antiurease	antiurease	NN
50458	575	16	_	_	NNP
50458	575	17	.	.	.
50458	576	1	[	[	-LRB-
50458	576	2	62	62	CD
50458	576	3	]	]	-RRB-
50458	576	4	HILDEBRANDT	hildebrandt	NN
50458	576	5	:	:	:
50458	576	6	Weiteres	weitere	NNS
50458	576	7	über	über	NN
50458	576	8	hydrolyt	hydrolyt	NN
50458	576	9	.	.	.
50458	577	1	Fermente	Fermente	NNP
50458	577	2	,	,	,
50458	577	3	etc	etc	FW
50458	577	4	.	.	.
50458	578	1	_	_	NNP
50458	578	2	Virch	Virch	NNP
50458	578	3	.	.	.
50458	579	1	Arch	Arch	NNP
50458	579	2	.	.	.
50458	579	3	_	_	NNP
50458	579	4	,	,	,
50458	579	5	CXXXI	CXXXI	NNP
50458	579	6	,	,	,
50458	579	7	1895	1895	CD
50458	579	8	,	,	,
50458	579	9	P.	P.	NNP
50458	579	10	5	5	CD
50458	579	11	.	.	.
50458	580	1	[	[	-LRB-
50458	580	2	63	63	CD
50458	580	3	]	]	-RRB-
50458	580	4	CAMUS	CAMUS	NNP
50458	580	5	and	and	CC
50458	580	6	GLEY	GLEY	NNP
50458	580	7	:	:	:
50458	580	8	_	_	NNP
50458	580	9	Compt	Compt	NNP
50458	580	10	.	.	.
50458	581	1	rend	rend	VB
50458	581	2	.	.	.
50458	582	1	de	de	NNP
50458	582	2	la	la	NNP
50458	582	3	Soc	Soc	NNP
50458	582	4	.	.	.
50458	583	1	de	de	NNP
50458	583	2	Biolog	Biolog	NNP
50458	583	3	.	.	.
50458	583	4	_	_	NNP
50458	583	5	,	,	,
50458	583	6	1897	1897	CD
50458	583	7	.	.	.
50458	584	1	[	[	-LRB-
50458	584	2	64	64	CD
50458	584	3	]	]	-RRB-
50458	584	4	MESNIL	mesnil	NN
50458	584	5	:	:	:
50458	584	6	Sur	sur	NN
50458	584	7	la	la	JJ
50458	584	8	digestion	digestion	NN
50458	584	9	des	des	FW
50458	584	10	actinies	actinie	NNS
50458	584	11	.	.	.
50458	585	1	_	_	NNP
50458	585	2	Annales	Annales	NNP
50458	585	3	de	de	NNP
50458	585	4	l'Institut	l'Institut	NNP
50458	585	5	Pasteur	Pasteur	NNP
50458	585	6	_	_	NNP
50458	585	7	,	,	,
50458	585	8	1901	1901	CD
50458	585	9	.	.	.
50458	586	1	[	[	-LRB-
50458	586	2	65	65	CD
50458	586	3	]	]	-RRB-
50458	586	4	CHARRIN	charrin	NN
50458	586	5	and	and	CC
50458	586	6	LEVADITI	levaditi	NN
50458	586	7	:	:	:
50458	586	8	_	_	NNP
50458	586	9	Compt	Compt	NNP
50458	586	10	.	.	.
50458	587	1	rend	rend	VB
50458	587	2	.	.	.
50458	588	1	de	de	NNP
50458	588	2	l'Académie	l'Académie	NNP
50458	588	3	dest	d	JJS
50458	588	4	Sciences	Sciences	NNPS
50458	588	5	_	_	NNP
50458	588	6	,	,	,
50458	588	7	1900	1900	CD
50458	588	8	.	.	.
50458	589	1	[	[	-LRB-
50458	589	2	66	66	CD
50458	589	3	]	]	-RRB-
50458	589	4	SACHS	SACHS	NNP
50458	589	5	:	:	:
50458	589	6	Ueber	Ueber	NNP
50458	589	7	Antiseptika	Antiseptika	NNP
50458	589	8	.	.	.
50458	590	1	_	_	NNP
50458	590	2	Zeitschr	Zeitschr	NNP
50458	590	3	.	.	.
50458	591	1	f.	f.	NNP
50458	591	2	Biolog	Biolog	NNP
50458	591	3	.	.	.
50458	591	4	_	_	NNP
50458	591	5	,	,	,
50458	591	6	1901	1901	CD
50458	591	7	,	,	,
50458	591	8	XXVI	XXVI	NNP
50458	591	9	.	.	.
50458	592	1	[	[	-LRB-
50458	592	2	67	67	CD
50458	592	3	]	]	-RRB-
50458	592	4	GESSARD	gessard	NN
50458	592	5	:	:	:
50458	592	6	_	_	NNP
50458	592	7	Annales	Annales	NNP
50458	592	8	de	de	NNP
50458	592	9	l'Institut	l'Institut	NNP
50458	592	10	Pasteur	Pasteur	NNP
50458	592	11	_	_	NNP
50458	592	12	,	,	,
50458	592	13	1901	1901	CD
50458	592	14	,	,	,
50458	592	15	p.	p.	NN
50458	592	16	609	609	CD
50458	592	17	;	;	:
50458	592	18	_	_	NNP
50458	592	19	Comp	Comp	NNP
50458	592	20	.	.	.
50458	593	1	rend	rend	VB
50458	593	2	.	.	.
50458	594	1	de	de	NNP
50458	594	2	la	la	NNP
50458	594	3	Société	Société	NNP
50458	594	4	de	de	NNP
50458	594	5	Biologie	Biologie	NNP
50458	594	6	_	_	NNP
50458	594	7	,	,	,
50458	594	8	May	May	NNP
50458	594	9	,	,	,
50458	594	10	1902	1902	CD
50458	594	11	.	.	.
50458	595	1	The	the	DT
50458	595	2	most	most	RBS
50458	595	3	important	important	JJ
50458	595	4	researches	research	NNS
50458	595	5	regarding	regard	VBG
50458	595	6	this	this	DT
50458	595	7	subject	subject	NN
50458	595	8	have	have	VBP
50458	595	9	been	be	VBN
50458	595	10	published	publish	VBN
50458	595	11	by	by	IN
50458	595	12	Morgenroth	Morgenroth	NNP
50458	595	13	,	,	,
50458	595	14	Briot,[68	Briot,[68	NNP
50458	595	15	]	]	-RRB-
50458	595	16	and	and	CC
50458	595	17	Korschum[69	Korschum[69	NNP
50458	595	18	]	]	-RRB-
50458	595	19	on	on	IN
50458	595	20	_	_	NNP
50458	595	21	antilab	antilab	NNP
50458	595	22	_	_	NNP
50458	595	23	(	(	-LRB-
50458	595	24	or	or	CC
50458	595	25	_	_	NNP
50458	595	26	antirennet	antirennet	NN
50458	595	27	_	_	NNP
50458	595	28	)	)	-RRB-
50458	595	29	.	.	.
50458	596	1	The	the	DT
50458	596	2	researches	research	NNS
50458	596	3	of	of	IN
50458	596	4	these	these	DT
50458	596	5	authors	author	NNS
50458	596	6	have	have	VBP
50458	596	7	fully	fully	RB
50458	596	8	demonstrated	demonstrate	VBN
50458	596	9	that	that	IN
50458	596	10	there	there	EX
50458	596	11	is	be	VBZ
50458	596	12	considerable	considerable	JJ
50458	596	13	difference	difference	NN
50458	596	14	between	between	IN
50458	596	15	the	the	DT
50458	596	16	various	various	JJ
50458	596	17	rennets	rennet	NNS
50458	596	18	,	,	,
50458	596	19	which	which	WDT
50458	596	20	had	have	VBD
50458	596	21	heretofore	heretofore	RB
50458	596	22	been	be	VBN
50458	596	23	confounded	confound	VBN
50458	596	24	under	under	IN
50458	596	25	one	one	CD
50458	596	26	head	head	NN
50458	596	27	;	;	:
50458	596	28	thus	thus	RB
50458	596	29	there	there	EX
50458	596	30	is	be	VBZ
50458	596	31	no	no	DT
50458	596	32	difference	difference	NN
50458	596	33	whatever	whatever	WDT
50458	596	34	between	between	IN
50458	596	35	animal	animal	NN
50458	596	36	rennet	rennet	NN
50458	596	37	and	and	CC
50458	596	38	the	the	DT
50458	596	39	rennet	rennet	NN
50458	596	40	extracted	extract	VBN
50458	596	41	by	by	IN
50458	596	42	Rosetti[70	Rosetti[70	NNP
50458	596	43	]	]	-RRB-
50458	596	44	from	from	IN
50458	596	45	Cynara	Cynara	NNP
50458	596	46	cardunculus	cardunculus	NNP
50458	596	47	(	(	-LRB-
50458	596	48	cardoon	cardoon	NN
50458	596	49	)	)	-RRB-
50458	596	50	so	so	RB
50458	596	51	far	far	RB
50458	596	52	as	as	IN
50458	596	53	their	-PRON-	PRP$
50458	596	54	coagulant	coagulant	JJ
50458	596	55	action	action	NN
50458	596	56	on	on	IN
50458	596	57	milk	milk	NN
50458	596	58	is	be	VBZ
50458	596	59	concerned	concern	VBN
50458	596	60	,	,	,
50458	596	61	yet	yet	CC
50458	596	62	each	each	DT
50458	596	63	yields	yield	VBZ
50458	596	64	an	an	DT
50458	596	65	antibody	antibody	NN
50458	596	66	which	which	WDT
50458	596	67	is	be	VBZ
50458	596	68	strictly	strictly	RB
50458	596	69	specific	specific	JJ
50458	596	70	to	to	IN
50458	596	71	itself	-PRON-	PRP
50458	596	72	.	.	.
50458	597	1	From	from	IN
50458	597	2	a	a	DT
50458	597	3	scientific	scientific	JJ
50458	597	4	point	point	NN
50458	597	5	of	of	IN
50458	597	6	view	view	NN
50458	597	7	we	-PRON-	PRP
50458	597	8	see	see	VBP
50458	597	9	,	,	,
50458	597	10	therefore	therefore	RB
50458	597	11	,	,	,
50458	597	12	that	that	IN
50458	597	13	the	the	DT
50458	597	14	preparation	preparation	NN
50458	597	15	of	of	IN
50458	597	16	antidiastases	antidiastase	NNS
50458	597	17	permits	permit	VBZ
50458	597	18	us	-PRON-	PRP
50458	597	19	to	to	TO
50458	597	20	differentiate	differentiate	VB
50458	597	21	certain	certain	JJ
50458	597	22	diastases	diastasis	NNS
50458	597	23	that	that	WDT
50458	597	24	could	could	MD
50458	597	25	otherwise	otherwise	RB
50458	597	26	not	not	RB
50458	597	27	be	be	VB
50458	597	28	differentiated	differentiate	VBN
50458	597	29	.	.	.
50458	598	1	[	[	-LRB-
50458	598	2	68	68	CD
50458	598	3	]	]	-RRB-
50458	598	4	BRIOT	BRIOT	NNP
50458	598	5	:	:	:
50458	598	6	Thèse	Thèse	NNP
50458	598	7	de	de	FW
50458	598	8	Doctorat	Doctorat	NNP
50458	598	9	ès	ès	NNP
50458	598	10	-	-	HYPH
50458	598	11	Sciences	Sciences	NNPS
50458	598	12	,	,	,
50458	598	13	Paris	Paris	NNP
50458	598	14	,	,	,
50458	598	15	1900	1900	CD
50458	598	16	.	.	.
50458	599	1	[	[	-LRB-
50458	599	2	69	69	CD
50458	599	3	]	]	-RRB-
50458	599	4	KORSCHUM	KORSCHUM	NNP
50458	599	5	:	:	:
50458	599	6	_	_	NNP
50458	599	7	Zeitschr	Zeitschr	NNP
50458	599	8	.	.	.
50458	600	1	f.	f.	NNP
50458	600	2	physiolog	physiolog	NNP
50458	600	3	.	.	.
50458	601	1	Chemie	Chemie	NNP
50458	601	2	_	_	NNP
50458	601	3	,	,	,
50458	601	4	1902	1902	CD
50458	601	5	,	,	,
50458	601	6	XXXI	XXXI	NNP
50458	601	7	.	.	.
50458	602	1	[	[	-LRB-
50458	602	2	70	70	CD
50458	602	3	]	]	-RRB-
50458	602	4	ROSETTI	ROSETTI	NNP
50458	602	5	:	:	:
50458	602	6	_	_	NNP
50458	602	7	L'Orosi	L'Orosi	NNP
50458	602	8	,	,	,
50458	602	9	giorn	giorn	NN
50458	602	10	.	.	.
50458	603	1	di	di	NNP
50458	603	2	chemica	chemica	NNP
50458	603	3	,	,	,
50458	603	4	farmacia	farmacia	NNP
50458	603	5	et	et	NNP
50458	603	6	scienza	scienza	NNP
50458	603	7	affini	affini	NNP
50458	603	8	_	_	NNP
50458	603	9	,	,	,
50458	603	10	1898	1898	CD
50458	603	11	.	.	.
50458	604	1	III	iii	CD
50458	604	2	.	.	.
50458	605	1	ANIMAL	ANIMAL	NNP
50458	605	2	TOXINS	toxin	NNS
50458	605	3	.	.	.
50458	606	1	As	as	IN
50458	606	2	we	-PRON-	PRP
50458	606	3	have	have	VBP
50458	606	4	shown	show	VBN
50458	606	5	at	at	IN
50458	606	6	the	the	DT
50458	606	7	beginning	beginning	NN
50458	606	8	of	of	IN
50458	606	9	this	this	DT
50458	606	10	chapter	chapter	NN
50458	606	11	,	,	,
50458	606	12	certain	certain	JJ
50458	606	13	diastases	diastasis	NNS
50458	606	14	,	,	,
50458	606	15	and	and	CC
50458	606	16	particularly	particularly	RB
50458	606	17	those	those	DT
50458	606	18	that	that	WDT
50458	606	19	are	be	VBP
50458	606	20	concerned	concern	VBN
50458	606	21	with	with	IN
50458	606	22	the	the	DT
50458	606	23	digestive	digestive	JJ
50458	606	24	processes	process	NNS
50458	606	25	,	,	,
50458	606	26	pepsin	pepsin	NNP
50458	606	27	,	,	,
50458	606	28	trypsin	trypsin	NNP
50458	606	29	,	,	,
50458	606	30	etc	etc	FW
50458	606	31	.	.	FW
50458	606	32	,	,	,
50458	606	33	and	and	CC
50458	606	34	which	which	WDT
50458	606	35	are	be	VBP
50458	606	36	produced	produce	VBN
50458	606	37	in	in	IN
50458	606	38	abundance	abundance	NN
50458	606	39	by	by	IN
50458	606	40	the	the	DT
50458	606	41	entire	entire	JJ
50458	606	42	living	living	NN
50458	606	43	organism	organism	NN
50458	606	44	,	,	,
50458	606	45	possess	possess	VBP
50458	606	46	quite	quite	RB
50458	606	47	clearly	clearly	RB
50458	606	48	defined	define	VBN
50458	606	49	toxic	toxic	JJ
50458	606	50	properties	property	NNS
50458	606	51	,	,	,
50458	606	52	and	and	CC
50458	606	53	sometimes	sometimes	RB
50458	606	54	to	to	TO
50458	606	55	even	even	RB
50458	606	56	a	a	DT
50458	606	57	considerable	considerable	JJ
50458	606	58	extent	extent	NN
50458	606	59	.	.	.
50458	607	1	[	[	-LRB-
50458	607	2	71	71	CD
50458	607	3	]	]	-RRB-
50458	607	4	[	[	-LRB-
50458	607	5	71	71	CD
50458	607	6	]	]	-RRB-
50458	607	7	GUSTAVE	GUSTAVE	NNP
50458	607	8	SAUX	SAUX	NNP
50458	607	9	:	:	:
50458	607	10	De	De	NNP
50458	607	11	la	la	NNP
50458	607	12	toxicité	toxicité	NNP
50458	607	13	des	des	FW
50458	607	14	produits	produits	NNP
50458	607	15	de	de	NNP
50458	607	16	la	la	NNP
50458	607	17	digestion	digestion	NNP
50458	607	18	peptique	peptique	NNP
50458	607	19	.	.	.
50458	608	1	_	_	NNP
50458	608	2	Thèse	Thèse	NNP
50458	608	3	de	de	NNP
50458	608	4	doctorat	doctorat	NNP
50458	608	5	_	_	NNP
50458	608	6	,	,	,
50458	608	7	Bordeaux	Bordeaux	NNP
50458	608	8	,	,	,
50458	608	9	1902	1902	CD
50458	608	10	.	.	.
50458	609	1	Hemialbumose	hemialbumose	UH
50458	609	2	,	,	,
50458	609	3	from	from	IN
50458	609	4	which	which	WDT
50458	609	5	peptones	peptone	NNS
50458	609	6	are	be	VBP
50458	609	7	formed	form	VBN
50458	609	8	,	,	,
50458	609	9	is	be	VBZ
50458	609	10	itself	-PRON-	PRP
50458	609	11	a	a	DT
50458	609	12	dangerous	dangerous	JJ
50458	609	13	toxin	toxin	NN
50458	609	14	.	.	.
50458	610	1	It	-PRON-	PRP
50458	610	2	is	be	VBZ
50458	610	3	generally	generally	RB
50458	610	4	believed	believe	VBN
50458	610	5	that	that	IN
50458	610	6	the	the	DT
50458	610	7	toxic	toxic	JJ
50458	610	8	action	action	NN
50458	610	9	of	of	IN
50458	610	10	the	the	DT
50458	610	11	peptones	peptone	NNS
50458	610	12	and	and	CC
50458	610	13	of	of	IN
50458	610	14	the	the	DT
50458	610	15	products	product	NNS
50458	610	16	of	of	IN
50458	610	17	digestion	digestion	NN
50458	610	18	of	of	IN
50458	610	19	the	the	DT
50458	610	20	albuminoids	albuminoid	NNS
50458	610	21	is	be	VBZ
50458	610	22	due	due	JJ
50458	610	23	not	not	RB
50458	610	24	to	to	IN
50458	610	25	the	the	DT
50458	610	26	peptone	peptone	NN
50458	610	27	itself	-PRON-	PRP
50458	610	28	,	,	,
50458	610	29	but	but	CC
50458	610	30	to	to	IN
50458	610	31	the	the	DT
50458	610	32	more	more	RBR
50458	610	33	advanced	advanced	JJ
50458	610	34	products	product	NNS
50458	610	35	of	of	IN
50458	610	36	digestion	digestion	NN
50458	610	37	,	,	,
50458	610	38	alkaloidal	alkaloidal	NN
50458	610	39	products	product	NNS
50458	610	40	unquestionably	unquestionably	RB
50458	610	41	closely	closely	RB
50458	610	42	allied	ally	VBN
50458	610	43	to	to	IN
50458	610	44	the	the	DT
50458	610	45	ptomaines	ptomaine	NNS
50458	610	46	.	.	.
50458	611	1	Nevertheless	nevertheless	RB
50458	611	2	,	,	,
50458	611	3	the	the	DT
50458	611	4	true	true	JJ
50458	611	5	peptones	peptone	NNS
50458	611	6	behave	behave	VBP
50458	611	7	just	just	RB
50458	611	8	like	like	IN
50458	611	9	true	true	JJ
50458	611	10	poisons	poison	NNS
50458	611	11	,	,	,
50458	611	12	when	when	WRB
50458	611	13	they	-PRON-	PRP
50458	611	14	are	be	VBP
50458	611	15	introduced	introduce	VBN
50458	611	16	hypodermically	hypodermically	RB
50458	611	17	into	into	IN
50458	611	18	the	the	DT
50458	611	19	blood	blood	NN
50458	611	20	.	.	.
50458	612	1	[	[	-LRB-
50458	612	2	72	72	CD
50458	612	3	]	]	-RRB-
50458	612	4	[	[	-LRB-
50458	612	5	72	72	CD
50458	612	6	]	]	-RRB-
50458	612	7	SCHMIDT	schmidt	NN
50458	612	8	:	:	:
50458	612	9	_	_	NNP
50458	612	10	Mühlheim	Mühlheim	NNP
50458	612	11	,	,	,
50458	612	12	Arch	Arch	NNP
50458	612	13	.	.	.
50458	613	1	de	de	NNP
50458	613	2	physiol	physiol	NNP
50458	613	3	.	.	.
50458	613	4	_	_	NNP
50458	613	5	,	,	,
50458	613	6	1880	1880	CD
50458	613	7	.	.	.
50458	614	1	Brieger	Brieger	NNP
50458	614	2	has	have	VBZ
50458	614	3	made	make	VBN
50458	614	4	us	-PRON-	PRP
50458	614	5	acquainted	acquaint	VBN
50458	614	6	with	with	IN
50458	614	7	a	a	DT
50458	614	8	non	non	JJ
50458	614	9	-	-	JJ
50458	614	10	proteid	proteid	JJ
50458	614	11	substance	substance	NN
50458	614	12	,	,	,
50458	614	13	under	under	IN
50458	614	14	the	the	DT
50458	614	15	name	name	NN
50458	614	16	of	of	IN
50458	614	17	"	"	``
50458	614	18	peptotoxin	peptotoxin	NN
50458	614	19	,	,	,
50458	614	20	"	"	''
50458	614	21	which	which	WDT
50458	614	22	is	be	VBZ
50458	614	23	met	meet	VBN
50458	614	24	with	with	IN
50458	614	25	at	at	IN
50458	614	26	the	the	DT
50458	614	27	beginning	beginning	NN
50458	614	28	of	of	IN
50458	614	29	the	the	DT
50458	614	30	putrefaction	putrefaction	NN
50458	614	31	of	of	IN
50458	614	32	albuminoids	albuminoid	NNS
50458	614	33	.	.	.
50458	615	1	This	this	DT
50458	615	2	toxin	toxin	NN
50458	615	3	,	,	,
50458	615	4	which	which	WDT
50458	615	5	is	be	VBZ
50458	615	6	not	not	RB
50458	615	7	a	a	DT
50458	615	8	protein	protein	NN
50458	615	9	,	,	,
50458	615	10	is	be	VBZ
50458	615	11	nothing	nothing	NN
50458	615	12	else	else	RB
50458	615	13	but	but	CC
50458	615	14	a	a	DT
50458	615	15	ptomaine	ptomaine	NN
50458	615	16	.	.	.
50458	616	1	It	-PRON-	PRP
50458	616	2	is	be	VBZ
50458	616	3	not	not	RB
50458	616	4	altered	alter	VBN
50458	616	5	by	by	IN
50458	616	6	heat	heat	NN
50458	616	7	,	,	,
50458	616	8	and	and	CC
50458	616	9	possesses	possess	VBZ
50458	616	10	a	a	DT
50458	616	11	very	very	RB
50458	616	12	high	high	JJ
50458	616	13	toxicity	toxicity	NN
50458	616	14	.	.	.
50458	617	1	Brieger	Brieger	NNP
50458	617	2	claims	claim	VBZ
50458	617	3	that	that	IN
50458	617	4	it	-PRON-	PRP
50458	617	5	is	be	VBZ
50458	617	6	a	a	DT
50458	617	7	hydroxylized	hydroxylized	JJ
50458	617	8	derivative	derivative	NN
50458	617	9	of	of	IN
50458	617	10	an	an	DT
50458	617	11	aromatic	aromatic	JJ
50458	617	12	amide	amide	NN
50458	617	13	.	.	.
50458	618	1	[	[	-LRB-
50458	618	2	73	73	CD
50458	618	3	]	]	-RRB-
50458	618	4	[	[	-LRB-
50458	618	5	73	73	CD
50458	618	6	]	]	-RRB-
50458	618	7	BRIEGER	BRIEGER	NNP
50458	618	8	:	:	:
50458	618	9	_	_	NNP
50458	618	10	Berichte	Berichte	NNP
50458	618	11	d.	d.	NNP
50458	618	12	D.	D.	NNP
50458	618	13	chem	chem	NNP
50458	618	14	.	.	.
50458	619	1	Gesellsch	Gesellsch	NNP
50458	619	2	.	.	.
50458	619	3	_	_	NNP
50458	619	4	,	,	,
50458	619	5	XIX	XIX	NNP
50458	619	6	,	,	,
50458	619	7	p.	p.	NN
50458	619	8	3120	3120	CD
50458	619	9	;	;	:
50458	619	10	and	and	CC
50458	619	11	_	_	NNP
50458	619	12	Verhandl	Verhandl	NNP
50458	619	13	.	.	.
50458	620	1	d.	d.	NNP
50458	620	2	Congress	Congress	NNP
50458	620	3	f.	f.	NNP
50458	620	4	innere	innere	NNP
50458	620	5	Med	Med	NNP
50458	620	6	.	.	.
50458	620	7	_	_	NNP
50458	620	8	,	,	,
50458	620	9	II	II	NNP
50458	620	10	,	,	,
50458	620	11	p.	p.	NN
50458	620	12	277	277	CD
50458	620	13	.	.	.
50458	621	1	Besides	besides	IN
50458	621	2	these	these	DT
50458	621	3	facts	fact	NNS
50458	621	4	,	,	,
50458	621	5	experiment	experiment	NN
50458	621	6	has	have	VBZ
50458	621	7	shown	show	VBN
50458	621	8	that	that	IN
50458	621	9	the	the	DT
50458	621	10	leucocytes	leucocyte	NNS
50458	621	11	,	,	,
50458	621	12	or	or	CC
50458	621	13	white	white	JJ
50458	621	14	corpuscles	corpuscle	NNS
50458	621	15	,	,	,
50458	621	16	the	the	DT
50458	621	17	defensive	defensive	NN
50458	621	18	rôle	rôle	VBZ
50458	621	19	of	of	IN
50458	621	20	which	which	WDT
50458	621	21	we	-PRON-	PRP
50458	621	22	have	have	VBP
50458	621	23	noted	note	VBN
50458	621	24	in	in	IN
50458	621	25	phagocytosis	phagocytosis	NN
50458	621	26	,	,	,
50458	621	27	owe	owe	VBP
50458	621	28	their	-PRON-	PRP$
50458	621	29	properties	property	NNS
50458	621	30	to	to	IN
50458	621	31	the	the	DT
50458	621	32	ferments	ferment	NNS
50458	621	33	which	which	WDT
50458	621	34	they	-PRON-	PRP
50458	621	35	secrete	secrete	VBP
50458	621	36	,	,	,
50458	621	37	and	and	CC
50458	621	38	particularly	particularly	RB
50458	621	39	to	to	IN
50458	621	40	some	some	DT
50458	621	41	of	of	IN
50458	621	42	the	the	DT
50458	621	43	digestive	digestive	JJ
50458	621	44	ferments	ferment	NNS
50458	621	45	.	.	.
50458	622	1	These	these	DT
50458	622	2	white	white	JJ
50458	622	3	corpuscles	corpuscle	NNS
50458	622	4	are	be	VBP
50458	622	5	very	very	RB
50458	622	6	rich	rich	JJ
50458	622	7	in	in	IN
50458	622	8	ferments	ferment	NNS
50458	622	9	of	of	IN
50458	622	10	all	all	DT
50458	622	11	kinds	kind	NNS
50458	622	12	.	.	.
50458	623	1	Rossbach	Rossbach	NNP
50458	623	2	found	find	VBD
50458	623	3	in	in	IN
50458	623	4	them	-PRON-	PRP
50458	623	5	amylase	amylase	RB
50458	623	6	;	;	:
50458	623	7	Achalme	Achalme	NNP
50458	623	8	found	find	VBD
50458	623	9	lipase	lipase	NN
50458	623	10	,	,	,
50458	623	11	casease	casease	VB
50458	623	12	,	,	,
50458	623	13	and	and	CC
50458	623	14	trypsin	trypsin	NN
50458	623	15	;	;	:
50458	623	16	and	and	CC
50458	623	17	the	the	DT
50458	623	18	study	study	NN
50458	623	19	of	of	IN
50458	623	20	immunity	immunity	NN
50458	623	21	has	have	VBZ
50458	623	22	brought	bring	VBN
50458	623	23	to	to	TO
50458	623	24	light	light	VB
50458	623	25	a	a	DT
50458	623	26	series	series	NN
50458	623	27	of	of	IN
50458	623	28	other	other	JJ
50458	623	29	ferments	ferment	NNS
50458	623	30	,	,	,
50458	623	31	the	the	DT
50458	623	32	alexins	alexin	NNS
50458	623	33	or	or	CC
50458	623	34	cytases	cytase	NNS
50458	623	35	(	(	-LRB-
50458	623	36	microcytase	microcytase	NN
50458	623	37	and	and	CC
50458	623	38	macrocytase	macrocytase	NNP
50458	623	39	)	)	-RRB-
50458	623	40	,	,	,
50458	623	41	which	which	WDT
50458	623	42	have	have	VBP
50458	623	43	an	an	DT
50458	623	44	exceedingly	exceedingly	RB
50458	623	45	important	important	JJ
50458	623	46	rôle	rôle	NN
50458	623	47	to	to	TO
50458	623	48	play	play	VB
50458	623	49	.	.	.
50458	624	1	It	-PRON-	PRP
50458	624	2	may	may	MD
50458	624	3	easily	easily	RB
50458	624	4	be	be	VB
50458	624	5	conceived	conceive	VBN
50458	624	6	that	that	IN
50458	624	7	under	under	IN
50458	624	8	certain	certain	JJ
50458	624	9	circumstances	circumstance	NNS
50458	624	10	a	a	DT
50458	624	11	part	part	NN
50458	624	12	or	or	CC
50458	624	13	the	the	DT
50458	624	14	whole	whole	NN
50458	624	15	of	of	IN
50458	624	16	these	these	DT
50458	624	17	ferments	ferment	NNS
50458	624	18	can	can	MD
50458	624	19	pass	pass	VB
50458	624	20	into	into	IN
50458	624	21	the	the	DT
50458	624	22	blood	blood	NN
50458	624	23	of	of	IN
50458	624	24	the	the	DT
50458	624	25	fluids	fluid	NNS
50458	624	26	of	of	IN
50458	624	27	the	the	DT
50458	624	28	body	body	NN
50458	624	29	,	,	,
50458	624	30	when	when	WRB
50458	624	31	they	-PRON-	PRP
50458	624	32	give	give	VBP
50458	624	33	rise	rise	NN
50458	624	34	to	to	IN
50458	624	35	serious	serious	JJ
50458	624	36	disturbances	disturbance	NNS
50458	624	37	in	in	IN
50458	624	38	certain	certain	JJ
50458	624	39	cases	case	NNS
50458	624	40	,	,	,
50458	624	41	or	or	CC
50458	624	42	confer	confer	VBP
50458	624	43	immunity	immunity	NN
50458	624	44	in	in	IN
50458	624	45	others	other	NNS
50458	624	46	.	.	.
50458	625	1	It	-PRON-	PRP
50458	625	2	is	be	VBZ
50458	625	3	thus	thus	RB
50458	625	4	that	that	IN
50458	625	5	,	,	,
50458	625	6	according	accord	VBG
50458	625	7	to	to	IN
50458	625	8	Gautier	Gautier	NNP
50458	625	9	,	,	,
50458	625	10	the	the	DT
50458	625	11	rise	rise	NN
50458	625	12	of	of	IN
50458	625	13	temperature	temperature	NN
50458	625	14	which	which	WDT
50458	625	15	characterizes	characterize	VBZ
50458	625	16	fever	fever	NN
50458	625	17	is	be	VBZ
50458	625	18	a	a	DT
50458	625	19	consequence	consequence	NN
50458	625	20	of	of	IN
50458	625	21	the	the	DT
50458	625	22	abnormal	abnormal	JJ
50458	625	23	transudation	transudation	NN
50458	625	24	of	of	IN
50458	625	25	these	these	DT
50458	625	26	normal	normal	JJ
50458	625	27	ferments	ferment	NNS
50458	625	28	into	into	IN
50458	625	29	the	the	DT
50458	625	30	blood	blood	NN
50458	625	31	,	,	,
50458	625	32	and	and	CC
50458	625	33	their	-PRON-	PRP$
50458	625	34	transmission	transmission	NN
50458	625	35	by	by	IN
50458	625	36	the	the	DT
50458	625	37	general	general	JJ
50458	625	38	circulation	circulation	NN
50458	625	39	to	to	IN
50458	625	40	the	the	DT
50458	625	41	nervous	nervous	JJ
50458	625	42	centers	center	NNS
50458	625	43	.	.	.
50458	626	1	However	however	RB
50458	626	2	,	,	,
50458	626	3	it	-PRON-	PRP
50458	626	4	is	be	VBZ
50458	626	5	not	not	RB
50458	626	6	only	only	RB
50458	626	7	in	in	IN
50458	626	8	the	the	DT
50458	626	9	leucocytes	leucocyte	NNS
50458	626	10	that	that	IN
50458	626	11	we	-PRON-	PRP
50458	626	12	meet	meet	VBP
50458	626	13	with	with	IN
50458	626	14	these	these	DT
50458	626	15	toxic	toxic	JJ
50458	626	16	digestive	digestive	JJ
50458	626	17	ferments	ferment	NNS
50458	626	18	;	;	:
50458	626	19	it	-PRON-	PRP
50458	626	20	appears	appear	VBZ
50458	626	21	quite	quite	RB
50458	626	22	probable	probable	JJ
50458	626	23	,	,	,
50458	626	24	and	and	CC
50458	626	25	has	have	VBZ
50458	626	26	even	even	RB
50458	626	27	been	be	VBN
50458	626	28	partially	partially	RB
50458	626	29	demonstrated	demonstrate	VBN
50458	626	30	,	,	,
50458	626	31	that	that	IN
50458	626	32	they	-PRON-	PRP
50458	626	33	occur	occur	VBP
50458	626	34	in	in	IN
50458	626	35	a	a	DT
50458	626	36	large	large	JJ
50458	626	37	number	number	NN
50458	626	38	of	of	IN
50458	626	39	other	other	JJ
50458	626	40	cellular	cellular	JJ
50458	626	41	elements	element	NNS
50458	626	42	.	.	.
50458	627	1	It	-PRON-	PRP
50458	627	2	is	be	VBZ
50458	627	3	not	not	RB
50458	627	4	necessary	necessary	JJ
50458	627	5	here	here	RB
50458	627	6	to	to	TO
50458	627	7	dwell	dwell	VB
50458	627	8	upon	upon	IN
50458	627	9	the	the	DT
50458	627	10	formation	formation	NN
50458	627	11	of	of	IN
50458	627	12	the	the	DT
50458	627	13	antibodies	antibody	NNS
50458	627	14	of	of	IN
50458	627	15	this	this	DT
50458	627	16	group	group	NN
50458	627	17	of	of	IN
50458	627	18	active	active	JJ
50458	627	19	substances	substance	NNS
50458	627	20	.	.	.
50458	628	1	The	the	DT
50458	628	2	animal	animal	NN
50458	628	3	toxins	toxin	NNS
50458	628	4	are	be	VBP
50458	628	5	animal	animal	NN
50458	628	6	diastases	diastasis	NNS
50458	628	7	,	,	,
50458	628	8	and	and	CC
50458	628	9	we	-PRON-	PRP
50458	628	10	have	have	VBP
50458	628	11	seen	see	VBN
50458	628	12	in	in	IN
50458	628	13	the	the	DT
50458	628	14	preceding	precede	VBG
50458	628	15	paragraph	paragraph	NN
50458	628	16	that	that	IN
50458	628	17	these	these	DT
50458	628	18	substances	substance	NNS
50458	628	19	yield	yield	VBP
50458	628	20	specific	specific	JJ
50458	628	21	antibodies	antibody	NNS
50458	628	22	with	with	IN
50458	628	23	great	great	JJ
50458	628	24	facility	facility	NN
50458	628	25	.	.	.
50458	629	1	For	for	IN
50458	629	2	the	the	DT
50458	629	3	rest	rest	NN
50458	629	4	,	,	,
50458	629	5	we	-PRON-	PRP
50458	629	6	will	will	MD
50458	629	7	dwell	dwell	VB
50458	629	8	more	more	RBR
50458	629	9	fully	fully	RB
50458	629	10	on	on	IN
50458	629	11	these	these	DT
50458	629	12	antibodies	antibody	NNS
50458	629	13	of	of	IN
50458	629	14	the	the	DT
50458	629	15	animal	animal	NN
50458	629	16	toxins	toxin	NNS
50458	629	17	in	in	IN
50458	629	18	another	another	DT
50458	629	19	volume	volume	NN
50458	629	20	of	of	IN
50458	629	21	this	this	DT
50458	629	22	collection	collection	NN
50458	629	23	,	,	,
50458	629	24	specially	specially	RB
50458	629	25	devoted	devoted	JJ
50458	629	26	to	to	IN
50458	629	27	the	the	DT
50458	629	28	study	study	NN
50458	629	29	of	of	IN
50458	629	30	these	these	DT
50458	629	31	substances	substance	NNS
50458	629	32	,	,	,
50458	629	33	and	and	CC
50458	629	34	entitled	entitle	VBN
50458	629	35	"	"	``
50458	629	36	_	_	NNP
50458	629	37	Les	Les	NNP
50458	629	38	Serums	Serums	NNP
50458	629	39	Immunisants	Immunisants	NNP
50458	629	40	_	_	NNP
50458	629	41	,	,	,
50458	629	42	"	"	''
50458	629	43	to	to	TO
50458	629	44	which	which	WDT
50458	629	45	we	-PRON-	PRP
50458	629	46	refer	refer	VBP
50458	629	47	the	the	DT
50458	629	48	reader	reader	NN
50458	629	49	who	who	WP
50458	629	50	is	be	VBZ
50458	629	51	desirous	desirous	JJ
50458	629	52	of	of	IN
50458	629	53	obtaining	obtain	VBG
50458	629	54	more	more	RBR
50458	629	55	complete	complete	JJ
50458	629	56	details	detail	NNS
50458	629	57	than	than	IN
50458	629	58	he	-PRON-	PRP
50458	629	59	can	can	MD
50458	629	60	obtain	obtain	VB
50458	629	61	in	in	IN
50458	629	62	the	the	DT
50458	629	63	present	present	JJ
50458	629	64	volume	volume	NN
50458	629	65	.	.	.
50458	630	1	=	=	NFP
50458	630	2	Alimentary	Alimentary	NNP
50458	630	3	Intoxications.=--What	Intoxications.=--What	NNP
50458	630	4	we	-PRON-	PRP
50458	630	5	have	have	VBP
50458	630	6	already	already	RB
50458	630	7	stated	state	VBN
50458	630	8	permits	permit	VBZ
50458	630	9	us	-PRON-	PRP
50458	630	10	to	to	TO
50458	630	11	understand	understand	VB
50458	630	12	the	the	DT
50458	630	13	phenomena	phenomenon	NNS
50458	630	14	of	of	IN
50458	630	15	indigestion	indigestion	NN
50458	630	16	and	and	CC
50458	630	17	botulism	botulism	NN
50458	630	18	.	.	.
50458	631	1	The	the	DT
50458	631	2	toxic	toxic	JJ
50458	631	3	substances	substance	NNS
50458	631	4	form	form	VBP
50458	631	5	within	within	IN
50458	631	6	the	the	DT
50458	631	7	digestive	digestive	JJ
50458	631	8	tract	tract	NN
50458	631	9	when	when	WRB
50458	631	10	the	the	DT
50458	631	11	nervous	nervous	JJ
50458	631	12	conditions	condition	NNS
50458	631	13	modify	modify	VBP
50458	631	14	the	the	DT
50458	631	15	composition	composition	NN
50458	631	16	of	of	IN
50458	631	17	the	the	DT
50458	631	18	gastric	gastric	JJ
50458	631	19	juice	juice	NN
50458	631	20	,	,	,
50458	631	21	and	and	CC
50458	631	22	arrest	arrest	VB
50458	631	23	the	the	DT
50458	631	24	flow	flow	NN
50458	631	25	of	of	IN
50458	631	26	hydrochloric	hydrochloric	JJ
50458	631	27	acid	acid	NN
50458	631	28	,	,	,
50458	631	29	the	the	DT
50458	631	30	presence	presence	NN
50458	631	31	of	of	IN
50458	631	32	which	which	WDT
50458	631	33	normally	normally	RB
50458	631	34	checks	check	VBZ
50458	631	35	the	the	DT
50458	631	36	development	development	NN
50458	631	37	of	of	IN
50458	631	38	the	the	DT
50458	631	39	microbial	microbial	JJ
50458	631	40	flora	flora	NNS
50458	631	41	,	,	,
50458	631	42	so	so	RB
50458	631	43	rich	rich	JJ
50458	631	44	within	within	IN
50458	631	45	the	the	DT
50458	631	46	stomach	stomach	NN
50458	631	47	.	.	.
50458	632	1	The	the	DT
50458	632	2	result	result	NN
50458	632	3	is	be	VBZ
50458	632	4	the	the	DT
50458	632	5	production	production	NN
50458	632	6	,	,	,
50458	632	7	within	within	IN
50458	632	8	the	the	DT
50458	632	9	organism	organism	NN
50458	632	10	,	,	,
50458	632	11	of	of	IN
50458	632	12	all	all	DT
50458	632	13	kinds	kind	NNS
50458	632	14	of	of	IN
50458	632	15	dangerous	dangerous	JJ
50458	632	16	toxins	toxin	NNS
50458	632	17	.	.	.
50458	633	1	The	the	DT
50458	633	2	same	same	JJ
50458	633	3	thing	thing	NN
50458	633	4	happens	happen	VBZ
50458	633	5	when	when	WRB
50458	633	6	the	the	DT
50458	633	7	liver	liver	NN
50458	633	8	does	do	VBZ
50458	633	9	not	not	RB
50458	633	10	functionate	functionate	VB
50458	633	11	normally	normally	RB
50458	633	12	,	,	,
50458	633	13	and	and	CC
50458	633	14	this	this	DT
50458	633	15	,	,	,
50458	633	16	affords	afford	VBZ
50458	633	17	us	-PRON-	PRP
50458	633	18	a	a	DT
50458	633	19	knowledge	knowledge	NN
50458	633	20	of	of	IN
50458	633	21	the	the	DT
50458	633	22	mechanism	mechanism	NN
50458	633	23	by	by	IN
50458	633	24	which	which	WDT
50458	633	25	foods	food	NNS
50458	633	26	that	that	WDT
50458	633	27	are	be	VBP
50458	633	28	most	most	RBS
50458	633	29	wholesome	wholesome	JJ
50458	633	30	may	may	MD
50458	633	31	become	become	VB
50458	633	32	toxic	toxic	JJ
50458	633	33	by	by	IN
50458	633	34	reason	reason	NN
50458	633	35	of	of	IN
50458	633	36	poor	poor	JJ
50458	633	37	digestion	digestion	NN
50458	633	38	or	or	CC
50458	633	39	poor	poor	JJ
50458	633	40	assimilation	assimilation	NN
50458	633	41	.	.	.
50458	634	1	The	the	DT
50458	634	2	absorption	absorption	NN
50458	634	3	of	of	IN
50458	634	4	spoiled	spoiled	JJ
50458	634	5	viands	viand	NNS
50458	634	6	may	may	MD
50458	634	7	,	,	,
50458	634	8	_	_	NNP
50458	634	9	a	a	DT
50458	634	10	fortiori	fortiori	NN
50458	634	11	_	_	NNP
50458	634	12	,	,	,
50458	634	13	produce	produce	VBP
50458	634	14	serious	serious	JJ
50458	634	15	results	result	NNS
50458	634	16	.	.	.
50458	635	1	The	the	DT
50458	635	2	alteration	alteration	NN
50458	635	3	may	may	MD
50458	635	4	be	be	VB
50458	635	5	due	due	JJ
50458	635	6	not	not	RB
50458	635	7	only	only	RB
50458	635	8	to	to	IN
50458	635	9	a	a	DT
50458	635	10	bacterial	bacterial	JJ
50458	635	11	infection	infection	NN
50458	635	12	,	,	,
50458	635	13	as	as	IN
50458	635	14	in	in	IN
50458	635	15	tainted	tainted	JJ
50458	635	16	meat	meat	NN
50458	635	17	,	,	,
50458	635	18	but	but	CC
50458	635	19	it	-PRON-	PRP
50458	635	20	has	have	VBZ
50458	635	21	also	also	RB
50458	635	22	been	be	VBN
50458	635	23	proved	prove	VBN
50458	635	24	that	that	IN
50458	635	25	the	the	DT
50458	635	26	flesh	flesh	NN
50458	635	27	of	of	IN
50458	635	28	an	an	DT
50458	635	29	animal	animal	NN
50458	635	30	that	that	WDT
50458	635	31	has	have	VBZ
50458	635	32	died	die	VBN
50458	635	33	of	of	IN
50458	635	34	terror	terror	NN
50458	635	35	or	or	CC
50458	635	36	madness	madness	NN
50458	635	37	may	may	MD
50458	635	38	be	be	VB
50458	635	39	very	very	RB
50458	635	40	dangerous	dangerous	JJ
50458	635	41	as	as	IN
50458	635	42	a	a	DT
50458	635	43	food	food	NN
50458	635	44	,	,	,
50458	635	45	even	even	RB
50458	635	46	after	after	IN
50458	635	47	cooking	cooking	NN
50458	635	48	,	,	,
50458	635	49	because	because	IN
50458	635	50	,	,	,
50458	635	51	although	although	IN
50458	635	52	there	there	EX
50458	635	53	are	be	VBP
50458	635	54	toxins	toxin	NNS
50458	635	55	which	which	WDT
50458	635	56	are	be	VBP
50458	635	57	destroyed	destroy	VBN
50458	635	58	by	by	IN
50458	635	59	a	a	DT
50458	635	60	sufficient	sufficient	JJ
50458	635	61	heat	heat	NN
50458	635	62	,	,	,
50458	635	63	there	there	EX
50458	635	64	are	be	VBP
50458	635	65	ptomaines	ptomaine	NNS
50458	635	66	and	and	CC
50458	635	67	certain	certain	JJ
50458	635	68	toxins	toxin	NNS
50458	635	69	that	that	WDT
50458	635	70	resist	resist	VBP
50458	635	71	destruction	destruction	NN
50458	635	72	under	under	IN
50458	635	73	these	these	DT
50458	635	74	conditions	condition	NNS
50458	635	75	.	.	.
50458	636	1	[	[	-LRB-
50458	636	2	74	74	CD
50458	636	3	]	]	-RRB-
50458	636	4	[	[	-LRB-
50458	636	5	74	74	CD
50458	636	6	]	]	-RRB-
50458	636	7	POLLIN	POLLIN	NNP
50458	636	8	and	and	CC
50458	636	9	LABIT	LABIT	NNP
50458	636	10	:	:	:
50458	636	11	_	_	NNP
50458	636	12	Examens	Examens	NNP
50458	636	13	des	des	NNP
50458	636	14	aliments	aliment	NNS
50458	636	15	suspects	suspect	VBZ
50458	636	16	_	_	NNP
50458	636	17	,	,	,
50458	636	18	Masson	Masson	NNP
50458	636	19	,	,	,
50458	636	20	publisher	publisher	NN
50458	636	21	.	.	.
50458	637	1	The	the	DT
50458	637	2	use	use	NN
50458	637	3	of	of	IN
50458	637	4	preserved	preserve	VBN
50458	637	5	but	but	CC
50458	637	6	spoiled	spoiled	JJ
50458	637	7	beef	beef	NN
50458	637	8	,	,	,
50458	637	9	preserved	preserve	VBN
50458	637	10	ham	ham	NN
50458	637	11	or	or	CC
50458	637	12	birds	bird	NNS
50458	637	13	,	,	,
50458	637	14	sausages	sausage	NNS
50458	637	15	frequently	frequently	RB
50458	637	16	,	,	,
50458	637	17	and	and	CC
50458	637	18	pieces	piece	NNS
50458	637	19	of	of	IN
50458	637	20	pork	pork	NN
50458	637	21	tainted	taint	VBN
50458	637	22	by	by	IN
50458	637	23	sausage	sausage	NN
50458	637	24	poison	poison	NN
50458	637	25	,	,	,
50458	637	26	gives	give	VBZ
50458	637	27	rise	rise	NN
50458	637	28	to	to	IN
50458	637	29	a	a	DT
50458	637	30	succession	succession	NN
50458	637	31	of	of	IN
50458	637	32	toxic	toxic	JJ
50458	637	33	symptoms	symptom	NNS
50458	637	34	the	the	DT
50458	637	35	principal	principal	JJ
50458	637	36	ones	one	NNS
50458	637	37	of	of	IN
50458	637	38	which	which	WDT
50458	637	39	are	be	VBP
50458	637	40	dryness	dryness	NN
50458	637	41	,	,	,
50458	637	42	constriction	constriction	NN
50458	637	43	of	of	IN
50458	637	44	the	the	DT
50458	637	45	pharynx	pharynx	NN
50458	637	46	,	,	,
50458	637	47	bilious	bilious	JJ
50458	637	48	vomiting	vomiting	NN
50458	637	49	,	,	,
50458	637	50	diarrhea	diarrhea	NN
50458	637	51	,	,	,
50458	637	52	dyspnea	dyspnea	JJ
50458	637	53	with	with	IN
50458	637	54	pulmonary	pulmonary	JJ
50458	637	55	edema	edema	NN
50458	637	56	,	,	,
50458	637	57	etc	etc	FW
50458	637	58	.	.	.
50458	638	1	Fish	fish	NN
50458	638	2	and	and	CC
50458	638	3	eggs	egg	NNS
50458	638	4	are	be	VBP
50458	638	5	foods	food	NNS
50458	638	6	quite	quite	RB
50458	638	7	frequently	frequently	RB
50458	638	8	capable	capable	JJ
50458	638	9	of	of	IN
50458	638	10	developing	develop	VBG
50458	638	11	serious	serious	JJ
50458	638	12	results	result	NNS
50458	638	13	;	;	:
50458	638	14	the	the	DT
50458	638	15	same	same	JJ
50458	638	16	is	be	VBZ
50458	638	17	the	the	DT
50458	638	18	case	case	NN
50458	638	19	with	with	IN
50458	638	20	molluscs	molluscs	NNP
50458	638	21	,	,	,
50458	638	22	mussels	mussel	NNS
50458	638	23	,	,	,
50458	638	24	oysters	oyster	NNS
50458	638	25	,	,	,
50458	638	26	lobsters	lobster	NNS
50458	638	27	,	,	,
50458	638	28	and	and	CC
50458	638	29	snails	snail	NNS
50458	638	30	.	.	.
50458	639	1	Lastly	lastly	RB
50458	639	2	,	,	,
50458	639	3	moldy	moldy	JJ
50458	639	4	bread	bread	NN
50458	639	5	,	,	,
50458	639	6	spoiled	spoiled	JJ
50458	639	7	cheese	cheese	NN
50458	639	8	,	,	,
50458	639	9	putrid	putrid	JJ
50458	639	10	water	water	NN
50458	639	11	,	,	,
50458	639	12	and	and	CC
50458	639	13	spoiled	spoil	VBD
50458	639	14	vegetables	vegetable	NNS
50458	639	15	themselves	-PRON-	PRP
50458	639	16	,	,	,
50458	639	17	are	be	VBP
50458	639	18	proper	proper	JJ
50458	639	19	agents	agent	NNS
50458	639	20	for	for	IN
50458	639	21	determining	determine	VBG
50458	639	22	attacks	attack	NNS
50458	639	23	of	of	IN
50458	639	24	botulic	botulic	JJ
50458	639	25	poisoning	poisoning	NN
50458	639	26	.	.	.
50458	640	1	We	-PRON-	PRP
50458	640	2	have	have	VBP
50458	640	3	seen	see	VBN
50458	640	4	,	,	,
50458	640	5	at	at	IN
50458	640	6	the	the	DT
50458	640	7	beginning	beginning	NN
50458	640	8	of	of	IN
50458	640	9	this	this	DT
50458	640	10	volume	volume	NN
50458	640	11	,	,	,
50458	640	12	that	that	WDT
50458	640	13	putrid	putrid	VBP
50458	640	14	meats	meat	NNS
50458	640	15	contain	contain	VBP
50458	640	16	ptomaines	ptomaine	NNS
50458	640	17	,	,	,
50458	640	18	which	which	WDT
50458	640	19	are	be	VBP
50458	640	20	among	among	IN
50458	640	21	the	the	DT
50458	640	22	most	most	RBS
50458	640	23	toxic	toxic	JJ
50458	640	24	alkaloidal	alkaloidal	NN
50458	640	25	bases	basis	NNS
50458	640	26	.	.	.
50458	641	1	We	-PRON-	PRP
50458	641	2	have	have	VBP
50458	641	3	shown	show	VBN
50458	641	4	that	that	IN
50458	641	5	Brieger	Brieger	NNP
50458	641	6	has	have	VBZ
50458	641	7	isolated	isolate	VBN
50458	641	8	from	from	IN
50458	641	9	them	-PRON-	PRP
50458	641	10	neuridine	neuridine	JJ
50458	641	11	,	,	,
50458	641	12	putrescine	putrescine	NN
50458	641	13	,	,	,
50458	641	14	muscarine	muscarine	NNP
50458	641	15	,	,	,
50458	641	16	and	and	CC
50458	641	17	guanidine	guanidine	NN
50458	641	18	;	;	:
50458	641	19	that	that	IN
50458	641	20	Nencki	Nencki	NNP
50458	641	21	has	have	VBZ
50458	641	22	isolated	isolate	VBN
50458	641	23	hydrocollidine	hydrocollidine	NN
50458	641	24	;	;	:
50458	641	25	and	and	CC
50458	641	26	that	that	DT
50458	641	27	Gautier	Gautier	NNP
50458	641	28	and	and	CC
50458	641	29	Etard	Etard	NNP
50458	641	30	have	have	VBP
50458	641	31	obtained	obtain	VBN
50458	641	32	from	from	IN
50458	641	33	them	-PRON-	PRP
50458	641	34	parvoline	parvoline	NN
50458	641	35	--	--	:
50458	641	36	only	only	RB
50458	641	37	to	to	TO
50458	641	38	mention	mention	VB
50458	641	39	a	a	DT
50458	641	40	few	few	JJ
50458	641	41	of	of	IN
50458	641	42	them	-PRON-	PRP
50458	641	43	.	.	.
50458	642	1	Lastly	lastly	RB
50458	642	2	,	,	,
50458	642	3	there	there	EX
50458	642	4	may	may	MD
50458	642	5	develop	develop	VB
50458	642	6	within	within	IN
50458	642	7	the	the	DT
50458	642	8	gastrointestinal	gastrointestinal	JJ
50458	642	9	tract	tract	NN
50458	642	10	dangerous	dangerous	JJ
50458	642	11	putrefactions	putrefaction	NNS
50458	642	12	,	,	,
50458	642	13	the	the	DT
50458	642	14	products	product	NNS
50458	642	15	of	of	IN
50458	642	16	which	which	WDT
50458	642	17	may	may	MD
50458	642	18	enter	enter	VB
50458	642	19	the	the	DT
50458	642	20	veins	vein	NNS
50458	642	21	and	and	CC
50458	642	22	arteries	artery	NNS
50458	642	23	from	from	IN
50458	642	24	the	the	DT
50458	642	25	ileum	ileum	NN
50458	642	26	(	(	-LRB-
50458	642	27	a	a	DT
50458	642	28	portion	portion	NN
50458	642	29	of	of	IN
50458	642	30	the	the	DT
50458	642	31	small	small	JJ
50458	642	32	intestine	intestine	NN
50458	642	33	)	)	-RRB-
50458	642	34	and	and	CC
50458	642	35	be	be	VB
50458	642	36	distributed	distribute	VBN
50458	642	37	throughout	throughout	IN
50458	642	38	the	the	DT
50458	642	39	organism	organism	NN
50458	642	40	.	.	.
50458	643	1	Although	although	IN
50458	643	2	such	such	JJ
50458	643	3	poisonings	poisoning	NNS
50458	643	4	occur	occur	VBP
50458	643	5	,	,	,
50458	643	6	they	-PRON-	PRP
50458	643	7	do	do	VBP
50458	643	8	not	not	RB
50458	643	9	immediately	immediately	RB
50458	643	10	follow	follow	VB
50458	643	11	the	the	DT
50458	643	12	ingestion	ingestion	NN
50458	643	13	of	of	IN
50458	643	14	the	the	DT
50458	643	15	spoiled	spoiled	JJ
50458	643	16	or	or	CC
50458	643	17	toxic	toxic	JJ
50458	643	18	foods	food	NNS
50458	643	19	,	,	,
50458	643	20	but	but	CC
50458	643	21	they	-PRON-	PRP
50458	643	22	are	be	VBP
50458	643	23	always	always	RB
50458	643	24	preceded	precede	VBN
50458	643	25	by	by	IN
50458	643	26	a	a	DT
50458	643	27	period	period	NN
50458	643	28	of	of	IN
50458	643	29	incubation	incubation	NN
50458	643	30	varying	vary	VBG
50458	643	31	from	from	IN
50458	643	32	several	several	JJ
50458	643	33	hours	hour	NNS
50458	643	34	to	to	IN
50458	643	35	several	several	JJ
50458	643	36	days	day	NNS
50458	643	37	.	.	.
50458	644	1	These	these	DT
50458	644	2	alimentary	alimentary	JJ
50458	644	3	poisonings	poisoning	NNS
50458	644	4	are	be	VBP
50458	644	5	recognized	recognize	VBN
50458	644	6	by	by	IN
50458	644	7	a	a	DT
50458	644	8	great	great	JJ
50458	644	9	physical	physical	JJ
50458	644	10	depression	depression	NN
50458	644	11	,	,	,
50458	644	12	accompanied	accompany	VBN
50458	644	13	by	by	IN
50458	644	14	vomiting	vomiting	NN
50458	644	15	and	and	CC
50458	644	16	paralysis	paralysis	NN
50458	644	17	of	of	IN
50458	644	18	the	the	DT
50458	644	19	lower	low	JJR
50458	644	20	extremities	extremity	NNS
50458	644	21	,	,	,
50458	644	22	sweats	sweat	NNS
50458	644	23	,	,	,
50458	644	24	and	and	CC
50458	644	25	diarrheas	diarrhea	NNS
50458	644	26	.	.	.
50458	645	1	In	in	IN
50458	645	2	some	some	DT
50458	645	3	cases	case	NNS
50458	645	4	there	there	RB
50458	645	5	occur	occur	VBP
50458	645	6	cutaneous	cutaneous	JJ
50458	645	7	eruptions	eruption	NNS
50458	645	8	;	;	:
50458	645	9	and	and	CC
50458	645	10	when	when	WRB
50458	645	11	death	death	NN
50458	645	12	happens	happen	VBZ
50458	645	13	,	,	,
50458	645	14	this	this	DT
50458	645	15	occurs	occur	VBZ
50458	645	16	only	only	RB
50458	645	17	several	several	JJ
50458	645	18	days	day	NNS
50458	645	19	later	later	RB
50458	645	20	,	,	,
50458	645	21	and	and	CC
50458	645	22	generally	generally	RB
50458	645	23	without	without	IN
50458	645	24	being	be	VBG
50458	645	25	preceded	precede	VBN
50458	645	26	by	by	IN
50458	645	27	any	any	DT
50458	645	28	great	great	JJ
50458	645	29	pain	pain	NN
50458	645	30	.	.	.
50458	646	1	=	=	NFP
50458	646	2	Urinary	Urinary	NNP
50458	646	3	Toxins.=--As	Toxins.=--As	NNP
50458	646	4	we	-PRON-	PRP
50458	646	5	have	have	VBP
50458	646	6	already	already	RB
50458	646	7	remarked	remark	VBN
50458	646	8	several	several	JJ
50458	646	9	times	time	NNS
50458	646	10	,	,	,
50458	646	11	it	-PRON-	PRP
50458	646	12	is	be	VBZ
50458	646	13	by	by	IN
50458	646	14	the	the	DT
50458	646	15	renal	renal	JJ
50458	646	16	way	way	NN
50458	646	17	that	that	WDT
50458	646	18	the	the	DT
50458	646	19	organism	organism	NN
50458	646	20	voids	void	VBZ
50458	646	21	its	-PRON-	PRP$
50458	646	22	principal	principal	JJ
50458	646	23	waste	waste	NN
50458	646	24	products	product	NNS
50458	646	25	.	.	.
50458	647	1	We	-PRON-	PRP
50458	647	2	have	have	VBP
50458	647	3	seen	see	VBN
50458	647	4	also	also	RB
50458	647	5	that	that	IN
50458	647	6	it	-PRON-	PRP
50458	647	7	is	be	VBZ
50458	647	8	by	by	IN
50458	647	9	the	the	DT
50458	647	10	kidneys	kidney	NNS
50458	647	11	that	that	IN
50458	647	12	the	the	DT
50458	647	13	toxins	toxin	NNS
50458	647	14	are	be	VBP
50458	647	15	eliminated	eliminate	VBN
50458	647	16	in	in	IN
50458	647	17	all	all	DT
50458	647	18	pathological	pathological	JJ
50458	647	19	conditions	condition	NNS
50458	647	20	.	.	.
50458	648	1	As	as	IN
50458	648	2	a	a	DT
50458	648	3	general	general	JJ
50458	648	4	rule	rule	NN
50458	648	5	,	,	,
50458	648	6	the	the	DT
50458	648	7	urines	urine	NNS
50458	648	8	are	be	VBP
50458	648	9	always	always	RB
50458	648	10	more	more	RBR
50458	648	11	or	or	CC
50458	648	12	less	less	RBR
50458	648	13	toxic	toxic	JJ
50458	648	14	.	.	.
50458	649	1	This	this	DT
50458	649	2	toxicity	toxicity	NN
50458	649	3	of	of	IN
50458	649	4	the	the	DT
50458	649	5	urines	urine	NNS
50458	649	6	must	must	MD
50458	649	7	be	be	VB
50458	649	8	attributed	attribute	VBN
50458	649	9	in	in	IN
50458	649	10	the	the	DT
50458	649	11	first	first	JJ
50458	649	12	place	place	NN
50458	649	13	to	to	IN
50458	649	14	the	the	DT
50458	649	15	crystallizable	crystallizable	JJ
50458	649	16	organic	organic	JJ
50458	649	17	principles	principle	NNS
50458	649	18	(	(	-LRB-
50458	649	19	ptomaines	ptomaine	NNS
50458	649	20	and	and	CC
50458	649	21	leucomaines[75	leucomaines[75	NNP
50458	649	22	]	]	-RRB-
50458	649	23	)	)	-RRB-
50458	649	24	which	which	WDT
50458	649	25	they	-PRON-	PRP
50458	649	26	contain	contain	VBP
50458	649	27	;	;	:
50458	649	28	secondly	secondly	RB
50458	649	29	,	,	,
50458	649	30	to	to	IN
50458	649	31	the	the	DT
50458	649	32	non	non	JJ
50458	649	33	-	-	JJ
50458	649	34	crystallizable[76	crystallizable[76	JJ
50458	649	35	]	]	-RRB-
50458	649	36	extractive	extractive	JJ
50458	649	37	matters	matter	NNS
50458	649	38	not	not	RB
50458	649	39	so	so	RB
50458	649	40	well	well	RB
50458	649	41	known	known	JJ
50458	649	42	;	;	:
50458	649	43	and	and	CC
50458	649	44	lastly	lastly	RB
50458	649	45	,	,	,
50458	649	46	to	to	IN
50458	649	47	the	the	DT
50458	649	48	saline	saline	JJ
50458	649	49	substances	substance	NNS
50458	649	50	,	,	,
50458	649	51	among	among	IN
50458	649	52	which	which	WDT
50458	649	53	the	the	DT
50458	649	54	potassium	potassium	NN
50458	649	55	salts	salt	NNS
50458	649	56	are	be	VBP
50458	649	57	the	the	DT
50458	649	58	most	most	RBS
50458	649	59	active	active	JJ
50458	649	60	.	.	.
50458	650	1	We	-PRON-	PRP
50458	650	2	find	find	VBP
50458	650	3	these	these	DT
50458	650	4	mineral	mineral	NN
50458	650	5	salts	salt	NNS
50458	650	6	particularly	particularly	RB
50458	650	7	abundant	abundant	JJ
50458	650	8	under	under	IN
50458	650	9	normal	normal	JJ
50458	650	10	conditions	condition	NNS
50458	650	11	in	in	IN
50458	650	12	the	the	DT
50458	650	13	urines	urine	NNS
50458	650	14	of	of	IN
50458	650	15	the	the	DT
50458	650	16	herbivora	herbivora	NN
50458	650	17	.	.	.
50458	651	1	According	accord	VBG
50458	651	2	to	to	IN
50458	651	3	Bouchard	Bouchard	NNP
50458	651	4	,	,	,
50458	651	5	0.18	0.18	CD
50458	651	6	Gm	Gm	NNP
50458	651	7	.	.	.
50458	652	1	of	of	IN
50458	652	2	potassium	potassium	NN
50458	652	3	chloride	chloride	NN
50458	652	4	are	be	VBP
50458	652	5	sufficient	sufficient	JJ
50458	652	6	to	to	TO
50458	652	7	prove	prove	VB
50458	652	8	fatal	fatal	JJ
50458	652	9	to	to	IN
50458	652	10	1000	1000	CD
50458	652	11	Gm	Gm	NNP
50458	652	12	.	.	.
50458	653	1	of	of	IN
50458	653	2	living	living	NN
50458	653	3	organism	organism	NN
50458	653	4	;	;	,
50458	653	5	a	a	DT
50458	653	6	man	man	NN
50458	653	7	excretes	excrete	VBZ
50458	653	8	on	on	IN
50458	653	9	the	the	DT
50458	653	10	average	average	JJ
50458	653	11	2.5	2.5	CD
50458	653	12	Gm	Gm	NNP
50458	653	13	.	.	.
50458	654	1	of	of	IN
50458	654	2	this	this	DT
50458	654	3	salt	salt	NN
50458	654	4	,	,	,
50458	654	5	and	and	CC
50458	654	6	a	a	DT
50458	654	7	rabbit	rabbit	NN
50458	654	8	excretes	excrete	NNS
50458	654	9	about	about	IN
50458	654	10	double	double	PDT
50458	654	11	this	this	DT
50458	654	12	quantity	quantity	NN
50458	654	13	,	,	,
50458	654	14	weight	weight	NN
50458	654	15	for	for	IN
50458	654	16	weight	weight	NN
50458	654	17	.	.	.
50458	655	1	[	[	-LRB-
50458	655	2	75	75	CD
50458	655	3	]	]	-RRB-
50458	655	4	ADDUCO	adduco	NN
50458	655	5	:	:	:
50458	655	6	_	_	NNP
50458	655	7	Arch	Arch	NNP
50458	655	8	.	.	.
50458	656	1	Ital	Ital	NNP
50458	656	2	.	.	.
50458	657	1	de	de	NNP
50458	657	2	biolog	biolog	NNP
50458	657	3	.	.	.
50458	657	4	_	_	NNP
50458	657	5	,	,	,
50458	657	6	1891	1891	CD
50458	657	7	.	.	.
50458	658	1	[	[	-LRB-
50458	658	2	76	76	CD
50458	658	3	]	]	-RRB-
50458	658	4	POUCHET	POUCHET	NNP
50458	658	5	:	:	:
50458	658	6	_	_	NNP
50458	658	7	Thèse	Thèse	NNP
50458	658	8	de	de	NNP
50458	658	9	Doctorat	Doctorat	NNP
50458	658	10	en	en	NNP
50458	658	11	Médecine	Médecine	NNP
50458	658	12	_	_	NNP
50458	658	13	,	,	,
50458	658	14	Paris	Paris	NNP
50458	658	15	,	,	,
50458	658	16	1878	1878	CD
50458	658	17	.	.	.
50458	659	1	A	a	DT
50458	659	2	very	very	RB
50458	659	3	large	large	JJ
50458	659	4	number	number	NN
50458	659	5	of	of	IN
50458	659	6	hypotheses	hypothesis	NNS
50458	659	7	have	have	VBP
50458	659	8	been	be	VBN
50458	659	9	advanced	advance	VBN
50458	659	10	regarding	regard	VBG
50458	659	11	the	the	DT
50458	659	12	toxicity	toxicity	NN
50458	659	13	of	of	IN
50458	659	14	the	the	DT
50458	659	15	urines	urine	NNS
50458	659	16	.	.	.
50458	660	1	Wilson	Wilson	NNP
50458	660	2	considers	consider	VBZ
50458	660	3	the	the	DT
50458	660	4	urea	urea	NN
50458	660	5	as	as	IN
50458	660	6	being	be	VBG
50458	660	7	responsible	responsible	JJ
50458	660	8	for	for	IN
50458	660	9	it	-PRON-	PRP
50458	660	10	;	;	:
50458	660	11	Stadthagen[77	stadthagen[77	ADD
50458	660	12	]	]	-RRB-
50458	660	13	believes	believe	VBZ
50458	660	14	it	-PRON-	PRP
50458	660	15	to	to	TO
50458	660	16	be	be	VB
50458	660	17	due	due	IN
50458	660	18	to	to	IN
50458	660	19	the	the	DT
50458	660	20	potassium	potassium	NN
50458	660	21	salts	salt	NNS
50458	660	22	,	,	,
50458	660	23	etc	etc	FW
50458	660	24	.	.	.
50458	661	1	Bouchard[78	Bouchard[78	NNP
50458	661	2	]	]	-RRB-
50458	661	3	was	be	VBD
50458	661	4	the	the	DT
50458	661	5	first	first	JJ
50458	661	6	to	to	TO
50458	661	7	recognize	recognize	VB
50458	661	8	that	that	IN
50458	661	9	the	the	DT
50458	661	10	toxicity	toxicity	NN
50458	661	11	of	of	IN
50458	661	12	the	the	DT
50458	661	13	urines	urine	NNS
50458	661	14	is	be	VBZ
50458	661	15	due	due	JJ
50458	661	16	to	to	IN
50458	661	17	a	a	DT
50458	661	18	number	number	NN
50458	661	19	of	of	IN
50458	661	20	causes	cause	NNS
50458	661	21	.	.	.
50458	662	1	We	-PRON-	PRP
50458	662	2	will	will	MD
50458	662	3	not	not	RB
50458	662	4	dwell	dwell	VB
50458	662	5	further	further	RB
50458	662	6	on	on	IN
50458	662	7	these	these	DT
50458	662	8	active	active	JJ
50458	662	9	principles	principle	NNS
50458	662	10	which	which	WDT
50458	662	11	,	,	,
50458	662	12	in	in	IN
50458	662	13	the	the	DT
50458	662	14	last	last	JJ
50458	662	15	analysis	analysis	NN
50458	662	16	,	,	,
50458	662	17	are	be	VBP
50458	662	18	no	no	DT
50458	662	19	other	other	JJ
50458	662	20	than	than	IN
50458	662	21	those	those	DT
50458	662	22	that	that	DT
50458	662	23	form	form	VBP
50458	662	24	in	in	IN
50458	662	25	the	the	DT
50458	662	26	various	various	JJ
50458	662	27	portions	portion	NNS
50458	662	28	of	of	IN
50458	662	29	the	the	DT
50458	662	30	organism	organism	NN
50458	662	31	,	,	,
50458	662	32	and	and	CC
50458	662	33	which	which	WDT
50458	662	34	are	be	VBP
50458	662	35	eliminated	eliminate	VBN
50458	662	36	by	by	IN
50458	662	37	the	the	DT
50458	662	38	urine	urine	NN
50458	662	39	.	.	.
50458	663	1	[	[	-LRB-
50458	663	2	77	77	CD
50458	663	3	]	]	-RRB-
50458	663	4	STADTHAGEN	STADTHAGEN	NNP
50458	663	5	:	:	:
50458	663	6	_	_	NNP
50458	663	7	Zeitschr	Zeitschr	NNP
50458	663	8	.	.	.
50458	664	1	f.	f.	NNP
50458	664	2	Klin	Klin	NNP
50458	664	3	.	.	.
50458	665	1	Med	Med	NNP
50458	665	2	.	.	.
50458	665	3	_	_	NNP
50458	665	4	,	,	,
50458	665	5	XV	XV	NNP
50458	665	6	.	.	.
50458	666	1	[	[	-LRB-
50458	666	2	78	78	CD
50458	666	3	]	]	-RRB-
50458	666	4	BOUCHARD	BOUCHARD	NNP
50458	666	5	:	:	:
50458	666	6	_	_	NNP
50458	666	7	Leçons	Leçons	NNPS
50458	666	8	sur	sur	FW
50458	666	9	les	les	FW
50458	666	10	Autointoxications	Autointoxications	NNP
50458	666	11	_	_	NNP
50458	666	12	.	.	.
50458	667	1	It	-PRON-	PRP
50458	667	2	is	be	VBZ
50458	667	3	self	self	NN
50458	667	4	-	-	HYPH
50458	667	5	evident	evident	JJ
50458	667	6	,	,	,
50458	667	7	and	and	CC
50458	667	8	it	-PRON-	PRP
50458	667	9	has	have	VBZ
50458	667	10	already	already	RB
50458	667	11	been	be	VBN
50458	667	12	shown	show	VBN
50458	667	13	,	,	,
50458	667	14	that	that	IN
50458	667	15	the	the	DT
50458	667	16	toxicity	toxicity	NN
50458	667	17	of	of	IN
50458	667	18	the	the	DT
50458	667	19	urines	urine	NNS
50458	667	20	varies	vary	VBZ
50458	667	21	greatly	greatly	RB
50458	667	22	according	accord	VBG
50458	667	23	to	to	IN
50458	667	24	the	the	DT
50458	667	25	malady	malady	JJ
50458	667	26	,	,	,
50458	667	27	in	in	IN
50458	667	28	consequence	consequence	NN
50458	667	29	of	of	IN
50458	667	30	the	the	DT
50458	667	31	elimination	elimination	NN
50458	667	32	of	of	IN
50458	667	33	toxins	toxin	NNS
50458	667	34	by	by	IN
50458	667	35	the	the	DT
50458	667	36	urines	urine	NNS
50458	667	37	.	.	.
50458	668	1	According	accord	VBG
50458	668	2	to	to	IN
50458	668	3	Bouchard	Bouchard	NNP
50458	668	4	,	,	,
50458	668	5	in	in	IN
50458	668	6	infectious	infectious	JJ
50458	668	7	maladies	malady	NNS
50458	668	8	the	the	DT
50458	668	9	urines	urine	NNS
50458	668	10	are	be	VBP
50458	668	11	twelve	twelve	CD
50458	668	12	times	time	NNS
50458	668	13	more	more	RBR
50458	668	14	highly	highly	RB
50458	668	15	charged	charge	VBN
50458	668	16	with	with	IN
50458	668	17	toxins	toxin	NNS
50458	668	18	than	than	IN
50458	668	19	is	be	VBZ
50458	668	20	blood	blood	NN
50458	668	21	serum	serum	NN
50458	668	22	.	.	.
50458	669	1	Moreover	moreover	RB
50458	669	2	,	,	,
50458	669	3	the	the	DT
50458	669	4	toxicity	toxicity	NN
50458	669	5	of	of	IN
50458	669	6	the	the	DT
50458	669	7	urines	urine	NNS
50458	669	8	is	be	VBZ
50458	669	9	considerably	considerably	RB
50458	669	10	augmented	augment	VBN
50458	669	11	the	the	DT
50458	669	12	moment	moment	NN
50458	669	13	there	there	EX
50458	669	14	is	be	VBZ
50458	669	15	the	the	DT
50458	669	16	least	least	JJS
50458	669	17	febrile	febrile	NN
50458	669	18	condition	condition	NN
50458	669	19	,	,	,
50458	669	20	no	no	RB
50458	669	21	matter	matter	RB
50458	669	22	what	what	WP
50458	669	23	the	the	DT
50458	669	24	cause	cause	NN
50458	669	25	is	be	VBZ
50458	669	26	.	.	.
50458	670	1	[	[	-LRB-
50458	670	2	79	79	CD
50458	670	3	]	]	-RRB-
50458	670	4	[	[	-LRB-
50458	670	5	79	79	CD
50458	670	6	]	]	-RRB-
50458	670	7	Regarding	regard	VBG
50458	670	8	this	this	DT
50458	670	9	point	point	NN
50458	670	10	see	see	VBP
50458	670	11	the	the	DT
50458	670	12	excellent	excellent	JJ
50458	670	13	work	work	NN
50458	670	14	by	by	IN
50458	670	15	A.	a.	NN
50458	670	16	CHARRIN	CHARRIN	NNP
50458	670	17	:	:	:
50458	670	18	_	_	NNP
50458	670	19	Poisons	Poisons	NNPS
50458	670	20	de	de	IN
50458	670	21	l'Organism	l'Organism	NNP
50458	670	22	_	_	NNP
50458	670	23	.	.	.
50458	671	1	Masson	Masson	NNP
50458	671	2	,	,	,
50458	671	3	publ	publ	NNS
50458	671	4	.	.	.
50458	672	1	Even	even	RB
50458	672	2	in	in	IN
50458	672	3	the	the	DT
50458	672	4	normal	normal	JJ
50458	672	5	condition	condition	NN
50458	672	6	,	,	,
50458	672	7	the	the	DT
50458	672	8	urinary	urinary	JJ
50458	672	9	toxicity	toxicity	NN
50458	672	10	varies	vary	VBZ
50458	672	11	greatly	greatly	RB
50458	672	12	;	;	:
50458	672	13	and	and	CC
50458	672	14	this	this	DT
50458	672	15	is	be	VBZ
50458	672	16	easily	easily	RB
50458	672	17	conceived	conceive	VBN
50458	672	18	since	since	IN
50458	672	19	the	the	DT
50458	672	20	physiological	physiological	JJ
50458	672	21	phenomena	phenomenon	NNS
50458	672	22	that	that	WDT
50458	672	23	control	control	VBP
50458	672	24	this	this	DT
50458	672	25	secretion	secretion	NN
50458	672	26	undergo	undergo	VBP
50458	672	27	incessant	incessant	NN
50458	672	28	rise	rise	NN
50458	672	29	and	and	CC
50458	672	30	fall	fall	VBP
50458	672	31	.	.	.
50458	673	1	Thus	thus	RB
50458	673	2	,	,	,
50458	673	3	for	for	IN
50458	673	4	example	example	NN
50458	673	5	,	,	,
50458	673	6	the	the	DT
50458	673	7	urines	urine	NNS
50458	673	8	eliminated	eliminate	VBD
50458	673	9	during	during	IN
50458	673	10	sleep	sleep	NN
50458	673	11	are	be	VBP
50458	673	12	less	less	RBR
50458	673	13	active	active	JJ
50458	673	14	than	than	IN
50458	673	15	those	those	DT
50458	673	16	produced	produce	VBN
50458	673	17	during	during	IN
50458	673	18	waking	waking	NN
50458	673	19	,	,	,
50458	673	20	because	because	IN
50458	673	21	during	during	IN
50458	673	22	sleep	sleep	NN
50458	673	23	the	the	DT
50458	673	24	elimination	elimination	NN
50458	673	25	of	of	IN
50458	673	26	cellular	cellular	JJ
50458	673	27	poisons	poison	NNS
50458	673	28	is	be	VBZ
50458	673	29	at	at	IN
50458	673	30	a	a	DT
50458	673	31	minimum	minimum	NN
50458	673	32	.	.	.
50458	674	1	Exercise	exercise	NN
50458	674	2	,	,	,
50458	674	3	walking	walk	VBG
50458	674	4	,	,	,
50458	674	5	physical	physical	JJ
50458	674	6	and	and	CC
50458	674	7	intellectual	intellectual	JJ
50458	674	8	labor	labor	NN
50458	674	9	,	,	,
50458	674	10	exert	exert	VB
50458	674	11	their	-PRON-	PRP$
50458	674	12	portion	portion	NN
50458	674	13	of	of	IN
50458	674	14	influence	influence	NN
50458	674	15	on	on	IN
50458	674	16	these	these	DT
50458	674	17	oscillations	oscillation	NNS
50458	674	18	of	of	IN
50458	674	19	toxicity	toxicity	NN
50458	674	20	;	;	:
50458	674	21	and	and	CC
50458	674	22	this	this	DT
50458	674	23	variation	variation	NN
50458	674	24	of	of	IN
50458	674	25	toxicity	toxicity	NN
50458	674	26	is	be	VBZ
50458	674	27	due	due	JJ
50458	674	28	not	not	RB
50458	674	29	to	to	IN
50458	674	30	any	any	DT
50458	674	31	one	one	CD
50458	674	32	variation	variation	NN
50458	674	33	in	in	IN
50458	674	34	the	the	DT
50458	674	35	mineral	mineral	NN
50458	674	36	extractive	extractive	JJ
50458	674	37	matters	matter	NNS
50458	674	38	,	,	,
50458	674	39	but	but	CC
50458	674	40	rather	rather	RB
50458	674	41	more	more	RBR
50458	674	42	or	or	CC
50458	674	43	less	less	JJR
50458	674	44	to	to	IN
50458	674	45	the	the	DT
50458	674	46	organic	organic	JJ
50458	674	47	toxic	toxic	JJ
50458	674	48	products	product	NNS
50458	674	49	.	.	.
50458	675	1	We	-PRON-	PRP
50458	675	2	will	will	MD
50458	675	3	not	not	RB
50458	675	4	dwell	dwell	VB
50458	675	5	further	further	RB
50458	675	6	on	on	IN
50458	675	7	this	this	DT
50458	675	8	subject	subject	NN
50458	675	9	,	,	,
50458	675	10	but	but	CC
50458	675	11	will	will	MD
50458	675	12	simply	simply	RB
50458	675	13	refer	refer	VB
50458	675	14	to	to	IN
50458	675	15	the	the	DT
50458	675	16	work	work	NN
50458	675	17	by	by	IN
50458	675	18	Charrin	Charrin	NNP
50458	675	19	,	,	,
50458	675	20	already	already	RB
50458	675	21	mentioned	mention	VBN
50458	675	22	,	,	,
50458	675	23	for	for	IN
50458	675	24	all	all	DT
50458	675	25	supplementary	supplementary	JJ
50458	675	26	details	detail	NNS
50458	675	27	.	.	.
50458	676	1	=	=	NFP
50458	676	2	Autointoxications.=[80]--The	autointoxications.=[80]--the	NN
50458	676	3	cells	cell	NNS
50458	676	4	of	of	IN
50458	676	5	the	the	DT
50458	676	6	organism	organism	NN
50458	676	7	having	have	VBG
50458	676	8	,	,	,
50458	676	9	as	as	IN
50458	676	10	a	a	DT
50458	676	11	whole	whole	NN
50458	676	12	,	,	,
50458	676	13	a	a	DT
50458	676	14	life	life	NN
50458	676	15	very	very	RB
50458	676	16	much	much	RB
50458	676	17	like	like	IN
50458	676	18	that	that	DT
50458	676	19	of	of	IN
50458	676	20	the	the	DT
50458	676	21	microbes	microbe	NNS
50458	676	22	,	,	,
50458	676	23	it	-PRON-	PRP
50458	676	24	is	be	VBZ
50458	676	25	quite	quite	RB
50458	676	26	natural	natural	JJ
50458	676	27	that	that	IN
50458	676	28	among	among	IN
50458	676	29	the	the	DT
50458	676	30	excreted	excreted	JJ
50458	676	31	products	product	NNS
50458	676	32	of	of	IN
50458	676	33	the	the	DT
50458	676	34	living	live	VBG
50458	676	35	tissues	tissue	NNS
50458	676	36	there	there	EX
50458	676	37	should	should	MD
50458	676	38	be	be	VB
50458	676	39	found	find	VBN
50458	676	40	the	the	DT
50458	676	41	same	same	JJ
50458	676	42	substances	substance	NNS
50458	676	43	formed	form	VBN
50458	676	44	as	as	IN
50458	676	45	a	a	DT
50458	676	46	result	result	NN
50458	676	47	of	of	IN
50458	676	48	the	the	DT
50458	676	49	anaerobic	anaerobic	JJ
50458	676	50	fermentation	fermentation	NN
50458	676	51	of	of	IN
50458	676	52	albuminoids	albuminoid	NNS
50458	676	53	.	.	.
50458	677	1	Experiment	experiment	NN
50458	677	2	has	have	VBZ
50458	677	3	demonstrated	demonstrate	VBN
50458	677	4	that	that	IN
50458	677	5	this	this	DT
50458	677	6	is	be	VBZ
50458	677	7	so	so	RB
50458	677	8	,	,	,
50458	677	9	and	and	CC
50458	677	10	Armand	Armand	NNP
50458	677	11	Gautier	Gautier	NNP
50458	677	12	has	have	VBZ
50458	677	13	irrefutably	irrefutably	RB
50458	677	14	proven	prove	VBN
50458	677	15	the	the	DT
50458	677	16	existence	existence	NN
50458	677	17	of	of	IN
50458	677	18	these	these	DT
50458	677	19	principles	principle	NNS
50458	677	20	.	.	.
50458	678	1	[	[	-LRB-
50458	678	2	81	81	CD
50458	678	3	]	]	-RRB-
50458	678	4	Bouchard	Bouchard	NNP
50458	678	5	was	be	VBD
50458	678	6	the	the	DT
50458	678	7	first	first	JJ
50458	678	8	to	to	TO
50458	678	9	demonstrate	demonstrate	VB
50458	678	10	the	the	DT
50458	678	11	toxic	toxic	JJ
50458	678	12	nature	nature	NN
50458	678	13	of	of	IN
50458	678	14	muscle	muscle	NN
50458	678	15	extract,[82	extract,[82	NNP
50458	678	16	]	]	-RRB-
50458	678	17	and	and	CC
50458	678	18	Roger[83	roger[83	CD
50458	678	19	]	]	-RRB-
50458	678	20	established	establish	VBD
50458	678	21	the	the	DT
50458	678	22	fact	fact	NN
50458	678	23	that	that	IN
50458	678	24	the	the	DT
50458	678	25	toxicity	toxicity	NN
50458	678	26	of	of	IN
50458	678	27	this	this	DT
50458	678	28	extract	extract	NN
50458	678	29	is	be	VBZ
50458	678	30	due	due	JJ
50458	678	31	to	to	IN
50458	678	32	ferment	ferment	NN
50458	678	33	-	-	HYPH
50458	678	34	toxins	toxin	NNS
50458	678	35	;	;	:
50458	678	36	it	-PRON-	PRP
50458	678	37	has	have	VBZ
50458	678	38	since	since	IN
50458	678	39	been	be	VBN
50458	678	40	recognized	recognize	VBN
50458	678	41	that	that	IN
50458	678	42	after	after	IN
50458	678	43	death	death	NN
50458	678	44	these	these	DT
50458	678	45	toxins	toxin	NNS
50458	678	46	accumulate	accumulate	VBP
50458	678	47	in	in	IN
50458	678	48	the	the	DT
50458	678	49	muscles	muscle	NNS
50458	678	50	.	.	.
50458	679	1	[	[	-LRB-
50458	679	2	80	80	CD
50458	679	3	]	]	-RRB-
50458	679	4	CH	CH	NNP
50458	679	5	.	.	.
50458	680	1	BOUCHARD	BOUCHARD	NNP
50458	680	2	:	:	:
50458	680	3	_	_	NNP
50458	680	4	Des	Des	NNP
50458	680	5	Autointoxications	Autointoxications	NNP
50458	680	6	_	_	NNP
50458	680	7	.	.	.
50458	681	1	Paris	Paris	NNP
50458	681	2	,	,	,
50458	681	3	1887	1887	CD
50458	681	4	.	.	.
50458	682	1	[	[	-LRB-
50458	682	2	81	81	CD
50458	682	3	]	]	-RRB-
50458	682	4	_	_	NNP
50458	682	5	Bull	Bull	NNP
50458	682	6	.	.	.
50458	683	1	Acad	Acad	NNP
50458	683	2	,	,	,
50458	683	3	de	de	NNP
50458	683	4	Médecine	Médecine	NNP
50458	683	5	_	_	NNP
50458	683	6	(	(	-LRB-
50458	683	7	2	2	CD
50458	683	8	)	)	-RRB-
50458	683	9	,	,	,
50458	683	10	X	x	NN
50458	683	11	,	,	,
50458	683	12	p.	p.	NN
50458	683	13	947	947	CD
50458	683	14	,	,	,
50458	683	15	and	and	CC
50458	683	16	XX	XX	NNP
50458	683	17	,	,	,
50458	683	18	p.	p.	NN
50458	683	19	115	115	CD
50458	683	20	.	.	.
50458	684	1	[	[	-LRB-
50458	684	2	82	82	CD
50458	684	3	]	]	-RRB-
50458	684	4	BOUCHARD	BOUCHARD	NNP
50458	684	5	:	:	:
50458	684	6	_	_	NNP
50458	684	7	Leçons	Leçons	NNPS
50458	684	8	sur	sur	FW
50458	684	9	les	les	FW
50458	684	10	Autointoxications	Autointoxications	NNP
50458	684	11	_	_	NNP
50458	684	12	,	,	,
50458	684	13	Paris	Paris	NNP
50458	684	14	,	,	,
50458	684	15	1887	1887	CD
50458	684	16	.	.	.
50458	685	1	[	[	-LRB-
50458	685	2	83	83	CD
50458	685	3	]	]	-RRB-
50458	685	4	ROGER	ROGER	NNP
50458	685	5	:	:	:
50458	685	6	Toxicité	Toxicité	NNP
50458	685	7	des	des	FW
50458	685	8	Extraits	Extraits	NNP
50458	685	9	des	des	NNP
50458	685	10	Tissus	Tissus	NNP
50458	685	11	Normaux	Normaux	NNP
50458	685	12	.	.	.
50458	686	1	_	_	NNP
50458	686	2	Soc	Soc	NNP
50458	686	3	.	.	.
50458	687	1	de	de	NNP
50458	687	2	Biolog	Biolog	NNP
50458	687	3	.	.	.
50458	687	4	_	_	NNP
50458	687	5	,	,	,
50458	687	6	1891	1891	CD
50458	687	7	,	,	,
50458	687	8	p.	p.	NN
50458	687	9	728	728	CD
50458	687	10	.	.	.
50458	688	1	The	the	DT
50458	688	2	extract	extract	NN
50458	688	3	of	of	IN
50458	688	4	kidney	kidney	NN
50458	688	5	made	make	VBD
50458	688	6	rapidly	rapidly	RB
50458	688	7	by	by	IN
50458	688	8	cold	cold	JJ
50458	688	9	process	process	NN
50458	688	10	by	by	IN
50458	688	11	triturating	triturate	VBG
50458	688	12	the	the	DT
50458	688	13	washed	washed	JJ
50458	688	14	kidney	kidney	NN
50458	688	15	with	with	IN
50458	688	16	glycerin	glycerin	NNP
50458	688	17	,	,	,
50458	688	18	and	and	CC
50458	688	19	precipitating	precipitate	VBG
50458	688	20	the	the	DT
50458	688	21	glycerinic	glycerinic	JJ
50458	688	22	solution	solution	NN
50458	688	23	with	with	IN
50458	688	24	alcohol	alcohol	NN
50458	688	25	,	,	,
50458	688	26	contains	contain	VBZ
50458	688	27	toxic	toxic	JJ
50458	688	28	ferments	ferment	NNS
50458	688	29	to	to	TO
50458	688	30	which	which	WDT
50458	688	31	the	the	DT
50458	688	32	name	name	NN
50458	688	33	"	"	``
50458	688	34	_	_	NNP
50458	688	35	hystozymes	hystozymes	NNP
50458	688	36	_	_	NNP
50458	688	37	"	"	``
50458	688	38	has	have	VBZ
50458	688	39	been	be	VBN
50458	688	40	given	give	VBN
50458	688	41	.	.	.
50458	689	1	[	[	-LRB-
50458	689	2	84	84	CD
50458	689	3	]	]	-RRB-
50458	689	4	These	these	DT
50458	689	5	ferments	ferment	NNS
50458	689	6	split	split	VBD
50458	689	7	up	up	RP
50458	689	8	hippuric	hippuric	NN
50458	689	9	acid	acid	NN
50458	689	10	into	into	IN
50458	689	11	benzoic	benzoic	JJ
50458	689	12	acid	acid	NN
50458	689	13	and	and	CC
50458	689	14	glycocoll	glycocoll	NN
50458	689	15	.	.	.
50458	690	1	Lépine	Lépine	NNP
50458	690	2	has	have	VBZ
50458	690	3	likewise	likewise	RB
50458	690	4	discovered	discover	VBN
50458	690	5	in	in	IN
50458	690	6	the	the	DT
50458	690	7	kidney	kidney	NN
50458	690	8	a	a	DT
50458	690	9	very	very	RB
50458	690	10	toxic	toxic	JJ
50458	690	11	pyrogenic	pyrogenic	JJ
50458	690	12	substance	substance	NN
50458	690	13	.	.	.
50458	691	1	[	[	-LRB-
50458	691	2	85	85	CD
50458	691	3	]	]	-RRB-
50458	691	4	Roger	Roger	NNP
50458	691	5	has	have	VBZ
50458	691	6	given	give	VBN
50458	691	7	us	-PRON-	PRP
50458	691	8	evidence	evidence	NN
50458	691	9	of	of	IN
50458	691	10	the	the	DT
50458	691	11	toxic	toxic	JJ
50458	691	12	properties	property	NNS
50458	691	13	of	of	IN
50458	691	14	the	the	DT
50458	691	15	liver	liver	NN
50458	691	16	,	,	,
50458	691	17	washed	wash	VBD
50458	691	18	and	and	CC
50458	691	19	pulped	pulp	VBD
50458	691	20	,	,	,
50458	691	21	and	and	CC
50458	691	22	then	then	RB
50458	691	23	sterilized	sterilize	VBN
50458	691	24	by	by	IN
50458	691	25	filtration	filtration	NN
50458	691	26	through	through	IN
50458	691	27	a	a	DT
50458	691	28	porous	porous	JJ
50458	691	29	diaphragm	diaphragm	NN
50458	691	30	.	.	.
50458	692	1	This	this	DT
50458	692	2	scientist	scientist	NN
50458	692	3	has	have	VBZ
50458	692	4	shown	show	VBN
50458	692	5	that	that	IN
50458	692	6	the	the	DT
50458	692	7	toxic	toxic	JJ
50458	692	8	properties	property	NNS
50458	692	9	are	be	VBP
50458	692	10	due	due	JJ
50458	692	11	to	to	IN
50458	692	12	albuminoids	albuminoid	NNS
50458	692	13	,	,	,
50458	692	14	which	which	WDT
50458	692	15	lose	lose	VBP
50458	692	16	their	-PRON-	PRP$
50458	692	17	activity	activity	NN
50458	692	18	when	when	WRB
50458	692	19	heated	heat	VBN
50458	692	20	to	to	IN
50458	692	21	100	100	CD
50458	692	22	°	°	NNS
50458	692	23	C	C	NNP
50458	692	24	.	.	.
50458	693	1	[	[	-LRB-
50458	693	2	86	86	CD
50458	693	3	]	]	-RRB-
50458	693	4	[	[	-LRB-
50458	693	5	84	84	CD
50458	693	6	]	]	-RRB-
50458	693	7	It	-PRON-	PRP
50458	693	8	is	be	VBZ
50458	693	9	well	well	JJ
50458	693	10	to	to	TO
50458	693	11	recall	recall	VB
50458	693	12	here	here	RB
50458	693	13	that	that	IN
50458	693	14	the	the	DT
50458	693	15	kidneys	kidney	NNS
50458	693	16	contain	contain	VBP
50458	693	17	both	both	CC
50458	693	18	reducing	reduce	VBG
50458	693	19	and	and	CC
50458	693	20	oxidizing	oxidize	VBG
50458	693	21	ferments	ferment	NNS
50458	693	22	,	,	,
50458	693	23	as	as	IN
50458	693	24	has	have	VBZ
50458	693	25	been	be	VBN
50458	693	26	demonstrated	demonstrate	VBN
50458	693	27	by	by	IN
50458	693	28	de	de	NNP
50458	693	29	Rey	Rey	NNP
50458	693	30	-	-	HYPH
50458	693	31	Pailhade	Pailhade	NNP
50458	693	32	,	,	,
50458	693	33	and	and	CC
50458	693	34	later	later	RB
50458	693	35	by	by	IN
50458	693	36	Abelous	Abelous	NNP
50458	693	37	and	and	CC
50458	693	38	Gérard	Gérard	NNP
50458	693	39	.	.	.
50458	694	1	[	[	-LRB-
50458	694	2	85	85	CD
50458	694	3	]	]	-RRB-
50458	694	4	LÉPINE	LÉPINE	NNP
50458	694	5	:	:	:
50458	694	6	_	_	NNP
50458	694	7	Compt	Compt	NNP
50458	694	8	.	.	.
50458	695	1	rend	rend	VB
50458	695	2	.	.	.
50458	696	1	de	de	NNP
50458	696	2	l'Acad	l'Acad	NNP
50458	696	3	.	.	.
50458	697	1	des	des	NNP
50458	697	2	Sciences	Sciences	NNPS
50458	697	3	_	_	NNP
50458	697	4	,	,	,
50458	697	5	May	May	NNP
50458	697	6	13	13	CD
50458	697	7	,	,	,
50458	697	8	1889	1889	CD
50458	697	9	;	;	:
50458	697	10	_	_	NNP
50458	697	11	Soc	Soc	NNP
50458	697	12	.	.	.
50458	698	1	de	de	NNP
50458	698	2	Biol	Biol	NNP
50458	698	3	.	.	.
50458	698	4	_	_	NNP
50458	698	5	,	,	,
50458	698	6	1891	1891	CD
50458	698	7	,	,	,
50458	698	8	p.	p.	NN
50458	698	9	724	724	CD
50458	698	10	.	.	.
50458	699	1	[	[	-LRB-
50458	699	2	86	86	CD
50458	699	3	]	]	-RRB-
50458	699	4	ROGER	ROGER	NNP
50458	699	5	:	:	:
50458	699	6	_	_	NNP
50458	699	7	Compt	Compt	NNP
50458	699	8	.	.	.
50458	700	1	rend	rend	VB
50458	700	2	.	.	.
50458	701	1	Soc	Soc	NNP
50458	701	2	.	.	.
50458	702	1	Biol	Biol	NNP
50458	702	2	.	.	.
50458	702	3	_	_	NNP
50458	702	4	,	,	,
50458	702	5	1891	1891	CD
50458	702	6	,	,	,
50458	702	7	p.	p.	NN
50458	702	8	727	727	CD
50458	702	9	.	.	.
50458	703	1	It	-PRON-	PRP
50458	703	2	must	must	MD
50458	703	3	be	be	VB
50458	703	4	remarked	remark	VBN
50458	703	5	that	that	IN
50458	703	6	the	the	DT
50458	703	7	organs	organ	NNS
50458	703	8	we	-PRON-	PRP
50458	703	9	have	have	VBP
50458	703	10	studied	study	VBN
50458	703	11	are	be	VBP
50458	703	12	essentially	essentially	RB
50458	703	13	reducers	reducer	NNS
50458	703	14	,	,	,
50458	703	15	and	and	CC
50458	703	16	that	that	IN
50458	703	17	the	the	DT
50458	703	18	more	more	RBR
50458	703	19	powerful	powerful	JJ
50458	703	20	reducers	reducer	NNS
50458	703	21	yield	yield	VBP
50458	703	22	the	the	DT
50458	703	23	most	most	RBS
50458	703	24	toxic	toxic	JJ
50458	703	25	extracts	extract	NNS
50458	703	26	.	.	.
50458	704	1	We	-PRON-	PRP
50458	704	2	find	find	VBP
50458	704	3	here	here	RB
50458	704	4	a	a	DT
50458	704	5	confirmation	confirmation	NN
50458	704	6	of	of	IN
50458	704	7	Armand	Armand	NNP
50458	704	8	Gautier	Gautier	NNP
50458	704	9	's	's	POS
50458	704	10	views	view	NNS
50458	704	11	regarding	regard	VBG
50458	704	12	the	the	DT
50458	704	13	anaerobic	anaerobic	JJ
50458	704	14	origin	origin	NN
50458	704	15	of	of	IN
50458	704	16	the	the	DT
50458	704	17	toxic	toxic	JJ
50458	704	18	substances	substance	NNS
50458	704	19	formed	form	VBN
50458	704	20	within	within	IN
50458	704	21	the	the	DT
50458	704	22	organism	organism	NN
50458	704	23	.	.	.
50458	705	1	[	[	-LRB-
50458	705	2	87	87	CD
50458	705	3	]	]	-RRB-
50458	705	4	[	[	-LRB-
50458	705	5	87	87	CD
50458	705	6	]	]	-RRB-
50458	705	7	POZZI	POZZI	NNP
50458	705	8	-	-	HYPH
50458	705	9	ESCOT	ESCOT	NNP
50458	705	10	:	:	:
50458	705	11	_	_	NNP
50458	705	12	Compt	Compt	NNP
50458	705	13	.	.	.
50458	706	1	rend	rend	VB
50458	706	2	.	.	.
50458	707	1	de	de	NNP
50458	707	2	l'Acad	l'Acad	NNP
50458	707	3	.	.	.
50458	708	1	de	de	NNP
50458	708	2	Médecine	Médecine	NNP
50458	708	3	_	_	NNP
50458	708	4	(	(	-LRB-
50458	708	5	3	3	CD
50458	708	6	)	)	-RRB-
50458	708	7	,	,	,
50458	708	8	XLVII	XLVII	NNP
50458	708	9	,	,	,
50458	708	10	p.	p.	NN
50458	708	11	400	400	CD
50458	708	12	.	.	.
50458	709	1	See	see	VB
50458	709	2	also	also	RB
50458	709	3	POZZI	POZZI	NNP
50458	709	4	-	-	HYPH
50458	709	5	ESCOT	ESCOT	NNP
50458	709	6	:	:	:
50458	709	7	_	_	NNP
50458	709	8	Etat	Etat	NNP
50458	709	9	actuel	actuel	NNP
50458	709	10	de	de	FW
50458	709	11	nos	nos	NNP
50458	709	12	Connaissances	Connaissances	NNP
50458	709	13	sur	sur	FW
50458	709	14	les	les	FW
50458	709	15	Oxydases	Oxydases	NNP
50458	709	16	et	et	FW
50458	709	17	les	les	FW
50458	709	18	Réductases	Réductases	NNP
50458	709	19	_	_	NNP
50458	709	20	.	.	.
50458	710	1	Dunod	dunod	NN
50458	710	2	,	,	,
50458	710	3	publ	publ	NNS
50458	710	4	.	.	.
50458	710	5	,	,	,
50458	710	6	Paris	Paris	NNP
50458	710	7	.	.	.
50458	711	1	1902	1902	CD
50458	711	2	.	.	.
50458	712	1	Blood	blood	NN
50458	712	2	serum	serum	NN
50458	712	3	precipitated	precipitate	VBN
50458	712	4	by	by	IN
50458	712	5	alcohol	alcohol	NN
50458	712	6	affords	afford	NNS
50458	712	7	products	product	NNS
50458	712	8	which	which	WDT
50458	712	9	possess	possess	VBP
50458	712	10	very	very	RB
50458	712	11	marked	mark	VBN
50458	712	12	toxic	toxic	JJ
50458	712	13	power	power	NN
50458	712	14	.	.	.
50458	713	1	It	-PRON-	PRP
50458	713	2	would	would	MD
50458	713	3	appear	appear	VB
50458	713	4	that	that	IN
50458	713	5	the	the	DT
50458	713	6	toxic	toxic	JJ
50458	713	7	products	product	NNS
50458	713	8	we	-PRON-	PRP
50458	713	9	speak	speak	VBP
50458	713	10	of	of	IN
50458	713	11	here	here	RB
50458	713	12	are	be	VBP
50458	713	13	thermogenic	thermogenic	JJ
50458	713	14	diastatic	diastatic	JJ
50458	713	15	substances	substance	NNS
50458	713	16	derived	derive	VBN
50458	713	17	from	from	IN
50458	713	18	the	the	DT
50458	713	19	white	white	JJ
50458	713	20	blood	blood	NN
50458	713	21	corpuscles	corpuscle	NNS
50458	713	22	.	.	.
50458	714	1	In	in	IN
50458	714	2	certain	certain	JJ
50458	714	3	diseases	disease	NNS
50458	714	4	the	the	DT
50458	714	5	blood	blood	NN
50458	714	6	serum	serum	NN
50458	714	7	may	may	MD
50458	714	8	acquire	acquire	VB
50458	714	9	a	a	DT
50458	714	10	high	high	JJ
50458	714	11	degree	degree	NN
50458	714	12	of	of	IN
50458	714	13	toxicity	toxicity	NN
50458	714	14	.	.	.
50458	715	1	We	-PRON-	PRP
50458	715	2	will	will	MD
50458	715	3	recur	recur	VB
50458	715	4	again	again	RB
50458	715	5	presently	presently	RB
50458	715	6	to	to	IN
50458	715	7	this	this	DT
50458	715	8	property	property	NN
50458	715	9	as	as	IN
50458	715	10	a	a	DT
50458	715	11	normal	normal	JJ
50458	715	12	characteristic	characteristic	NN
50458	715	13	of	of	IN
50458	715	14	the	the	DT
50458	715	15	blood	blood	NN
50458	715	16	of	of	IN
50458	715	17	various	various	JJ
50458	715	18	animal	animal	NN
50458	715	19	species	specie	NNS
50458	715	20	,	,	,
50458	715	21	and	and	CC
50458	715	22	will	will	MD
50458	715	23	study	study	VB
50458	715	24	it	-PRON-	PRP
50458	715	25	in	in	IN
50458	715	26	greater	great	JJR
50458	715	27	detail	detail	NN
50458	715	28	in	in	IN
50458	715	29	a	a	DT
50458	715	30	future	future	JJ
50458	715	31	volume	volume	NN
50458	715	32	of	of	IN
50458	715	33	this	this	DT
50458	715	34	collection	collection	NN
50458	715	35	,	,	,
50458	715	36	devoted	devote	VBN
50458	715	37	to	to	IN
50458	715	38	the	the	DT
50458	715	39	immunizing	immunize	VBG
50458	715	40	active	active	JJ
50458	715	41	principles	principle	NNS
50458	715	42	.	.	.
50458	716	1	=	=	NFP
50458	716	2	Glandular	Glandular	NNP
50458	716	3	Secretions.=--On	Secretions.=--On	NNS
50458	716	4	studying	study	VBG
50458	716	5	the	the	DT
50458	716	6	venoms	venom	NNS
50458	716	7	we	-PRON-	PRP
50458	716	8	will	will	MD
50458	716	9	see	see	VB
50458	716	10	that	that	IN
50458	716	11	a	a	DT
50458	716	12	certain	certain	JJ
50458	716	13	number	number	NN
50458	716	14	of	of	IN
50458	716	15	these	these	DT
50458	716	16	products	product	NNS
50458	716	17	are	be	VBP
50458	716	18	the	the	DT
50458	716	19	result	result	NN
50458	716	20	of	of	IN
50458	716	21	glandular	glandular	JJ
50458	716	22	secretion	secretion	NN
50458	716	23	.	.	.
50458	717	1	This	this	DT
50458	717	2	is	be	VBZ
50458	717	3	a	a	DT
50458	717	4	general	general	JJ
50458	717	5	property	property	NN
50458	717	6	of	of	IN
50458	717	7	the	the	DT
50458	717	8	glands	gland	NNS
50458	717	9	;	;	:
50458	717	10	and	and	CC
50458	717	11	it	-PRON-	PRP
50458	717	12	was	be	VBD
50458	717	13	Brown	Brown	NNP
50458	717	14	-	-	HYPH
50458	717	15	Sequard	Sequard	NNP
50458	717	16	who	who	WP
50458	717	17	first	first	RB
50458	717	18	drew	draw	VBD
50458	717	19	attention	attention	NN
50458	717	20	to	to	IN
50458	717	21	the	the	DT
50458	717	22	rôle	rôle	NN
50458	717	23	played	play	VBN
50458	717	24	by	by	IN
50458	717	25	these	these	DT
50458	717	26	glands	gland	NNS
50458	717	27	,	,	,
50458	717	28	and	and	CC
50458	717	29	to	to	IN
50458	717	30	the	the	DT
50458	717	31	importance	importance	NN
50458	717	32	of	of	IN
50458	717	33	the	the	DT
50458	717	34	products	product	NNS
50458	717	35	that	that	WDT
50458	717	36	they	-PRON-	PRP
50458	717	37	throw	throw	VBP
50458	717	38	into	into	IN
50458	717	39	the	the	DT
50458	717	40	blood	blood	NN
50458	717	41	.	.	.
50458	718	1	[	[	-LRB-
50458	718	2	88	88	CD
50458	718	3	]	]	-RRB-
50458	718	4	[	[	-LRB-
50458	718	5	88	88	CD
50458	718	6	]	]	-RRB-
50458	718	7	_	_	NNP
50458	718	8	Compt	Compt	NNP
50458	718	9	.	.	.
50458	719	1	rend	rend	VB
50458	719	2	.	.	.
50458	720	1	de	de	NNP
50458	720	2	l'Acad	l'Acad	NNP
50458	720	3	.	.	.
50458	721	1	des	des	NNP
50458	721	2	Sciences	Sciences	NNPS
50458	721	3	_	_	NNP
50458	721	4	,	,	,
50458	721	5	CXIV	CXIV	NNP
50458	721	6	,	,	,
50458	721	7	pp	pp	NNP
50458	721	8	.	.	.
50458	722	1	1237	1237	CD
50458	722	2	,	,	,
50458	722	3	1318	1318	CD
50458	722	4	,	,	,
50458	722	5	1399	1399	CD
50458	722	6	,	,	,
50458	722	7	and	and	CC
50458	722	8	1534	1534	CD
50458	722	9	;	;	:
50458	722	10	CXV	CXV	NNP
50458	722	11	,	,	,
50458	722	12	p.	p.	NN
50458	722	13	375	375	CD
50458	722	14	;	;	:
50458	722	15	and	and	CC
50458	722	16	CXVI	CXVI	NNP
50458	722	17	,	,	,
50458	722	18	p.	p.	NN
50458	722	19	856	856	CD
50458	722	20	.	.	.
50458	723	1	P.	P.	NNP
50458	723	2	Noel	Noel	NNP
50458	723	3	showed	show	VBD
50458	723	4	later	later	RB
50458	723	5	that	that	IN
50458	723	6	the	the	DT
50458	723	7	testicular	testicular	JJ
50458	723	8	juice	juice	NN
50458	723	9	possesses	possess	VBZ
50458	723	10	a	a	DT
50458	723	11	high	high	JJ
50458	723	12	degree	degree	NN
50458	723	13	of	of	IN
50458	723	14	activity	activity	NN
50458	723	15	,	,	,
50458	723	16	which	which	WDT
50458	723	17	he	-PRON-	PRP
50458	723	18	attributed	attribute	VBD
50458	723	19	to	to	IN
50458	723	20	an	an	DT
50458	723	21	oxidizing	oxidizing	JJ
50458	723	22	ferment	ferment	NN
50458	723	23	,	,	,
50458	723	24	and	and	CC
50458	723	25	which	which	WDT
50458	723	26	we	-PRON-	PRP
50458	723	27	have	have	VBP
50458	723	28	already	already	RB
50458	723	29	mentioned	mention	VBN
50458	723	30	,	,	,
50458	723	31	_	_	NNP
50458	723	32	spermine	spermine	NN
50458	723	33	_	_	NNP
50458	723	34	.	.	.
50458	724	1	The	the	DT
50458	724	2	greater	great	JJR
50458	724	3	number	number	NN
50458	724	4	of	of	IN
50458	724	5	the	the	DT
50458	724	6	other	other	JJ
50458	724	7	glands	gland	NNS
50458	724	8	contain	contain	VBP
50458	724	9	proteid	proteid	NN
50458	724	10	matters	matter	NNS
50458	724	11	and	and	CC
50458	724	12	various	various	JJ
50458	724	13	peptones	peptone	NNS
50458	724	14	,	,	,
50458	724	15	more	more	RBR
50458	724	16	or	or	CC
50458	724	17	less	less	RBR
50458	724	18	toxic	toxic	JJ
50458	724	19	,	,	,
50458	724	20	with	with	IN
50458	724	21	amides	amide	NNS
50458	724	22	and	and	CC
50458	724	23	alkaloids	alkaloid	NNS
50458	724	24	.	.	.
50458	725	1	Particular	particular	JJ
50458	725	2	mention	mention	NN
50458	725	3	must	must	MD
50458	725	4	be	be	VB
50458	725	5	made	make	VBN
50458	725	6	of	of	IN
50458	725	7	the	the	DT
50458	725	8	thyroid	thyroid	NNP
50458	725	9	gland	gland	NNP
50458	725	10	,	,	,
50458	725	11	the	the	DT
50458	725	12	secretions	secretion	NNS
50458	725	13	of	of	IN
50458	725	14	which	which	WDT
50458	725	15	exercise	exercise	VBP
50458	725	16	a	a	DT
50458	725	17	powerful	powerful	JJ
50458	725	18	action	action	NN
50458	725	19	on	on	IN
50458	725	20	the	the	DT
50458	725	21	nervous	nervous	JJ
50458	725	22	centers	center	NNS
50458	725	23	and	and	CC
50458	725	24	on	on	IN
50458	725	25	nutrition	nutrition	NN
50458	725	26	.	.	.
50458	726	1	[	[	-LRB-
50458	726	2	89	89	CD
50458	726	3	]	]	-RRB-
50458	726	4	It	-PRON-	PRP
50458	726	5	appears	appear	VBZ
50458	726	6	reasonable	reasonable	JJ
50458	726	7	to	to	TO
50458	726	8	attribute	attribute	VB
50458	726	9	to	to	IN
50458	726	10	the	the	DT
50458	726	11	secretions	secretion	NNS
50458	726	12	of	of	IN
50458	726	13	this	this	DT
50458	726	14	gland	gland	NN
50458	726	15	a	a	DT
50458	726	16	very	very	RB
50458	726	17	powerful	powerful	JJ
50458	726	18	antitoxic	antitoxic	JJ
50458	726	19	action	action	NN
50458	726	20	,	,	,
50458	726	21	and	and	CC
50458	726	22	the	the	DT
50458	726	23	first	first	JJ
50458	726	24	proof	proof	NN
50458	726	25	of	of	IN
50458	726	26	this	this	DT
50458	726	27	fact	fact	NN
50458	726	28	is	be	VBZ
50458	726	29	that	that	IN
50458	726	30	the	the	DT
50458	726	31	organisms	organism	NNS
50458	726	32	deprived	deprive	VBN
50458	726	33	of	of	IN
50458	726	34	this	this	DT
50458	726	35	gland	gland	NN
50458	726	36	become	become	VBP
50458	726	37	the	the	DT
50458	726	38	seat	seat	NN
50458	726	39	of	of	IN
50458	726	40	serious	serious	JJ
50458	726	41	derangements	derangement	NNS
50458	726	42	;	;	:
50458	726	43	the	the	DT
50458	726	44	urines	urine	NNS
50458	726	45	of	of	IN
50458	726	46	such	such	JJ
50458	726	47	organisms	organism	NNS
50458	726	48	become	become	VBP
50458	726	49	particularly	particularly	RB
50458	726	50	toxic	toxic	JJ
50458	726	51	,	,	,
50458	726	52	while	while	IN
50458	726	53	,	,	,
50458	726	54	on	on	IN
50458	726	55	the	the	DT
50458	726	56	other	other	JJ
50458	726	57	hand	hand	NN
50458	726	58	,	,	,
50458	726	59	the	the	DT
50458	726	60	hypodermic	hypodermic	JJ
50458	726	61	injections	injection	NNS
50458	726	62	of	of	IN
50458	726	63	the	the	DT
50458	726	64	aqueous	aqueous	JJ
50458	726	65	extract	extract	NN
50458	726	66	of	of	IN
50458	726	67	the	the	DT
50458	726	68	gland	gland	NN
50458	726	69	,	,	,
50458	726	70	when	when	WRB
50458	726	71	the	the	DT
50458	726	72	derangements	derangement	NNS
50458	726	73	spoken	speak	VBN
50458	726	74	of	of	IN
50458	726	75	exist	exist	NN
50458	726	76	,	,	,
50458	726	77	cause	cause	VB
50458	726	78	the	the	DT
50458	726	79	immediate	immediate	JJ
50458	726	80	disappearance	disappearance	NN
50458	726	81	of	of	IN
50458	726	82	the	the	DT
50458	726	83	derangements	derangement	NNS
50458	726	84	caused	cause	VBN
50458	726	85	by	by	IN
50458	726	86	the	the	DT
50458	726	87	excision	excision	NN
50458	726	88	of	of	IN
50458	726	89	the	the	DT
50458	726	90	gland	gland	NN
50458	726	91	.	.	.
50458	727	1	[	[	-LRB-
50458	727	2	90	90	CD
50458	727	3	]	]	-RRB-
50458	727	4	[	[	-LRB-
50458	727	5	89	89	CD
50458	727	6	]	]	-RRB-
50458	727	7	LAULANIÉ	LAULANIÉ	NNP
50458	727	8	:	:	:
50458	727	9	_	_	NNP
50458	727	10	Compt	Compt	NNP
50458	727	11	.	.	.
50458	728	1	rend	rend	VB
50458	728	2	.	.	.
50458	729	1	Soc	Soc	NNP
50458	729	2	.	.	.
50458	730	1	de	de	NNP
50458	730	2	Biol	Biol	NNP
50458	730	3	.	.	.
50458	730	4	_	_	NNP
50458	730	5	,	,	,
50458	730	6	1894	1894	CD
50458	730	7	,	,	,
50458	730	8	p.	p.	NN
50458	730	9	187	187	CD
50458	730	10	.	.	.
50458	731	1	[	[	-LRB-
50458	731	2	90	90	CD
50458	731	3	]	]	-RRB-
50458	731	4	GLEY	GLEY	NNP
50458	731	5	:	:	:
50458	731	6	_	_	NNP
50458	731	7	Compt	Compt	NNP
50458	731	8	.	.	.
50458	732	1	rend	rend	VB
50458	732	2	.	.	.
50458	733	1	Soc	Soc	NNP
50458	733	2	.	.	.
50458	734	1	de	de	NNP
50458	734	2	Biol	Biol	NNP
50458	734	3	.	.	.
50458	734	4	_	_	NNP
50458	734	5	,	,	,
50458	734	6	1891	1891	CD
50458	734	7	,	,	,
50458	734	8	p.	p.	NN
50458	734	9	250	250	CD
50458	734	10	.	.	.
50458	735	1	Attempts	attempt	NNS
50458	735	2	have	have	VBP
50458	735	3	been	be	VBN
50458	735	4	made	make	VBN
50458	735	5	to	to	TO
50458	735	6	isolate	isolate	VB
50458	735	7	the	the	DT
50458	735	8	active	active	JJ
50458	735	9	principle	principle	NN
50458	735	10	of	of	IN
50458	735	11	the	the	DT
50458	735	12	glands	gland	NNS
50458	735	13	.	.	.
50458	736	1	Notkine	Notkine	NNP
50458	736	2	isolated	isolate	VBD
50458	736	3	a	a	DT
50458	736	4	_	_	NNP
50458	736	5	tyroproteid_,[91	tyroproteid_,[91	NN
50458	736	6	]	]	-RRB-
50458	736	7	which	which	WDT
50458	736	8	is	be	VBZ
50458	736	9	not	not	RB
50458	736	10	sensibly	sensibly	RB
50458	736	11	toxic	toxic	JJ
50458	736	12	to	to	IN
50458	736	13	animals	animal	NNS
50458	736	14	who	who	WP
50458	736	15	still	still	RB
50458	736	16	retain	retain	VBP
50458	736	17	the	the	DT
50458	736	18	gland	gland	NN
50458	736	19	,	,	,
50458	736	20	but	but	CC
50458	736	21	which	which	WDT
50458	736	22	becomes	become	VBZ
50458	736	23	toxic	toxic	JJ
50458	736	24	when	when	WRB
50458	736	25	the	the	DT
50458	736	26	gland	gland	NN
50458	736	27	is	be	VBZ
50458	736	28	excised	excise	VBN
50458	736	29	.	.	.
50458	737	1	It	-PRON-	PRP
50458	737	2	seems	seem	VBZ
50458	737	3	probable	probable	JJ
50458	737	4	,	,	,
50458	737	5	however	however	RB
50458	737	6	,	,	,
50458	737	7	that	that	IN
50458	737	8	this	this	DT
50458	737	9	product	product	NN
50458	737	10	is	be	VBZ
50458	737	11	not	not	RB
50458	737	12	the	the	DT
50458	737	13	principal	principal	JJ
50458	737	14	agent	agent	NN
50458	737	15	of	of	IN
50458	737	16	the	the	DT
50458	737	17	thyroid	thyroid	NNP
50458	737	18	gland	gland	NNP
50458	737	19	.	.	.
50458	738	1	[	[	-LRB-
50458	738	2	91	91	CD
50458	738	3	]	]	-RRB-
50458	738	4	_	_	NNP
50458	738	5	Semaine	Semaine	NNP
50458	738	6	Médicale	Médicale	NNP
50458	738	7	_	_	NNP
50458	738	8	,	,	,
50458	738	9	Apr.	April	NNP
50458	739	1	3	3	CD
50458	739	2	,	,	,
50458	739	3	1895	1895	CD
50458	739	4	,	,	,
50458	739	5	p.	p.	NN
50458	739	6	138	138	CD
50458	739	7	.	.	.
50458	740	1	From	from	IN
50458	740	2	the	the	DT
50458	740	3	researches	research	NNS
50458	740	4	of	of	IN
50458	740	5	Schaeffer	Schaeffer	NNP
50458	740	6	,	,	,
50458	740	7	Roos	Roos	NNP
50458	740	8	,	,	,
50458	740	9	and	and	CC
50458	740	10	Sigmund	Sigmund	NNP
50458	740	11	Fraenkel[92	Fraenkel[92	NNP
50458	740	12	]	]	-RRB-
50458	740	13	it	-PRON-	PRP
50458	740	14	results	result	VBZ
50458	740	15	that	that	IN
50458	740	16	the	the	DT
50458	740	17	active	active	JJ
50458	740	18	principle	principle	NN
50458	740	19	of	of	IN
50458	740	20	the	the	DT
50458	740	21	gland	gland	NN
50458	740	22	is	be	VBZ
50458	740	23	not	not	RB
50458	740	24	a	a	DT
50458	740	25	toxin	toxin	NN
50458	740	26	,	,	,
50458	740	27	but	but	CC
50458	740	28	a	a	DT
50458	740	29	purely	purely	RB
50458	740	30	chemical	chemical	JJ
50458	740	31	substance	substance	NN
50458	740	32	,	,	,
50458	740	33	a	a	DT
50458	740	34	true	true	JJ
50458	740	35	leucomaine	leucomaine	NN
50458	740	36	,	,	,
50458	740	37	which	which	WDT
50458	740	38	has	have	VBZ
50458	740	39	received	receive	VBN
50458	740	40	the	the	DT
50458	740	41	name	name	NN
50458	740	42	_	_	NNP
50458	740	43	thyroantitoxin	thyroantitoxin	NN
50458	740	44	_	_	NNP
50458	740	45	.	.	.
50458	741	1	[	[	-LRB-
50458	741	2	92	92	CD
50458	741	3	]	]	-RRB-
50458	741	4	_	_	NNP
50458	741	5	Wiener	Wiener	NNP
50458	741	6	Med	Med	NNP
50458	741	7	.	.	.
50458	742	1	Blätter	Blätter	NNP
50458	742	2	_	_	NNP
50458	742	3	,	,	,
50458	742	4	No	no	UH
50458	742	5	.	.	.
50458	743	1	48	48	CD
50458	743	2	;	;	:
50458	743	3	and	and	CC
50458	743	4	_	_	NNP
50458	743	5	Gesellsch	Gesellsch	NNP
50458	743	6	.	.	.
50458	744	1	d.	d.	NNP
50458	744	2	Aerzte	Aerzte	NNP
50458	744	3	in	in	IN
50458	744	4	Wien	Wien	NNP
50458	744	5	_	_	NNP
50458	744	6	,	,	,
50458	744	7	Nov.	November	NNP
50458	744	8	22	22	CD
50458	744	9	,	,	,
50458	744	10	1895	1895	CD
50458	744	11	.	.	.
50458	745	1	On	on	IN
50458	745	2	the	the	DT
50458	745	3	other	other	JJ
50458	745	4	hand	hand	NN
50458	745	5	,	,	,
50458	745	6	Baumann	Baumann	NNP
50458	745	7	quite	quite	RB
50458	745	8	recently	recently	RB
50458	745	9	extracted	extract	VBD
50458	745	10	from	from	IN
50458	745	11	the	the	DT
50458	745	12	thyroid	thyroid	NN
50458	745	13	gland	gland	NNP
50458	745	14	an	an	DT
50458	745	15	iodized	iodized	JJ
50458	745	16	substance	substance	NN
50458	745	17	,	,	,
50458	745	18	which	which	WDT
50458	745	19	he	-PRON-	PRP
50458	745	20	named	name	VBD
50458	745	21	_	_	NNP
50458	745	22	thyroiodine	thyroiodine	NN
50458	745	23	_	_	NNP
50458	745	24	.	.	.
50458	746	1	[	[	-LRB-
50458	746	2	93	93	CD
50458	746	3	]	]	-RRB-
50458	746	4	[	[	-LRB-
50458	746	5	93	93	CD
50458	746	6	]	]	-RRB-
50458	746	7	_	_	NNP
50458	746	8	Zeitschr	Zeitschr	NNP
50458	746	9	.	.	.
50458	747	1	f.	f.	NNP
50458	747	2	Physiol	Physiol	NNP
50458	747	3	.	.	.
50458	748	1	Chem	Chem	NNP
50458	748	2	.	.	.
50458	748	3	_	_	NNP
50458	748	4	,	,	,
50458	748	5	XXI	XXI	NNP
50458	748	6	,	,	,
50458	748	7	pp	pp	NNP
50458	748	8	.	.	.
50458	749	1	319	319	CD
50458	749	2	and	and	CC
50458	749	3	481	481	CD
50458	749	4	;	;	:
50458	749	5	and	and	CC
50458	749	6	XXII	XXII	NNP
50458	749	7	,	,	,
50458	749	8	p.	p.	NN
50458	749	9	1	1	CD
50458	749	10	.	.	.
50458	750	1	ARMAND	ARMAND	NNP
50458	750	2	GAUTIER	GAUTIER	NNP
50458	750	3	:	:	:
50458	750	4	Chimie	Chimie	NNP
50458	750	5	Biologique	Biologique	NNP
50458	750	6	,	,	,
50458	750	7	2d	2d	CD
50458	750	8	edit	edit	NN
50458	750	9	.	.	.
50458	750	10	,	,	,
50458	750	11	pp	pp	NNP
50458	750	12	.	.	.
50458	751	1	330	330	CD
50458	751	2	-	-	SYM
50458	751	3	332	332	CD
50458	751	4	.	.	.
50458	752	1	Masson	Masson	NNP
50458	752	2	,	,	,
50458	752	3	publ	publ	NNS
50458	752	4	.	.	.
50458	753	1	The	the	DT
50458	753	2	suprarenal	suprarenal	JJ
50458	753	3	capsules	capsule	NNS
50458	753	4	also	also	RB
50458	753	5	possess	possess	VBP
50458	753	6	properties	property	NNS
50458	753	7	that	that	WDT
50458	753	8	have	have	VBP
50458	753	9	often	often	RB
50458	753	10	attracted	attract	VBN
50458	753	11	the	the	DT
50458	753	12	attention	attention	NN
50458	753	13	of	of	IN
50458	753	14	physiologists	physiologist	NNS
50458	753	15	during	during	IN
50458	753	16	the	the	DT
50458	753	17	last	last	JJ
50458	753	18	few	few	JJ
50458	753	19	years	year	NNS
50458	753	20	.	.	.
50458	754	1	They	-PRON-	PRP
50458	754	2	are	be	VBP
50458	754	3	considered	consider	VBN
50458	754	4	as	as	IN
50458	754	5	being	be	VBG
50458	754	6	,	,	,
50458	754	7	just	just	RB
50458	754	8	like	like	IN
50458	754	9	the	the	DT
50458	754	10	thyroid	thyroid	NNP
50458	754	11	gland	gland	NNP
50458	754	12	,	,	,
50458	754	13	producers	producer	NNS
50458	754	14	of	of	IN
50458	754	15	antitoxins	antitoxin	NNS
50458	754	16	;	;	:
50458	754	17	they	-PRON-	PRP
50458	754	18	destroy	destroy	VBP
50458	754	19	,	,	,
50458	754	20	or	or	CC
50458	754	21	seem	seem	VBP
50458	754	22	to	to	TO
50458	754	23	destroy	destroy	VB
50458	754	24	,	,	,
50458	754	25	toxins	toxin	NNS
50458	754	26	that	that	WDT
50458	754	27	are	be	VBP
50458	754	28	artificially	artificially	RB
50458	754	29	introduced	introduce	VBN
50458	754	30	into	into	IN
50458	754	31	the	the	DT
50458	754	32	circulation	circulation	NN
50458	754	33	.	.	.
50458	755	1	Albanèse[94	Albanèse[94	NFP
50458	755	2	]	]	-RRB-
50458	755	3	maintains	maintain	VBZ
50458	755	4	that	that	IN
50458	755	5	the	the	DT
50458	755	6	function	function	NN
50458	755	7	of	of	IN
50458	755	8	the	the	DT
50458	755	9	suprarenal	suprarenal	JJ
50458	755	10	capsules	capsule	NNS
50458	755	11	is	be	VBZ
50458	755	12	to	to	TO
50458	755	13	neutralize	neutralize	VB
50458	755	14	neurine	neurine	NNP
50458	755	15	,	,	,
50458	755	16	the	the	DT
50458	755	17	toxic	toxic	JJ
50458	755	18	product	product	NN
50458	755	19	of	of	IN
50458	755	20	the	the	DT
50458	755	21	disassimilation	disassimilation	NN
50458	755	22	of	of	IN
50458	755	23	the	the	DT
50458	755	24	nervous	nervous	JJ
50458	755	25	system	system	NN
50458	755	26	;	;	:
50458	755	27	this	this	DT
50458	755	28	view	view	NN
50458	755	29	,	,	,
50458	755	30	however	however	RB
50458	755	31	,	,	,
50458	755	32	is	be	VBZ
50458	755	33	opposed	oppose	VBN
50458	755	34	by	by	IN
50458	755	35	Boinet[95	boinet[95	CD
50458	755	36	]	]	-RRB-
50458	755	37	and	and	CC
50458	755	38	Langlois	Langlois	NNP
50458	755	39	.	.	.
50458	756	1	[	[	-LRB-
50458	756	2	96	96	CD
50458	756	3	]	]	-RRB-
50458	756	4	On	on	IN
50458	756	5	the	the	DT
50458	756	6	contrary	contrary	NN
50458	756	7	,	,	,
50458	756	8	it	-PRON-	PRP
50458	756	9	has	have	VBZ
50458	756	10	been	be	VBN
50458	756	11	definitely	definitely	RB
50458	756	12	proven	prove	VBN
50458	756	13	that	that	IN
50458	756	14	the	the	DT
50458	756	15	suprarenal	suprarenal	JJ
50458	756	16	glands	gland	NNS
50458	756	17	exert	exert	VBP
50458	756	18	a	a	DT
50458	756	19	specific	specific	JJ
50458	756	20	action	action	NN
50458	756	21	on	on	IN
50458	756	22	the	the	DT
50458	756	23	poisons	poison	NNS
50458	756	24	of	of	IN
50458	756	25	muscular	muscular	JJ
50458	756	26	origin	origin	NN
50458	756	27	.	.	.
50458	757	1	Abelous	abelous	JJ
50458	757	2	and	and	CC
50458	757	3	Langlois[97	Langlois[97	NNP
50458	757	4	]	]	-RRB-
50458	757	5	have	have	VBP
50458	757	6	in	in	IN
50458	757	7	fact	fact	NN
50458	757	8	demonstrated	demonstrate	VBN
50458	757	9	that	that	IN
50458	757	10	the	the	DT
50458	757	11	alcoholic	alcoholic	JJ
50458	757	12	extract	extract	NN
50458	757	13	of	of	IN
50458	757	14	the	the	DT
50458	757	15	muscle	muscle	NN
50458	757	16	of	of	IN
50458	757	17	a	a	DT
50458	757	18	decapsulated	decapsulate	VBN
50458	757	19	animal	animal	NN
50458	757	20	has	have	VBZ
50458	757	21	the	the	DT
50458	757	22	same	same	JJ
50458	757	23	properties	property	NNS
50458	757	24	as	as	IN
50458	757	25	the	the	DT
50458	757	26	extract	extract	NN
50458	757	27	of	of	IN
50458	757	28	tetanized	tetanized	JJ
50458	757	29	muscle	muscle	NN
50458	757	30	;	;	:
50458	757	31	the	the	DT
50458	757	32	decapsulated	decapsulate	VBN
50458	757	33	animal	animal	NN
50458	757	34	gives	give	VBZ
50458	757	35	ergographic	ergographic	JJ
50458	757	36	tracings	tracing	NNS
50458	757	37	analogous	analogous	JJ
50458	757	38	to	to	IN
50458	757	39	those	those	DT
50458	757	40	afforded	afford	VBN
50458	757	41	by	by	IN
50458	757	42	tetanized	tetanize	VBN
50458	757	43	animals	animal	NNS
50458	757	44	.	.	.
50458	758	1	The	the	DT
50458	758	2	removal	removal	NN
50458	758	3	of	of	IN
50458	758	4	the	the	DT
50458	758	5	suprarenal	suprarenal	JJ
50458	758	6	capsule	capsule	NN
50458	758	7	from	from	IN
50458	758	8	an	an	DT
50458	758	9	animal	animal	NN
50458	758	10	brings	bring	VBZ
50458	758	11	results	result	NNS
50458	758	12	,	,	,
50458	758	13	hence	hence	RB
50458	758	14	,	,	,
50458	758	15	analogous	analogous	JJ
50458	758	16	to	to	IN
50458	758	17	those	those	DT
50458	758	18	of	of	IN
50458	758	19	fatigue	fatigue	NN
50458	758	20	--	--	:
50458	758	21	that	that	DT
50458	758	22	is	be	VBZ
50458	758	23	to	to	TO
50458	758	24	say	say	VB
50458	758	25	,	,	,
50458	758	26	that	that	IN
50458	758	27	the	the	DT
50458	758	28	toxic	toxic	JJ
50458	758	29	substances	substance	NNS
50458	758	30	which	which	WDT
50458	758	31	accumulate	accumulate	VBP
50458	758	32	as	as	IN
50458	758	33	a	a	DT
50458	758	34	result	result	NN
50458	758	35	of	of	IN
50458	758	36	the	the	DT
50458	758	37	decapsulation	decapsulation	NN
50458	758	38	resemble	resemble	VBP
50458	758	39	those	those	DT
50458	758	40	that	that	WDT
50458	758	41	result	result	VBP
50458	758	42	from	from	IN
50458	758	43	muscular	muscular	JJ
50458	758	44	exertion	exertion	NN
50458	758	45	.	.	.
50458	759	1	The	the	DT
50458	759	2	suprarenal	suprarenal	JJ
50458	759	3	capsules	capsule	NNS
50458	759	4	exert	exert	VBP
50458	759	5	their	-PRON-	PRP$
50458	759	6	action	action	NN
50458	759	7	furthermore	furthermore	RB
50458	759	8	on	on	IN
50458	759	9	other	other	JJ
50458	759	10	toxic	toxic	JJ
50458	759	11	products	product	NNS
50458	759	12	as	as	RB
50458	759	13	well	well	RB
50458	759	14	,	,	,
50458	759	15	as	as	IN
50458	759	16	Guieysse[98	Guieysse[98	NNP
50458	759	17	]	]	-RRB-
50458	759	18	has	have	VBZ
50458	759	19	shown	show	VBN
50458	759	20	,	,	,
50458	759	21	and	and	CC
50458	759	22	particularly	particularly	RB
50458	759	23	on	on	IN
50458	759	24	the	the	DT
50458	759	25	exogenous	exogenous	JJ
50458	759	26	poisons	poison	NNS
50458	759	27	.	.	.
50458	760	1	In	in	IN
50458	760	2	conclusion	conclusion	NN
50458	760	3	,	,	,
50458	760	4	it	-PRON-	PRP
50458	760	5	may	may	MD
50458	760	6	be	be	VB
50458	760	7	said	say	VBN
50458	760	8	that	that	IN
50458	760	9	the	the	DT
50458	760	10	matter	matter	NN
50458	760	11	concerns	concern	VBZ
50458	760	12	a	a	DT
50458	760	13	most	most	RBS
50458	760	14	important	important	JJ
50458	760	15	rôle	rôle	NN
50458	760	16	,	,	,
50458	760	17	and	and	CC
50458	760	18	we	-PRON-	PRP
50458	760	19	can	can	MD
50458	760	20	not	not	RB
50458	760	21	do	do	VB
50458	760	22	better	well	RBR
50458	760	23	in	in	IN
50458	760	24	this	this	DT
50458	760	25	respect	respect	NN
50458	760	26	than	than	IN
50458	760	27	to	to	TO
50458	760	28	refer	refer	VB
50458	760	29	the	the	DT
50458	760	30	reader	reader	NN
50458	760	31	to	to	IN
50458	760	32	the	the	DT
50458	760	33	memoir	memoir	NN
50458	760	34	presented	present	VBN
50458	760	35	by	by	IN
50458	760	36	Sergent	Sergent	NNP
50458	760	37	and	and	CC
50458	760	38	Bernard	Bernard	NNP
50458	760	39	to	to	IN
50458	760	40	the	the	DT
50458	760	41	Académie	Académie	NNP
50458	760	42	de	de	IN
50458	760	43	Médecine	Médecine	NNP
50458	760	44	in	in	IN
50458	760	45	1902	1902	CD
50458	760	46	and	and	CC
50458	760	47	entitled	entitle	VBN
50458	760	48	_	_	NNP
50458	760	49	l'Insuffisance	l'Insuffisance	NNP
50458	760	50	Surrénale	Surrénale	NNP
50458	760	51	_	_	NNP
50458	760	52	.	.	.
50458	761	1	[	[	-LRB-
50458	761	2	99	99	CD
50458	761	3	]	]	-RRB-
50458	761	4	[	[	-LRB-
50458	761	5	94	94	CD
50458	761	6	]	]	-RRB-
50458	761	7	ALBANÈSE	albanèse	NN
50458	761	8	:	:	:
50458	761	9	Recherches	recherche	NNS
50458	761	10	sur	sur	FW
50458	761	11	les	les	FW
50458	761	12	fonctions	fonction	NNS
50458	761	13	des	des	FW
50458	761	14	capsules	capsules	NNP
50458	761	15	surrénales	surrénale	NNS
50458	761	16	.	.	.
50458	762	1	_	_	NNP
50458	762	2	Arch	Arch	NNP
50458	762	3	.	.	.
50458	763	1	Italiennes	Italiennes	NNP
50458	763	2	Biol	Biol	NNP
50458	763	3	.	.	.
50458	763	4	_	_	NNP
50458	763	5	,	,	,
50458	763	6	1892	1892	CD
50458	763	7	.	.	.
50458	764	1	[	[	-LRB-
50458	764	2	95	95	CD
50458	764	3	]	]	-RRB-
50458	764	4	BOINET	BOINET	NNP
50458	764	5	:	:	:
50458	764	6	_	_	NNP
50458	764	7	Compt	Compt	NNP
50458	764	8	.	.	.
50458	765	1	rend	rend	VB
50458	765	2	.	.	.
50458	766	1	Soc	Soc	NNP
50458	766	2	.	.	.
50458	767	1	de	de	NNP
50458	767	2	Biol	Biol	NNP
50458	767	3	.	.	.
50458	767	4	_	_	NNP
50458	767	5	,	,	,
50458	767	6	Mch	Mch	NNP
50458	767	7	.	.	.
50458	768	1	1896	1896	CD
50458	768	2	.	.	.
50458	769	1	[	[	-LRB-
50458	769	2	96	96	CD
50458	769	3	]	]	-RRB-
50458	769	4	See	see	VB
50458	769	5	_	_	NNP
50458	769	6	Compt	Compt	NNP
50458	769	7	.	.	.
50458	770	1	rend	rend	VB
50458	770	2	.	.	.
50458	771	1	de	de	NNP
50458	771	2	Biol	Biol	NNP
50458	771	3	.	.	.
50458	772	1	et	et	FW
50458	772	2	Arch	arch	JJ
50458	772	3	.	.	.
50458	773	1	Physiologie	Physiologie	NNP
50458	773	2	_	_	NNP
50458	773	3	,	,	,
50458	773	4	1891	1891	CD
50458	773	5	-	-	SYM
50458	773	6	1897	1897	CD
50458	773	7	.	.	.
50458	774	1	[	[	-LRB-
50458	774	2	97	97	CD
50458	774	3	]	]	-RRB-
50458	774	4	LANGLOIS	LANGLOIS	NNP
50458	774	5	:	:	:
50458	774	6	Thèse	Thèse	NNP
50458	774	7	de	de	FW
50458	774	8	doctorat	doctorat	FW
50458	774	9	en	en	IN
50458	774	10	Méd	Méd	NNP
50458	774	11	.	.	.
50458	774	12	,	,	,
50458	774	13	Paris	Paris	NNP
50458	774	14	,	,	,
50458	774	15	1897	1897	CD
50458	774	16	.	.	.
50458	775	1	[	[	-LRB-
50458	775	2	98	98	CD
50458	775	3	]	]	-RRB-
50458	775	4	GUIEYSSE	GUIEYSSE	NNP
50458	775	5	:	:	:
50458	775	6	_	_	NNP
50458	775	7	Les	Les	NNP
50458	775	8	capsules	capsule	VBZ
50458	775	9	surrénales	surrénale	NNS
50458	775	10	du	du	NNP
50458	775	11	cobaye	cobaye	NNP
50458	775	12	_	_	NNP
50458	775	13	,	,	,
50458	775	14	Thèse	Thèse	NNP
50458	775	15	,	,	,
50458	775	16	Paris	Paris	NNP
50458	775	17	,	,	,
50458	775	18	1901	1901	CD
50458	775	19	.	.	.
50458	776	1	[	[	-LRB-
50458	776	2	99	99	CD
50458	776	3	]	]	-RRB-
50458	776	4	Encyclopédie	Encyclopédie	NNP
50458	776	5	Léauté	Léauté	NNP
50458	776	6	,	,	,
50458	776	7	CCCXIV	CCCXIV	NNP
50458	776	8	,	,	,
50458	776	9	Masson	Masson	NNP
50458	776	10	,	,	,
50458	776	11	publ	publ	NNS
50458	776	12	.	.	.
50458	776	13	,	,	,
50458	776	14	Paris	Paris	NNP
50458	776	15	,	,	,
50458	776	16	1904	1904	CD
50458	776	17	.	.	.
50458	777	1	CHAPTER	CHAPTER	NNP
50458	777	2	IV	IV	NNP
50458	777	3	.	.	.
50458	778	1	THE	the	DT
50458	778	2	MICROBIAL	MICROBIAL	NNP
50458	778	3	TOXINS	toxin	NNS
50458	778	4	.	.	.
50458	779	1	There	there	EX
50458	779	2	is	be	VBZ
50458	779	3	but	but	CC
50458	779	4	one	one	CD
50458	779	5	way	way	NN
50458	779	6	of	of	IN
50458	779	7	characterizing	characterize	VBG
50458	779	8	the	the	DT
50458	779	9	toxic	toxic	JJ
50458	779	10	poisons	poison	NNS
50458	779	11	secreted	secrete	VBN
50458	779	12	by	by	IN
50458	779	13	microbes	microbe	NNS
50458	779	14	,	,	,
50458	779	15	and	and	CC
50458	779	16	that	that	DT
50458	779	17	is	be	VBZ
50458	779	18	to	to	TO
50458	779	19	apply	apply	VB
50458	779	20	to	to	IN
50458	779	21	them	-PRON-	PRP
50458	779	22	the	the	DT
50458	779	23	name	name	NN
50458	779	24	of	of	IN
50458	779	25	the	the	DT
50458	779	26	microbes	microbe	NNS
50458	779	27	generating	generate	VBG
50458	779	28	them	-PRON-	PRP
50458	779	29	;	;	:
50458	779	30	thus	thus	RB
50458	779	31	the	the	DT
50458	779	32	soluble	soluble	JJ
50458	779	33	and	and	CC
50458	779	34	toxic	toxic	JJ
50458	779	35	poison	poison	NN
50458	779	36	of	of	IN
50458	779	37	the	the	DT
50458	779	38	tetanus	tetanus	NNP
50458	779	39	bacilli	bacilli	NNP
50458	779	40	has	have	VBZ
50458	779	41	received	receive	VBN
50458	779	42	the	the	DT
50458	779	43	name	name	NN
50458	779	44	_	_	NNP
50458	779	45	tetanus	tetanus	NN
50458	779	46	toxin	toxin	NNP
50458	779	47	_	_	NNP
50458	779	48	.	.	.
50458	780	1	In	in	IN
50458	780	2	toxic	toxic	JJ
50458	780	3	microbial	microbial	JJ
50458	780	4	cultures	culture	NNS
50458	780	5	it	-PRON-	PRP
50458	780	6	is	be	VBZ
50458	780	7	necessary	necessary	JJ
50458	780	8	to	to	TO
50458	780	9	distinguish	distinguish	VB
50458	780	10	the	the	DT
50458	780	11	toxins	toxin	NNS
50458	780	12	proper	proper	JJ
50458	780	13	from	from	IN
50458	780	14	the	the	DT
50458	780	15	toxic	toxic	JJ
50458	780	16	alkaloids	alkaloid	NNS
50458	780	17	(	(	-LRB-
50458	780	18	ptomaines	ptomaine	NNS
50458	780	19	)	)	-RRB-
50458	780	20	which	which	WDT
50458	780	21	generally	generally	RB
50458	780	22	accompany	accompany	VBP
50458	780	23	them	-PRON-	PRP
50458	780	24	;	;	:
50458	780	25	this	this	DT
50458	780	26	is	be	VBZ
50458	780	27	easily	easily	RB
50458	780	28	accomplished	accomplish	VBN
50458	780	29	by	by	IN
50458	780	30	evaporating	evaporate	VBG
50458	780	31	the	the	DT
50458	780	32	solution	solution	NN
50458	780	33	in	in	IN
50458	780	34	a	a	DT
50458	780	35	vacuum	vacuum	NN
50458	780	36	at	at	IN
50458	780	37	about	about	RB
50458	780	38	30	30	CD
50458	780	39	°	°	,
50458	780	40	C	C	NNP
50458	780	41	.	.	NNP
50458	780	42	,	,	,
50458	780	43	and	and	CC
50458	780	44	then	then	RB
50458	780	45	treating	treat	VBG
50458	780	46	with	with	IN
50458	780	47	alcohol	alcohol	NN
50458	780	48	and	and	CC
50458	780	49	ether	ether	NN
50458	780	50	,	,	,
50458	780	51	in	in	IN
50458	780	52	which	which	WDT
50458	780	53	the	the	DT
50458	780	54	alkaloids	alkaloid	NNS
50458	780	55	are	be	VBP
50458	780	56	soluble	soluble	JJ
50458	780	57	,	,	,
50458	780	58	while	while	IN
50458	780	59	the	the	DT
50458	780	60	true	true	JJ
50458	780	61	toxins	toxin	NNS
50458	780	62	are	be	VBP
50458	780	63	insoluble	insoluble	JJ
50458	780	64	.	.	.
50458	781	1	By	by	IN
50458	781	2	fractional	fractional	JJ
50458	781	3	precipitation	precipitation	NN
50458	781	4	with	with	IN
50458	781	5	alcohol	alcohol	NN
50458	781	6	it	-PRON-	PRP
50458	781	7	is	be	VBZ
50458	781	8	easy	easy	JJ
50458	781	9	to	to	TO
50458	781	10	isolate	isolate	VB
50458	781	11	the	the	DT
50458	781	12	peptones	peptone	NNS
50458	781	13	and	and	CC
50458	781	14	true	true	JJ
50458	781	15	toxins	toxin	NNS
50458	781	16	.	.	.
50458	782	1	The	the	DT
50458	782	2	microbial	microbial	JJ
50458	782	3	toxins	toxin	NNS
50458	782	4	possess	possess	VBP
50458	782	5	two	two	CD
50458	782	6	essential	essential	JJ
50458	782	7	properties	property	NNS
50458	782	8	;	;	:
50458	782	9	one	one	CD
50458	782	10	the	the	DT
50458	782	11	pyogenic	pyogenic	JJ
50458	782	12	property	property	NN
50458	782	13	,	,	,
50458	782	14	thanks	thank	NNS
50458	782	15	to	to	IN
50458	782	16	which	which	WDT
50458	782	17	the	the	DT
50458	782	18	toxins	toxin	NNS
50458	782	19	first	first	RB
50458	782	20	attract	attract	NN
50458	782	21	,	,	,
50458	782	22	then	then	RB
50458	782	23	destroy	destroy	VB
50458	782	24	the	the	DT
50458	782	25	white	white	JJ
50458	782	26	blood	blood	NN
50458	782	27	corpuscles	corpuscle	NNS
50458	782	28	or	or	CC
50458	782	29	leucocytes	leucocyte	NNS
50458	782	30	,	,	,
50458	782	31	and	and	CC
50458	782	32	transform	transform	VB
50458	782	33	them	-PRON-	PRP
50458	782	34	into	into	IN
50458	782	35	pus	pus	NNP
50458	782	36	,	,	,
50458	782	37	and	and	CC
50458	782	38	the	the	DT
50458	782	39	other	other	JJ
50458	782	40	the	the	DT
50458	782	41	pyretogenic	pyretogenic	NN
50458	782	42	property	property	NN
50458	782	43	,	,	,
50458	782	44	which	which	WDT
50458	782	45	appears	appear	VBZ
50458	782	46	to	to	TO
50458	782	47	belong	belong	VB
50458	782	48	only	only	RB
50458	782	49	quite	quite	RB
50458	782	50	indirectly	indirectly	RB
50458	782	51	to	to	IN
50458	782	52	the	the	DT
50458	782	53	pyogenic	pyogenic	JJ
50458	782	54	substance	substance	NN
50458	782	55	.	.	.
50458	783	1	The	the	DT
50458	783	2	toxins	toxin	NNS
50458	783	3	in	in	IN
50458	783	4	general	general	NNP
50458	783	5	retard	retard	VBP
50458	783	6	the	the	DT
50458	783	7	heart	heart	NN
50458	783	8	action	action	NN
50458	783	9	.	.	.
50458	784	1	We	-PRON-	PRP
50458	784	2	will	will	MD
50458	784	3	not	not	RB
50458	784	4	speak	speak	VB
50458	784	5	of	of	IN
50458	784	6	the	the	DT
50458	784	7	distinctions	distinction	NNS
50458	784	8	it	-PRON-	PRP
50458	784	9	has	have	VBZ
50458	784	10	been	be	VBN
50458	784	11	sought	seek	VBN
50458	784	12	to	to	TO
50458	784	13	establish	establish	VB
50458	784	14	between	between	IN
50458	784	15	the	the	DT
50458	784	16	substances	substance	NNS
50458	784	17	which	which	WDT
50458	784	18	possess	possess	VBP
50458	784	19	these	these	DT
50458	784	20	different	different	JJ
50458	784	21	properties	property	NNS
50458	784	22	,	,	,
50458	784	23	but	but	CC
50458	784	24	will	will	MD
50458	784	25	at	at	IN
50458	784	26	once	once	RB
50458	784	27	take	take	VB
50458	784	28	up	up	RP
50458	784	29	the	the	DT
50458	784	30	discussion	discussion	NN
50458	784	31	of	of	IN
50458	784	32	several	several	JJ
50458	784	33	of	of	IN
50458	784	34	the	the	DT
50458	784	35	microbial	microbial	JJ
50458	784	36	toxins	toxin	NNS
50458	784	37	.	.	.
50458	785	1	=	=	NFP
50458	785	2	Anthrax	Anthrax	NNP
50458	785	3	Toxin=[100	Toxin=[100	NNPS
50458	785	4	]	]	-RRB-
50458	785	5	(	(	-LRB-
50458	785	6	from	from	IN
50458	785	7	Bacillus	Bacillus	NNP
50458	785	8	Anthracis).--We	Anthracis).--We	NNP
50458	785	9	will	will	MD
50458	785	10	describe	describe	VB
50458	785	11	the	the	DT
50458	785	12	preparation	preparation	NN
50458	785	13	of	of	IN
50458	785	14	this	this	DT
50458	785	15	toxin	toxin	NN
50458	785	16	as	as	IN
50458	785	17	a	a	DT
50458	785	18	type	type	NN
50458	785	19	.	.	.
50458	786	1	[	[	-LRB-
50458	786	2	100	100	CD
50458	786	3	]	]	-RRB-
50458	786	4	ARLOING	arloing	NN
50458	786	5	,	,	,
50458	786	6	CORNEVIN	CORNEVIN	NNP
50458	786	7	,	,	,
50458	786	8	THOMAS	THOMAS	NNP
50458	786	9	:	:	:
50458	786	10	_	_	NNP
50458	786	11	Le	Le	NNP
50458	786	12	Charbon	Charbon	NNP
50458	786	13	Symptomatique	Symptomatique	NNP
50458	786	14	_	_	NNP
50458	786	15	,	,	,
50458	786	16	1st	1st	JJ
50458	786	17	edit	edit	NN
50458	786	18	.	.	.
50458	786	19	,	,	,
50458	786	20	Paris	Paris	NNP
50458	786	21	;	;	:
50458	786	22	and	and	CC
50458	786	23	LE	LE	NNP
50458	786	24	DANTEC	DANTEC	NNP
50458	786	25	:	:	:
50458	786	26	_	_	NNP
50458	786	27	La	La	NNP
50458	786	28	Bactéridie	Bactéridie	NNP
50458	786	29	du	du	NNP
50458	786	30	Charbon	Charbon	NNP
50458	786	31	_	_	NNP
50458	786	32	,	,	,
50458	786	33	Masson	Masson	NNP
50458	786	34	,	,	,
50458	786	35	publ	publ	NNS
50458	786	36	.	.	.
50458	787	1	;	;	:
50458	787	2	STRAUS	STRAUS	NNP
50458	787	3	:	:	:
50458	787	4	_	_	NNP
50458	787	5	Le	Le	NNP
50458	787	6	Charbon	Charbon	NNP
50458	787	7	des	des	FW
50458	787	8	Animaux	Animaux	NNP
50458	787	9	et	et	FW
50458	787	10	de	de	FW
50458	787	11	l'Homme	l'Homme	NNP
50458	787	12	_	_	NNP
50458	787	13	,	,	,
50458	787	14	Paris	Paris	NNP
50458	787	15	,	,	,
50458	787	16	1887	1887	CD
50458	787	17	.	.	.
50458	788	1	The	the	DT
50458	788	2	cultures	culture	NNS
50458	788	3	of	of	IN
50458	788	4	the	the	DT
50458	788	5	bacillus	bacillus	NN
50458	788	6	are	be	VBP
50458	788	7	made	make	VBN
50458	788	8	in	in	IN
50458	788	9	Liebig	Liebig	NNP
50458	788	10	's	's	POS
50458	788	11	bouillon	bouillon	NN
50458	788	12	,	,	,
50458	788	13	to	to	TO
50458	788	14	which	which	WDT
50458	788	15	has	have	VBZ
50458	788	16	been	be	VBN
50458	788	17	added	add	VBN
50458	788	18	0.1	0.1	CD
50458	788	19	%	%	NN
50458	788	20	of	of	IN
50458	788	21	fibrin	fibrin	NN
50458	788	22	,	,	,
50458	788	23	the	the	DT
50458	788	24	whole	whole	JJ
50458	788	25	being	be	VBG
50458	788	26	carefully	carefully	RB
50458	788	27	sterilized	sterilize	VBN
50458	788	28	for	for	IN
50458	788	29	a	a	DT
50458	788	30	long	long	JJ
50458	788	31	time	time	NN
50458	788	32	at	at	IN
50458	788	33	110	110	CD
50458	788	34	°	°	NNS
50458	788	35	C.	C.	NNP
50458	788	36	The	the	DT
50458	788	37	cultures	culture	NNS
50458	788	38	medium	medium	NN
50458	788	39	is	be	VBZ
50458	788	40	inoculated	inoculate	VBN
50458	788	41	with	with	IN
50458	788	42	a	a	DT
50458	788	43	drop	drop	NN
50458	788	44	of	of	IN
50458	788	45	blood	blood	NN
50458	788	46	taken	take	VBN
50458	788	47	from	from	IN
50458	788	48	the	the	DT
50458	788	49	heart	heart	NN
50458	788	50	or	or	CC
50458	788	51	spleen	spleen	NN
50458	788	52	of	of	IN
50458	788	53	an	an	DT
50458	788	54	animal	animal	NN
50458	788	55	that	that	WDT
50458	788	56	has	have	VBZ
50458	788	57	died	die	VBN
50458	788	58	of	of	IN
50458	788	59	anthrax	anthrax	NN
50458	788	60	.	.	.
50458	789	1	At	at	IN
50458	789	2	the	the	DT
50458	789	3	end	end	NN
50458	789	4	of	of	IN
50458	789	5	a	a	DT
50458	789	6	week	week	NN
50458	789	7	,	,	,
50458	789	8	the	the	DT
50458	789	9	culture	culture	NN
50458	789	10	is	be	VBZ
50458	789	11	filtered	filter	VBN
50458	789	12	,	,	,
50458	789	13	and	and	CC
50458	789	14	the	the	DT
50458	789	15	filtrate	filtrate	JJ
50458	789	16	acidulated	acidulate	VBN
50458	789	17	with	with	IN
50458	789	18	a	a	DT
50458	789	19	little	little	JJ
50458	789	20	acetic	acetic	JJ
50458	789	21	acid	acid	NN
50458	789	22	and	and	CC
50458	789	23	precipitated	precipitate	VBN
50458	789	24	by	by	IN
50458	789	25	adding	add	VBG
50458	789	26	powdered	powder	VBN
50458	789	27	ammonium	ammonium	NN
50458	789	28	sulphate	sulphate	NN
50458	789	29	.	.	.
50458	790	1	The	the	DT
50458	790	2	flocculent	flocculent	JJ
50458	790	3	precipitate	precipitate	NN
50458	790	4	is	be	VBZ
50458	790	5	collected	collect	VBN
50458	790	6	,	,	,
50458	790	7	washed	wash	VBN
50458	790	8	,	,	,
50458	790	9	dissolved	dissolve	VBN
50458	790	10	in	in	IN
50458	790	11	distilled	distilled	JJ
50458	790	12	water	water	NN
50458	790	13	,	,	,
50458	790	14	and	and	CC
50458	790	15	dialyzed	dialyzed	JJ
50458	790	16	.	.	.
50458	791	1	The	the	DT
50458	791	2	dialyzed	dialyzed	JJ
50458	791	3	solution	solution	NN
50458	791	4	is	be	VBZ
50458	791	5	concentrated	concentrate	VBN
50458	791	6	in	in	IN
50458	791	7	vacuo	vacuo	NNS
50458	791	8	at	at	IN
50458	791	9	40	40	CD
50458	791	10	-	-	SYM
50458	791	11	45	45	CD
50458	791	12	°	°	,
50458	791	13	C.	C.	NNP
50458	791	14	,	,	,
50458	791	15	and	and	CC
50458	791	16	precipitated	precipitate	VBN
50458	791	17	by	by	IN
50458	791	18	adding	add	VBG
50458	791	19	to	to	IN
50458	791	20	it	-PRON-	PRP
50458	791	21	alcohol	alcohol	NN
50458	791	22	.	.	.
50458	792	1	The	the	DT
50458	792	2	precipitate	precipitate	NN
50458	792	3	formed	form	VBN
50458	792	4	is	be	VBZ
50458	792	5	then	then	RB
50458	792	6	collected	collect	VBN
50458	792	7	and	and	CC
50458	792	8	dried	dry	VBN
50458	792	9	.	.	.
50458	793	1	[	[	-LRB-
50458	793	2	101	101	CD
50458	793	3	]	]	-RRB-
50458	793	4	[	[	-LRB-
50458	793	5	101	101	CD
50458	793	6	]	]	-RRB-
50458	793	7	HANKIN	HANKIN	NNP
50458	793	8	:	:	:
50458	793	9	_	_	NNP
50458	793	10	British	British	NNP
50458	793	11	Medical	Medical	NNP
50458	793	12	Journal	Journal	NNP
50458	793	13	_	_	NNP
50458	793	14	,	,	,
50458	793	15	Oct.	October	NNP
50458	793	16	12	12	CD
50458	793	17	,	,	,
50458	793	18	1889	1889	CD
50458	793	19	,	,	,
50458	793	20	and	and	CC
50458	793	21	July	July	NNP
50458	793	22	12	12	CD
50458	793	23	,	,	,
50458	793	24	1890	1890	CD
50458	793	25	.	.	.
50458	794	1	In	in	IN
50458	794	2	this	this	DT
50458	794	3	manner	manner	NN
50458	794	4	there	there	EX
50458	794	5	is	be	VBZ
50458	794	6	obtained	obtain	VBN
50458	794	7	a	a	DT
50458	794	8	grayish	grayish	NN
50458	794	9	-	-	HYPH
50458	794	10	white	white	JJ
50458	794	11	substance	substance	NN
50458	794	12	which	which	WDT
50458	794	13	is	be	VBZ
50458	794	14	soluble	soluble	JJ
50458	794	15	in	in	IN
50458	794	16	water	water	NN
50458	794	17	,	,	,
50458	794	18	and	and	CC
50458	794	19	which	which	WDT
50458	794	20	is	be	VBZ
50458	794	21	fatal	fatal	JJ
50458	794	22	in	in	IN
50458	794	23	large	large	JJ
50458	794	24	doses	dose	NNS
50458	794	25	,	,	,
50458	794	26	but	but	CC
50458	794	27	which	which	WDT
50458	794	28	,	,	,
50458	794	29	given	give	VBN
50458	794	30	in	in	IN
50458	794	31	repeated	repeat	VBN
50458	794	32	small	small	JJ
50458	794	33	doses	dose	NNS
50458	794	34	,	,	,
50458	794	35	confers	confer	NNS
50458	794	36	immunity	immunity	NN
50458	794	37	against	against	IN
50458	794	38	anthrax	anthrax	NN
50458	794	39	.	.	.
50458	795	1	According	accord	VBG
50458	795	2	to	to	IN
50458	795	3	Hankin	Hankin	NNP
50458	795	4	,	,	,
50458	795	5	it	-PRON-	PRP
50458	795	6	seems	seem	VBZ
50458	795	7	that	that	IN
50458	795	8	the	the	DT
50458	795	9	toxic	toxic	JJ
50458	795	10	property	property	NN
50458	795	11	of	of	IN
50458	795	12	this	this	DT
50458	795	13	toxin	toxin	NN
50458	795	14	is	be	VBZ
50458	795	15	due	due	JJ
50458	795	16	to	to	IN
50458	795	17	an	an	DT
50458	795	18	albumose	albumose	NN
50458	795	19	.	.	.
50458	796	1	Marchoux[102	Marchoux[102	NNS
50458	796	2	]	]	-RRB-
50458	796	3	has	have	VBZ
50458	796	4	been	be	VBN
50458	796	5	able	able	JJ
50458	796	6	to	to	TO
50458	796	7	confer	confer	VB
50458	796	8	immunity	immunity	NN
50458	796	9	upon	upon	IN
50458	796	10	sheep	sheep	NN
50458	796	11	by	by	IN
50458	796	12	injecting	inject	VBG
50458	796	13	first	first	JJ
50458	796	14	small	small	JJ
50458	796	15	quantities	quantity	NNS
50458	796	16	of	of	IN
50458	796	17	the	the	DT
50458	796	18	filtered	filter	VBN
50458	796	19	culture	culture	NN
50458	796	20	of	of	IN
50458	796	21	the	the	DT
50458	796	22	anthrax	anthrax	NN
50458	796	23	bacilli	bacilli	NNP
50458	796	24	,	,	,
50458	796	25	and	and	CC
50458	796	26	then	then	RB
50458	796	27	the	the	DT
50458	796	28	virulent	virulent	JJ
50458	796	29	anthrax	anthrax	NN
50458	796	30	itself	-PRON-	PRP
50458	796	31	.	.	.
50458	797	1	[	[	-LRB-
50458	797	2	102	102	CD
50458	797	3	]	]	-RRB-
50458	797	4	_	_	NNP
50458	797	5	Annal	Annal	NNP
50458	797	6	.	.	.
50458	798	1	Instit	Instit	NNP
50458	798	2	.	.	.
50458	799	1	Pasteur	Pasteur	NNP
50458	799	2	_	_	NNP
50458	799	3	,	,	,
50458	799	4	IX	IX	NNP
50458	799	5	,	,	,
50458	799	6	p.	p.	NN
50458	799	7	785	785	CD
50458	799	8	.	.	.
50458	800	1	The	the	DT
50458	800	2	animals	animal	NNS
50458	800	3	thus	thus	RB
50458	800	4	rendered	render	VBD
50458	800	5	immune	immune	JJ
50458	800	6	yield	yield	NN
50458	800	7	a	a	DT
50458	800	8	serum	serum	NN
50458	800	9	which	which	WDT
50458	800	10	may	may	MD
50458	800	11	be	be	VB
50458	800	12	used	use	VBN
50458	800	13	as	as	IN
50458	800	14	a	a	DT
50458	800	15	vaccin	vaccin	NNS
50458	800	16	against	against	IN
50458	800	17	anthrax	anthrax	NN
50458	800	18	,	,	,
50458	800	19	and	and	CC
50458	800	20	which	which	WDT
50458	800	21	even	even	RB
50458	800	22	possesses	possess	VBZ
50458	800	23	curative	curative	JJ
50458	800	24	properties	property	NNS
50458	800	25	under	under	IN
50458	800	26	certain	certain	JJ
50458	800	27	conditions	condition	NNS
50458	800	28	.	.	.
50458	801	1	In	in	IN
50458	801	2	every	every	DT
50458	801	3	case	case	NN
50458	801	4	the	the	DT
50458	801	5	acquired	acquire	VBN
50458	801	6	immunity	immunity	NN
50458	801	7	is	be	VBZ
50458	801	8	only	only	RB
50458	801	9	temporary	temporary	JJ
50458	801	10	.	.	.
50458	802	1	We	-PRON-	PRP
50458	802	2	will	will	MD
50458	802	3	recall	recall	VB
50458	802	4	to	to	TO
50458	802	5	recollection	recollection	VB
50458	802	6	the	the	DT
50458	802	7	method	method	NN
50458	802	8	employed	employ	VBN
50458	802	9	by	by	IN
50458	802	10	Pasteur	Pasteur	NNP
50458	802	11	for	for	IN
50458	802	12	vaccinating	vaccinate	VBG
50458	802	13	against	against	IN
50458	802	14	anthrax	anthrax	NN
50458	802	15	,	,	,
50458	802	16	using	use	VBG
50458	802	17	attenuated	attenuate	VBN
50458	802	18	cultures	culture	NNS
50458	802	19	,	,	,
50458	802	20	a	a	DT
50458	802	21	method	method	NN
50458	802	22	which	which	WDT
50458	802	23	is	be	VBZ
50458	802	24	practiced	practice	VBN
50458	802	25	daily	daily	RB
50458	802	26	at	at	IN
50458	802	27	the	the	DT
50458	802	28	present	present	JJ
50458	802	29	time	time	NN
50458	802	30	.	.	.
50458	803	1	[	[	-LRB-
50458	803	2	103	103	CD
50458	803	3	]	]	-RRB-
50458	803	4	[	[	-LRB-
50458	803	5	103	103	CD
50458	803	6	]	]	-RRB-
50458	803	7	CHAMBERLAND	CHAMBERLAND	NNP
50458	803	8	:	:	:
50458	803	9	_	_	NNP
50458	803	10	Le	Le	NNP
50458	803	11	Charbon	Charbon	NNP
50458	803	12	et	et	NNP
50458	803	13	la	la	NNP
50458	803	14	Vaccination	Vaccination	NNP
50458	803	15	Charbonneuse	Charbonneuse	NNP
50458	803	16	_	_	NNP
50458	803	17	,	,	,
50458	803	18	Paris	Paris	NNP
50458	803	19	,	,	,
50458	803	20	1887	1887	CD
50458	803	21	.	.	.
50458	804	1	PETERMANN	PETERMANN	NNP
50458	804	2	:	:	:
50458	804	3	_	_	NNP
50458	804	4	Annal	Annal	NNP
50458	804	5	.	.	.
50458	805	1	Instit	Instit	NNP
50458	805	2	.	.	.
50458	806	1	Pasteur	Pasteur	NNP
50458	806	2	_	_	NNP
50458	806	3	,	,	,
50458	806	4	VI	VI	NNP
50458	806	5	,	,	,
50458	806	6	p.	p.	NN
50458	806	7	32	32	CD
50458	806	8	.	.	.
50458	807	1	From	from	IN
50458	807	2	the	the	DT
50458	807	3	cultures	culture	NNS
50458	807	4	of	of	IN
50458	807	5	symptomatic	symptomatic	JJ
50458	807	6	anthrax	anthrax	NN
50458	807	7	(	(	-LRB-
50458	807	8	Bacillus	Bacillus	NNP
50458	807	9	Chauvæ	Chauvæ	NNP
50458	807	10	)	)	-RRB-
50458	807	11	Chauvée	Chauvée	NNP
50458	807	12	extracted	extract	VBD
50458	807	13	a	a	DT
50458	807	14	very	very	RB
50458	807	15	active	active	JJ
50458	807	16	toxin	toxin	NN
50458	807	17	which	which	WDT
50458	807	18	can	can	MD
50458	807	19	withstand	withstand	VB
50458	807	20	without	without	IN
50458	807	21	impairment	impairment	NN
50458	807	22	a	a	DT
50458	807	23	temperature	temperature	NN
50458	807	24	of	of	IN
50458	807	25	110	110	CD
50458	807	26	°	°	,
50458	807	27	C	C	NNP
50458	807	28	.	.	.
50458	808	1	[	[	-LRB-
50458	808	2	104	104	NNP
50458	808	3	]	]	-RRB-
50458	808	4	Roux[105	Roux[105	NNP
50458	808	5	]	]	-RRB-
50458	808	6	has	have	VBZ
50458	808	7	shown	show	VBN
50458	808	8	that	that	IN
50458	808	9	the	the	DT
50458	808	10	serum	serum	NN
50458	808	11	of	of	IN
50458	808	12	animals	animal	NNS
50458	808	13	that	that	WDT
50458	808	14	have	have	VBP
50458	808	15	succumbed	succumb	VBN
50458	808	16	to	to	IN
50458	808	17	the	the	DT
50458	808	18	symptomatic	symptomatic	JJ
50458	808	19	anthrax	anthrax	NN
50458	808	20	is	be	VBZ
50458	808	21	capable	capable	JJ
50458	808	22	of	of	IN
50458	808	23	vaccinating	vaccinate	VBG
50458	808	24	against	against	IN
50458	808	25	this	this	DT
50458	808	26	disease	disease	NN
50458	808	27	;	;	:
50458	808	28	we	-PRON-	PRP
50458	808	29	have	have	VBP
50458	808	30	here	here	RB
50458	808	31	a	a	DT
50458	808	32	new	new	JJ
50458	808	33	proof	proof	NN
50458	808	34	that	that	IN
50458	808	35	the	the	DT
50458	808	36	antitoxin	antitoxin	NN
50458	808	37	is	be	VBZ
50458	808	38	in	in	IN
50458	808	39	fact	fact	NN
50458	808	40	a	a	DT
50458	808	41	product	product	NN
50458	808	42	of	of	IN
50458	808	43	the	the	DT
50458	808	44	defense	defense	NN
50458	808	45	of	of	IN
50458	808	46	the	the	DT
50458	808	47	cells	cell	NNS
50458	808	48	of	of	IN
50458	808	49	the	the	DT
50458	808	50	organism	organism	NN
50458	808	51	,	,	,
50458	808	52	and	and	CC
50458	808	53	the	the	DT
50458	808	54	author	author	NN
50458	808	55	mentioned	mention	VBD
50458	808	56	has	have	VBZ
50458	808	57	been	be	VBN
50458	808	58	able	able	JJ
50458	808	59	to	to	TO
50458	808	60	vaccinate	vaccinate	VB
50458	808	61	guinea	guinea	NN
50458	808	62	-	-	HYPH
50458	808	63	pigs	pig	NNS
50458	808	64	by	by	IN
50458	808	65	injecting	inject	VBG
50458	808	66	into	into	IN
50458	808	67	the	the	DT
50458	808	68	peritoneum	peritoneum	NN
50458	808	69	culture	culture	NN
50458	808	70	bouillon	bouillon	NN
50458	808	71	sterilized	sterilize	VBN
50458	808	72	by	by	IN
50458	808	73	heating	heat	VBG
50458	808	74	to	to	IN
50458	808	75	115	115	CD
50458	808	76	°	°	NNS
50458	808	77	C.	C.	NNP
50458	808	78	or	or	CC
50458	808	79	by	by	IN
50458	808	80	filtering	filter	VBG
50458	808	81	through	through	IN
50458	808	82	porcelain	porcelain	NN
50458	808	83	.	.	.
50458	809	1	[	[	-LRB-
50458	809	2	104	104	CD
50458	809	3	]	]	-RRB-
50458	809	4	DEUTSCHMANN	deutschmann	NN
50458	809	5	:	:	:
50458	809	6	_	_	NNP
50458	809	7	Annal	Annal	NNP
50458	809	8	.	.	.
50458	810	1	Instit	Instit	NNP
50458	810	2	.	.	.
50458	811	1	Pasteur	Pasteur	NNP
50458	811	2	_	_	NNP
50458	811	3	,	,	,
50458	811	4	VIII	VIII	NNP
50458	811	5	,	,	,
50458	811	6	p.	p.	NN
50458	811	7	403	403	CD
50458	811	8	.	.	.
50458	812	1	[	[	-LRB-
50458	812	2	105	105	CD
50458	812	3	]	]	-RRB-
50458	812	4	_	_	NNP
50458	812	5	Annal	Annal	NNP
50458	812	6	.	.	.
50458	813	1	Inst	inst	RB
50458	813	2	.	.	.
50458	814	1	Pasteur	Pasteur	NNP
50458	814	2	_	_	NNP
50458	814	3	,	,	,
50458	814	4	Feb.	February	NNP
50458	814	5	1888	1888	CD
50458	814	6	.	.	.
50458	815	1	=	=	NFP
50458	815	2	Tubercular	Tubercular	NNP
50458	815	3	Toxin.=--The	toxin.=--the	NN
50458	815	4	culture	culture	NN
50458	815	5	bouillons	bouillon	NNS
50458	815	6	of	of	IN
50458	815	7	Koch	Koch	NNP
50458	815	8	's	's	POS
50458	815	9	bacillus	bacillus	NN
50458	815	10	contain	contain	VBP
50458	815	11	one	one	CD
50458	815	12	or	or	CC
50458	815	13	more	more	RBR
50458	815	14	active	active	JJ
50458	815	15	substances	substance	NNS
50458	815	16	which	which	WDT
50458	815	17	constitute	constitute	VBP
50458	815	18	,	,	,
50458	815	19	and	and	CC
50458	815	20	which	which	WDT
50458	815	21	is	be	VBZ
50458	815	22	at	at	IN
50458	815	23	the	the	DT
50458	815	24	present	present	NN
50458	815	25	designated	designate	VBN
50458	815	26	as	as	IN
50458	815	27	,	,	,
50458	815	28	tuberculin	tuberculin	NN
50458	815	29	.	.	.
50458	816	1	[	[	-LRB-
50458	816	2	106	106	CD
50458	816	3	]	]	-RRB-
50458	816	4	Koch	Koch	NNP
50458	816	5	's	's	POS
50458	816	6	therapeutic	therapeutic	JJ
50458	816	7	tuberculin	tuberculin	NN
50458	816	8	is	be	VBZ
50458	816	9	obtained	obtain	VBN
50458	816	10	by	by	IN
50458	816	11	evaporating	evaporate	VBG
50458	816	12	to	to	IN
50458	816	13	one	one	CD
50458	816	14	-	-	HYPH
50458	816	15	tenth	tenth	NN
50458	816	16	its	-PRON-	PRP$
50458	816	17	volume	volume	NN
50458	816	18	a	a	DT
50458	816	19	culture	culture	NN
50458	816	20	bouillon	bouillon	NN
50458	816	21	of	of	IN
50458	816	22	Koch	Koch	NNP
50458	816	23	's	's	POS
50458	816	24	tubercle	tubercle	NN
50458	816	25	bacilli	bacilli	NNP
50458	816	26	prepared	prepare	VBD
50458	816	27	from	from	IN
50458	816	28	a	a	DT
50458	816	29	4-per	4-per	NNP
50458	816	30	cent	cent	NN
50458	816	31	.	.	.
50458	817	1	glycerinic	glycerinic	JJ
50458	817	2	mutton	mutton	NNP
50458	817	3	bouillon	bouillon	NNP
50458	817	4	,	,	,
50458	817	5	and	and	CC
50458	817	6	filtering	filter	VBG
50458	817	7	through	through	IN
50458	817	8	porcelain	porcelain	NN
50458	817	9	.	.	.
50458	818	1	By	by	IN
50458	818	2	fractional	fractional	JJ
50458	818	3	precipitation	precipitation	NN
50458	818	4	it	-PRON-	PRP
50458	818	5	is	be	VBZ
50458	818	6	possible	possible	JJ
50458	818	7	to	to	TO
50458	818	8	obtain	obtain	VB
50458	818	9	from	from	IN
50458	818	10	the	the	DT
50458	818	11	crude	crude	JJ
50458	818	12	tuberculin	tuberculin	NN
50458	818	13	so	so	RB
50458	818	14	prepared	prepare	VBD
50458	818	15	a	a	DT
50458	818	16	product	product	NN
50458	818	17	which	which	WDT
50458	818	18	is	be	VBZ
50458	818	19	considered	consider	VBN
50458	818	20	as	as	IN
50458	818	21	pure	pure	JJ
50458	818	22	tuberculin	tuberculin	NN
50458	818	23	,	,	,
50458	818	24	and	and	CC
50458	818	25	which	which	WDT
50458	818	26	possesses	possess	VBZ
50458	818	27	considerable	considerable	JJ
50458	818	28	activity	activity	NN
50458	818	29	.	.	.
50458	819	1	[	[	-LRB-
50458	819	2	106	106	CD
50458	819	3	]	]	-RRB-
50458	819	4	AUCLAIR	AUCLAIR	NNP
50458	819	5	:	:	:
50458	819	6	_	_	NNP
50458	819	7	Thèse	Thèse	NNP
50458	819	8	de	de	NNP
50458	819	9	doctorat	doctorat	NNP
50458	819	10	_	_	NNP
50458	819	11	,	,	,
50458	819	12	Paris	Paris	NNP
50458	819	13	,	,	,
50458	819	14	1897	1897	CD
50458	819	15	;	;	:
50458	819	16	and	and	CC
50458	819	17	_	_	NNP
50458	819	18	Arch	Arch	NNP
50458	819	19	.	.	.
50458	820	1	de	de	NNP
50458	820	2	Médecine	Médecine	NNP
50458	820	3	_	_	NNP
50458	820	4	,	,	,
50458	820	5	exp	exp	NN
50458	820	6	.	.	.
50458	821	1	1898	1898	CD
50458	821	2	.	.	.
50458	822	1	Prolonged	prolonged	JJ
50458	822	2	boiling	boiling	NN
50458	822	3	on	on	IN
50458	822	4	the	the	DT
50458	822	5	water	water	NN
50458	822	6	-	-	HYPH
50458	822	7	bath	bath	NN
50458	822	8	completely	completely	RB
50458	822	9	destroys	destroy	VBZ
50458	822	10	the	the	DT
50458	822	11	activity	activity	NN
50458	822	12	of	of	IN
50458	822	13	this	this	DT
50458	822	14	tuberculin	tuberculin	NN
50458	822	15	,	,	,
50458	822	16	which	which	WDT
50458	822	17	moreover	moreover	RB
50458	822	18	hardly	hardly	RB
50458	822	19	ever	ever	RB
50458	822	20	keeps	keep	VBZ
50458	822	21	longer	long	JJR
50458	822	22	than	than	IN
50458	822	23	three	three	CD
50458	822	24	weeks	week	NNS
50458	822	25	.	.	.
50458	823	1	It	-PRON-	PRP
50458	823	2	has	have	VBZ
50458	823	3	been	be	VBN
50458	823	4	found	find	VBN
50458	823	5	possible	possible	JJ
50458	823	6	to	to	TO
50458	823	7	preserve	preserve	VB
50458	823	8	it	-PRON-	PRP
50458	823	9	for	for	IN
50458	823	10	an	an	DT
50458	823	11	indefinite	indefinite	JJ
50458	823	12	period	period	NN
50458	823	13	,	,	,
50458	823	14	however	however	RB
50458	823	15	,	,	,
50458	823	16	by	by	IN
50458	823	17	adding	add	VBG
50458	823	18	to	to	IN
50458	823	19	it	-PRON-	PRP
50458	823	20	30	30	CD
50458	823	21	to	to	TO
50458	823	22	40	40	CD
50458	823	23	per	per	NN
50458	823	24	cent	cent	NN
50458	823	25	.	.	.
50458	824	1	of	of	IN
50458	824	2	glycerin	glycerin	NNP
50458	824	3	.	.	.
50458	825	1	It	-PRON-	PRP
50458	825	2	possesses	possess	VBZ
50458	825	3	all	all	PDT
50458	825	4	the	the	DT
50458	825	5	general	general	JJ
50458	825	6	reactions	reaction	NNS
50458	825	7	of	of	IN
50458	825	8	albuminoids	albuminoid	NNS
50458	825	9	.	.	.
50458	826	1	Tuberculin	tuberculin	NN
50458	826	2	is	be	VBZ
50458	826	3	not	not	RB
50458	826	4	toxic	toxic	JJ
50458	826	5	in	in	IN
50458	826	6	the	the	DT
50458	826	7	proper	proper	JJ
50458	826	8	sense	sense	NN
50458	826	9	of	of	IN
50458	826	10	the	the	DT
50458	826	11	word	word	NN
50458	826	12	.	.	.
50458	827	1	Injected	inject	VBN
50458	827	2	in	in	IN
50458	827	3	small	small	JJ
50458	827	4	quantities	quantity	NNS
50458	827	5	into	into	IN
50458	827	6	the	the	DT
50458	827	7	healthy	healthy	JJ
50458	827	8	human	human	NN
50458	827	9	being[107	being[107	NNP
50458	827	10	]	]	-RRB-
50458	827	11	and	and	CC
50458	827	12	into	into	IN
50458	827	13	healthy	healthy	JJ
50458	827	14	animals	animal	NNS
50458	827	15	,	,	,
50458	827	16	it	-PRON-	PRP
50458	827	17	exerts	exert	VBZ
50458	827	18	no	no	DT
50458	827	19	effect	effect	NN
50458	827	20	;	;	:
50458	827	21	on	on	IN
50458	827	22	the	the	DT
50458	827	23	other	other	JJ
50458	827	24	hand	hand	NN
50458	827	25	,	,	,
50458	827	26	however	however	RB
50458	827	27	,	,	,
50458	827	28	in	in	IN
50458	827	29	tubercular	tubercular	JJ
50458	827	30	organisms	organism	NNS
50458	827	31	,	,	,
50458	827	32	even	even	RB
50458	827	33	in	in	IN
50458	827	34	incipient	incipient	JJ
50458	827	35	stages	stage	NNS
50458	827	36	of	of	IN
50458	827	37	the	the	DT
50458	827	38	disease	disease	NN
50458	827	39	,	,	,
50458	827	40	even	even	RB
50458	827	41	where	where	WRB
50458	827	42	it	-PRON-	PRP
50458	827	43	is	be	VBZ
50458	827	44	almost	almost	RB
50458	827	45	impossible	impossible	JJ
50458	827	46	to	to	TO
50458	827	47	make	make	VB
50458	827	48	a	a	DT
50458	827	49	clinical	clinical	JJ
50458	827	50	diagnosis	diagnosis	NN
50458	827	51	,	,	,
50458	827	52	the	the	DT
50458	827	53	injection	injection	NN
50458	827	54	of	of	IN
50458	827	55	very	very	RB
50458	827	56	small	small	JJ
50458	827	57	quantities	quantity	NNS
50458	827	58	develops	develop	VBZ
50458	827	59	a	a	DT
50458	827	60	lively	lively	JJ
50458	827	61	and	and	CC
50458	827	62	characteristic	characteristic	JJ
50458	827	63	reaction	reaction	NN
50458	827	64	.	.	.
50458	828	1	[	[	-LRB-
50458	828	2	108	108	CD
50458	828	3	]	]	-RRB-
50458	828	4	[	[	-LRB-
50458	828	5	107	107	CD
50458	828	6	]	]	-RRB-
50458	828	7	KOCH	KOCH	NNP
50458	828	8	:	:	:
50458	828	9	_	_	NNP
50458	828	10	Deutsch	Deutsch	NNP
50458	828	11	.	.	.
50458	829	1	Med	Med	NNP
50458	829	2	.	.	.
50458	830	1	Woch	Woch	NNP
50458	830	2	.	.	.
50458	830	3	_	_	NNP
50458	830	4	,	,	,
50458	830	5	Nov.	November	NNP
50458	830	6	13	13	CD
50458	830	7	,	,	,
50458	830	8	1890	1890	CD
50458	830	9	-	-	SYM
50458	830	10	1897	1897	CD
50458	830	11	,	,	,
50458	830	12	No	no	UH
50458	830	13	.	.	.
50458	831	1	14	14	CD
50458	831	2	,	,	,
50458	831	3	p.	p.	NN
50458	831	4	209	209	CD
50458	831	5	.	.	.
50458	832	1	[	[	-LRB-
50458	832	2	108	108	CD
50458	832	3	]	]	-RRB-
50458	832	4	_	_	NNP
50458	832	5	Annal	Annal	NNP
50458	832	6	.	.	.
50458	833	1	de	de	NNP
50458	833	2	l'Instit	l'Instit	NNP
50458	833	3	.	.	.
50458	834	1	Pasteur	Pasteur	NNP
50458	834	2	_	_	NNP
50458	834	3	,	,	,
50458	834	4	V	V	NNP
50458	834	5	,	,	,
50458	834	6	p.	p.	NN
50458	834	7	191	191	CD
50458	834	8	;	;	:
50458	834	9	_	_	NNP
50458	834	10	Arch	Arch	NNP
50458	834	11	.	.	.
50458	835	1	de	de	NNP
50458	835	2	la	la	NNP
50458	835	3	Soc	Soc	NNP
50458	835	4	.	.	.
50458	836	1	Biol	Biol	NNP
50458	836	2	.	.	.
50458	837	1	de	de	NNP
50458	837	2	Saint	Saint	NNP
50458	837	3	-	-	HYPH
50458	837	4	Pétersbourg	Pétersbourg	NNP
50458	837	5	_	_	NNP
50458	837	6	,	,	,
50458	837	7	I	-PRON-	PRP
50458	837	8	,	,	,
50458	837	9	p.	p.	NN
50458	837	10	213	213	CD
50458	837	11	.	.	.
50458	838	1	Grasset	Grasset	NNP
50458	838	2	and	and	CC
50458	838	3	Vedel	Vedel	NNP
50458	838	4	consider	consider	VBP
50458	838	5	the	the	DT
50458	838	6	tuberculin	tuberculin	NN
50458	838	7	as	as	IN
50458	838	8	an	an	DT
50458	838	9	excellent	excellent	JJ
50458	838	10	means	means	NN
50458	838	11	of	of	IN
50458	838	12	diagnosing	diagnose	VBG
50458	838	13	tuberculosis	tuberculosis	NN
50458	838	14	in	in	IN
50458	838	15	man	man	NN
50458	838	16	,	,	,
50458	838	17	but	but	CC
50458	838	18	in	in	IN
50458	838	19	such	such	PDT
50458	838	20	a	a	DT
50458	838	21	case	case	NN
50458	838	22	it	-PRON-	PRP
50458	838	23	is	be	VBZ
50458	838	24	necessary	necessary	JJ
50458	838	25	to	to	TO
50458	838	26	operate	operate	VB
50458	838	27	with	with	IN
50458	838	28	the	the	DT
50458	838	29	greatest	great	JJS
50458	838	30	caution	caution	NN
50458	838	31	,	,	,
50458	838	32	with	with	IN
50458	838	33	very	very	RB
50458	838	34	small	small	JJ
50458	838	35	quantities	quantity	NNS
50458	838	36	of	of	IN
50458	838	37	the	the	DT
50458	838	38	tuberculin	tuberculin	NN
50458	838	39	,	,	,
50458	838	40	and	and	CC
50458	838	41	to	to	TO
50458	838	42	feel	feel	VB
50458	838	43	,	,	,
50458	838	44	in	in	IN
50458	838	45	some	some	DT
50458	838	46	sort	sort	NN
50458	838	47	,	,	,
50458	838	48	the	the	DT
50458	838	49	sensitiveness	sensitiveness	NN
50458	838	50	of	of	IN
50458	838	51	the	the	DT
50458	838	52	patient	patient	NN
50458	838	53	,	,	,
50458	838	54	particularly	particularly	RB
50458	838	55	in	in	IN
50458	838	56	the	the	DT
50458	838	57	case	case	NN
50458	838	58	of	of	IN
50458	838	59	children	child	NNS
50458	838	60	.	.	.
50458	839	1	It	-PRON-	PRP
50458	839	2	is	be	VBZ
50458	839	3	chiefly	chiefly	RB
50458	839	4	for	for	IN
50458	839	5	the	the	DT
50458	839	6	diagnosis	diagnosis	NN
50458	839	7	of	of	IN
50458	839	8	tuberculosis	tuberculosis	NN
50458	839	9	in	in	IN
50458	839	10	cattle	cattle	NNS
50458	839	11	,	,	,
50458	839	12	however	however	RB
50458	839	13	,	,	,
50458	839	14	that	that	IN
50458	839	15	tuberculin	tuberculin	NN
50458	839	16	is	be	VBZ
50458	839	17	valuable	valuable	JJ
50458	839	18	.	.	.
50458	840	1	Thanks	thank	NNS
50458	840	2	to	to	IN
50458	840	3	Nocard	Nocard	NNP
50458	840	4	,	,	,
50458	840	5	the	the	DT
50458	840	6	procedure	procedure	NN
50458	840	7	has	have	VBZ
50458	840	8	to	to	IN
50458	840	9	-	-	HYPH
50458	840	10	day	day	NN
50458	840	11	become	become	VB
50458	840	12	a	a	DT
50458	840	13	common	common	JJ
50458	840	14	practice	practice	NN
50458	840	15	.	.	.
50458	841	1	The	the	DT
50458	841	2	injection	injection	NN
50458	841	3	of	of	IN
50458	841	4	a	a	DT
50458	841	5	fairly	fairly	RB
50458	841	6	large	large	JJ
50458	841	7	dose	dose	NN
50458	841	8	,	,	,
50458	841	9	0.3	0.3	CD
50458	841	10	to	to	TO
50458	841	11	0.4	0.4	CD
50458	841	12	Gm	Gm	NNP
50458	841	13	.	.	.
50458	841	14	,	,	,
50458	841	15	according	accord	VBG
50458	841	16	to	to	IN
50458	841	17	the	the	DT
50458	841	18	size	size	NN
50458	841	19	of	of	IN
50458	841	20	the	the	DT
50458	841	21	animal	animal	NN
50458	841	22	,	,	,
50458	841	23	causes	cause	NNS
50458	841	24	,	,	,
50458	841	25	in	in	IN
50458	841	26	about	about	RB
50458	841	27	ten	ten	CD
50458	841	28	hours	hour	NNS
50458	841	29	or	or	CC
50458	841	30	so	so	RB
50458	841	31	,	,	,
50458	841	32	if	if	IN
50458	841	33	the	the	DT
50458	841	34	animal	animal	NN
50458	841	35	is	be	VBZ
50458	841	36	tuberculous	tuberculous	JJ
50458	841	37	,	,	,
50458	841	38	a	a	DT
50458	841	39	strong	strong	JJ
50458	841	40	febrile	febrile	NN
50458	841	41	reaction	reaction	NN
50458	841	42	with	with	IN
50458	841	43	an	an	DT
50458	841	44	elevation	elevation	NN
50458	841	45	of	of	IN
50458	841	46	temperature	temperature	NN
50458	841	47	of	of	IN
50458	841	48	1.5	1.5	CD
50458	841	49	to	to	TO
50458	841	50	3	3	CD
50458	841	51	°	°	,
50458	841	52	C.	C.	NNP
50458	841	53	,	,	,
50458	841	54	whereas	whereas	IN
50458	841	55	if	if	IN
50458	841	56	the	the	DT
50458	841	57	animal	animal	NN
50458	841	58	is	be	VBZ
50458	841	59	not	not	RB
50458	841	60	tuberculous	tuberculous	JJ
50458	841	61	no	no	DT
50458	841	62	such	such	JJ
50458	841	63	reaction	reaction	NN
50458	841	64	takes	take	VBZ
50458	841	65	place	place	NN
50458	841	66	.	.	.
50458	842	1	Cases	case	NNS
50458	842	2	in	in	IN
50458	842	3	which	which	WDT
50458	842	4	tuberculosis	tuberculosis	NN
50458	842	5	is	be	VBZ
50458	842	6	far	far	RB
50458	842	7	advanced	advanced	JJ
50458	842	8	,	,	,
50458	842	9	and	and	CC
50458	842	10	in	in	IN
50458	842	11	which	which	WDT
50458	842	12	the	the	DT
50458	842	13	organism	organism	NN
50458	842	14	is	be	VBZ
50458	842	15	impregnated	impregnate	VBN
50458	842	16	with	with	IN
50458	842	17	tuberculin	tuberculin	NN
50458	842	18	,	,	,
50458	842	19	do	do	VBP
50458	842	20	not	not	RB
50458	842	21	react	react	VB
50458	842	22	after	after	IN
50458	842	23	the	the	DT
50458	842	24	injection	injection	NN
50458	842	25	of	of	IN
50458	842	26	tuberculin	tuberculin	NN
50458	842	27	.	.	.
50458	843	1	[	[	-LRB-
50458	843	2	109	109	CD
50458	843	3	]	]	-RRB-
50458	843	4	[	[	-LRB-
50458	843	5	109	109	CD
50458	843	6	]	]	-RRB-
50458	843	7	NOCARD	NOCARD	NNP
50458	843	8	and	and	CC
50458	843	9	LECLAINCHE	LECLAINCHE	NNP
50458	843	10	:	:	:
50458	843	11	_	_	NNP
50458	843	12	Les	Les	NNP
50458	843	13	Maladies	Maladies	NNP
50458	843	14	Microbiennes	Microbiennes	NNP
50458	843	15	des	des	NNP
50458	843	16	Animaux	Animaux	NNP
50458	843	17	_	_	NNP
50458	843	18	.	.	.
50458	844	1	Tuberculin	Tuberculin	NNP
50458	844	2	does	do	VBZ
50458	844	3	not	not	RB
50458	844	4	confer	confer	VB
50458	844	5	immunity	immunity	NN
50458	844	6	,	,	,
50458	844	7	and	and	CC
50458	844	8	the	the	DT
50458	844	9	bacillus	bacillus	NN
50458	844	10	retains	retain	VBZ
50458	844	11	all	all	PDT
50458	844	12	its	-PRON-	PRP$
50458	844	13	virulence	virulence	NN
50458	844	14	,	,	,
50458	844	15	even	even	RB
50458	844	16	in	in	IN
50458	844	17	injected	inject	VBN
50458	844	18	tissues	tissue	NNS
50458	844	19	;	;	:
50458	844	20	nevertheless	nevertheless	RB
50458	844	21	,	,	,
50458	844	22	the	the	DT
50458	844	23	return	return	NN
50458	844	24	to	to	IN
50458	844	25	health	health	NN
50458	844	26	of	of	IN
50458	844	27	animals	animal	NNS
50458	844	28	in	in	IN
50458	844	29	which	which	WDT
50458	844	30	injections	injection	NNS
50458	844	31	have	have	VBP
50458	844	32	been	be	VBN
50458	844	33	recently	recently	RB
50458	844	34	made	make	VBN
50458	844	35	may	may	MD
50458	844	36	be	be	VB
50458	844	37	due	due	IN
50458	844	38	to	to	IN
50458	844	39	the	the	DT
50458	844	40	action	action	NN
50458	844	41	of	of	IN
50458	844	42	large	large	JJ
50458	844	43	doses	dose	NNS
50458	844	44	of	of	IN
50458	844	45	the	the	DT
50458	844	46	serum	serum	NN
50458	844	47	;	;	:
50458	844	48	and	and	CC
50458	844	49	on	on	IN
50458	844	50	the	the	DT
50458	844	51	other	other	JJ
50458	844	52	hand	hand	NN
50458	844	53	the	the	DT
50458	844	54	tuberculin	tuberculin	NN
50458	844	55	,	,	,
50458	844	56	in	in	IN
50458	844	57	large	large	JJ
50458	844	58	quantities	quantity	NNS
50458	844	59	,	,	,
50458	844	60	may	may	MD
50458	844	61	render	render	VB
50458	844	62	the	the	DT
50458	844	63	location	location	NN
50458	844	64	unsuitable	unsuitable	JJ
50458	844	65	for	for	IN
50458	844	66	the	the	DT
50458	844	67	development	development	NN
50458	844	68	of	of	IN
50458	844	69	the	the	DT
50458	844	70	tubercle	tubercle	NN
50458	844	71	bacilli	bacilli	NNP
50458	844	72	.	.	.
50458	845	1	=	=	NFP
50458	845	2	Diphtheria	Diphtheria	NNP
50458	845	3	Toxin.=--The	Toxin.=--The	NNP
50458	845	4	most	most	RBS
50458	845	5	characteristic	characteristic	JJ
50458	845	6	property	property	NN
50458	845	7	of	of	IN
50458	845	8	the	the	DT
50458	845	9	diphtheria	diphtheria	NN
50458	845	10	bacillus	bacillus	NN
50458	845	11	is	be	VBZ
50458	845	12	the	the	DT
50458	845	13	production	production	NN
50458	845	14	,	,	,
50458	845	15	in	in	IN
50458	845	16	culture	culture	NN
50458	845	17	media	medium	NNS
50458	845	18	,	,	,
50458	845	19	of	of	IN
50458	845	20	a	a	DT
50458	845	21	special	special	JJ
50458	845	22	toxic	toxic	JJ
50458	845	23	substance	substance	NN
50458	845	24	which	which	WDT
50458	845	25	has	have	VBZ
50458	845	26	been	be	VBN
50458	845	27	named	name	VBN
50458	845	28	_	_	NNP
50458	845	29	diphtheritic	diphtheritic	JJ
50458	845	30	toxin	toxin	NN
50458	845	31	_	_	NNP
50458	845	32	;	;	:
50458	845	33	this	this	DT
50458	845	34	name	name	NN
50458	845	35	,	,	,
50458	845	36	however	however	RB
50458	845	37	,	,	,
50458	845	38	has	have	VBZ
50458	845	39	come	come	VBN
50458	845	40	to	to	TO
50458	845	41	be	be	VB
50458	845	42	also	also	RB
50458	845	43	extended	extend	VBN
50458	845	44	to	to	IN
50458	845	45	a	a	DT
50458	845	46	liquid	liquid	NN
50458	845	47	in	in	IN
50458	845	48	which	which	WDT
50458	845	49	the	the	DT
50458	845	50	bacilli	bacilli	NNP
50458	845	51	have	have	VBP
50458	845	52	lived	live	VBN
50458	845	53	,	,	,
50458	845	54	and	and	CC
50458	845	55	which	which	WDT
50458	845	56	has	have	VBZ
50458	845	57	been	be	VBN
50458	845	58	sterilized	sterilize	VBN
50458	845	59	by	by	IN
50458	845	60	filtration	filtration	NN
50458	845	61	or	or	CC
50458	845	62	by	by	IN
50458	845	63	any	any	DT
50458	845	64	other	other	JJ
50458	845	65	suitable	suitable	JJ
50458	845	66	process	process	NN
50458	845	67	.	.	.
50458	846	1	Roux	roux	VB
50458	846	2	and	and	CC
50458	846	3	Yersin[110	Yersin[110	NNS
50458	846	4	]	]	-RRB-
50458	846	5	were	be	VBD
50458	846	6	the	the	DT
50458	846	7	first	first	JJ
50458	846	8	to	to	TO
50458	846	9	affirm	affirm	VB
50458	846	10	that	that	IN
50458	846	11	diphtheria	diphtheria	NN
50458	846	12	is	be	VBZ
50458	846	13	an	an	DT
50458	846	14	autointoxication	autointoxication	NN
50458	846	15	caused	cause	VBN
50458	846	16	by	by	IN
50458	846	17	a	a	DT
50458	846	18	very	very	RB
50458	846	19	active	active	JJ
50458	846	20	poison	poison	NN
50458	846	21	formed	form	VBN
50458	846	22	by	by	IN
50458	846	23	the	the	DT
50458	846	24	microbe	microbe	NN
50458	846	25	in	in	IN
50458	846	26	the	the	DT
50458	846	27	restricted	restricted	JJ
50458	846	28	locality	locality	NN
50458	846	29	where	where	WRB
50458	846	30	it	-PRON-	PRP
50458	846	31	develops	develop	VBZ
50458	846	32	.	.	.
50458	847	1	In	in	IN
50458	847	2	order	order	NN
50458	847	3	to	to	TO
50458	847	4	obtain	obtain	VB
50458	847	5	this	this	DT
50458	847	6	toxin[111	toxin[111	NN
50458	847	7	]	]	-RRB-
50458	847	8	a	a	DT
50458	847	9	culture	culture	NN
50458	847	10	of	of	IN
50458	847	11	the	the	DT
50458	847	12	bacillus	bacillus	NN
50458	847	13	is	be	VBZ
50458	847	14	first	first	RB
50458	847	15	made	make	VBN
50458	847	16	in	in	IN
50458	847	17	a	a	DT
50458	847	18	mutton	mutton	NN
50458	847	19	bouillon	bouillon	NN
50458	847	20	made	make	VBD
50458	847	21	strongly	strongly	RB
50458	847	22	alkaline	alkaline	VB
50458	847	23	with	with	IN
50458	847	24	sodium	sodium	NN
50458	847	25	carbonate	carbonate	NN
50458	847	26	(	(	-LRB-
50458	847	27	10	10	CD
50458	847	28	grams	gram	NNS
50458	847	29	per	per	IN
50458	847	30	liter	liter	NN
50458	847	31	)	)	-RRB-
50458	847	32	,	,	,
50458	847	33	and	and	CC
50458	847	34	with	with	IN
50458	847	35	the	the	DT
50458	847	36	addition	addition	NN
50458	847	37	of	of	IN
50458	847	38	2	2	CD
50458	847	39	per	per	NN
50458	847	40	cent	cent	NN
50458	847	41	.	.	.
50458	848	1	of	of	IN
50458	848	2	peptone	peptone	NNP
50458	848	3	.	.	.
50458	849	1	At	at	IN
50458	849	2	the	the	DT
50458	849	3	end	end	NN
50458	849	4	of	of	IN
50458	849	5	about	about	RB
50458	849	6	one	one	CD
50458	849	7	month	month	NN
50458	849	8	,	,	,
50458	849	9	the	the	DT
50458	849	10	culture	culture	NN
50458	849	11	being	be	VBG
50458	849	12	kept	keep	VBN
50458	849	13	at	at	IN
50458	849	14	about	about	RB
50458	849	15	37	37	CD
50458	849	16	°	°	,
50458	849	17	C.	C.	NNP
50458	849	18	,	,	,
50458	849	19	the	the	DT
50458	849	20	liquid	liquid	NN
50458	849	21	is	be	VBZ
50458	849	22	filtered	filter	VBN
50458	849	23	through	through	IN
50458	849	24	porcelain	porcelain	NN
50458	849	25	.	.	.
50458	850	1	It	-PRON-	PRP
50458	850	2	is	be	VBZ
50458	850	3	indispensable	indispensable	JJ
50458	850	4	to	to	TO
50458	850	5	employ	employ	VB
50458	850	6	a	a	DT
50458	850	7	very	very	RB
50458	850	8	virulent	virulent	JJ
50458	850	9	bacillus	bacillus	NN
50458	850	10	;	;	:
50458	850	11	it	-PRON-	PRP
50458	850	12	is	be	VBZ
50458	850	13	hence	hence	RB
50458	850	14	frequently	frequently	RB
50458	850	15	advantageous	advantageous	JJ
50458	850	16	to	to	TO
50458	850	17	increase	increase	VB
50458	850	18	the	the	DT
50458	850	19	virulence	virulence	NN
50458	850	20	and	and	CC
50458	850	21	toxigenic	toxigenic	JJ
50458	850	22	power	power	NN
50458	850	23	of	of	IN
50458	850	24	the	the	DT
50458	850	25	bacilli	bacilli	NN
50458	850	26	it	-PRON-	PRP
50458	850	27	is	be	VBZ
50458	850	28	desired	desire	VBN
50458	850	29	to	to	TO
50458	850	30	use	use	VB
50458	850	31	.	.	.
50458	851	1	[	[	-LRB-
50458	851	2	110	110	CD
50458	851	3	]	]	-RRB-
50458	851	4	_	_	NNP
50458	851	5	Annal	Annal	NNP
50458	851	6	.	.	.
50458	852	1	de	de	NNP
50458	852	2	l'Instit	l'Instit	NNP
50458	852	3	.	.	.
50458	853	1	Pasteur	Pasteur	NNP
50458	853	2	_	_	NNP
50458	853	3	,	,	,
50458	853	4	II	II	NNP
50458	853	5	,	,	,
50458	853	6	p.	p.	NN
50458	853	7	632	632	CD
50458	853	8	,	,	,
50458	853	9	and	and	CC
50458	853	10	VIII	VIII	NNP
50458	853	11	,	,	,
50458	853	12	p.	p.	NN
50458	853	13	611	611	CD
50458	853	14	.	.	.
50458	854	1	[	[	-LRB-
50458	854	2	111	111	CD
50458	854	3	]	]	-RRB-
50458	854	4	See	see	VB
50458	854	5	SPRONK	spronk	NN
50458	854	6	:	:	:
50458	854	7	_	_	NNP
50458	854	8	Annal	Annal	NNP
50458	854	9	.	.	.
50458	855	1	de	de	NNP
50458	855	2	l'Instit	l'Instit	NNP
50458	855	3	.	.	.
50458	856	1	Pasteur	Pasteur	NNP
50458	856	2	_	_	NNP
50458	856	3	,	,	,
50458	856	4	IX	IX	NNP
50458	856	5	,	,	,
50458	856	6	p.	p.	NN
50458	856	7	785	785	CD
50458	856	8	;	;	:
50458	856	9	_	_	NNP
50458	856	10	Ibid	Ibid	NNP
50458	856	11	.	.	.
50458	856	12	_	_	NNP
50458	856	13	,	,	,
50458	856	14	X	X	NNP
50458	856	15	,	,	,
50458	856	16	p.	p.	NN
50458	856	17	333	333	CD
50458	856	18	;	;	:
50458	856	19	MARTIN	MARTIN	NNP
50458	856	20	,	,	,
50458	856	21	_	_	NNP
50458	856	22	Ibid	Ibid	NNP
50458	856	23	.	.	.
50458	856	24	_	_	NNP
50458	856	25	,	,	,
50458	856	26	XII	XII	NNP
50458	856	27	,	,	,
50458	856	28	p.	p.	NN
50458	856	29	26	26	CD
50458	856	30	;	;	:
50458	856	31	SPRONK	SPRONK	NNP
50458	856	32	,	,	,
50458	856	33	_	_	NNP
50458	856	34	Ibid	Ibid	NNP
50458	856	35	.	.	.
50458	856	36	_	_	NNP
50458	856	37	,	,	,
50458	856	38	XII	XII	NNP
50458	856	39	,	,	,
50458	856	40	p.	p.	NN
50458	856	41	711	711	CD
50458	856	42	.	.	.
50458	857	1	The	the	DT
50458	857	2	toxic	toxic	JJ
50458	857	3	liquid	liquid	NN
50458	857	4	obtained	obtain	VBN
50458	857	5	is	be	VBZ
50458	857	6	exceedingly	exceedingly	RB
50458	857	7	powerful	powerful	JJ
50458	857	8	:	:	:
50458	857	9	0.1	0.1	CD
50458	857	10	Cc	Cc	NNP
50458	857	11	.	.	.
50458	858	1	kills	kill	VBZ
50458	858	2	a	a	DT
50458	858	3	rabbit	rabbit	NN
50458	858	4	in	in	IN
50458	858	5	forty	forty	CD
50458	858	6	-	-	HYPH
50458	858	7	eight	eight	CD
50458	858	8	hours	hour	NNS
50458	858	9	.	.	.
50458	859	1	This	this	DT
50458	859	2	toxin	toxin	NN
50458	859	3	is	be	VBZ
50458	859	4	very	very	RB
50458	859	5	sensitive	sensitive	JJ
50458	859	6	to	to	IN
50458	859	7	the	the	DT
50458	859	8	effects	effect	NNS
50458	859	9	of	of	IN
50458	859	10	heat	heat	NN
50458	859	11	.	.	.
50458	860	1	When	when	WRB
50458	860	2	heated	heat	VBN
50458	860	3	to	to	IN
50458	860	4	65	65	CD
50458	860	5	°	°	,
50458	860	6	C.	C.	NNP
50458	860	7	it	-PRON-	PRP
50458	860	8	loses	lose	VBZ
50458	860	9	almost	almost	RB
50458	860	10	all	all	DT
50458	860	11	its	-PRON-	PRP$
50458	860	12	toxicity	toxicity	NN
50458	860	13	;	;	:
50458	860	14	at	at	IN
50458	860	15	70º	70º	CD
50458	860	16	C.	C.	NNP
50458	860	17	it	-PRON-	PRP
50458	860	18	becomes	become	VBZ
50458	860	19	innocuous	innocuous	JJ
50458	860	20	;	;	:
50458	860	21	and	and	CC
50458	860	22	it	-PRON-	PRP
50458	860	23	only	only	RB
50458	860	24	requires	require	VBZ
50458	860	25	to	to	TO
50458	860	26	be	be	VB
50458	860	27	heated	heat	VBN
50458	860	28	to	to	IN
50458	860	29	100	100	CD
50458	860	30	°	°	NNS
50458	860	31	C.	C.	NNP
50458	860	32	for	for	IN
50458	860	33	fifteen	fifteen	CD
50458	860	34	minutes	minute	NNS
50458	860	35	in	in	IN
50458	860	36	order	order	NN
50458	860	37	to	to	TO
50458	860	38	lose	lose	VB
50458	860	39	all	all	DT
50458	860	40	immediate	immediate	JJ
50458	860	41	activity	activity	NN
50458	860	42	even	even	RB
50458	860	43	in	in	IN
50458	860	44	large	large	JJ
50458	860	45	doses	dose	NNS
50458	860	46	.	.	.
50458	861	1	Nevertheless	nevertheless	RB
50458	861	2	toxins	toxin	NNS
50458	861	3	thus	thus	RB
50458	861	4	weakened	weaken	VBN
50458	861	5	are	be	VBP
50458	861	6	capable	capable	JJ
50458	861	7	of	of	IN
50458	861	8	proving	prove	VBG
50458	861	9	fatal	fatal	JJ
50458	861	10	to	to	IN
50458	861	11	an	an	DT
50458	861	12	animal	animal	NN
50458	861	13	even	even	RB
50458	861	14	after	after	IN
50458	861	15	five	five	CD
50458	861	16	or	or	CC
50458	861	17	six	six	CD
50458	861	18	months	month	NNS
50458	861	19	.	.	.
50458	862	1	Light	light	NN
50458	862	2	,	,	,
50458	862	3	oxygen	oxygen	NN
50458	862	4	,	,	,
50458	862	5	ozone	ozone	NN
50458	862	6	and	and	CC
50458	862	7	all	all	DT
50458	862	8	oxidizers	oxidizer	NNS
50458	862	9	destroy	destroy	VBP
50458	862	10	the	the	DT
50458	862	11	active	active	JJ
50458	862	12	principle	principle	NN
50458	862	13	of	of	IN
50458	862	14	the	the	DT
50458	862	15	diphtheria	diphtheria	NN
50458	862	16	toxin	toxin	NN
50458	862	17	,	,	,
50458	862	18	which	which	WDT
50458	862	19	is	be	VBZ
50458	862	20	,	,	,
50458	862	21	moreover	moreover	RB
50458	862	22	,	,	,
50458	862	23	rendered	render	VBN
50458	862	24	almost	almost	RB
50458	862	25	inactive	inactive	JJ
50458	862	26	by	by	IN
50458	862	27	organic	organic	JJ
50458	862	28	acids	acid	NNS
50458	862	29	.	.	.
50458	863	1	This	this	DT
50458	863	2	toxin	toxin	NN
50458	863	3	is	be	VBZ
50458	863	4	capable	capable	JJ
50458	863	5	of	of	IN
50458	863	6	diffusing	diffuse	VBG
50458	863	7	through	through	IN
50458	863	8	animal	animal	NN
50458	863	9	membranes	membrane	NNS
50458	863	10	,	,	,
50458	863	11	a	a	DT
50458	863	12	fact	fact	NN
50458	863	13	that	that	WDT
50458	863	14	is	be	VBZ
50458	863	15	in	in	IN
50458	863	16	agreement	agreement	NN
50458	863	17	with	with	IN
50458	863	18	the	the	DT
50458	863	19	toxic	toxic	JJ
50458	863	20	effect	effect	NN
50458	863	21	seen	see	VBN
50458	863	22	in	in	IN
50458	863	23	a	a	DT
50458	863	24	subject	subject	NN
50458	863	25	attacked	attack	VBN
50458	863	26	with	with	IN
50458	863	27	diphtheria	diphtheria	NN
50458	863	28	,	,	,
50458	863	29	and	and	CC
50458	863	30	due	due	IN
50458	863	31	to	to	IN
50458	863	32	the	the	DT
50458	863	33	toxin	toxin	NN
50458	863	34	passing	pass	VBG
50458	863	35	through	through	IN
50458	863	36	the	the	DT
50458	863	37	mucosa	mucosa	NNS
50458	863	38	.	.	.
50458	864	1	In	in	IN
50458	864	2	spite	spite	NN
50458	864	3	of	of	IN
50458	864	4	this	this	DT
50458	864	5	property	property	NN
50458	864	6	,	,	,
50458	864	7	however	however	RB
50458	864	8	,	,	,
50458	864	9	the	the	DT
50458	864	10	diphtheritic	diphtheritic	JJ
50458	864	11	poison	poison	NN
50458	864	12	may	may	MD
50458	864	13	be	be	VB
50458	864	14	taken	take	VBN
50458	864	15	into	into	IN
50458	864	16	the	the	DT
50458	864	17	stomach	stomach	NN
50458	864	18	without	without	IN
50458	864	19	any	any	DT
50458	864	20	pernicious	pernicious	JJ
50458	864	21	results	result	NNS
50458	864	22	.	.	.
50458	865	1	Roux	Roux	NNP
50458	865	2	and	and	CC
50458	865	3	Yersin	Yersin	NNP
50458	865	4	have	have	VBP
50458	865	5	shown	show	VBN
50458	865	6	that	that	IN
50458	865	7	,	,	,
50458	865	8	like	like	IN
50458	865	9	all	all	PDT
50458	865	10	the	the	DT
50458	865	11	diastases	diastasis	NNS
50458	865	12	,	,	,
50458	865	13	it	-PRON-	PRP
50458	865	14	may	may	MD
50458	865	15	be	be	VB
50458	865	16	precipitated	precipitate	VBN
50458	865	17	from	from	IN
50458	865	18	its	-PRON-	PRP$
50458	865	19	solutions	solution	NNS
50458	865	20	by	by	IN
50458	865	21	the	the	DT
50458	865	22	development	development	NN
50458	865	23	,	,	,
50458	865	24	within	within	IN
50458	865	25	these	these	DT
50458	865	26	,	,	,
50458	865	27	of	of	IN
50458	865	28	certain	certain	JJ
50458	865	29	precipitates	precipitate	NNS
50458	865	30	,	,	,
50458	865	31	particularly	particularly	RB
50458	865	32	calcium	calcium	NN
50458	865	33	phosphate	phosphate	NN
50458	865	34	.	.	.
50458	866	1	It	-PRON-	PRP
50458	866	2	is	be	VBZ
50458	866	3	precipitated	precipitate	VBN
50458	866	4	from	from	IN
50458	866	5	its	-PRON-	PRP$
50458	866	6	solutions	solution	NNS
50458	866	7	by	by	IN
50458	866	8	alcohol	alcohol	NN
50458	866	9	,	,	,
50458	866	10	as	as	IN
50458	866	11	has	have	VBZ
50458	866	12	been	be	VBN
50458	866	13	observed	observe	VBN
50458	866	14	also	also	RB
50458	866	15	in	in	IN
50458	866	16	the	the	DT
50458	866	17	case	case	NN
50458	866	18	of	of	IN
50458	866	19	diastatic	diastatic	JJ
50458	866	20	solutions	solution	NNS
50458	866	21	.	.	.
50458	867	1	All	all	PDT
50458	867	2	the	the	DT
50458	867	3	toxic	toxic	JJ
50458	867	4	substance	substance	NN
50458	867	5	is	be	VBZ
50458	867	6	contained	contain	VBN
50458	867	7	in	in	IN
50458	867	8	the	the	DT
50458	867	9	albuminous	albuminous	JJ
50458	867	10	precipitate	precipitate	NN
50458	867	11	thus	thus	RB
50458	867	12	obtained	obtain	VBN
50458	867	13	;	;	:
50458	867	14	but	but	CC
50458	867	15	the	the	DT
50458	867	16	prolonged	prolonged	JJ
50458	867	17	action	action	NN
50458	867	18	of	of	IN
50458	867	19	alcohol	alcohol	NN
50458	867	20	,	,	,
50458	867	21	or	or	CC
50458	867	22	repeated	repeat	VBN
50458	867	23	successive	successive	JJ
50458	867	24	precipitations	precipitation	NNS
50458	867	25	,	,	,
50458	867	26	alter	alter	VB
50458	867	27	it	-PRON-	PRP
50458	867	28	finally	finally	RB
50458	867	29	.	.	.
50458	868	1	Diphtheria	diphtheria	NN
50458	868	2	toxin	toxin	NN
50458	868	3	is	be	VBZ
50458	868	4	likewise	likewise	RB
50458	868	5	precipitated	precipitate	VBN
50458	868	6	by	by	IN
50458	868	7	the	the	DT
50458	868	8	reagents	reagent	NNS
50458	868	9	for	for	IN
50458	868	10	albumoses	albumose	NNS
50458	868	11	,	,	,
50458	868	12	particularly	particularly	RB
50458	868	13	sodium	sodium	NN
50458	868	14	sulphate	sulphate	NN
50458	868	15	in	in	IN
50458	868	16	saturated	saturate	VBN
50458	868	17	solution	solution	NN
50458	868	18	.	.	.
50458	869	1	This	this	DT
50458	869	2	procedure	procedure	NN
50458	869	3	has	have	VBZ
50458	869	4	been	be	VBN
50458	869	5	utilized	utilize	VBN
50458	869	6	by	by	IN
50458	869	7	Brieger	Brieger	NNP
50458	869	8	and	and	CC
50458	869	9	Fraenkel	Fraenkel	NNP
50458	869	10	for	for	IN
50458	869	11	preparing	prepare	VBG
50458	869	12	the	the	DT
50458	869	13	pure	pure	JJ
50458	869	14	toxin	toxin	NN
50458	869	15	,	,	,
50458	869	16	which	which	WDT
50458	869	17	they	-PRON-	PRP
50458	869	18	obtained	obtain	VBD
50458	869	19	in	in	IN
50458	869	20	the	the	DT
50458	869	21	form	form	NN
50458	869	22	of	of	IN
50458	869	23	very	very	RB
50458	869	24	light	light	JJ
50458	869	25	,	,	,
50458	869	26	brilliant	brilliant	JJ
50458	869	27	white	white	JJ
50458	869	28	,	,	,
50458	869	29	amorphous	amorphous	JJ
50458	869	30	flocks	flock	NNS
50458	869	31	,	,	,
50458	869	32	affording	afford	VBG
50458	869	33	all	all	PDT
50458	869	34	the	the	DT
50458	869	35	principal	principal	JJ
50458	869	36	reactions	reaction	NNS
50458	869	37	of	of	IN
50458	869	38	the	the	DT
50458	869	39	soluble	soluble	JJ
50458	869	40	albumoses	albumose	NNS
50458	869	41	(	(	-LRB-
50458	869	42	biuret	biuret	NN
50458	869	43	,	,	,
50458	869	44	xanthoproteic	xanthoproteic	NNP
50458	869	45	,	,	,
50458	869	46	Millon	Millon	NNP
50458	869	47	's	's	POS
50458	869	48	)	)	-RRB-
50458	869	49	,	,	,
50458	869	50	and	and	CC
50458	869	51	which	which	WDT
50458	869	52	they	-PRON-	PRP
50458	869	53	characterized	characterize	VBD
50458	869	54	as	as	IN
50458	869	55	a	a	DT
50458	869	56	toxalbumin	toxalbumin	NN
50458	869	57	.	.	.
50458	870	1	On	on	IN
50458	870	2	injecting	inject	VBG
50458	870	3	into	into	IN
50458	870	4	healthy	healthy	JJ
50458	870	5	animals	animal	NNS
50458	870	6	this	this	DT
50458	870	7	diphtheria	diphtheria	NN
50458	870	8	toxin	toxin	NN
50458	870	9	attenuated	attenuate	VBN
50458	870	10	by	by	IN
50458	870	11	sufficiently	sufficiently	RB
50458	870	12	heating	heat	VBG
50458	870	13	at	at	IN
50458	870	14	70	70	CD
50458	870	15	°	°	,
50458	870	16	C	C	NNP
50458	870	17	,	,	,
50458	870	18	employing	employ	VBG
50458	870	19	at	at	IN
50458	870	20	first	first	JJ
50458	870	21	small	small	JJ
50458	870	22	doses	dose	NNS
50458	870	23	,	,	,
50458	870	24	and	and	CC
50458	870	25	gradually	gradually	RB
50458	870	26	increasing	increase	VBG
50458	870	27	,	,	,
50458	870	28	it	-PRON-	PRP
50458	870	29	is	be	VBZ
50458	870	30	possible	possible	JJ
50458	870	31	to	to	TO
50458	870	32	immunize	immunize	VB
50458	870	33	them	-PRON-	PRP
50458	870	34	against	against	IN
50458	870	35	diphtheria	diphtheria	NN
50458	870	36	,	,	,
50458	870	37	as	as	IN
50458	870	38	was	be	VBD
50458	870	39	first	first	RB
50458	870	40	demonstrated	demonstrate	VBN
50458	870	41	by	by	IN
50458	870	42	Carl	Carl	NNP
50458	870	43	Fraenkel	Fraenkel	NNP
50458	870	44	.	.	.
50458	871	1	Roux	Roux	NNP
50458	871	2	and	and	CC
50458	871	3	Martin	Martin	NNP
50458	871	4	,	,	,
50458	871	5	who	who	WP
50458	871	6	have	have	VBP
50458	871	7	specially	specially	RB
50458	871	8	studied	study	VBN
50458	871	9	this	this	DT
50458	871	10	procedure,[112	procedure,[112	NN
50458	871	11	]	]	-RRB-
50458	871	12	have	have	VBP
50458	871	13	shown	show	VBN
50458	871	14	that	that	IN
50458	871	15	a	a	DT
50458	871	16	horse	horse	NN
50458	871	17	may	may	MD
50458	871	18	be	be	VB
50458	871	19	easily	easily	RB
50458	871	20	immunized	immunize	VBN
50458	871	21	by	by	IN
50458	871	22	injecting	inject	VBG
50458	871	23	into	into	IN
50458	871	24	the	the	DT
50458	871	25	animal	animal	NN
50458	871	26	the	the	DT
50458	871	27	toxin	toxin	NN
50458	871	28	diluted	dilute	VBN
50458	871	29	with	with	IN
50458	871	30	a	a	DT
50458	871	31	third	third	NN
50458	871	32	of	of	IN
50458	871	33	its	-PRON-	PRP$
50458	871	34	volume	volume	NN
50458	871	35	of	of	IN
50458	871	36	Gram	Gram	NNP
50458	871	37	's	's	POS
50458	871	38	iodine	iodine	NN
50458	871	39	solution	solution	NN
50458	871	40	,	,	,
50458	871	41	and	and	CC
50458	871	42	in	in	IN
50458	871	43	successively	successively	RB
50458	871	44	increasing	increase	VBG
50458	871	45	doses	dose	NNS
50458	871	46	.	.	.
50458	872	1	The	the	DT
50458	872	2	initial	initial	JJ
50458	872	3	dose	dose	NN
50458	872	4	is	be	VBZ
50458	872	5	0.25	0.25	CD
50458	872	6	Cc	Cc	NNP
50458	872	7	.	.	.
50458	873	1	;	;	:
50458	873	2	then	then	RB
50458	873	3	,	,	,
50458	873	4	after	after	IN
50458	873	5	two	two	CD
50458	873	6	days	day	NNS
50458	873	7	,	,	,
50458	873	8	0.5	0.5	CD
50458	873	9	Cc	Cc	NNP
50458	873	10	.	.	.
50458	874	1	of	of	IN
50458	874	2	the	the	DT
50458	874	3	same	same	JJ
50458	874	4	toxin	toxin	NN
50458	874	5	is	be	VBZ
50458	874	6	injected	inject	VBN
50458	874	7	,	,	,
50458	874	8	and	and	CC
50458	874	9	in	in	IN
50458	874	10	like	like	NNP
50458	874	11	manner	manner	NN
50458	874	12	the	the	DT
50458	874	13	dose	dose	NN
50458	874	14	is	be	VBZ
50458	874	15	increased	increase	VBN
50458	874	16	up	up	IN
50458	874	17	to	to	IN
50458	874	18	the	the	DT
50458	874	19	eighteenth	eighteenth	JJ
50458	874	20	day	day	NN
50458	874	21	,	,	,
50458	874	22	when	when	WRB
50458	874	23	the	the	DT
50458	874	24	pure	pure	JJ
50458	874	25	toxin	toxin	NN
50458	874	26	is	be	VBZ
50458	874	27	injected	inject	VBN
50458	874	28	,	,	,
50458	874	29	at	at	IN
50458	874	30	first	first	RB
50458	874	31	in	in	IN
50458	874	32	small	small	JJ
50458	874	33	doses	dose	NNS
50458	874	34	,	,	,
50458	874	35	which	which	WDT
50458	874	36	are	be	VBP
50458	874	37	gradually	gradually	RB
50458	874	38	increased	increase	VBN
50458	874	39	so	so	IN
50458	874	40	that	that	IN
50458	874	41	at	at	IN
50458	874	42	the	the	DT
50458	874	43	end	end	NN
50458	874	44	of	of	IN
50458	874	45	two	two	CD
50458	874	46	or	or	CC
50458	874	47	three	three	CD
50458	874	48	months	month	NNS
50458	874	49	injections	injection	NNS
50458	874	50	of	of	IN
50458	874	51	80	80	CD
50458	874	52	Cc	Cc	NNP
50458	874	53	.	.	.
50458	875	1	of	of	IN
50458	875	2	the	the	DT
50458	875	3	pure	pure	JJ
50458	875	4	toxin	toxin	NN
50458	875	5	may	may	MD
50458	875	6	be	be	VB
50458	875	7	given	give	VBN
50458	875	8	without	without	IN
50458	875	9	danger	danger	NN
50458	875	10	;	;	:
50458	875	11	the	the	DT
50458	875	12	animal	animal	NN
50458	875	13	is	be	VBZ
50458	875	14	then	then	RB
50458	875	15	completely	completely	RB
50458	875	16	immunized	immunized	JJ
50458	875	17	.	.	.
50458	876	1	[	[	-LRB-
50458	876	2	112	112	CD
50458	876	3	]	]	-RRB-
50458	876	4	Contribution	Contribution	NNP
50458	876	5	à	à	NNP
50458	876	6	l'Étude	l'Étude	NNP
50458	876	7	de	de	NNP
50458	876	8	la	la	NNP
50458	876	9	Diphtérie	Diphtérie	NNP
50458	876	10	.	.	.
50458	877	1	_	_	NNP
50458	877	2	Annal	Annal	NNP
50458	877	3	.	.	.
50458	878	1	de	de	NNP
50458	878	2	l'Instit	l'Instit	NNP
50458	878	3	.	.	.
50458	879	1	Pasteur	Pasteur	NNP
50458	879	2	_	_	NNP
50458	879	3	,	,	,
50458	879	4	VIII	VIII	NNP
50458	879	5	,	,	,
50458	879	6	p.	p.	NN
50458	879	7	609	609	CD
50458	879	8	;	;	:
50458	879	9	_	_	NNP
50458	879	10	Ibid	Ibid	NNP
50458	879	11	.	.	.
50458	879	12	_	_	NNP
50458	879	13	,	,	,
50458	879	14	p.	p.	NN
50458	879	15	640	640	CD
50458	879	16	.	.	.
50458	880	1	The	the	DT
50458	880	2	serum	serum	NN
50458	880	3	of	of	IN
50458	880	4	an	an	DT
50458	880	5	animal	animal	NN
50458	880	6	rendered	render	VBN
50458	880	7	immune	immune	JJ
50458	880	8	in	in	IN
50458	880	9	this	this	DT
50458	880	10	manner	manner	NN
50458	880	11	contains	contain	VBZ
50458	880	12	a	a	DT
50458	880	13	diphtheria	diphtheria	NN
50458	880	14	antitoxin	antitoxin	NN
50458	880	15	which	which	WDT
50458	880	16	possesses	possess	VBZ
50458	880	17	high	high	JJ
50458	880	18	power	power	NN
50458	880	19	.	.	.
50458	881	1	A	a	DT
50458	881	2	guinea	guinea	NN
50458	881	3	-	-	HYPH
50458	881	4	pig	pig	NN
50458	881	5	which	which	WDT
50458	881	6	has	have	VBZ
50458	881	7	received	receive	VBN
50458	881	8	an	an	DT
50458	881	9	injection	injection	NN
50458	881	10	of	of	IN
50458	881	11	0.01	0.01	CD
50458	881	12	Cc	Cc	NNP
50458	881	13	.	.	.
50458	882	1	of	of	IN
50458	882	2	the	the	DT
50458	882	3	antitoxin	antitoxin	NN
50458	882	4	is	be	VBZ
50458	882	5	perfectly	perfectly	RB
50458	882	6	capable	capable	JJ
50458	882	7	of	of	IN
50458	882	8	withstanding	withstand	VBG
50458	882	9	a	a	DT
50458	882	10	lethal	lethal	JJ
50458	882	11	dose	dose	NN
50458	882	12	of	of	IN
50458	882	13	0.5	0.5	CD
50458	882	14	Cc	Cc	NNP
50458	882	15	.	.	.
50458	883	1	of	of	IN
50458	883	2	the	the	DT
50458	883	3	toxin	toxin	NN
50458	883	4	.	.	.
50458	884	1	The	the	DT
50458	884	2	antidiphtheria	antidiphtheria	NN
50458	884	3	serum	serum	NN
50458	884	4	thus	thus	RB
50458	884	5	obtained	obtain	VBN
50458	884	6	,	,	,
50458	884	7	and	and	CC
50458	884	8	in	in	IN
50458	884	9	almost	almost	RB
50458	884	10	limitless	limitless	JJ
50458	884	11	quantities	quantity	NNS
50458	884	12	,	,	,
50458	884	13	from	from	IN
50458	884	14	an	an	DT
50458	884	15	immunized	immunized	JJ
50458	884	16	animal	animal	NN
50458	884	17	,	,	,
50458	884	18	is	be	VBZ
50458	884	19	capable	capable	JJ
50458	884	20	of	of	IN
50458	884	21	saturating	saturate	VBG
50458	884	22	the	the	DT
50458	884	23	therapeutic	therapeutic	JJ
50458	884	24	diphtheritic	diphtheritic	JJ
50458	884	25	toxin	toxin	NN
50458	884	26	,	,	,
50458	884	27	and	and	CC
50458	884	28	has	have	VBZ
50458	884	29	to	to	IN
50458	884	30	-	-	HYPH
50458	884	31	day	day	NN
50458	884	32	taken	take	VBN
50458	884	33	rank	rank	NN
50458	884	34	in	in	IN
50458	884	35	therapeutics	therapeutic	NNS
50458	884	36	as	as	IN
50458	884	37	the	the	DT
50458	884	38	most	most	RBS
50458	884	39	efficacious	efficacious	JJ
50458	884	40	remedy	remedy	NN
50458	884	41	in	in	IN
50458	884	42	diphtheria	diphtheria	NN
50458	884	43	.	.	.
50458	885	1	Injected	inject	VBN
50458	885	2	in	in	IN
50458	885	3	varying	vary	VBG
50458	885	4	doses	dose	NNS
50458	885	5	,	,	,
50458	885	6	it	-PRON-	PRP
50458	885	7	confers	confer	VBZ
50458	885	8	a	a	DT
50458	885	9	temporary	temporary	JJ
50458	885	10	but	but	CC
50458	885	11	immediate	immediate	JJ
50458	885	12	immunity	immunity	NN
50458	885	13	.	.	.
50458	886	1	Nevertheless	nevertheless	RB
50458	886	2	antidiphtheria	antidiphtheria	NN
50458	886	3	serum	serum	NN
50458	886	4	must	must	MD
50458	886	5	not	not	RB
50458	886	6	be	be	VB
50458	886	7	considered	consider	VBN
50458	886	8	as	as	IN
50458	886	9	an	an	DT
50458	886	10	antidote	antidote	NN
50458	886	11	;	;	:
50458	886	12	and	and	CC
50458	886	13	in	in	IN
50458	886	14	pathological	pathological	JJ
50458	886	15	diphtheria	diphtheria	NN
50458	886	16	,	,	,
50458	886	17	the	the	DT
50458	886	18	more	more	JJR
50458	886	19	serum	serum	NN
50458	886	20	is	be	VBZ
50458	886	21	required	require	VBN
50458	886	22	the	the	DT
50458	886	23	later	later	JJ
50458	886	24	it	-PRON-	PRP
50458	886	25	is	be	VBZ
50458	886	26	used	use	VBN
50458	886	27	.	.	.
50458	887	1	[	[	-LRB-
50458	887	2	113	113	CD
50458	887	3	]	]	-RRB-
50458	887	4	In	in	IN
50458	887	5	certain	certain	JJ
50458	887	6	cases	case	NNS
50458	887	7	,	,	,
50458	887	8	if	if	IN
50458	887	9	employed	employ	VBN
50458	887	10	too	too	RB
50458	887	11	late	late	RB
50458	887	12	,	,	,
50458	887	13	it	-PRON-	PRP
50458	887	14	may	may	MD
50458	887	15	prove	prove	VB
50458	887	16	ineffective	ineffective	JJ
50458	887	17	.	.	.
50458	888	1	[	[	-LRB-
50458	888	2	113	113	CD
50458	888	3	]	]	-RRB-
50458	888	4	BAYEUX	BAYEUX	NNP
50458	888	5	:	:	:
50458	888	6	_	_	NNP
50458	888	7	Thèse	Thèse	NNP
50458	888	8	de	de	NNP
50458	888	9	Doctorat	Doctorat	NNP
50458	888	10	_	_	NNP
50458	888	11	,	,	,
50458	888	12	Paris	Paris	NNP
50458	888	13	,	,	,
50458	888	14	1899	1899	CD
50458	888	15	.	.	.
50458	889	1	The	the	DT
50458	889	2	preventive	preventive	JJ
50458	889	3	action	action	NN
50458	889	4	of	of	IN
50458	889	5	the	the	DT
50458	889	6	serum	serum	NN
50458	889	7	is	be	VBZ
50458	889	8	remarkable	remarkable	JJ
50458	889	9	.	.	.
50458	890	1	In	in	IN
50458	890	2	10	10	CD
50458	890	3	000	000	CD
50458	890	4	inoculated	inoculate	VBN
50458	890	5	cases	case	NNS
50458	890	6	Behring	behre	VBG
50458	890	7	and	and	CC
50458	890	8	Ehrlich	Ehrlich	NNP
50458	890	9	have	have	VBP
50458	890	10	had	have	VBN
50458	890	11	but	but	CC
50458	890	12	10	10	CD
50458	890	13	cases	case	NNS
50458	890	14	of	of	IN
50458	890	15	diphtheria	diphtheria	NN
50458	890	16	,	,	,
50458	890	17	and	and	CC
50458	890	18	these	these	DT
50458	890	19	were	be	VBD
50458	890	20	,	,	,
50458	890	21	moreover	moreover	RB
50458	890	22	,	,	,
50458	890	23	of	of	IN
50458	890	24	a	a	DT
50458	890	25	benign	benign	JJ
50458	890	26	character	character	NN
50458	890	27	.	.	.
50458	891	1	The	the	DT
50458	891	2	duration	duration	NN
50458	891	3	of	of	IN
50458	891	4	the	the	DT
50458	891	5	immunizing	immunize	VBG
50458	891	6	action	action	NN
50458	891	7	appears	appear	VBZ
50458	891	8	to	to	TO
50458	891	9	be	be	VB
50458	891	10	from	from	IN
50458	891	11	three	three	CD
50458	891	12	weeks	week	NNS
50458	891	13	to	to	IN
50458	891	14	two	two	CD
50458	891	15	months	month	NNS
50458	891	16	.	.	.
50458	892	1	This	this	DT
50458	892	2	diphtheria	diphtheria	NN
50458	892	3	antitoxin	antitoxin	NN
50458	892	4	was	be	VBD
50458	892	5	first	first	RB
50458	892	6	prepared	prepare	VBN
50458	892	7	by	by	IN
50458	892	8	Guérin	Guérin	NNP
50458	892	9	and	and	CC
50458	892	10	Macé[114	macé[114	CD
50458	892	11	]	]	-RRB-
50458	892	12	by	by	IN
50458	892	13	adding	add	VBG
50458	892	14	to	to	IN
50458	892	15	the	the	DT
50458	892	16	antidiphtheria	antidiphtheria	NN
50458	892	17	serum	serum	NN
50458	892	18	a	a	DT
50458	892	19	large	large	JJ
50458	892	20	volume	volume	NN
50458	892	21	of	of	IN
50458	892	22	alcohol	alcohol	NN
50458	892	23	,	,	,
50458	892	24	washing	wash	VBG
50458	892	25	the	the	DT
50458	892	26	precipitate	precipitate	NN
50458	892	27	,	,	,
50458	892	28	and	and	CC
50458	892	29	drying	dry	VBG
50458	892	30	it	-PRON-	PRP
50458	892	31	in	in	IN
50458	892	32	a	a	DT
50458	892	33	vacuum	vacuum	NN
50458	892	34	.	.	.
50458	893	1	It	-PRON-	PRP
50458	893	2	is	be	VBZ
50458	893	3	soluble	soluble	JJ
50458	893	4	in	in	IN
50458	893	5	water	water	NN
50458	893	6	,	,	,
50458	893	7	and	and	CC
50458	893	8	loses	lose	VBZ
50458	893	9	its	-PRON-	PRP$
50458	893	10	activity	activity	NN
50458	893	11	when	when	WRB
50458	893	12	heated	heat	VBN
50458	893	13	to	to	IN
50458	893	14	65	65	CD
50458	893	15	°	°	,
50458	893	16	C.	C.	NNP
50458	893	17	Wassermann[115	Wassermann[115	NNP
50458	893	18	]	]	-RRB-
50458	893	19	has	have	VBZ
50458	893	20	proposed	propose	VBN
50458	893	21	to	to	TO
50458	893	22	extract	extract	VB
50458	893	23	it	-PRON-	PRP
50458	893	24	from	from	IN
50458	893	25	the	the	DT
50458	893	26	milk	milk	NN
50458	893	27	of	of	IN
50458	893	28	immunized	immunized	JJ
50458	893	29	animals	animal	NNS
50458	893	30	,	,	,
50458	893	31	by	by	IN
50458	893	32	first	first	RB
50458	893	33	coagulating	coagulate	VBG
50458	893	34	the	the	DT
50458	893	35	milk	milk	NN
50458	893	36	by	by	IN
50458	893	37	rennet	rennet	NN
50458	893	38	in	in	IN
50458	893	39	the	the	DT
50458	893	40	presence	presence	NN
50458	893	41	of	of	IN
50458	893	42	sodium	sodium	NN
50458	893	43	chloride	chloride	NN
50458	893	44	,	,	,
50458	893	45	filtering	filtering	NN
50458	893	46	,	,	,
50458	893	47	and	and	CC
50458	893	48	removing	remove	VBG
50458	893	49	the	the	DT
50458	893	50	fat	fat	NN
50458	893	51	from	from	IN
50458	893	52	the	the	DT
50458	893	53	clear	clear	JJ
50458	893	54	liquid	liquid	NN
50458	893	55	by	by	IN
50458	893	56	means	mean	NNS
50458	893	57	of	of	IN
50458	893	58	chloroform	chloroform	NN
50458	893	59	.	.	.
50458	894	1	After	after	IN
50458	894	2	decanting	decant	VBG
50458	894	3	,	,	,
50458	894	4	the	the	DT
50458	894	5	clear	clear	JJ
50458	894	6	solution	solution	NN
50458	894	7	obtained	obtain	VBN
50458	894	8	is	be	VBZ
50458	894	9	precipitated	precipitate	VBN
50458	894	10	by	by	IN
50458	894	11	adding	add	VBG
50458	894	12	to	to	IN
50458	894	13	it	-PRON-	PRP
50458	894	14	30	30	CD
50458	894	15	to	to	TO
50458	894	16	33	33	CD
50458	894	17	per	per	NN
50458	894	18	cent	cent	NN
50458	894	19	.	.	.
50458	895	1	of	of	IN
50458	895	2	ammonium	ammonium	NN
50458	895	3	sulphate	sulphate	NN
50458	895	4	.	.	.
50458	896	1	The	the	DT
50458	896	2	precipitate	precipitate	NN
50458	896	3	is	be	VBZ
50458	896	4	dried	dry	VBN
50458	896	5	in	in	IN
50458	896	6	a	a	DT
50458	896	7	vacuum	vacuum	NN
50458	896	8	on	on	IN
50458	896	9	a	a	DT
50458	896	10	polished	polished	JJ
50458	896	11	porcelain	porcelain	NN
50458	896	12	slab	slab	NN
50458	896	13	after	after	IN
50458	896	14	having	have	VBG
50458	896	15	first	first	RB
50458	896	16	been	be	VBN
50458	896	17	strongly	strongly	RB
50458	896	18	expressed	express	VBN
50458	896	19	.	.	.
50458	897	1	It	-PRON-	PRP
50458	897	2	is	be	VBZ
50458	897	3	then	then	RB
50458	897	4	dissolved	dissolve	VBN
50458	897	5	in	in	IN
50458	897	6	water	water	NN
50458	897	7	.	.	.
50458	898	1	[	[	-LRB-
50458	898	2	116	116	CD
50458	898	3	]	]	-RRB-
50458	898	4	[	[	-LRB-
50458	898	5	114	114	CD
50458	898	6	]	]	-RRB-
50458	898	7	_	_	NNP
50458	898	8	Compt	Compt	NNP
50458	898	9	.	.	.
50458	899	1	rend	rend	VB
50458	899	2	.	.	.
50458	900	1	de	de	NNP
50458	900	2	l'Acad	l'Acad	NNP
50458	900	3	.	.	.
50458	901	1	des	des	NNP
50458	901	2	Sc	Sc	NNP
50458	901	3	.	.	.
50458	901	4	_	_	NNP
50458	901	5	,	,	,
50458	901	6	Apr.	April	NNP
50458	902	1	5	5	CD
50458	902	2	,	,	,
50458	902	3	1895	1895	CD
50458	902	4	.	.	.
50458	903	1	[	[	-LRB-
50458	903	2	115	115	CD
50458	903	3	]	]	-RRB-
50458	903	4	_	_	NNP
50458	903	5	Zeitschr	Zeitschr	NNP
50458	903	6	.	.	.
50458	904	1	für	für	NNP
50458	904	2	Hygiene	Hygiene	NNP
50458	904	3	_	_	NNP
50458	904	4	,	,	,
50458	904	5	XVIII	XVIII	NNP
50458	904	6	,	,	,
50458	904	7	p.	p.	NN
50458	904	8	235	235	CD
50458	904	9	.	.	.
50458	905	1	[	[	-LRB-
50458	905	2	116	116	CD
50458	905	3	]	]	-RRB-
50458	905	4	ROUX	ROUX	NNS
50458	905	5	and	and	CC
50458	905	6	MARTIN	MARTIN	NNP
50458	905	7	:	:	:
50458	905	8	Contribution	Contribution	NNP
50458	905	9	à	à	NNP
50458	905	10	l'Étude	l'Étude	NNP
50458	905	11	de	de	NNP
50458	905	12	la	la	NNP
50458	905	13	Diphtérie	Diphtérie	NNP
50458	905	14	.	.	.
50458	906	1	_	_	NNP
50458	906	2	Annal	Annal	NNP
50458	906	3	.	.	.
50458	907	1	de	de	NNP
50458	907	2	l'Instit	l'Instit	NNP
50458	907	3	.	.	.
50458	908	1	Pasteur	Pasteur	NNP
50458	908	2	_	_	NNP
50458	908	3	,	,	,
50458	908	4	VIII	VIII	NNP
50458	908	5	,	,	,
50458	908	6	p.	p.	NN
50458	908	7	512	512	CD
50458	908	8	.	.	.
50458	909	1	=	=	NFP
50458	909	2	Tetanus	tetanus	NN
50458	909	3	Toxin.=--The	Toxin.=--The	NNP
50458	909	4	fact	fact	NN
50458	909	5	that	that	IN
50458	909	6	the	the	DT
50458	909	7	tetanus	tetanus	JJ
50458	909	8	bacillus	bacillus	NN
50458	909	9	never	never	RB
50458	909	10	penetrates	penetrate	VBZ
50458	909	11	to	to	IN
50458	909	12	the	the	DT
50458	909	13	interior	interior	NN
50458	909	14	of	of	IN
50458	909	15	the	the	DT
50458	909	16	organism	organism	NN
50458	909	17	enabled	enable	VBD
50458	909	18	us	-PRON-	PRP
50458	909	19	long	long	RB
50458	909	20	ago	ago	RB
50458	909	21	to	to	TO
50458	909	22	foretell	foretell	VB
50458	909	23	that	that	IN
50458	909	24	it	-PRON-	PRP
50458	909	25	secretes	secrete	VBZ
50458	909	26	a	a	DT
50458	909	27	very	very	RB
50458	909	28	powerful	powerful	JJ
50458	909	29	toxin	toxin	NN
50458	909	30	capable	capable	JJ
50458	909	31	of	of	IN
50458	909	32	dialyzing	dialyze	VBG
50458	909	33	and	and	CC
50458	909	34	diffusing	diffuse	VBG
50458	909	35	through	through	IN
50458	909	36	the	the	DT
50458	909	37	economy	economy	NN
50458	909	38	.	.	.
50458	910	1	Kuno	Kuno	NNP
50458	910	2	Faber	Faber	NNP
50458	910	3	was	be	VBD
50458	910	4	the	the	DT
50458	910	5	first	first	JJ
50458	910	6	to	to	TO
50458	910	7	fully	fully	RB
50458	910	8	recognize	recognize	VB
50458	910	9	the	the	DT
50458	910	10	fact	fact	NN
50458	910	11	that	that	IN
50458	910	12	the	the	DT
50458	910	13	culture	culture	NN
50458	910	14	bouillon	bouillon	NN
50458	910	15	of	of	IN
50458	910	16	this	this	DT
50458	910	17	bacillus	bacillus	NN
50458	910	18	,	,	,
50458	910	19	fully	fully	RB
50458	910	20	sterilized	sterilize	VBN
50458	910	21	by	by	IN
50458	910	22	filtration	filtration	NN
50458	910	23	through	through	IN
50458	910	24	porcelain	porcelain	NN
50458	910	25	,	,	,
50458	910	26	possesses	possess	VBZ
50458	910	27	an	an	DT
50458	910	28	exceedingly	exceedingly	RB
50458	910	29	high	high	JJ
50458	910	30	toxicity	toxicity	NN
50458	910	31	,	,	,
50458	910	32	and	and	CC
50458	910	33	exerts	exert	VBZ
50458	910	34	a	a	DT
50458	910	35	toxic	toxic	JJ
50458	910	36	effect	effect	NN
50458	910	37	on	on	IN
50458	910	38	50	50	CD
50458	910	39	000	000	CD
50458	910	40	000	000	CD
50458	910	41	times	time	NNS
50458	910	42	its	-PRON-	PRP$
50458	910	43	own	own	JJ
50458	910	44	weight	weight	NN
50458	910	45	of	of	IN
50458	910	46	living	living	NN
50458	910	47	organism	organism	NN
50458	910	48	.	.	.
50458	911	1	Brieger	Brieger	NNP
50458	911	2	had	have	VBD
50458	911	3	previously	previously	RB
50458	911	4	,	,	,
50458	911	5	however	however	RB
50458	911	6	,	,	,
50458	911	7	extracted	extract	VBD
50458	911	8	three	three	CD
50458	911	9	ptomaines	ptomaine	NNS
50458	911	10	from	from	IN
50458	911	11	the	the	DT
50458	911	12	cultures	culture	NNS
50458	911	13	of	of	IN
50458	911	14	the	the	DT
50458	911	15	bacillus--_tetanin	bacillus--_tetanin	NNP
50458	911	16	_	_	NNP
50458	911	17	,	,	,
50458	911	18	_	_	NNP
50458	911	19	tetanotoxin	tetanotoxin	NN
50458	911	20	_	_	NNP
50458	911	21	,	,	,
50458	911	22	and	and	CC
50458	911	23	_	_	NNP
50458	911	24	spasmotoxin	spasmotoxin	NN
50458	911	25	_	_	NNP
50458	911	26	.	.	.
50458	912	1	[	[	-LRB-
50458	912	2	117	117	CD
50458	912	3	]	]	-RRB-
50458	912	4	In	in	IN
50458	912	5	order	order	NN
50458	912	6	to	to	TO
50458	912	7	obtain	obtain	VB
50458	912	8	a	a	DT
50458	912	9	highly	highly	RB
50458	912	10	active	active	JJ
50458	912	11	liquid	liquid	NN
50458	912	12	,	,	,
50458	912	13	the	the	DT
50458	912	14	same	same	JJ
50458	912	15	culture	culture	NN
50458	912	16	medium	medium	NN
50458	912	17	is	be	VBZ
50458	912	18	inoculated	inoculate	VBN
50458	912	19	several	several	JJ
50458	912	20	times	time	NNS
50458	912	21	in	in	IN
50458	912	22	succession	succession	NN
50458	912	23	,	,	,
50458	912	24	but	but	CC
50458	912	25	filtering	filter	VBG
50458	912	26	each	each	DT
50458	912	27	time	time	NN
50458	912	28	before	before	IN
50458	912	29	the	the	DT
50458	912	30	new	new	JJ
50458	912	31	inoculation	inoculation	NN
50458	912	32	;	;	:
50458	912	33	the	the	DT
50458	912	34	microbes	microbe	NNS
50458	912	35	greatly	greatly	RB
50458	912	36	increase	increase	VBP
50458	912	37	in	in	IN
50458	912	38	number	number	NN
50458	912	39	after	after	IN
50458	912	40	each	each	DT
50458	912	41	fresh	fresh	JJ
50458	912	42	inoculation	inoculation	NN
50458	912	43	,	,	,
50458	912	44	and	and	CC
50458	912	45	the	the	DT
50458	912	46	toxic	toxic	JJ
50458	912	47	substance	substance	NN
50458	912	48	developed	develop	VBN
50458	912	49	by	by	IN
50458	912	50	them	-PRON-	PRP
50458	912	51	accumulates	accumulate	NNS
50458	912	52	.	.	.
50458	913	1	[	[	-LRB-
50458	913	2	118	118	CD
50458	913	3	]	]	-RRB-
50458	913	4	[	[	-LRB-
50458	913	5	117	117	CD
50458	913	6	]	]	-RRB-
50458	913	7	Die	die	VB
50458	913	8	Pathogenese	pathogenese	JJ
50458	913	9	des	des	NN
50458	913	10	Tetanus	Tetanus	NNP
50458	913	11	.	.	.
50458	914	1	_	_	NNP
50458	914	2	Berlin	Berlin	NNP
50458	914	3	.	.	.
50458	915	1	Klin	Klin	NNP
50458	915	2	.	.	.
50458	916	1	Wochenschr	Wochenschr	NNP
50458	916	2	.	.	.
50458	916	3	_	_	NNP
50458	916	4	,	,	,
50458	916	5	1890	1890	CD
50458	916	6	,	,	,
50458	916	7	No	no	UH
50458	916	8	.	.	.
50458	917	1	31	31	CD
50458	917	2	.	.	.
50458	918	1	[	[	-LRB-
50458	918	2	118	118	CD
50458	918	3	]	]	-RRB-
50458	918	4	NAILLARD	NAILLARD	NNP
50458	918	5	:	:	:
50458	918	6	_	_	NNP
50458	918	7	Compt	Compt	NNP
50458	918	8	.	.	.
50458	919	1	rend	rend	VB
50458	919	2	.	.	.
50458	920	1	de	de	NNP
50458	920	2	l'Acad	l'Acad	NNP
50458	920	3	.	.	.
50458	921	1	des	des	NNP
50458	921	2	Sciences	Sciences	NNPS
50458	921	3	_	_	NNP
50458	921	4	,	,	,
50458	921	5	CXX	CXX	NNP
50458	921	6	,	,	,
50458	921	7	p.	p.	NN
50458	921	8	1181	1181	CD
50458	921	9	.	.	.
50458	922	1	Experiment	experiment	NN
50458	922	2	has	have	VBZ
50458	922	3	shown	show	VBN
50458	922	4	that	that	IN
50458	922	5	the	the	DT
50458	922	6	culture	culture	NN
50458	922	7	bouillon	bouillon	NN
50458	922	8	thus	thus	RB
50458	922	9	obtained	obtain	VBD
50458	922	10	contains	contain	VBZ
50458	922	11	two	two	CD
50458	922	12	kinds	kind	NNS
50458	922	13	of	of	IN
50458	922	14	toxic	toxic	JJ
50458	922	15	substances[119]--highly	substances[119]--highly	NNP
50458	922	16	toxic	toxic	JJ
50458	922	17	alkaloidal	alkaloidal	NN
50458	922	18	bases	basis	NNS
50458	922	19	(	(	-LRB-
50458	922	20	ptomaines	ptomaine	NNS
50458	922	21	,	,	,
50458	922	22	tetanin	tetanin	NNS
50458	922	23	,	,	,
50458	922	24	tetanotoxin	tetanotoxin	NN
50458	922	25	,	,	,
50458	922	26	etc	etc	FW
50458	922	27	.	.	.
50458	923	1	)	)	-RRB-
50458	923	2	,	,	,
50458	923	3	and	and	CC
50458	923	4	a	a	DT
50458	923	5	true	true	JJ
50458	923	6	toxin	toxin	NN
50458	923	7	,	,	,
50458	923	8	possessing	possess	VBG
50458	923	9	diastatic	diastatic	JJ
50458	923	10	properties	property	NNS
50458	923	11	,	,	,
50458	923	12	and	and	CC
50458	923	13	of	of	IN
50458	923	14	almost	almost	RB
50458	923	15	incredible	incredible	JJ
50458	923	16	toxic	toxic	JJ
50458	923	17	power	power	NN
50458	923	18	.	.	.
50458	924	1	[	[	-LRB-
50458	924	2	119	119	CD
50458	924	3	]	]	-RRB-
50458	924	4	_	_	NNP
50458	924	5	Annal	Annal	NNP
50458	924	6	.	.	.
50458	925	1	Instit	Instit	NNP
50458	925	2	.	.	.
50458	926	1	Pasteur	Pasteur	NNP
50458	926	2	_	_	NNP
50458	926	3	,	,	,
50458	926	4	V	V	NNP
50458	926	5	,	,	,
50458	926	6	15	15	CD
50458	926	7	.	.	.
50458	927	1	This	this	DT
50458	927	2	toxin	toxin	NN
50458	927	3	had	have	VBD
50458	927	4	already	already	RB
50458	927	5	been	be	VBN
50458	927	6	isolated	isolate	VBN
50458	927	7	by	by	IN
50458	927	8	Kitasato	Kitasato	NNP
50458	927	9	.	.	.
50458	928	1	It	-PRON-	PRP
50458	928	2	is	be	VBZ
50458	928	3	a	a	DT
50458	928	4	toxalbumin	toxalbumin	NN
50458	928	5	,	,	,
50458	928	6	and	and	CC
50458	928	7	is	be	VBZ
50458	928	8	very	very	RB
50458	928	9	sensitive	sensitive	JJ
50458	928	10	to	to	IN
50458	928	11	the	the	DT
50458	928	12	action	action	NN
50458	928	13	of	of	IN
50458	928	14	heat	heat	NN
50458	928	15	.	.	.
50458	929	1	A	a	DT
50458	929	2	temperature	temperature	NN
50458	929	3	of	of	IN
50458	929	4	65	65	CD
50458	929	5	°	°	,
50458	929	6	C.	C.	NNP
50458	929	7	,	,	,
50458	929	8	maintained	maintain	VBD
50458	929	9	for	for	IN
50458	929	10	30	30	CD
50458	929	11	minutes	minute	NNS
50458	929	12	,	,	,
50458	929	13	renders	render	VBZ
50458	929	14	it	-PRON-	PRP
50458	929	15	quite	quite	RB
50458	929	16	inactive	inactive	JJ
50458	929	17	;	;	:
50458	929	18	and	and	CC
50458	929	19	it	-PRON-	PRP
50458	929	20	becomes	become	VBZ
50458	929	21	oxidized	oxidized	JJ
50458	929	22	and	and	CC
50458	929	23	is	be	VBZ
50458	929	24	destroyed	destroy	VBN
50458	929	25	by	by	IN
50458	929	26	the	the	DT
50458	929	27	action	action	NN
50458	929	28	of	of	IN
50458	929	29	the	the	DT
50458	929	30	air	air	NN
50458	929	31	in	in	IN
50458	929	32	the	the	DT
50458	929	33	presence	presence	NN
50458	929	34	of	of	IN
50458	929	35	light	light	NN
50458	929	36	.	.	.
50458	930	1	Brieger	Brieger	NNP
50458	930	2	and	and	CC
50458	930	3	Boer,[120	Boer,[120	NNP
50458	930	4	]	]	-RRB-
50458	930	5	by	by	IN
50458	930	6	precipitating	precipitate	VBG
50458	930	7	with	with	IN
50458	930	8	zinc	zinc	NN
50458	930	9	chloride	chloride	NN
50458	930	10	the	the	DT
50458	930	11	filtered	filter	VBN
50458	930	12	culture	culture	NN
50458	930	13	bouillon	bouillon	NN
50458	930	14	,	,	,
50458	930	15	obtained	obtain	VBD
50458	930	16	a	a	DT
50458	930	17	pure	pure	JJ
50458	930	18	,	,	,
50458	930	19	amorphous	amorphous	JJ
50458	930	20	tetanus	tetanus	NN
50458	930	21	toxin	toxin	NN
50458	930	22	,	,	,
50458	930	23	which	which	WDT
50458	930	24	they	-PRON-	PRP
50458	930	25	also	also	RB
50458	930	26	considered	consider	VBD
50458	930	27	as	as	IN
50458	930	28	a	a	DT
50458	930	29	toxalbumin	toxalbumin	NN
50458	930	30	,	,	,
50458	930	31	and	and	CC
50458	930	32	which	which	WDT
50458	930	33	possesses	possess	VBZ
50458	930	34	exceedingly	exceedingly	RB
50458	930	35	toxic	toxic	JJ
50458	930	36	properties	property	NNS
50458	930	37	.	.	.
50458	931	1	[	[	-LRB-
50458	931	2	120	120	CD
50458	931	3	]	]	-RRB-
50458	931	4	_	_	NNP
50458	931	5	Deutsche	Deutsche	NNP
50458	931	6	Med	Med	NNP
50458	931	7	.	.	.
50458	932	1	Wochenschr	Wochenschr	NNP
50458	932	2	.	.	.
50458	932	3	_	_	NNP
50458	932	4	,	,	,
50458	932	5	No	no	UH
50458	932	6	.	.	.
50458	933	1	49	49	CD
50458	933	2	,	,	,
50458	933	3	Dec.	December	NNP
50458	933	4	3	3	CD
50458	933	5	,	,	,
50458	933	6	1896	1896	CD
50458	933	7	.	.	.
50458	934	1	If	if	IN
50458	934	2	a	a	DT
50458	934	3	precipitate	precipitate	NN
50458	934	4	be	be	VB
50458	934	5	caused	cause	VBN
50458	934	6	to	to	TO
50458	934	7	form	form	VB
50458	934	8	in	in	IN
50458	934	9	these	these	DT
50458	934	10	toxic	toxic	JJ
50458	934	11	solutions	solution	NNS
50458	934	12	,	,	,
50458	934	13	as	as	IN
50458	934	14	,	,	,
50458	934	15	for	for	IN
50458	934	16	instance	instance	NN
50458	934	17	,	,	,
50458	934	18	a	a	DT
50458	934	19	precipitate	precipitate	NN
50458	934	20	of	of	IN
50458	934	21	calcium	calcium	NN
50458	934	22	phosphate	phosphate	NN
50458	934	23	,	,	,
50458	934	24	this	this	DT
50458	934	25	carries	carry	VBZ
50458	934	26	down	down	RP
50458	934	27	with	with	IN
50458	934	28	it	-PRON-	PRP
50458	934	29	all	all	PDT
50458	934	30	the	the	DT
50458	934	31	toxin	toxin	NN
50458	934	32	present	present	JJ
50458	934	33	in	in	IN
50458	934	34	the	the	DT
50458	934	35	liquid	liquid	NN
50458	934	36	.	.	.
50458	935	1	0.0005	0.0005	NNP
50458	935	2	Gm	Gm	NNP
50458	935	3	.	.	.
50458	936	1	of	of	IN
50458	936	2	this	this	DT
50458	936	3	precipitate	precipitate	NN
50458	936	4	is	be	VBZ
50458	936	5	surely	surely	RB
50458	936	6	fatal	fatal	JJ
50458	936	7	to	to	IN
50458	936	8	a	a	DT
50458	936	9	guinea	guinea	NN
50458	936	10	-	-	HYPH
50458	936	11	pig	pig	NN
50458	936	12	.	.	.
50458	937	1	Dozon	Dozon	NNP
50458	937	2	and	and	CC
50458	937	3	Cournemont	Cournemont	NNP
50458	937	4	have	have	VBP
50458	937	5	observed	observe	VBN
50458	937	6	that	that	IN
50458	937	7	even	even	RB
50458	937	8	in	in	IN
50458	937	9	doses	dose	NNS
50458	937	10	of	of	IN
50458	937	11	300	300	CD
50458	937	12	to	to	TO
50458	937	13	400	400	CD
50458	937	14	Gm	Gm	NNP
50458	937	15	.	.	.
50458	938	1	of	of	IN
50458	938	2	the	the	DT
50458	938	3	filtered	filter	VBN
50458	938	4	culture	culture	NN
50458	938	5	liquid	liquid	NN
50458	938	6	,	,	,
50458	938	7	this	this	DT
50458	938	8	toxin	toxin	NN
50458	938	9	is	be	VBZ
50458	938	10	not	not	RB
50458	938	11	immediately	immediately	RB
50458	938	12	toxic	toxic	JJ
50458	938	13	to	to	IN
50458	938	14	a	a	DT
50458	938	15	horse	horse	NN
50458	938	16	,	,	,
50458	938	17	but	but	CC
50458	938	18	kills	kill	VBZ
50458	938	19	the	the	DT
50458	938	20	animal	animal	NN
50458	938	21	only	only	RB
50458	938	22	after	after	IN
50458	938	23	a	a	DT
50458	938	24	period	period	NN
50458	938	25	of	of	IN
50458	938	26	incubation	incubation	NN
50458	938	27	of	of	IN
50458	938	28	at	at	IN
50458	938	29	least	least	JJS
50458	938	30	twenty	twenty	CD
50458	938	31	-	-	HYPH
50458	938	32	four	four	CD
50458	938	33	hours	hour	NNS
50458	938	34	.	.	.
50458	939	1	The	the	DT
50458	939	2	blood	blood	NN
50458	939	3	of	of	IN
50458	939	4	such	such	PDT
50458	939	5	an	an	DT
50458	939	6	animal	animal	NN
50458	939	7	,	,	,
50458	939	8	however	however	RB
50458	939	9	,	,	,
50458	939	10	is	be	VBZ
50458	939	11	immediately	immediately	RB
50458	939	12	and	and	CC
50458	939	13	directly	directly	RB
50458	939	14	fatal	fatal	JJ
50458	939	15	to	to	IN
50458	939	16	animals	animal	NNS
50458	939	17	into	into	IN
50458	939	18	which	which	WDT
50458	939	19	it	-PRON-	PRP
50458	939	20	is	be	VBZ
50458	939	21	injected	inject	VBN
50458	939	22	.	.	.
50458	940	1	[	[	-LRB-
50458	940	2	121	121	CD
50458	940	3	]	]	-RRB-
50458	940	4	[	[	-LRB-
50458	940	5	121	121	CD
50458	940	6	]	]	-RRB-
50458	940	7	_	_	NNP
50458	940	8	Compt	Compt	NNP
50458	940	9	.	.	.
50458	941	1	rend	rend	VB
50458	941	2	.	.	.
50458	942	1	Soc	Soc	NNP
50458	942	2	.	.	.
50458	943	1	Biol	Biol	NNP
50458	943	2	.	.	.
50458	943	3	_	_	NNP
50458	943	4	,	,	,
50458	943	5	1893	1893	CD
50458	943	6	,	,	,
50458	943	7	p.	p.	NN
50458	943	8	294	294	CD
50458	943	9	;	;	:
50458	943	10	_	_	NNP
50458	943	11	Ibid	Ibid	NNP
50458	943	12	.	.	.
50458	943	13	_	_	NNP
50458	943	14	,	,	,
50458	943	15	1894	1894	CD
50458	943	16	,	,	,
50458	943	17	p.	p.	NN
50458	943	18	878	878	CD
50458	943	19	.	.	.
50458	944	1	Experiment	experiment	NN
50458	944	2	has	have	VBZ
50458	944	3	shown	show	VBN
50458	944	4	that	that	IN
50458	944	5	animals	animal	NNS
50458	944	6	that	that	WDT
50458	944	7	have	have	VBP
50458	944	8	been	be	VBN
50458	944	9	cured	cure	VBN
50458	944	10	of	of	IN
50458	944	11	tetanus	tetanus	NN
50458	944	12	possess	possess	VBP
50458	944	13	no	no	DT
50458	944	14	immunity	immunity	NN
50458	944	15	whatever	whatever	WDT
50458	944	16	against	against	IN
50458	944	17	tetanus	tetanus	NN
50458	944	18	;	;	:
50458	944	19	nevertheless	nevertheless	RB
50458	944	20	Behring	Behring	NNP
50458	944	21	and	and	CC
50458	944	22	Kitasato[122	Kitasato[122	NNP
50458	944	23	]	]	-RRB-
50458	944	24	first	first	RB
50458	944	25	,	,	,
50458	944	26	and	and	CC
50458	944	27	Wassermann	Wassermann	NNP
50458	944	28	and	and	CC
50458	944	29	Kitasato	Kitasato	NNP
50458	944	30	later	later	RB
50458	944	31	on	on	RB
50458	944	32	,	,	,
50458	944	33	succeeded	succeed	VBN
50458	944	34	in	in	IN
50458	944	35	preparing	prepare	VBG
50458	944	36	a	a	DT
50458	944	37	_	_	NNP
50458	944	38	tetanus	tetanus	NN
50458	944	39	antitoxin	antitoxin	NN
50458	944	40	_	_	NNP
50458	944	41	.	.	.
50458	945	1	To	to	TO
50458	945	2	obtain	obtain	VB
50458	945	3	this	this	DT
50458	945	4	,	,	,
50458	945	5	the	the	DT
50458	945	6	immunization	immunization	NN
50458	945	7	of	of	IN
50458	945	8	the	the	DT
50458	945	9	animal	animal	NN
50458	945	10	,	,	,
50458	945	11	horse	horse	NN
50458	945	12	or	or	CC
50458	945	13	cow	cow	NN
50458	945	14	,	,	,
50458	945	15	is	be	VBZ
50458	945	16	effected	effect	VBN
50458	945	17	by	by	IN
50458	945	18	injecting	inject	VBG
50458	945	19	increasing	increase	VBG
50458	945	20	quantities	quantity	NNS
50458	945	21	of	of	IN
50458	945	22	the	the	DT
50458	945	23	toxin	toxin	NN
50458	945	24	,	,	,
50458	945	25	more	more	RBR
50458	945	26	or	or	CC
50458	945	27	less	less	RBR
50458	945	28	attenuated	attenuate	VBN
50458	945	29	by	by	IN
50458	945	30	mixing	mix	VBG
50458	945	31	it	-PRON-	PRP
50458	945	32	with	with	IN
50458	945	33	Gramm	Gramm	NNP
50458	945	34	's	's	POS
50458	945	35	iodine	iodine	NN
50458	945	36	solution	solution	NN
50458	945	37	;	;	:
50458	945	38	the	the	DT
50458	945	39	immunization	immunization	NN
50458	945	40	is	be	VBZ
50458	945	41	easily	easily	RB
50458	945	42	and	and	CC
50458	945	43	rapidly	rapidly	RB
50458	945	44	accomplished	accomplish	VBN
50458	945	45	by	by	IN
50458	945	46	the	the	DT
50458	945	47	process	process	NN
50458	945	48	devised	devise	VBN
50458	945	49	by	by	IN
50458	945	50	Roux	Roux	NNP
50458	945	51	and	and	CC
50458	945	52	Vaillard	Vaillard	NNP
50458	945	53	.	.	.
50458	946	1	[	[	-LRB-
50458	946	2	123	123	CD
50458	946	3	]	]	-RRB-
50458	946	4	[	[	-LRB-
50458	946	5	122	122	CD
50458	946	6	]	]	-RRB-
50458	946	7	_	_	NNP
50458	946	8	Deutsch	Deutsch	NNP
50458	946	9	.	.	.
50458	947	1	Med	Med	NNP
50458	947	2	.	.	.
50458	948	1	Wochenschr	Wochenschr	NNP
50458	948	2	.	.	.
50458	948	3	_	_	NNP
50458	948	4	,	,	,
50458	948	5	1890	1890	CD
50458	948	6	.	.	.
50458	949	1	[	[	-LRB-
50458	949	2	123	123	CD
50458	949	3	]	]	-RRB-
50458	949	4	_	_	NNP
50458	949	5	Annal	Annal	NNP
50458	949	6	.	.	.
50458	950	1	Instit	Instit	NNP
50458	950	2	.	.	.
50458	951	1	Pasteur	Pasteur	NNP
50458	951	2	_	_	NNP
50458	951	3	,	,	,
50458	951	4	VII	VII	NNP
50458	951	5	,	,	,
50458	951	6	p.	p.	NN
50458	951	7	64	64	CD
50458	951	8	.	.	.
50458	952	1	The	the	DT
50458	952	2	immunized	immunized	JJ
50458	952	3	animals	animal	NNS
50458	952	4	yield	yield	VBP
50458	952	5	a	a	DT
50458	952	6	serum	serum	NN
50458	952	7	which	which	WDT
50458	952	8	,	,	,
50458	952	9	mixed	mix	VBN
50458	952	10	with	with	IN
50458	952	11	tetanus	tetanus	NN
50458	952	12	cultures	culture	NNS
50458	952	13	,	,	,
50458	952	14	renders	render	VBZ
50458	952	15	these	these	DT
50458	952	16	innocuous	innocuous	JJ
50458	952	17	,	,	,
50458	952	18	and	and	CC
50458	952	19	which	which	WDT
50458	952	20	enjoys	enjoy	VBZ
50458	952	21	an	an	DT
50458	952	22	antitoxic	antitoxic	JJ
50458	952	23	power	power	NN
50458	952	24	that	that	WDT
50458	952	25	borders	border	VBZ
50458	952	26	on	on	IN
50458	952	27	the	the	DT
50458	952	28	marvelous	marvelous	JJ
50458	952	29	.	.	.
50458	953	1	[	[	-LRB-
50458	953	2	124	124	CD
50458	953	3	]	]	-RRB-
50458	953	4	A	a	DT
50458	953	5	quintillionth	quintillionth	NN
50458	953	6	of	of	IN
50458	953	7	a	a	DT
50458	953	8	cubic	cubic	JJ
50458	953	9	centimeter	centimeter	NN
50458	953	10	of	of	IN
50458	953	11	the	the	DT
50458	953	12	serum	serum	NN
50458	953	13	per	per	IN
50458	953	14	gramme	gramme	NNP
50458	953	15	weight	weight	NN
50458	953	16	of	of	IN
50458	953	17	a	a	DT
50458	953	18	live	live	JJ
50458	953	19	mouse	mouse	NN
50458	953	20	suffices	suffice	NNS
50458	953	21	to	to	TO
50458	953	22	protect	protect	VB
50458	953	23	the	the	DT
50458	953	24	animal	animal	NN
50458	953	25	from	from	IN
50458	953	26	an	an	DT
50458	953	27	otherwise	otherwise	RB
50458	953	28	fatal	fatal	JJ
50458	953	29	quantity	quantity	NN
50458	953	30	of	of	IN
50458	953	31	tetanus	tetanus	NN
50458	953	32	toxin	toxin	NN
50458	953	33	.	.	.
50458	954	1	[	[	-LRB-
50458	954	2	125	125	CD
50458	954	3	]	]	-RRB-
50458	954	4	[	[	-LRB-
50458	954	5	124	124	CD
50458	954	6	]	]	-RRB-
50458	954	7	NOCARD	NOCARD	NNP
50458	954	8	:	:	:
50458	954	9	_	_	NNP
50458	954	10	Bull	Bull	NNP
50458	954	11	.	.	.
50458	955	1	de	de	NNP
50458	955	2	l'Acad	l'Acad	NNP
50458	955	3	.	.	.
50458	956	1	de	de	NNP
50458	956	2	Médecine	Médecine	NNP
50458	956	3	_	_	NNP
50458	956	4	,	,	,
50458	956	5	Oct.	October	NNP
50458	956	6	22	22	CD
50458	956	7	,	,	,
50458	956	8	1895	1895	CD
50458	956	9	.	.	.
50458	957	1	[	[	-LRB-
50458	957	2	125	125	CD
50458	957	3	]	]	-RRB-
50458	957	4	NAILLARD	NAILLARD	NNP
50458	957	5	:	:	:
50458	957	6	_	_	NNP
50458	957	7	Compt	Compt	NNP
50458	957	8	.	.	.
50458	958	1	rend	rend	VB
50458	958	2	.	.	.
50458	959	1	de	de	NNP
50458	959	2	l'Acad	l'Acad	NNP
50458	959	3	.	.	.
50458	960	1	de	de	NNP
50458	960	2	Sciences	Sciences	NNP
50458	960	3	_	_	NNP
50458	960	4	,	,	,
50458	960	5	CXX	CXX	NNP
50458	960	6	,	,	,
50458	960	7	p.	p.	NN
50458	960	8	1181	1181	CD
50458	960	9	.	.	.
50458	961	1	This	this	DT
50458	961	2	serum	serum	NN
50458	961	3	is	be	VBZ
50458	961	4	nevertheless	nevertheless	RB
50458	961	5	powerless	powerless	JJ
50458	961	6	to	to	TO
50458	961	7	preserve	preserve	VB
50458	961	8	man	man	NN
50458	961	9	in	in	IN
50458	961	10	cases	case	NNS
50458	961	11	of	of	IN
50458	961	12	acute	acute	JJ
50458	961	13	tetanus	tetanus	NN
50458	961	14	;	;	:
50458	961	15	it	-PRON-	PRP
50458	961	16	confers	confer	VBZ
50458	961	17	an	an	DT
50458	961	18	immediate	immediate	NN
50458	961	19	,	,	,
50458	961	20	but	but	CC
50458	961	21	only	only	RB
50458	961	22	transitory	transitory	NN
50458	961	23	,	,	,
50458	961	24	immunity	immunity	NN
50458	961	25	.	.	.
50458	962	1	As	as	IN
50458	962	2	to	to	IN
50458	962	3	its	-PRON-	PRP$
50458	962	4	mode	mode	NN
50458	962	5	of	of	IN
50458	962	6	action	action	NN
50458	962	7	,	,	,
50458	962	8	it	-PRON-	PRP
50458	962	9	appears	appear	VBZ
50458	962	10	to	to	TO
50458	962	11	cause	cause	VB
50458	962	12	a	a	DT
50458	962	13	permanent	permanent	JJ
50458	962	14	condition	condition	NN
50458	962	15	of	of	IN
50458	962	16	excitation	excitation	NN
50458	962	17	or	or	CC
50458	962	18	of	of	IN
50458	962	19	nutritive	nutritive	JJ
50458	962	20	reaction	reaction	NN
50458	962	21	of	of	IN
50458	962	22	the	the	DT
50458	962	23	cells	cell	NNS
50458	962	24	,	,	,
50458	962	25	which	which	WDT
50458	962	26	makes	make	VBZ
50458	962	27	these	these	DT
50458	962	28	resistant	resistant	JJ
50458	962	29	to	to	IN
50458	962	30	the	the	DT
50458	962	31	poison	poison	NN
50458	962	32	.	.	.
50458	963	1	As	as	IN
50458	963	2	in	in	IN
50458	963	3	the	the	DT
50458	963	4	case	case	NN
50458	963	5	of	of	IN
50458	963	6	the	the	DT
50458	963	7	other	other	JJ
50458	963	8	toxins	toxin	NNS
50458	963	9	,	,	,
50458	963	10	the	the	DT
50458	963	11	quantity	quantity	NN
50458	963	12	of	of	IN
50458	963	13	antitoxin	antitoxin	NN
50458	963	14	necessary	necessary	JJ
50458	963	15	to	to	TO
50458	963	16	protect	protect	VB
50458	963	17	an	an	DT
50458	963	18	organism	organism	NN
50458	963	19	is	be	VBZ
50458	963	20	so	so	RB
50458	963	21	much	much	RB
50458	963	22	greater	great	JJR
50458	963	23	the	the	DT
50458	963	24	later	later	RB
50458	963	25	the	the	DT
50458	963	26	treatment	treatment	NN
50458	963	27	is	be	VBZ
50458	963	28	applied	apply	VBN
50458	963	29	.	.	.
50458	964	1	=	=	NFP
50458	964	2	Mallein	Mallein	NNP
50458	964	3	(	(	-LRB-
50458	964	4	Toxin	Toxin	NNP
50458	964	5	of	of	IN
50458	964	6	Glanders).=--Among	Glanders).=--Among	NNP
50458	964	7	the	the	DT
50458	964	8	soluble	soluble	JJ
50458	964	9	products	product	NNS
50458	964	10	secreted	secrete	VBN
50458	964	11	in	in	IN
50458	964	12	the	the	DT
50458	964	13	culture	culture	NN
50458	964	14	media	medium	NNS
50458	964	15	by	by	IN
50458	964	16	the	the	DT
50458	964	17	glanders	glander	NNS
50458	964	18	bacilli	bacilli	NNP
50458	964	19	,	,	,
50458	964	20	there	there	EX
50458	964	21	are	be	VBP
50458	964	22	found	find	VBN
50458	964	23	true	true	JJ
50458	964	24	toxins	toxin	NNS
50458	964	25	to	to	TO
50458	964	26	which	which	WDT
50458	964	27	are	be	VBP
50458	964	28	ascribed	ascribe	VBN
50458	964	29	certain	certain	JJ
50458	964	30	symptoms	symptom	NNS
50458	964	31	of	of	IN
50458	964	32	glanders	glander	NNS
50458	964	33	infection	infection	NN
50458	964	34	.	.	.
50458	965	1	These	these	DT
50458	965	2	toxins	toxin	NNS
50458	965	3	have	have	VBP
50458	965	4	been	be	VBN
50458	965	5	isolated	isolate	VBN
50458	965	6	and	and	CC
50458	965	7	designated	designate	VBN
50458	965	8	by	by	IN
50458	965	9	the	the	DT
50458	965	10	name	name	NN
50458	965	11	_	_	NNP
50458	965	12	mallein	mallein	NNP
50458	965	13	_	_	NNP
50458	965	14	.	.	.
50458	966	1	First	first	RB
50458	966	2	prepared	prepare	VBN
50458	966	3	by	by	IN
50458	966	4	Helman	Helman	NNP
50458	966	5	and	and	CC
50458	966	6	Kalmino	Kalmino	NNP
50458	966	7	,	,	,
50458	966	8	mallein	mallein	NNP
50458	966	9	was	be	VBD
50458	966	10	later	later	RB
50458	966	11	on	on	RB
50458	966	12	specially	specially	RB
50458	966	13	studied	study	VBN
50458	966	14	by	by	IN
50458	966	15	Roux	Roux	NNP
50458	966	16	and	and	CC
50458	966	17	Nocard	Nocard	NNP
50458	966	18	,	,	,
50458	966	19	and	and	CC
50458	966	20	,	,	,
50458	966	21	in	in	IN
50458	966	22	consequence	consequence	NN
50458	966	23	of	of	IN
50458	966	24	the	the	DT
50458	966	25	researches	research	NNS
50458	966	26	of	of	IN
50458	966	27	the	the	DT
50458	966	28	last	last	RB
50458	966	29	-	-	HYPH
50458	966	30	mentioned	mention	VBN
50458	966	31	scientist	scientist	NN
50458	966	32	,	,	,
50458	966	33	it	-PRON-	PRP
50458	966	34	has	have	VBZ
50458	966	35	acquired	acquire	VBN
50458	966	36	great	great	JJ
50458	966	37	importance	importance	NN
50458	966	38	.	.	.
50458	967	1	[	[	-LRB-
50458	967	2	126	126	CD
50458	967	3	]	]	-RRB-
50458	967	4	It	-PRON-	PRP
50458	967	5	is	be	VBZ
50458	967	6	obtained	obtain	VBN
50458	967	7	by	by	IN
50458	967	8	sterilizing	sterilize	VBG
50458	967	9	at	at	IN
50458	967	10	110	110	CD
50458	967	11	°	°	NNS
50458	967	12	C.	C.	NNP
50458	967	13	cultures	culture	NNS
50458	967	14	of	of	IN
50458	967	15	the	the	DT
50458	967	16	glanders	glander	NNS
50458	967	17	bacillus	bacillus	NN
50458	967	18	made	make	VBN
50458	967	19	with	with	IN
50458	967	20	mutton	mutton	NN
50458	967	21	bouillon	bouillon	NN
50458	967	22	with	with	IN
50458	967	23	the	the	DT
50458	967	24	addition	addition	NN
50458	967	25	of	of	IN
50458	967	26	salt	salt	NN
50458	967	27	,	,	,
50458	967	28	glycerin	glycerin	NNP
50458	967	29	,	,	,
50458	967	30	and	and	CC
50458	967	31	peptones	peptone	NNS
50458	967	32	.	.	.
50458	968	1	To	to	TO
50458	968	2	isolate	isolate	VB
50458	968	3	the	the	DT
50458	968	4	toxin	toxin	NN
50458	968	5	the	the	DT
50458	968	6	culture	culture	NN
50458	968	7	bouillon	bouillon	NN
50458	968	8	is	be	VBZ
50458	968	9	first	first	RB
50458	968	10	sterilized	sterilize	VBN
50458	968	11	by	by	IN
50458	968	12	heating	heat	VBG
50458	968	13	for	for	IN
50458	968	14	half	half	PDT
50458	968	15	an	an	DT
50458	968	16	hour	hour	NN
50458	968	17	in	in	IN
50458	968	18	an	an	DT
50458	968	19	autoclave	autoclave	NN
50458	968	20	at	at	IN
50458	968	21	100	100	CD
50458	968	22	°	°	NNS
50458	968	23	C.	C.	NNP
50458	968	24	It	-PRON-	PRP
50458	968	25	is	be	VBZ
50458	968	26	then	then	RB
50458	968	27	filtered	filter	VBN
50458	968	28	,	,	,
50458	968	29	concentrated	concentrate	VBD
50458	968	30	to	to	IN
50458	968	31	one	one	CD
50458	968	32	-	-	HYPH
50458	968	33	tenth	tenth	NN
50458	968	34	its	-PRON-	PRP$
50458	968	35	volume	volume	NN
50458	968	36	on	on	IN
50458	968	37	a	a	DT
50458	968	38	water	water	NN
50458	968	39	-	-	HYPH
50458	968	40	bath	bath	NN
50458	968	41	,	,	,
50458	968	42	and	and	CC
50458	968	43	filtered	filter	VBD
50458	968	44	through	through	IN
50458	968	45	a	a	DT
50458	968	46	Chardin	Chardin	NNP
50458	968	47	filter	filter	NN
50458	968	48	.	.	.
50458	969	1	The	the	DT
50458	969	2	mallein	mallein	NN
50458	969	3	is	be	VBZ
50458	969	4	thus	thus	RB
50458	969	5	obtained	obtain	VBN
50458	969	6	in	in	IN
50458	969	7	the	the	DT
50458	969	8	form	form	NN
50458	969	9	of	of	IN
50458	969	10	a	a	DT
50458	969	11	brown	brown	JJ
50458	969	12	syrupy	syrupy	NN
50458	969	13	liquid	liquid	NN
50458	969	14	containing	contain	VBG
50458	969	15	half	half	PDT
50458	969	16	its	-PRON-	PRP$
50458	969	17	weight	weight	NN
50458	969	18	of	of	IN
50458	969	19	glycerin	glycerin	NNP
50458	969	20	.	.	.
50458	970	1	[	[	-LRB-
50458	970	2	126	126	CD
50458	970	3	]	]	-RRB-
50458	970	4	NOCARD	NOCARD	NNP
50458	970	5	:	:	:
50458	970	6	_	_	NNP
50458	970	7	Les	Les	NNP
50458	970	8	Maladies	Maladies	NNP
50458	970	9	microbiennes	microbienne	NNS
50458	970	10	des	des	NNP
50458	970	11	animaux	animaux	NNP
50458	970	12	_	_	NNP
50458	970	13	,	,	,
50458	970	14	Paris	Paris	NNP
50458	970	15	.	.	.
50458	971	1	This	this	DT
50458	971	2	solution	solution	NN
50458	971	3	keeps	keep	VBZ
50458	971	4	well	well	RB
50458	971	5	when	when	WRB
50458	971	6	kept	keep	VBN
50458	971	7	from	from	IN
50458	971	8	air	air	NN
50458	971	9	,	,	,
50458	971	10	light	light	NN
50458	971	11	,	,	,
50458	971	12	and	and	CC
50458	971	13	heat	heat	NN
50458	971	14	.	.	.
50458	972	1	In	in	IN
50458	972	2	practice	practice	NN
50458	972	3	it	-PRON-	PRP
50458	972	4	is	be	VBZ
50458	972	5	employed	employ	VBN
50458	972	6	in	in	IN
50458	972	7	10-per	10-per	CD
50458	972	8	cent	cent	NN
50458	972	9	.	.	.
50458	973	1	solution	solution	NN
50458	973	2	in	in	IN
50458	973	3	phenolated	phenolate	VBN
50458	973	4	water	water	NN
50458	973	5	(	(	-LRB-
50458	973	6	5:1000	5:1000	CD
50458	973	7	)	)	-RRB-
50458	973	8	.	.	.
50458	974	1	The	the	DT
50458	974	2	mallein	mallein	NN
50458	974	3	may	may	MD
50458	974	4	be	be	VB
50458	974	5	precipitated	precipitate	VBN
50458	974	6	from	from	IN
50458	974	7	the	the	DT
50458	974	8	crude	crude	JJ
50458	974	9	solution	solution	NN
50458	974	10	by	by	IN
50458	974	11	the	the	DT
50458	974	12	addition	addition	NN
50458	974	13	of	of	IN
50458	974	14	alcohol	alcohol	NN
50458	974	15	,	,	,
50458	974	16	as	as	IN
50458	974	17	recommended	recommend	VBN
50458	974	18	by	by	IN
50458	974	19	Foth	Foth	NNP
50458	974	20	.	.	.
50458	975	1	Foth	Foth	NNP
50458	975	2	's	's	POS
50458	975	3	mallein	mallein	NN
50458	975	4	occurs	occur	VBZ
50458	975	5	as	as	IN
50458	975	6	a	a	DT
50458	975	7	white	white	JJ
50458	975	8	,	,	,
50458	975	9	light	light	JJ
50458	975	10	powder	powder	NN
50458	975	11	,	,	,
50458	975	12	very	very	RB
50458	975	13	easily	easily	RB
50458	975	14	soluble	soluble	JJ
50458	975	15	in	in	IN
50458	975	16	water	water	NN
50458	975	17	.	.	.
50458	976	1	Mallein	Mallein	NNP
50458	976	2	enjoys	enjoy	VBZ
50458	976	3	a	a	DT
50458	976	4	very	very	RB
50458	976	5	important	important	JJ
50458	976	6	rôle	rôle	NN
50458	976	7	in	in	IN
50458	976	8	veterinary	veterinary	JJ
50458	976	9	therapeutics	therapeutic	NNS
50458	976	10	,	,	,
50458	976	11	a	a	DT
50458	976	12	rôle	rôle	NN
50458	976	13	analogous	analogous	JJ
50458	976	14	to	to	IN
50458	976	15	that	that	DT
50458	976	16	of	of	IN
50458	976	17	tuberculin	tuberculin	NN
50458	976	18	,	,	,
50458	976	19	permitting	permit	VBG
50458	976	20	the	the	DT
50458	976	21	diagnosis	diagnosis	NN
50458	976	22	of	of	IN
50458	976	23	incipient	incipient	JJ
50458	976	24	glanders	glander	NNS
50458	976	25	.	.	.
50458	977	1	[	[	-LRB-
50458	977	2	127	127	CD
50458	977	3	]	]	-RRB-
50458	977	4	[	[	-LRB-
50458	977	5	127	127	CD
50458	977	6	]	]	-RRB-
50458	977	7	STRAUSS	STRAUSS	NNP
50458	977	8	:	:	:
50458	977	9	_	_	NNP
50458	977	10	Arch	Arch	NNP
50458	977	11	.	.	.
50458	978	1	de	de	NNP
50458	978	2	Médic	Médic	NNP
50458	978	3	.	.	.
50458	979	1	expériment	expériment	NNP
50458	979	2	_	_	NNP
50458	979	3	,	,	,
50458	979	4	1886	1886	CD
50458	979	5	.	.	.
50458	980	1	Experience	experience	NN
50458	980	2	has	have	VBZ
50458	980	3	shown	show	VBN
50458	980	4	that	that	IN
50458	980	5	in	in	IN
50458	980	6	animals	animal	NNS
50458	980	7	already	already	RB
50458	980	8	attacked	attack	VBN
50458	980	9	by	by	IN
50458	980	10	glanders	glander	NNS
50458	980	11	,	,	,
50458	980	12	even	even	RB
50458	980	13	if	if	IN
50458	980	14	ever	ever	RB
50458	980	15	so	so	RB
50458	980	16	slightly	slightly	RB
50458	980	17	,	,	,
50458	980	18	the	the	DT
50458	980	19	thermic	thermic	NN
50458	980	20	reaction	reaction	NN
50458	980	21	never	never	RB
50458	980	22	fails	fail	VBZ
50458	980	23	when	when	WRB
50458	980	24	0.25	0.25	CD
50458	980	25	Cc	Cc	NNP
50458	980	26	.	.	.
50458	981	1	of	of	IN
50458	981	2	the	the	DT
50458	981	3	mallein	mallein	NNP
50458	981	4	solution	solution	NN
50458	981	5	is	be	VBZ
50458	981	6	injected	inject	VBN
50458	981	7	.	.	.
50458	982	1	In	in	IN
50458	982	2	healthy	healthy	JJ
50458	982	3	animals	animal	NNS
50458	982	4	,	,	,
50458	982	5	however	however	RB
50458	982	6	,	,	,
50458	982	7	the	the	DT
50458	982	8	injection	injection	NN
50458	982	9	of	of	IN
50458	982	10	mallein	mallein	NNP
50458	982	11	,	,	,
50458	982	12	even	even	RB
50458	982	13	in	in	IN
50458	982	14	much	much	RB
50458	982	15	larger	large	JJR
50458	982	16	quantities	quantity	NNS
50458	982	17	,	,	,
50458	982	18	causes	cause	VBZ
50458	982	19	no	no	DT
50458	982	20	apparent	apparent	JJ
50458	982	21	effect	effect	NN
50458	982	22	.	.	.
50458	983	1	In	in	IN
50458	983	2	animals	animal	NNS
50458	983	3	attacked	attack	VBN
50458	983	4	by	by	IN
50458	983	5	glanders	glander	NNS
50458	983	6	the	the	DT
50458	983	7	reaction	reaction	NN
50458	983	8	attains	attain	VBZ
50458	983	9	its	-PRON-	PRP$
50458	983	10	maximum	maximum	NN
50458	983	11	in	in	IN
50458	983	12	twelve	twelve	CD
50458	983	13	hours	hour	NNS
50458	983	14	,	,	,
50458	983	15	and	and	CC
50458	983	16	several	several	JJ
50458	983	17	days	day	NNS
50458	983	18	are	be	VBP
50458	983	19	required	require	VBN
50458	983	20	for	for	IN
50458	983	21	the	the	DT
50458	983	22	temperature	temperature	NN
50458	983	23	to	to	TO
50458	983	24	return	return	VB
50458	983	25	to	to	IN
50458	983	26	normal	normal	JJ
50458	983	27	.	.	.
50458	984	1	[	[	-LRB-
50458	984	2	128	128	CD
50458	984	3	]	]	-RRB-
50458	984	4	[	[	-LRB-
50458	984	5	128	128	CD
50458	984	6	]	]	-RRB-
50458	984	7	CADIOT	CADIOT	NNP
50458	984	8	and	and	CC
50458	984	9	ROGER	ROGER	NNP
50458	984	10	:	:	:
50458	984	11	_	_	NNP
50458	984	12	Compt	Compt	NNP
50458	984	13	.	.	.
50458	985	1	rend	rend	VB
50458	985	2	.	.	.
50458	986	1	Soc	Soc	NNP
50458	986	2	.	.	.
50458	987	1	Biol	Biol	NNP
50458	987	2	.	.	.
50458	987	3	_	_	NNP
50458	987	4	,	,	,
50458	987	5	1895	1895	CD
50458	987	6	,	,	,
50458	987	7	p.	p.	NN
50458	987	8	770	770	CD
50458	987	9	;	;	:
50458	987	10	WLADIMIROW	WLADIMIROW	NNP
50458	987	11	:	:	:
50458	987	12	_	_	NNP
50458	987	13	Arch	Arch	NNP
50458	987	14	.	.	.
50458	988	1	des	des	NNP
50458	988	2	Sciences	Sciences	NNPS
50458	988	3	Biol	Biol	NNP
50458	988	4	.	.	.
50458	989	1	de	de	NNP
50458	989	2	St.-Pétersbourg	St.-Pétersbourg	NNP
50458	989	3	_	_	NNP
50458	989	4	,	,	,
50458	989	5	IV	IV	NNP
50458	989	6	,	,	,
50458	989	7	p.	p.	NN
50458	989	8	30	30	CD
50458	989	9	;	;	:
50458	989	10	BOURGES	bourges	NN
50458	989	11	and	and	CC
50458	989	12	MÉRY	MÉRY	NNP
50458	989	13	:	:	:
50458	989	14	_	_	NNP
50458	989	15	Soc	Soc	NNP
50458	989	16	.	.	.
50458	990	1	de	de	NNP
50458	990	2	Biol	Biol	NNP
50458	990	3	.	.	.
50458	990	4	_	_	NNP
50458	990	5	,	,	,
50458	990	6	Feb.	February	NNP
50458	990	7	5	5	CD
50458	990	8	,	,	,
50458	990	9	1878	1878	CD
50458	990	10	.	.	.
50458	991	1	According	accord	VBG
50458	991	2	to	to	IN
50458	991	3	Nocard	Nocard	NNP
50458	991	4	,	,	,
50458	991	5	mallein	mallein	NNP
50458	991	6	possesses	possess	VBZ
50458	991	7	no	no	DT
50458	991	8	immunizing	immunize	VBG
50458	991	9	properties	property	NNS
50458	991	10	whatever	whatever	WDT
50458	991	11	.	.	.
50458	992	1	[	[	-LRB-
50458	992	2	129	129	CD
50458	992	3	]	]	-RRB-
50458	992	4	[	[	-LRB-
50458	992	5	129	129	CD
50458	992	6	]	]	-RRB-
50458	992	7	GALTIER	GALTIER	NNP
50458	992	8	:	:	:
50458	992	9	_	_	NNP
50458	992	10	Compt	Compt	NNP
50458	992	11	.	.	.
50458	993	1	rend	rend	VB
50458	993	2	.	.	.
50458	994	1	de	de	NNP
50458	994	2	l'Acad	l'Acad	NNP
50458	994	3	.	.	.
50458	995	1	des	des	NNP
50458	995	2	Sciences	Sciences	NNPS
50458	995	3	_	_	NNP
50458	995	4	,	,	,
50458	995	5	XCII	XCII	NNP
50458	995	6	,	,	,
50458	995	7	p.	p.	NN
50458	995	8	303	303	CD
50458	995	9	;	;	:
50458	995	10	STRAUSS	STRAUSS	NNP
50458	995	11	:	:	:
50458	995	12	_	_	NNP
50458	995	13	Arch	Arch	NNP
50458	995	14	.	.	.
50458	996	1	de	de	NNP
50458	996	2	Médic	Médic	NNP
50458	996	3	.	.	.
50458	997	1	expériment	expériment	NNP
50458	997	2	_	_	NNP
50458	997	3	,	,	,
50458	997	4	I	-PRON-	PRP
50458	997	5	,	,	,
50458	997	6	p.	p.	NN
50458	997	7	489	489	CD
50458	997	8	.	.	.
50458	998	1	=	=	NFP
50458	998	2	Typhoid	Typhoid	NNP
50458	998	3	Toxin.=--This	Toxin.=--This	NNP
50458	998	4	is	be	VBZ
50458	998	5	obtained	obtain	VBN
50458	998	6	,	,	,
50458	998	7	like	like	IN
50458	998	8	the	the	DT
50458	998	9	other	other	JJ
50458	998	10	microbial	microbial	JJ
50458	998	11	toxins	toxin	NNS
50458	998	12	,	,	,
50458	998	13	from	from	IN
50458	998	14	a	a	DT
50458	998	15	culture	culture	NN
50458	998	16	,	,	,
50458	998	17	prepared	prepare	VBN
50458	998	18	with	with	IN
50458	998	19	more	more	JJR
50458	998	20	or	or	CC
50458	998	21	less	less	JJR
50458	998	22	difficulty	difficulty	NN
50458	998	23	,	,	,
50458	998	24	from	from	IN
50458	998	25	Eberth	Eberth	NNP
50458	998	26	's	's	POS
50458	998	27	typhoid	typhoid	NN
50458	998	28	bacillus	bacillus	NN
50458	998	29	.	.	.
50458	999	1	This	this	DT
50458	999	2	toxin	toxin	NN
50458	999	3	,	,	,
50458	999	4	injected	inject	VBN
50458	999	5	into	into	IN
50458	999	6	guinea	guinea	NN
50458	999	7	-	-	HYPH
50458	999	8	pigs	pig	NNS
50458	999	9	,	,	,
50458	999	10	develops	develop	VBZ
50458	999	11	in	in	IN
50458	999	12	them	-PRON-	PRP
50458	999	13	typhoid	typhoid	JJ
50458	999	14	fever	fever	NN
50458	999	15	.	.	.
50458	1000	1	In	in	IN
50458	1000	2	the	the	DT
50458	1000	3	solution	solution	NN
50458	1000	4	there	there	EX
50458	1000	5	occurs	occur	VBZ
50458	1000	6	a	a	DT
50458	1000	7	ptomaine	ptomaine	NN
50458	1000	8	,	,	,
50458	1000	9	which	which	WDT
50458	1000	10	has	have	VBZ
50458	1000	11	been	be	VBN
50458	1000	12	isolated	isolate	VBN
50458	1000	13	by	by	IN
50458	1000	14	Brieger	Brieger	NNP
50458	1000	15	,	,	,
50458	1000	16	and	and	CC
50458	1000	17	which	which	WDT
50458	1000	18	gives	give	VBZ
50458	1000	19	rise	rise	NN
50458	1000	20	to	to	IN
50458	1000	21	almost	almost	RB
50458	1000	22	all	all	PDT
50458	1000	23	the	the	DT
50458	1000	24	phenomena	phenomenon	NNS
50458	1000	25	of	of	IN
50458	1000	26	typhoid	typhoid	NN
50458	1000	27	fever	fever	NN
50458	1000	28	;	;	:
50458	1000	29	this	this	DT
50458	1000	30	ptomaine	ptomaine	NN
50458	1000	31	is	be	VBZ
50458	1000	32	called	call	VBN
50458	1000	33	_	_	NNP
50458	1000	34	typhotoxin	typhotoxin	NN
50458	1000	35	_	_	NNP
50458	1000	36	.	.	.
50458	1001	1	[	[	-LRB-
50458	1001	2	130	130	CD
50458	1001	3	]	]	-RRB-
50458	1001	4	[	[	-LRB-
50458	1001	5	130	130	CD
50458	1001	6	]	]	-RRB-
50458	1001	7	BRIEGER	BRIEGER	NNP
50458	1001	8	:	:	:
50458	1001	9	_	_	NNP
50458	1001	10	Microbes	Microbes	NNPS
50458	1001	11	,	,	,
50458	1001	12	Ptomaïnes	Ptomaïnes	NNPS
50458	1001	13	et	et	NNP
50458	1001	14	Maladies	malady	NNS
50458	1001	15	_	_	NNP
50458	1001	16	,	,	,
50458	1001	17	Doin	do	NNP
50458	1001	18	,	,	,
50458	1001	19	publ	publ	NNS
50458	1001	20	.	.	.
50458	1001	21	,	,	,
50458	1001	22	Paris	Paris	NNP
50458	1001	23	,	,	,
50458	1001	24	1887	1887	CD
50458	1001	25	;	;	:
50458	1001	26	LUFF	LUFF	NNP
50458	1001	27	:	:	:
50458	1001	28	_	_	NNP
50458	1001	29	Brit	Brit	NNP
50458	1001	30	.	.	.
50458	1002	1	Med	Med	NNP
50458	1002	2	.	.	.
50458	1003	1	Journ	Journ	NNP
50458	1003	2	.	.	.
50458	1003	3	_	_	NNP
50458	1003	4	,	,	,
50458	1003	5	1889	1889	CD
50458	1003	6	.	.	.
50458	1004	1	The	the	DT
50458	1004	2	same	same	JJ
50458	1004	3	author	author	NN
50458	1004	4	,	,	,
50458	1004	5	in	in	IN
50458	1004	6	collaboration	collaboration	NN
50458	1004	7	with	with	IN
50458	1004	8	Fraenkel,[131	Fraenkel,[131	NNP
50458	1004	9	]	]	-RRB-
50458	1004	10	later	later	RB
50458	1004	11	on	on	IN
50458	1004	12	isolated	isolate	VBN
50458	1004	13	a	a	DT
50458	1004	14	toxalbumin	toxalbumin	NN
50458	1004	15	from	from	IN
50458	1004	16	the	the	DT
50458	1004	17	culture	culture	NN
50458	1004	18	bouillon	bouillon	NN
50458	1004	19	of	of	IN
50458	1004	20	the	the	DT
50458	1004	21	typhoid	typhoid	NN
50458	1004	22	bacillus	bacillus	NN
50458	1004	23	.	.	.
50458	1005	1	Sanarelli[132	sanarelli[132	NN
50458	1005	2	]	]	-RRB-
50458	1005	3	obtained	obtain	VBD
50458	1005	4	an	an	DT
50458	1005	5	active	active	JJ
50458	1005	6	toxin	toxin	NN
50458	1005	7	by	by	IN
50458	1005	8	macerating	macerate	VBG
50458	1005	9	for	for	IN
50458	1005	10	several	several	JJ
50458	1005	11	days	day	NNS
50458	1005	12	at	at	IN
50458	1005	13	60	60	CD
50458	1005	14	°	°	NNS
50458	1005	15	C.	C.	NNP
50458	1005	16	a	a	DT
50458	1005	17	month	month	NN
50458	1005	18	-	-	HYPH
50458	1005	19	old	old	JJ
50458	1005	20	culture	culture	NN
50458	1005	21	of	of	IN
50458	1005	22	the	the	DT
50458	1005	23	typhoid	typhoid	NN
50458	1005	24	bacillus	bacillus	NN
50458	1005	25	made	make	VBN
50458	1005	26	with	with	IN
50458	1005	27	a	a	DT
50458	1005	28	2-per	2-per	CD
50458	1005	29	cent	cent	NN
50458	1005	30	.	.	.
50458	1006	1	glycerin	glycerin	NNP
50458	1006	2	-	-	HYPH
50458	1006	3	bouillon	bouillon	NNP
50458	1006	4	.	.	.
50458	1007	1	Chantemesse	Chantemesse	NNP
50458	1007	2	has	have	VBZ
50458	1007	3	also	also	RB
50458	1007	4	published	publish	VBN
50458	1007	5	a	a	DT
50458	1007	6	process	process	NN
50458	1007	7	which	which	WDT
50458	1007	8	yields	yield	VBZ
50458	1007	9	a	a	DT
50458	1007	10	highly	highly	RB
50458	1007	11	virulent	virulent	JJ
50458	1007	12	toxin	toxin	NN
50458	1007	13	.	.	.
50458	1008	1	[	[	-LRB-
50458	1008	2	133	133	CD
50458	1008	3	]	]	-RRB-
50458	1008	4	[	[	-LRB-
50458	1008	5	131	131	CD
50458	1008	6	]	]	-RRB-
50458	1008	7	_	_	NNP
50458	1008	8	Berlin	Berlin	NNP
50458	1008	9	.	.	.
50458	1009	1	Klin	Klin	NNP
50458	1009	2	.	.	.
50458	1010	1	Wochenschr	Wochenschr	NNP
50458	1010	2	.	.	.
50458	1010	3	_	_	NNP
50458	1010	4	,	,	,
50458	1010	5	1890	1890	CD
50458	1010	6	.	.	.
50458	1011	1	[	[	-LRB-
50458	1011	2	132	132	CD
50458	1011	3	]	]	-RRB-
50458	1011	4	_	_	NNP
50458	1011	5	Annal	Annal	NNP
50458	1011	6	.	.	.
50458	1012	1	de	de	NNP
50458	1012	2	l'Instit	l'Instit	NNP
50458	1012	3	.	.	.
50458	1013	1	Pasteur	Pasteur	NNP
50458	1013	2	_	_	NNP
50458	1013	3	,	,	,
50458	1013	4	VIII	VIII	NNP
50458	1013	5	,	,	,
50458	1013	6	p.	p.	NN
50458	1013	7	103	103	CD
50458	1013	8	.	.	.
50458	1014	1	[	[	-LRB-
50458	1014	2	133	133	CD
50458	1014	3	]	]	-RRB-
50458	1014	4	_	_	NNP
50458	1014	5	Compt	Compt	NNP
50458	1014	6	.	.	.
50458	1015	1	rend	rend	VB
50458	1015	2	.	.	.
50458	1016	1	Soc	Soc	NNP
50458	1016	2	.	.	.
50458	1017	1	de	de	NNP
50458	1017	2	Biol	Biol	NNP
50458	1017	3	.	.	.
50458	1017	4	_	_	NNP
50458	1017	5	,	,	,
50458	1017	6	p.	p.	NN
50458	1017	7	232	232	CD
50458	1017	8	,	,	,
50458	1017	9	Jan.	January	NNP
50458	1017	10	30	30	CD
50458	1017	11	,	,	,
50458	1017	12	1897	1897	CD
50458	1017	13	.	.	.
50458	1018	1	_	_	NNP
50458	1018	2	Congrès	Congrès	NNP
50458	1018	3	d'Hygiène	d'Hygiène	NNP
50458	1018	4	de	de	NNP
50458	1018	5	Madrid	Madrid	NNP
50458	1018	6	_	_	NNP
50458	1018	7	,	,	,
50458	1018	8	1898	1898	CD
50458	1018	9	.	.	.
50458	1019	1	Chantemesse	chantemesse	NN
50458	1019	2	and	and	CC
50458	1019	3	Widal[134	Widal[134	NNP
50458	1019	4	]	]	-RRB-
50458	1019	5	have	have	VBP
50458	1019	6	shown	show	VBN
50458	1019	7	that	that	IN
50458	1019	8	on	on	IN
50458	1019	9	injecting	inject	VBG
50458	1019	10	into	into	IN
50458	1019	11	an	an	DT
50458	1019	12	organism	organism	NN
50458	1019	13	increasing	increase	VBG
50458	1019	14	quantities	quantity	NNS
50458	1019	15	of	of	IN
50458	1019	16	the	the	DT
50458	1019	17	sterilized	sterilize	VBN
50458	1019	18	cultures	culture	NNS
50458	1019	19	of	of	IN
50458	1019	20	Eberth	Eberth	NNP
50458	1019	21	's	's	POS
50458	1019	22	Bacillus	Bacillus	NNP
50458	1019	23	,	,	,
50458	1019	24	it	-PRON-	PRP
50458	1019	25	is	be	VBZ
50458	1019	26	possible	possible	JJ
50458	1019	27	to	to	TO
50458	1019	28	fully	fully	RB
50458	1019	29	immunize	immunize	VB
50458	1019	30	an	an	DT
50458	1019	31	animal	animal	NN
50458	1019	32	against	against	IN
50458	1019	33	the	the	DT
50458	1019	34	bacillus	bacillus	NN
50458	1019	35	itself	-PRON-	PRP
50458	1019	36	,	,	,
50458	1019	37	and	and	CC
50458	1019	38	even	even	RB
50458	1019	39	also	also	RB
50458	1019	40	against	against	IN
50458	1019	41	the	the	DT
50458	1019	42	Bacillus	Bacillus	NNP
50458	1019	43	coli	coli	NNS
50458	1019	44	communis	communis	NN
50458	1019	45	.	.	.
50458	1020	1	The	the	DT
50458	1020	2	operation	operation	NN
50458	1020	3	,	,	,
50458	1020	4	however	however	RB
50458	1020	5	,	,	,
50458	1020	6	is	be	VBZ
50458	1020	7	tedious	tedious	JJ
50458	1020	8	and	and	CC
50458	1020	9	painful	painful	JJ
50458	1020	10	.	.	.
50458	1021	1	The	the	DT
50458	1021	2	serum	serum	NN
50458	1021	3	of	of	IN
50458	1021	4	immunized	immunized	JJ
50458	1021	5	animals	animal	NNS
50458	1021	6	possesses	possess	VBZ
50458	1021	7	preventive	preventive	JJ
50458	1021	8	and	and	CC
50458	1021	9	curative	curative	JJ
50458	1021	10	properties	property	NNS
50458	1021	11	respecting	respect	VBG
50458	1021	12	the	the	DT
50458	1021	13	effects	effect	NNS
50458	1021	14	of	of	IN
50458	1021	15	typhoid	typhoid	NNP
50458	1021	16	bacilli	bacilli	NNP
50458	1021	17	.	.	.
50458	1022	1	[	[	-LRB-
50458	1022	2	134	134	CD
50458	1022	3	]	]	-RRB-
50458	1022	4	_	_	NNP
50458	1022	5	Annal	Annal	NNP
50458	1022	6	.	.	.
50458	1023	1	l'Instit	l'Instit	NNP
50458	1023	2	.	.	.
50458	1024	1	Pasteur	Pasteur	NNP
50458	1024	2	_	_	NNP
50458	1024	3	,	,	,
50458	1024	4	VI	VI	NNP
50458	1024	5	,	,	,
50458	1024	6	p.	p.	NN
50458	1024	7	755	755	CD
50458	1024	8	;	;	:
50458	1024	9	SANARELLI	sanarelli	NN
50458	1024	10	:	:	:
50458	1024	11	_	_	NNP
50458	1024	12	Ibid	Ibid	NNP
50458	1024	13	.	.	.
50458	1024	14	_	_	NNP
50458	1024	15	,	,	,
50458	1024	16	p.	p.	NN
50458	1024	17	721	721	CD
50458	1024	18	.	.	.
50458	1025	1	A	a	DT
50458	1025	2	dose	dose	NN
50458	1025	3	of	of	IN
50458	1025	4	the	the	DT
50458	1025	5	filtered	filter	VBN
50458	1025	6	culture	culture	NN
50458	1025	7	,	,	,
50458	1025	8	which	which	WDT
50458	1025	9	is	be	VBZ
50458	1025	10	fatal	fatal	JJ
50458	1025	11	to	to	IN
50458	1025	12	a	a	DT
50458	1025	13	guinea	guinea	NN
50458	1025	14	-	-	HYPH
50458	1025	15	pig	pig	NN
50458	1025	16	,	,	,
50458	1025	17	becomes	become	VBZ
50458	1025	18	innocuous	innocuous	JJ
50458	1025	19	when	when	WRB
50458	1025	20	mixed	mix	VBN
50458	1025	21	with	with	IN
50458	1025	22	0.5	0.5	CD
50458	1025	23	Cc	Cc	NNP
50458	1025	24	.	.	.
50458	1026	1	of	of	IN
50458	1026	2	the	the	DT
50458	1026	3	serum	serum	NN
50458	1026	4	of	of	IN
50458	1026	5	a	a	DT
50458	1026	6	vaccinated	vaccinated	JJ
50458	1026	7	guinea	guinea	NN
50458	1026	8	-	-	HYPH
50458	1026	9	pig	pig	NN
50458	1026	10	;	;	:
50458	1026	11	6	6	CD
50458	1026	12	Cc	Cc	NNP
50458	1026	13	.	.	.
50458	1027	1	of	of	IN
50458	1027	2	the	the	DT
50458	1027	3	serum	serum	NN
50458	1027	4	injected	inject	VBD
50458	1027	5	six	six	CD
50458	1027	6	hours	hour	NNS
50458	1027	7	after	after	IN
50458	1027	8	an	an	DT
50458	1027	9	injection	injection	NN
50458	1027	10	of	of	IN
50458	1027	11	the	the	DT
50458	1027	12	virulent	virulent	NN
50458	1027	13	culture	culture	NN
50458	1027	14	,	,	,
50458	1027	15	hence	hence	RB
50458	1027	16	when	when	WRB
50458	1027	17	this	this	DT
50458	1027	18	is	be	VBZ
50458	1027	19	in	in	IN
50458	1027	20	full	full	JJ
50458	1027	21	action	action	NN
50458	1027	22	,	,	,
50458	1027	23	suffice	suffice	VBP
50458	1027	24	to	to	TO
50458	1027	25	save	save	VB
50458	1027	26	the	the	DT
50458	1027	27	animal	animal	NN
50458	1027	28	.	.	.
50458	1028	1	[	[	-LRB-
50458	1028	2	135	135	CD
50458	1028	3	]	]	-RRB-
50458	1028	4	So	so	RB
50458	1028	5	far	far	RB
50458	1028	6	as	as	IN
50458	1028	7	the	the	DT
50458	1028	8	human	human	NN
50458	1028	9	being	being	NN
50458	1028	10	is	be	VBZ
50458	1028	11	concerned	concern	VBN
50458	1028	12	,	,	,
50458	1028	13	the	the	DT
50458	1028	14	results	result	NNS
50458	1028	15	obtained	obtain	VBD
50458	1028	16	have	have	VBP
50458	1028	17	not	not	RB
50458	1028	18	been	be	VBN
50458	1028	19	sufficiently	sufficiently	RB
50458	1028	20	satisfactory	satisfactory	JJ
50458	1028	21	.	.	.
50458	1029	1	[	[	-LRB-
50458	1029	2	135	135	CD
50458	1029	3	]	]	-RRB-
50458	1029	4	FUNCK	FUNCK	NNP
50458	1029	5	:	:	:
50458	1029	6	_	_	NNP
50458	1029	7	La	La	NNP
50458	1029	8	Sérothérapie	Sérothérapie	NNP
50458	1029	9	de	de	NNP
50458	1029	10	la	la	NNP
50458	1029	11	Fièvre	Fièvre	NNP
50458	1029	12	Typhoïde	Typhoïde	NNP
50458	1029	13	_	_	NNP
50458	1029	14	,	,	,
50458	1029	15	I	-PRON-	PRP
50458	1029	16	,	,	,
50458	1029	17	Brussels	Brussels	NNP
50458	1029	18	,	,	,
50458	1029	19	1896	1896	CD
50458	1029	20	.	.	.
50458	1030	1	The	the	DT
50458	1030	2	culture	culture	NN
50458	1030	3	bouillon	bouillon	NN
50458	1030	4	of	of	IN
50458	1030	5	the	the	DT
50458	1030	6	Bacillus	Bacillus	NNP
50458	1030	7	coli	coli	NNS
50458	1030	8	communis	communis	NN
50458	1030	9	,	,	,
50458	1030	10	which	which	WDT
50458	1030	11	is	be	VBZ
50458	1030	12	closely	closely	RB
50458	1030	13	allied	ally	VBN
50458	1030	14	to	to	IN
50458	1030	15	Eberth	Eberth	NNP
50458	1030	16	's	's	POS
50458	1030	17	bacillus	bacillus	NN
50458	1030	18	,	,	,
50458	1030	19	also	also	RB
50458	1030	20	contains	contain	VBZ
50458	1030	21	soluble	soluble	JJ
50458	1030	22	toxic	toxic	JJ
50458	1030	23	substances	substance	NNS
50458	1030	24	which	which	WDT
50458	1030	25	have	have	VBP
50458	1030	26	been	be	VBN
50458	1030	27	named	name	VBN
50458	1030	28	coli	coli	NNS
50458	1030	29	-	-	HYPH
50458	1030	30	bacillus	bacillus	NN
50458	1030	31	toxin	toxin	NN
50458	1030	32	.	.	.
50458	1031	1	This	this	DT
50458	1031	2	substance	substance	NN
50458	1031	3	,	,	,
50458	1031	4	which	which	WDT
50458	1031	5	is	be	VBZ
50458	1031	6	produced	produce	VBN
50458	1031	7	only	only	RB
50458	1031	8	in	in	IN
50458	1031	9	small	small	JJ
50458	1031	10	quantity	quantity	NN
50458	1031	11	by	by	IN
50458	1031	12	the	the	DT
50458	1031	13	microbe	microbe	NN
50458	1031	14	,	,	,
50458	1031	15	is	be	VBZ
50458	1031	16	fatal	fatal	JJ
50458	1031	17	only	only	RB
50458	1031	18	in	in	IN
50458	1031	19	very	very	RB
50458	1031	20	large	large	JJ
50458	1031	21	doses	dose	NNS
50458	1031	22	.	.	.
50458	1032	1	=	=	NFP
50458	1032	2	Cholera	Cholera	NNP
50458	1032	3	Toxin.=--Very	toxin.=--very	NN
50458	1032	4	little	little	JJ
50458	1032	5	is	be	VBZ
50458	1032	6	known	know	VBN
50458	1032	7	regarding	regard	VBG
50458	1032	8	the	the	DT
50458	1032	9	toxic	toxic	JJ
50458	1032	10	products	product	NNS
50458	1032	11	of	of	IN
50458	1032	12	the	the	DT
50458	1032	13	spirillium	spirillium	NN
50458	1032	14	choleræ	choleræ	JJ
50458	1032	15	;	;	:
50458	1032	16	nevertheless	nevertheless	RB
50458	1032	17	,	,	,
50458	1032	18	the	the	DT
50458	1032	19	fact	fact	NN
50458	1032	20	that	that	IN
50458	1032	21	typical	typical	JJ
50458	1032	22	cholera	cholera	NN
50458	1032	23	exhibits	exhibit	VBZ
50458	1032	24	every	every	DT
50458	1032	25	symptom	symptom	NN
50458	1032	26	of	of	IN
50458	1032	27	the	the	DT
50458	1032	28	action	action	NN
50458	1032	29	of	of	IN
50458	1032	30	a	a	DT
50458	1032	31	toxic	toxic	JJ
50458	1032	32	agent	agent	NN
50458	1032	33	demonstrates	demonstrate	VBZ
50458	1032	34	quite	quite	RB
50458	1032	35	clearly	clearly	RB
50458	1032	36	the	the	DT
50458	1032	37	elaboration	elaboration	NN
50458	1032	38	of	of	IN
50458	1032	39	some	some	DT
50458	1032	40	toxic	toxic	JJ
50458	1032	41	substance	substance	NN
50458	1032	42	within	within	IN
50458	1032	43	the	the	DT
50458	1032	44	cultures	culture	NNS
50458	1032	45	of	of	IN
50458	1032	46	this	this	DT
50458	1032	47	microbe	microbe	NN
50458	1032	48	.	.	.
50458	1033	1	Villiers[136	Villiers[136	NNP
50458	1033	2	]	]	-RRB-
50458	1033	3	found	find	VBN
50458	1033	4	in	in	IN
50458	1033	5	it	-PRON-	PRP
50458	1033	6	a	a	DT
50458	1033	7	liquid	liquid	JJ
50458	1033	8	ptomaine	ptomaine	NN
50458	1033	9	;	;	:
50458	1033	10	Klebs[137	Klebs[137	NNP
50458	1033	11	]	]	-RRB-
50458	1033	12	found	find	VBD
50458	1033	13	another	another	DT
50458	1033	14	and	and	CC
50458	1033	15	crystallizable	crystallizable	JJ
50458	1033	16	ptomaine	ptomaine	NN
50458	1033	17	;	;	:
50458	1033	18	while	while	IN
50458	1033	19	Pitai	Pitai	NNP
50458	1033	20	discovered	discover	VBD
50458	1033	21	in	in	IN
50458	1033	22	it	-PRON-	PRP
50458	1033	23	a	a	DT
50458	1033	24	toxin	toxin	NN
50458	1033	25	unalterable	unalterable	JJ
50458	1033	26	by	by	IN
50458	1033	27	heat	heat	NN
50458	1033	28	,	,	,
50458	1033	29	and	and	CC
50458	1033	30	which	which	WDT
50458	1033	31	he	-PRON-	PRP
50458	1033	32	considered	consider	VBD
50458	1033	33	as	as	IN
50458	1033	34	a	a	DT
50458	1033	35	toxopeptone	toxopeptone	NN
50458	1033	36	.	.	.
50458	1034	1	According	accord	VBG
50458	1034	2	to	to	IN
50458	1034	3	Gamaleia[138	gamaleia[138	CD
50458	1034	4	]	]	-RRB-
50458	1034	5	there	there	EX
50458	1034	6	is	be	VBZ
50458	1034	7	present	present	JJ
50458	1034	8	a	a	DT
50458	1034	9	true	true	JJ
50458	1034	10	toxin	toxin	NN
50458	1034	11	,	,	,
50458	1034	12	alterable	alterable	JJ
50458	1034	13	by	by	IN
50458	1034	14	heat	heat	NN
50458	1034	15	,	,	,
50458	1034	16	and	and	CC
50458	1034	17	the	the	DT
50458	1034	18	reactions	reaction	NNS
50458	1034	19	of	of	IN
50458	1034	20	which	which	WDT
50458	1034	21	entitle	entitle	VBP
50458	1034	22	it	-PRON-	PRP
50458	1034	23	to	to	TO
50458	1034	24	be	be	VB
50458	1034	25	considered	consider	VBN
50458	1034	26	as	as	IN
50458	1034	27	a	a	DT
50458	1034	28	nucleo	nucleo	NN
50458	1034	29	-	-	HYPH
50458	1034	30	albumin	albumin	NN
50458	1034	31	;	;	:
50458	1034	32	he	-PRON-	PRP
50458	1034	33	has	have	VBZ
50458	1034	34	also	also	RB
50458	1034	35	found	find	VBN
50458	1034	36	in	in	IN
50458	1034	37	it	-PRON-	PRP
50458	1034	38	a	a	DT
50458	1034	39	toxic	toxic	JJ
50458	1034	40	nuclein	nuclein	NN
50458	1034	41	.	.	.
50458	1035	1	[	[	-LRB-
50458	1035	2	136	136	CD
50458	1035	3	]	]	-RRB-
50458	1035	4	_	_	NNP
50458	1035	5	Compt	Compt	NNP
50458	1035	6	.	.	.
50458	1036	1	rend	rend	VB
50458	1036	2	.	.	.
50458	1037	1	de	de	NNP
50458	1037	2	l'Acad	l'Acad	NNP
50458	1037	3	.	.	.
50458	1038	1	des	des	NNP
50458	1038	2	Sciences	Sciences	NNPS
50458	1038	3	_	_	NNP
50458	1038	4	,	,	,
50458	1038	5	Jan.	January	NNP
50458	1038	6	12	12	CD
50458	1038	7	,	,	,
50458	1038	8	1885	1885	CD
50458	1038	9	.	.	.
50458	1039	1	[	[	-LRB-
50458	1039	2	137	137	CD
50458	1039	3	]	]	-RRB-
50458	1039	4	KLEBS	KLEBS	NNP
50458	1039	5	:	:	:
50458	1039	6	_	_	NNP
50458	1039	7	Allgem	Allgem	NNP
50458	1039	8	.	.	.
50458	1040	1	Wien	Wien	NNP
50458	1040	2	.	.	.
50458	1041	1	Med	Med	NNP
50458	1041	2	.	.	.
50458	1042	1	Zeit	Zeit	NNP
50458	1042	2	.	.	.
50458	1042	3	_	_	NNP
50458	1042	4	,	,	,
50458	1042	5	1887	1887	CD
50458	1042	6	.	.	.
50458	1043	1	[	[	-LRB-
50458	1043	2	138	138	CD
50458	1043	3	]	]	-RRB-
50458	1043	4	_	_	NNP
50458	1043	5	Arch	Arch	NNP
50458	1043	6	.	.	.
50458	1044	1	de	de	NNP
50458	1044	2	Méd	Méd	NNP
50458	1044	3	.	.	.
50458	1045	1	Expérim	Expérim	NNP
50458	1045	2	.	.	.
50458	1045	3	_	_	NNP
50458	1045	4	,	,	,
50458	1045	5	IV	IV	NNP
50458	1045	6	,	,	,
50458	1045	7	p.	p.	NN
50458	1045	8	173	173	CD
50458	1045	9	.	.	.
50458	1046	1	These	these	DT
50458	1046	2	toxic	toxic	JJ
50458	1046	3	substances	substance	NNS
50458	1046	4	are	be	VBP
50458	1046	5	found	find	VBN
50458	1046	6	,	,	,
50458	1046	7	according	accord	VBG
50458	1046	8	to	to	IN
50458	1046	9	Gamaleia	Gamaleia	NNP
50458	1046	10	,	,	,
50458	1046	11	Pfeiffer	Pfeiffer	NNP
50458	1046	12	,	,	,
50458	1046	13	and	and	CC
50458	1046	14	Sanarelli,[139	Sanarelli,[139	NNP
50458	1046	15	]	]	-RRB-
50458	1046	16	confined	confine	VBN
50458	1046	17	during	during	IN
50458	1046	18	the	the	DT
50458	1046	19	life	life	NN
50458	1046	20	of	of	IN
50458	1046	21	the	the	DT
50458	1046	22	microbe	microbe	NN
50458	1046	23	within	within	IN
50458	1046	24	its	-PRON-	PRP$
50458	1046	25	cellular	cellular	JJ
50458	1046	26	envelope	envelope	NN
50458	1046	27	,	,	,
50458	1046	28	and	and	CC
50458	1046	29	does	do	VBZ
50458	1046	30	not	not	RB
50458	1046	31	diffuse	diffuse	VB
50458	1046	32	through	through	IN
50458	1046	33	this	this	DT
50458	1046	34	.	.	.
50458	1047	1	Metchnikoff	Metchnikoff	NNP
50458	1047	2	and	and	CC
50458	1047	3	Roux	Roux	NNP
50458	1047	4	are	be	VBP
50458	1047	5	of	of	IN
50458	1047	6	the	the	DT
50458	1047	7	contrary	contrary	JJ
50458	1047	8	opinion,[140	opinion,[140	NN
50458	1047	9	]	]	-RRB-
50458	1047	10	however	however	RB
50458	1047	11	,	,	,
50458	1047	12	and	and	CC
50458	1047	13	they	-PRON-	PRP
50458	1047	14	have	have	VBP
50458	1047	15	prepared	prepare	VBN
50458	1047	16	a	a	DT
50458	1047	17	toxin	toxin	NN
50458	1047	18	almost	almost	RB
50458	1047	19	insensitive	insensitive	JJ
50458	1047	20	to	to	IN
50458	1047	21	a	a	DT
50458	1047	22	temperature	temperature	NN
50458	1047	23	of	of	IN
50458	1047	24	100	100	CD
50458	1047	25	°	°	NNS
50458	1047	26	C.	C.	NNP
50458	1047	27	,	,	,
50458	1047	28	and	and	CC
50458	1047	29	precipitable	precipitable	JJ
50458	1047	30	from	from	IN
50458	1047	31	its	-PRON-	PRP$
50458	1047	32	solutions	solution	NNS
50458	1047	33	by	by	IN
50458	1047	34	ammonium	ammonium	NN
50458	1047	35	sulphate	sulphate	NN
50458	1047	36	or	or	CC
50458	1047	37	strong	strong	JJ
50458	1047	38	alcohol	alcohol	NN
50458	1047	39	;	;	:
50458	1047	40	the	the	DT
50458	1047	41	toxin	toxin	NN
50458	1047	42	is	be	VBZ
50458	1047	43	a	a	DT
50458	1047	44	toxalbumin	toxalbumin	NN
50458	1047	45	.	.	.
50458	1048	1	This	this	DT
50458	1048	2	toxin	toxin	NN
50458	1048	3	is	be	VBZ
50458	1048	4	quite	quite	RB
50458	1048	5	toxic	toxic	JJ
50458	1048	6	;	;	:
50458	1048	7	one	one	CD
50458	1048	8	-	-	HYPH
50458	1048	9	third	third	NN
50458	1048	10	of	of	IN
50458	1048	11	a	a	DT
50458	1048	12	cubic	cubic	JJ
50458	1048	13	centimeter	centimeter	NN
50458	1048	14	suffices	suffice	VBZ
50458	1048	15	to	to	TO
50458	1048	16	kill	kill	VB
50458	1048	17	100	100	CD
50458	1048	18	Gm	Gm	NNP
50458	1048	19	.	.	.
50458	1049	1	of	of	IN
50458	1049	2	guinea	guinea	NN
50458	1049	3	-	-	HYPH
50458	1049	4	pig	pig	NN
50458	1049	5	in	in	IN
50458	1049	6	18	18	CD
50458	1049	7	hours	hour	NNS
50458	1049	8	;	;	,
50458	1049	9	with	with	IN
50458	1049	10	larger	large	JJR
50458	1049	11	doses	dose	NNS
50458	1049	12	,	,	,
50458	1049	13	death	death	NN
50458	1049	14	is	be	VBZ
50458	1049	15	almost	almost	RB
50458	1049	16	immediate	immediate	JJ
50458	1049	17	.	.	.
50458	1050	1	[	[	-LRB-
50458	1050	2	139	139	CD
50458	1050	3	]	]	-RRB-
50458	1050	4	_	_	NNP
50458	1050	5	Annal	Annal	NNP
50458	1050	6	.	.	.
50458	1051	1	de	de	NNP
50458	1051	2	l'Instit	l'Instit	NNP
50458	1051	3	.	.	.
50458	1052	1	Pasteur	Pasteur	NNP
50458	1052	2	_	_	NNP
50458	1052	3	,	,	,
50458	1052	4	IX	IX	NNP
50458	1052	5	,	,	,
50458	1052	6	p.	p.	NN
50458	1052	7	129	129	CD
50458	1052	8	.	.	.
50458	1053	1	[	[	-LRB-
50458	1053	2	140	140	CD
50458	1053	3	]	]	-RRB-
50458	1053	4	_	_	NNP
50458	1053	5	Ibid	Ibid	NNP
50458	1053	6	.	.	.
50458	1053	7	_	_	NNP
50458	1053	8	,	,	,
50458	1053	9	X	X	NNP
50458	1053	10	,	,	,
50458	1053	11	p.	p.	NN
50458	1053	12	257	257	CD
50458	1053	13	.	.	.
50458	1054	1	By	by	IN
50458	1054	2	immunizing	immunize	VBG
50458	1054	3	guinea	guinea	NN
50458	1054	4	-	-	HYPH
50458	1054	5	pigs	pig	NNS
50458	1054	6	,	,	,
50458	1054	7	rabbits	rabbit	NNS
50458	1054	8	,	,	,
50458	1054	9	and	and	CC
50458	1054	10	horses	horse	NNS
50458	1054	11	with	with	IN
50458	1054	12	this	this	DT
50458	1054	13	cholera	cholera	NN
50458	1054	14	toxin	toxin	NN
50458	1054	15	,	,	,
50458	1054	16	Metchnikoff	Metchnikoff	NNP
50458	1054	17	and	and	CC
50458	1054	18	Roux	Roux	NNP
50458	1054	19	obtained	obtain	VBD
50458	1054	20	a	a	DT
50458	1054	21	serum	serum	NN
50458	1054	22	which	which	WDT
50458	1054	23	is	be	VBZ
50458	1054	24	distinctly	distinctly	RB
50458	1054	25	antitoxic	antitoxic	JJ
50458	1054	26	for	for	IN
50458	1054	27	rabbits	rabbit	NNS
50458	1054	28	.	.	.
50458	1055	1	Nothing	nothing	NN
50458	1055	2	absolutely	absolutely	RB
50458	1055	3	certain	certain	JJ
50458	1055	4	has	have	VBZ
50458	1055	5	been	be	VBN
50458	1055	6	found	find	VBN
50458	1055	7	as	as	IN
50458	1055	8	to	to	IN
50458	1055	9	its	-PRON-	PRP$
50458	1055	10	action	action	NN
50458	1055	11	on	on	IN
50458	1055	12	man	man	NN
50458	1055	13	.	.	.
50458	1056	1	[	[	-LRB-
50458	1056	2	141	141	CD
50458	1056	3	]	]	-RRB-
50458	1056	4	[	[	-LRB-
50458	1056	5	141	141	CD
50458	1056	6	]	]	-RRB-
50458	1056	7	HAFFKINE	haffkine	NN
50458	1056	8	:	:	:
50458	1056	9	_	_	NNP
50458	1056	10	Compt	Compt	NNP
50458	1056	11	.	.	.
50458	1057	1	rend	rend	VB
50458	1057	2	.	.	.
50458	1058	1	de	de	NNP
50458	1058	2	l'Acad	l'Acad	NNP
50458	1058	3	.	.	.
50458	1059	1	des	des	NNP
50458	1059	2	Sciences	Sciences	NNPS
50458	1059	3	_	_	NNP
50458	1059	4	,	,	,
50458	1059	5	1892	1892	CD
50458	1059	6	;	;	:
50458	1059	7	METCHNIKOFF	METCHNIKOFF	NNP
50458	1059	8	:	:	:
50458	1059	9	_	_	NNP
50458	1059	10	Annal	Annal	NNP
50458	1059	11	.	.	.
50458	1060	1	de	de	NNP
50458	1060	2	l'Instit	l'Instit	NNP
50458	1060	3	.	.	.
50458	1061	1	Pasteur	Pasteur	NNP
50458	1061	2	_	_	NNP
50458	1061	3	,	,	,
50458	1061	4	VII	VII	NNP
50458	1061	5	,	,	,
50458	1061	6	p.	p.	NN
50458	1061	7	403	403	CD
50458	1061	8	;	;	:
50458	1061	9	and	and	CC
50458	1061	10	ROUX	roux	VB
50458	1061	11	:	:	:
50458	1061	12	_	_	NNP
50458	1061	13	Ibid	Ibid	NNP
50458	1061	14	.	.	.
50458	1061	15	_	_	NNP
50458	1061	16	,	,	,
50458	1061	17	X	X	NNP
50458	1061	18	,	,	,
50458	1061	19	p.	p.	NN
50458	1061	20	253	253	CD
50458	1061	21	.	.	.
50458	1062	1	*	*	NFP
50458	1062	2	*	*	NFP
50458	1062	3	*	*	NFP
50458	1062	4	*	*	NFP
50458	1062	5	*	*	NFP
50458	1062	6	We	-PRON-	PRP
50458	1062	7	will	will	MD
50458	1062	8	not	not	RB
50458	1062	9	dwell	dwell	VB
50458	1062	10	longer	long	RBR
50458	1062	11	here	here	RB
50458	1062	12	on	on	IN
50458	1062	13	the	the	DT
50458	1062	14	toxins	toxin	NNS
50458	1062	15	of	of	IN
50458	1062	16	microbial	microbial	JJ
50458	1062	17	origin	origin	NN
50458	1062	18	.	.	.
50458	1063	1	It	-PRON-	PRP
50458	1063	2	appears	appear	VBZ
50458	1063	3	evident	evident	JJ
50458	1063	4	,	,	,
50458	1063	5	however	however	RB
50458	1063	6	,	,	,
50458	1063	7	from	from	IN
50458	1063	8	what	what	WP
50458	1063	9	has	have	VBZ
50458	1063	10	been	be	VBN
50458	1063	11	stated	state	VBN
50458	1063	12	above	above	RB
50458	1063	13	,	,	,
50458	1063	14	that	that	IN
50458	1063	15	the	the	DT
50458	1063	16	great	great	JJ
50458	1063	17	majority	majority	NN
50458	1063	18	,	,	,
50458	1063	19	if	if	IN
50458	1063	20	not	not	RB
50458	1063	21	all	all	DT
50458	1063	22	,	,	,
50458	1063	23	of	of	IN
50458	1063	24	the	the	DT
50458	1063	25	virulent	virulent	NN
50458	1063	26	microbes	microbe	NNS
50458	1063	27	manifest	manifest	VBP
50458	1063	28	their	-PRON-	PRP$
50458	1063	29	virulence	virulence	NN
50458	1063	30	by	by	IN
50458	1063	31	means	mean	NNS
50458	1063	32	of	of	IN
50458	1063	33	toxic	toxic	JJ
50458	1063	34	secretions	secretion	NNS
50458	1063	35	.	.	.
50458	1064	1	Almost	almost	RB
50458	1064	2	every	every	DT
50458	1064	3	one	one	CD
50458	1064	4	of	of	IN
50458	1064	5	these	these	DT
50458	1064	6	toxins	toxin	NNS
50458	1064	7	has	have	VBZ
50458	1064	8	been	be	VBN
50458	1064	9	the	the	DT
50458	1064	10	subject	subject	NN
50458	1064	11	of	of	IN
50458	1064	12	study	study	NN
50458	1064	13	.	.	.
50458	1065	1	They	-PRON-	PRP
50458	1065	2	would	would	MD
50458	1065	3	otherwise	otherwise	RB
50458	1065	4	not	not	RB
50458	1065	5	have	have	VB
50458	1065	6	interested	interest	VBN
50458	1065	7	us	-PRON-	PRP
50458	1065	8	here	here	RB
50458	1065	9	,	,	,
50458	1065	10	where	where	WRB
50458	1065	11	our	-PRON-	PRP$
50458	1065	12	main	main	JJ
50458	1065	13	object	object	NN
50458	1065	14	was	be	VBD
50458	1065	15	but	but	CC
50458	1065	16	to	to	TO
50458	1065	17	dwell	dwell	VB
50458	1065	18	upon	upon	IN
50458	1065	19	the	the	DT
50458	1065	20	general	general	JJ
50458	1065	21	properties	property	NNS
50458	1065	22	.	.	.
50458	1066	1	CHAPTER	CHAPTER	NNP
50458	1066	2	V.	V.	NNP
50458	1066	3	THE	the	DT
50458	1066	4	VENOMS	VENOMS	NNP
50458	1066	5	.	.	.
50458	1067	1	=	=	NFP
50458	1067	2	General	General	NNP
50458	1067	3	Nature	Nature	NNP
50458	1067	4	of	of	IN
50458	1067	5	Venoms.=--The	Venoms.=--The	NNP
50458	1067	6	venoms	venom	NNS
50458	1067	7	are	be	VBP
50458	1067	8	more	more	RBR
50458	1067	9	or	or	CC
50458	1067	10	less	less	JJR
50458	1067	11	toxic	toxic	JJ
50458	1067	12	products	product	NNS
50458	1067	13	secreted	secrete	VBN
50458	1067	14	by	by	IN
50458	1067	15	certain	certain	JJ
50458	1067	16	reptiles	reptile	NNS
50458	1067	17	,	,	,
50458	1067	18	batrachians	batrachian	NNS
50458	1067	19	,	,	,
50458	1067	20	and	and	CC
50458	1067	21	fish	fish	NN
50458	1067	22	;	;	:
50458	1067	23	by	by	IN
50458	1067	24	a	a	DT
50458	1067	25	large	large	JJ
50458	1067	26	number	number	NN
50458	1067	27	of	of	IN
50458	1067	28	invertebrates	invertebrate	NNS
50458	1067	29	;	;	:
50458	1067	30	by	by	IN
50458	1067	31	arachnids	arachnid	NNS
50458	1067	32	,	,	,
50458	1067	33	apids	apid	NNS
50458	1067	34	,	,	,
50458	1067	35	scorpionids	scorpionid	NNS
50458	1067	36	,	,	,
50458	1067	37	araneids	araneid	NNS
50458	1067	38	,	,	,
50458	1067	39	and	and	CC
50458	1067	40	a	a	DT
50458	1067	41	large	large	JJ
50458	1067	42	number	number	NN
50458	1067	43	of	of	IN
50458	1067	44	other	other	JJ
50458	1067	45	insects	insect	NNS
50458	1067	46	.	.	.
50458	1068	1	The	the	DT
50458	1068	2	venoms	venom	NNS
50458	1068	3	are	be	VBP
50458	1068	4	toxic	toxic	JJ
50458	1068	5	principles	principle	NNS
50458	1068	6	very	very	RB
50458	1068	7	closely	closely	RB
50458	1068	8	allied	allied	JJ
50458	1068	9	to	to	IN
50458	1068	10	the	the	DT
50458	1068	11	microbial	microbial	JJ
50458	1068	12	toxins	toxin	NNS
50458	1068	13	;	;	:
50458	1068	14	like	like	IN
50458	1068	15	the	the	DT
50458	1068	16	latter	latter	JJ
50458	1068	17	,	,	,
50458	1068	18	they	-PRON-	PRP
50458	1068	19	form	form	VBP
50458	1068	20	two	two	CD
50458	1068	21	classes	class	NNS
50458	1068	22	,	,	,
50458	1068	23	the	the	DT
50458	1068	24	one	one	CD
50458	1068	25	alkaloidal	alkaloidal	NN
50458	1068	26	,	,	,
50458	1068	27	the	the	DT
50458	1068	28	other	other	JJ
50458	1068	29	proteid	proteid	NN
50458	1068	30	,	,	,
50458	1068	31	possessing	possess	VBG
50458	1068	32	a	a	DT
50458	1068	33	true	true	JJ
50458	1068	34	diastatic	diastatic	JJ
50458	1068	35	character	character	NN
50458	1068	36	.	.	.
50458	1069	1	They	-PRON-	PRP
50458	1069	2	closely	closely	RB
50458	1069	3	resemble	resemble	VBP
50458	1069	4	the	the	DT
50458	1069	5	microbial	microbial	NN
50458	1069	6	toxins	toxin	NNS
50458	1069	7	,	,	,
50458	1069	8	moreover	moreover	RB
50458	1069	9	,	,	,
50458	1069	10	by	by	IN
50458	1069	11	the	the	DT
50458	1069	12	fact	fact	NN
50458	1069	13	that	that	IN
50458	1069	14	they	-PRON-	PRP
50458	1069	15	are	be	VBP
50458	1069	16	capable	capable	JJ
50458	1069	17	of	of	IN
50458	1069	18	being	be	VBG
50458	1069	19	transformed	transform	VBN
50458	1069	20	into	into	IN
50458	1069	21	vaccins	vaccin	NNS
50458	1069	22	by	by	IN
50458	1069	23	attenuation	attenuation	NN
50458	1069	24	of	of	IN
50458	1069	25	their	-PRON-	PRP$
50458	1069	26	virulence	virulence	NN
50458	1069	27	,	,	,
50458	1069	28	by	by	IN
50458	1069	29	the	the	DT
50458	1069	30	action	action	NN
50458	1069	31	of	of	IN
50458	1069	32	heat	heat	NN
50458	1069	33	or	or	CC
50458	1069	34	chemical	chemical	NN
50458	1069	35	reagents	reagent	NNS
50458	1069	36	,	,	,
50458	1069	37	and	and	CC
50458	1069	38	of	of	IN
50458	1069	39	leading	lead	VBG
50458	1069	40	to	to	IN
50458	1069	41	habituation	habituation	NN
50458	1069	42	of	of	IN
50458	1069	43	use	use	NN
50458	1069	44	and	and	CC
50458	1069	45	the	the	DT
50458	1069	46	conference	conference	NN
50458	1069	47	of	of	IN
50458	1069	48	immunity	immunity	NN
50458	1069	49	.	.	.
50458	1070	1	[	[	-LRB-
50458	1070	2	142	142	CD
50458	1070	3	]	]	-RRB-
50458	1070	4	Moreover	moreover	RB
50458	1070	5	,	,	,
50458	1070	6	like	like	IN
50458	1070	7	the	the	DT
50458	1070	8	various	various	JJ
50458	1070	9	viruses	virus	NNS
50458	1070	10	,	,	,
50458	1070	11	the	the	DT
50458	1070	12	serum	serum	NN
50458	1070	13	of	of	IN
50458	1070	14	immunized	immunized	JJ
50458	1070	15	animals	animal	NNS
50458	1070	16	is	be	VBZ
50458	1070	17	antivenomous	antivenomous	JJ
50458	1070	18	,	,	,
50458	1070	19	so	so	IN
50458	1070	20	that	that	IN
50458	1070	21	if	if	IN
50458	1070	22	injected	inject	VBN
50458	1070	23	into	into	IN
50458	1070	24	the	the	DT
50458	1070	25	veins	vein	NNS
50458	1070	26	or	or	CC
50458	1070	27	beneath	beneath	IN
50458	1070	28	the	the	DT
50458	1070	29	skin	skin	NN
50458	1070	30	of	of	IN
50458	1070	31	non	non	JJ
50458	1070	32	-	-	JJ
50458	1070	33	immunized	immunized	JJ
50458	1070	34	animals	animal	NNS
50458	1070	35	,	,	,
50458	1070	36	the	the	DT
50458	1070	37	serum	serum	NN
50458	1070	38	confers	confer	VBZ
50458	1070	39	upon	upon	IN
50458	1070	40	them	-PRON-	PRP
50458	1070	41	an	an	DT
50458	1070	42	immunity	immunity	NN
50458	1070	43	against	against	IN
50458	1070	44	venom	venom	NN
50458	1070	45	which	which	WDT
50458	1070	46	lasts	last	VBZ
50458	1070	47	for	for	IN
50458	1070	48	some	some	DT
50458	1070	49	time	time	NN
50458	1070	50	.	.	.
50458	1071	1	[	[	-LRB-
50458	1071	2	142	142	CD
50458	1071	3	]	]	-RRB-
50458	1071	4	_	_	NNP
50458	1071	5	Annal	Annal	NNP
50458	1071	6	.	.	.
50458	1072	1	de	de	NNP
50458	1072	2	l'Instit	l'Instit	NNP
50458	1072	3	.	.	.
50458	1073	1	Pasteur	Pasteur	NNP
50458	1073	2	_	_	NNP
50458	1073	3	,	,	,
50458	1073	4	VIII	VIII	NNP
50458	1073	5	,	,	,
50458	1073	6	p.	p.	NN
50458	1073	7	281	281	CD
50458	1073	8	;	;	:
50458	1073	9	_	_	NNP
50458	1073	10	Journ	Journ	NNP
50458	1073	11	.	.	.
50458	1074	1	of	of	IN
50458	1074	2	Physiol	Physiol	NNP
50458	1074	3	.	.	.
50458	1074	4	_	_	NNP
50458	1074	5	,	,	,
50458	1074	6	VIII	VIII	NNP
50458	1074	7	,	,	,
50458	1074	8	p.	p.	NN
50458	1074	9	203	203	CD
50458	1074	10	;	;	:
50458	1074	11	and	and	CC
50458	1074	12	_	_	NNP
50458	1074	13	Soc	Soc	NNP
50458	1074	14	.	.	.
50458	1075	1	de	de	NNP
50458	1075	2	Biol	Biol	NNP
50458	1075	3	.	.	.
50458	1075	4	_	_	NNP
50458	1075	5	,	,	,
50458	1075	6	1894	1894	CD
50458	1075	7	,	,	,
50458	1075	8	p.	p.	NN
50458	1075	9	111	111	CD
50458	1075	10	.	.	.
50458	1076	1	These	these	DT
50458	1076	2	venoms	venom	NNS
50458	1076	3	,	,	,
50458	1076	4	like	like	IN
50458	1076	5	the	the	DT
50458	1076	6	microbial	microbial	JJ
50458	1076	7	toxins	toxin	NNS
50458	1076	8	,	,	,
50458	1076	9	possess	possess	NN
50458	1076	10	but	but	CC
50458	1076	11	slight	slight	JJ
50458	1076	12	toxicity	toxicity	NN
50458	1076	13	when	when	WRB
50458	1076	14	absorbed	absorb	VBN
50458	1076	15	via	via	IN
50458	1076	16	the	the	DT
50458	1076	17	stomach	stomach	NN
50458	1076	18	.	.	.
50458	1077	1	Fraser	Fraser	NNP
50458	1077	2	,	,	,
50458	1077	3	utilizing	utilize	VBG
50458	1077	4	a	a	DT
50458	1077	5	method	method	NN
50458	1077	6	previously	previously	RB
50458	1077	7	advocated	advocate	VBN
50458	1077	8	,	,	,
50458	1077	9	succeeded	succeed	VBD
50458	1077	10	,	,	,
50458	1077	11	by	by	IN
50458	1077	12	following	follow	VBG
50458	1077	13	this	this	DT
50458	1077	14	method	method	NN
50458	1077	15	,	,	,
50458	1077	16	in	in	IN
50458	1077	17	vaccinating	vaccinate	VBG
50458	1077	18	against	against	IN
50458	1077	19	serpent	serpent	NN
50458	1077	20	-	-	HYPH
50458	1077	21	venom	venom	NN
50458	1077	22	by	by	IN
50458	1077	23	causing	cause	VBG
50458	1077	24	the	the	DT
50458	1077	25	absorption	absorption	NN
50458	1077	26	by	by	IN
50458	1077	27	animals	animal	NNS
50458	1077	28	of	of	IN
50458	1077	29	constantly	constantly	RB
50458	1077	30	increasing	increase	VBG
50458	1077	31	doses	dose	NNS
50458	1077	32	of	of	IN
50458	1077	33	venom	venom	NN
50458	1077	34	.	.	.
50458	1078	1	It	-PRON-	PRP
50458	1078	2	was	be	VBD
50458	1078	3	thus	thus	RB
50458	1078	4	possible	possible	JJ
50458	1078	5	to	to	TO
50458	1078	6	make	make	VB
50458	1078	7	the	the	DT
50458	1078	8	animals	animal	NNS
50458	1078	9	withstand	withstand	VB
50458	1078	10	doses	dose	NNS
50458	1078	11	a	a	DT
50458	1078	12	thousand	thousand	CD
50458	1078	13	times	time	NNS
50458	1078	14	greater	great	JJR
50458	1078	15	than	than	IN
50458	1078	16	the	the	DT
50458	1078	17	ordinary	ordinary	JJ
50458	1078	18	lethal	lethal	JJ
50458	1078	19	dose	dose	NN
50458	1078	20	;	;	:
50458	1078	21	the	the	DT
50458	1078	22	blood	blood	NN
50458	1078	23	and	and	CC
50458	1078	24	serums	serum	NNS
50458	1078	25	of	of	IN
50458	1078	26	these	these	DT
50458	1078	27	animals	animal	NNS
50458	1078	28	at	at	IN
50458	1078	29	this	this	DT
50458	1078	30	point	point	NN
50458	1078	31	possessed	possess	VBD
50458	1078	32	immunizing	immunize	VBG
50458	1078	33	properties	property	NNS
50458	1078	34	,	,	,
50458	1078	35	and	and	CC
50458	1078	36	this	this	DT
50458	1078	37	property	property	NN
50458	1078	38	passed	pass	VBN
50458	1078	39	by	by	IN
50458	1078	40	heredity	heredity	NN
50458	1078	41	to	to	IN
50458	1078	42	the	the	DT
50458	1078	43	offspring	offspring	NN
50458	1078	44	,	,	,
50458	1078	45	to	to	TO
50458	1078	46	which	which	WDT
50458	1078	47	it	-PRON-	PRP
50458	1078	48	is	be	VBZ
50458	1078	49	transmitted	transmit	VBN
50458	1078	50	by	by	IN
50458	1078	51	the	the	DT
50458	1078	52	blood	blood	NN
50458	1078	53	itself	-PRON-	PRP
50458	1078	54	,	,	,
50458	1078	55	and	and	CC
50458	1078	56	by	by	IN
50458	1078	57	the	the	DT
50458	1078	58	milk	milk	NN
50458	1078	59	during	during	IN
50458	1078	60	feeding	feed	VBG
50458	1078	61	.	.	.
50458	1079	1	Along	along	IN
50458	1079	2	with	with	IN
50458	1079	3	these	these	DT
50458	1079	4	resemblances	resemblance	NNS
50458	1079	5	between	between	IN
50458	1079	6	the	the	DT
50458	1079	7	venoms	venom	NNS
50458	1079	8	and	and	CC
50458	1079	9	toxins	toxin	NNS
50458	1079	10	,	,	,
50458	1079	11	attention	attention	NN
50458	1079	12	must	must	MD
50458	1079	13	be	be	VB
50458	1079	14	called	call	VBN
50458	1079	15	to	to	IN
50458	1079	16	a	a	DT
50458	1079	17	very	very	RB
50458	1079	18	important	important	JJ
50458	1079	19	difference	difference	NN
50458	1079	20	.	.	.
50458	1080	1	As	as	IN
50458	1080	2	we	-PRON-	PRP
50458	1080	3	have	have	VBP
50458	1080	4	already	already	RB
50458	1080	5	seen	see	VBN
50458	1080	6	,	,	,
50458	1080	7	the	the	DT
50458	1080	8	action	action	NN
50458	1080	9	of	of	IN
50458	1080	10	the	the	DT
50458	1080	11	toxins	toxin	NNS
50458	1080	12	on	on	IN
50458	1080	13	the	the	DT
50458	1080	14	organism	organism	NN
50458	1080	15	is	be	VBZ
50458	1080	16	always	always	RB
50458	1080	17	preceded	precede	VBN
50458	1080	18	by	by	IN
50458	1080	19	a	a	DT
50458	1080	20	certain	certain	JJ
50458	1080	21	period	period	NN
50458	1080	22	of	of	IN
50458	1080	23	incubation	incubation	NN
50458	1080	24	;	;	,
50458	1080	25	the	the	DT
50458	1080	26	action	action	NN
50458	1080	27	of	of	IN
50458	1080	28	the	the	DT
50458	1080	29	venoms	venom	NNS
50458	1080	30	,	,	,
50458	1080	31	on	on	IN
50458	1080	32	the	the	DT
50458	1080	33	contrary	contrary	NN
50458	1080	34	,	,	,
50458	1080	35	is	be	VBZ
50458	1080	36	almost	almost	RB
50458	1080	37	instantaneous	instantaneous	JJ
50458	1080	38	,	,	,
50458	1080	39	and	and	CC
50458	1080	40	in	in	IN
50458	1080	41	this	this	DT
50458	1080	42	respect	respect	NN
50458	1080	43	they	-PRON-	PRP
50458	1080	44	behave	behave	VBP
50458	1080	45	like	like	UH
50458	1080	46	chemical	chemical	JJ
50458	1080	47	agents	agent	NNS
50458	1080	48	and	and	CC
50458	1080	49	alkaloidal	alkaloidal	NN
50458	1080	50	toxins	toxin	NNS
50458	1080	51	.	.	.
50458	1081	1	If	if	IN
50458	1081	2	the	the	DT
50458	1081	3	venoms	venom	NNS
50458	1081	4	are	be	VBP
50458	1081	5	preserved	preserve	VBN
50458	1081	6	in	in	IN
50458	1081	7	a	a	DT
50458	1081	8	moist	moist	JJ
50458	1081	9	condition	condition	NN
50458	1081	10	,	,	,
50458	1081	11	they	-PRON-	PRP
50458	1081	12	change	change	VBP
50458	1081	13	because	because	IN
50458	1081	14	they	-PRON-	PRP
50458	1081	15	undergo	undergo	VBP
50458	1081	16	putrefaction	putrefaction	NN
50458	1081	17	,	,	,
50458	1081	18	which	which	WDT
50458	1081	19	is	be	VBZ
50458	1081	20	generally	generally	RB
50458	1081	21	the	the	DT
50458	1081	22	case	case	NN
50458	1081	23	with	with	IN
50458	1081	24	all	all	DT
50458	1081	25	diastatic	diastatic	JJ
50458	1081	26	substances	substance	NNS
50458	1081	27	,	,	,
50458	1081	28	and	and	CC
50458	1081	29	particularly	particularly	RB
50458	1081	30	the	the	DT
50458	1081	31	toxins	toxin	NNS
50458	1081	32	.	.	.
50458	1082	1	It	-PRON-	PRP
50458	1082	2	is	be	VBZ
50458	1082	3	interesting	interesting	JJ
50458	1082	4	to	to	TO
50458	1082	5	note	note	VB
50458	1082	6	that	that	IN
50458	1082	7	animals	animal	NNS
50458	1082	8	which	which	WDT
50458	1082	9	have	have	VBP
50458	1082	10	been	be	VBN
50458	1082	11	bitten	bite	VBN
50458	1082	12	by	by	IN
50458	1082	13	a	a	DT
50458	1082	14	venomous	venomous	JJ
50458	1082	15	serpent	serpent	NN
50458	1082	16	,	,	,
50458	1082	17	but	but	CC
50458	1082	18	which	which	WDT
50458	1082	19	,	,	,
50458	1082	20	for	for	IN
50458	1082	21	some	some	DT
50458	1082	22	reason	reason	NN
50458	1082	23	or	or	CC
50458	1082	24	other	other	JJ
50458	1082	25	,	,	,
50458	1082	26	have	have	VBP
50458	1082	27	not	not	RB
50458	1082	28	succumbed	succumb	VBN
50458	1082	29	to	to	IN
50458	1082	30	the	the	DT
50458	1082	31	venom	venom	NN
50458	1082	32	,	,	,
50458	1082	33	never	never	RB
50458	1082	34	recover	recover	VBP
50458	1082	35	their	-PRON-	PRP$
50458	1082	36	former	former	JJ
50458	1082	37	condition	condition	NN
50458	1082	38	;	;	:
50458	1082	39	if	if	IN
50458	1082	40	they	-PRON-	PRP
50458	1082	41	were	be	VBD
50458	1082	42	young	young	JJ
50458	1082	43	,	,	,
50458	1082	44	their	-PRON-	PRP$
50458	1082	45	functions	function	NNS
50458	1082	46	cease	cease	VBP
50458	1082	47	to	to	TO
50458	1082	48	develop	develop	VB
50458	1082	49	,	,	,
50458	1082	50	and	and	CC
50458	1082	51	they	-PRON-	PRP
50458	1082	52	droop	droop	VBP
50458	1082	53	;	;	:
50458	1082	54	if	if	IN
50458	1082	55	they	-PRON-	PRP
50458	1082	56	are	be	VBP
50458	1082	57	adults	adult	NNS
50458	1082	58	,	,	,
50458	1082	59	their	-PRON-	PRP$
50458	1082	60	general	general	JJ
50458	1082	61	condition	condition	NN
50458	1082	62	remains	remain	VBZ
50458	1082	63	that	that	DT
50458	1082	64	of	of	IN
50458	1082	65	stupefaction	stupefaction	NN
50458	1082	66	.	.	.
50458	1083	1	=	=	NFP
50458	1083	2	Venomous	venomous	JJ
50458	1083	3	Serpents.=--Among	Serpents.=--Among	.
50458	1083	4	the	the	DT
50458	1083	5	venomous	venomous	JJ
50458	1083	6	serpents,[143	serpents,[143	NNP
50458	1083	7	]	]	-RRB-
50458	1083	8	the	the	DT
50458	1083	9	most	most	RBS
50458	1083	10	important	important	JJ
50458	1083	11	as	as	RB
50458	1083	12	well	well	RB
50458	1083	13	as	as	IN
50458	1083	14	the	the	DT
50458	1083	15	most	most	RBS
50458	1083	16	dangerous	dangerous	JJ
50458	1083	17	are	be	VBP
50458	1083	18	the	the	DT
50458	1083	19	following	follow	VBG
50458	1083	20	:	:	:
50458	1083	21	Cobra	cobra	VB
50458	1083	22	di	di	FW
50458	1083	23	capello	capello	NN
50458	1083	24	(	(	-LRB-
50458	1083	25	Naja	Naja	NNP
50458	1083	26	tripudians	tripudian	NNS
50458	1083	27	,	,	,
50458	1083	28	the	the	DT
50458	1083	29	hooded	hood	VBN
50458	1083	30	cobra	cobra	NN
50458	1083	31	)	)	-RRB-
50458	1083	32	and	and	CC
50458	1083	33	its	-PRON-	PRP$
50458	1083	34	analogues	analogue	NNS
50458	1083	35	,	,	,
50458	1083	36	the	the	DT
50458	1083	37	black	black	JJ
50458	1083	38	Naja	Naja	NNP
50458	1083	39	,	,	,
50458	1083	40	Naja	Naja	NNP
50458	1083	41	hagé	hagé	NN
50458	1083	42	,	,	,
50458	1083	43	etc	etc	FW
50458	1083	44	.	.	.
50458	1084	1	;	;	:
50458	1084	2	the	the	DT
50458	1084	3	elops	elop	NNS
50458	1084	4	(	(	-LRB-
50458	1084	5	coral	coral	JJ
50458	1084	6	serpent	serpent	NN
50458	1084	7	)	)	-RRB-
50458	1084	8	;	;	:
50458	1084	9	the	the	DT
50458	1084	10	bungurus	bungurus	NN
50458	1084	11	of	of	IN
50458	1084	12	Bengal	Bengal	NNP
50458	1084	13	and	and	CC
50458	1084	14	Burmah	Burmah	NNP
50458	1084	15	;	;	:
50458	1084	16	the	the	DT
50458	1084	17	Platycercus	platycercus	JJ
50458	1084	18	proteroglyphia	proteroglyphia	NN
50458	1084	19	,	,	,
50458	1084	20	which	which	WDT
50458	1084	21	is	be	VBZ
50458	1084	22	found	find	VBN
50458	1084	23	chiefly	chiefly	RB
50458	1084	24	in	in	IN
50458	1084	25	the	the	DT
50458	1084	26	waters	water	NNS
50458	1084	27	of	of	IN
50458	1084	28	the	the	DT
50458	1084	29	Indian	Indian	NNP
50458	1084	30	Ocean	Ocean	NNP
50458	1084	31	;	;	:
50458	1084	32	the	the	DT
50458	1084	33	crotalian	crotalian	JJ
50458	1084	34	solenoglyphs	solenoglyphs	NN
50458	1084	35	of	of	IN
50458	1084	36	the	the	DT
50458	1084	37	two	two	CD
50458	1084	38	Americas	Americas	NNPS
50458	1084	39	,	,	,
50458	1084	40	and	and	CC
50458	1084	41	among	among	IN
50458	1084	42	which	which	WDT
50458	1084	43	in	in	IN
50458	1084	44	particular	particular	JJ
50458	1084	45	are	be	VBP
50458	1084	46	the	the	DT
50458	1084	47	rattlesnake	rattlesnake	NN
50458	1084	48	,	,	,
50458	1084	49	the	the	DT
50458	1084	50	fer	fer	JJ
50458	1084	51	-	-	HYPH
50458	1084	52	de	de	NN
50458	1084	53	-	-	HYPH
50458	1084	54	lance	lance	NNP
50458	1084	55	(	(	-LRB-
50458	1084	56	the	the	DT
50458	1084	57	yellow	yellow	JJ
50458	1084	58	viper	viper	NN
50458	1084	59	)	)	-RRB-
50458	1084	60	of	of	IN
50458	1084	61	Martinique	Martinique	NNP
50458	1084	62	;	;	:
50458	1084	63	the	the	DT
50458	1084	64	surucucu	surucucu	NN
50458	1084	65	of	of	IN
50458	1084	66	Guiana	Guiana	NNP
50458	1084	67	;	;	:
50458	1084	68	and	and	CC
50458	1084	69	the	the	DT
50458	1084	70	moccasins	moccasin	NNS
50458	1084	71	and	and	CC
50458	1084	72	copperheads	copperhead	NNS
50458	1084	73	of	of	IN
50458	1084	74	Texas	Texas	NNP
50458	1084	75	and	and	CC
50458	1084	76	Florida	Florida	NNP
50458	1084	77	.	.	.
50458	1085	1	Lastly	lastly	RB
50458	1085	2	,	,	,
50458	1085	3	the	the	DT
50458	1085	4	entire	entire	JJ
50458	1085	5	group	group	NN
50458	1085	6	of	of	IN
50458	1085	7	viperian	viperian	JJ
50458	1085	8	solenoglyphs	solenoglyph	NNS
50458	1085	9	,	,	,
50458	1085	10	among	among	IN
50458	1085	11	which	which	WDT
50458	1085	12	are	be	VBP
50458	1085	13	the	the	DT
50458	1085	14	Echidnæ	Echidnæ	NNP
50458	1085	15	,	,	,
50458	1085	16	the	the	DT
50458	1085	17	bite	bite	NN
50458	1085	18	of	of	IN
50458	1085	19	some	some	DT
50458	1085	20	of	of	IN
50458	1085	21	which	which	WDT
50458	1085	22	,	,	,
50458	1085	23	for	for	IN
50458	1085	24	instance	instance	NN
50458	1085	25	the	the	DT
50458	1085	26	daboia	daboia	NN
50458	1085	27	or	or	CC
50458	1085	28	echidna	echidna	NN
50458	1085	29	,	,	,
50458	1085	30	is	be	VBZ
50458	1085	31	dreadful	dreadful	JJ
50458	1085	32	;	;	:
50458	1085	33	the	the	DT
50458	1085	34	African	african	JJ
50458	1085	35	vipers	viper	NNS
50458	1085	36	,	,	,
50458	1085	37	among	among	IN
50458	1085	38	which	which	WDT
50458	1085	39	may	may	MD
50458	1085	40	be	be	VB
50458	1085	41	mentioned	mention	VBN
50458	1085	42	the	the	DT
50458	1085	43	horned	horned	JJ
50458	1085	44	viper	viper	NN
50458	1085	45	,	,	,
50458	1085	46	the	the	DT
50458	1085	47	bite	bite	NN
50458	1085	48	of	of	IN
50458	1085	49	which	which	WDT
50458	1085	50	will	will	MD
50458	1085	51	kill	kill	VB
50458	1085	52	a	a	DT
50458	1085	53	camel	camel	NN
50458	1085	54	;	;	:
50458	1085	55	the	the	DT
50458	1085	56	springing	springing	NN
50458	1085	57	viper	viper	NN
50458	1085	58	of	of	IN
50458	1085	59	Congo	Congo	NNP
50458	1085	60	,	,	,
50458	1085	61	and	and	CC
50458	1085	62	the	the	DT
50458	1085	63	rhinoceros	rhinoceros	NN
50458	1085	64	-	-	HYPH
50458	1085	65	viper	viper	NN
50458	1085	66	of	of	IN
50458	1085	67	Gabun	Gabun	NNP
50458	1085	68	;	;	:
50458	1085	69	the	the	DT
50458	1085	70	European	european	JJ
50458	1085	71	vipers	viper	NNS
50458	1085	72	,	,	,
50458	1085	73	the	the	DT
50458	1085	74	most	most	RBS
50458	1085	75	dangerous	dangerous	JJ
50458	1085	76	of	of	IN
50458	1085	77	which	which	WDT
50458	1085	78	is	be	VBZ
50458	1085	79	certainly	certainly	RB
50458	1085	80	the	the	DT
50458	1085	81	asp	asp	NN
50458	1085	82	of	of	IN
50458	1085	83	France	France	NNP
50458	1085	84	,	,	,
50458	1085	85	which	which	WDT
50458	1085	86	is	be	VBZ
50458	1085	87	exceedingly	exceedingly	RB
50458	1085	88	numerous	numerous	JJ
50458	1085	89	in	in	IN
50458	1085	90	certain	certain	JJ
50458	1085	91	regions	region	NNS
50458	1085	92	.	.	.
50458	1086	1	[	[	-LRB-
50458	1086	2	143	143	CD
50458	1086	3	]	]	-RRB-
50458	1086	4	CALMETTE	calmette	NN
50458	1086	5	:	:	:
50458	1086	6	_	_	NNP
50458	1086	7	Le	Le	NNP
50458	1086	8	Venin	Venin	NNP
50458	1086	9	des	des	NNP
50458	1086	10	Serpents	Serpents	NNP
50458	1086	11	_	_	NNP
50458	1086	12	,	,	,
50458	1086	13	Paris	Paris	NNP
50458	1086	14	,	,	,
50458	1086	15	1896	1896	CD
50458	1086	16	.	.	.
50458	1087	1	The	the	DT
50458	1087	2	effects	effect	NNS
50458	1087	3	of	of	IN
50458	1087	4	the	the	DT
50458	1087	5	bites	bite	NNS
50458	1087	6	of	of	IN
50458	1087	7	venomous	venomous	JJ
50458	1087	8	serpents	serpent	NNS
50458	1087	9	on	on	IN
50458	1087	10	man	man	NN
50458	1087	11	and	and	CC
50458	1087	12	animals	animal	NNS
50458	1087	13	are	be	VBP
50458	1087	14	generally	generally	RB
50458	1087	15	well	well	RB
50458	1087	16	known	known	JJ
50458	1087	17	to	to	IN
50458	1087	18	the	the	DT
50458	1087	19	public	public	NN
50458	1087	20	;	;	:
50458	1087	21	it	-PRON-	PRP
50458	1087	22	is	be	VBZ
50458	1087	23	well	well	JJ
50458	1087	24	to	to	TO
50458	1087	25	recall	recall	VB
50458	1087	26	them	-PRON-	PRP
50458	1087	27	,	,	,
50458	1087	28	nevertheless	nevertheless	RB
50458	1087	29	.	.	.
50458	1088	1	From	from	IN
50458	1088	2	the	the	DT
50458	1088	3	moment	moment	NN
50458	1088	4	the	the	DT
50458	1088	5	bite	bite	NN
50458	1088	6	has	have	VBZ
50458	1088	7	been	be	VBN
50458	1088	8	inflicted	inflict	VBN
50458	1088	9	,	,	,
50458	1088	10	complete	complete	JJ
50458	1088	11	symptoms	symptom	NNS
50458	1088	12	of	of	IN
50458	1088	13	poisoning	poisoning	NN
50458	1088	14	develop	develop	NN
50458	1088	15	,	,	,
50458	1088	16	attended	attend	VBN
50458	1088	17	by	by	IN
50458	1088	18	a	a	DT
50458	1088	19	condition	condition	NN
50458	1088	20	of	of	IN
50458	1088	21	extreme	extreme	JJ
50458	1088	22	and	and	CC
50458	1088	23	increasing	increase	VBG
50458	1088	24	weakness	weakness	NN
50458	1088	25	,	,	,
50458	1088	26	with	with	IN
50458	1088	27	vomiting	vomiting	NN
50458	1088	28	,	,	,
50458	1088	29	hemorrhage	hemorrhage	NN
50458	1088	30	,	,	,
50458	1088	31	and	and	CC
50458	1088	32	decomposition	decomposition	NN
50458	1088	33	of	of	IN
50458	1088	34	the	the	DT
50458	1088	35	blood	blood	NN
50458	1088	36	.	.	.
50458	1089	1	There	there	EX
50458	1089	2	are	be	VBP
50458	1089	3	,	,	,
50458	1089	4	besides	besides	RB
50458	1089	5	,	,	,
50458	1089	6	particular	particular	JJ
50458	1089	7	effects	effect	NNS
50458	1089	8	which	which	WDT
50458	1089	9	vary	vary	VBP
50458	1089	10	with	with	IN
50458	1089	11	every	every	DT
50458	1089	12	venom	venom	NN
50458	1089	13	.	.	.
50458	1090	1	The	the	DT
50458	1090	2	following	follow	VBG
50458	1090	3	table	table	NN
50458	1090	4	by	by	IN
50458	1090	5	Calmette[144	Calmette[144	NNP
50458	1090	6	]	]	-RRB-
50458	1090	7	gives	give	VBZ
50458	1090	8	the	the	DT
50458	1090	9	comparative	comparative	JJ
50458	1090	10	toxicity	toxicity	NN
50458	1090	11	of	of	IN
50458	1090	12	various	various	JJ
50458	1090	13	venoms	venom	NNS
50458	1090	14	,	,	,
50458	1090	15	taking	take	VBG
50458	1090	16	as	as	IN
50458	1090	17	the	the	DT
50458	1090	18	standard	standard	NN
50458	1090	19	of	of	IN
50458	1090	20	comparison	comparison	NN
50458	1090	21	the	the	DT
50458	1090	22	quantity	quantity	NN
50458	1090	23	sufficient	sufficient	JJ
50458	1090	24	to	to	TO
50458	1090	25	kill	kill	VB
50458	1090	26	a	a	DT
50458	1090	27	rabbit	rabbit	NN
50458	1090	28	in	in	IN
50458	1090	29	three	three	CD
50458	1090	30	or	or	CC
50458	1090	31	four	four	CD
50458	1090	32	hours	hour	NNS
50458	1090	33	:	:	:
50458	1090	34	Naja	Naja	NNP
50458	1090	35	tripudians	tripudian	VBZ
50458	1090	36	0.00047	0.00047	CD
50458	1090	37	Naja	Naja	NNP
50458	1090	38	hagé	hagé	NN
50458	1090	39	0.0003	0.0003	CD
50458	1090	40	-	-	:
50458	1090	41	0.0007	0.0007	CD
50458	1090	42	Acanthophis	Acanthophis	NNP
50458	1090	43	antarctica	antarctica	NN
50458	1090	44	0.001	0.001	CD
50458	1090	45	Ceraste	Ceraste	NNP
50458	1090	46	0.0017	0.0017	CD
50458	1090	47	-	-	HYPH
50458	1090	48	0.0021	0.0021	CD
50458	1090	49	Haplocephalus	haplocephalus	JJ
50458	1090	50	variegatus	variegatus	NN
50458	1090	51	0.0025	0.0025	CD
50458	1090	52	Trigonocephalus	trigonocephalus	JJ
50458	1090	53	0.0025	0.0025	NNS
50458	1090	54	[	[	-LRB-
50458	1090	55	144	144	CD
50458	1090	56	]	]	-RRB-
50458	1090	57	CALMETTE	CALMETTE	NNP
50458	1090	58	:	:	:
50458	1090	59	_	_	NNP
50458	1090	60	Annal	Annal	NNP
50458	1090	61	.	.	.
50458	1091	1	Instit	Instit	NNP
50458	1091	2	.	.	.
50458	1092	1	Pasteur	Pasteur	NNP
50458	1092	2	_	_	NNP
50458	1092	3	,	,	,
50458	1092	4	VIII	VIII	NNP
50458	1092	5	,	,	,
50458	1092	6	p.	p.	NN
50458	1092	7	276	276	CD
50458	1092	8	;	;	:
50458	1092	9	IX	IX	NNP
50458	1092	10	,	,	,
50458	1092	11	p.	p.	NN
50458	1092	12	229	229	CD
50458	1092	13	.	.	.
50458	1093	1	=	=	NFP
50458	1093	2	Nature	nature	NN
50458	1093	3	of	of	IN
50458	1093	4	Serpent	Serpent	NNP
50458	1093	5	-	-	HYPH
50458	1093	6	venoms.=--These	venoms.=--These	NNS
50458	1093	7	venoms	venom	NNS
50458	1093	8	are	be	VBP
50458	1093	9	homogeneous	homogeneous	JJ
50458	1093	10	liquids	liquid	NNS
50458	1093	11	,	,	,
50458	1093	12	somewhat	somewhat	RB
50458	1093	13	more	more	RBR
50458	1093	14	dense	dense	JJ
50458	1093	15	than	than	IN
50458	1093	16	water	water	NN
50458	1093	17	,	,	,
50458	1093	18	in	in	IN
50458	1093	19	which	which	WDT
50458	1093	20	they	-PRON-	PRP
50458	1093	21	are	be	VBP
50458	1093	22	soluble	soluble	JJ
50458	1093	23	,	,	,
50458	1093	24	slightly	slightly	RB
50458	1093	25	colored	color	VBN
50458	1093	26	green	green	JJ
50458	1093	27	or	or	CC
50458	1093	28	yellow	yellow	JJ
50458	1093	29	,	,	,
50458	1093	30	transparent	transparent	JJ
50458	1093	31	,	,	,
50458	1093	32	and	and	CC
50458	1093	33	insoluble	insoluble	JJ
50458	1093	34	in	in	IN
50458	1093	35	alcohol	alcohol	NN
50458	1093	36	;	;	:
50458	1093	37	they	-PRON-	PRP
50458	1093	38	contain	contain	VBP
50458	1093	39	from	from	IN
50458	1093	40	30	30	CD
50458	1093	41	to	to	TO
50458	1093	42	35	35	CD
50458	1093	43	per	per	NN
50458	1093	44	cent	cent	NN
50458	1093	45	.	.	.
50458	1094	1	of	of	IN
50458	1094	2	solid	solid	JJ
50458	1094	3	matter	matter	NN
50458	1094	4	.	.	.
50458	1095	1	When	when	WRB
50458	1095	2	fresh	fresh	JJ
50458	1095	3	,	,	,
50458	1095	4	they	-PRON-	PRP
50458	1095	5	have	have	VBP
50458	1095	6	a	a	DT
50458	1095	7	slightly	slightly	RB
50458	1095	8	acid	acid	JJ
50458	1095	9	reaction	reaction	NN
50458	1095	10	.	.	.
50458	1096	1	Towards	towards	IN
50458	1096	2	chemical	chemical	NN
50458	1096	3	reagents	reagent	NNS
50458	1096	4	,	,	,
50458	1096	5	and	and	CC
50458	1096	6	particularly	particularly	RB
50458	1096	7	acids	acid	NNS
50458	1096	8	,	,	,
50458	1096	9	they	-PRON-	PRP
50458	1096	10	behave	behave	VBP
50458	1096	11	like	like	IN
50458	1096	12	albuminoids	albuminoid	NNS
50458	1096	13	;	;	,
50458	1096	14	almost	almost	RB
50458	1096	15	all	all	PDT
50458	1096	16	the	the	DT
50458	1096	17	combinations	combination	NNS
50458	1096	18	they	-PRON-	PRP
50458	1096	19	afford	afford	VBP
50458	1096	20	with	with	IN
50458	1096	21	the	the	DT
50458	1096	22	various	various	JJ
50458	1096	23	albuminoid	albuminoid	NN
50458	1096	24	reagents	reagent	NNS
50458	1096	25	are	be	VBP
50458	1096	26	active	active	JJ
50458	1096	27	,	,	,
50458	1096	28	despite	despite	IN
50458	1096	29	their	-PRON-	PRP$
50458	1096	30	insolubility	insolubility	NN
50458	1096	31	.	.	.
50458	1097	1	According	accord	VBG
50458	1097	2	to	to	IN
50458	1097	3	Gautier	Gautier	NNP
50458	1097	4	,	,	,
50458	1097	5	they	-PRON-	PRP
50458	1097	6	are	be	VBP
50458	1097	7	decomposed	decompose	VBN
50458	1097	8	by	by	IN
50458	1097	9	caustic	caustic	JJ
50458	1097	10	potash	potash	NN
50458	1097	11	.	.	.
50458	1098	1	According	accord	VBG
50458	1098	2	to	to	IN
50458	1098	3	numerous	numerous	JJ
50458	1098	4	researches	research	NNS
50458	1098	5	,	,	,
50458	1098	6	oxidizers	oxidizer	VBZ
50458	1098	7	like	like	IN
50458	1098	8	potassium	potassium	NN
50458	1098	9	permanganate	permanganate	NNP
50458	1098	10	,	,	,
50458	1098	11	the	the	DT
50458	1098	12	hypochlorites	hypochlorite	NNS
50458	1098	13	,	,	,
50458	1098	14	hydrogen	hydrogen	NN
50458	1098	15	peroxide	peroxide	NN
50458	1098	16	,	,	,
50458	1098	17	and	and	CC
50458	1098	18	gold	gold	NN
50458	1098	19	chloride	chloride	NN
50458	1098	20	(	(	-LRB-
50458	1098	21	in	in	IN
50458	1098	22	1	1	CD
50458	1098	23	%	%	NN
50458	1098	24	solution	solution	NN
50458	1098	25	)	)	-RRB-
50458	1098	26	destroy	destroy	VB
50458	1098	27	the	the	DT
50458	1098	28	venoms	venom	NNS
50458	1098	29	;	;	:
50458	1098	30	in	in	IN
50458	1098	31	certain	certain	JJ
50458	1098	32	cases	case	NNS
50458	1098	33	when	when	WRB
50458	1098	34	immediately	immediately	RB
50458	1098	35	injected	inject	VBD
50458	1098	36	hypodermically	hypodermically	RB
50458	1098	37	in	in	IN
50458	1098	38	the	the	DT
50458	1098	39	poisoned	poison	VBN
50458	1098	40	region	region	NN
50458	1098	41	,	,	,
50458	1098	42	these	these	DT
50458	1098	43	substances	substance	NNS
50458	1098	44	are	be	VBP
50458	1098	45	excellent	excellent	JJ
50458	1098	46	antidotes	antidote	NNS
50458	1098	47	_	_	NNP
50458	1098	48	in	in	IN
50458	1098	49	vivo	vivo	NNP
50458	1098	50	_	_	NNP
50458	1098	51	.	.	.
50458	1099	1	[	[	-LRB-
50458	1099	2	145	145	CD
50458	1099	3	]	]	-RRB-
50458	1099	4	[	[	-LRB-
50458	1099	5	145	145	CD
50458	1099	6	]	]	-RRB-
50458	1099	7	WINTER	WINTER	NNP
50458	1099	8	and	and	CC
50458	1099	9	BLYTH	BLYTH	NNP
50458	1099	10	:	:	:
50458	1099	11	_	_	NNP
50458	1099	12	The	the	DT
50458	1099	13	Analyst	Analyst	NNP
50458	1099	14	_	_	NNP
50458	1099	15	,	,	,
50458	1099	16	1877	1877	CD
50458	1099	17	,	,	,
50458	1099	18	p.	p.	NN
50458	1099	19	204	204	CD
50458	1099	20	;	;	:
50458	1099	21	LACERDA	lacerda	NN
50458	1099	22	:	:	:
50458	1099	23	_	_	NNP
50458	1099	24	Compt	Compt	NNP
50458	1099	25	.	.	.
50458	1100	1	rend	rend	VB
50458	1100	2	.	.	.
50458	1101	1	de	de	NNP
50458	1101	2	l'Acad	l'Acad	NNP
50458	1101	3	.	.	.
50458	1102	1	des	des	NNP
50458	1102	2	Sciences	Sciences	NNPS
50458	1102	3	_	_	NNP
50458	1102	4	,	,	,
50458	1102	5	XCIII	xciii	NN
50458	1102	6	,	,	,
50458	1102	7	p.	p.	NN
50458	1102	8	466	466	CD
50458	1102	9	;	;	:
50458	1102	10	CALMETTE	calmette	NN
50458	1102	11	:	:	:
50458	1102	12	_	_	NNP
50458	1102	13	Annal	Annal	NNP
50458	1102	14	.	.	.
50458	1103	1	Instit	Instit	NNP
50458	1103	2	.	.	.
50458	1104	1	Pasteur	Pasteur	NNP
50458	1104	2	_	_	NNP
50458	1104	3	,	,	,
50458	1104	4	VI	VI	NNP
50458	1104	5	,	,	,
50458	1104	6	p.	p.	NN
50458	1104	7	175	175	CD
50458	1104	8	,	,	,
50458	1104	9	and	and	CC
50458	1104	10	VIII	VIII	NNP
50458	1104	11	,	,	,
50458	1104	12	p.	p.	NN
50458	1104	13	278	278	CD
50458	1104	14	.	.	.
50458	1105	1	We	-PRON-	PRP
50458	1105	2	shall	shall	MD
50458	1105	3	not	not	RB
50458	1105	4	here	here	RB
50458	1105	5	enter	enter	VB
50458	1105	6	upon	upon	IN
50458	1105	7	a	a	DT
50458	1105	8	detailed	detailed	JJ
50458	1105	9	study	study	NN
50458	1105	10	of	of	IN
50458	1105	11	the	the	DT
50458	1105	12	toxic	toxic	JJ
50458	1105	13	albuminoid	albuminoid	NN
50458	1105	14	principles	principle	NNS
50458	1105	15	of	of	IN
50458	1105	16	serpent	serpent	NN
50458	1105	17	-	-	HYPH
50458	1105	18	venoms	venom	NNS
50458	1105	19	;	;	:
50458	1105	20	moreover	moreover	RB
50458	1105	21	,	,	,
50458	1105	22	our	-PRON-	PRP$
50458	1105	23	knowledge	knowledge	NN
50458	1105	24	is	be	VBZ
50458	1105	25	rather	rather	RB
50458	1105	26	vague	vague	JJ
50458	1105	27	,	,	,
50458	1105	28	as	as	IN
50458	1105	29	it	-PRON-	PRP
50458	1105	30	is	be	VBZ
50458	1105	31	,	,	,
50458	1105	32	on	on	IN
50458	1105	33	a	a	DT
50458	1105	34	number	number	NN
50458	1105	35	of	of	IN
50458	1105	36	points	point	NNS
50458	1105	37	.	.	.
50458	1106	1	It	-PRON-	PRP
50458	1106	2	will	will	MD
50458	1106	3	suffice	suffice	VB
50458	1106	4	us	-PRON-	PRP
50458	1106	5	to	to	TO
50458	1106	6	know	know	VB
50458	1106	7	that	that	IN
50458	1106	8	,	,	,
50458	1106	9	taken	take	VBN
50458	1106	10	altogether	altogether	RB
50458	1106	11	,	,	,
50458	1106	12	the	the	DT
50458	1106	13	active	active	JJ
50458	1106	14	albuminoids	albuminoid	NNS
50458	1106	15	of	of	IN
50458	1106	16	these	these	DT
50458	1106	17	venoms	venom	NNS
50458	1106	18	are	be	VBP
50458	1106	19	numerous	numerous	JJ
50458	1106	20	,	,	,
50458	1106	21	and	and	CC
50458	1106	22	that	that	IN
50458	1106	23	each	each	DT
50458	1106	24	venom	venom	NN
50458	1106	25	has	have	VBZ
50458	1106	26	its	-PRON-	PRP$
50458	1106	27	own	own	JJ
50458	1106	28	particular	particular	JJ
50458	1106	29	active	active	JJ
50458	1106	30	constituents	constituent	NNS
50458	1106	31	,	,	,
50458	1106	32	differing	differ	VBG
50458	1106	33	according	accord	VBG
50458	1106	34	to	to	IN
50458	1106	35	the	the	DT
50458	1106	36	species	species	NN
50458	1106	37	and	and	CC
50458	1106	38	variety	variety	NN
50458	1106	39	of	of	IN
50458	1106	40	the	the	DT
50458	1106	41	snake	snake	NN
50458	1106	42	.	.	.
50458	1107	1	Each	each	DT
50458	1107	2	one	one	NN
50458	1107	3	of	of	IN
50458	1107	4	these	these	DT
50458	1107	5	substances	substance	NNS
50458	1107	6	acts	act	VBZ
50458	1107	7	more	more	RBR
50458	1107	8	or	or	CC
50458	1107	9	less	less	RBR
50458	1107	10	rapidly	rapidly	RB
50458	1107	11	,	,	,
50458	1107	12	and	and	CC
50458	1107	13	may	may	MD
50458	1107	14	be	be	VB
50458	1107	15	associated	associate	VBN
50458	1107	16	with	with	IN
50458	1107	17	different	different	JJ
50458	1107	18	principles	principle	NNS
50458	1107	19	which	which	WDT
50458	1107	20	give	give	VBP
50458	1107	21	rise	rise	NN
50458	1107	22	to	to	IN
50458	1107	23	the	the	DT
50458	1107	24	variability	variability	NN
50458	1107	25	of	of	IN
50458	1107	26	the	the	DT
50458	1107	27	action	action	NN
50458	1107	28	of	of	IN
50458	1107	29	these	these	DT
50458	1107	30	toxic	toxic	JJ
50458	1107	31	agents	agent	NNS
50458	1107	32	.	.	.
50458	1108	1	Among	among	IN
50458	1108	2	these	these	DT
50458	1108	3	toxic	toxic	JJ
50458	1108	4	albuminoids	albuminoid	NNS
50458	1108	5	,	,	,
50458	1108	6	the	the	DT
50458	1108	7	most	most	RBS
50458	1108	8	virulent	virulent	NN
50458	1108	9	appear	appear	VBP
50458	1108	10	to	to	TO
50458	1108	11	be	be	VB
50458	1108	12	true	true	JJ
50458	1108	13	albumins	albumin	NNS
50458	1108	14	and	and	CC
50458	1108	15	globulins	globulin	NNS
50458	1108	16	,	,	,
50458	1108	17	followed	follow	VBN
50458	1108	18	by	by	IN
50458	1108	19	the	the	DT
50458	1108	20	nucleo	nucleo	NNP
50458	1108	21	-	-	HYPH
50458	1108	22	albumins	albumin	NNS
50458	1108	23	,	,	,
50458	1108	24	as	as	IN
50458	1108	25	we	-PRON-	PRP
50458	1108	26	have	have	VBP
50458	1108	27	already	already	RB
50458	1108	28	stated	state	VBN
50458	1108	29	;	;	:
50458	1108	30	there	there	EX
50458	1108	31	are	be	VBP
50458	1108	32	also	also	RB
50458	1108	33	found	find	VBN
50458	1108	34	in	in	IN
50458	1108	35	venoms	venom	NNS
50458	1108	36	alkaloidal	alkaloidal	NN
50458	1108	37	bases	basis	NNS
50458	1108	38	,	,	,
50458	1108	39	but	but	CC
50458	1108	40	these	these	DT
50458	1108	41	principles	principle	NNS
50458	1108	42	are	be	VBP
50458	1108	43	present	present	JJ
50458	1108	44	only	only	RB
50458	1108	45	in	in	IN
50458	1108	46	very	very	RB
50458	1108	47	slight	slight	JJ
50458	1108	48	quantity	quantity	NN
50458	1108	49	.	.	.
50458	1109	1	These	these	DT
50458	1109	2	bases	basis	NNS
50458	1109	3	are	be	VBP
50458	1109	4	but	but	CC
50458	1109	5	very	very	RB
50458	1109	6	slightly	slightly	RB
50458	1109	7	toxic	toxic	JJ
50458	1109	8	compared	compare	VBN
50458	1109	9	with	with	IN
50458	1109	10	the	the	DT
50458	1109	11	toxins	toxin	NNS
50458	1109	12	that	that	WDT
50458	1109	13	accompany	accompany	VBP
50458	1109	14	them	-PRON-	PRP
50458	1109	15	.	.	.
50458	1110	1	=	=	NFP
50458	1110	2	Natural	natural	JJ
50458	1110	3	Immunity	Immunity	NNP
50458	1110	4	towards	towards	IN
50458	1110	5	Serpent	Serpent	NNP
50458	1110	6	-	-	HYPH
50458	1110	7	venoms.=--Certain	venoms.=--Certain	``
50458	1110	8	animals	animal	NNS
50458	1110	9	exhibit	exhibit	VBP
50458	1110	10	a	a	DT
50458	1110	11	natural	natural	JJ
50458	1110	12	immunity	immunity	NN
50458	1110	13	toward	toward	IN
50458	1110	14	snake	snake	NN
50458	1110	15	-	-	HYPH
50458	1110	16	bites	bite	NNS
50458	1110	17	;	;	:
50458	1110	18	among	among	IN
50458	1110	19	them	-PRON-	PRP
50458	1110	20	are	be	VBP
50458	1110	21	the	the	DT
50458	1110	22	snakes	snake	NNS
50458	1110	23	themselves	-PRON-	PRP
50458	1110	24	,	,	,
50458	1110	25	the	the	DT
50458	1110	26	hog	hog	NN
50458	1110	27	,	,	,
50458	1110	28	the	the	DT
50458	1110	29	hedgehog	hedgehog	NN
50458	1110	30	,	,	,
50458	1110	31	and	and	CC
50458	1110	32	the	the	DT
50458	1110	33	mongoos	mongoo	NNS
50458	1110	34	(	(	-LRB-
50458	1110	35	an	an	DT
50458	1110	36	Egyptian	egyptian	JJ
50458	1110	37	rat	rat	NN
50458	1110	38	)	)	-RRB-
50458	1110	39	;	;	:
50458	1110	40	the	the	DT
50458	1110	41	blood	blood	NN
50458	1110	42	of	of	IN
50458	1110	43	these	these	DT
50458	1110	44	animals	animal	NNS
50458	1110	45	contains	contain	VBZ
50458	1110	46	apparently	apparently	RB
50458	1110	47	an	an	DT
50458	1110	48	antitoxin	antitoxin	NN
50458	1110	49	.	.	.
50458	1111	1	[	[	-LRB-
50458	1111	2	146	146	CD
50458	1111	3	]	]	-RRB-
50458	1111	4	[	[	-LRB-
50458	1111	5	146	146	CD
50458	1111	6	]	]	-RRB-
50458	1111	7	_	_	NNP
50458	1111	8	Compt	Compt	NNP
50458	1111	9	.	.	.
50458	1112	1	rend	rend	VB
50458	1112	2	.	.	.
50458	1113	1	de	de	NNP
50458	1113	2	l'Acad	l'Acad	NNP
50458	1113	3	.	.	.
50458	1114	1	des	des	NNP
50458	1114	2	Sciences	Sciences	NNPS
50458	1114	3	_	_	NNP
50458	1114	4	,	,	,
50458	1114	5	CXXI	CXXI	NNP
50458	1114	6	,	,	,
50458	1114	7	p.	p.	NN
50458	1114	8	745	745	CD
50458	1114	9	;	;	:
50458	1114	10	JACODOT	JACODOT	NNP
50458	1114	11	:	:	:
50458	1114	12	_	_	NNP
50458	1114	13	Arch	Arch	NNP
50458	1114	14	.	.	.
50458	1115	1	de	de	NNP
50458	1115	2	Médecine	Médecine	NNP
50458	1115	3	Navale	Navale	NNP
50458	1115	4	_	_	NNP
50458	1115	5	,	,	,
50458	1115	6	VII	VII	NNP
50458	1115	7	,	,	,
50458	1115	8	p.	p.	NN
50458	1115	9	390	390	CD
50458	1115	10	.	.	.
50458	1116	1	Fontana[147	fontana[147	CD
50458	1116	2	]	]	-RRB-
50458	1116	3	had	have	VBD
50458	1116	4	remarked	remark	VBN
50458	1116	5	that	that	IN
50458	1116	6	snakes	snake	NNS
50458	1116	7	were	be	VBD
50458	1116	8	quite	quite	RB
50458	1116	9	unaffected	unaffected	JJ
50458	1116	10	by	by	IN
50458	1116	11	the	the	DT
50458	1116	12	bite	bite	NN
50458	1116	13	of	of	IN
50458	1116	14	the	the	DT
50458	1116	15	viper	viper	NN
50458	1116	16	,	,	,
50458	1116	17	even	even	RB
50458	1116	18	when	when	WRB
50458	1116	19	inoculated	inoculate	VBN
50458	1116	20	with	with	IN
50458	1116	21	the	the	DT
50458	1116	22	venom	venom	NN
50458	1116	23	hypodermically	hypodermically	RB
50458	1116	24	.	.	.
50458	1117	1	Physalix	physalix	NN
50458	1117	2	and	and	CC
50458	1117	3	Bertrand[148	Bertrand[148	NNP
50458	1117	4	]	]	-RRB-
50458	1117	5	confirmed	confirm	VBD
50458	1117	6	these	these	DT
50458	1117	7	statements	statement	NNS
50458	1117	8	,	,	,
50458	1117	9	and	and	CC
50458	1117	10	showed	show	VBD
50458	1117	11	that	that	IN
50458	1117	12	the	the	DT
50458	1117	13	snake	snake	NN
50458	1117	14	perfectly	perfectly	RB
50458	1117	15	resisted	resist	VBD
50458	1117	16	quantities	quantity	NNS
50458	1117	17	of	of	IN
50458	1117	18	viper	viper	NN
50458	1117	19	-	-	HYPH
50458	1117	20	venom	venom	NN
50458	1117	21	capable	capable	JJ
50458	1117	22	of	of	IN
50458	1117	23	killing	kill	VBG
50458	1117	24	at	at	RB
50458	1117	25	least	least	RBS
50458	1117	26	20	20	CD
50458	1117	27	guinea	guinea	NN
50458	1117	28	-	-	HYPH
50458	1117	29	pigs	pig	NNS
50458	1117	30	.	.	.
50458	1118	1	According	accord	VBG
50458	1118	2	to	to	IN
50458	1118	3	these	these	DT
50458	1118	4	scientists	scientist	NNS
50458	1118	5	,	,	,
50458	1118	6	this	this	DT
50458	1118	7	natural	natural	JJ
50458	1118	8	immunity	immunity	NN
50458	1118	9	is	be	VBZ
50458	1118	10	due	due	JJ
50458	1118	11	to	to	IN
50458	1118	12	the	the	DT
50458	1118	13	existence	existence	NN
50458	1118	14	in	in	IN
50458	1118	15	the	the	DT
50458	1118	16	blood	blood	NN
50458	1118	17	of	of	IN
50458	1118	18	toxic	toxic	JJ
50458	1118	19	principles	principle	NNS
50458	1118	20	analogous	analogous	JJ
50458	1118	21	to	to	IN
50458	1118	22	those	those	DT
50458	1118	23	of	of	IN
50458	1118	24	viper	viper	NN
50458	1118	25	's	's	POS
50458	1118	26	venom	venom	NN
50458	1118	27	--	--	:
50458	1118	28	principles	principle	NNS
50458	1118	29	that	that	WDT
50458	1118	30	exist	exist	VBP
50458	1118	31	in	in	IN
50458	1118	32	the	the	DT
50458	1118	33	labial	labial	JJ
50458	1118	34	glands	gland	NNS
50458	1118	35	of	of	IN
50458	1118	36	the	the	DT
50458	1118	37	snake	snake	NN
50458	1118	38	,	,	,
50458	1118	39	and	and	CC
50458	1118	40	pass	pass	VB
50458	1118	41	into	into	IN
50458	1118	42	the	the	DT
50458	1118	43	blood	blood	NN
50458	1118	44	and	and	CC
50458	1118	45	the	the	DT
50458	1118	46	fluids	fluid	NNS
50458	1118	47	via	via	IN
50458	1118	48	the	the	DT
50458	1118	49	internal	internal	JJ
50458	1118	50	secretions	secretion	NNS
50458	1118	51	.	.	.
50458	1119	1	These	these	DT
50458	1119	2	writers	writer	NNS
50458	1119	3	,	,	,
50458	1119	4	and	and	CC
50458	1119	5	also	also	RB
50458	1119	6	Calmette	Calmette	NNP
50458	1119	7	,	,	,
50458	1119	8	have	have	VBP
50458	1119	9	shown	show	VBN
50458	1119	10	that	that	IN
50458	1119	11	the	the	DT
50458	1119	12	blood	blood	NN
50458	1119	13	of	of	IN
50458	1119	14	venomous	venomous	JJ
50458	1119	15	serpents	serpent	NNS
50458	1119	16	becomes	become	VBZ
50458	1119	17	antitoxic	antitoxic	NN
50458	1119	18	when	when	WRB
50458	1119	19	heated	heat	VBN
50458	1119	20	.	.	.
50458	1120	1	[	[	-LRB-
50458	1120	2	147	147	CD
50458	1120	3	]	]	-RRB-
50458	1120	4	_	_	NNP
50458	1120	5	Traité	Traité	NNP
50458	1120	6	sur	sur	FW
50458	1120	7	le	le	NNP
50458	1120	8	Venin	Venin	NNP
50458	1120	9	de	de	NNP
50458	1120	10	la	la	NNP
50458	1120	11	Vipère	Vipère	NNP
50458	1120	12	_	_	NNP
50458	1120	13	,	,	,
50458	1120	14	Florence	Florence	NNP
50458	1120	15	,	,	,
50458	1120	16	1781	1781	CD
50458	1120	17	.	.	.
50458	1121	1	[	[	-LRB-
50458	1121	2	148	148	CD
50458	1121	3	]	]	-RRB-
50458	1121	4	_	_	NNP
50458	1121	5	Archives	Archives	NNP
50458	1121	6	de	de	IN
50458	1121	7	Physiologie	Physiologie	NNP
50458	1121	8	_	_	NNP
50458	1121	9	,	,	,
50458	1121	10	1894	1894	CD
50458	1121	11	,	,	,
50458	1121	12	p.	p.	NN
50458	1121	13	423	423	CD
50458	1121	14	.	.	.
50458	1122	1	It	-PRON-	PRP
50458	1122	2	has	have	VBZ
50458	1122	3	been	be	VBN
50458	1122	4	known	know	VBN
50458	1122	5	for	for	IN
50458	1122	6	a	a	DT
50458	1122	7	long	long	JJ
50458	1122	8	time	time	NN
50458	1122	9	that	that	WDT
50458	1122	10	the	the	DT
50458	1122	11	hedgehog	hedgehog	NN
50458	1122	12	and	and	CC
50458	1122	13	the	the	DT
50458	1122	14	mongoos	mongoo	NNS
50458	1122	15	eat	eat	VBP
50458	1122	16	certain	certain	JJ
50458	1122	17	venomous	venomous	JJ
50458	1122	18	reptiles	reptile	NNS
50458	1122	19	,	,	,
50458	1122	20	and	and	CC
50458	1122	21	eagerly	eagerly	RB
50458	1122	22	hunt	hunt	VB
50458	1122	23	for	for	IN
50458	1122	24	the	the	DT
50458	1122	25	vipers	viper	NNS
50458	1122	26	in	in	IN
50458	1122	27	particular	particular	JJ
50458	1122	28	.	.	.
50458	1123	1	When	when	WRB
50458	1123	2	the	the	DT
50458	1123	3	hedgehog	hedgehog	NN
50458	1123	4	is	be	VBZ
50458	1123	5	bitten	bite	VBN
50458	1123	6	,	,	,
50458	1123	7	which	which	WDT
50458	1123	8	happens	happen	VBZ
50458	1123	9	quite	quite	RB
50458	1123	10	often	often	RB
50458	1123	11	despite	despite	IN
50458	1123	12	its	-PRON-	PRP$
50458	1123	13	dexterity	dexterity	NN
50458	1123	14	,	,	,
50458	1123	15	it	-PRON-	PRP
50458	1123	16	resists	resist	VBZ
50458	1123	17	the	the	DT
50458	1123	18	viper	viper	NN
50458	1123	19	-	-	HYPH
50458	1123	20	venom	venom	NN
50458	1123	21	quite	quite	RB
50458	1123	22	well	well	RB
50458	1123	23	.	.	.
50458	1124	1	Physalix	physalix	NN
50458	1124	2	and	and	CC
50458	1124	3	Bertrand[149	bertrand[149	IN
50458	1124	4	]	]	-RRB-
50458	1124	5	have	have	VBP
50458	1124	6	experimentally	experimentally	RB
50458	1124	7	demonstrated	demonstrate	VBN
50458	1124	8	that	that	IN
50458	1124	9	the	the	DT
50458	1124	10	hedgehog	hedgehog	NN
50458	1124	11	withstands	withstand	VBZ
50458	1124	12	a	a	DT
50458	1124	13	dose	dose	NN
50458	1124	14	of	of	IN
50458	1124	15	viper	viper	NN
50458	1124	16	-	-	HYPH
50458	1124	17	venom	venom	NN
50458	1124	18	capable	capable	JJ
50458	1124	19	of	of	IN
50458	1124	20	killing	kill	VBG
50458	1124	21	at	at	RB
50458	1124	22	least	least	RBS
50458	1124	23	40	40	CD
50458	1124	24	guinea	guinea	NN
50458	1124	25	-	-	HYPH
50458	1124	26	pigs	pig	NNS
50458	1124	27	.	.	.
50458	1125	1	Levin[150	Levin[150	NNP
50458	1125	2	]	]	-RRB-
50458	1125	3	has	have	VBZ
50458	1125	4	shown	show	VBN
50458	1125	5	that	that	IN
50458	1125	6	young	young	JJ
50458	1125	7	individuals	individual	NNS
50458	1125	8	are	be	VBP
50458	1125	9	less	less	RBR
50458	1125	10	resistant	resistant	JJ
50458	1125	11	,	,	,
50458	1125	12	and	and	CC
50458	1125	13	it	-PRON-	PRP
50458	1125	14	is	be	VBZ
50458	1125	15	concluded	conclude	VBN
50458	1125	16	from	from	IN
50458	1125	17	this	this	DT
50458	1125	18	,	,	,
50458	1125	19	and	and	CC
50458	1125	20	perhaps	perhaps	RB
50458	1125	21	incorrectly	incorrectly	RB
50458	1125	22	so	so	RB
50458	1125	23	,	,	,
50458	1125	24	that	that	IN
50458	1125	25	the	the	DT
50458	1125	26	immunity	immunity	NN
50458	1125	27	of	of	IN
50458	1125	28	the	the	DT
50458	1125	29	hedgehog	hedgehog	NN
50458	1125	30	is	be	VBZ
50458	1125	31	naturally	naturally	RB
50458	1125	32	acquired	acquire	VBN
50458	1125	33	,	,	,
50458	1125	34	rather	rather	RB
50458	1125	35	than	than	IN
50458	1125	36	inherent	inherent	JJ
50458	1125	37	.	.	.
50458	1126	1	Bertrand	Bertrand	NNP
50458	1126	2	and	and	CC
50458	1126	3	Physalix	Physalix	NNP
50458	1126	4	have	have	VBP
50458	1126	5	nevertheless	nevertheless	RB
50458	1126	6	shown	show	VBN
50458	1126	7	that	that	IN
50458	1126	8	on	on	IN
50458	1126	9	heating	heat	VBG
50458	1126	10	the	the	DT
50458	1126	11	blood	blood	NN
50458	1126	12	of	of	IN
50458	1126	13	the	the	DT
50458	1126	14	hedgehog	hedgehog	NN
50458	1126	15	to	to	IN
50458	1126	16	88	88	CD
50458	1126	17	°	°	,
50458	1126	18	C.	C.	NNP
50458	1126	19	it	-PRON-	PRP
50458	1126	20	manifests	manifest	VBZ
50458	1126	21	an	an	DT
50458	1126	22	antitoxic	antitoxic	JJ
50458	1126	23	power	power	NN
50458	1126	24	toward	toward	IN
50458	1126	25	serpent	serpent	NN
50458	1126	26	-	-	HYPH
50458	1126	27	venom	venom	NN
50458	1126	28	_	_	NNP
50458	1126	29	in	in	IN
50458	1126	30	vitro	vitro	FW
50458	1126	31	_	_	NNP
50458	1126	32	.	.	.
50458	1127	1	[	[	-LRB-
50458	1127	2	149	149	CD
50458	1127	3	]	]	-RRB-
50458	1127	4	_	_	NNP
50458	1127	5	Bull	Bull	NNP
50458	1127	6	.	.	.
50458	1128	1	Muséum	Muséum	NNP
50458	1128	2	Histoire	Histoire	NNP
50458	1128	3	Naturelle	Naturelle	NNP
50458	1128	4	_	_	NNP
50458	1128	5	,	,	,
50458	1128	6	I	-PRON-	PRP
50458	1128	7	,	,	,
50458	1128	8	p.	p.	NN
50458	1128	9	294	294	CD
50458	1128	10	;	;	:
50458	1128	11	_	_	NNP
50458	1128	12	Compt	Compt	NNP
50458	1128	13	.	.	.
50458	1129	1	rend	rend	VB
50458	1129	2	.	.	.
50458	1130	1	Soc	Soc	NNP
50458	1130	2	.	.	.
50458	1131	1	de	de	NNP
50458	1131	2	Biol	Biol	NNP
50458	1131	3	.	.	.
50458	1131	4	_	_	NNP
50458	1131	5	,	,	,
50458	1131	6	1899	1899	CD
50458	1131	7	.	.	.
50458	1131	8	p.	p.	NN
50458	1131	9	77	77	CD
50458	1131	10	.	.	.
50458	1132	1	[	[	-LRB-
50458	1132	2	150	150	CD
50458	1132	3	]	]	-RRB-
50458	1132	4	_	_	NNP
50458	1132	5	Deutsche	Deutsche	NNP
50458	1132	6	med	med	NNP
50458	1132	7	.	.	.
50458	1133	1	Woch	Woch	NNP
50458	1133	2	.	.	.
50458	1133	3	_	_	NNP
50458	1133	4	,	,	,
50458	1133	5	1898	1898	CD
50458	1133	6	,	,	,
50458	1133	7	p.	p.	NN
50458	1133	8	629	629	CD
50458	1133	9	.	.	.
50458	1134	1	=	=	NFP
50458	1134	2	Artificial	Artificial	NNP
50458	1134	3	Immunity	immunity	NN
50458	1134	4	toward	toward	IN
50458	1134	5	Serpent	Serpent	NNP
50458	1134	6	-	-	HYPH
50458	1134	7	venom.=--Immunity	venom.=--immunity	NN
50458	1134	8	may	may	MD
50458	1134	9	be	be	VB
50458	1134	10	conferred	confer	VBN
50458	1134	11	upon	upon	IN
50458	1134	12	every	every	DT
50458	1134	13	individual	individual	NN
50458	1134	14	by	by	IN
50458	1134	15	utilizing	utilize	VBG
50458	1134	16	the	the	DT
50458	1134	17	method	method	NN
50458	1134	18	of	of	IN
50458	1134	19	habituation	habituation	NN
50458	1134	20	.	.	.
50458	1135	1	This	this	DT
50458	1135	2	fact	fact	NN
50458	1135	3	was	be	VBD
50458	1135	4	simultaneously	simultaneously	RB
50458	1135	5	elicited	elicit	VBN
50458	1135	6	by	by	IN
50458	1135	7	Calmette	Calmette	NNP
50458	1135	8	,	,	,
50458	1135	9	Bertrand	Bertrand	NNP
50458	1135	10	,	,	,
50458	1135	11	and	and	CC
50458	1135	12	Physalix	Physalix	NNP
50458	1135	13	.	.	.
50458	1136	1	To	to	TO
50458	1136	2	effect	effect	VB
50458	1136	3	the	the	DT
50458	1136	4	immunity	immunity	NN
50458	1136	5	these	these	DT
50458	1136	6	scientists	scientist	NNS
50458	1136	7	prepare	prepare	VBP
50458	1136	8	an	an	DT
50458	1136	9	antivenomous	antivenomous	JJ
50458	1136	10	serum	serum	NN
50458	1136	11	and	and	CC
50458	1136	12	inject	inject	VB
50458	1136	13	it	-PRON-	PRP
50458	1136	14	into	into	IN
50458	1136	15	animals	animal	NNS
50458	1136	16	,	,	,
50458	1136	17	giving	give	VBG
50458	1136	18	at	at	IN
50458	1136	19	first	first	RB
50458	1136	20	very	very	RB
50458	1136	21	small	small	JJ
50458	1136	22	quantities	quantity	NNS
50458	1136	23	of	of	IN
50458	1136	24	the	the	DT
50458	1136	25	diluted	diluted	JJ
50458	1136	26	venom	venom	NN
50458	1136	27	,	,	,
50458	1136	28	and	and	CC
50458	1136	29	gradually	gradually	RB
50458	1136	30	increasing	increase	VBG
50458	1136	31	the	the	DT
50458	1136	32	doses	dose	NNS
50458	1136	33	,	,	,
50458	1136	34	and	and	CC
50458	1136	35	the	the	DT
50458	1136	36	periods	period	NNS
50458	1136	37	intervening	intervene	VBG
50458	1136	38	between	between	IN
50458	1136	39	the	the	DT
50458	1136	40	injections	injection	NNS
50458	1136	41	.	.	.
50458	1137	1	At	at	IN
50458	1137	2	the	the	DT
50458	1137	3	end	end	NN
50458	1137	4	of	of	IN
50458	1137	5	about	about	RB
50458	1137	6	two	two	CD
50458	1137	7	months	month	NNS
50458	1137	8	of	of	IN
50458	1137	9	this	this	DT
50458	1137	10	treatment	treatment	NN
50458	1137	11	,	,	,
50458	1137	12	the	the	DT
50458	1137	13	immunity	immunity	NN
50458	1137	14	has	have	VBZ
50458	1137	15	reached	reach	VBN
50458	1137	16	its	-PRON-	PRP$
50458	1137	17	maximum	maximum	NN
50458	1137	18	.	.	.
50458	1138	1	Certain	certain	JJ
50458	1138	2	rabbits	rabbit	NNS
50458	1138	3	,	,	,
50458	1138	4	thus	thus	RB
50458	1138	5	slowly	slowly	RB
50458	1138	6	inoculated	inoculate	VBN
50458	1138	7	,	,	,
50458	1138	8	have	have	VBP
50458	1138	9	been	be	VBN
50458	1138	10	able	able	JJ
50458	1138	11	to	to	TO
50458	1138	12	withstand	withstand	VB
50458	1138	13	0.04	0.04	CD
50458	1138	14	Gm	Gm	NNP
50458	1138	15	.	.	.
50458	1139	1	of	of	IN
50458	1139	2	the	the	DT
50458	1139	3	venom	venom	NN
50458	1139	4	of	of	IN
50458	1139	5	the	the	DT
50458	1139	6	naja	naja	NNS
50458	1139	7	at	at	IN
50458	1139	8	a	a	DT
50458	1139	9	single	single	JJ
50458	1139	10	injection	injection	NN
50458	1139	11	;	;	:
50458	1139	12	such	such	JJ
50458	1139	13	rabbits	rabbit	NNS
50458	1139	14	then	then	RB
50458	1139	15	yield	yield	VBP
50458	1139	16	a	a	DT
50458	1139	17	vaccinal	vaccinal	JJ
50458	1139	18	serum	serum	NN
50458	1139	19	.	.	.
50458	1140	1	[	[	-LRB-
50458	1140	2	151	151	CD
50458	1140	3	]	]	-RRB-
50458	1140	4	[	[	-LRB-
50458	1140	5	151	151	CD
50458	1140	6	]	]	-RRB-
50458	1140	7	_	_	NNP
50458	1140	8	Annal	Annal	NNP
50458	1140	9	.	.	.
50458	1141	1	de	de	NNP
50458	1141	2	l'Instit	l'Instit	NNP
50458	1141	3	.	.	.
50458	1142	1	Pasteur	Pasteur	NNP
50458	1142	2	_	_	NNP
50458	1142	3	,	,	,
50458	1142	4	1895	1895	CD
50458	1142	5	,	,	,
50458	1142	6	p.	p.	NN
50458	1142	7	229	229	CD
50458	1142	8	;	;	:
50458	1142	9	_	_	NNP
50458	1142	10	Compt	Compt	NNP
50458	1142	11	.	.	.
50458	1143	1	rend	rend	VB
50458	1143	2	.	.	.
50458	1144	1	de	de	NNP
50458	1144	2	l'Acad	l'Acad	NNP
50458	1144	3	.	.	.
50458	1145	1	des	des	NNP
50458	1145	2	Sciences	Sciences	NNPS
50458	1145	3	_	_	NNP
50458	1145	4	,	,	,
50458	1145	5	CXXII	CXXII	NNP
50458	1145	6	,	,	,
50458	1145	7	p.	p.	NN
50458	1145	8	203	203	CD
50458	1145	9	.	.	.
50458	1146	1	At	at	IN
50458	1146	2	the	the	DT
50458	1146	3	Institut	Institut	NNP
50458	1146	4	Pasteur	Pasteur	NNP
50458	1146	5	at	at	IN
50458	1146	6	Lille	Lille	NNP
50458	1146	7	there	there	EX
50458	1146	8	is	be	VBZ
50458	1146	9	prepared	prepare	VBN
50458	1146	10	in	in	IN
50458	1146	11	this	this	DT
50458	1146	12	manner	manner	NN
50458	1146	13	an	an	DT
50458	1146	14	antivenomous	antivenomous	JJ
50458	1146	15	serum	serum	NN
50458	1146	16	from	from	IN
50458	1146	17	the	the	DT
50458	1146	18	horse	horse	NN
50458	1146	19	;	;	:
50458	1146	20	it	-PRON-	PRP
50458	1146	21	is	be	VBZ
50458	1146	22	capable	capable	JJ
50458	1146	23	of	of	IN
50458	1146	24	acting	act	VBG
50458	1146	25	upon	upon	IN
50458	1146	26	20	20	CD
50458	1146	27	000	000	CD
50458	1146	28	times	time	NNS
50458	1146	29	its	-PRON-	PRP$
50458	1146	30	own	own	JJ
50458	1146	31	weight	weight	NN
50458	1146	32	.	.	.
50458	1147	1	This	this	DT
50458	1147	2	has	have	VBZ
50458	1147	3	rendered	render	VBN
50458	1147	4	great	great	JJ
50458	1147	5	service	service	NN
50458	1147	6	in	in	IN
50458	1147	7	the	the	DT
50458	1147	8	treatment	treatment	NN
50458	1147	9	of	of	IN
50458	1147	10	snake	snake	NN
50458	1147	11	-	-	HYPH
50458	1147	12	bites	bite	NNS
50458	1147	13	,	,	,
50458	1147	14	particularly	particularly	RB
50458	1147	15	in	in	IN
50458	1147	16	hot	hot	JJ
50458	1147	17	countries	country	NNS
50458	1147	18	,	,	,
50458	1147	19	where	where	WRB
50458	1147	20	the	the	DT
50458	1147	21	accidents	accident	NNS
50458	1147	22	are	be	VBP
50458	1147	23	of	of	IN
50458	1147	24	daily	daily	JJ
50458	1147	25	occurrence	occurrence	NN
50458	1147	26	.	.	.
50458	1148	1	_	_	NNP
50458	1148	2	In	in	IN
50458	1148	3	vitro	vitro	FW
50458	1148	4	_	_	NNP
50458	1148	5	it	-PRON-	PRP
50458	1148	6	acts	act	VBZ
50458	1148	7	quite	quite	RB
50458	1148	8	as	as	RB
50458	1148	9	well	well	RB
50458	1148	10	preventively	preventively	RB
50458	1148	11	as	as	RB
50458	1148	12	therapeutically	therapeutically	RB
50458	1148	13	.	.	.
50458	1149	1	It	-PRON-	PRP
50458	1149	2	arrests	arrest	VBZ
50458	1149	3	the	the	DT
50458	1149	4	effects	effect	NNS
50458	1149	5	of	of	IN
50458	1149	6	the	the	DT
50458	1149	7	naja	naja	NNP
50458	1149	8	,	,	,
50458	1149	9	the	the	DT
50458	1149	10	horned	horned	JJ
50458	1149	11	ceraste	ceraste	NN
50458	1149	12	,	,	,
50458	1149	13	the	the	DT
50458	1149	14	trigonocephalus	trigonocephalus	NN
50458	1149	15	,	,	,
50458	1149	16	the	the	DT
50458	1149	17	rattlesnake	rattlesnake	NN
50458	1149	18	,	,	,
50458	1149	19	and	and	CC
50458	1149	20	of	of	IN
50458	1149	21	almost	almost	RB
50458	1149	22	every	every	DT
50458	1149	23	one	one	CD
50458	1149	24	of	of	IN
50458	1149	25	the	the	DT
50458	1149	26	venomous	venomous	JJ
50458	1149	27	serpents	serpent	NNS
50458	1149	28	known	know	VBN
50458	1149	29	.	.	.
50458	1150	1	The	the	DT
50458	1150	2	relatively	relatively	RB
50458	1150	3	considerable	considerable	JJ
50458	1150	4	immunity	immunity	NN
50458	1150	5	possessed	possess	VBN
50458	1150	6	by	by	IN
50458	1150	7	certain	certain	JJ
50458	1150	8	snake	snake	NN
50458	1150	9	-	-	HYPH
50458	1150	10	charmers	charmer	NNS
50458	1150	11	,	,	,
50458	1150	12	and	and	CC
50458	1150	13	which	which	WDT
50458	1150	14	passes	pass	VBZ
50458	1150	15	for	for	IN
50458	1150	16	a	a	DT
50458	1150	17	magical	magical	JJ
50458	1150	18	gift	gift	NN
50458	1150	19	,	,	,
50458	1150	20	is	be	VBZ
50458	1150	21	due	due	JJ
50458	1150	22	to	to	IN
50458	1150	23	nothing	nothing	NN
50458	1150	24	else	else	RB
50458	1150	25	but	but	CC
50458	1150	26	a	a	DT
50458	1150	27	natural	natural	JJ
50458	1150	28	immunity	immunity	NN
50458	1150	29	,	,	,
50458	1150	30	acquired	acquire	VBN
50458	1150	31	perhaps	perhaps	RB
50458	1150	32	by	by	IN
50458	1150	33	heredity	heredity	NN
50458	1150	34	,	,	,
50458	1150	35	and	and	CC
50458	1150	36	it	-PRON-	PRP
50458	1150	37	always	always	RB
50458	1150	38	appears	appear	VBZ
50458	1150	39	to	to	TO
50458	1150	40	follow	follow	VB
50458	1150	41	as	as	IN
50458	1150	42	a	a	DT
50458	1150	43	result	result	NN
50458	1150	44	of	of	IN
50458	1150	45	a	a	DT
50458	1150	46	nonfatal	nonfatal	JJ
50458	1150	47	snake	snake	NN
50458	1150	48	-	-	HYPH
50458	1150	49	bite	bite	NN
50458	1150	50	.	.	.
50458	1151	1	=	=	NFP
50458	1151	2	Venoms	Venoms	NNP
50458	1151	3	of	of	IN
50458	1151	4	Batrachians	Batrachians	NNPS
50458	1151	5	and	and	CC
50458	1151	6	Saurians.=--We	Saurians.=--We	NNP
50458	1151	7	observe	observe	VBP
50458	1151	8	here	here	RB
50458	1151	9	a	a	DT
50458	1151	10	fundamental	fundamental	JJ
50458	1151	11	difference	difference	NN
50458	1151	12	between	between	IN
50458	1151	13	these	these	DT
50458	1151	14	poisons	poison	NNS
50458	1151	15	and	and	CC
50458	1151	16	those	those	DT
50458	1151	17	of	of	IN
50458	1151	18	snakes	snake	NNS
50458	1151	19	,	,	,
50458	1151	20	as	as	IN
50458	1151	21	we	-PRON-	PRP
50458	1151	22	shall	shall	MD
50458	1151	23	see	see	VB
50458	1151	24	.	.	.
50458	1152	1	These	these	DT
50458	1152	2	latter	latter	JJ
50458	1152	3	,	,	,
50458	1152	4	in	in	IN
50458	1152	5	fact	fact	NN
50458	1152	6	,	,	,
50458	1152	7	appear	appear	VB
50458	1152	8	to	to	TO
50458	1152	9	owe	owe	VB
50458	1152	10	all	all	DT
50458	1152	11	their	-PRON-	PRP$
50458	1152	12	toxicity	toxicity	NN
50458	1152	13	to	to	IN
50458	1152	14	true	true	JJ
50458	1152	15	toxins	toxin	NNS
50458	1152	16	which	which	WDT
50458	1152	17	they	-PRON-	PRP
50458	1152	18	contain	contain	VBP
50458	1152	19	,	,	,
50458	1152	20	while	while	IN
50458	1152	21	the	the	DT
50458	1152	22	poisons	poison	NNS
50458	1152	23	of	of	IN
50458	1152	24	batrachians	batrachian	NNS
50458	1152	25	and	and	CC
50458	1152	26	saurians	saurians	NNPS
50458	1152	27	are	be	VBP
50458	1152	28	chiefly	chiefly	RB
50458	1152	29	composed	compose	VBN
50458	1152	30	of	of	IN
50458	1152	31	alkaloidal	alkaloidal	NN
50458	1152	32	bases	basis	NNS
50458	1152	33	.	.	.
50458	1153	1	[	[	-LRB-
50458	1153	2	152	152	CD
50458	1153	3	]	]	-RRB-
50458	1153	4	[	[	-LRB-
50458	1153	5	152	152	CD
50458	1153	6	]	]	-RRB-
50458	1153	7	CLOEZ	CLOEZ	NNP
50458	1153	8	:	:	:
50458	1153	9	_	_	NNP
50458	1153	10	Compt	Compt	NNP
50458	1153	11	.	.	.
50458	1154	1	rend	rend	VB
50458	1154	2	.	.	.
50458	1155	1	de	de	NNP
50458	1155	2	l'Acad	l'Acad	NNP
50458	1155	3	.	.	.
50458	1156	1	des	des	NNP
50458	1156	2	Sciences	Sciences	NNPS
50458	1156	3	_	_	NNP
50458	1156	4	,	,	,
50458	1156	5	XXXIV	XXXIV	NNP
50458	1156	6	,	,	,
50458	1156	7	p.	p.	NN
50458	1156	8	592	592	CD
50458	1156	9	.	.	.
50458	1157	1	The	the	DT
50458	1157	2	poison	poison	NN
50458	1157	3	of	of	IN
50458	1157	4	toads	toad	NNS
50458	1157	5	and	and	CC
50458	1157	6	frogs	frog	NNS
50458	1157	7	(	(	-LRB-
50458	1157	8	studied	study	VBN
50458	1157	9	by	by	IN
50458	1157	10	Faust	Faust	NNP
50458	1157	11	,	,	,
50458	1157	12	Bertrand	Bertrand	NNP
50458	1157	13	,	,	,
50458	1157	14	and	and	CC
50458	1157	15	Physalix	Physalix	NNP
50458	1157	16	)	)	-RRB-
50458	1157	17	is	be	VBZ
50458	1157	18	chiefly	chiefly	RB
50458	1157	19	secreted	secrete	VBN
50458	1157	20	by	by	IN
50458	1157	21	the	the	DT
50458	1157	22	glands	gland	NNS
50458	1157	23	of	of	IN
50458	1157	24	the	the	DT
50458	1157	25	subcutaneous	subcutaneous	JJ
50458	1157	26	tissues	tissue	NNS
50458	1157	27	of	of	IN
50458	1157	28	these	these	DT
50458	1157	29	animals	animal	NNS
50458	1157	30	;	;	:
50458	1157	31	it	-PRON-	PRP
50458	1157	32	has	have	VBZ
50458	1157	33	but	but	CC
50458	1157	34	a	a	DT
50458	1157	35	very	very	RB
50458	1157	36	slight	slight	JJ
50458	1157	37	action	action	NN
50458	1157	38	on	on	IN
50458	1157	39	the	the	DT
50458	1157	40	unbroken	unbroken	JJ
50458	1157	41	skin	skin	NN
50458	1157	42	,	,	,
50458	1157	43	but	but	CC
50458	1157	44	it	-PRON-	PRP
50458	1157	45	rapidly	rapidly	RB
50458	1157	46	inflames	inflame	VBZ
50458	1157	47	the	the	DT
50458	1157	48	nasal	nasal	NN
50458	1157	49	and	and	CC
50458	1157	50	buccal	buccal	JJ
50458	1157	51	conjunctival	conjunctival	NN
50458	1157	52	mucosa	mucosa	NNS
50458	1157	53	.	.	.
50458	1158	1	The	the	DT
50458	1158	2	poison	poison	NN
50458	1158	3	is	be	VBZ
50458	1158	4	a	a	DT
50458	1158	5	yellowish	yellowish	JJ
50458	1158	6	liquid	liquid	NN
50458	1158	7	,	,	,
50458	1158	8	milky	milky	NNP
50458	1158	9	and	and	CC
50458	1158	10	viscid	viscid	NNP
50458	1158	11	,	,	,
50458	1158	12	with	with	IN
50458	1158	13	a	a	DT
50458	1158	14	waxy	waxy	NN
50458	1158	15	odor	odor	NN
50458	1158	16	and	and	CC
50458	1158	17	an	an	DT
50458	1158	18	insupportably	insupportably	RB
50458	1158	19	bitter	bitter	JJ
50458	1158	20	taste	taste	NN
50458	1158	21	.	.	.
50458	1159	1	It	-PRON-	PRP
50458	1159	2	is	be	VBZ
50458	1159	3	strongly	strongly	RB
50458	1159	4	acid	acid	JJ
50458	1159	5	and	and	CC
50458	1159	6	caustic	caustic	JJ
50458	1159	7	.	.	.
50458	1160	1	When	when	WRB
50458	1160	2	dried	dry	VBN
50458	1160	3	,	,	,
50458	1160	4	the	the	DT
50458	1160	5	poison	poison	NN
50458	1160	6	yields	yield	NNS
50458	1160	7	to	to	TO
50458	1160	8	ether	ether	VB
50458	1160	9	a	a	DT
50458	1160	10	fatty	fatty	NN
50458	1160	11	matter	matter	NN
50458	1160	12	which	which	WDT
50458	1160	13	,	,	,
50458	1160	14	when	when	WRB
50458	1160	15	absorbed	absorb	VBN
50458	1160	16	by	by	IN
50458	1160	17	an	an	DT
50458	1160	18	animal	animal	NN
50458	1160	19	,	,	,
50458	1160	20	plunges	plunge	VBZ
50458	1160	21	the	the	DT
50458	1160	22	latter	latter	JJ
50458	1160	23	into	into	IN
50458	1160	24	a	a	DT
50458	1160	25	coma	coma	NN
50458	1160	26	that	that	WDT
50458	1160	27	may	may	MD
50458	1160	28	end	end	VB
50458	1160	29	in	in	IN
50458	1160	30	death	death	NN
50458	1160	31	.	.	.
50458	1161	1	The	the	DT
50458	1161	2	residue	residue	NN
50458	1161	3	insoluble	insoluble	JJ
50458	1161	4	in	in	IN
50458	1161	5	ether	ether	NN
50458	1161	6	contains	contain	VBZ
50458	1161	7	the	the	DT
50458	1161	8	non	non	JJ
50458	1161	9	-	-	JJ
50458	1161	10	toxic	toxic	JJ
50458	1161	11	albuminoids	albuminoid	NNS
50458	1161	12	,	,	,
50458	1161	13	and	and	CC
50458	1161	14	ptomaines	ptomaine	NNS
50458	1161	15	,	,	,
50458	1161	16	such	such	JJ
50458	1161	17	as	as	IN
50458	1161	18	methylcarbylamine,[153	methylcarbylamine,[153	NNP
50458	1161	19	]	]	-RRB-
50458	1161	20	and	and	CC
50458	1161	21	isocyanacetic	isocyanacetic	JJ
50458	1161	22	acid	acid	NN
50458	1161	23	,	,	,
50458	1161	24	resulting	result	VBG
50458	1161	25	from	from	IN
50458	1161	26	the	the	DT
50458	1161	27	decomposition	decomposition	NN
50458	1161	28	of	of	IN
50458	1161	29	a	a	DT
50458	1161	30	lecithin	lecithin	NN
50458	1161	31	that	that	WDT
50458	1161	32	appears	appear	VBZ
50458	1161	33	to	to	TO
50458	1161	34	be	be	VB
50458	1161	35	soluble	soluble	JJ
50458	1161	36	in	in	IN
50458	1161	37	ether	ether	NN
50458	1161	38	.	.	.
50458	1162	1	[	[	-LRB-
50458	1162	2	153	153	CD
50458	1162	3	]	]	-RRB-
50458	1162	4	_	_	NNP
50458	1162	5	Ibid	Ibid	NNP
50458	1162	6	.	.	.
50458	1162	7	_	_	NNP
50458	1162	8	,	,	,
50458	1162	9	XCVIII	XCVIII	NNP
50458	1162	10	,	,	,
50458	1162	11	p.	p.	NN
50458	1162	12	538	538	CD
50458	1162	13	.	.	.
50458	1163	1	To	to	TO
50458	1163	2	obtain	obtain	VB
50458	1163	3	this	this	DT
50458	1163	4	venom	venom	NN
50458	1163	5	,	,	,
50458	1163	6	Physalix	Physalix	NNP
50458	1163	7	and	and	CC
50458	1163	8	Bertrand[154	Bertrand[154	NNP
50458	1163	9	]	]	-RRB-
50458	1163	10	skin	skin	NN
50458	1163	11	the	the	DT
50458	1163	12	toads	toad	NNS
50458	1163	13	,	,	,
50458	1163	14	first	first	RB
50458	1163	15	chloroformed	chloroform	VBN
50458	1163	16	,	,	,
50458	1163	17	and	and	CC
50458	1163	18	dry	dry	VB
50458	1163	19	the	the	DT
50458	1163	20	skins	skin	NNS
50458	1163	21	in	in	IN
50458	1163	22	a	a	DT
50458	1163	23	vacuum	vacuum	NN
50458	1163	24	over	over	IN
50458	1163	25	sulphuric	sulphuric	JJ
50458	1163	26	acid	acid	NN
50458	1163	27	;	;	:
50458	1163	28	the	the	DT
50458	1163	29	skins	skin	NNS
50458	1163	30	are	be	VBP
50458	1163	31	then	then	RB
50458	1163	32	cleaned	clean	VBN
50458	1163	33	by	by	IN
50458	1163	34	treating	treat	VBG
50458	1163	35	with	with	IN
50458	1163	36	carbon	carbon	NN
50458	1163	37	disulphide	disulphide	NN
50458	1163	38	to	to	TO
50458	1163	39	remove	remove	VB
50458	1163	40	fatty	fatty	NN
50458	1163	41	matters	matter	NNS
50458	1163	42	,	,	,
50458	1163	43	and	and	CC
50458	1163	44	the	the	DT
50458	1163	45	toxic	toxic	JJ
50458	1163	46	principles	principle	NNS
50458	1163	47	removed	remove	VBN
50458	1163	48	by	by	IN
50458	1163	49	means	mean	NNS
50458	1163	50	of	of	IN
50458	1163	51	95-per	95-per	CD
50458	1163	52	cent	cent	NN
50458	1163	53	.	.	.
50458	1164	1	alcohol	alcohol	NN
50458	1164	2	;	;	:
50458	1164	3	the	the	DT
50458	1164	4	poison	poison	NN
50458	1164	5	so	so	RB
50458	1164	6	obtained	obtain	VBN
50458	1164	7	,	,	,
50458	1164	8	however	however	RB
50458	1164	9	,	,	,
50458	1164	10	is	be	VBZ
50458	1164	11	impure	impure	NN
50458	1164	12	.	.	.
50458	1165	1	A	a	DT
50458	1165	2	better	well	JJR
50458	1165	3	procedure	procedure	NN
50458	1165	4	is	be	VBZ
50458	1165	5	to	to	TO
50458	1165	6	express	express	VB
50458	1165	7	the	the	DT
50458	1165	8	parotid	parotid	NN
50458	1165	9	glands	gland	NNS
50458	1165	10	which	which	WDT
50458	1165	11	have	have	VBP
50458	1165	12	been	be	VBN
50458	1165	13	placed	place	VBN
50458	1165	14	in	in	IN
50458	1165	15	distilled	distilled	JJ
50458	1165	16	water	water	NN
50458	1165	17	.	.	.
50458	1166	1	Faust	Faust	NNP
50458	1166	2	found	find	VBN
50458	1166	3	in	in	IN
50458	1166	4	this	this	DT
50458	1166	5	venom	venom	NN
50458	1166	6	a	a	DT
50458	1166	7	principle	principle	NN
50458	1166	8	which	which	WDT
50458	1166	9	he	-PRON-	PRP
50458	1166	10	named	name	VBD
50458	1166	11	_	_	NNP
50458	1166	12	bufonin	bufonin	VBD
50458	1166	13	_	_	NNP
50458	1166	14	.	.	.
50458	1167	1	Physalix	Physalix	NNP
50458	1167	2	and	and	CC
50458	1167	3	Bertrand	Bertrand	NNP
50458	1167	4	isolated	isolate	VBD
50458	1167	5	from	from	IN
50458	1167	6	it	-PRON-	PRP
50458	1167	7	also	also	RB
50458	1167	8	a	a	DT
50458	1167	9	resinoid	resinoid	JJ
50458	1167	10	substance	substance	NN
50458	1167	11	soluble	soluble	JJ
50458	1167	12	in	in	IN
50458	1167	13	alcohol	alcohol	NN
50458	1167	14	and	and	CC
50458	1167	15	in	in	IN
50458	1167	16	a	a	DT
50458	1167	17	large	large	JJ
50458	1167	18	excess	excess	NN
50458	1167	19	of	of	IN
50458	1167	20	water	water	NN
50458	1167	21	;	;	:
50458	1167	22	this	this	DT
50458	1167	23	substance	substance	NN
50458	1167	24	,	,	,
50458	1167	25	which	which	WDT
50458	1167	26	they	-PRON-	PRP
50458	1167	27	named	name	VBD
50458	1167	28	_	_	NNP
50458	1167	29	bufotaline	bufotaline	NN
50458	1167	30	_	_	NNP
50458	1167	31	,	,	,
50458	1167	32	acts	act	VBZ
50458	1167	33	upon	upon	IN
50458	1167	34	the	the	DT
50458	1167	35	heart	heart	NN
50458	1167	36	.	.	.
50458	1168	1	These	these	DT
50458	1168	2	authors	author	NNS
50458	1168	3	have	have	VBP
50458	1168	4	also	also	RB
50458	1168	5	obtained	obtain	VBN
50458	1168	6	another	another	DT
50458	1168	7	substance	substance	NN
50458	1168	8	which	which	WDT
50458	1168	9	has	have	VBZ
50458	1168	10	a	a	DT
50458	1168	11	paralyzing	paralyzing	NN
50458	1168	12	action	action	NN
50458	1168	13	,	,	,
50458	1168	14	and	and	CC
50458	1168	15	which	which	WDT
50458	1168	16	they	-PRON-	PRP
50458	1168	17	have	have	VBP
50458	1168	18	named	name	VBN
50458	1168	19	_	_	NNP
50458	1168	20	bufotenin	bufotenin	VBN
50458	1168	21	_	_	NNP
50458	1168	22	.	.	.
50458	1169	1	[	[	-LRB-
50458	1169	2	154	154	CD
50458	1169	3	]	]	-RRB-
50458	1169	4	_	_	NNP
50458	1169	5	Ibid	Ibid	NNP
50458	1169	6	.	.	.
50458	1169	7	_	_	NNP
50458	1169	8	,	,	,
50458	1169	9	CXXVIII	CXXVIII	NNP
50458	1169	10	,	,	,
50458	1169	11	pp	pp	NNP
50458	1169	12	.	.	.
50458	1170	1	45	45	CD
50458	1170	2	-	-	SYM
50458	1170	3	48	48	CD
50458	1170	4	.	.	.
50458	1171	1	The	the	DT
50458	1171	2	poison	poison	NN
50458	1171	3	of	of	IN
50458	1171	4	the	the	DT
50458	1171	5	common	common	JJ
50458	1171	6	toad	toad	NN
50458	1171	7	acts	act	VBZ
50458	1171	8	as	as	IN
50458	1171	9	a	a	DT
50458	1171	10	paralyzant	paralyzant	NN
50458	1171	11	upon	upon	IN
50458	1171	12	the	the	DT
50458	1171	13	heart	heart	NN
50458	1171	14	and	and	CC
50458	1171	15	on	on	IN
50458	1171	16	the	the	DT
50458	1171	17	spinal	spinal	JJ
50458	1171	18	marrow[155	marrow[155	NN
50458	1171	19	]	]	-RRB-
50458	1171	20	;	;	:
50458	1171	21	that	that	DT
50458	1171	22	of	of	IN
50458	1171	23	the	the	DT
50458	1171	24	common	common	JJ
50458	1171	25	frog	frog	NN
50458	1171	26	possesses	possess	VBZ
50458	1171	27	similar	similar	JJ
50458	1171	28	properties	property	NNS
50458	1171	29	.	.	.
50458	1172	1	The	the	DT
50458	1172	2	poison	poison	NN
50458	1172	3	of	of	IN
50458	1172	4	the	the	DT
50458	1172	5	tritons	triton	NNS
50458	1172	6	is	be	VBZ
50458	1172	7	quite	quite	RB
50458	1172	8	analogous	analogous	JJ
50458	1172	9	to	to	IN
50458	1172	10	that	that	DT
50458	1172	11	of	of	IN
50458	1172	12	the	the	DT
50458	1172	13	toads	toad	NNS
50458	1172	14	;	;	:
50458	1172	15	it	-PRON-	PRP
50458	1172	16	contains	contain	VBZ
50458	1172	17	a	a	DT
50458	1172	18	lecithin	lecithin	JJ
50458	1172	19	hydrolyzable	hydrolyzable	JJ
50458	1172	20	by	by	IN
50458	1172	21	water	water	NN
50458	1172	22	with	with	IN
50458	1172	23	the	the	DT
50458	1172	24	formation	formation	NN
50458	1172	25	of	of	IN
50458	1172	26	alanin	alanin	NN
50458	1172	27	,	,	,
50458	1172	28	formic	formic	NN
50458	1172	29	acid	acid	NN
50458	1172	30	,	,	,
50458	1172	31	and	and	CC
50458	1172	32	alpha	alpha	NN
50458	1172	33	-	-	HYPH
50458	1172	34	isocyanopropionic	isocyanopropionic	JJ
50458	1172	35	acid	acid	NN
50458	1172	36	.	.	.
50458	1173	1	[	[	-LRB-
50458	1173	2	155	155	CD
50458	1173	3	]	]	-RRB-
50458	1173	4	P.	P.	NNP
50458	1173	5	BERT	BERT	NNP
50458	1173	6	:	:	:
50458	1173	7	_	_	NNP
50458	1173	8	Compt	Compt	NNP
50458	1173	9	.	.	.
50458	1174	1	rend	rend	VB
50458	1174	2	.	.	.
50458	1175	1	de	de	NNP
50458	1175	2	la	la	NNP
50458	1175	3	Soc	Soc	NNP
50458	1175	4	.	.	.
50458	1176	1	de	de	NNP
50458	1176	2	Biologie	Biologie	NNP
50458	1176	3	_	_	NNP
50458	1176	4	,	,	,
50458	1176	5	1885	1885	CD
50458	1176	6	,	,	,
50458	1176	7	p.	p.	NN
50458	1176	8	524	524	CD
50458	1176	9	.	.	.
50458	1177	1	Zalnosky[156	Zalnosky[156	NNP
50458	1177	2	]	]	-RRB-
50458	1177	3	isolated	isolate	VBN
50458	1177	4	from	from	IN
50458	1177	5	the	the	DT
50458	1177	6	glands	gland	NNS
50458	1177	7	of	of	IN
50458	1177	8	the	the	DT
50458	1177	9	skin	skin	NN
50458	1177	10	of	of	IN
50458	1177	11	the	the	DT
50458	1177	12	salamander	salamander	JJ
50458	1177	13	a	a	DT
50458	1177	14	white	white	JJ
50458	1177	15	,	,	,
50458	1177	16	thick	thick	JJ
50458	1177	17	,	,	,
50458	1177	18	bitter	bitter	JJ
50458	1177	19	and	and	CC
50458	1177	20	alkaline	alkaline	JJ
50458	1177	21	liquid	liquid	JJ
50458	1177	22	poison	poison	NN
50458	1177	23	,	,	,
50458	1177	24	containing	contain	VBG
50458	1177	25	a	a	DT
50458	1177	26	highly	highly	RB
50458	1177	27	poisonous	poisonous	JJ
50458	1177	28	alkaloid	alkaloid	NN
50458	1177	29	,	,	,
50458	1177	30	_	_	NNP
50458	1177	31	salamandrine	salamandrine	NNP
50458	1177	32	_	_	NNP
50458	1177	33	,	,	,
50458	1177	34	or	or	CC
50458	1177	35	_	_	NNP
50458	1177	36	samandarine	samandarine	NN
50458	1177	37	_	_	NNP
50458	1177	38	,	,	,
50458	1177	39	which	which	WDT
50458	1177	40	acts	act	VBZ
50458	1177	41	on	on	IN
50458	1177	42	the	the	DT
50458	1177	43	brain	brain	NN
50458	1177	44	,	,	,
50458	1177	45	the	the	DT
50458	1177	46	medulla	medulla	NN
50458	1177	47	,	,	,
50458	1177	48	and	and	CC
50458	1177	49	the	the	DT
50458	1177	50	spinal	spinal	JJ
50458	1177	51	cord	cord	NN
50458	1177	52	,	,	,
50458	1177	53	and	and	CC
50458	1177	54	which	which	WDT
50458	1177	55	has	have	VBZ
50458	1177	56	the	the	DT
50458	1177	57	formula	formula	NN
50458	1177	58	C{54}H{60}N{2}O{5	c{54}h{60}n{2}o{5	NN
50458	1177	59	}	}	-RRB-
50458	1177	60	;	;	:
50458	1177	61	it	-PRON-	PRP
50458	1177	62	is	be	VBZ
50458	1177	63	a	a	DT
50458	1177	64	strong	strong	JJ
50458	1177	65	base	base	NN
50458	1177	66	and	and	CC
50458	1177	67	yields	yield	NNS
50458	1177	68	crystallizable	crystallizable	JJ
50458	1177	69	salts	salt	NNS
50458	1177	70	.	.	.
50458	1178	1	[	[	-LRB-
50458	1178	2	156	156	CD
50458	1178	3	]	]	-RRB-
50458	1178	4	_	_	NNP
50458	1178	5	Bull	Bull	NNP
50458	1178	6	.	.	.
50458	1179	1	Soc	Soc	NNP
50458	1179	2	.	.	.
50458	1180	1	Chim	Chim	NNP
50458	1180	2	.	.	.
50458	1180	3	_	_	NNP
50458	1180	4	[	[	-LRB-
50458	1180	5	2	2	CD
50458	1180	6	]	]	-RRB-
50458	1180	7	,	,	,
50458	1180	8	VI	VI	NNP
50458	1180	9	,	,	,
50458	1180	10	p.	p.	NN
50458	1180	11	344	344	CD
50458	1180	12	.	.	.
50458	1181	1	=	=	NFP
50458	1181	2	Fish	fish	NN
50458	1181	3	-	-	HYPH
50458	1181	4	poisons.=[157]--Very	poisons.=[157]--very	NN
50458	1181	5	little	little	JJ
50458	1181	6	accurate	accurate	JJ
50458	1181	7	knowledge	knowledge	NN
50458	1181	8	is	be	VBZ
50458	1181	9	extant	extant	JJ
50458	1181	10	regarding	regard	VBG
50458	1181	11	these	these	DT
50458	1181	12	.	.	.
50458	1182	1	Many	many	JJ
50458	1182	2	fish	fish	NN
50458	1182	3	are	be	VBP
50458	1182	4	poisonous	poisonous	JJ
50458	1182	5	,	,	,
50458	1182	6	and	and	CC
50458	1182	7	among	among	IN
50458	1182	8	them	-PRON-	PRP
50458	1182	9	are	be	VBP
50458	1182	10	the	the	DT
50458	1182	11	synanceia	synanceia	NNS
50458	1182	12	,	,	,
50458	1182	13	found	find	VBN
50458	1182	14	in	in	IN
50458	1182	15	the	the	DT
50458	1182	16	Indian	Indian	NNP
50458	1182	17	Ocean	Ocean	NNP
50458	1182	18	between	between	IN
50458	1182	19	the	the	DT
50458	1182	20	Netherland	Netherland	NNP
50458	1182	21	Isles	Isles	NNPS
50458	1182	22	and	and	CC
50458	1182	23	New	New	NNP
50458	1182	24	Caledonia	Caledonia	NNP
50458	1182	25	;	;	:
50458	1182	26	considerable	considerable	JJ
50458	1182	27	numbers	number	NNS
50458	1182	28	are	be	VBP
50458	1182	29	found	find	VBN
50458	1182	30	in	in	IN
50458	1182	31	the	the	DT
50458	1182	32	neighborhood	neighborhood	NN
50458	1182	33	of	of	IN
50458	1182	34	the	the	DT
50458	1182	35	latter	latter	JJ
50458	1182	36	locality	locality	NN
50458	1182	37	.	.	.
50458	1183	1	These	these	DT
50458	1183	2	fish	fish	NNS
50458	1183	3	are	be	VBP
50458	1183	4	provided	provide	VBN
50458	1183	5	with	with	IN
50458	1183	6	spiny	spiny	JJ
50458	1183	7	rays	ray	NNS
50458	1183	8	which	which	WDT
50458	1183	9	are	be	VBP
50458	1183	10	in	in	IN
50458	1183	11	direct	direct	JJ
50458	1183	12	communication	communication	NN
50458	1183	13	with	with	IN
50458	1183	14	a	a	DT
50458	1183	15	poisonous	poisonous	JJ
50458	1183	16	system	system	NN
50458	1183	17	having	have	VBG
50458	1183	18	its	-PRON-	PRP$
50458	1183	19	seat	seat	NN
50458	1183	20	in	in	IN
50458	1183	21	the	the	DT
50458	1183	22	dorsal	dorsal	NN
50458	1183	23	fin	fin	NN
50458	1183	24	.	.	.
50458	1184	1	The	the	DT
50458	1184	2	prick	prick	NN
50458	1184	3	of	of	IN
50458	1184	4	one	one	CD
50458	1184	5	of	of	IN
50458	1184	6	the	the	DT
50458	1184	7	spiny	spiny	JJ
50458	1184	8	rays	ray	NNS
50458	1184	9	of	of	IN
50458	1184	10	this	this	DT
50458	1184	11	fish	fish	NN
50458	1184	12	may	may	MD
50458	1184	13	under	under	IN
50458	1184	14	certain	certain	JJ
50458	1184	15	circumstances	circumstance	NNS
50458	1184	16	result	result	VBP
50458	1184	17	fatally	fatally	RB
50458	1184	18	,	,	,
50458	1184	19	and	and	CC
50458	1184	20	in	in	IN
50458	1184	21	every	every	DT
50458	1184	22	case	case	NN
50458	1184	23	it	-PRON-	PRP
50458	1184	24	causes	cause	VBZ
50458	1184	25	a	a	DT
50458	1184	26	rapid	rapid	JJ
50458	1184	27	and	and	CC
50458	1184	28	painful	painful	JJ
50458	1184	29	gangrene	gangrene	NN
50458	1184	30	.	.	.
50458	1185	1	[	[	-LRB-
50458	1185	2	157	157	CD
50458	1185	3	]	]	-RRB-
50458	1185	4	BOFFORD	BOFFORD	NNP
50458	1185	5	:	:	:
50458	1185	6	_	_	NNP
50458	1185	7	Thèse	Thèse	NNP
50458	1185	8	de	de	NNP
50458	1185	9	doctorat	doctorat	FW
50458	1185	10	en	en	FW
50458	1185	11	Médecine	Médecine	NNP
50458	1185	12	--	--	:
50458	1185	13	Les	Les	NNP
50458	1185	14	Poissons	Poissons	NNPS
50458	1185	15	venimeux	venimeux	JJ
50458	1185	16	_	_	NNP
50458	1185	17	,	,	,
50458	1185	18	Paris	Paris	NNP
50458	1185	19	,	,	,
50458	1185	20	1889	1889	CD
50458	1185	21	;	;	:
50458	1185	22	O.	O.	NNP
50458	1185	23	ARCOS	ARCOS	NNP
50458	1185	24	:	:	:
50458	1185	25	_	_	NNP
50458	1185	26	Thèse	Thèse	NNP
50458	1185	27	de	de	NNP
50458	1185	28	doctorat	doctorat	NN
50458	1185	29	--	--	.
50458	1185	30	Essais	essais	JJ
50458	1185	31	sur	sur	FW
50458	1185	32	les	les	NNP
50458	1185	33	accidents	accident	NNS
50458	1185	34	causés	causé	VBZ
50458	1185	35	par	par	NNP
50458	1185	36	les	les	NNP
50458	1185	37	poissons	poisson	NNS
50458	1185	38	venimeux	venimeux	JJ
50458	1185	39	_	_	NNP
50458	1185	40	,	,	,
50458	1185	41	Paris	Paris	NNP
50458	1185	42	,	,	,
50458	1185	43	1887	1887	CD
50458	1185	44	.	.	.
50458	1186	1	From	from	IN
50458	1186	2	the	the	DT
50458	1186	3	reservoir	reservoir	NN
50458	1186	4	the	the	DT
50458	1186	5	poison	poison	NN
50458	1186	6	is	be	VBZ
50458	1186	7	conducted	conduct	VBN
50458	1186	8	to	to	IN
50458	1186	9	the	the	DT
50458	1186	10	sharp	sharp	JJ
50458	1186	11	extremity	extremity	NN
50458	1186	12	of	of	IN
50458	1186	13	the	the	DT
50458	1186	14	spines	spine	NNS
50458	1186	15	by	by	IN
50458	1186	16	a	a	DT
50458	1186	17	deep	deep	JJ
50458	1186	18	channel	channel	NN
50458	1186	19	with	with	IN
50458	1186	20	which	which	WDT
50458	1186	21	each	each	DT
50458	1186	22	spiny	spiny	NNP
50458	1186	23	ray	ray	NNP
50458	1186	24	is	be	VBZ
50458	1186	25	provided	provide	VBN
50458	1186	26	;	;	:
50458	1186	27	the	the	DT
50458	1186	28	animal	animal	NN
50458	1186	29	has	have	VBZ
50458	1186	30	26	26	CD
50458	1186	31	poison	poison	NN
50458	1186	32	-	-	HYPH
50458	1186	33	sacs	sacs	NN
50458	1186	34	,	,	,
50458	1186	35	two	two	CD
50458	1186	36	for	for	IN
50458	1186	37	each	each	DT
50458	1186	38	ray	ray	NN
50458	1186	39	,	,	,
50458	1186	40	and	and	CC
50458	1186	41	the	the	DT
50458	1186	42	sacs	sac	NNS
50458	1186	43	burst	burst	VBD
50458	1186	44	when	when	WRB
50458	1186	45	the	the	DT
50458	1186	46	corresponding	corresponding	JJ
50458	1186	47	sting	sting	NN
50458	1186	48	is	be	VBZ
50458	1186	49	in	in	IN
50458	1186	50	any	any	DT
50458	1186	51	manner	manner	NN
50458	1186	52	compressed	compress	VBN
50458	1186	53	.	.	.
50458	1187	1	The	the	DT
50458	1187	2	poison	poison	NN
50458	1187	3	is	be	VBZ
50458	1187	4	an	an	DT
50458	1187	5	odorless	odorless	JJ
50458	1187	6	liquid	liquid	NN
50458	1187	7	having	have	VBG
50458	1187	8	a	a	DT
50458	1187	9	slight	slight	JJ
50458	1187	10	styptic	styptic	JJ
50458	1187	11	or	or	CC
50458	1187	12	acidulous	acidulous	JJ
50458	1187	13	taste	taste	NN
50458	1187	14	,	,	,
50458	1187	15	and	and	CC
50458	1187	16	exhibiting	exhibit	VBG
50458	1187	17	a	a	DT
50458	1187	18	bluish	bluish	JJ
50458	1187	19	fluorescence	fluorescence	NN
50458	1187	20	;	;	:
50458	1187	21	it	-PRON-	PRP
50458	1187	22	rapidly	rapidly	RB
50458	1187	23	becomes	become	VBZ
50458	1187	24	turbid	turbid	RB
50458	1187	25	.	.	.
50458	1188	1	The	the	DT
50458	1188	2	weevers	weever	NNS
50458	1188	3	,	,	,
50458	1188	4	which	which	WDT
50458	1188	5	are	be	VBP
50458	1188	6	numerous	numerous	JJ
50458	1188	7	on	on	IN
50458	1188	8	the	the	DT
50458	1188	9	shores	shore	NNS
50458	1188	10	of	of	IN
50458	1188	11	the	the	DT
50458	1188	12	Mediterranean	Mediterranean	NNP
50458	1188	13	Sea	Sea	NNP
50458	1188	14	,	,	,
50458	1188	15	and	and	CC
50458	1188	16	which	which	WDT
50458	1188	17	are	be	VBP
50458	1188	18	also	also	RB
50458	1188	19	met	meet	VBN
50458	1188	20	with	with	IN
50458	1188	21	in	in	IN
50458	1188	22	the	the	DT
50458	1188	23	northeastern	northeastern	JJ
50458	1188	24	portion	portion	NN
50458	1188	25	of	of	IN
50458	1188	26	the	the	DT
50458	1188	27	Atlantic	Atlantic	NNP
50458	1188	28	Ocean	Ocean	NNP
50458	1188	29	,	,	,
50458	1188	30	are	be	VBP
50458	1188	31	likewise	likewise	RB
50458	1188	32	very	very	RB
50458	1188	33	dangerous	dangerous	JJ
50458	1188	34	,	,	,
50458	1188	35	which	which	WDT
50458	1188	36	explains	explain	VBZ
50458	1188	37	their	-PRON-	PRP$
50458	1188	38	popular	popular	JJ
50458	1188	39	names	name	NNS
50458	1188	40	"	"	''
50458	1188	41	viper	viper	NN
50458	1188	42	-	-	HYPH
50458	1188	43	weever	weever	NN
50458	1188	44	,	,	,
50458	1188	45	"	"	''
50458	1188	46	"	"	``
50458	1188	47	spiderweever	spiderweever	NNP
50458	1188	48	,	,	,
50458	1188	49	"	"	''
50458	1188	50	etc	etc	FW
50458	1188	51	.	.	.
50458	1189	1	These	these	DT
50458	1189	2	fish	fish	NNS
50458	1189	3	are	be	VBP
50458	1189	4	provided	provide	VBN
50458	1189	5	with	with	IN
50458	1189	6	a	a	DT
50458	1189	7	double	double	JJ
50458	1189	8	set	set	NN
50458	1189	9	of	of	IN
50458	1189	10	poisonous	poisonous	JJ
50458	1189	11	apparatus	apparatus	NN
50458	1189	12	,	,	,
50458	1189	13	the	the	DT
50458	1189	14	one	one	CD
50458	1189	15	opercular	opercular	JJ
50458	1189	16	,	,	,
50458	1189	17	which	which	WDT
50458	1189	18	is	be	VBZ
50458	1189	19	the	the	DT
50458	1189	20	more	more	RBR
50458	1189	21	dangerous	dangerous	JJ
50458	1189	22	,	,	,
50458	1189	23	and	and	CC
50458	1189	24	the	the	DT
50458	1189	25	other	other	JJ
50458	1189	26	dorsal	dorsal	NN
50458	1189	27	.	.	.
50458	1190	1	The	the	DT
50458	1190	2	opercular	opercular	JJ
50458	1190	3	spine	spine	NN
50458	1190	4	has	have	VBZ
50458	1190	5	a	a	DT
50458	1190	6	double	double	JJ
50458	1190	7	channel	channel	NN
50458	1190	8	in	in	IN
50458	1190	9	connection	connection	NN
50458	1190	10	with	with	IN
50458	1190	11	a	a	DT
50458	1190	12	conical	conical	JJ
50458	1190	13	cavity	cavity	NN
50458	1190	14	hollowed	hollow	VBD
50458	1190	15	out	out	RP
50458	1190	16	in	in	IN
50458	1190	17	the	the	DT
50458	1190	18	base	base	NN
50458	1190	19	of	of	IN
50458	1190	20	the	the	DT
50458	1190	21	opercular	opercular	JJ
50458	1190	22	bone	bone	NN
50458	1190	23	.	.	.
50458	1191	1	The	the	DT
50458	1191	2	bottom	bottom	NN
50458	1191	3	of	of	IN
50458	1191	4	this	this	DT
50458	1191	5	cavity	cavity	NN
50458	1191	6	is	be	VBZ
50458	1191	7	provided	provide	VBN
50458	1191	8	with	with	IN
50458	1191	9	special	special	JJ
50458	1191	10	cells	cell	NNS
50458	1191	11	which	which	WDT
50458	1191	12	secrete	secrete	VBP
50458	1191	13	the	the	DT
50458	1191	14	poison	poison	NN
50458	1191	15	.	.	.
50458	1192	1	The	the	DT
50458	1192	2	dorsal	dorsal	NN
50458	1192	3	glands	gland	NNS
50458	1192	4	have	have	VBP
50458	1192	5	a	a	DT
50458	1192	6	similar	similar	JJ
50458	1192	7	structure	structure	NN
50458	1192	8	.	.	.
50458	1193	1	The	the	DT
50458	1193	2	poison	poison	NN
50458	1193	3	of	of	IN
50458	1193	4	the	the	DT
50458	1193	5	weever	weever	NN
50458	1193	6	is	be	VBZ
50458	1193	7	a	a	DT
50458	1193	8	liquid	liquid	JJ
50458	1193	9	,	,	,
50458	1193	10	limpid	limpid	JJ
50458	1193	11	when	when	WRB
50458	1193	12	the	the	DT
50458	1193	13	fish	fish	NN
50458	1193	14	is	be	VBZ
50458	1193	15	alive	alive	JJ
50458	1193	16	,	,	,
50458	1193	17	and	and	CC
50458	1193	18	turbid	turbid	RB
50458	1193	19	when	when	WRB
50458	1193	20	dead	dead	JJ
50458	1193	21	;	;	:
50458	1193	22	it	-PRON-	PRP
50458	1193	23	has	have	VBZ
50458	1193	24	a	a	DT
50458	1193	25	slight	slight	JJ
50458	1193	26	bluish	bluish	JJ
50458	1193	27	fluorescence	fluorescence	NN
50458	1193	28	,	,	,
50458	1193	29	is	be	VBZ
50458	1193	30	neutral	neutral	JJ
50458	1193	31	in	in	IN
50458	1193	32	reaction	reaction	NN
50458	1193	33	,	,	,
50458	1193	34	and	and	CC
50458	1193	35	is	be	VBZ
50458	1193	36	coagulated	coagulate	VBN
50458	1193	37	by	by	IN
50458	1193	38	acids	acid	NNS
50458	1193	39	and	and	CC
50458	1193	40	bases	basis	NNS
50458	1193	41	.	.	.
50458	1194	1	It	-PRON-	PRP
50458	1194	2	acts	act	VBZ
50458	1194	3	as	as	IN
50458	1194	4	a	a	DT
50458	1194	5	paralyzant	paralyzant	NN
50458	1194	6	,	,	,
50458	1194	7	its	-PRON-	PRP$
50458	1194	8	action	action	NN
50458	1194	9	being	be	VBG
50458	1194	10	exerted	exert	VBN
50458	1194	11	on	on	IN
50458	1194	12	the	the	DT
50458	1194	13	medulla	medulla	NN
50458	1194	14	and	and	CC
50458	1194	15	spinal	spinal	JJ
50458	1194	16	cord	cord	NN
50458	1194	17	;	;	:
50458	1194	18	it	-PRON-	PRP
50458	1194	19	retards	retard	VBZ
50458	1194	20	the	the	DT
50458	1194	21	heart	heart	NN
50458	1194	22	's	's	POS
50458	1194	23	action	action	NN
50458	1194	24	.	.	.
50458	1195	1	These	these	DT
50458	1195	2	examples	example	NNS
50458	1195	3	will	will	MD
50458	1195	4	suffice	suffice	VB
50458	1195	5	;	;	:
50458	1195	6	and	and	CC
50458	1195	7	we	-PRON-	PRP
50458	1195	8	will	will	MD
50458	1195	9	not	not	RB
50458	1195	10	dilate	dilate	VB
50458	1195	11	further	far	RBR
50458	1195	12	on	on	IN
50458	1195	13	this	this	DT
50458	1195	14	subject	subject	NN
50458	1195	15	,	,	,
50458	1195	16	because	because	IN
50458	1195	17	,	,	,
50458	1195	18	as	as	IN
50458	1195	19	already	already	RB
50458	1195	20	stated	state	VBN
50458	1195	21	,	,	,
50458	1195	22	but	but	CC
50458	1195	23	little	little	JJ
50458	1195	24	is	be	VBZ
50458	1195	25	accurately	accurately	RB
50458	1195	26	known	know	VBN
50458	1195	27	regarding	regard	VBG
50458	1195	28	the	the	DT
50458	1195	29	subject	subject	NN
50458	1195	30	,	,	,
50458	1195	31	and	and	CC
50458	1195	32	what	what	WP
50458	1195	33	is	be	VBZ
50458	1195	34	known	know	VBN
50458	1195	35	may	may	MD
50458	1195	36	be	be	VB
50458	1195	37	summed	sum	VBN
50458	1195	38	up	up	RP
50458	1195	39	as	as	IN
50458	1195	40	follows	follow	VBZ
50458	1195	41	:	:	:
50458	1195	42	Fish	fish	NN
50458	1195	43	-	-	HYPH
50458	1195	44	poisons	poison	NNS
50458	1195	45	always	always	RB
50458	1195	46	give	give	VBP
50458	1195	47	rise	rise	NN
50458	1195	48	to	to	IN
50458	1195	49	an	an	DT
50458	1195	50	intense	intense	JJ
50458	1195	51	pain	pain	NN
50458	1195	52	,	,	,
50458	1195	53	frequently	frequently	RB
50458	1195	54	with	with	IN
50458	1195	55	motor	motor	NN
50458	1195	56	paralysis	paralysis	NN
50458	1195	57	,	,	,
50458	1195	58	followed	follow	VBN
50458	1195	59	by	by	IN
50458	1195	60	paralysis	paralysis	NN
50458	1195	61	of	of	IN
50458	1195	62	sensation	sensation	NN
50458	1195	63	;	;	:
50458	1195	64	they	-PRON-	PRP
50458	1195	65	affect	affect	VBP
50458	1195	66	the	the	DT
50458	1195	67	heart	heart	NN
50458	1195	68	,	,	,
50458	1195	69	arresting	arrest	VBG
50458	1195	70	it	-PRON-	PRP
50458	1195	71	in	in	IN
50458	1195	72	diastole	diastole	NNP
50458	1195	73	;	;	:
50458	1195	74	and	and	CC
50458	1195	75	they	-PRON-	PRP
50458	1195	76	are	be	VBP
50458	1195	77	more	more	RBR
50458	1195	78	dangerous	dangerous	JJ
50458	1195	79	to	to	TO
50458	1195	80	fish	fish	VB
50458	1195	81	and	and	CC
50458	1195	82	cold	cold	JJ
50458	1195	83	-	-	HYPH
50458	1195	84	blooded	blooded	JJ
50458	1195	85	animals	animal	NNS
50458	1195	86	than	than	IN
50458	1195	87	to	to	IN
50458	1195	88	mammifers	mammifer	NNS
50458	1195	89	.	.	.
50458	1196	1	=	=	NFP
50458	1196	2	Poisons	poison	NNS
50458	1196	3	of	of	IN
50458	1196	4	the	the	DT
50458	1196	5	Hymenoptera.=[158]--The	Hymenoptera.=[158]--The	NNP
50458	1196	6	poison	poison	NN
50458	1196	7	system	system	NN
50458	1196	8	of	of	IN
50458	1196	9	the	the	DT
50458	1196	10	bee	bee	NN
50458	1196	11	,	,	,
50458	1196	12	and	and	CC
50458	1196	13	of	of	IN
50458	1196	14	such	such	JJ
50458	1196	15	insects	insect	NNS
50458	1196	16	as	as	IN
50458	1196	17	the	the	DT
50458	1196	18	wasps	wasp	NNS
50458	1196	19	,	,	,
50458	1196	20	bumblebees	bumblebee	NNS
50458	1196	21	,	,	,
50458	1196	22	etc	etc	FW
50458	1196	23	.	.	.
50458	1196	24	,	,	,
50458	1196	25	is	be	VBZ
50458	1196	26	known	know	VBN
50458	1196	27	to	to	TO
50458	1196	28	consist	consist	VB
50458	1196	29	of	of	IN
50458	1196	30	a	a	DT
50458	1196	31	hollow	hollow	JJ
50458	1196	32	sting	ste	VBG
50458	1196	33	consisting	consist	VBG
50458	1196	34	of	of	IN
50458	1196	35	two	two	CD
50458	1196	36	sharp	sharp	JJ
50458	1196	37	needles	needle	NNS
50458	1196	38	communicating	communicate	VBG
50458	1196	39	with	with	IN
50458	1196	40	two	two	CD
50458	1196	41	poison	poison	NN
50458	1196	42	-	-	HYPH
50458	1196	43	bearing	bear	VBG
50458	1196	44	glands	gland	NNS
50458	1196	45	,	,	,
50458	1196	46	and	and	CC
50458	1196	47	forming	form	VBG
50458	1196	48	a	a	DT
50458	1196	49	flexible	flexible	JJ
50458	1196	50	tube	tube	NN
50458	1196	51	.	.	.
50458	1197	1	One	one	CD
50458	1197	2	of	of	IN
50458	1197	3	these	these	DT
50458	1197	4	glands	gland	NNS
50458	1197	5	secretes	secrete	VBZ
50458	1197	6	an	an	DT
50458	1197	7	acid	acid	JJ
50458	1197	8	liquid	liquid	NN
50458	1197	9	(	(	-LRB-
50458	1197	10	formic	formic	JJ
50458	1197	11	acid	acid	NN
50458	1197	12	)	)	-RRB-
50458	1197	13	;	;	:
50458	1197	14	the	the	DT
50458	1197	15	other	other	JJ
50458	1197	16	secretes	secrete	VBZ
50458	1197	17	an	an	DT
50458	1197	18	alkaline	alkaline	NN
50458	1197	19	fluid	fluid	NN
50458	1197	20	.	.	.
50458	1198	1	[	[	-LRB-
50458	1198	2	158	158	CD
50458	1198	3	]	]	-RRB-
50458	1198	4	PHILOUZE	PHILOUZE	NNP
50458	1198	5	:	:	:
50458	1198	6	Venin	Venin	NNP
50458	1198	7	des	des	NNP
50458	1198	8	Abeilles	Abeilles	NNP
50458	1198	9	.	.	.
50458	1199	1	_	_	NNP
50458	1199	2	Annales	Annales	NNP
50458	1199	3	de	de	IN
50458	1199	4	la	la	NNP
50458	1199	5	Société	Société	NNP
50458	1199	6	Linn	Linn	NNP
50458	1199	7	.	.	.
50458	1200	1	du	du	NNP
50458	1200	2	Maine	Maine	NNP
50458	1200	3	-	-	HYPH
50458	1200	4	et	et	FW
50458	1200	5	-	-	HYPH
50458	1200	6	Loire	Loire	NNP
50458	1200	7	_	_	NNP
50458	1200	8	,	,	,
50458	1200	9	IV	IV	NNP
50458	1200	10	.	.	.
50458	1201	1	The	the	DT
50458	1201	2	action	action	NN
50458	1201	3	of	of	IN
50458	1201	4	the	the	DT
50458	1201	5	bee	bee	NNP
50458	1201	6	-	-	HYPH
50458	1201	7	poison	poison	NN
50458	1201	8	is	be	VBZ
50458	1201	9	very	very	RB
50458	1201	10	often	often	RB
50458	1201	11	benign	benign	JJ
50458	1201	12	,	,	,
50458	1201	13	but	but	CC
50458	1201	14	there	there	EX
50458	1201	15	have	have	VBP
50458	1201	16	been	be	VBN
50458	1201	17	cases	case	NNS
50458	1201	18	where	where	WRB
50458	1201	19	death	death	NN
50458	1201	20	followed	follow	VBD
50458	1201	21	the	the	DT
50458	1201	22	infliction	infliction	NN
50458	1201	23	of	of	IN
50458	1201	24	numerous	numerous	JJ
50458	1201	25	stings	sting	NNS
50458	1201	26	.	.	.
50458	1202	1	Our	-PRON-	PRP$
50458	1202	2	information	information	NN
50458	1202	3	regarding	regard	VBG
50458	1202	4	the	the	DT
50458	1202	5	poison	poison	NN
50458	1202	6	of	of	IN
50458	1202	7	the	the	DT
50458	1202	8	cantharides	cantharide	NNS
50458	1202	9	and	and	CC
50458	1202	10	flies	fly	NNS
50458	1202	11	is	be	VBZ
50458	1202	12	very	very	RB
50458	1202	13	vague[159	vague[159	JJ
50458	1202	14	]	]	-RRB-
50458	1202	15	;	;	:
50458	1202	16	the	the	DT
50458	1202	17	same	same	JJ
50458	1202	18	is	be	VBZ
50458	1202	19	true	true	JJ
50458	1202	20	of	of	IN
50458	1202	21	the	the	DT
50458	1202	22	poisons	poison	NNS
50458	1202	23	of	of	IN
50458	1202	24	various	various	JJ
50458	1202	25	arachnids	arachnid	NNS
50458	1202	26	,	,	,
50458	1202	27	acarides	acaride	NNS
50458	1202	28	,	,	,
50458	1202	29	and	and	CC
50458	1202	30	myriapoda	myriapoda	NNP
50458	1202	31	.	.	.
50458	1203	1	So	so	RB
50458	1203	2	far	far	RB
50458	1203	3	as	as	IN
50458	1203	4	spiders	spider	NNS
50458	1203	5	are	be	VBP
50458	1203	6	concerned	concern	VBN
50458	1203	7	,	,	,
50458	1203	8	it	-PRON-	PRP
50458	1203	9	is	be	VBZ
50458	1203	10	known	know	VBN
50458	1203	11	that	that	IN
50458	1203	12	their	-PRON-	PRP$
50458	1203	13	poison	poison	NN
50458	1203	14	is	be	VBZ
50458	1203	15	an	an	DT
50458	1203	16	oily	oily	JJ
50458	1203	17	liquid	liquid	NN
50458	1203	18	having	have	VBG
50458	1203	19	an	an	DT
50458	1203	20	acid	acid	JJ
50458	1203	21	and	and	CC
50458	1203	22	bitter	bitter	JJ
50458	1203	23	taste	taste	NN
50458	1203	24	,	,	,
50458	1203	25	and	and	CC
50458	1203	26	containing	contain	VBG
50458	1203	27	a	a	DT
50458	1203	28	toxalbumin	toxalbumin	NN
50458	1203	29	derived	derive	VBN
50458	1203	30	from	from	IN
50458	1203	31	the	the	DT
50458	1203	32	skin	skin	NN
50458	1203	33	of	of	IN
50458	1203	34	the	the	DT
50458	1203	35	insect	insect	NN
50458	1203	36	.	.	.
50458	1204	1	The	the	DT
50458	1204	2	bite	bite	NN
50458	1204	3	of	of	IN
50458	1204	4	the	the	DT
50458	1204	5	ordinary	ordinary	JJ
50458	1204	6	spider	spider	NN
50458	1204	7	occasions	occasion	NNS
50458	1204	8	simply	simply	RB
50458	1204	9	a	a	DT
50458	1204	10	slight	slight	JJ
50458	1204	11	local	local	JJ
50458	1204	12	pain	pain	NN
50458	1204	13	,	,	,
50458	1204	14	with	with	IN
50458	1204	15	redness	redness	NN
50458	1204	16	;	;	:
50458	1204	17	that	that	DT
50458	1204	18	of	of	IN
50458	1204	19	the	the	DT
50458	1204	20	large	large	JJ
50458	1204	21	poisonous	poisonous	JJ
50458	1204	22	spider	spider	NN
50458	1204	23	,	,	,
50458	1204	24	however	however	RB
50458	1204	25	,	,	,
50458	1204	26	may	may	MD
50458	1204	27	kill	kill	VB
50458	1204	28	the	the	DT
50458	1204	29	larger	large	JJR
50458	1204	30	animals	animal	NNS
50458	1204	31	,	,	,
50458	1204	32	and	and	CC
50458	1204	33	even	even	RB
50458	1204	34	man	man	NN
50458	1204	35	.	.	.
50458	1205	1	[	[	-LRB-
50458	1205	2	159	159	CD
50458	1205	3	]	]	-RRB-
50458	1205	4	JOYEUX	JOYEUX	NNP
50458	1205	5	-	-	HYPH
50458	1205	6	LAFFRIÉE	LAFFRIÉE	NNP
50458	1205	7	:	:	:
50458	1205	8	_	_	NNP
50458	1205	9	Thèse	Thèse	NNP
50458	1205	10	de	de	NNP
50458	1205	11	doctorat	doctorat	FW
50458	1205	12	en	en	FW
50458	1205	13	Médecine	Médecine	NNP
50458	1205	14	_	_	NNP
50458	1205	15	,	,	,
50458	1205	16	Paris	Paris	NNP
50458	1205	17	,	,	,
50458	1205	18	1883	1883	CD
50458	1205	19	;	;	:
50458	1205	20	P.	P.	NNP
50458	1205	21	BERT	BERT	NNP
50458	1205	22	:	:	:
50458	1205	23	_	_	NNP
50458	1205	24	Compt	Compt	NNP
50458	1205	25	.	.	.
50458	1206	1	rend	rend	VB
50458	1206	2	.	.	.
50458	1207	1	de	de	NNP
50458	1207	2	la	la	NNP
50458	1207	3	Soc	Soc	NNP
50458	1207	4	.	.	.
50458	1208	1	de	de	NNP
50458	1208	2	Biol	Biol	NNP
50458	1208	3	.	.	.
50458	1208	4	_	_	NNP
50458	1208	5	,	,	,
50458	1208	6	II	II	NNP
50458	1208	7	[	[	-LRB-
50458	1208	8	4	4	CD
50458	1208	9	]	]	-RRB-
50458	1208	10	,	,	,
50458	1208	11	p.	p.	NN
50458	1208	12	136	136	CD
50458	1208	13	.	.	.
50458	1209	1	=	=	NFP
50458	1209	2	Poison	poison	NN
50458	1209	3	of	of	IN
50458	1209	4	Scorpions.=[160]--This	scorpions.=[160]--this	JJ
50458	1209	5	poison	poison	NN
50458	1209	6	is	be	VBZ
50458	1209	7	a	a	DT
50458	1209	8	colorless	colorless	JJ
50458	1209	9	,	,	,
50458	1209	10	acid	acid	JJ
50458	1209	11	liquid	liquid	NN
50458	1209	12	,	,	,
50458	1209	13	having	have	VBG
50458	1209	14	a	a	DT
50458	1209	15	higher	high	JJR
50458	1209	16	specific	specific	JJ
50458	1209	17	gravity	gravity	NN
50458	1209	18	than	than	IN
50458	1209	19	water	water	NN
50458	1209	20	,	,	,
50458	1209	21	in	in	IN
50458	1209	22	which	which	WDT
50458	1209	23	liquid	liquid	NN
50458	1209	24	it	-PRON-	PRP
50458	1209	25	is	be	VBZ
50458	1209	26	soluble	soluble	JJ
50458	1209	27	.	.	.
50458	1210	1	The	the	DT
50458	1210	2	famed	famed	JJ
50458	1210	3	legend	legend	NN
50458	1210	4	of	of	IN
50458	1210	5	the	the	DT
50458	1210	6	suicide	suicide	NN
50458	1210	7	of	of	IN
50458	1210	8	scorpions	scorpion	NNS
50458	1210	9	is	be	VBZ
50458	1210	10	well	well	RB
50458	1210	11	known	known	JJ
50458	1210	12	to	to	IN
50458	1210	13	all	all	DT
50458	1210	14	.	.	.
50458	1211	1	It	-PRON-	PRP
50458	1211	2	is	be	VBZ
50458	1211	3	stated	state	VBN
50458	1211	4	that	that	IN
50458	1211	5	when	when	WRB
50458	1211	6	the	the	DT
50458	1211	7	insect	insect	NN
50458	1211	8	finds	find	VBZ
50458	1211	9	itself	-PRON-	PRP
50458	1211	10	in	in	IN
50458	1211	11	a	a	DT
50458	1211	12	position	position	NN
50458	1211	13	where	where	WRB
50458	1211	14	its	-PRON-	PRP$
50458	1211	15	death	death	NN
50458	1211	16	is	be	VBZ
50458	1211	17	inevitable	inevitable	JJ
50458	1211	18	,	,	,
50458	1211	19	it	-PRON-	PRP
50458	1211	20	stings	sting	VBZ
50458	1211	21	itself	-PRON-	PRP
50458	1211	22	,	,	,
50458	1211	23	and	and	CC
50458	1211	24	dies	die	VBZ
50458	1211	25	from	from	IN
50458	1211	26	the	the	DT
50458	1211	27	effects	effect	NNS
50458	1211	28	of	of	IN
50458	1211	29	its	-PRON-	PRP$
50458	1211	30	own	own	JJ
50458	1211	31	poison	poison	NN
50458	1211	32	.	.	.
50458	1212	1	A	a	DT
50458	1212	2	simple	simple	JJ
50458	1212	3	method	method	NN
50458	1212	4	has	have	VBZ
50458	1212	5	even	even	RB
50458	1212	6	been	be	VBN
50458	1212	7	described	describe	VBN
50458	1212	8	of	of	IN
50458	1212	9	bringing	bring	VBG
50458	1212	10	this	this	DT
50458	1212	11	result	result	NN
50458	1212	12	about	about	IN
50458	1212	13	experimentally	experimentally	RB
50458	1212	14	by	by	IN
50458	1212	15	surrounding	surround	VBG
50458	1212	16	the	the	DT
50458	1212	17	insect	insect	NN
50458	1212	18	with	with	IN
50458	1212	19	a	a	DT
50458	1212	20	circle	circle	NN
50458	1212	21	of	of	IN
50458	1212	22	fire	fire	NN
50458	1212	23	.	.	.
50458	1213	1	Bounne	Bounne	NNP
50458	1213	2	,	,	,
50458	1213	3	of	of	IN
50458	1213	4	Madras,[161	Madras,[161	NNP
50458	1213	5	]	]	-RRB-
50458	1213	6	who	who	WP
50458	1213	7	has	have	VBZ
50458	1213	8	studied	study	VBN
50458	1213	9	the	the	DT
50458	1213	10	procedure	procedure	NN
50458	1213	11	,	,	,
50458	1213	12	has	have	VBZ
50458	1213	13	demonstrated	demonstrate	VBN
50458	1213	14	its	-PRON-	PRP$
50458	1213	15	entire	entire	JJ
50458	1213	16	falsity	falsity	NN
50458	1213	17	by	by	IN
50458	1213	18	showing	show	VBG
50458	1213	19	,	,	,
50458	1213	20	first	first	RB
50458	1213	21	of	of	IN
50458	1213	22	all	all	DT
50458	1213	23	,	,	,
50458	1213	24	that	that	IN
50458	1213	25	the	the	DT
50458	1213	26	insect	insect	NN
50458	1213	27	dies	die	VBZ
50458	1213	28	from	from	IN
50458	1213	29	the	the	DT
50458	1213	30	effects	effect	NNS
50458	1213	31	of	of	IN
50458	1213	32	the	the	DT
50458	1213	33	excessive	excessive	JJ
50458	1213	34	heat	heat	NN
50458	1213	35	,	,	,
50458	1213	36	and	and	CC
50458	1213	37	further	far	RBR
50458	1213	38	,	,	,
50458	1213	39	that	that	IN
50458	1213	40	the	the	DT
50458	1213	41	poison	poison	NN
50458	1213	42	of	of	IN
50458	1213	43	the	the	DT
50458	1213	44	scorpion	scorpion	NN
50458	1213	45	is	be	VBZ
50458	1213	46	harmless	harmless	JJ
50458	1213	47	to	to	IN
50458	1213	48	individuals	individual	NNS
50458	1213	49	of	of	IN
50458	1213	50	the	the	DT
50458	1213	51	species	specie	NNS
50458	1213	52	that	that	WDT
50458	1213	53	furnish	furnish	VBP
50458	1213	54	it	-PRON-	PRP
50458	1213	55	.	.	.
50458	1214	1	[	[	-LRB-
50458	1214	2	160	160	CD
50458	1214	3	]	]	-RRB-
50458	1214	4	CALMETTE	CALMETTE	NNP
50458	1214	5	:	:	:
50458	1214	6	_	_	NNP
50458	1214	7	Annales	Annales	NNP
50458	1214	8	de	de	NNP
50458	1214	9	l'Instit	l'Instit	NNP
50458	1214	10	.	.	.
50458	1215	1	Pasteur	Pasteur	NNP
50458	1215	2	_	_	NNP
50458	1215	3	,	,	,
50458	1215	4	X	X	NNP
50458	1215	5	,	,	,
50458	1215	6	p.	p.	NN
50458	1215	7	232	232	CD
50458	1215	8	.	.	.
50458	1216	1	[	[	-LRB-
50458	1216	2	161	161	CD
50458	1216	3	]	]	-RRB-
50458	1216	4	_	_	NNP
50458	1216	5	Proceedings	Proceedings	NNP
50458	1216	6	of	of	IN
50458	1216	7	the	the	DT
50458	1216	8	Royal	Royal	NNP
50458	1216	9	Society	Society	NNP
50458	1216	10	_	_	NNP
50458	1216	11	,	,	,
50458	1216	12	XLII	XLII	NNP
50458	1216	13	,	,	,
50458	1216	14	p.	p.	NN
50458	1216	15	17	17	CD
50458	1216	16	.	.	.
50458	1217	1	Metchinkoff[162	metchinkoff[162	NN
50458	1217	2	]	]	-RRB-
50458	1217	3	has	have	VBZ
50458	1217	4	confirmed	confirm	VBN
50458	1217	5	these	these	DT
50458	1217	6	facts	fact	NNS
50458	1217	7	,	,	,
50458	1217	8	and	and	CC
50458	1217	9	has	have	VBZ
50458	1217	10	moreover	moreover	RB
50458	1217	11	demonstrated	demonstrate	VBN
50458	1217	12	that	that	IN
50458	1217	13	the	the	DT
50458	1217	14	blood	blood	NN
50458	1217	15	of	of	IN
50458	1217	16	the	the	DT
50458	1217	17	scorpion	scorpion	NN
50458	1217	18	possesses	possess	VBZ
50458	1217	19	an	an	DT
50458	1217	20	undoubted	undoubted	JJ
50458	1217	21	antitoxic	antitoxic	NN
50458	1217	22	power	power	NN
50458	1217	23	against	against	IN
50458	1217	24	the	the	DT
50458	1217	25	poison	poison	NN
50458	1217	26	of	of	IN
50458	1217	27	the	the	DT
50458	1217	28	insect	insect	NN
50458	1217	29	.	.	.
50458	1218	1	[	[	-LRB-
50458	1218	2	162	162	CD
50458	1218	3	]	]	-RRB-
50458	1218	4	METCHNIKOFF	METCHNIKOFF	NNP
50458	1218	5	:	:	:
50458	1218	6	_	_	NNP
50458	1218	7	L'Immunité	L'Immunité	NNP
50458	1218	8	_	_	NNP
50458	1218	9	,	,	,
50458	1218	10	p.	p.	NN
50458	1218	11	344	344	CD
50458	1218	12	.	.	.
50458	1219	1	The	the	DT
50458	1219	2	poison	poison	NN
50458	1219	3	of	of	IN
50458	1219	4	the	the	DT
50458	1219	5	scorpion	scorpion	NN
50458	1219	6	serves	serve	VBZ
50458	1219	7	it	-PRON-	PRP
50458	1219	8	to	to	TO
50458	1219	9	kill	kill	VB
50458	1219	10	the	the	DT
50458	1219	11	insects	insect	NNS
50458	1219	12	which	which	WDT
50458	1219	13	are	be	VBP
50458	1219	14	its	-PRON-	PRP$
50458	1219	15	prey	prey	NN
50458	1219	16	.	.	.
50458	1220	1	Frogs	frog	NNS
50458	1220	2	and	and	CC
50458	1220	3	birds	bird	NNS
50458	1220	4	stung	sting	VBN
50458	1220	5	by	by	IN
50458	1220	6	the	the	DT
50458	1220	7	scorpion	scorpion	NN
50458	1220	8	also	also	RB
50458	1220	9	generally	generally	RB
50458	1220	10	die	die	VBP
50458	1220	11	.	.	.
50458	1221	1	A	a	DT
50458	1221	2	dose	dose	NN
50458	1221	3	of	of	IN
50458	1221	4	0.0005	0.0005	NNP
50458	1221	5	Gm	Gm	NNP
50458	1221	6	.	.	.
50458	1222	1	kills	kill	VBZ
50458	1222	2	a	a	DT
50458	1222	3	guinea	guinea	NN
50458	1222	4	-	-	HYPH
50458	1222	5	pig	pig	NN
50458	1222	6	in	in	IN
50458	1222	7	less	less	JJR
50458	1222	8	than	than	IN
50458	1222	9	one	one	CD
50458	1222	10	hour	hour	NN
50458	1222	11	;	;	:
50458	1222	12	and	and	CC
50458	1222	13	according	accord	VBG
50458	1222	14	to	to	IN
50458	1222	15	Calmette[163	Calmette[163	NNP
50458	1222	16	]	]	-RRB-
50458	1222	17	less	less	JJR
50458	1222	18	than	than	IN
50458	1222	19	0.0005	0.0005	NNP
50458	1222	20	will	will	MD
50458	1222	21	kill	kill	VB
50458	1222	22	a	a	DT
50458	1222	23	white	white	JJ
50458	1222	24	mouse	mouse	NN
50458	1222	25	in	in	IN
50458	1222	26	two	two	CD
50458	1222	27	hours	hour	NNS
50458	1222	28	.	.	.
50458	1223	1	Oxidizers	oxidizer	NNS
50458	1223	2	destroy	destroy	VBP
50458	1223	3	the	the	DT
50458	1223	4	toxicity	toxicity	NN
50458	1223	5	of	of	IN
50458	1223	6	the	the	DT
50458	1223	7	poison	poison	NN
50458	1223	8	.	.	.
50458	1224	1	Guinea	guinea	NN
50458	1224	2	-	-	HYPH
50458	1224	3	pigs	pig	NNS
50458	1224	4	immunized	immunize	VBN
50458	1224	5	against	against	IN
50458	1224	6	the	the	DT
50458	1224	7	poison	poison	NN
50458	1224	8	of	of	IN
50458	1224	9	the	the	DT
50458	1224	10	scorpion	scorpion	NN
50458	1224	11	resist	resist	VBP
50458	1224	12	perfectly	perfectly	RB
50458	1224	13	very	very	RB
50458	1224	14	large	large	JJ
50458	1224	15	doses	dose	NNS
50458	1224	16	of	of	IN
50458	1224	17	the	the	DT
50458	1224	18	poison	poison	NN
50458	1224	19	.	.	.
50458	1225	1	[	[	-LRB-
50458	1225	2	163	163	CD
50458	1225	3	]	]	-RRB-
50458	1225	4	CALMETTE	CALMETTE	NNP
50458	1225	5	:	:	:
50458	1225	6	_	_	NNP
50458	1225	7	Annal	Annal	NNP
50458	1225	8	.	.	.
50458	1226	1	de	de	NNP
50458	1226	2	l'Instit	l'Instit	NNP
50458	1226	3	.	.	.
50458	1227	1	Pasteur	Pasteur	NNP
50458	1227	2	_	_	NNP
50458	1227	3	,	,	,
50458	1227	4	X	X	NNP
50458	1227	5	,	,	,
50458	1227	6	p.	p.	NN
50458	1227	7	232	232	CD
50458	1227	8	.	.	.
50458	1228	1	=	=	NFP
50458	1228	2	Poisonous	Poisonous	NNP
50458	1228	3	Blood	Blood	NNP
50458	1228	4	and	and	CC
50458	1228	5	Serums.=--It	Serums.=--It	NNP
50458	1228	6	is	be	VBZ
50458	1228	7	an	an	DT
50458	1228	8	almost	almost	RB
50458	1228	9	general	general	JJ
50458	1228	10	fact	fact	NN
50458	1228	11	that	that	IN
50458	1228	12	the	the	DT
50458	1228	13	blood	blood	NN
50458	1228	14	and	and	CC
50458	1228	15	blood	blood	NN
50458	1228	16	serum	serum	NN
50458	1228	17	of	of	IN
50458	1228	18	batrachians	batrachian	NNS
50458	1228	19	,	,	,
50458	1228	20	eels	eel	NNS
50458	1228	21	,	,	,
50458	1228	22	lampreys	lamprey	NNS
50458	1228	23	,	,	,
50458	1228	24	snakes	snake	NNS
50458	1228	25	(	(	-LRB-
50458	1228	26	even	even	RB
50458	1228	27	non	non	JJ
50458	1228	28	-	-	JJ
50458	1228	29	poisonous	poisonous	JJ
50458	1228	30	ones	one	NNS
50458	1228	31	)	)	-RRB-
50458	1228	32	,	,	,
50458	1228	33	and	and	CC
50458	1228	34	hedgehogs	hedgehog	NNS
50458	1228	35	are	be	VBP
50458	1228	36	very	very	RB
50458	1228	37	poisonous	poisonous	JJ
50458	1228	38	.	.	.
50458	1229	1	Mosso	Mosso	NNP
50458	1229	2	has	have	VBZ
50458	1229	3	found	find	VBN
50458	1229	4	in	in	IN
50458	1229	5	the	the	DT
50458	1229	6	blood	blood	NN
50458	1229	7	serum	serum	NN
50458	1229	8	of	of	IN
50458	1229	9	the	the	DT
50458	1229	10	lamprey	lamprey	NNP
50458	1229	11	a	a	DT
50458	1229	12	toxin	toxin	NN
50458	1229	13	possessing	possess	VBG
50458	1229	14	a	a	DT
50458	1229	15	strong	strong	JJ
50458	1229	16	hemolytic	hemolytic	JJ
50458	1229	17	power	power	NN
50458	1229	18	,	,	,
50458	1229	19	and	and	CC
50458	1229	20	which	which	WDT
50458	1229	21	he	-PRON-	PRP
50458	1229	22	has	have	VBZ
50458	1229	23	named	name	VBN
50458	1229	24	_	_	NNP
50458	1229	25	ichthyotoxin	ichthyotoxin	NN
50458	1229	26	_	_	NNP
50458	1229	27	.	.	.
50458	1230	1	O.5	O.5	NNP
50458	1230	2	Cc	Cc	NNP
50458	1230	3	.	.	.
50458	1231	1	of	of	IN
50458	1231	2	this	this	DT
50458	1231	3	serum	serum	NN
50458	1231	4	injected	inject	VBN
50458	1231	5	into	into	IN
50458	1231	6	a	a	DT
50458	1231	7	dog	dog	NN
50458	1231	8	kills	kill	VBZ
50458	1231	9	it	-PRON-	PRP
50458	1231	10	in	in	IN
50458	1231	11	a	a	DT
50458	1231	12	few	few	JJ
50458	1231	13	minutes	minute	NNS
50458	1231	14	.	.	.
50458	1232	1	He	-PRON-	PRP
50458	1232	2	also	also	RB
50458	1232	3	observed	observe	VBD
50458	1232	4	,	,	,
50458	1232	5	in	in	IN
50458	1232	6	1888	1888	CD
50458	1232	7	,	,	,
50458	1232	8	that	that	IN
50458	1232	9	the	the	DT
50458	1232	10	blood	blood	NN
50458	1232	11	of	of	IN
50458	1232	12	the	the	DT
50458	1232	13	eel	eel	NN
50458	1232	14	,	,	,
50458	1232	15	in	in	IN
50458	1232	16	like	like	UH
50458	1232	17	dose	dose	NN
50458	1232	18	,	,	,
50458	1232	19	kills	kill	VBZ
50458	1232	20	a	a	DT
50458	1232	21	dog	dog	NN
50458	1232	22	almost	almost	RB
50458	1232	23	immediately	immediately	RB
50458	1232	24	,	,	,
50458	1232	25	and	and	CC
50458	1232	26	that	that	IN
50458	1232	27	the	the	DT
50458	1232	28	blood	blood	NN
50458	1232	29	contains	contain	VBZ
50458	1232	30	an	an	DT
50458	1232	31	ichthyotoxin	ichthyotoxin	NN
50458	1232	32	analogous	analogous	JJ
50458	1232	33	to	to	IN
50458	1232	34	that	that	DT
50458	1232	35	of	of	IN
50458	1232	36	the	the	DT
50458	1232	37	lamprey	lamprey	NN
50458	1232	38	.	.	.
50458	1233	1	This	this	DT
50458	1233	2	substance	substance	NN
50458	1233	3	,	,	,
50458	1233	4	which	which	WDT
50458	1233	5	appears	appear	VBZ
50458	1233	6	to	to	TO
50458	1233	7	be	be	VB
50458	1233	8	closely	closely	RB
50458	1233	9	allied	ally	VBN
50458	1233	10	to	to	IN
50458	1233	11	the	the	DT
50458	1233	12	sero	sero	NN
50458	1233	13	-	-	:
50458	1233	14	albumin	albumin	NN
50458	1233	15	of	of	IN
50458	1233	16	the	the	DT
50458	1233	17	blood	blood	NN
50458	1233	18	,	,	,
50458	1233	19	has	have	VBZ
50458	1233	20	a	a	DT
50458	1233	21	phosphorus	phosphorus	NN
50458	1233	22	-	-	HYPH
50458	1233	23	like	like	JJ
50458	1233	24	,	,	,
50458	1233	25	sharp	sharp	JJ
50458	1233	26	,	,	,
50458	1233	27	and	and	CC
50458	1233	28	burning	burn	VBG
50458	1233	29	taste	taste	NN
50458	1233	30	.	.	.
50458	1234	1	By	by	IN
50458	1234	2	digestion	digestion	NN
50458	1234	3	it	-PRON-	PRP
50458	1234	4	loses	lose	VBZ
50458	1234	5	its	-PRON-	PRP$
50458	1234	6	toxicity	toxicity	NN
50458	1234	7	,	,	,
50458	1234	8	as	as	RB
50458	1234	9	well	well	RB
50458	1234	10	as	as	IN
50458	1234	11	by	by	IN
50458	1234	12	heating	heating	NN
50458	1234	13	at	at	IN
50458	1234	14	68	68	CD
50458	1234	15	°	°	NNS
50458	1234	16	to	to	IN
50458	1234	17	70	70	CD
50458	1234	18	°	°	,
50458	1234	19	C.	C.	NNP
50458	1234	20	It	-PRON-	PRP
50458	1234	21	is	be	VBZ
50458	1234	22	easily	easily	RB
50458	1234	23	obtained	obtain	VBN
50458	1234	24	by	by	IN
50458	1234	25	precipitating	precipitate	VBG
50458	1234	26	with	with	IN
50458	1234	27	ammonium	ammonium	NN
50458	1234	28	sulphate	sulphate	VBP
50458	1234	29	the	the	DT
50458	1234	30	serum	serum	NN
50458	1234	31	of	of	IN
50458	1234	32	eels	eel	NNS
50458	1234	33	,	,	,
50458	1234	34	and	and	CC
50458	1234	35	dialyzing	dialyze	VBG
50458	1234	36	the	the	DT
50458	1234	37	precipitate	precipitate	NN
50458	1234	38	dissolved	dissolve	VBN
50458	1234	39	in	in	IN
50458	1234	40	water	water	NN
50458	1234	41	.	.	.
50458	1235	1	The	the	DT
50458	1235	2	power	power	NN
50458	1235	3	of	of	IN
50458	1235	4	this	this	DT
50458	1235	5	substance	substance	NN
50458	1235	6	is	be	VBZ
50458	1235	7	almost	almost	RB
50458	1235	8	as	as	RB
50458	1235	9	great	great	JJ
50458	1235	10	as	as	IN
50458	1235	11	that	that	DT
50458	1235	12	of	of	IN
50458	1235	13	the	the	DT
50458	1235	14	cobra	cobra	NN
50458	1235	15	poison	poison	NN
50458	1235	16	,	,	,
50458	1235	17	0.002	0.002	CD
50458	1235	18	Gm	Gm	NNP
50458	1235	19	.	.	.
50458	1236	1	being	be	VBG
50458	1236	2	instantly	instantly	RB
50458	1236	3	fatal	fatal	JJ
50458	1236	4	per	per	IN
50458	1236	5	kilo	kilo	NN
50458	1236	6	of	of	IN
50458	1236	7	dog	dog	NN
50458	1236	8	.	.	.
50458	1237	1	The	the	DT
50458	1237	2	blood	blood	NN
50458	1237	3	of	of	IN
50458	1237	4	snakes	snake	NNS
50458	1237	5	is	be	VBZ
50458	1237	6	likewise	likewise	RB
50458	1237	7	very	very	RB
50458	1237	8	toxic	toxic	JJ
50458	1237	9	;	;	:
50458	1237	10	the	the	DT
50458	1237	11	same	same	JJ
50458	1237	12	is	be	VBZ
50458	1237	13	true	true	JJ
50458	1237	14	of	of	IN
50458	1237	15	the	the	DT
50458	1237	16	blood	blood	NN
50458	1237	17	of	of	IN
50458	1237	18	the	the	DT
50458	1237	19	viper	viper	NN
50458	1237	20	,	,	,
50458	1237	21	as	as	IN
50458	1237	22	0.02	0.02	CD
50458	1237	23	Cc	Cc	NNP
50458	1237	24	.	.	.
50458	1238	1	will	will	MD
50458	1238	2	kill	kill	VB
50458	1238	3	a	a	DT
50458	1238	4	guinea	guinea	NN
50458	1238	5	-	-	HYPH
50458	1238	6	pig	pig	NN
50458	1238	7	in	in	IN
50458	1238	8	two	two	CD
50458	1238	9	hours	hour	NNS
50458	1238	10	.	.	.
50458	1239	1	All	all	PDT
50458	1239	2	these	these	DT
50458	1239	3	bloods	blood	NNS
50458	1239	4	lose	lose	VBP
50458	1239	5	their	-PRON-	PRP$
50458	1239	6	toxicity	toxicity	NN
50458	1239	7	when	when	WRB
50458	1239	8	heated	heat	VBN
50458	1239	9	above	above	IN
50458	1239	10	70	70	CD
50458	1239	11	°	°	,
50458	1239	12	C.	C.	NNP
50458	1239	13	The	the	DT
50458	1239	14	serum	serum	NN
50458	1239	15	of	of	IN
50458	1239	16	the	the	DT
50458	1239	17	hedgehog	hedgehog	NN
50458	1239	18	is	be	VBZ
50458	1239	19	peculiar	peculiar	JJ
50458	1239	20	in	in	IN
50458	1239	21	this	this	DT
50458	1239	22	respect	respect	NN
50458	1239	23	;	;	:
50458	1239	24	when	when	WRB
50458	1239	25	heated	heat	VBN
50458	1239	26	at	at	IN
50458	1239	27	38	38	CD
50458	1239	28	°	°	,
50458	1239	29	C.	C.	NNP
50458	1239	30	for	for	IN
50458	1239	31	fifteen	fifteen	CD
50458	1239	32	minutes	minute	NNS
50458	1239	33	it	-PRON-	PRP
50458	1239	34	loses	lose	VBZ
50458	1239	35	its	-PRON-	PRP$
50458	1239	36	toxicity	toxicity	NN
50458	1239	37	,	,	,
50458	1239	38	but	but	CC
50458	1239	39	it	-PRON-	PRP
50458	1239	40	then	then	RB
50458	1239	41	possesses	possess	VBZ
50458	1239	42	an	an	DT
50458	1239	43	immunizing	immunize	VBG
50458	1239	44	power	power	NN
50458	1239	45	against	against	IN
50458	1239	46	the	the	DT
50458	1239	47	poisons	poison	NNS
50458	1239	48	.	.	.
50458	1240	1	The	the	DT
50458	1240	2	subject	subject	JJ
50458	1240	3	possesses	possess	VBZ
50458	1240	4	great	great	JJ
50458	1240	5	interest	interest	NN
50458	1240	6	,	,	,
50458	1240	7	because	because	IN
50458	1240	8	it	-PRON-	PRP
50458	1240	9	was	be	VBD
50458	1240	10	in	in	IN
50458	1240	11	studying	study	VBG
50458	1240	12	these	these	DT
50458	1240	13	immunizing	immunize	VBG
50458	1240	14	properties	property	NNS
50458	1240	15	that	that	WDT
50458	1240	16	Camus	Camus	NNP
50458	1240	17	and	and	CC
50458	1240	18	Gley,[164	Gley,[164	NNP
50458	1240	19	]	]	-RRB-
50458	1240	20	and	and	CC
50458	1240	21	later	later	RB
50458	1240	22	on	on	IN
50458	1240	23	Kossel[165	Kossel[165	NNP
50458	1240	24	]	]	-RRB-
50458	1240	25	and	and	CC
50458	1240	26	Tchistowitch,[166	tchistowitch,[166	CD
50458	1240	27	]	]	-RRB-
50458	1240	28	discovered	discover	VBD
50458	1240	29	the	the	DT
50458	1240	30	first	first	JJ
50458	1240	31	anticytotoxin,[167	anticytotoxin,[167	NN
50458	1240	32	]	]	-RRB-
50458	1240	33	which	which	WDT
50458	1240	34	they	-PRON-	PRP
50458	1240	35	obtained	obtain	VBD
50458	1240	36	by	by	IN
50458	1240	37	treating	treat	VBG
50458	1240	38	the	the	DT
50458	1240	39	animals	animal	NNS
50458	1240	40	with	with	IN
50458	1240	41	increasing	increase	VBG
50458	1240	42	quantities	quantity	NNS
50458	1240	43	of	of	IN
50458	1240	44	the	the	DT
50458	1240	45	serum	serum	NN
50458	1240	46	of	of	IN
50458	1240	47	eels	eel	NNS
50458	1240	48	.	.	.
50458	1241	1	On	on	IN
50458	1241	2	mixing	mix	VBG
50458	1241	3	the	the	DT
50458	1241	4	antitoxic	antitoxic	NN
50458	1241	5	serum	serum	NN
50458	1241	6	of	of	IN
50458	1241	7	these	these	DT
50458	1241	8	animals	animal	NNS
50458	1241	9	_	_	NNP
50458	1241	10	in	in	IN
50458	1241	11	vitro	vitro	FW
50458	1241	12	_	_	NNP
50458	1241	13	with	with	IN
50458	1241	14	the	the	DT
50458	1241	15	red	red	JJ
50458	1241	16	blood	blood	NN
50458	1241	17	-	-	HYPH
50458	1241	18	corpuscles	corpuscle	NNS
50458	1241	19	of	of	IN
50458	1241	20	the	the	DT
50458	1241	21	species	specie	NNS
50458	1241	22	furnishing	furnish	VBG
50458	1241	23	the	the	DT
50458	1241	24	serum	serum	NN
50458	1241	25	and	and	CC
50458	1241	26	of	of	IN
50458	1241	27	the	the	DT
50458	1241	28	hemolytic	hemolytic	JJ
50458	1241	29	serum	serum	NN
50458	1241	30	of	of	IN
50458	1241	31	eels	eel	NNS
50458	1241	32	,	,	,
50458	1241	33	it	-PRON-	PRP
50458	1241	34	is	be	VBZ
50458	1241	35	found	find	VBN
50458	1241	36	that	that	IN
50458	1241	37	the	the	DT
50458	1241	38	blood	blood	NN
50458	1241	39	-	-	HYPH
50458	1241	40	corpuscles	corpuscle	NNS
50458	1241	41	kept	keep	VBD
50458	1241	42	quite	quite	RB
50458	1241	43	well	well	RB
50458	1241	44	.	.	.
50458	1242	1	[	[	-LRB-
50458	1242	2	164	164	CD
50458	1242	3	]	]	-RRB-
50458	1242	4	_	_	NNP
50458	1242	5	Archives	Archives	NNP
50458	1242	6	internat	internat	NN
50458	1242	7	.	.	.
50458	1243	1	de	de	NNP
50458	1243	2	Pharmacodynamie	Pharmacodynamie	NNP
50458	1243	3	_	_	NNP
50458	1243	4	,	,	,
50458	1243	5	III	III	NNP
50458	1243	6	and	and	CC
50458	1243	7	IV	IV	NNP
50458	1243	8	.	.	.
50458	1244	1	[	[	-LRB-
50458	1244	2	165	165	CD
50458	1244	3	]	]	-RRB-
50458	1244	4	_	_	NNP
50458	1244	5	Berliner	Berliner	NNP
50458	1244	6	Klin	Klin	NNP
50458	1244	7	.	.	.
50458	1245	1	Wochenschr	Wochenschr	NNP
50458	1245	2	.	.	.
50458	1245	3	_	_	NNP
50458	1245	4	,	,	,
50458	1245	5	1895	1895	CD
50458	1245	6	,	,	,
50458	1245	7	No	no	UH
50458	1245	8	.	.	.
50458	1246	1	7	7	LS
50458	1246	2	.	.	.
50458	1247	1	[	[	-LRB-
50458	1247	2	166	166	CD
50458	1247	3	]	]	-RRB-
50458	1247	4	_	_	NNP
50458	1247	5	Annal	Annal	NNP
50458	1247	6	.	.	.
50458	1248	1	de	de	NNP
50458	1248	2	l'Instit	l'Instit	NNP
50458	1248	3	.	.	.
50458	1249	1	Pasteur	Pasteur	NNP
50458	1249	2	_	_	NNP
50458	1249	3	,	,	,
50458	1249	4	XIII	XIII	NNP
50458	1249	5	,	,	,
50458	1249	6	p.	p.	NN
50458	1249	7	406	406	CD
50458	1249	8	.	.	.
50458	1250	1	[	[	-LRB-
50458	1250	2	167	167	CD
50458	1250	3	]	]	-RRB-
50458	1250	4	The	the	DT
50458	1250	5	name	name	NN
50458	1250	6	"	"	``
50458	1250	7	cytases	cytase	VBZ
50458	1250	8	"	"	''
50458	1250	9	or	or	CC
50458	1250	10	"	"	``
50458	1250	11	alexins	alexin	NNS
50458	1250	12	"	"	''
50458	1250	13	has	have	VBZ
50458	1250	14	been	be	VBN
50458	1250	15	given	give	VBN
50458	1250	16	to	to	IN
50458	1250	17	hemolyzing	hemolyzing	JJ
50458	1250	18	diastatic	diastatic	JJ
50458	1250	19	substances	substance	NNS
50458	1250	20	which	which	WDT
50458	1250	21	are	be	VBP
50458	1250	22	found	find	VBN
50458	1250	23	in	in	IN
50458	1250	24	certain	certain	JJ
50458	1250	25	serums	serum	NNS
50458	1250	26	.	.	.
50458	1251	1	It	-PRON-	PRP
50458	1251	2	has	have	VBZ
50458	1251	3	been	be	VBN
50458	1251	4	known	know	VBN
50458	1251	5	for	for	IN
50458	1251	6	a	a	DT
50458	1251	7	long	long	JJ
50458	1251	8	time	time	NN
50458	1251	9	that	that	IN
50458	1251	10	the	the	DT
50458	1251	11	serum	serum	NN
50458	1251	12	of	of	IN
50458	1251	13	the	the	DT
50458	1251	14	blood	blood	NN
50458	1251	15	of	of	IN
50458	1251	16	many	many	JJ
50458	1251	17	animals	animal	NNS
50458	1251	18	destroys	destroy	VBZ
50458	1251	19	the	the	DT
50458	1251	20	red	red	JJ
50458	1251	21	blood	blood	NN
50458	1251	22	-	-	HYPH
50458	1251	23	corpuscles	corpuscle	NNS
50458	1251	24	of	of	IN
50458	1251	25	other	other	JJ
50458	1251	26	and	and	CC
50458	1251	27	different	different	JJ
50458	1251	28	species	specie	NNS
50458	1251	29	.	.	.
50458	1252	1	The	the	DT
50458	1252	2	chemical	chemical	JJ
50458	1252	3	composition	composition	NN
50458	1252	4	of	of	IN
50458	1252	5	these	these	DT
50458	1252	6	cytases	cytase	NNS
50458	1252	7	or	or	CC
50458	1252	8	alexins	alexin	NNS
50458	1252	9	is	be	VBZ
50458	1252	10	not	not	RB
50458	1252	11	yet	yet	RB
50458	1252	12	definitely	definitely	RB
50458	1252	13	known	know	VBN
50458	1252	14	,	,	,
50458	1252	15	but	but	CC
50458	1252	16	the	the	DT
50458	1252	17	substances	substance	NNS
50458	1252	18	rank	rank	VBP
50458	1252	19	among	among	IN
50458	1252	20	the	the	DT
50458	1252	21	albuminoids	albuminoid	NNS
50458	1252	22	;	;	:
50458	1252	23	they	-PRON-	PRP
50458	1252	24	are	be	VBP
50458	1252	25	destroyed	destroy	VBN
50458	1252	26	by	by	IN
50458	1252	27	a	a	DT
50458	1252	28	temperature	temperature	NN
50458	1252	29	of	of	IN
50458	1252	30	55	55	CD
50458	1252	31	°	°	NNS
50458	1252	32	to	to	IN
50458	1252	33	56	56	CD
50458	1252	34	°	°	NNS
50458	1252	35	C.	C.	NNP
50458	1252	36	,	,	,
50458	1252	37	and	and	CC
50458	1252	38	act	act	VB
50458	1252	39	only	only	RB
50458	1252	40	in	in	IN
50458	1252	41	saline	saline	JJ
50458	1252	42	solutions	solution	NNS
50458	1252	43	(	(	-LRB-
50458	1252	44	Ehrlich	Ehrlich	NNP
50458	1252	45	and	and	CC
50458	1252	46	Morgenroth	Morgenroth	NNP
50458	1252	47	,	,	,
50458	1252	48	_	_	NNP
50458	1252	49	Berlin	Berlin	NNP
50458	1252	50	.	.	.
50458	1253	1	Klin	Klin	NNP
50458	1253	2	.	.	.
50458	1254	1	Woch	Woch	NNP
50458	1254	2	.	.	.
50458	1254	3	_	_	NNP
50458	1254	4	,	,	,
50458	1254	5	pp	pp	NNP
50458	1254	6	.	.	.
50458	1255	1	6	6	CD
50458	1255	2	and	and	CC
50458	1255	3	481	481	CD
50458	1255	4	)	)	-RRB-
50458	1255	5	.	.	.
50458	1256	1	The	the	DT
50458	1256	2	cytases	cytase	NNS
50458	1256	3	or	or	CC
50458	1256	4	alexins	alexin	NNS
50458	1256	5	,	,	,
50458	1256	6	which	which	WDT
50458	1256	7	will	will	MD
50458	1256	8	be	be	VB
50458	1256	9	studied	study	VBN
50458	1256	10	in	in	IN
50458	1256	11	another	another	DT
50458	1256	12	volume	volume	NN
50458	1256	13	of	of	IN
50458	1256	14	this	this	DT
50458	1256	15	collection	collection	NN
50458	1256	16	,	,	,
50458	1256	17	and	and	CC
50458	1256	18	which	which	WDT
50458	1256	19	will	will	MD
50458	1256	20	discuss	discuss	VB
50458	1256	21	the	the	DT
50458	1256	22	active	active	JJ
50458	1256	23	principles	principle	NNS
50458	1256	24	of	of	IN
50458	1256	25	the	the	DT
50458	1256	26	immunizing	immunize	VBG
50458	1256	27	serums	serum	NNS
50458	1256	28	,	,	,
50458	1256	29	constitute	constitute	VBP
50458	1256	30	one	one	CD
50458	1256	31	of	of	IN
50458	1256	32	the	the	DT
50458	1256	33	numerous	numerous	JJ
50458	1256	34	soluble	soluble	JJ
50458	1256	35	intraleucocytary	intraleucocytary	JJ
50458	1256	36	ferments	ferment	NNS
50458	1256	37	,	,	,
50458	1256	38	and	and	CC
50458	1256	39	they	-PRON-	PRP
50458	1256	40	pass	pass	VBP
50458	1256	41	into	into	IN
50458	1256	42	the	the	DT
50458	1256	43	serous	serous	JJ
50458	1256	44	liquids	liquid	NNS
50458	1256	45	of	of	IN
50458	1256	46	the	the	DT
50458	1256	47	organism	organism	NN
50458	1256	48	only	only	RB
50458	1256	49	as	as	IN
50458	1256	50	the	the	DT
50458	1256	51	result	result	NN
50458	1256	52	of	of	IN
50458	1256	53	a	a	DT
50458	1256	54	rupture	rupture	NN
50458	1256	55	of	of	IN
50458	1256	56	or	or	CC
50458	1256	57	injury	injury	NN
50458	1256	58	to	to	IN
50458	1256	59	the	the	DT
50458	1256	60	phagocytes	phagocyte	NNS
50458	1256	61	.	.	.
50458	1257	1	As	as	IN
50458	1257	2	to	to	IN
50458	1257	3	the	the	DT
50458	1257	4	blood	blood	NN
50458	1257	5	of	of	IN
50458	1257	6	the	the	DT
50458	1257	7	hedgehog	hedgehog	NN
50458	1257	8	,	,	,
50458	1257	9	we	-PRON-	PRP
50458	1257	10	have	have	VBP
50458	1257	11	already	already	RB
50458	1257	12	seen	see	VBN
50458	1257	13	that	that	IN
50458	1257	14	Physalix	Physalix	NNP
50458	1257	15	and	and	CC
50458	1257	16	Bertrand	Bertrand	NNP
50458	1257	17	have	have	VBP
50458	1257	18	shown	show	VBN
50458	1257	19	that	that	IN
50458	1257	20	it	-PRON-	PRP
50458	1257	21	may	may	MD
50458	1257	22	be	be	VB
50458	1257	23	a	a	DT
50458	1257	24	counter	counter	NN
50458	1257	25	-	-	NN
50458	1257	26	poison	poison	NN
50458	1257	27	towards	towards	IN
50458	1257	28	serpent	serpent	NN
50458	1257	29	-	-	HYPH
50458	1257	30	venom	venom	NN
50458	1257	31	under	under	IN
50458	1257	32	certain	certain	JJ
50458	1257	33	conditions	condition	NNS
50458	1257	34	.	.	.
50458	1258	1	In	in	IN
50458	1258	2	its	-PRON-	PRP$
50458	1258	3	normal	normal	JJ
50458	1258	4	condition	condition	NN
50458	1258	5	it	-PRON-	PRP
50458	1258	6	is	be	VBZ
50458	1258	7	highly	highly	RB
50458	1258	8	toxic	toxic	JJ
50458	1258	9	.	.	.
50458	1259	1	=	=	NFP
50458	1259	2	Poisonous	poisonous	JJ
50458	1259	3	Meats.=--It	Meats.=--It	NNP
50458	1259	4	is	be	VBZ
50458	1259	5	particularly	particularly	RB
50458	1259	6	among	among	IN
50458	1259	7	the	the	DT
50458	1259	8	fish	fish	NN
50458	1259	9	that	that	WDT
50458	1259	10	we	-PRON-	PRP
50458	1259	11	find	find	VBP
50458	1259	12	these	these	DT
50458	1259	13	normally	normally	RB
50458	1259	14	present	present	JJ
50458	1259	15	,	,	,
50458	1259	16	and	and	CC
50458	1259	17	it	-PRON-	PRP
50458	1259	18	is	be	VBZ
50458	1259	19	a	a	DT
50458	1259	20	singular	singular	JJ
50458	1259	21	fact	fact	NN
50458	1259	22	that	that	IN
50458	1259	23	,	,	,
50458	1259	24	for	for	IN
50458	1259	25	a	a	DT
50458	1259	26	given	give	VBN
50458	1259	27	species	species	NN
50458	1259	28	,	,	,
50458	1259	29	the	the	DT
50458	1259	30	toxicity	toxicity	NN
50458	1259	31	frequently	frequently	RB
50458	1259	32	depends	depend	VBZ
50458	1259	33	upon	upon	IN
50458	1259	34	the	the	DT
50458	1259	35	period	period	NN
50458	1259	36	of	of	IN
50458	1259	37	the	the	DT
50458	1259	38	year	year	NN
50458	1259	39	.	.	.
50458	1260	1	Thus	thus	RB
50458	1260	2	,	,	,
50458	1260	3	at	at	IN
50458	1260	4	the	the	DT
50458	1260	5	period	period	NN
50458	1260	6	of	of	IN
50458	1260	7	spawning	spawning	NN
50458	1260	8	,	,	,
50458	1260	9	certain	certain	JJ
50458	1260	10	fish	fish	NN
50458	1260	11	may	may	MD
50458	1260	12	be	be	VB
50458	1260	13	extremely	extremely	RB
50458	1260	14	poisonous	poisonous	JJ
50458	1260	15	,	,	,
50458	1260	16	or	or	CC
50458	1260	17	,	,	,
50458	1260	18	on	on	IN
50458	1260	19	the	the	DT
50458	1260	20	contrary	contrary	NN
50458	1260	21	,	,	,
50458	1260	22	may	may	MD
50458	1260	23	entirely	entirely	RB
50458	1260	24	cease	cease	VB
50458	1260	25	to	to	TO
50458	1260	26	be	be	VB
50458	1260	27	so	so	RB
50458	1260	28	.	.	.
50458	1261	1	The	the	DT
50458	1261	2	anchovy	anchovy	JJ
50458	1261	3	ballassa	ballassa	NN
50458	1261	4	from	from	IN
50458	1261	5	the	the	DT
50458	1261	6	shores	shore	NNS
50458	1261	7	of	of	IN
50458	1261	8	India	India	NNP
50458	1261	9	occasions	occasion	NNS
50458	1261	10	death	death	NN
50458	1261	11	even	even	RB
50458	1261	12	in	in	IN
50458	1261	13	very	very	RB
50458	1261	14	small	small	JJ
50458	1261	15	quantity	quantity	NN
50458	1261	16	;	;	:
50458	1261	17	the	the	DT
50458	1261	18	poisonous	poisonous	JJ
50458	1261	19	meltite	meltite	NN
50458	1261	20	of	of	IN
50458	1261	21	the	the	DT
50458	1261	22	same	same	JJ
50458	1261	23	seas	sea	NNS
50458	1261	24	causes	cause	VBZ
50458	1261	25	violent	violent	JJ
50458	1261	26	vomiting	vomiting	NN
50458	1261	27	;	;	:
50458	1261	28	the	the	DT
50458	1261	29	fugu	fugu	NNS
50458	1261	30	of	of	IN
50458	1261	31	the	the	DT
50458	1261	32	Japanese	japanese	JJ
50458	1261	33	seas	sea	NNS
50458	1261	34	possesses	possess	VBZ
50458	1261	35	an	an	DT
50458	1261	36	extreme	extreme	JJ
50458	1261	37	poisonousness	poisonousness	NN
50458	1261	38	at	at	IN
50458	1261	39	the	the	DT
50458	1261	40	spawning	spawning	NN
50458	1261	41	period	period	NN
50458	1261	42	,	,	,
50458	1261	43	while	while	IN
50458	1261	44	,	,	,
50458	1261	45	on	on	IN
50458	1261	46	the	the	DT
50458	1261	47	contrary	contrary	NN
50458	1261	48	,	,	,
50458	1261	49	it	-PRON-	PRP
50458	1261	50	is	be	VBZ
50458	1261	51	perfectly	perfectly	RB
50458	1261	52	innocuous	innocuous	JJ
50458	1261	53	at	at	IN
50458	1261	54	all	all	DT
50458	1261	55	other	other	JJ
50458	1261	56	periods	period	NNS
50458	1261	57	.	.	.
50458	1262	1	Numerous	numerous	JJ
50458	1262	2	cases	case	NNS
50458	1262	3	of	of	IN
50458	1262	4	poisoning	poisoning	NN
50458	1262	5	have	have	VBP
50458	1262	6	been	be	VBN
50458	1262	7	chronicled	chronicle	VBN
50458	1262	8	every	every	DT
50458	1262	9	year	year	NN
50458	1262	10	by	by	IN
50458	1262	11	the	the	DT
50458	1262	12	journals	journal	NNS
50458	1262	13	,	,	,
50458	1262	14	due	due	IN
50458	1262	15	to	to	IN
50458	1262	16	the	the	DT
50458	1262	17	ingestion	ingestion	NN
50458	1262	18	of	of	IN
50458	1262	19	mussels	mussel	NNS
50458	1262	20	;	;	:
50458	1262	21	in	in	IN
50458	1262	22	the	the	DT
50458	1262	23	flesh	flesh	NN
50458	1262	24	of	of	IN
50458	1262	25	these	these	DT
50458	1262	26	crustaceæ	crustaceæ	NN
50458	1262	27	is	be	VBZ
50458	1262	28	found	find	VBN
50458	1262	29	a	a	DT
50458	1262	30	dangerous	dangerous	JJ
50458	1262	31	toxin	toxin	NN
50458	1262	32	,	,	,
50458	1262	33	_	_	NNP
50458	1262	34	methylotoxin	methylotoxin	NNP
50458	1262	35	_	_	NNP
50458	1262	36	.	.	.
50458	1263	1	The	the	DT
50458	1263	2	flesh	flesh	NN
50458	1263	3	of	of	IN
50458	1263	4	oysters	oyster	NNS
50458	1263	5	is	be	VBZ
50458	1263	6	also	also	RB
50458	1263	7	unwholesome	unwholesome	JJ
50458	1263	8	at	at	IN
50458	1263	9	the	the	DT
50458	1263	10	spawning	spawning	NN
50458	1263	11	period	period	NN
50458	1263	12	.	.	.
50458	1264	1	The	the	DT
50458	1264	2	toxic	toxic	JJ
50458	1264	3	symptoms	symptom	NNS
50458	1264	4	caused	cause	VBN
50458	1264	5	by	by	IN
50458	1264	6	these	these	DT
50458	1264	7	animals	animal	NNS
50458	1264	8	become	become	VBP
50458	1264	9	apparent	apparent	JJ
50458	1264	10	in	in	IN
50458	1264	11	not	not	RB
50458	1264	12	less	less	JJR
50458	1264	13	than	than	IN
50458	1264	14	twenty	twenty	CD
50458	1264	15	-	-	HYPH
50458	1264	16	four	four	CD
50458	1264	17	hours	hour	NNS
50458	1264	18	after	after	IN
50458	1264	19	ingestion	ingestion	NN
50458	1264	20	.	.	.
50458	1265	1	The	the	DT
50458	1265	2	poisoning	poisoning	NN
50458	1265	3	due	due	IN
50458	1265	4	to	to	IN
50458	1265	5	these	these	DT
50458	1265	6	fresh	fresh	JJ
50458	1265	7	meats	meat	NNS
50458	1265	8	must	must	MD
50458	1265	9	not	not	RB
50458	1265	10	,	,	,
50458	1265	11	however	however	RB
50458	1265	12	,	,	,
50458	1265	13	be	be	VB
50458	1265	14	confounded	confound	VBN
50458	1265	15	with	with	IN
50458	1265	16	that	that	DT
50458	1265	17	caused	cause	VBN
50458	1265	18	by	by	IN
50458	1265	19	tainted	tainted	JJ
50458	1265	20	or	or	CC
50458	1265	21	spoiled	spoil	VBN
50458	1265	22	meats	meat	NNS
50458	1265	23	.	.	.
50458	1266	1	WORKS	WORKS	NNP
50458	1266	2	OF	of	IN
50458	1266	3	ALFRED	ALFRED	NNP
50458	1266	4	I.	i.	NN
50458	1266	5	COHN	cohn	NN
50458	1266	6	PUBLISHED	publish	VBN
50458	1266	7	BY	by	IN
50458	1266	8	JOHN	JOHN	NNP
50458	1266	9	WILEY	WILEY	NNP
50458	1266	10	&	&	CC
50458	1266	11	SONS	SONS	NNP
50458	1266	12	.	.	.
50458	1267	1	=	=	NFP
50458	1267	2	Indicators	Indicators	NNP
50458	1267	3	and	and	CC
50458	1267	4	Test	Test	NNP
50458	1267	5	-	-	HYPH
50458	1267	6	papers.=	papers.=	NNP
50458	1267	7	Their	-PRON-	PRP$
50458	1267	8	Source	Source	NNP
50458	1267	9	,	,	,
50458	1267	10	Preparation	Preparation	NNP
50458	1267	11	,	,	,
50458	1267	12	Application	Application	NNP
50458	1267	13	,	,	,
50458	1267	14	and	and	CC
50458	1267	15	Tests	Tests	NNPS
50458	1267	16	for	for	IN
50458	1267	17	Sensitiveness	Sensitiveness	NNP
50458	1267	18	.	.	.
50458	1268	1	With	with	IN
50458	1268	2	Tabular	Tabular	NNP
50458	1268	3	Summary	Summary	NNP
50458	1268	4	of	of	IN
50458	1268	5	the	the	DT
50458	1268	6	Application	Application	NNP
50458	1268	7	of	of	IN
50458	1268	8	Indicators	Indicators	NNPS
50458	1268	9	.	.	.
50458	1269	1	Second	Second	NNP
50458	1269	2	Edition	Edition	NNP
50458	1269	3	,	,	,
50458	1269	4	Revised	Revised	NNP
50458	1269	5	and	and	CC
50458	1269	6	Enlarged	Enlarged	NNP
50458	1269	7	.	.	.
50458	1270	1	12mo	12mo	JJ
50458	1270	2	,	,	,
50458	1270	3	ix	ix	NN
50458	1270	4	+	+	CC
50458	1270	5	267	267	CD
50458	1270	6	pages	page	NNS
50458	1270	7	.	.	.
50458	1271	1	Cloth	cloth	NN
50458	1271	2	,	,	,
50458	1271	3	$	$	$
50458	1271	4	2.00	2.00	CD
50458	1271	5	.	.	.
50458	1272	1	=	=	NFP
50458	1272	2	Tests	test	NNS
50458	1272	3	and	and	CC
50458	1272	4	Reagents.=	Reagents.=	NNP
50458	1272	5	Chemical	Chemical	NNP
50458	1272	6	and	and	CC
50458	1272	7	Microscopical	Microscopical	NNP
50458	1272	8	,	,	,
50458	1272	9	known	know	VBN
50458	1272	10	by	by	IN
50458	1272	11	their	-PRON-	PRP$
50458	1272	12	Authors	author	NNS
50458	1272	13	'	'	POS
50458	1272	14	Names	name	NNS
50458	1272	15	;	;	:
50458	1272	16	together	together	RB
50458	1272	17	with	with	IN
50458	1272	18	an	an	DT
50458	1272	19	Index	Index	NNP
50458	1272	20	of	of	IN
50458	1272	21	Subjects	Subjects	NNPS
50458	1272	22	.	.	.
50458	1273	1	8vo	8vo	NNP
50458	1273	2	,	,	,
50458	1273	3	iii	iii	CD
50458	1273	4	+	+	SYM
50458	1273	5	383	383	CD
50458	1273	6	pages	page	NNS
50458	1273	7	.	.	.
50458	1274	1	Cloth	cloth	NN
50458	1274	2	,	,	,
50458	1274	3	$	$	$
50458	1274	4	3.00	3.00	CD
50458	1274	5	.	.	.
50458	1275	1	_	_	NNP
50458	1275	2	TRANSLATIONS	TRANSLATIONS	NNP
50458	1275	3	.	.	.
50458	1275	4	_	_	NNP
50458	1275	5	=	=	SYM
50458	1275	6	Fresenius	Fresenius	NNP
50458	1275	7	's	's	POS
50458	1275	8	Quantitative	Quantitative	NNP
50458	1275	9	Chemical	Chemical	NNP
50458	1275	10	Analysis.=	Analysis.=	NNP
50458	1275	11	New	New	NNP
50458	1275	12	Authorized	Authorized	NNP
50458	1275	13	Translation	Translation	NNP
50458	1275	14	of	of	IN
50458	1275	15	the	the	DT
50458	1275	16	latest	late	JJS
50458	1275	17	German	German	NNP
50458	1275	18	Edition	Edition	NNP
50458	1275	19	.	.	.
50458	1276	1	In	in	IN
50458	1276	2	two	two	CD
50458	1276	3	volumes	volume	NNS
50458	1276	4	.	.	.
50458	1277	1	By	by	IN
50458	1277	2	Alfred	Alfred	NNP
50458	1277	3	I.	I.	NNP
50458	1277	4	Cohn	Cohn	NNP
50458	1277	5	,	,	,
50458	1277	6	Phar	Phar	NNP
50458	1277	7	.	.	.
50458	1277	8	D.	D.	NNP
50458	1278	1	Recalculated	recalculate	VBN
50458	1278	2	on	on	IN
50458	1278	3	the	the	DT
50458	1278	4	basis	basis	NN
50458	1278	5	of	of	IN
50458	1278	6	the	the	DT
50458	1278	7	latest	late	JJS
50458	1278	8	atomic	atomic	JJ
50458	1278	9	weights	weight	NNS
50458	1278	10	,	,	,
50458	1278	11	and	and	CC
50458	1278	12	also	also	RB
50458	1278	13	greatly	greatly	RB
50458	1278	14	amplified	amplify	VBN
50458	1278	15	by	by	IN
50458	1278	16	the	the	DT
50458	1278	17	translator	translator	NN
50458	1278	18	.	.	.
50458	1279	1	8vo	8vo	JJ
50458	1279	2	,	,	,
50458	1279	3	2	2	CD
50458	1279	4	vols	vol	NNS
50458	1279	5	.	.	.
50458	1279	6	,	,	,
50458	1279	7	upwards	upward	NNS
50458	1279	8	of	of	IN
50458	1279	9	2000	2000	CD
50458	1279	10	pages	page	NNS
50458	1279	11	,	,	,
50458	1279	12	280	280	CD
50458	1279	13	figures	figure	NNS
50458	1279	14	.	.	.
50458	1280	1	Cloth	Cloth	NNP
50458	1280	2	,	,	,
50458	1280	3	$	$	$
50458	1280	4	12.50	12.50	CD
50458	1280	5	.	.	.
50458	1281	1	=	=	NFP
50458	1281	2	Techno	Techno	NNP
50458	1281	3	-	-	HYPH
50458	1281	4	Chemical	Chemical	NNP
50458	1281	5	Analysis.=	Analysis.=	NNP
50458	1281	6	By	by	IN
50458	1281	7	Dr.	Dr.	NNP
50458	1281	8	G.	G.	NNP
50458	1281	9	LUNGE	LUNGE	NNP
50458	1281	10	,	,	,
50458	1281	11	Professor	Professor	NNP
50458	1281	12	at	at	IN
50458	1281	13	the	the	DT
50458	1281	14	Eidgenössische	Eidgenössische	NNP
50458	1281	15	Polytechnische	Polytechnische	NNP
50458	1281	16	Schule	Schule	NNP
50458	1281	17	,	,	,
50458	1281	18	Zurich	Zurich	NNP
50458	1281	19	.	.	.
50458	1282	1	Authorized	authorized	JJ
50458	1282	2	Translation	translation	NN
50458	1282	3	by	by	IN
50458	1282	4	Alfred	Alfred	NNP
50458	1282	5	I.	I.	NNP
50458	1282	6	Cohn	Cohn	NNP
50458	1282	7	,	,	,
50458	1282	8	Phar	Phar	NNP
50458	1282	9	.	.	.
50458	1282	10	D.	D.	NNP
50458	1283	1	12mo	12mo	JJ
50458	1283	2	,	,	,
50458	1283	3	vii	vii	NN
50458	1283	4	+	+	SYM
50458	1283	5	136	136	CD
50458	1283	6	pages	page	NNS
50458	1283	7	,	,	,
50458	1283	8	16	16	CD
50458	1283	9	figures	figure	NNS
50458	1283	10	.	.	.
50458	1284	1	Cloth	cloth	NN
50458	1284	2	,	,	,
50458	1284	3	$	$	$
50458	1284	4	1.00	1.00	CD
50458	1284	5	.	.	.
50458	1285	1	=	=	NFP
50458	1285	2	Toxins	Toxins	NNP
50458	1285	3	and	and	CC
50458	1285	4	Venoms	venom	NNS
50458	1285	5	and	and	CC
50458	1285	6	Their	-PRON-	PRP$
50458	1285	7	Antibodies.=	antibodies.=	NN
50458	1285	8	By	by	IN
50458	1285	9	EM	em	NN
50458	1285	10	.	.	.
50458	1286	1	POZZI	POZZI	NNP
50458	1286	2	-	-	HYPH
50458	1286	3	ESCOT	ESCOT	NNP
50458	1286	4	.	.	.
50458	1287	1	Authorized	authorized	JJ
50458	1287	2	Translation	translation	NN
50458	1287	3	by	by	IN
50458	1287	4	Alfred	Alfred	NNP
50458	1287	5	I.	I.	NNP
50458	1287	6	Cohn	Cohn	NNP
50458	1287	7	,	,	,
50458	1287	8	Phar	Phar	NNP
50458	1287	9	.	.	.
50458	1287	10	D.	D.	NNP
50458	1288	1	12mo	12mo	JJ
50458	1288	2	,	,	,
50458	1288	3	vii	vii	NN
50458	1288	4	+	+	SYM
50458	1288	5	101	101	CD
50458	1288	6	pages	page	NNS
50458	1288	7	.	.	.
50458	1289	1	Cloth	cloth	NN
50458	1289	2	,	,	,
50458	1289	3	$	$	$
50458	1289	4	1.00	1.00	CD
50458	1289	5	,	,	,
50458	1289	6	_	_	NNP
50458	1289	7	net	net	NN
50458	1289	8	_	_	NNP
50458	1289	9	.	.	.
50458	1290	1	Transcriber	Transcriber	NNP
50458	1290	2	's	's	POS
50458	1290	3	Notes	Notes	NNP
50458	1290	4	Obvious	obvious	JJ
50458	1290	5	typographical	typographical	JJ
50458	1290	6	errors	error	NNS
50458	1290	7	have	have	VBP
50458	1290	8	been	be	VBN
50458	1290	9	silently	silently	RB
50458	1290	10	corrected	correct	VBN
50458	1290	11	,	,	,
50458	1290	12	but	but	CC
50458	1290	13	all	all	DT
50458	1290	14	other	other	JJ
50458	1290	15	variations	variation	NNS
50458	1290	16	in	in	IN
50458	1290	17	spelling	spelling	NN
50458	1290	18	,	,	,
50458	1290	19	punctuation	punctuation	NN
50458	1290	20	and	and	CC
50458	1290	21	accents	accent	NNS
50458	1290	22	are	be	VBP
50458	1290	23	as	as	IN
50458	1290	24	in	in	IN
50458	1290	25	the	the	DT
50458	1290	26	original	original	JJ
50458	1290	27	,	,	,
50458	1290	28	with	with	IN
50458	1290	29	the	the	DT
50458	1290	30	exception	exception	NN
50458	1290	31	of	of	IN
50458	1290	32	Symptomatology	Symptomatology	NNP
50458	1290	33	(	(	-LRB-
50458	1290	34	in	in	IN
50458	1290	35	the	the	DT
50458	1290	36	contents	content	NNS
50458	1290	37	list	list	NN
50458	1290	38	)	)	-RRB-
50458	1290	39	and	and	CC
50458	1290	40	symptomology	symptomology	NN
50458	1290	41	(	(	-LRB-
50458	1290	42	in	in	IN
50458	1290	43	the	the	DT
50458	1290	44	text	text	NN
50458	1290	45	)	)	-RRB-
50458	1290	46	which	which	WDT
50458	1290	47	has	have	VBZ
50458	1290	48	been	be	VBN
50458	1290	49	corrected	correct	VBN
50458	1290	50	to	to	IN
50458	1290	51	symptomatology	symptomatology	NN
50458	1290	52	.	.	.
50458	1291	1	Variations	variation	NNS
50458	1291	2	between	between	IN
50458	1291	3	the	the	DT
50458	1291	4	treatment	treatment	NN
50458	1291	5	and	and	CC
50458	1291	6	phrasing	phrasing	NN
50458	1291	7	of	of	IN
50458	1291	8	headings	heading	NNS
50458	1291	9	in	in	IN
50458	1291	10	the	the	DT
50458	1291	11	table	table	NN
50458	1291	12	of	of	IN
50458	1291	13	contents	content	NNS
50458	1291	14	and	and	CC
50458	1291	15	in	in	IN
50458	1291	16	the	the	DT
50458	1291	17	text	text	NN
50458	1291	18	have	have	VBP
50458	1291	19	not	not	RB
50458	1291	20	been	be	VBN
50458	1291	21	changed	change	VBN
50458	1291	22	.	.	.
50458	1292	1	Italics	italic	NNS
50458	1292	2	are	be	VBP
50458	1292	3	represent	represent	NN
50458	1292	4	thus	thus	RB
50458	1292	5	_	_	NNP
50458	1292	6	italic	italic	JJ
50458	1292	7	_	_	NNP
50458	1292	8	and	and	CC
50458	1292	9	bold	bold	JJ
50458	1292	10	thus	thus	RB
50458	1292	11	=	=	VBZ
50458	1292	12	bold=.	bold=.	.
50458	1293	1	Subscripts	subscript	NNS
50458	1293	2	are	be	VBP
50458	1293	3	represented	represent	VBN
50458	1293	4	thus	thus	RB
50458	1293	5	{	{	-LRB-
50458	1293	6	2	2	CD
50458	1293	7	}	}	-RRB-
50458	1293	8	The	the	DT
50458	1293	9	book	book	NN
50458	1293	10	begins	begin	VBZ
50458	1293	11	with	with	IN
50458	1293	12	a	a	DT
50458	1293	13	page	page	NN
50458	1293	14	of	of	IN
50458	1293	15	adverts	advert	NNS
50458	1293	16	for	for	IN
50458	1293	17	works	work	NNS
50458	1293	18	by	by	IN
50458	1293	19	the	the	DT
50458	1293	20	translator	translator	NN
50458	1293	21	,	,	,
50458	1293	22	this	this	DT
50458	1293	23	has	have	VBZ
50458	1293	24	been	be	VBN
50458	1293	25	moved	move	VBN
50458	1293	26	to	to	IN
50458	1293	27	the	the	DT
50458	1293	28	end	end	NN
50458	1293	29	.	.	.